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Homoallylic amines and alcohols, particularly those amenable to further functionalization, 
are among the most widely used building blocks in chemical synthesis and are typically accessed 
by addition of an allyl-metal compound to an electrophile. Studies discussed herein have focused 
on advancing stereoselective synthesis of versatile allylboron compounds and their utilization in 
catalytic regio-, diastereo-, and enantioselective addition to various electrophiles. Mechanistic 
principles have been central to the investigations described in this thesis, and it has been on this 
basis that catalytic strategies for practical synthesis of bioactive molecules were developed.  
Chapter One. Vicinal amino alcohols are ubiquitous in natural products and serve as versatile 
synthetic intermediates and we envisaged that diastereo- and enantioselective additions of O-
substituted allyl boronates offers an attractive option to access these motifs. In the presence of zinc 
(II) methoxide as co-catalyst, it will be demonstrated that sequence of events may occur, wherein 
isomerization of an initially formed allyl complex occurs prior to addition of an aldimine with 
kinetic selectivity. As will be described, through the use of an optimal catalyst, N-
protecting/activating group and appropriate reaction conditions, differentially protected vicinal 
amino alcohol derivatives may be synthesized in high enantiopurity. The utility of the approach is 
highlighted through synthesis of an NK1 agonist.  
Chapter Two. It will be demonstrated that additions of various organoboron compounds converts 
readily accessible and easy-to-handle silyl-substituted a-tertiary amines. Contrary to additions to 
aldimines, isomerization of the initially generated aminophenol-allyl complex is preempted, such
	  
that linear products are favored. DFT analysis suggests that high enantioselectivity likely 
originates from attractive electrostatic interaction between a trifluoromethyl group and the 
catalyst’s ammonium moiety. The synthetic utility was highlighted through concise, 
enantioselective synthesis of a key intermediate of a recently reported BACE-1 inhibitor on gram 
scale. 
Chapter Three. This section details the development of a method for direct synthesis of 
homoallylic alcohols bearing a Z-alkenyl chloride, which may be directly subjected to stereo-
retentive cross coupling without wasteful protection/deprotection or redox operations. Products 
were obtained in high regio- and enantioselectivity for aliphatic, alkenyl- and heteroaryl-
substituted aldehydes. The approach was utilized in a concise, protecting group-free synthesis of 
anti-tumor agent mycothiazole.  
Chapter Four. A method for stereoselective synthesis of fluorine-containing trisubstituted allyl 
boronates will be presented. It will then be illustrated that in the presence of an appropriate 
aminophenol catalyst, a large assortment of homoallylic alcohols containing a quaternary fluoro- 
and trifluoromethyl-substituted stereogenic center may be obtained with efficiency and high 
diastereo- and enantioselectivity. The obtained products were then elaborated to the furanose core 
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Chapter One 
Diastereo- and Enantioselective Synthesis of Amino Alcohols and 
Derivatives 
1.1 Introduction 
The predictable and high diastereoselectivity in which substituted allyl metal reagents add 
to electrophiles is an effective strategy for generating vicinal stereogenic centers, especially in 
acyclic systems.1 Models for stereoselective addition, delineated as Type I, II, and III by Denmark2 
and Seebach,3 account for stereochemical outcome based upon the identity of the crotyl-metal 
reagent.  
Type I additions are proposed to proceed through a closed, six-membered transition state 
where Z- and E-substituted reagents afford cis- and trans-configured products. Additions classified 
as Type II afford syn diastereomer, regardless of the initial stereochemistry of the allyl reagent, 
owing to a favorable orientation of the crotyl metal compound’s substituent and the Lewis acid 
such that steric pressure is minimized (Scheme 1.1b). Type III additions involve crotyl-metal 
speciess (typically Cr-, Li-, Ti- or Zn-based) with the ability to equilibrate to the more 




1) For a recent review regarding enantioselective addition of allyl nucleophiles to carbonyl compounds and imines, 
see: Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774–7854. For a recent review on 
diastereoselective methods for these transformations, see: Yus, M. González-Gómez, J. C.; Foubelo, F. Chem. Rev. 
2013, 113, 5595–5698. 
2) Denmark, S. E.; Weber, E. J. Helv. Chim. Acta. 1983, 66, 1655–1660. 
3) Seebach, D.; Prelog, V. Angew. Chem. Int. Ed. 1982, 21, 654–660. 
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Scheme 1.1. Classification of Crotyl-Metal Additions to Carbonyl Compounds and Imines 
 
1.2 Background 
1.2.1 Highlights of the State-of-the-Art for Additions to Imines 
 Enantiomerically enriched homoallylic amines, which serve as valuable synthetic 
intermediates en route to many bioactive molecules and natural products, may be accessed by 
addition of substituted allyl metal compounds to imines.4 Despite major advances, the available 
methods are typically limited to additions to enantiomerically pure N-tert-butylsulfinyl imines 
1.1,5 or to those derived from amino alcohol auxiliaries, such as 1.4 (Scheme 1.2a).6  
																																																								
4) Kobayashi, S.; Mori, Y.; Fossey, J. S.; Salter, M. M. Chem. Rev. 2011, 111, 2626–2704. 
5) Reddy, L. R.; Bin, H.; Prashad, M.; Prashad, K. Org. Lett. 2008, 10, 3109–3112. 
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Scheme 1.2. Representative Additions of Crotyl Metal Reagents to Imines 
 
Leighton and co-workers have developed strain-release strategies for synthesis of 
enantiomerically pure allyl-substituted silacycles 1.8 to N-aryl or N-benzyl imines. Each 
diastereomer may be accessed through modification of the N-protecting group of 1.7. However, 
the method is limited to aryl-substituted silacycles.7 In follow up studies, Leighton et al. expanded 
the method’s scope to include alkyl-substituted imines and other allyl silanes.8 Still, unmasking 
the NH2 amine required strongly reducing conditions (Pd(OH)2/C, ammonium carbonate), 
resulting in concomitant reduction of the olefin.9 
																																																								
7) Huber, J. D.; Leighton, J. L. J. Am. Chem. Soc. 2007, 129, 14552–14553. 
8) Huber, J. D.; Perl, N. R.; Leighton, J. L. Angew. Chem. Int. Ed. 2008, 47, 3037–3039. 
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thf
–78 °C, 8 h
(Taddei et al., Ref. 6)
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 In addition to reactions involving enantiomerically pure imines or reagents, there are a 
handful of reports detailing strategies for additions with alkyl-substituted stannanes,10 silanes,11 
indium-based compounds,12 and boronates13 to aldimines, generating products bearing vicinal 
stereogenic centers diastereo- and enantioselectively. Two examples of this class are highlighted 
in Scheme 1.3. 
 
Scheme 1.3. Catalytic Enantioselective Addition of Allyl Boronates to Imines 
 
																																																								
10) (a) Fang, X.; Johannsen, M.; Yao, S.; Gathergood, N.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 1999, 64, 
4844–4849. (b) Gastner, T.; Ishitani, H.; Akiyama, R.; Kobayashi, S. Angew. Chem. Int. Ed. 2001, 40, 1896–1898.  
11) (a) Naodovic, M.; Wadamoto, M.; Yamamoto, H. Eur. J. Org. Chem. 2009, 30, 5129–5131. (b) Momiyama, N.; 
Nishimoto, H.; Terada, M. Org. Lett. 2011, 13, 2126–2129. 
12) Tian, K. L.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2007, 46, 1315–1317. 
13) (a) Lou, S.; Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2007, 129, 15398–15404. (b) Fujita, M.; Nagano, T.; 
Schneider, U.; Hamada, T.; Ogawa, C.; Kobayashi, S. J. Am. Chem. Soc. 2008, 130, 2914–2915. (c) Luo, Y.; Hepburn, 
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98:2 d.r, >98:2 er
a. Kobayashi’s indium catalyzed additions to hydrazones
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In 2010, Kobayashi outlined a strategy for indium(I)-catalyzed additions of racemic a-
substituted allyl boronic pinacol ester 1.12 to aryl- and heteroaryl-substituted hydrazones 1.11 
(Scheme 1.3a), furnishing products 1.14 in 83–98% yield, 87:5–95:5 dr, and 92:8–96.5:3.5 er.14 
Unfortunately, neither additions to aliphatic hydrazones nor unmasking the amine were addressed. 
In a related report involving additions of organoboron compounds, Schaus disclosed a method for 
addition of the air- and moisture-sensitive E-crotyl allyl boronate 1.16 to N-acyl aldimine 1.15 
affording trans-homoallylic amide 1.18 as a single diastereomer and in >98:2 er. The scope of the 
approach was not expanded further, however. Under the same conditions, the Z isomer of 1.16 
afforded the same product 1.18 in 98:2 dr and 94:6 er. 
 We reasoned that a more broadly applicable and versatile catalytic approach would 
constitute a valuable addition to the state-of-the-art, and thus became interested in additions of 
heteroatom-substituted allyl boronates. We were particularly keen on developing additions with 
O-substituted allyl boronates, as such transformations would provide access to differentially 
protected 1,2-aminoalcohols and derivatives.  
 
1.2.2 Methods for Synthesis of Amino Alcohols 
Vicinal amino alcohols are prevalent in many bioactive compounds (Scheme 1.4),15 serve 
as chiral auxillaries16 for diastereoselective synthesis, and are employed as ligands to promote 
																																																								
14) Chakrabarti, A.; Konishi, H.; Yamaguchi, M.; Schneider, U.; Kobayashi, S. Angew. Chem. Int. Ed. 2010, 49, 
1838–1841. 
15) For synthesis and bioactivity of cytoxazone, see: Lingamurthy, M.; Nallibonia, G. R.; Rao, M. W.; Rao, B. V.; 
Reddy, B. S.; Kumar, H. M. S. Tetrahedron 2017, 73, 1473–1481. For synthesis and bioactivity of hapalosin, see: 
Okuno, T.; Ohmori, K.; Nishiyama, S.; Yamamura, S. Tetrahedron, 1996, 52, 14723–14734. For synthesis od 
indolizine and pyrrolizidine alkaloids deoxyallonojirimycin and castanospermine, see: Michael, J. P.; Nat. Prod. Rep. 
2008, 25, 139–165 and references therein. For synthesis of homopumiliotoxion 223G, see: Tokuyama, T.; Nishimori, 
N.; Shimada, A.; Edwards, M. W.; Daly, J. W. Tetrahedron 1987, 43, 643–652. (b) Kibayashi, C.; Aoyagi, S.; Wang, 
T.-C.; Saito, K.; Daly, J. W.; Spande, T. F. J. Nat. Prod. 2000, 63, 1157–1159. 
16) Lait, S. M.; Rankic, D. A.; Keay, B. A. Chem. Rev. 2007, 107, 767–796. 
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catalytic transformations.17 As a result, considerable effort has been directed towards 
development of methods that afford these structural motifs.18  
 




 Among the strategies developed for enantioselective synthesis of vicinal amino alcohol 
derivatives, are those involving addition of oxygen-substituted enolates to imines.19 In an early 
report, Kobayashi and co-workers disclosed enantioselective addition of silyl ketene acetal 1.20 to 
N-aryl substituted imine 1.19 promoted by zinc-based binapthol complex 1.21, furnishing products 
1.22 in 41–98% yield, 68:32–94:6 dr and 88:12–98:2 er (Scheme 1.5a).20 The scope was limited 
to aryl imines, and three steps were required to unmask the amine, including alkylation of the 
phenol and subsequent oxidation with ceric ammonium nitrate (CAN). In 2004, Shibasaki outlined 
an approach regarding diastereo- and enantioselective synthesis of a-hydroxy-b-amino ketones 
1.26 through addition of an in situ generated enolate to phosphinoyl imine 1.23 (Scheme 1.5b).  
																																																								
17) Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96, 835–876. 
18) For a recent review, see: Bergmeier, S. C. Tetrahedron, 2000, 56, 2561–2576. (b) Karjalainen, O. K.; Koskinen, 
A. M. P. Org. Biomol. Chem. 2012, 10, 4311–4326. 
19) Trost, B. M.; Terrell, L. R. J. Am. Chem. Soc. 2002, 125, 338–339. Wu, C.; Fu, X.; Li, S. Tetrahedron: Asymmetry 
2011, 22, 1063–1073. 
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Transformations were promoted by binapthol-Zn complex 1.25,21 and either diastereomer 
may be accessed by this method. Nonetheless, only o-methoxyketone 1.24 can be used as the 
nucleophilic precursor. In related account, Trost has detailed the application of zinc-based 
prophenol complexes for highly enantioselective, but minimally diastereoselective, additions to 
the same class of imines.22 In 2006, Barbas and co-workers showed that Mannich reactions of 
																																																								
21) Matsunaga, S.; Yoshida, T.; Morimoto, H.; Kumagai, N.; Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 8777–8785. 




































3Å MS, thf/CH2Cl2, 
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a. Zn-Binapthol promoted addition of ketene acetals




























c. Mannich-type addition of hydroxy-substituted ketones
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benzyl-substituted a-hydroxy ketones 1.29 to in-situ generated aryl imines can be catalyzed by 20 
mol % of a readily available amino acid (Scheme 1.5c).23  
Another relevant strategy entails reductive coupling of imines and aldehydes,24 typically 
promoted by stoichiometric quantities of SmI2, and accompanied by formation of side products 
derived from homocoupling or reduction. Recently, a method has been disclosed for 
intramolecular coupling for enantioselective synthesis of a limited set of amino alcohols and 
derivatives, wherein two catalysts, one to serve as a photosensitizer and the other, a chiral 
phosphoric acid, promotes enantioselective C–C bond formation.25 Huang has introduced a more 
generally applicable strategy for reductive coupling of aromatic aldehydes 1.34 and nitrones 1.33 
(Scheme 1.6). Reactions proceed through single electron transfer (SET) to the aldehyde, followed 
by C–C bond formation facilitated by Sc-based chiral complex 1.35.26  
 
Scheme 1.6. Catalytic Reductive Coupling of Nitrones and Aldehydes 
 
																																																								
23) Ramasastry, S. S. V.; Zhang, H.; Tanaka, F.; Barbas, C. F. J. Am. Chem. Soc. 2006, 129, 288–289. 
24) (a) Masson, G.; Py, S.; Vallée, Y. Angew. Chem. Int. Ed. 2002, 41, 1772–1775. (b) Zhong, Y.-W.; Dong, Y.-Z.; 
Fang, K.; Izumi, K.; Xu, M.-H.; Lin, G.-Q. J. Am. Chem. Soc. 2005, 127, 11956–11957. (c) Burchak, O. N.; Py, S. 
Tetrahedron 2009, 65, 7333–7356. (d) Wang, B.; Wang, Y.-J. Org. Lett. 2009, 11, 3410–3413.  
25) Rono, L. J.; Yayla, H. G.; Wang, D. Y.; Armstrong, M. F.; Knowles, R. R. J. Am. Chem. Soc. 2013, 135, 17735–
17738. 
26) Ye, C.-X.; Melcamu, Y. Y.; Li, H.-H.; Cheng, J.-T.; Zhang, T.-T.; Ruan, Y.-P.; Zheng, X.; Lu, X.; Huang, P.-Q. 




2.0 mol % Ru(bpy)3(PF6)2
15 mol % Sc(OTf)3
4.0 equiv teeda
1,2-dichloroethane, 65 W CFL
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Catalytic enantioselective strategies for addition of hydroxyl-amines to alkenes represents 
another noteworthy approach.27 Despite widespread applications in synthesis, such reactions can 
generate regioisomeric mixtures and chloro-containing byproducts. Incorporation of the source of 
nitrogen as a carbamate has led to improved selectivity in certain intramolecular examples,28 
nonetheless, the resulting cyclic amides present complications themselves. The transformation 
shown in Scheme 1.7 represents the most efficient available approach for synthesis of vicinal 
amino alcohols and derivatives.29  Vicinal amino alcohols may be accessed through catalytic 
enantioselective addition of N-based nucleophiles to epoxides,30 although regioselectivity can 
diminished in the absence of conjugation.31 Catalytic hydrogenation of enantiomerically enriched 
																																																								
27) (a) Li, G.; Angert, H. H.; Sharpless, K. B. Angew. Chem. Int. Ed. 1996, 35, 2813–2817. (b) Jiang, Y.; Chen, X.; 
Zheng, Y.; Xue, Z.; Chu, C.; Yuan, W.; Zhang, X. Angew. Chem. Int. Ed. 2011, 50, 7304–7307. (c) Donohoe, T. J.; 
Callens, C. K. A.; Flores, A.; Lacy, A. R.; Rathi, A. H. Chem. Eur. J. 2011, 17, 58–76. (d) Goodman, C. G.; Do, D. 
T.; Johnson, J. S. Org. Lett. 2013, 15, 2446–2449. 
28) Donohoe, T. J.; Chughtai, M. J.; Klauber, D. J.; Griffin, D.; Campbell, A. D. J. Am. Chem. Soc. 2006, 128, 2514–
2515. 
29) Harris, L.; Mee, S. P .H.; Furneaux, R. H.; Gainsford, G. J.; Luxenburger, A. J. Org. Chem. 2011, 76, 358–372. 
30) (a) Nugent, W. A. J. Am. Chem. Soc. 1992, 114, 2768–2769. (b) Jacobsen, E. N.; Acc. Chem. Res. 2000, 33, 421–
431. (c) Sabitha, G.; Babu, R. S.; Rajkumar, M.; Yadav, J. S. Org. Lett. 2002, 4, 343–345. (d) Bartoli, G.; Bosco, M.; 
Carlone. A.; Locatelli, M.; Massaccesi, M.; Melchiorre, P.; Sambri, L. Org. Lett. 2004, 6, 2173–2176. (e) Azoulay, 
S.; Manabe, K.; Kobayashi, S. Org. Lett. 2005, 7, 4593–4595. (f) Carrée, F.; Gil, R.; Collin, J. Org. Lett. 2005, 7, 
1023–1026. (g) Mai, E.; Schneider, C. Chem. Eur. J. 2007, 13, 2729–2741.  (h) Kureshy, R. I.; Prathap, K. J.; Agrawal, 
S.; Khan, N.-u. H.; Abdi, S. H. R.; Jasra, R. V. Eur. J. Org. Chem. 2008, 18, 3118–3128. (i) Agarwal, J.; Duley, A.; 
Rani, R.; Peddinti, R. Synthesis 2009, 16, 2790–2796. (j) Bao, H.; Wu, J.; Li, H.; Wang, Z.; You, T.; Ding, K. Eur. J. 
Org. Chem. 2010, 35, 6722–6726. Pujala, B.; Rana, S.; Chakraborti, A. K. J. Org. Chem. 2011, 76, 8768–8780. (k) 
Lu, H.-F.; Sun, L.-L.; Le, W.-J.; Yang, F.-F.; Zhou, J.-T.; Gao, Y.-H. Tetrahedron Lett. 2012, 53, 42674272. (l) Birrell, 
J. A.; Jacobsen, E. N. Org. Lett. 2013, 15, 2895–2897. (m) Weng, C.; Zhang, H.; Xiong, X.; Lu, X.; Zhou, Y.; Asian. 
J. Chem. 2014, 26, 3761–3768. (n) Kumar, M.; Kureshy, R. I.; Saravanan, S.; Verma, S.; Jakhar, A.; Khan, N.-u. H.; 
Abdi, S. H. R.; Bajaj, H. C. Org. Lett. 2014, 16, 2798–2801. (o) Srikanth, G.; Ramakrishna, K. V. S.; Sharma, G. V. 
M. Org. Lett. 2015, 17, 4576–4579. (p) Tak, R.; Kumar, M.; Kureshy, R. I.; Choudhary, M. K.; Khan, N.-u. H.; Bajaj, 
H. C. RSC Adv. 2016, 6, 7693–7700. (q) Tak. R.; Kumar, M.; Menapara, T.; Choudhary, M. K.; Kureshy, R. I.; Khan, 
N.-u. H. ChemCatChem 2017, 9, 322–328. 
31) Jaime, C.; Ortuno, R.; Font, J. J. Org. Chem. 1988, 53, 139–141. (b) Olofsson, B.; Somfai, P. J. Org. Chem. 2002, 
67, 8754–8583. 
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a-amino ketones32 and catalytic enantioselective reduction of a-ketoamides,33 represent other 
noteworthy strategies. 
 




Despite the potential utility of vicinal amino alcohols that contain a monosubstituted olefin, 
strategies for enantioselective allyl addition of O-substituted allyl boronates are uncommon.34 In a 
series of related reports, Ramanchandran35 and Soderquist36 introduced methods for reaction of N-
aluminoimine 1.42 with enantiomerically pure organoboron compounds to yield syn-1,2-
aminoalcohols 1.44 and 1.46, respectively (Scheme 1.8). The methoxyethoxymethyl ether group 
was removed during synthesis of β-amino acid derivatives (HCl/Et2O). However, conditions for 
hydrolysis of the methoxy ether within 1.46 were not disclosed. The above methods suffer from 
the following shortcomings: (1) The reagent must be prepared fresh for each reaction at low 
temperature. (2) Stoichiometric amounts of aluminum alkoxide are formed as byproducts, leading 
to emulsions that can become problematic, especially upon scale up.  
																																																								
32) Klingler, F. D. Acc. Chem. Res. 2007, 40, 1367–1376.  
33) Mamillapalli, N. C.; Sekar, G. Chem. Eur. J. 2015, 21, 18584–18588. 
34) For synthesis of 1,2-aminoalcohols through addition of nitrogen-substituted allyl reagents to aldehydes, see: Trost, 
B. M.; Cregg, J. J.; Quach, N. J. Am. Chem. Soc. 2017, 139, 5133–5139. (b) Spielmann, K.; Xiang, M.; Schwartz, L. 
A.; Krische, M. J. J. Am. Chem. Soc. 2019, 141, 14136–14141. 
35) Ramanchandran, P. V.; Burghardt, T. E. Chem. Eur. J. 2005, 11, 4387–4395. 
36) Muñoz-Hernández, L.; Soderquist, J. A. Org. Lett. 2009, 11, 2571–2574. (b) Muñoz-Hernández, L.; Seda, L. A.; 
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Scheme 1.8. Addition of Enantiomerically Pure O-Substituted Allyl Regents to Aldimines 
 
Amino alcohol derivatives may be generated through addition of racemic allenyl metal 
compounds to enantiomerically pure sulfinyl imines, generating either diastereomer of the 
propargylic amine depending on the identity of the allenyl metal. 37 Accordingly, upon reaction 
with a Zn-based nucleophile, anti-amino alcohol derivatives 1.49 were furnished as a single 
diastereomer in 77–91% yield. Attempts to gain access to the alternative stereoisomer through the 
addition of additives to disrupt chelation between the sulfinyl oxygen, methyl methoxyether and 
the lithium cation (as shown in Scheme 1.9a) were unsuccessful. However, when treated with two 
equivalents of lithium cuprate 1.51 and HMPA, the desired syn-1,2 amino alcohols 1.52 were 






37) (a) Chemla, F.; Ferreira, F. Synlett, 2006, 16, 2613–2616. (b) Louvel, J.; Botuha, C.; Chemla, F.; Demont, E.; 
Ferreira, F.; Pérez-Luna, A. Eur. J. Org. Chem. 2010, 2921–2926. (c) Louvel, J.; Chemla F.; Demont, E; Ferreira, F.; 
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2. HCl, 22 °C, 12h
a. Ramanchandran’s allyl addition to N-aluminoimines
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Scheme 1.9. Diastereoselective Synthesis of Syn- and Anti- 1,2–Amino Alcohols 
 
Diastereoselective C–C bond formation may be effected through additions of alkenyl metal 
nucleophiles to enantiomerically pure a-amino aldehydes.38 Coleman has shown that reaction with 
vinyl lithium 1.54 furnishes anti-1.56 as predicted by the Felkin-Ahn model. Whereas, syn-1.56 
may be obtained by reaction with an alkenylzinc halide (eg., 1.55) in 88:12 dr. More recently, 
Padron has introduced a similar strategy for diastereoselective additions of Grignard reagents to 
a-dibenzylamino aldehyde 1.57.39 Transformations may be performed in a single vessel, thereby 
obviating the need for reduction of the ester and subsequent oxidation to access a-amino 
aldehydes, as prescribed by the Reetz protocol.40 Related derivatives were prepared through Rh-




38) Coleman, R. S.; Carpenter, A. J. Tetrahedron Lett. 1992, 33, 1697–1700. 
39) Silveira-Dorta, G.; Donadel, O. J.; Martín, V. S.; Padrón, J. M. J. Org. Chem. 2014, 79, 6775–6782. 
40) (a) Reetz, M. T.; Drewes, M. W.; Schmitz, A. Angew Chem. Int. Ed. 1987, 26, 1141–1143. (b) Reetz, M. T.; 
Rölfing, K.; Griebenow, N. Tetrahedron Lett. 1994, 35, 1669–1972. 
41) Hooper, J. F.; Seo, S.; Truscott, F. R.; Neuhaus, J. D.; Willis, M. C. J. Am. Chem. Soc. 2016, 138, 1630–1634. 
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In perhaps the most general transformation to date, Lin has described addition of allyl zinc 
compounds generated from benzoyl-substituted allyl bromide 1.62 to aryl-, heteroaryl- and alkyl-
substituted sulfinyl imines 1.61, affording 1.63 in 75–99% yield, 78:22–99:1 dr and 90:10–99:1 
er. Aliphatic imines may be converted to the corresponding products in 90:10–93.5:6.5 er, 
nonetheless diastereoselectivity fluctuated depending on the size of the substituent (e.g., 78:22 and 
98:2 dr for β- and a- branched imines, respectively). Furthermore, HMPA 
(hexamethylphosphoramide) was essential for optimal selectivity.43 In a follow-up study,44 the 
same authors probed the possibility of avoiding HMPA, in favor of replacing it with an alternative 
Lewis base additive. Such efforts were unsuccessful. However, it was determined that when allyl 
																																																								
43) Lin, M.; Shen, A.; Sun, X.-W.; Xu, M.-H.; Lin, G-Q. Chem. Eur. J. 2010, 15, 10217–10224. 
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zinc compounds were synthesized according to procedures by Knochel,45 one diastereomer is 
formed preferentially (e.g., 1.63a in 96% yield, 99:1 dr and 98.5:1.5 er; Scheme 1.11a).  
 
Scheme 1.11. Addition of Alkoxy-Substituted Allylmetal Compounds to Imines 
	
Kobayashi and co-workers have outlined a diastereo- and enantioselective approach for 
addition of allyl boronates to hydrazono imino esters 1.64 in aqueous media (Scheme 1.11b).46 In 
this report, there is a single example involving  allylic boronate 1.65 substituted with a benzoloxy 
																																																								
45) Ren, H.; Dunet, G.; Mayer, P.; Knochel, P. J. Am. Chem. Soc. 2007, 129, 5376–5377. 
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a. Lin’s diastereoselective additions to sulfinyl imines
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ether affording 1,2-aminoalcohol derivative 1.67 as a in 65% yield, >99:1 a:g ratio, 99:1 dr and 
91:9 er. 
 
1.3 Organoboron Catalysts for Enantioselective C–C Bond Formation 
1.3.1  Aminophenol-Based Boryl Catalysts for Efficient and Enantioselective Allyl Additions 
Development of enantio- and diastereoselective C–C bond forming reactions, particularly 
those that can operate with broad scope and predicable stereochemical outcomes and are amenable 
to scale-up are crucial to furthering the state-of-the-art in chemical synthesis and drug discovery. 
In 2013, our group identified a simple organic molecule as a catalyst for efficient, enantio- and 
diastereoselective addition of a variety of allyl boronates to N-diphenylphosphinoyl aldimines.47 
The catalyst scaffold is robust, and may be rapidly optimized, as it is derived from amino acid 
residues often accessible in both enantiomers, and its synthesis is straightforward, scalable and 
inexpensive.  
It has been proposed that under the mildly acidic reaction conditions, the active complex 
contains an ammonium group, giving rise to unique reactivity observed and region- and 
enantioselectivity (Scheme 1.12b). The ammonium unit enhances boron Lewis acidity, ensures 
tight substrate binding, thereby rigidifying transition state structures and improving enantiofacial 
discrimination. Contrary to the majority of exisiting methods,13a additions are net a-selective (cf. 






47) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. Nature 
2013, 494, 216–221. 
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Synthesis of homoallylic amines bearing vicinal stereogenic centers, such as 1.84, therefore 
required an enantioenriched allyl boronate (1.78, Scheme 1.13). Despite the growing number of 
methods to synthesize these motifs,48 allylic boronates can undergo a 1,3-boryl shift, furnishing a 
more stable disubstituted olefin. We reasoned that we might take advantage of this propensity for 
isomerization as a design element for enantioselective transformations. That is, we could facilitate 
																																																								
48) For representative methods for synthesis of enantiopure allyl boronates bearing an allylic stereogenic center, see: 
(a) Seiber, J. D.; Morken, J. P. J. Am. Chem. Soc. 2006, 128, 74–75. (b) Ito, H.; Ito, S.; Sasaki, Y.; Matsuura, K.; 
Sawamura, M. J. Am. Chem. Soc. 2007, 129, 14856–14857. (c) Carosi, L.; Hall, D. G. Angew. Chem. Int. Ed. 2007, 
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isomerization of the initially generated 1.87 to complex 1.89 prior to C–C bond formation. In doing 
so, vicinal stereogenic centers would be generated without the need for enantiomerically pure 
reagents.  
 
Scheme 1.13. Formation of Vicinal Stereogenic Centers with Enantiomerically Enriched a-
Substituted Allyl Boronates 
 
We chose to explore development of this concept by carrying out diastereo- and 
enantioselective addition of 1.85 to phosphinoyl aldimine 1.81, because this particular class of 
imine exhibited stability under typical conditions (i.e., minimal hydrolysis in protic media).49 
Accordingly, there was only 35% conversion after 24 hr with 1.85. We reasoned that diminished 
efficiency is the result of the steric pressure generated by the g carbon (see Scheme 1.14, 1.86). 
Notably, the product was obtained as a mixture of regioisomers (1.90 and 1.91), which is in 
contrast to the a-selective formerly investigated (Scheme 1.12c). Considering the transformation 
does not proceed (<5%) in the absence of a catalyst, formation of the minor regioisomer (1.90) is 
																																																								
49) (a) Vieira, E. M.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 3332–3335. (b) Mszar, N. W.; 
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probably the result of reaction with 1.89, indicating that isomerization of allyl complex 1.87 is 
competitive with direct addition. To favor isomerization further, we identified a series of reaction 
conditions to increase the concentration of complex 1.89. The results of these studies are detailed 
below.  
 
Scheme 1.14. Addition of Allyl Boronates Containing a Monosubstituted Olefin 
 
1.3.2  Reactions with Crotyl Boronates and a Zinc Alkoxide as a Co-Catalyst 
Initial screening revealed that incorporation of a Lewis acid co-catalyst, namely, a zinc (II) 
salt improved efficiency and regioselectivity (1.90 as the major isomer, Scheme 1.15a). We 
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exchange (1.91), faster 1,3-borotropic shift (1.92) and/or an increase in the concentration of active 
complex 1.94 (by disfavoring amide coordination to the boron center). 50   
 
Scheme 1.15. Effect of Lewis Acidic Co-Catalyst 
 
 
It is important to note that, regardless of the initial stereochemistry of the allyl reagent (i.e., 
either E-1.85 or Z-1.85), only one diastereomer, namely, anti-homoallylic amine 1.90, was 
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formed. The increased efficiency for Z-1.85 may be rooted in faster allyl transfer benefiting due 
to release of strain inherent in a Z alkene and the probable syn-pentane interaction present in 1.86, 
that is lacking in 1.95. 
 
Scheme 1.16. Effect of Olefin Stereochemistry on Efficiency of Allyl Transfer 
 
 These findings are mechanistically informative, supporting idea that the same allyl 
complex stereoisomer may be accessed from either isomer of an E or Z allyl boronate, and 
intermediates 1.96 and 1.89 may interconvert prior to addition to an electrophile (Curtin-Hammett 
kinetics). Previous investigations had indicated that initial allyl transfer is probably 
stereospecific.47 Thus, by employing racemic 1.12, we expected a mixture of 1.96 and 1.86 would 
be generated in-situ. If these species were to be in rapid equilibrium prior to C–C bond formation, 
diastereoselectivity would be high. This was not the case, indicating that it is unlikely that 1.96 







51) For a detailed discussion of the role of borotropic shift in impacting the regioselectivity of addition with this class 
of chiral catalysts, see: van der Mei, F. W.; Miyamoto, H.; Silverio, D. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 
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Scheme 1.17 Probing Whether Allyl Boronate Isomerization/ C–C Bond Formation is 
Controlled by Curtin-Hammett Kinetics 
 
 
Another possible pathway would entail 1.86 being generated through a kinetically 
controlled 1,3-boryl shift to furnish a Z allyl intermediate.52 In such a case, kinetic selectivity 
would likely be due to minimization of a syn-pentane interaction between the allyl boronate 
substituent and the catalyst’s backbone (1.98, Scheme 1.18b). The efficiency with which 
rearrangement occurs is influenced by a number of factors. One is feasibility of alkene 
coordination with the partially vacant p-orbital of the boron atom. Therefore, the rate of 
																																																								
52) (a) Hancock, K. G.; Kramer, J. D. J. Am. Chem. Soc. 1973, 95, 6463–6465. (b) Hancock, K. G.; Kramer. J. D. J. 
Organomet. Chem. 1974, 64, C29–31. (c) Henriksen, U.; Snyder, J. P.; Halgren, T. A. J. Am. Chem. Soc. 1981, 46, 
3767–3768. (d) Bühl, M.; Schleyer, P. v. R.; Ibrahim, M. A.; Clark, T. J. Am. Chem. Soc. 1991, 113, 2466–2471. (e) 
Bubnov, Y. N.; Gurskii, M. E.; Gridnev, I. D.; Ignatenko, Y. A.; Ustynyuk, Y. A.; Mstislavsky, V. I. J. Organomet. 
Chem. 1992, 424, 127–132. (f) Gridnev, I. D.; Gursky, M. E.; Bubnov, Y. N.; Organometallics 1996, 15, 3696–3702. 
(g) Bubnov, Y. N. Pure Appl. Chem. 1987, 59, 895–906. (h) Choi. J. Y.; Kim, C. K.; Lee, I.; J. Phys. Chem. A 2002, 
106, 5709–5715. (i) Ess, D. H.; Kister, J.; Chen, M.; Roush, W. R. Org. Lett. 2009, 11, 5538–5541. (j) Gurskii, M. E.; 
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rearrangement may be hampered or increased depending on the identity of ligands substituted on 
the catalyst’s boron center.53  
 
Scheme 1.18. Mechanism of 1,3-Boryl Shift 
 
We have thus repurposed 1,3-boryl shift, previously only invoked as an explanation for 
isomerization of enantiomerically enriched allyl boronates,54 as a design element. What remained 
was to determine the extent of substitution that could be tolerated on the g-carbon (i.e., were 
																																																								
53) Fang, G. Y.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2007, 46, 359–362. 
54) Lachance, H.; Hall, D. G. Allylboration of Carbonyl Compounds in Organic Reactions, S. E.. Ed.; Wiley: New 
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efficient and enantioselective additions limited to alkyl groups?). We selected O–substituted allylic 
boronates for further investigation because the corresponding processes would provide convenient 
access to differentially protected amino alcohols derivatives.  
 
1.4 Catalytic Enantioselective Additions of O-Substituted Allyl Boronates to 
Aldimines 
1.4.1 Further Design Considerations 
A number of key issues had to be addressed. First, the reactivity of O-substituted 
organoboron reagents would be different than the corresponding alkyl-substituted derivatives. 
Specifically, as illustrated through resonance structures 1.100 and 1.102, we expected a decrease 
in the nucleophilicity of the g-carbon site, and diminishing the efficiency of allyl transfer as well 
as subsequent addition to the imine.  
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Furthermore, it was unclear whether complex 1.103 would undergo efficient 
rearrangement. We were encouraged by previous reports regarding organoboron reagents 
substituted with an allylic heteroatom being prone to borotropic shift.55 Nonetheless, it remained 
to be determined what factors would favor such a process to occur for aminophenol-based boryl 
complexes. 
 
Scheme 1.20. Analysis of Key Issues that Impact Regioselectivity 
	
	
1.4.2 Initial Optimization and Identification of Reaction Conditions 
 To begin, we synthesized a several allyl boronates (E-1.107a-b, Z-1.107a-c) and examined 
efficiency of addition (Table 1). Regardless of the stereochemical identity, reactions involving 
allyl boronates with a methyl ether 1.107a56 were inefficient at room temperature.57 Still, we were 
																																																								
55) Hoffmann, R. W.; Landmann, B. Chem. Ber. 1986, 119, 1039–1053. 
56) For reagent preparation, see: (a) Yamamoto, Y.; Fujikawa, R.; Yamada, A.; Miyaura, N. Chem. Lett. 1999, 28, 
1069–1070. (b) Zhang, P.; Roundtree, I.A.; Morken, J.P. Org. Lett., 2012, 14, 1416–1419. 
57 ) Low efficiency for methoxy-substituted boronates has been observed for additions to aldehydes, see: (a) 
Hoffmann, R. W.; Kemper, B.; Metternich, R.; Lehmeier, T. Leibigs Ann. Chem. 1985, 2246–2260. (b) Hoffmann, R. 
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encouraged by the fact that with Z-1.107a, we were able to isolate 1.106 in 96:4 dr and 94:6 er. To 
improve efficiency, the reaction was performed at 60 °C. Under these conditions, there was no 
detectable conversion with E-1.107a; however, there was an increase in conversion to 33% with 
Z-1.107a. Based on precedent established by Ramanchandran for efficient additions involving N-
aluminoimines,35 we reasoned that an allyl boronate that is MEMO-substituted 1.107b58 may be 
more efficient and amenable to further transformation. Accordingly, under the same conditions, 
additions of Z- and E-1.107b were more efficient (>98% and 83% conv, respectively). For 
reactions involving silyl ether Z-1.107c, the transformation proceeded to 66% conv and afforded 
the desired homoallylic amine in 90:10 er. However, we judged that the three-step preparation for 
the reagent requiring a relatively costly Ru-based complex rendered this a less attractive option.59 
Attempts to synthesize other silyl-based organoborons were thwarted by poor efficiency of olefin 
isomerization or silyl migration to lithiated alkenyl metal reagents.56b  
A notable observation was the difference in reactivity between the more sizable 
organoboron Z-1.107c and Z-1.107a, indicating that electronics might be dominant. To explore 
this further, we calculated the charge on the g-carbon of these reagents. In accordance with the 
experimentally obtained results, we found that there is a higher amount of charge on organoboron 
reagents possessing methoxyethoxy methyl- or siloxy-substituent (vs the more strongly donating 








58) For reagent preparation, see: Hoffmann, R. W.; Metternich, R.; Lanz, J. W. Liebigs. Ann. Chem. 1987, 881–887. 
59) Murata, M. Watanabe, S.; Masuda, Y. J. Chem. Research (S), 2002, 142–143. 
 
    Page 26 




aPerformed with 1.5 equiv of organoboron reagent under an atmosphere of dry N2. Conv, a:g and dr ratios 
(±2%) were determined by analysis of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance 
of 1.81. Yield of isolated and purified product as a mixture of diastereomers (±5%). Er values were 
determined by HPLC analysis (±1%). See Experimental Section for details. bAllylic alcohol isolated (Si-O 
bond cleavage upon work-up). MEM: CH2O(CH2)2OMe; na: not applicable; nd: not determined. See 
Experimental Section for details. 
 
Table 2. Computed Charges on Alkoxy-Substituted Boron Reagentsa 
	
aValues obtained based on analysis of the Fukui function. Calculations were performed at 
wB97XD/DEF2TZVPP//wB97XD/DEF2SVP level of theory in the gas phase. MEM: CH2O(CH2)2OMe. See 
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Table 3. Identification and Evaluation of the Optimal Aminophenola 
	
aPerformed with 1.5 equiv of organoboron reagent under an atmosphere of dry N2. Conv, a:g and dr ratios 
(±2%) were determined by analysis of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance 
of 1.81. Yield of isolated and purified product as a mixture of diastereomers (±5%). Er values were 
determined by HPLC analysis (±1%). MEM: CH2O(CH2)2OMe. See Experimental Section for details. 
 
Next, we sought to improve enantioselectivity by probing the effectiveness of several 
catalysts. We began with modification of the phenolic substituent, finding it to have minimal 
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by the size of the substituent (Table 3, entry 1 vs 4). Since there was no conversion without an 
aminophenol, we surmised that the observed decrease in regioselectivity might be the result of a 
less efficient 1,3-boryl shift, which must occur prior to C–C bond fomation (Scheme 1.20).  We 
considered two possible scenarios: (1) Increased steric pressure in the transition state for 1,3-boryl 
shift. (2) Less favorable coordination of the Zn(OMe)2 to the catalyst’s aryloxy moiety (lower 
boron Lewis acidity). The latter is supported by the finding that when the more sizable Zn(Ot-Bu)2 
was used, selectivity decreased to 55:45 g:a. 
To enhance the electrophilicity of the boron center, we synthesized and evaluated the 
effectiveness of ap-5, with contains a withdrawing nitro moiety. However, there was no 
discernable conversion of 1.81. 60  In contrast, with para-methoxyphenyl-substituted ap-6 
conversion was high, but the product was obtained in only 37% yield. We then turned to probing 
the effect of the amino acid residue. In line with previous mechanistic models,47 enantioselectivity 
increased with a tert-leucine derived aminophenol (95:5 vs 92:8 er); still 10% of the a-addition 
isomer was generated. To improve regioselectivity, we prepared and studied catalysts ap-8–10, 
bearing a smaller or no alkyl substituent. Optimal regio- and enantioselectivity were thus obtained 
by the catalyst derived from ap-10. To gain insight, DFT studies were carried out for analysis of 
1,3-boryl shift for model systems with–SiPh3 (ap-4) and –Et (ap-3) substituted complexes. We 
found that as hybridization at the boron center changes, there is greater steric pressure in transition 







60) Previous studies have indicated that catalysts possessing a more acidic phenol are less efficient for allyl addition 
to N-Phosphinoyl imines (see Ref. 50). This might be owing to more facile deprotonation of the phenolic proton. 
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Scheme 1.21. Transition State Analysis of Pathways for 1,3-Boryl Shifta 
	
aCalculations were performed at the wB97XD/DEF2SVPtoluene(SMD) and M062x/DEF2SVPtoluene(SMD) level of 
theory. See the Experimental Section for details.  
 
1.5 Evaluation of the Method’s Scope 
 Ortho-substituted imines (1.113–1.117), such as o-tolyl 1.116 and o-napthyl 1.117 were 
effective substrates. Additions to imines bearing an electron-donating or electron-withdrawing 
group proceeded with similar selectivity (93:7 dr and 98:2 er for para-methoxyphenyl 1.120 and 
para-CF3 1.122). We were able to determine absolute and relative stereochemistry by securing an 
X-ray of 1.122. We found it noteworthy that substrates bearing electron-withdrawing substituents 
performed as well as those that are more electron-rich. This might arise from hemiaminal 
formation decreasing the availability of the more electrophilic substrates, causing 1,3-boryl shift 
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aPerformed with 1.5 equiv of organoboron reagent under an atmosphere of dry N2. Conv, a:g and dr ratios 
(±2%) were determined by analysis of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance 
of imine. Yield of isolated and purified product as a mixture of diastereomers (±5%). Er values were 
determined by HPLC analysis (±1%). MEM: CH2O(CH2)2OMe. b7.5 mol % ap-10, 15 mol% Zn(OMe)2, 2.5 















98:2 !:", 89% yield
93:7 dr, 99:1 er
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 The less electrophilic imines bearing the strongly donating para-dimethylamino substituent 
(1.121) were less efficient. This was addressed by increasing the amount of Zn(OMe)2 (15 vs 7.5 
mol %) and addition of an equivalent of methanol for increased solubility of the substrate; 1.121 
was thus isolated in 83% yield, 93:7 dr, and 97:3 er. Reactions with alkenyl-substituted imines, 
both di- and tri-substituted, were fully chemoselective (1,2 vs 1,4 addition) and afforded 
homoallylic amides 1.124 and 1.125 in 82 and 92% yield, 94:6 and 95:5 dr and 98:2 er, 
respectively. Heteroaryl-substituted imines (1.126–1.130) were equally effective substrates, but 
selectivities were more varied, in particular for furyl-substituted 1.127 and 1.128. As described 
previously, 61  competitive electrostatic interaction involving the heterocyclic oxygen and the 
catalyst’s ammonium unit can compete with hydrogen bonding between the phosphinoyl amide. 
The same trend was not observed for thienyl-substituted 1.129 and 1.130, perhaps as a 
consequence of the more dispersed electron cloud for a sulfur atom. Larger amounts of the zinc 
alkoxide were required in the case of 3-pyridyl substituted 1.126, perhaps due to partial 
coordination of the Lewis acid with the pyridine nitrogen.  
Reactions of alkyl imines were less efficient and less enantioselective. For instance, with 
imines possessing a less hindered, linear substituent (1.131), regioselectivity decreased to 89:11 
g:a ratio. With the more sizable b-branched imine 1.132, regioselectivity remained high (98:2 g:a 











61) Lee, K.; Silverio, D. L.; Torker, S.; Robbins, D. W.; Haeffner, F.; van der Mei, F. W.; Hoveyda, A. H. Nature 
Chem. 2016, 8, 768–777. 
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Scheme 1.23 Catalytic Enantioselective Addition of O-Substituted Allyl Boronates to 
Heteroaryl and Alkyl-Substituted Iminesa 
 
	
aPerformed with 1.5 equiv of organoboron reagent under an atmosphere of dry N2. Conv, a:g and dr ratios 
(±2%) were determined by analysis of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance 
of imine. Yield of isolated and purified product as a mixture of diastereomers (±5%). Er values were 
determined by HPLC analysis (±1%). MEM: CH2O(CH2)2OMe. b7.5 mol % ap-10, 15 mol% Zn(OMe)2, 2.5 
equiv MeOH. See Experimental Section for details. 
 
1.5.1 Product Derivatization  
 At the outset of this investigation, we sought to develop a method affording access to 
differentially protected vicinal amino alcohol derivatives that can be chemoselectively unmasked 
to reveal useful fragments represented by homoallylic amine 1.134, allylic alcohol 1.133 or amino 
alcohol 1.136 (Scheme 1.24). Allylic alcohol was thus secured in 69% yield and 93:7 dr by 
treatment CeCl3/NaI.62 Activation of the alcohol group in 1.133 (PPh3, diad), as outlined by 
Sweeney,63 and the ensuing substitution afforded aziridine 1.135 in 73% yield and 96.5:3.5 dr.  
 
																																																								
62) Sabitha, G. S.; Babu, R. S.; Rajkumar, M.; Srividya, R.; Yadav, J. S. Org. Lett. 2001, 3, 1149–1151.  





96:4 !:", 77% yield












>98:2 !:", 91% yield.
96:4 dr, 98:2 er
1.129
93:7 !:", 88% yield
94:6 dr, 98:2 er
1.128
89:11 !:", 79% yield
86:14 dr, 90:10 er
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Scheme 1.24. Selective Functionalization of Vicinal Amino Alcohol Derivativesa 
	
aPerformed under an atmosphere of dry N2. Conv and dr ratios (±2%) were determined by analysis of 1H 
NMR spectra of unpurified mixtures. Yield of isolated and purified product as a mixture of diastereomers 
(±5%). Er values were determined by HPLC analysis (±1%). diad: diisopropyl azodicarboxylate. See 
Experimental Section for details. 
Allylic amine 1.134 was generated without harming the structural integrity of the acid 
sensitive alkyl ether group. Under the best circumstances, we found that mild reduction of the 
phosphine oxide through treatment with a combination of HPO(OPh)2 and triphenylphosphite, 
according to a protocol recently published by Metivier, 64  and hydrolysis of the resulting 
iminophosphorane furnished homoallylic amine 1.134 in 43% yield. Other recently reported 
methods for N–P bond cleavage were less effective.65 
 Complete deprotection was performed by treatment with concentrated aqueous 
hydrochloric acid in ethanol for four hours at 22 °C. Attempts at deprotection under anhydrous 
																																																								
64) Li, P.; Wischert, R.; Metivier, P. Angew. Chem. Int. Ed. 2017, 129, 16205–16208. 









MeCN/H2O, 60 ºC, 3h; 
80 ºC, 1 h
2.0 equiv HP(O)(OPh)2 
0.5 equiv P(OPh)3
0.5 equiv I2, 0.5 equiv Et3N
thf, 22 ºC, 5 h
1.133
69% yield, 93:7 dr
1.134











73% yield, 96.5:3.5 dr
b. Synthesis of alkenyl-substituted aziridine
a. Chemoselective removal of N–, O–based protecting groups
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conditions, led to N→O isomerization. 66  Amino alcohol 1.136 was directly subjected to 
chloroacetyl chloride, affording amide 1.137 in 67% yield. Base-induced cyclization in a mixture 
of thf/dmf afforded lactam 1.138 in 86% yield, which was then subjected to cross-metathesis to 
afford NK-1 receptor antagonist 1.139, and the precursor to the more active epoxide derivative 
1.141.67  
 
Scheme 1.25 Application to Synthesis of Biologically Active Compoundsa 
	
aPerformed under an atmosphere of dry N2. Conv and dr ratios (±2%) were determined by analysis of 1H 
NMR spectra of unpurified mixtures. Yield of isolated and purified (±5%). Er values were determined by 
HPLC analysis (±1%).  Mes: 2,4,6-trimethylphenyl. See Experimental Section for details. 
																																																								
66) Burgos, P. O.; Fernández, I.; Iglesias, M. J.; García-Granda, S.; Ortiz, F. L. Org. Lett. 2008, 10, 537–540. 
67) (a) Ladduwahetty, T.; Keown, L..; Cascieri, M. A.; Sadowski, S. Bioorg. Med. Chem. 1994, 4, 1917–1920. (b) 
Dorn, C. P.; Finke, P. E.; Hale, J. L.; Mills, G.; Shah, S.; Chambers, M. S.; Harrison, T.; Ladduwahetty, T.; Williams, 
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b. Bioactivity of 1.139 and related derivatives
a. Elaboration to NK1 Agonist
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1.6  Conclusions 
 We have developed a method for regio-, diastereo- and enantioselective addition of O–
substituted boronates to N-phosphinoyl aldimines. Reaction design was largely mechanism-based, 
allowing us to control the relative rates of 1,3-borotropic shift versus C–C bond formation.  An 
array of otherwise difficult-to-access and readily modifiable products may be synthesized through 
the approach efficiently and with high region-, diastero- and enantioselectivity. The utility of the 
approach was showcased through chemoselective deprotection to furnish homoallylic amines, 
allylic alcohols, or 1,2-aminoalcohols, as well as synthesis of an NK1 agonist.  
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1.7 Experimental Section 
1.7.1 General 
Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) spectrophotometer, 
νmax in cm-1. Bands are characterized as broad (br), strong (s), medium (m), and weak (w). 1H NMR 
spectra were recorded on a Varian Unity INOVA 400 (400 MHz), 500 (500 MHz) or 600 (600 
MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane with the solvent 
resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are reported as follows: chemical 
shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br s = broad singlet, 
m = multiplet, app. = apparent), and coupling constant (Hz). 13C NMR spectra were recorded on a 
Varian Unity INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 MHz) spectrometer with 
complete proton decoupling. Chemical shifts are reported in ppm from tetramethylsilane with the 
solvent resonance as the internal standard (CDCl3: δ 77.16 ppm). Carbons with directly attached 
boron atoms were not observed in some compounds, most likely due to quadrupolar relaxation.[
1] High-resolution mass spectrometry was performed on a JEOL AccuTOF DART (positive mode) 
at the Mass Spectrometry Facility, Boston College. Enantiomeric ratios were determined by high-
performance liquid chromatography (HPLC) with a Shimadzu chromatograph (Chiral 
Technologies Chiralpak AD-H (4.6 x 250 mm), Chiralpak AZ-H (4.6 x 250 mm), Chiralcel OZ-3 
(4.6 x 150 mm) in comparison to authentic racemic materials. Optical rotations were measured on 
a Rudolph Research Analytical Autopol IV Polarimeter. Melting points were measured on a 
Thomas Hoover capillary melting point apparatus and are uncorrected. Unless otherwise noted, all 
reactions were carried out with distilled and degassed solvents under an atmosphere of dry N2 in 
oven- (135 °C) or flame-dried glassware with standard dry box or vacuum-line techniques. 
Solvents were purified under a positive pressure of dry argon by a modified Innovative 
Technologies purification system: toluene, benzene and hexanes were purified through a copper 
oxide and alumina column, CH2Cl2 and Et2O were purged with Ar and purified by passage through 
two alumina columns. Tetrahydrofuran (thf; Fisher Chemical Co.) was purified by distillation from 
sodium benzophenone ketyl immediately prior to use unless otherwise specified. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from Fisher) in 
air. Aryl-, heteroaryl-, and alkenyl-N-diphenylphosphinoyl imines were synthesized through the 
use of a condensation promoted by TiCl4 between P,P-diphenylphosphinic amide and the 
corresponding aldehyde.[2] Alkyl substituted imines, precursors to 1.131 and 1.132, as well as the 
																																																								
1) Wrackmeyer, B. Prog. NMR Spectrosc. 1979, 12, 227–259. 
2) a) Jennings, W.B.; Lovely, C. J. Tetrahedron, 1991, 47, 5561–5568; b) Yamada,, K.-I.; Harwood, S. J.; Gröger, H.; 
Shibasaki, M. Angew. Chem. Int. Ed. 1999, 38, 3504–3506. 
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imine precursor to 1.122 were synthesized through the intermediacy of the corresponding sulfinyl 
adducts according to previously disclosed methods.[3] 
 
1.7.2 Reagents 
Acetone oxime was purchased from Aldrich and used as received. 
Allyl alcohol was purchased from Aldrich and used as received. 
Aminophenol compounds (ap-1, ap-2, ap-3, ap-4, ap-5) were prepared according to previously 
reported procedures.[4] 
Bis(1,5–cyclooctadiene)nickel (0) was purchased from Strem and used as received. 
Bis(cyclopentadienyl)zirconium(IV) chloride hydride (Schwartz’ Reagent) was purchased 
from Strem and used as received. 
Bis(pinacolato)diboron [B2(pin)2] was purchased from Frontier and used as received. 
3,5-Bis(trifluoromethyl)styrene was purchased from Synquest Laboratories and used as 
received. 
Carbonylchlorohydridotris(triphenylphosphine)ruthenium(II) was purchased from Alfa and 
used as received.  
Cerium trichloride heptahydrate was purchased from Aldrich and used as received. 
Chloroacetylchloride was purchased from Oakwood and distilled from Calcium hydride 
immediately before use.  
Chlorodiphenylphosphine was purchased from Strem and used as received. 
Chlorotrimethylsilane was purchased from Oakwood and used as received.  
(1,5-cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) hexafluorophosphate was 
purchased from Acros and used as received.  
Diisopropyl azodicarboxylate was purchased from Acros and used as received. 
N,N-Diisopropylethylamine was purchased from Oakwood and used as received.  
Diphenyl phosphite  was purchased from Aldrich and used as received. 
3-Ethyl-2-hydroxybenzaldehyde was prepared according to a previously reported procedure.5 
2-Ethylphenol was purchased from Combi-Blocks and distilled from calcium hydride 
immediately before use. 
Hydrochloric acid was purchased from Fisher and used as received.  
Second-generation catalyst (Ru-1) was purchased from Ark Pharm and used as received.  
																																																								
3) a) A. Côté, A. A. Boezio, A. B. Charrette, Proc. Natl. Acad. Sci. 2004, 101, 5405–5410; b) A. Yamaguchi, S. 
Matsunaga, M. Shibasaki, Tetrahedron Lett. 2006, 47, 3985–3989.  
4) D. L. Silvero, S. Torker, T. Pilyugina, E M. Vieira, M. L. Snapper, F. Haeffner, A. H. Hoveyda, Nature 2013, 494, 
216–221.  
5) E. V. Johnston, K. Bogár, J.-E. Bäckvall, J. Org. Chem. 2010, 75, 4569–4599. 
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Iodine was purchased from Alfa and used as received.  
2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from Oakwood and used 
as received.  
Magnesium (II) chloride was purchased from Strem and dried at 130 °C overnight before use.  
Methanol (extra dry) was purchased from Acros and used as received. 
Methoxyallene was purchased from Aldrich and used as received.  
3-((2-Methoxyethoxy)methoxy)prop-1-ene was prepared according to a previously reported 
procedure.6 
3-((2-Methoxyethoxy)methoxy)prop-1-yne was prepared according to a previously reported 
procedure.[7]  
2-Methoxyethoxymethyl chloride was purchased from Combi-Blocks and used as received. 
N-Boc-L-tert-leucine was purchased from Oakwood and used as received.  
Paraformaldehyde was purchased from Aldrich and dried overnight over P2O5 in vacuo before 
use.  
Pinacolborane was purchased from Oakwood and used as received.  
Propargyl alcohol was purchased from Aldrich and used as received.  
sec-Butyllithium (1.4 M in cyclohexane) was purchased from Aldrich and titrated with N-
Benzylbenzamide before each use.  
Sodium hydride was purchased from Strem and used as received.  
Sodium iodide was purchased from Alfa and used as received.  
tert-Butyldimethylchlorosilane was purchased from Oakwood and used as received.  
Triphenylphosphite was purchased from Aldrich and used as received. 
Tris(dibenzylideneacetone)platinum was prepared according to a previously reported 
procedure.[8] 
Tricyclohexylphosphine was purchased from Strem and used as received. 
Triethyl amine was purchased from Acros and distilled from calcium hydride immediately before 
use.  
Triphenylphosphine was purchased from Aldrich and used as received.  
Zinc (II) methoxide (97%, powder) was purchased from Aldrich and used as received.  
Zinc (II) tert–butoxide was purchased from Alfa and used as received.  
																																																								
6) Erb, W.; Grassot, J. M.; Linder, D.; Neuville, L. Angew. Chem. Int. Ed. 2015, 54, 1929–1932.  
7) Yang, X.; Xie, X.; Fox, J. M. Angew. Chem. Int. Ed. 2006, 45, 3960–3962. 
8) Mlynarski, S. N.; Schuster, C. H., J. P. Morken, Nature 2014, 505, 386–390. 
 
	 Page 39 
1.7.3 Alkoxy Substituted Allyl Boron Compounds 
(E)-2-(3-Methoxyallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (E-107a) was prepared 
according to a previously reported procedure, and analytical data are fully consistent with those 
reported previously.[9] 
(Z)-2-(3-Methoxyallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (Z-107a) was prepared 
according to a previously reported procedure and was obtained as a mixture of isomers.[ 10 ] 
Analytical data are fully consistent with those reported previously.[11]  
(Z)-Trimethyl((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-1-en-1-yl)oxy)silane (Z-
107c) was prepared according to a previously reported procedure and used as a mixture of alkenyl 
and allylic boronates.[12] IR (neat): 2978 (w, br), 1646 (w), 2882 (w), 1340 (s), 1252 (s), 1145 (s), 
1095 (s), 844 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.15 (dt, J = 5.8, 1.7 Hz, 1H), 4.60 (td, J 
= 7.6, 5.7 Hz, 1H), 1.71 – 1.60 (m, 2H), 1.23 (s, 12H), 0.15 (s, 6H); 13C NMR (100 MHz, CDCl3): 
δ 138.0, 106.2, 83.2, 24.9, 24.7, 15.4, –0.3; HRMS (DART): Calcd for C12H26BO3Si [M+H]+: 
257.1739; Found: 257.1752. 
(Z)-tert-Butyldimethyl((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-1-en-1-
yl)oxy)silane (S-2) was prepared according to a previously reported procedure and used as a 
mixture of alkenyl and allylic boronates.[12] IR (neat): 2978 (m), 2955 (m), 2931 (m), 2887 (m), 
2858 (m), 1341 (s) 1322 (s), 1258 (s), 1145 (s), 1101 (s), 838 (s), 778 (m) cm-1; 1H NMR (400 
MHz, CDCl3): δ 6.20 (dt, J = 5.7, 1.7 Hz, 1H), 4.57 (td, J = 7.7, 5.7 Hz, 1H), 1.75 – 1.65 (m, 2H), 
1.24 (s, 12H), 0.92 (s, 9H), 0.11 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 138.6, 105.4, 83.3, 26.1, 
24.9, 18.5, –5.2; HRMS (DART): Calcd for C15H32BO3Si [M+H]+: 299.2208; Found: 299.2222. 
(E)-2-(3-((2-Methoxyethoxy)methoxy)prop-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (S-1): The title compound was synthesized according to a modified procedure from 
Wang et al.[ 13 ] An oven-dried vial equipped with a stir bar was charged with 3-((2-
Methoxyethoxy)methoxy)prop-1-yne (1.44 g, 10.0 mmol) and 4,4,5,5-Tetramethyl-1,3,2-
dioxaborolane (1.52 mL, 10.5 mmol). Bis(cyclopentadienyl)zirconium(IV) chloride hydride 
(Caution: gas evolution, 258.0 mg, 1.0 mmol) and triethylamine (0.14 mL, 1.0 mmol) were then 
added to the solution. The vial was capped, sealed with electrical tape and allowed to stir at 60 °C 
for 16 h. Upon cooling to 22 °C, the solution was diluted with hexanes and filtered through a plug 
of celite topped with silica gel. The filtrate was concentrated to yield yellow oil, which was purified 
by silica gel chromatography (gradient eluting with 100:0 to 2:1 hexanes:Et2O) to afford S1 as 
colorless oil (1.93 g, 7.10 mmol, 71% yield).  
																																																								
9) Zhang, P.; Roundtree, I. A.; JMorken, J. P. Org. Lett. 2012, 14, 1416–1419. 
10) Yamamoto, Y.; Fujikawa, R.; Yamada, A.; Miyaura, N. Chem. Lett. 1999, 1069–1070. 
11) Hoffmann, R. W.; Metternich, R.; Lanz, J. W. Liebigs Ann. Chem. 1987, 881–887. 
12) Murata, M.; Watanabe, S.; Masuda,, Y. J. J. Chem. Research (S), 2002, 142–143. 
13) Wang, Y. D.; Kimball, G.; Prashad, A. S.; Wang, Y.; Tetrahedron Lett. 2005, 46, 87778780. 
 
	 Page 40 
IR (neat): 2978 (w, br), 2928 (w), 2882 (w), 1645 (m), 1348 (s), 1322 (s), 1143 (s), 1024 (s), 972 
(m) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.79 – 6.44 (m, 1H), 5.88 – 5.46 (m, 1H), 4.73 (d, J = 
0.7 Hz, 2H), 4.28 – 4.09 (m, 2H), 3.89 – 3.65 (m, 2H), 3.65 – 3.48 (m, 2H), 3.38 (s, 3H), 1.26 (d, 
J = 0.7 Hz, 12H); 13C NMR (150 MHz, CDCl3): δ 148.8, 95.1, 83.4, 71.9, 69.0, 67.0, 59.2, 24.9; 
11B NMR (160 MHz, CDCl3): δ 29.36; HRMS (DART): Calcd for C13H26BO5 [M+H]+: 
273.1873; Found: 273.1881. 
 
(E)-2-(3-((2-Methoxyethoxy)methoxy)allyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (E-
107b): The title compound was synthesized according to a modified procedure of Miyaura et al.[14] 
In a nitrogen-filled glovebox, an oven-dried 6-dram vial was charged with [Ir(cod)(PPh2Me)2]PF6 
(25.4 mg, 0.0300 mmol) and dissolved in thf (3 mL). The vial was sealed with a septum, removed 
from the glovebox and placed under an atmosphere of hydrogen. Once the solution turned light 
yellow, excess hydrogen was removed by purging the system with nitrogen. S1 (272.2 mg, 1.000 
mmol) was then added as a solution in thf (2 mL) and the mixture was allowed to stir for 1 h at 22 
°C. The solution was then diluted with anhydrous hexanes, and the resulting precipitate was 
filtered off. Concentration of the filtrate and purification by silica gel chromatography (gradient 
eluting with 100:0 to 1:3 hexanes: Et2O) afforded E-107b accompanied by 28% of S1 as clear oil 
(144.2 mg, 0.53 mmol, 53% yield, mixture of isomers).   
IR (neat): 2978 (m), 2931 (w), 2886 (w), 1455 (s), 1358 (s), 1323 (s), 1142 (s), 1061 (s), 881 (m) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 6.28 – 6.10 (m, 1H), 5.09 (dtd, J = 12.3, 7.7, 0.9 Hz, 1H), 
4.94 – 4.68 (m, 2H), 3.77 – 3.62 (m, 2H), 3.61 – 3.51 (m, 2H), 3.38 (s, 3H), 1.55 – 1.48 (m, 2H), 
1.24 (s, 12H); 13C NMR (150 MHz, CDCl3): δ 143.6, 104.1, 94.9, 83.4, 71.8, 69.7, 67.4, 66.7, 
24.9; 11B NMR (160 MHz, CDCl3) δ 32.78; HRMS (DART): Calcd for C13H26BO5 [M+H]+: 
273.1868; Found: 273.1876. 
(Z)-2-(3-((2-Methoxyethoxy)methoxy)allyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (Z-
107b): The title compound was synthesized according to a modified procedure from Hoffmann et 
al.[11] To a cooled (–78 °C) solution of 3-((2-Methoxyethoxy)methoxy)prop-1-ene (6.0 g, 41 mmol) 
in thf (40 mL) was added sec-BuLi (26.0 mL, 1.4 M in cyclohexane) and allowed to stir for 30 
min. 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (7.6 mL, 37.3 mmol) was then added 
in a dropwise manner, and the solution was allowed to warm to 22 °C and stir for 12 h. The mixture 
was then cooled to 0 °C, after which it was treated with a saturated solution of aqueous NH4Cl (45 
mL) followed by 1M HCl (55 mL). The mixture was allowed to stir for 1 h, and then the aqueous 
layer was washed with Et2O (3 x 50 mL). The combined organic layers were dried over Na2SO4 
and concentrated in vacuo to afford yellow oil, which was purified by silica gel chromatography 
(basic alumina, 10:1 to 0:100 hexanes:Et2O) to yield colorless oil (contained 10–15% unreacted 
starting material, which was removed under high vacuum with gentle heating) to afford Z-107b 
(3.654 g, 13.43 mmol, 36% yield).  
																																																								
14) Yamamoto, Y.; Miyairi, T.; Ohmura, T.; Miyaura, N. J. Org. Chem., 1999, 64, 296–298. 
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IR: 2978 (w), 2931 (w), 2889 (w), 1666 (w), 1351 (m), 1322 (m), 1143 (s), 1042 (s), 847 (m) cm-
1; 1H NMR (600 MHz, CDCl3): δ 6.15 (dt, J = 6.1, 1.6 Hz, 1H), 4.88 (s, 2H), 4.59 (td, J = 7.7, 6.1 
Hz, 1H), 3.82 – 3.67 (m, 2H), 3.61 – 3.47 (m, 2H), 3.38 (s, 3H), 1.67 (dd, J = 7.5, 1.8 Hz, 2H), 
1.24 (s, 12H); 13C NMR (150 MHz, CDCl3): δ 142.3, 103.7, 95.3, 83.3, 71.8, 67.3, 59.1, 28.4, 
25.00; 11B NMR (160 MHz, CDCl3): δ 33.12; HRMS (DART): Calcd for C13H26BO5 [M+H]+: 
273.1868; Found: 273.1877. 
1.7.4 Aminophenol Compounds 
(S)-2-((3-Ethyl-2-hydroxybenzyl)amino)-3-methyl-1-(pyrrolidin-1-yl)butan-1-one (ap-3): 
Viscous oil; IR: 3284 (w), 2961 (m), 2873 (m), 1633 (s), 1460 (s), 1428 (s), 1224 (m), 838 (m), 
749 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 10.89 (s, 1H), 7.06 (dd, J = 7.4, 1.9 Hz, 1H), 6.76 
(dd, J = 7.5, 1.9 Hz, 1H), 6.70 (t, J = 7.4 Hz, 1H), 4.07 (d, J = 13.7 Hz, 1H), 3.70 – 3.59 (m, 1H), 
3.56 – 3.44 (m, 2H), 3.29 (ddd, J = 10.6, 7.0, 5.4 Hz, 1H), 3.21 (dt, J = 10.5, 6.4 Hz, 1H), 3.09 (s, 
1H), 2.92 – 2.43 (m, 2H), 2.06 – 1.70 (m, 5H), 1.22 (t, J = 7.5 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H), 
0.96 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 172.0, 156.0, 131.5, 128.5, 126.2, 122.0, 
118.9, 63.9, 51.3, 46.5, 45.9, 31.4, 26.3, 24.4, 23.1, 20.1, 18.5, 14.3; HRMS (DART): Calcd for 
C18H29N2O2 [M+H]+: 305.2224; Found: 305.2230; Specific rotation: [α]23.9D –30.7 (c = 1.55, 
CHCl3).  
(S)-2-((2-Hydroxybenzyl)amino)-3-methyl-1-(pyrrolidin-1-yl)butan-1-one (ap-8): Viscous oil; 
IR: 3283 (w), 2960 (m), 2873 (m), 1631 (s), 1590 (m), 1489 (m), 1427 (s), 1255 (s), 755 (s) cm-1; 
1H NMR (400 MHz, CDCl3): δ 10.84 (s, 1H), 7.21 – 7.11 (m, 1H), 6.90 (d, J = 7.4 Hz, 1H), 6.84 
(dd, J = 8.0, 1.3 Hz, 1H), 6.75 (tt, J = 7.4, 1.3 Hz, 1H), 4.09 (d, J = 13.8 Hz, 1H), 3.68 – 3.53 (m, 
2H), 3.54 – 3.43 (m, 1H), 3.28 (td, J = 8.5, 6.9, 3.7 Hz, 1H), 3.17 (dd, J = 10.4, 5.9 Hz, 1H), 3.11 
(dd, J = 6.8, 1.1 Hz, 1H), 1.98 – 1.77 (m, 5H), 0.98 (ddd, J = 20.1, 6.8, 1.1 Hz, 6H); 13C NMR 
(100 MHz, CDCl3): δ 171.9, 158.3, 129.0, 128.6, 122.5, 119.2, 116.5, 63.9, 51.2, 46.5, 45.9, 31.5, 
26.3, 24.3, 20.1, 18.5; HRMS (DART): Calcd for C16H25N2O2 [M+H]+: 277.1911; Found: 
277.1915; Specific rotation: [α]23.7D –11.2 (c = 1.16, CHCl3).  
(S)-2-((3-Ethyl-2-hydroxybenzyl)amino)-3,3-dimethyl-1-(pyrrolidin-1-yl)butan-1-one (ap-
10): White solid; M.p. = 98 – 100 °C; IR: 3294 (w), 2958 (m), 2872 (m), 1628 (s), 1460 (s), 1426 
(s), 1252 (m), 1224 (m), 839 (m), 749 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 10.68 (s, 1H), 
7.04 (dd, J = 7.3, 1.9 Hz, 1H), 6.86 – 6.48 (m, 2H), 4.04 (d, J = 13.7 Hz, 1H), 3.62 (td, J = 7.5, 5.2 
Hz, 1H), 3.53 – 3.39 (m, 2H, peaks overlapped), 3.34 – 3.24 (m, 1H), 3.18 (dt, J = 10.1, 6.3 Hz, 
1H), 3.09 (s, 1H), 2.80 – 2.58 (m, 2H), 1.87 (tt, J = 6.1, 4.1, 3.5 Hz, 5H), 1.19 (t, J = 7.5 Hz, 3H), 
0.98 (d, J = 1.0 Hz, 9H); 13C NMR (100 MHz, CDCl3): δ 171.4, 155.8, 131.4, 128.5, 126.1, 121.9, 
118.8, 65.5, 51.1, 47.2, 45.6, 34.4, 26.9, 26.2, 24.2, 23.0, 14.2; HRMS (DART): Calcd for 




	 Page 42 
1.7.5 General Procedure for Additions to N-Phosphinoyl Imines with Z-107b 
In a nitrogen-filled glovebox, Zn(OMe)2 (1.0 mg, 0.0075 mmol) was added to an oven dried 2-
dram vial equipped with a stir bar, followed by a solution of ap-10 in toluene (2.4 mg, 0.0075 
mmol in 0.5 mL toluene). The mixture was allowed to stir at 22 °C for 5 min, after which 
phosphinoylimine (33.1 mg, 0.100 mmol), Z-107b (42 µL, 0.15 mmol), and MeOH (7 µL, 0.15 
mmol) were added sequentially. The vial was then sealed with a cap and electrical tape and 
removed from the glovebox. The mixture was placed in a preheated oil bath and was allowed to 
stir for 14 h at 60 °C. After the solution was allowed to cool to 22 °C, it was subjected to silica gel 
chromatography (gradient eluting with 10:1 to 0:100 hexanes:EtOAc, ultimately thoroughly 
washing with 20:1 CH2Cl2:MeOH) to yield the desired product as a mixture of diastereomers.  
	
Procedure for Gram-Scale Catalytic Enantioselective Addition 
 
In a nitrogen-filled glovebox, Zn(OMe)2 (31.3 mg, 0.245 mmol) was added to an oven-dried 6-
dram vial equipped with a stir bar followed by ap-10 (36.3 mg, 0.115 mmol). The solids were 
dissolved in toluene (5 mL) and the vial was sealed with a septum and removed from the glovebox. 
In ambient atmosphere, phosphinoyl imine 1.81 (1.00 g, 3.28 mmol) was added to an oven-dried 
25 mL round bottom flask, placed under an atmosphere of N2, and dissolved in toluene (8 mL). 
The solution of ap-10 and Zn(OMe)2 was then added by syringe and the vial was washed with an 
additional aliquot of toluene (3 mL). Compound Z-107b (1.34 g, 4.91 mmol) was added by 
syringe, followed by methanol (used without purification, 265 µL, 6.55 mmol). The reaction vessel 
was placed in an oil bath pre-heated to 60 °C and allowed to stir for 14 h. After the mixture was 
allowed to cool to 22 °C, it was concentrated to ~20% of its original volume in vacuo, and was 
purified by silica gel chromatography, as described above.  
1.7.6 General Procedure for Screening of Alkoxy-Substituted Allyl Boron Compounds 
Compounds Z-107a, E-107b, Z-107c, and Z-107d were obtained as mixtures of regioisomers. The 
data in Table 2 were obtained by calculating the corresponding amount of desired reagent (1.5 
equiv.), with the assumption of isomeric purity and by multiplying the result by the isomeric ratio 
to obtain a corrected value. For example, E-107b was obtained as 72:28 regioisomeric mixture, 
therefore the calculated amount (assumed isomeric purity) was divided by a factor of 0.72 to obtain 
a true 1.5 equiv. of the desired allyl boron. For screening studies, the un-reacted imine was 
hydrolyzed by the addition of 3 M HCl and allowed to stir for 1h. The aqueous layer was washed 
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1.7.7 Analytical Data for Diastereo- and Enantiomerically Enriched g-Addition Products 
N-((1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-phenylbut-3-en-1-yl)-P,P-diphenylphosphinic 
amide (1.106): Viscous oil; IR (neat): 3195 (w, br), 2925 (w), 2885 (w), 1438 (m), 1190 (s), 1109 
(s), 1032 (s), 698 (m), 535 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.92 – 7.81 (m, 2H), 7.78 – 
7.66 (m, 2H), 7.55 – 7.46 (m, 1H), 7.45 – 7.36 (m, 3H), 7.32 – 7.27 (m, 2H), 7.25 – 7.21 (m, 3H), 
7.18 (dd, J = 7.5, 2.0 Hz, 2H), 5.40 (m, 1H), 5.34 – 5.11 (m, 2H), 4.84 – 4.63 (m, 2H), 4.54 – 4.47 
(m, 1H), 4.26 (td, J = 10.6, 4.4 Hz, 1H), 4.14 (dd, J = 10.6, 7.0 Hz, 1H), 3.67 – 3.48 (m, 2H), 3.48 
– 3.33 (m, 2H), 3.27 (s, 3 H); 13C NMR (100 MHz, CDCl3): δ 140.1 (d, J = 4.6 Hz), 135.1, 133.2 
(d, J = 128 Hz), 132.7 (d, J = 9.7 Hz), 132.2 (d, J = 131 Hz), 132.0 (d, J = 9.6 Hz), 132.0 (d, J = 
2.8 Hz), 131.8 (d, J = 2.8 Hz), 128.6 (d, J = 12.6 Hz), 128.4 (d, J = 12.7 Hz), 128.2, 128.0, 127.3, 
119.6, 93.7, 82.2 (d, J = 4.5 Hz), 71.8, 67.6, 59.0, 58.3; HRMS (DART): Calcd for C26H31NO4P 
[M+H]+: 452.1991; Found: 452.1798; Specific rotation: [α]26.0D –7.4 (c = 1.45, CHCl3) for a 97:3 
e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 18.331 min 




diphenylphosphinic amide (1.113): White solid; M.p. = 87 – 89 °C; IR (neat): 3201 (w, br), 
2928 (w), 2889 (w), 1438 (m), 1183 (s), 1108 (s), 1027 (s), 725 (m), 697 (m) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.89 – 7.80 (m, 2H), 7.76 – 7.69 (m, 2H), 7.53 – 7.46 (m, 1H), 7.46 – 7.39 (m, 
3H), 7.38 – 7.27 (m, 3H), 7.24 – 7.16 (m, 1H), 7.08 (td, J = 7.6, 1.2 Hz, 1H), 6.90 (ddd, J = 9.6, 
8.1, 1.2 Hz, 1H),  5.57 – 5.45 (m, 1H), 5.34 – 5.19 (m, 2H), 4.79 – 4.57 (m, 2H), 4.58 (dd, J = 
10.7, 5.1 Hz, 1H), 4.54 – 4.46 (m, 1H), 4.09 (dd, J = 10.7, 7.3 Hz, 1H), 3.43 – 3.38 (m, 2H), 3.38 
– 3.30 (m, 2H), 3.28 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 160.2 (d, J = 244 Hz), 134.6, 132.8 
(d, J = 127 Hz), 132.5 (d, J = 10 Hz), 132.2 (d, J = 130 Hz), 132.1 (d, J = 9.6 Hz), 132.0 (d, J = 
2.8 Hz), 131.9 (d, J = 2.8 Hz), 130.2 (d, J = 4.2 Hz), 129.0 (d, J = 8.3 Hz), 128.6 (d, J = 12.5 Hz), 
128.4 (d, J = 12.7 Hz), 127.6 (dd, J = 13.1 Hz, 4.0 Hz), 124.0 (d, J = 3.4 Hz), 119.9, 115.2 (d, J = 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 17.151 50.233 1 18.331 97.349 
2 21.463 49.767 2 22.716 2.651 
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22.5 Hz), 93.6, 81.1 (dd, J = 5.3 Hz, 1.4 Hz), 71.7, 67.4, 59.0, 52.5; 19F NMR: –111.52; HRMS 
(DART): Calcd for C26H30NO4PF [M+H]+: 470.1897; Found: 470.1901; Specific rotation: 
[α]28.7D –54.3 (c = 0.92, CHCl3) for a 99:1 e.r. sample. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (Chiralpak AD-H, 94:6 




diphenylphosphinic amide (1.114): Viscous yellow oil; IR (neat): 3201 (w, br), 2924 (w), 2887 
(w), 1438 (m), 1187 (s), 1109 (s), 1033 (s), 725 (m), 696 (m) cm-1; 1H NMR (400 MHz, CDCl3): 
δ 7.89 – 7.80 (m, 2H), 7.77 – 7.68 (m, 2H), 7.55 – 7.45 (m, 2H), 7.45 – 7.37 (m, 3H), 7.30 (td, J = 
7.6, 3.2 Hz, 2H), 7.25 – 7.11 (m, 3H), 5.48 (ddd, J = 17.0, 10.4, 6.8 Hz, 1H), 5.34 – 5.19 (m, 2H), 
4.82 (s, 1H), 4.72 (t, J = 5.6 Hz, 2H), 4.56 (t, J = 5.6 Hz, 1H), 4.12 (dd, J = 10.2, 6.7 Hz, 1H), 3.54 
(s, 2H), 3.49 – 3.34 (m, 2H), 3.29 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 138.0 (d, J = 3.7 Hz), 
133.8, 133.1 (broad peak), 132.7 (d, J = 128 Hz), 132.6 (d, J = 9.7 Hz), 132.1 (d, J = 9.6 Hz), 132.1 
(d, J = 129 Hz), 132.0 (d, J = 2.7 Hz), 131.9 (J = 2.7 Hz), 130.3 (broad peak), 129.2, 128.5 (d, J 
= 12.6 Hz), 128.5, 128.4 (d, J = 12.7 Hz), 126.6, 119.9, 80.1 (d, J = 5.2 Hz), 71.5, 67.3, 59.0; 
HRMS (DART): Calcd for C26H30NO4PCl [M+H]+: 486.1601; Found: 486.1614; Specific 
rotation: [α]27.9D –29.4 (c = 1.02, CHCl3) for a 99:1 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H, 
90:10 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 52.871 min (minor) and 61.321 min (major).  
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 39.652 49.380 1 39.341 99.617 
2 49.184 50.620 2 48.862 0.383 
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Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 52.850 49.772 1 52.871 0.934 
2 61.440 50.228 2 61.321 99.066 
 
N-((1S,2R)-1-(2-Bromophenyl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.115): White solid; M.p. = 76 – 78 °C; IR (neat): 3203 (w, br), 
2927 (w), 2887 (w), 1438 (m), 1189 (s), 1123 (s), 1023 (s), 725 (m), 696 (m), 541 (m) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.92 – 7.79 (m, 2H), 7.80 – 7.67 (m, 2H), 7.59 – 7.35 (m, 6H), 7.36 
– 7.28 (m, 3H), 7.18 – 6.98 (m, 1H), 5.47 (dd, J = 16.8, 7.9 Hz, 1H), 5.41 – 5.15 (m, 2H), 4.92 – 
4.77 (m, 1H), 4.74 (s, 2H), 4.55 (t, J = 5.6 Hz, 1H), 4.13 (dd, J = 10.1, 6.5 Hz, 1H), 3.55 (br s, 
2H), 3.51 – 3.37 (m, 2H), 3.30 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 139.5 (d, J = 3.8 Hz), 
133.7, 132.7 (d, J = 128 Hz), 132.6 (d, J = 9.7 Hz), 132.6 (broad peak, peaks overlapped at 132.6), 
132.2 (d, J = 9.6 Hz), 132.1 (d, J = 131 Hz), 132.0 (d, J = 2.8 Hz), 131.9 (d, J = 2.7 Hz), 131.4, 
130.5 (broad peak), 128.8, 128.5 (d, J = 12.6 Hz peaks overlapped at 128.5), 128.4 (d, J = 12.8 
Hz), 127.3, 123.8, 112.0, 93.5, 80.0, 71.8, 67.6, 59.1; HRMS (DART): Calcd for C26H30NO4PBr 
[M+H]+: 530.1096; Found: 530.1113; Specific rotation: [α]28.7D –23.2 (c = 1.02, CHCl3) for a 
97:3 e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 
20.942 min (minor) and 22.751 min (major). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 20.596 51.327 1 20.942 2.915 
2 22.752 48.673 2 22.752 97.085 
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N-((1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-(o-tolyl)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.116): White solid; M.p. = 100 – 102 °C; IR (neat): 3198 (w, br), 
2924 (w), 2885 (w), 1438 (m), 1186 (s), 1108 (s), 1070 (s), 1021 (s), 725 (s), 696 (s) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.95 – 7.76 (m, 2H), 7.75 – 7.57 (m, 2H), 7.55 – 7.45 (m, 2H), 7.44 
– 7.35 (m, 3H), 7.25 – 7.18 (m, 3H), 7.11 (td, J = 7.4, 1.5 Hz, 1H), 6.94 (ddd, J = 7.6, 1.5, 0.7 Hz, 
1H), 5.43 (ddd, J = 17.4, 10.1, 7.4 Hz, 1H), 5.34 – 5.26 (m, 1H), 5.21 (ddd, J = 10.1, 2.1, 0.8 Hz, 
1H), 4.79 – 4.56 (m, 2H), 4.54 (ddd, J = 11.7, 10.1, 4.9 Hz, 1H), 4.41 (dd, J = 7.4, 5.0 Hz, 1H), 
4.09 (dd, J = 10.1, 6.9 Hz, 1H), 3.49 (dd, J = 5.1, 3.8 Hz, 2H), 3.46 – 3.32 (m, 2H), 3.29 (s, 3H), 
1.79 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 138.9 (d, J = 4.2 Hz), 135.3, 134.5, 132.9 (d, J = 
128 Hz), 132.5 (d, J = 9.7 Hz), 131.7 (d, J = 9.5 Hz), 131.6 (d, J = 131.2 Hz), 131.6 (d, J = 2 Hz, 
peaks overlapped at 131.6), 131.5 (d, J = 2.8 Hz), 129.6, 128.3 (d, J = 12.5 Hz), 128.0 (d, J = 12.5 
Hz), 127.6, 126.8, 125.7, 119.9, 93.0, 81.2 (d, J = 4.5 Hz), 71.5, 67.1, 58.7, 52.7, 19.1; HRMS 
(DART): Calcd for C27H33NO4P [M+H]+: 466.2147; Found: 466.2159; Specific rotation: [α]28.7D 
–47.8 (c = 0.94, CHCl3) for a 98:2 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralcel OZ-3, 90:10 hexanes:iPrOH, 
1.2 mL/min, 220 nm): tR: 13.678 min (major) and 40.499 min (minor).  
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 14.040 50.825 1 13.678 97.732 
2 39.093 49.175 2 40.499 2.268 
 
N-((1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-(naphthalen-1-yl)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.117): Viscous oil; IR (neat): 3208 (w, br), 2926 (w), 2887 (w), 
1438 (m), 1324 (s), 1190 (s), 1107 (s), 1023 (s), 778 (m), 724 (s), 696 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.84 (ddd, J = 12.0, 8.3, 1.4 Hz, 2H), 7.80 – 7.58 (m, 7H), 7.50 – 7.41 (m, 2H), 
7.41 – 7.33 (m, 3H), 7.31 – 7.25 (m, 2H), 7.16 – 7.03 (m, 2H), 5.47 – 5.32 (m, 1H), 5.22 (td, J = 
10.4, 4.6 Hz, 1H), 5.18 – 5.12 (m, 1H), 4.73 (d, J = 1.5 Hz, 2H), 4.69 – 4.61 (m, 1H), 4.06 (dd, J 
= 9.8, 6.9 Hz, 1H), 3.54 (s, 1H), 3.54 – 3.44 (m, 2H), 3.43 – 3.32 (m, 2H), 3.28 (s, 3H); 13C NMR 
(125 MHz, CDCl3): δ 136.6 (d, J = 3.8 Hz), 135.5, 134.5, 133.6, 133.0 (d, J = 128 Hz), 132.5 (d, 
J = 9.7 Hz), 132.1 (d, J = 9.6 Hz), 132.1, (d, J = 130 Hz, peaks overlapped at 131.6), 131.9 (d, J = 
2.7 Hz), 131.6 (d, J = 2.8 Hz), 131.0, 128.7, 128.5 (d, J = 12.5 Hz), 128.2 (d, J = 12.8 Hz), 128.0, 
126.0, 125.9, 125.4, 125.3, 123.2, 119.9, 93.6, 80.9 (d, J = 4.8 Hz), 71.8, 67.5, 59.1;  HRMS 
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(DART): Calcd for C30H33NO4P [M+H]+: 502.2147; Found: 502.2159; Specific rotation: [α]23.4D 
–39.9 (c = 1.29, CHCl3) for a 98:2 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 
1.0 mL/min, 220 nm): tR: 23.545 min (major) and 26.273 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 22.977 49.995 1 23.545 98.036 
2 25.537 50.005 2 26.273 1.964 
 
N-((1S,2R)-1-(3-Bromophenyl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.118): Viscous oil; IR (neat): 3178 (w, br), 2925 (w), 2886 (w), 
1438 (m), 1187 (s), 1107 (s), 1023 (s), 725 (m), 698 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.85 
(ddd, J = 12.0, 8.3, 1.4 Hz, 2H), 7.76 – 7.65 (m, 2H), 7.56 – 7.48 (m, 1H), 7.45 – 7.39 (m, 3H), 
7.35 – 7.28 (m, 4H), 7.14 – 7.04 (m, 2H), 5.39 (ddd, J = 17.2, 10.0, 7.1 Hz, 1H), 5.31 – 5.13 (m, 
2H), 4.81 – 4.64 (m, 2H), 4.48 (dd, J = 7.1, 4.2 Hz, 1H), 4.34 – 4.13 (m, 2H), 3.65 – 3.49 (m, 2H), 
3.49 – 3.33 (m, 2H), 3.27 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 142.6 (d, J = 4.2 Hz), 134.8, 
133.0 (d, J = 127 Hz), 132.7 (d, J = 9.7 Hz), 132.0 (d, J = 3.0 Hz, peaks overlapped at 132.0), 
132.0 (d, J = 130 Hz), 132.0 (d, J = 9.7 Hz), 131.9 (d, J = 2.8 Hz, peaks overlapped at 131.9), 
131.3, 130.4, 129.6, 128.6 (d, J = 12.5 Hz), 128.4 (d, J = 12.7 Hz), 127.2, 122.2, 120.0, 93.7, 82.1 
(d, J = 4.8 Hz), 71.8, 67.7, 59.0, 57.8; HRMS (DART): Calcd for C26H30NO4PBr [M+H]+: 
530.1096; Found: 530.1112; Specific rotation: [α]28.7D +3.05 (c = 2.04, CHCl3) for a 95:5 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 17.205 min 
(major) and 20.005 min (minor). 
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Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 17.377 50.425 1 17.205 95.454 
2 20.161 49.575 2 20.005 4.546 
 
N-((1S,2R)-1-(4-Bromophenyl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.119): White solid, M.p = 84 – 86 °C; IR (neat): 3195 (w, br), 2887 
(w), 2835 (w), 1513 (m), 1438 (m), 1178 (s), 1120 (s), 1109 (s), 1023 (s), 723 (s), 694 (m), 525 (s) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.90 – 7.79 (m, 2H), 7.76 – 7.64 (m, 2H), 7.54 – 7.47 (m, 
1H), 7.43 (dddd, J = 9.4, 4.9, 2.7, 1.4 Hz, 3H), 7.36 (d, J = 8.5 Hz, 2H), 7.32 – 7.28 (m, 2H), 7.07 
(d, J = 8.5 Hz, 2H), 5.37 (ddd, J = 17.1, 10.0, 7.0 Hz, 1H), 5.29 – 5.09 (m, 2H), 4.77 – 4.60 (m, 
2H), 4.54 – 4.44 (m, 1H), 4.26 – 4.15 (m, 2H), 3.60 (ddd, J = 10.8, 5.8, 3.3 Hz, 1H), 3.53 (ddd, J 
= 10.8, 6.1, 3.3 Hz, 1H), 3.40 (qdd, J = 10.7, 6.0, 3.3 Hz, 2H), 3.26 (s, 3H); 13C NMR (100 MHz, 
CDCl3): δ 139.1 (d, J = 4.5 Hz), 134.9, 133.0 (d, J = 127 Hz), 132.6 (d, J = 9.6 Hz), 132.1 (d, J = 
130 Hz), 132.0 (d, J = 3.0 Hz), 132.0 (d, J = 9.6 Hz), 131.9 (d, J = 2.6 Hz), 131.1, 130.1, 128.6 (d, 
J = 12.5 Hz), 128.4 (d, J = 12.6 Hz), 121.3, 119.8, 93.9, 82.1 (d, J=4.7 Hz), 71.7, 67.7, 59.0, 57.8; 
HRMS (DART): Calcd for C26H30NO4PBr [M+H]+: 530.1096; Found: 530.1122; Specific 
rotation: [α]28.7D +51.9 (c = 2.03, CHCl3) for a 98:2 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralcel OZ-3, 
92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 16.064 min (minor) and 18.722 min (major). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 16.079 49.963 1 16.064 1.894 
2 18.884 50.037 2 18.722 98.106 
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N-((1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-(4-methoxyphenyl)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.120): Viscous oil; IR (neat): 3191 (w, br), 2887 (w), 2835 (w), 
1513 (m), 1438 (m), 1178 (s), 1108 (s), 1024 (s), 723 (m), 695 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.84 (ddd, J = 12.0, 8.3, 1.4 Hz, 2H), 7.81 – 7.65 (m, 2H), 7.59 – 7.37 (m, 4H), 7.30 
(tdd, J = 8.1, 3.0, 1.1 Hz, 2H), 7.11 (dd, J = 8.7, 0.4 Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 5.39 (ddd, 
J = 17.3, 10.1, 7.2 Hz, 1H), 5.30 – 5.13 (m, 2H), 4.82 – 4.57 (m, 2H), 4.52 – 4.39 (m, 1H), 4.21 
(td, J = 10.6, 4.2 Hz, 1H), 4.10 (dd, J = 10.4, 6.9 Hz, 1H), 3.79 (s, 3H), 3.62 (ddd, J = 10.8, 5.7, 
3.2 Hz, 1H), 3.53 (ddd, J = 10.8, 6.4, 3.2 Hz, 1H), 3.46 – 3.34 (m, 2H), 3.28 (s, 3H); 13C NMR 
(100 MHz, CDCl3): δ 158.8, 135.3, 133.3 (d, J = 127 Hz), 132.8 (d, J = 9.6 Hz), 132.4 (d, J = 130 
Hz), 132.3 (d, J  =  4.7 Hz), 132.0 (d, J = 9.5 Hz), 131.9 (d, J = 2.7 Hz), 131.8 (d, J = 2.7 Hz), 
129.4, 128.5 (d, J = 12.5 Hz), 128.3 (d, J = 12.6 Hz), 119.5, 113.4, 93.8, 82.4 (d, J = 4.6 Hz), 71.8, 
67.6, 59.0, 57.8, 55.4;  HRMS (DART): Calcd for C27H33NO5P [M+H]+: 482.2096; Found: 
482.2096; Specific rotation: [α]23.4D –13.4 (c = 0.76, CHCl3) for a 98:2 e.r. sample. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(Chiralpak AD-H, 95:5 hexanes:iPrOH, 0.6 mL/min, 220 nm): tR: 86.781 min (major) and 96.723 
min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 89.400 50.408 1 86.781 97.627 
2 97.650 49.592 2 96.723 2.373 
 
N-((1S,2R)-1-(4-(Dimethylamino)phenyl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.121): Viscous oil; IR (neat): 3215 (w, br), 2885 (w), 2813 (w), 
1672 (m), 1523 (m), 1438 (m), 1190 (s), 1109 (s), 1025 (s), 754 (m), 697 (s) cm-1; 1H NMR (400 
MHz, CDCl3):  δ 7.93 – 7.82 (m, 2H), 7.80 – 7.70 (m, 2H), 7.57 – 7.34 (m, 4H), 7.37 – 7.26 (m, 
2H), 7.05 (d, J = 8.7 Hz, 2H), 6.63 (d, J = 8.7 Hz, 2H), 5.41 (ddd, J = 17.3, 10.2, 7.2 Hz, 1H), 5.34 
– 5.07 (m, 2H), 4.84 – 4.60 (m, 2H), 4.47 (dd, J = 7.3, 4.2 Hz, 1H), 4.15 (td, J = 10.6, 4.2 Hz, 1H), 
4.06 (dd, J = 10.6, 6.9 Hz, 1H), 3.64 (ddd, J = 10.8, 5.6, 3.1 Hz, 1H), 3.55 (ddd, J = 10.9, 6.6, 3.1 
Hz, 1H), 3.39 (ddd, J = 10.7, 5.6, 3.2 Hz, 2H), 3.29 (s, 3H), 2.93 (s, 6H); 13C NMR (100 MHz, 
CDCl3): δ 149.8, 135.5, 133.4 (d, J = 128 Hz), 132.8 (d, J = 9.7 Hz), 132.4 (d, J = 131 Hz), 132.0 
(d, J = 9.6 Hz), 131.8 (d, J = 2.7 Hz), 131.7 (d, J = 2.8 Hz), 128.9, 128.5 (d, J = 12.5 Hz), 128.3 
(d, J = 12.7 Hz), 119.2, 112.3, 93.7, 82.5 (d, J = 4.3 Hz), 71.8, 67.5, 59.0, 58.0, 57.9, 40.9; HRMS 
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(DART): Calcd for C28H36N2O4P [M+H]+: 495.2413; Found: 495.2412; Specific rotation: [α]23.7D 
+30.6 (c = 1.11, CHCl3) for a 97:3 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralcel OZ-3, 92:8 hexanes:iPrOH, 1.0 
mL/min, 220 nm): tR: 54.462 min (minor) and 59.338 min (major). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 53.926 50.067 1 54.462 2.319 
2 61.825 49.933 2 59.338 97.681 
 
N-((1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-(4-(trifluoromethyl)phenyl)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.122): White solid; M.p. = 104 – 106 °C; IR (neat): 3175 (w, br), 
2888 (w), 2835 (w), 1438 (m), 1324 (s), 1111 (s), 1108 (s), 986 (s), 695 (m), 534 (s) cm-1; 1H 
NMR (600 MHz, CDCl3) δ 7.94 – 7.80 (m, 2H), 7.74 – 7.62 (m, 2H), 7.49 (dd, J = 13.6, 4.9 Hz, 
3H), 7.46 – 7.39 (m, 3H), 7.38 – 7.27 (m, 4H), 5.37 (ddd, J = 17.2, 10.2, 7.0 Hz, 1H), 5.31 – 5.12 
(m, 2H), 4.81 – 4.60 (m, 2H), 4.52 (dd, J = 7.1, 4.2 Hz, 1H), 4.33 (td, J = 10.2, 4.2 Hz, 1H), 4.27 
(dd, J = 10.2, 6.9 Hz, 1H), 3.63 – 3.46 (m, 2H), 3.47 – 3.30 (m, 2H), 3.25 (s, 3H); 13C NMR (100 
MHz, CDCl3): δ 144.4, 135.0, 133.0 (d, J = 129, peaks overlapped at 132.3), 132.9 (d, J = 9.7 
Hz), 132.4 (d, J=2.7 Hz), 132.3 (d, J = 9.7 Hz), 132.3 (d, J = 2.2 Hz, peaks overlapped at 132.3), 
132.2 (d, J=131 Hz), 129.8 (q, J = 32.4 Hz), 129.1, 128.9 (d, J=12.5 Hz), 128.7 (d, J = 12.6 Hz), 
125.2 (q, J = 3.7 Hz), 124.6 (q, J = 272 Hz), 120.3, 94.2, 82.4 (d, J=5.0 Hz), 72.0, 68.1, 59.3, 58.3; 
19F NMR (376 MHz): δ –62.52; HRMS (DART): Calcd for C27H30NO4PF3 [M+H]+: 520.1865; 
Found: 520.1838; Specific rotation: [α]23.1D –5.5 (c = 0.91, CHCl3) for a 98:2 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralcel OZ-3, 94:6 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 13.409 min (minor) and 
16.132 min (major). 
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Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 13.286 49.678 1 13.409 1.046 
2 16.341 50.322 2 16.132 98.954 
 
Methyl 4-((1S,2R)-1-((Diphenylphosphoryl)amino)-2-((2-methoxyethoxy)methoxy)but-3-en-
1-yl)benzoate (1.123): White solid; M.p. = 94 – 96 °C;  IR (neat): 3201 (w, br), 2924 (w), 2887 
(w), 1718 (s), 1436 (m), 1312 (s), 1184 (s), 1106 (s), 1020 (s), 696 (m), 536 (s) cm-1; 1H NMR 
(600 MHz, CDCl3): δ 7.91 (d, J = 8.0 Hz, 2H), 7.85 – 7.79 (m, 2H), 7.74 – 7.63 (m, 2H), 7.56 – 
7.46 (m, 1H), 7.47 – 7.36 (m, 3H), 7.30 – 7.25 (m, 4H), 5.41 – 5.31 (m, 1H), 5.31 – 5.12 (m, 2H), 
4.79 – 4.62 (m, 2H), 4.51 (dd, J = 7.2, 4.2 Hz, 1H), 4.32 (td, J = 10.6, 4.2 Hz, 1H), 4.26 (dd, J = 
10.3, 6.8 Hz, 1H), 3.90 (s, 3H), 3.65 – 3.48 (m, 2H), 3.46 – 3.31 (m, 2H), 3.25 (s, 3H); 13C NMR 
(100 MHz, CDCl3): δ 167.1, 145.3 (d, J = 4.5 Hz), 134.7, 132.9 (d, J = 128 Hz), 132.6 (d, J = 9.7 
Hz), 132.1 (d, J = 2.9 Hz), 132.0 (d, J = 9.7 Hz), 132.0 (d, J = 2.5 Hz), 131.9 (d, J = 131 Hz, peaks 
overlapped at 132.6), 131.9, 129.3, 128.6 (d, J = 12.6 Hz), 128.4 (d, J = 12.7 Hz), 128.4, 119.8, 
93.8, 82.1 (d,  J = 4.5 Hz), 71.7, 67.7, 59.0, 58.1, 52.2;  HRMS (DART): Calcd for C28H33NO6P 
[M+H]+: 510.2046; Found: 510.2054; Specific rotation: [α]21.2D +11.4 (c = 1.02, CHCl3) for a 
99:1 e.r. sample. Enantiomeric purity was determined by HPLC analysis of the corresponding 
alcohol in comparison with authentic racemic material (Chiralpak AZ-H, 90:10 hexanes:iPrOH, 
1.2 mL/min, 220 nm): tR: 45.457 min (minor) and 52.478 min (major). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 45.718 50.750 1 45.457 98.752 
2 52.556 49.250 2 52.478 1.248 
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N-((3S,4R,E)-4-((2-Methoxyethoxy)methoxy)-2-methyl-1-phenylhexa-1,5-dien-3-yl)-P,P-
diphenylphosphinic amide (1.124): Viscous oil; IR (neat): 3198 (w, br), 2922 (w), 2887 (w), 
1438 (m), 1245 (s), 1108 (s), 1108 (s), 1023 (s), 697 (s), 537 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.97 – 7.80 (m, 4H), 7.54 – 7.34 (m, 6H),  δ 7.33 – 7.25 (m, 2H), 7.21 – 7.14 (m, 1H), 
7.13 – 7.08 (m, 2H), 6.06 (d, J = 1.6 Hz, 1H), 5.68 (ddd, J = 17.5, 10.3, 7.3 Hz, 1H), 5.37 – 5.21 
(m, 2H), 4.80 – 4.66 (m, 2H), 4.37 (dd, J = 7.3, 4.3 Hz, 1H), 3.93 – 3.77 (m, 2H), 3.72 (ddd, J = 
10.9, 5.7, 3.2 Hz, 1H), 3.56 (ddd, J = 13.3, 6.0, 2.9 Hz, 1H), 3.51 – 3.36 (m, 2H), 3.27 (s, 3H), 
1.86 (d, J = 1.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 137.6, 136.3 (d, J = 3.9 Hz), 135.3, 
133.2 (d, J = 127 Hz), 132.8 (d, J = 9.6 Hz), 132.7 (d, J = 131 Hz), 132.0 (d, J = 9.6 Hz), 131.9 (d, 
J = 3.1 Hz, peaks overlapped at 131.9), 131.9 (d, J = 3.2 Hz, peaks overlapped at 131.9), 129.2, 
129.1, 128.6 (d, J = 12.5 Hz), 128.4 (d, J = 12.7 Hz), 128.1, 126.5, 119.3, 93.9, 81.3 (d, J = 5.5 
Hz) 71.8, 67.7, 61.6, 59.1, 15.2;  HRMS (DART): Calcd for C29H35NO4P [M+H]+: 492.2304; 
Found: 492.2314; Specific rotation: [α]23.4D –10.6 (c = 0.98, CHCl3) for a 94:6 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 14.122 min (major) and 
16.736 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 14.212 49.633 1 14.122 94.396 
2 16.756 50.367 2 16.736 5.604 
 
N-((3S,4R,E)-4-((2-Methoxyethoxy)methoxy)-1-phenylhexa-1,5-dien-3-yl)-P,P-
diphenylphosphinic amide (1.125): Viscous yellow oil; IR (neat): 3195 (w, br), 2921 (w), 2887 
(w), 1438 (m), 1191 (s), 1122 (s), 1028 (s), 721 (m), 695 (m) cm-1; 1H NMR (400 MHz, CDCl3): 
δ 8.02 – 7.76 (m, 4H), 7.54 – 7.31 (m, 6H), 7.29 – 7.25 (m, 4H), 7.22 – 7.15 (m, 1H), 6.34 (dd, J 
= 16.0, 1.0 Hz, 1H), 6.15 (dd, J = 15.9, 7.4 Hz, 1H), 5.68 (ddd, J = 17.4, 10.4, 7.0 Hz, 1H), 5.42 – 
5.15 (m, 2H), 4.83 – 4.68 (m, 2H), 4.49 – 4.35 (m, 1H), 3.98 (dd, J = 10.1, 6.9 Hz, 1H), 3.92 – 
3.81 (m, 1H), 3.76 (ddd, J = 10.9, 5.9, 3.1 Hz, 1H), 3.58 (ddd, J = 10.9, 6.3, 3.2 Hz, 1H), 3.43 
(qdd, J = 10.7, 6.0, 3.1 Hz, 2H), 3.24 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 136.9, 135.2, 133.3 
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(d, J = 130 Hz, overlaps with peak at 132.6), 132.8, 132.7 (d, J=130 Hz), 132.7 (d, J = 8.4 Hz), 
132.0 (d, J = 9.5 Hz), 131.9 (d, J=2.8 Hz, peaks overlapped at 131.9), 131.9, 131.9 (d, J=2.7 Hz, 
peaks overlapped at 131.9) 128.6 (d, J=12.5 Hz), 128.5, 128.5 (d, J=12.5 Hz) 127.7, 119.3, 94.2, 
82.6, 82.6, 71.8, 67.7, 59.0, 57.3; HRMS (DART): Calcd for C28H33NO4P [M+H]+: 478.2147; 
Found: 478.2158; Specific rotation: [α]26.0D +9.9 (c = 1.01, CHCl3) for a 98:2 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AD-H, 94:6 hexanes:iPrOH, 0.8 mL/min, 220 nm): tR: 29.987 min (major) and 
41.868 min (minor).  
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 30.170 50.380 1 29.987 97.617 
2 42.089 49.620 2 41.868 2.383 
 
N-((1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-(pyridin-3-yl)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.126): White solid; M.p. = 79 – 81 °C; IR (neat): 3172 (w, br), 
2978 (w), 2886 (w), 1438 (m), 1184 (s), 1108 (s), 1026 (s), 724 (s), 696 (s), 531 (s) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 8.46 (dd, J = 4.8, 1.6 Hz, 1H), 8.37 (d, J = 2.2 Hz, 1H), 7.94 – 7.79 (m, 2H), 
7.69 (ddd, J = 12.1, 8.1, 1.4 Hz, 2H), 7.57 (dt, J = 7.9, 2.0 Hz, 1H), 7.53 – 7.46 (m, 1H), 7.48 – 
7.37 (m, 3H), 7.30 (ddd, J = 8.5, 4.3, 2.9 Hz, 2H), 7.21 – 7.13 (m, 1H), 5.37 (ddd, J = 17.1, 10.1, 
7.0 Hz, 1H), 5.30 – 5.12 (m, 2H), 4.72 (q, J = 6.8 Hz, 2H), 4.54 (dd, J = 7.0, 4.0 Hz, 1H), 4.45 – 
4.34 (m, 1H), 4.27 (td, J = 10.4, 4.1 Hz, 1H),  3.63 (ddd, J = 10.8, 5.8, 3.2 Hz, 1H), 3.55 (ddd, J = 
10.9, 6.1, 3.2 Hz, 1H), 3.49 – 3.31 (m, 2H), 3.23 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 149.8, 
148.6, 136.2, 135.6, 135.5, 132.8 (d, J = 128 Hz), 131.9 (d, J = 131 Hz), 132.0 (d, J = 2.8 Hz, 
peaks overlapped at 132.0), 132.1 (d, J = 2.8 Hz), 132.0 (d, J = 9.6 Hz), 132.6 (d, J = 9.8 Hz), 
128.7 (d, J = 12.6 Hz), 128.5 (d, J = 12.8 Hz), 123.0, 120.1, 94.0, 82.4 (d, J = 4.7 Hz), 71.7, 67.8, 
59.0, 56.4; HRMS (DART): Calcd for C25H30N2O4P [M+H]+: 453.1943; Found: 453.1933; 
Specific rotation: [α]22.9D –4.9 (c = 1.09, CHCl3) for a 92:8 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AD-H, 
92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 58.509 min (major) and 85.229 min (minor). 
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Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 58.573 49.331 1 58.509 92.372 
2 84.697 50.669 2 85.229 7.628 
 
N-((1S,2R)-1-(Furan-3-yl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.127): Viscous oil; IR (neat): 3027 (w, br), 2925 (w), 2888 (w), 
1438 (m), 1190 (s), 1122 (s), 1022 (s), 726 (m), 698 (m), 529 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.93 – 7.73 (m, 4H), 7.57 – 7.36 (m, 6H), 7.32 (t, J = 1.7 Hz, 1H),  7.23 (dt, J = 1.6, 0.7 
Hz, 1H),  6.41 (dd, J = 1.8, 0.9 Hz, 1H), 5.52 (ddd, J = 17.4, 10.4, 7.1 Hz, 1H), 5.36 – 5.09 (m, 
2H), 4.88 – 4.66 (m, 2H), 4.51 (dd, J = 7.1, 3.4 Hz, 1H), 4.23 (td, J = 10.6, 3.5 Hz, 1H), 4.08 – 
3.95 (m, 1H), 3.74 (ddd, J = 10.9, 5.8, 3.1 Hz, 1H), 3.59 (ddd, J = 10.9, 6.3, 3.2 Hz, 1H), 3.51 – 
3.39 (m, 2H), 3.27 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 142.8, 140.6, 135.2, 133.1 (d, J = 127 
Hz), 132.7 (d, J = 9.6 Hz), 132.5 (d, J = 130 Hz), 132.1 (d, J = 9.6 Hz), 131.9 (d, J = 2.7 Hz), 
128.6 (d, J = 12.5 Hz), 128.5 (d, J = 2.7 Hz), 124.2 (d, J = 5.5 Hz), 119.4, 110.6, 94.2, 82.4 (d, J 
= 4.3 Hz), 71.8, 67.7, 59.0, 50.9;  HRMS (DART): Calcd for C24H29NO5P [M+H]+: 442.1783; 
Found: 442.1784; Specific rotation: [α]23.9D –36.3 (c = 1.1, CHCl3) for a 98:2 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralcel OZ-3, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 19.934 min (major) and 
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Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 20.197 51.441 1 19.934 98.249 
2 33.275 48.559 2 32.018 1.751 
 
N-((1R,2R)-1-(Furan-2-yl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.128): Viscous yellow oil; IR (neat): 3058 (w, br), 2890 (w), 2837 
(w), 1758 (m), 1438 (m), 1123 (s), 1107 (s), 1025 (s), 726 (s), 696 (s), 527 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.96 – 7.65 (m, 4H), 7.51 – 7.33 (m, 5H), 7.30 (q, J = 1.6 Hz, 2H), 7.23 (dt, J = 
1.3, 0.7 Hz, 1H), 6.39 (dt, J = 2.0, 1.0 Hz, 1H), 5.49 (dddd, J = 17.4, 10.4, 7.0, 1.1 Hz, 1H), 5.32 
– 5.05 (m, 2H), 4.88 – 4.70 (m, 2H), 4.48 (ddt, J = 7.6, 3.5, 1.1 Hz, 1H), 4.20 (td, J = 10.5, 3.5 Hz, 
1H), 4.02 (dd, J = 10.9, 7.6 Hz, 1H), 3.71 (dddd, J = 10.2, 5.9, 3.1, 1.1 Hz, 1H), 3.57 (dddd, J = 
10.7, 6.2, 3.2, 1.1 Hz, 1H), 3.52 – 3.34 (m, 2H), 3.26 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 
142.6, 140.4 134.9, 132.9 (d, J = 128 Hz), 132.5 (d, J = 9.6 Hz), 132.3 (d, J = 131 Hz), 131.9 (d, 
J = 9.6 Hz), 131.8 (d, J = 4.4 Hz, peaks overlapped at 131.8), 131.8 (d, J = 3.0 Hz), 128.4 (d, J = 
12.6 Hz), 128.3 (d, J = 12.7 Hz), 124.0 (d, J = 5.5 Hz), 119.2, 110.2, 94.0, 82.2 (d, J = 4.2 Hz), 
71.2, 67.6, 58.08, 50.8;  HRMS (DART): Calcd for C24H29NO5P [M+H]+: 442.1783; Found: 
442.1775; Specific rotation: [α]21.3D +3.6 (c = 0.88, CHCl3) for a 90:10 e.r. sample. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material 
(Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 21.861 min (major) and 24.622 
min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 21.029 48.634 1 21.861 90.565 
2 23.078 51.366 2 24.622 9.435 
 
N-((1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-(thiophen-3-yl)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.129): Viscous oil; IR (neat): 3199 (w, br), 2927 (w), 2887 (w), 
1438 (m), 1190 (s), 1123 (s), 1027 (s), 698 (m), 528 (m) cm-1; 1H NMR (500 MHz, CDCl3): δ 
7.85 (ddd, J = 12.0, 8.3, 1.4 Hz, 2H), 7.80 – 7.71 (m, 2H), 7.57 – 7.39 (m, 4H), 7.39 – 7.28 (m, 
2H), 7.20 (dd, J = 5.0, 3.0 Hz, 1H), 7.09 – 6.96 (m, 2H), 5.44 (ddd, J = 17.3, 10.3, 7.1 Hz, 1H), 
5.35 – 5.11 (m, 2H), 4.85 – 4.68 (m, 2H), 4.52 (ddt, J = 7.1, 3.9, 1.0 Hz, 1H), 4.38 (td, J = 10.6, 
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3.9 Hz, 1H), 4.09 (dd, J = 10.6, 7.6 Hz, 1H), 3.67 (ddd, J = 10.8, 5.8, 3.1 Hz, 1H), 3.56 (ddd, J = 
10.8, 6.3, 3.2 Hz, 1H), 3.52 – 3.37 (m, 2H), 3.27 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 141.0 
(d, J = 5.0 Hz), 135.1, 133.1 (d, J = 128 Hz), 132.7 (d, J = 9.6 Hz), 132.3 (d, J = 131 Hz), 132.0 
(d, J = 9.6 Hz), 131.9 (d, J = 2.3 Hz, peaks overlapped at 131.9), 131.9 (d, J = 2.8 Hz), 128.5 (d, J 
= 12.9 Hz, peaks overlapped at 128.5), 128.4 (d, J = 13.1 Hz, peaks overlapped at 128.5), 127.7, 
125.3, 122.9, 119.5, 94.0, 82.3 (d, J = 4.4 Hz), 71.8, 67.7, 59.0, 54.4; HRMS (DART): Calcd for 
C24H29NO4PS [M+H]+: 458.1555; Found: 458.1569; Specific rotation: [α]26.9D –2.8 (c = 1.10, 
CHCl3) for a 98:2 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 
220 nm): tR: 18.627 min (major) and 23.972 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 18.747 49.782 1 18.627 97.997 
2 24.190 50.218 2 23.972 2.003 
 
N-((1R,2R)-2-((2-Methoxyethoxy)methoxy)-1-(thiophen-2-yl)but-3-en-1-yl)-P,P-
diphenylphosphinic amide (1.130): Viscous oil; IR (neat): 3201 (w, br), 2922 (w), 2887 (w), 
1438 (s), 1194 (s), 1123 (s), 1109 (s), 1035 (s), 725 (s), 697 (m), 530 (s) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.88 – 7.73 (m, 4H), 7.53 – 7.37 (m, 4H), 7.37 – 7.28 (m, 2H), 7.17 (ddd, J = 4.1, 2.9, 
1.3 Hz, 1H), 6.83 (dd, J = 5.1, 3.5 Hz, 1H), 6.73 (ddd, J = 3.5, 1.3, 0.6 Hz, 1H), 5.48 (ddd, J = 
17.3, 10.3, 6.9 Hz, 1H), 5.31 – 5.15 (m, 2H), 4.77 (q, J = 6.8 Hz, 2H), 4.64 – 4.46 (m, 2H), 4.24 – 
4.12 (m, 1H), 3.71 (ddd, J = 10.9, 5.6, 3.2 Hz, 1H), 3.58 (ddd, J = 10.9, 6.5, 3.3 Hz, 1H), 3.41 
(qdd, J = 10.7, 6.1, 3.2 Hz, 2H), 3.25 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 143.1 (d, J = 6.1 
Hz), 134.9, 133.2 (d, J = 128 Hz), 132.7 (d, J = 9.8 Hz), 132.0 (d, J = 128 Hz), 132.0 (d, J = 2.9 
Hz, peaks overlapped at 132.0), 131.9 (d, J = 9.9 Hz), 131.9 (d, J = 2.9 Hz, peaks overlapped at 
131.9), 128.6 (d, J = 12.6 Hz), 128.4 (d, J = 12.7 Hz), 126.4, 126.2, 125.1, 119.8, 94.1, 82.5 (d, J 
= 3.8 Hz), 71.7, 67.8, 59.0, 54.6;  HRMS (DART): Calcd for C27H30NO4PF3 [M+H]+: 458.1555; 
Found: 458.1537, Specific rotation: [α]23.4D –13.1 (c = 1.1, CHCl3) for a 98:2 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 19.315 min (major) and 
25.096 min (minor). 
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Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 19.413 50.245 1 19.315 97.873 
2 25.192 49.755 2 25.096 2.127 
 
N-((3S,4R)-4-((2-Methoxyethoxy)methoxy)-1-phenylhex-5-en-3-yl)-P,P-diphenylphosphinic 
amide (1.131): Viscous oil; IR (neat): 3194 (w, br), 2928 (w), 2886 (w), 1453(m), 1242 (s), 1121 
(s), 1107 (s), 1027 (s), 724 (s), 696 (m), 552 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.94 (dddd, 
J = 12.0, 8.3, 5.5, 1.5 Hz, 4H), 7.55 – 7.34 (m, 6H), 7.24 – 7.18 (m, 2H), 7.14 (tt, J = 6.5, 1.1 Hz, 
3H), 5.68 (ddd, J = 17.3, 10.5, 6.2 Hz, 1H), 5.31 – 5.13 (m, 2H), 4.73 (q, J = 6.9 Hz, 2H), 4.36 
(ddt, J = 5.9, 2.8, 1.3 Hz, 1H), δ 3.72 (ddd, J = 10.9, 6.0, 3.2 Hz, 1H), 3.69 – 3.62 (m, 1H), 3.58 
(ddd, J = 10.9, 6.0, 3.3 Hz, 1H), 3.50 – 3.37 (m, 2H), 3.25 (s, 3H), 3.23 – 3.13 (m, 1H), 3.01 – 2.84 
(m, 1H), 2.67 – 2.47 (m, 1H), 1.91 – 1.73 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 142.4, 135.5, 
133.4 (d, J = 130 Hz), 133.3 (d, J = 128 Hz), 132.5 (d, J = 9.4 Hz), 132.4 (d, J = 9.5 Hz), 131.9 (d, 
J = 2.7 Hz), 131.8 (d, J = 2.7 Hz), 128.6, 128.6 (d, J =12.5 Hz), 128.5 (d, J = 12.3 Hz, peaks 
overlapped at 128.4 Hz), 125.8, 118.2, 94.7, 82.7 (d, J = 4.2 Hz), 71.8, 67.8, 59.0, 55.0, 33.4, 33.4. 
32.7;  HRMS (DART): Calcd for C28H35NO4P [M+H]+: 480.2304; Found: 480.2292; Specific 
rotation: [α]23.1D –2.9 (c = 1.82, CHCl3) for a 92:8 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H, 
92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 73.731 min (major) and 81.280 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 73.595 50.615 1 73.731 91.901 
2 80.975 49.385 2 81.280 8.099 
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N-((3R,4S)-3-((2-Methoxyethoxy)methoxy)-6-methylhept-1-en-4-yl)-P,P-
diphenylphosphinic amide (1.132): Viscous oil; IR (neat): 3203 (w, br), 3059 (w) 2953 (m), 
2870 (m), 1438 (m), 1192 (s), 1122 (s), 1109 (s), 725 (s), 698 (s), 532 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.94 (dddd, J = 12.0, 7.9, 6.0, 1.6 Hz, 4H), 7.55 – 7.38 (m, 6H), 5.69 (ddd, J = 
17.0, 10.6, 6.2 Hz, 1H), 5.26 – 5.13 (m, 2H), 4.78 – 4.68 (m, 2H), 4.40 – 4.31 (m, 1H), 3.72 (ddd, 
J = 11.0, 6.0, 3.2 Hz, 1H), 3.59 (ddd, J = 10.9, 6.0, 3.3 Hz, 1H), 3.52 – 3.39 (m, 3H), 3.26 (s, 3H), 
3.20 – 3.06 (m, 1H), 1.96 – 1.84 (m, 1H), 1.45 (ddd, J = 14.1, 9.5, 4.4 Hz, 1H), 1.25 (dt, J = 6.8, 
3.6 Hz, 2H), 0.86 (d, J = 6.7 Hz, 3H), 0.66 (d, J = 6.5 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 
135.6, 133.4 (d, J =131 Hz, peaks overlapped at 132.7), 133.3 (d, J = 129, peaks overlapped at 
132.7), 132.5 (d, J = 9.3 Hz), 132.4 (d, J = 9.3 Hz), 131.8 (d, J = 2.8 Hz), 131.7 (d, J = 2.8 Hz), 
128.5 (d, J = 12.6 Hz), 128.4 (d, J = 12.5 Hz), 118.1, 94.7, 82.8 (d, J = 3.7 Hz), 71.8, 67.7, 59.0, 
53.5, 40.9 (d, J = 5.5 Hz), 24.3, 23.8, 21.8; HRMS (DART): Calcd for C24H35NO4P [M+H]+: 
432.22982; Found: 432.2289; Specific rotation: [α]22.9D –22.4 (c = 1.24, CHCl3) for a 91:9 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 220 nm): tR: 9.123 min 
(minor) and 15.165 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 11.436 50.195 1 11.511 9.123 
2 15.106 49.805 2 15.165 90.877 
 
N-((1S,2R)-2-Methoxy-1-phenylbut-3-en-1-yl)-P,P-diphenylphosphinic amide: White solid; 
M.p. = 133 – 135 °C (decomposition); IR (neat): 3193 (w, br), 3058 (w), 2930 (w), 2821 (w), 
1438 (m), 1187 (s), 1123 (s), 1107 (s), 725 (s), 697 (s), 536 (s) cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.97 – 7.82 (m, 2H), 7.78 – 7.64 (m, 2H), 7.57 – 7.34 (m, 5H), 7.33 – 7.27 (m, 2H), 7.25 – 7.20 
(m, 2H), 7.14 (dd, J = 7.4, 2.3 Hz, 2H), 5.30 – 5.21 (m, 2H), 5.19 – 5.08 (m, 1H), 4.30 – 4.16 (m, 
2H), 4.15 – 4.03 (m, 1H), 3.30 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 139.7 (d, J = 5.9 Hz), 
135.3, 133.2 (d, J = 131 Hz, peaks overlapped at 132.6), 132.7 (d, J = 9.9 Hz), 131.8 (d, J = 131 
Hz), 131.7 (d, J = 9.5 Hz), 131.7 (d, J = 2.8 Hz), 131.6 (d, J = 2.8 Hz), 128.4 (d, J = 12.5 Hz), 
128.2, 128.1 (d, J = 12.8 Hz), 127.8, 127.1, 119.4, 86.4 (d, J = 3.0 Hz), 58.3, 56.8; HRMS 
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(DART): Calcd for C23H25NO2P [M+H]+: 378.1623; Found: 378.162; Specific rotation: [α]20.9D 
–3.6 (c = 0.94, CHCl3) for a 92:8 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 
1.0 mL/min, 220 nm): tR: 10.850 min (major) and 13.803 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 11.004 49.979 1 10.850 92.164 
2 13.913 50.021 2 13.803 7.836 
 
1.7.8 Product Derivatizations and Methods for Selective Removal of Protecting Groups 
 
N-((1S,2R)-2-Hydroxy-1-phenylbut-3-en-1-yl)-P,P-diphenylphosphinic amide (1.133):  To a 
solution of 1.106 (189.5 mg, 0.4200 mmol) in reagent-grade MeCN (2.5 mL) was added 
CeCl3×7H2O (470.0 mg, 1.260 mmol), NaI (188.0 mg, 1.260 mmol), and H2O (4 µL). The resulting 
solution was heated under a stream of nitrogen to 60 °C for 3 h and then to 80 °C for one h. The 
mixture was allowed to cool to 22 °C, diluted with EtOAc (5.0 mL), subjected to sonication, and 
the white solid was removed by filtration through a short plug of oven-dried celite. The filtrate was 
neutralized (pH 6-7) by the addition of a saturated solution of aqueous NaHCO3 (~8 mL). The 
resulting white solid was removed through filtration, and washed three times with EtOAc. The 
filtrate was then washed with EtOAc (3 x 15mL), and the combined organic layers were washed 
with brine (1 x 5 mL), dried over Na2SO4, and concentrated in vacuo. The resulting yellow solid 
was purified by silica gel chromatography (gradient eluting with 10:1 to 1:3 hexanes:EtOAc) to 
afford 1.133 as off-white solid (105.3 mg, 0.29 mmol, 69% yield). 
M.p. = 122 °C – decomposition; IR (neat): 3248 (br, w), 3060 (w), 1438 (m), 1171 (s), 1123, 925 
(s), 725 (s), 695 (s), 528 (s) cm-1; 1H NMR (500 MHz, CDCl3) δ 7.91 (dd, J = 12.0, 7.6 Hz, 2H), 
7.83 (dd, J = 12.2, 7.7 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.48 (td, J = 7.5, 2.9 Hz, 3H), 7.37 (dd, J 
= 8.9, 6.5 Hz, 4H), 7.33 – 7.27 (m, 3H), 5.59 (ddd, J = 17.4, 10.4, 3.5 Hz, 1H), 5.48 (d, J = 17.4 
Hz, 1H), 5.25 (d, J = 10.4 Hz, 1H), 4.53 (d, J = 7.1 Hz, 2H), 3.46 (d, J = 11.7 Hz, 1H); 13C NMR 
(100 MHz, CDCl3): δ 139.5 (d, J = 9.3 Hz), 135.0, 132.8 (d, J = 9.7 Hz), 132.5 (d, J = 2.9 Hz), 
132.4 (d, J = 2.7 Hz), 132.3 (d, J = 128 Hz), 131.8 (d, J = 9.9 Hz), 130.2 (d, J = 133 Hz), 128.9 (d, 
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J = 12.8 Hz), 128.8 (d, J = 12.9 Hz), 128.7, 127.6, 126.6, 118.2, 75.6, 60.6; HRMS (DART): 
Calcd for C22H23NO2P [M+H]+: 364.1461; Found: 364.1461; Specific rotation: [α]25D +52.0 (c = 
2.03, CHCl3) for a 96.5:3.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 
220 nm): tR: 15.310 min (major) and 17.901 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 13.307 49.326 1 15.310 96.483 
2 15.225 50.674 2 17.901 3.517 
 
(1S,2R)-2-((2-Methoxyethoxy)methoxy)-1-phenylbut-3-en-1-amine (1.134): To a solution of 
homoallylamide 1.106 (45.0 mg, 0.100 mmol, 97:3 e.r.) in thf (1.0 mL) was added 
diphenylphosphite (38 µL, 0.20 mmol), triphenylphosphite (12 µL, 0.050 mmol), I2 (6.3 mg, 0.050 
mmol), and Et3N (7 µL, 0.05 mmol). The solution was then purged with a stream of N2, and sealed 
with a septum. The solution was allowed to stir at 22 °C for 5 h, during which it turned colorless. 
The reaction was then quenched by the addition of water (0.5 mL) and a 1.0 M aqueous solution 
of HCl (0.1 mL). The aqueous layer was washed with Et2O (3 x 2 mL), and then basified to pH 
>12 by the addition of 2.0 M aqueous solution of NaOH (0.5 mL), and washed with 
dichloromethane (5 x 3 mL). The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo to afford 1.134 as yellow oil (10.8 mg, 0.043 mmol, 43% yield). 
IR (neat): 2928 (w, br), 2885 (w, br), 1101 (s), 1019 (s), 906 (s), 725 (s), 700 (s) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.37 (ddd, J = 8.2, 1.5, 0.5 Hz, 2H), 7.35 – 7.28 (m, 2H), 7.24 – 7.20 (m, 
1H), 5.67 (ddd, J = 16.8, 10.8, 7.6 Hz, 1H), 5.38 – 5.20 (m, 2H), 4.70 (d, J = 7.0 Hz, 1H), 4.58 – 
4.48 (m, 1H), 4.17 (ddt, J = 7.5, 6.5, 1.0 Hz, 1H), 4.01 (d, J = 6.5 Hz, 1H), 3.42 – 3.28 (m, 6H), 
3.28 – 3.15 (m, 1H), 1.53 (s, 2H); 13C NMR (100 MHz, CDCl3): δ 142.8, 135.0, 128.2, 127.7, 
127.3, 120.2, 92.7, 81.9, 71.8, 66.7, 59.0; HRMS (DART): Calcd for C14H22NO3 [M+H]+: 
252.1594; Found: 252.1594; Specific rotation: [α]23.3D –16.8 (c = 1.11, CHCl3).  
 
Diphenyl((2S,3R)-2-phenyl-3-vinylaziridin-1-yl)phosphine oxide (1.135): To a cooled (0 °C) 
solution of 1.134 (36.0 mg, 0.100 mmol) and PPh3 (44.0 mg, 0.150 mmol) in thf (1.0 mL) was 
added diad (30.0 mg, 0.150 mmol) in a dropwise manner. The solution was allowed to warm to 22 
°C and allowed to stir for 12 h. The volatiles were then removed in vacuo, and the resulting off-
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white solid was purified by silica gel chromatography (gradient eluting with 100:0 to 0:100 
hexanes:Et2O) to furnish 1.135 as white solid (25.1 mg, 0.073 mmol, 73% yield). The analytical 
data are fully consistent with those reported previously.[15] 1H NMR (400 MHz, CDCl3): δ 7.98 – 
7.90 (m, 2H), 7.90 – 7.81 (m, 2H), 7.53 – 7.36 (m, 4H), 7.35 – 7.24 (m, 7H), 6.30 (dddd, J = 17.0, 
10.2, 9.4, 0.6 Hz, 1H), 5.24 (dd, J = 17.0, 1.3 Hz, 1H), 5.13 (dd, J = 10.3, 1.3 Hz, 1H), 3.91 (dd, J 
= 15.8, 2.8 Hz, 1H), 3.17 (ddd, J = 12.4, 9.5, 2.9 Hz, 1H). Specific rotation: [α]22.2D –20.3 (c = 
0.72, CHCl3) for a 97:3 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 92:8 hexanes:iPrOH, 1.0 mL/min, 
220 nm): tR: 16.050 min (major) and 60.917 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 16.081 50.162 1 16.050 97.483 
2 61.484 49.838 2 60.917 2.517 
 
1.7.9 Formal Synthesis of NK1 Agonist 
 
2-Chloro-N-((1S,2R)-2-hydroxy-1-phenylbut-3-en-1-yl)acetamide (1.136): To a cooled (0 °C) 
solution of 1.106 (0.5 g, 1.10 mmol) in ethanol (10 mL) was added a 12.0 M aqueous solution of 
HCl (10 mL). The mixture was allowed to warm to 22 °C, and then allowed to stir for an additional 
4 h. The solution was then diluted with H2O (~5 mL), washed with toluene (3 x 5 mL), and then 
carefully basified to pH 10–11 by the addition of 2M aqueous solution of NaOH. The mixture was 
filtered and subjected to continuous extraction[16] for 14 h with CH2Cl2 to afford unpurified 9 as 
yellow oil. (Note: In some instances, incomplete acetal deprotection was observed; however, by 
allowing the unpurified residue to sit on the bench open to air for 24–48 h, the desired product 
could be obtained). To a solution of unpurified aminoalcohol 9 in thf (5 mL) was added 
triethylamine (0.21 mL, 1.5 mmol). The solution was allowed to cool to 0 °C, and then treated 
(dropwise) with freshly distilled chloroacetyl chloride (105 µL, 1.3 mmol). The solution was then 
allowed to warm to 22 °C and was allowed to stir for 1h. The reaction was then quenched by the 
addition of a saturated solution of NH4Cl (2.0 mL); water was added until homogeneity was 
																																																								
15) Jarvis, A.N.; McLaren, A. B.; Osborn, H. M. I.; Sweeney, J. Beilstein J. Org. Chem. 2013, 9, 852859.  
16) Chan, W. H.; Yu, W. K. J. Chem. Educ. 1988, 65, 634. 
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achieved. The aqueous layer was washed with Et2O (3 x 10 mL), and the combined organics were 
dried over Na2SO4 and concentrated in vacuo. The unpurified brown oil residue was purified by 
silica gel chromatography (gradient eluting with 15:1 to 0:100 hexanes: Et2O) to afford 1.136 as 
yellow oil (176.6 mg, 0.74 mmol, 67% yield). 
IR (neat): 3396 (w, br), 3304 (w, br), 1659 (s), 1520 (s), 1261 (w), 994 (w), 930 (w), 700 (m) cm-
1; 1H NMR (400 MHz, CDCl3): δ 7.50 – 7.28 (m, 5H), 5.70 (ddd, J = 17.2, 10.5, 5.6 Hz, 1H), 
5.41 – 5.18 (m, 2H), 5.11 (dd, J = 8.3, 4.0 Hz, 1H), 4.52 (ddt, J = 4.2, 2.7, 1.3 Hz, 1H), 4.18 – 3.93 
(m, 2H); 13C NMR (100 MHz, CDCl3): δ 166.2, 136.9, 136.0, 128.8, 128.3, 127.6, 118.0, 75.1, 
58.1, 42.9;  HRMS (DART): Calcd for C12H15NO2Cl [M+H]+: 240.0791; Found: 240.0784; 
Specific rotation: [α]23.9D +15.7 (c = 1.05, CHCl3).  
 
(5S,6R)-5-Phenyl-6-vinylmorpholin-3-one (1.138): To a cooled (0 °C) solution of 1.136 (100.0 
mg, 0.42 mmol) in thf/dmf (2.0 mL/0.4 mL) was added NaH (42.0 mg, 1.05 mmol) in three 
portions. The solution was allowed to warm to 22 °C and to stir for 5 h before it was diluted with 
Et2O (~5 mL). At this time, the reaction was quenched by the addition of a saturated solution of 
NH4Cl (2.0 mL); water was added until homogeneity was achieved. The aqueous layer was washed 
with Et2O (3 x 5 mL), and the combined organic layers were washed (2x) with brine, dried over 
Na2SO4, and concentrated in vacuo. The resulting viscous yellow oil residue was purified by silica 
gel chromatography (gradient eluting with 100:0:0 to 0:90:10 hexanes: EtOAc: acetone) to afford 
1.138 as white solid (73.4 mg, 0.36 mmol, 86% yield).  
M.p. = 143 – 145 °C; IR (neat): 3258 (w), 3219 (w), 1671 (s), 1454 (m), 1353 (m), 1109 (s), 701 
(s); 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.30 (m, 3H), 7.26 – 7.21 (m, 2H), 6.22 (s, 1H), 5.39 – 
5.31 (m, 1H), 5.31 – 5.22 (m, 1H), 5.15 (ddd, J = 10.1, 2.1, 0.9 Hz, 1H), 4.63 – 4.29 (m, 4H); 13C 
NMR (100 MHz, CDCl3): δ 168.1, 136.9, 133.2, 128.4, 128.3, 128.2, 118.9, 67.8, 59.8; HRMS 
(DART): Calcd for C12H14NO2 [M+H]+: 204.1025; Found: 204.1019; Specific rotation: [α]23.9D 
–44.3 (c = 0.91, CHCl3). 
 
(5S,6R)-6-((E)-3,5-Bis(trifluoromethyl)styryl)-5-phenylmorpholin-3-one (1.139): In a 
nitrogen-filled glovebox (with overhead lights off) 1.138 (58.0 mg, 0.29 mmol) and 3,5-
bistrifluoromethyl styrene (348.2 mg, 1.45 mmol) were combined in an oven-dried 6-dram vial. 
The reagents were dissolved in toluene (0.7 mL) and then a solution of Ru-1 (9.1 mg, 0.015) in 
toluene (0.7 mL) was added. The vial was capped, removed from the glovebox and placed in an 
oil bath preheated to 60 °C, covered with aluminum foil, and allowed to stir for 4 h. After the 
mixture was allowed to cool to 22 °C, it was diluted with EtOAc and filtered through a small plug 
of celite. The filtrate was concentrated in vacuo and the resulting purple oil was purified by silica 
gel chromatography (gradient eluting with 100:0 to 0:100 hexanes: EtOAc) to yield a mixture of 
the desired product and ~15% 11. Unreacted 1.138 was removed by crystallization in a mixture of 
hexanes and Et2O to yield the NK1 agonist as white foam (78.3 mg, 0.19 mmol, 65% yield). 
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IR (neat): 3224 (w), 3604 (w), 2926 (w), 1671 (s), 1381 (m), 1277 (s), 1174 (m), 1128 (s), 897 
(m), 700 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.71 (s, 1H), 7.55 (d, J = 1.5 Hz, 2H), 7.41 – 
7.31 (m, 3H), 7.24 (d, J = 2.2 Hz, 1H), 6.64 (s, 1H), 6.59 (dd, J = 16.0, 1.3 Hz, 1H), 5.83 (dd, J = 
16.0, 5.9 Hz, 1H), 4.73 (ddd, J = 5.5, 3.6, 1.6 Hz, 1H), 4.62 (t, J = 3.7 Hz, 1H), 4.59 – 4.35 (m, 
2H); 13C NMR (100 MHz, CDCl3): δ 168.2, 138.2, 136.8, 132.1 (q, J = 33.5 Hz), 130.2, 128.9, 
128.9, 128.6, 128.1, 126.4, 121.6 (q, J = 3.8 Hz), 123.3 (q, J = 273 Hz), 76.4, 68.0, 59.9; 19F NMR: 
δ –63.1;  HRMS (DART): Calcd for C20H16F6NO2 [M+H]+: 416.1085; Found: 416.1073; Specific 
rotation: [α]23.9D –47.9 (c = 1.12, CHCl3). 
 
1.7.10 DFT Studies 
DFT calculations were performed with the Gaussian 09 suite of programs[17 ] employing the 
dispersion corrected ωB97XD[18] functional. The Def2SVP[19] basis set and SMD[20] solvation 
model (toluene) was used for geometry optimization and frequency calculation. The nature of all 
stationary points was checked through vibrational analysis.  
																																																								
17) Frisch, M. J.; Trucks, G. W.;  Schlegel, H. B.; Scuseria, G.E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; 
Barone, V.; Mennucci, B.; Petersson, G. A. Nakatsuji, H.; Caricato,  M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; 
Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; 
Nakajima, T.; Honda, Y. Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, Jr. J.A.; Peralta, J. E.; Ogliaro, F.; Bearpark, 
M.;  Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayshi, R.; Normand, J.; Raghavachari, K.; Rendell, 
A.; Burant, J. C.; Iyenger, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; 
Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, 
C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.;  Dannenberg, J. J.; 
Dapprich, S.; Daniels, A. D.; Farkas, Ö; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, Revision 
D.01, Gaussian, Inc., Wallingford CT, 2009. 
18)] Chai, J.-D.; Head-Gordon, M. Phys. Chem. Chem. Phys. 2008, 10, 6615. 
19) Weigend, F.; Ahlrichs, R.  Phys. Chem. Chem. Phys. 2005, 7, 3297–3305. 
20) Marenich, A. V.; Cramer, C. J.; Truhlar, D. G. J. Phys. Chem. B 2009, 113, 6378–6396. 
 
















Table	 S1:	 Borotropic	 rearrangement	 energies	 and	 Gibbs	 free	 energies	 calculated	 with	
ωB97XD/Def2SVP,	calculations	were	carried	out	in	toluene	with	the	SMD	solvation	model.		







A-gs -1179.449824 0.00 -1178.966504 0.0 33.32 
A-ts -1179.422159 17.35 -1178.940174 16.52 -183.35 
B-gs -2083.711066 0.00 -2083.305771 0.00 12.53 
B-ts -2083.672653 25.66 -2083.265090 25.53 -348.50 
 
Table	 S2:	 Borotropic	 rearrangement	 energies	 and	 Gibbs	 free	 energies	 calculated	 with	
M062x/Def2SVP,	calculations	were	carried	out	in	toluene	with	the	SMD	solvation	model.		







A-gs -1179.24481 0.00 -1178.763151 0.0 37.11 
A-ts -1179.219741 15.73 -1178.739802 14.65 -151.03 
B-gs -2083.981355 0.00 -2083.037544 0.00 21.18 
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Table	S3:	Fukui	indices	for	O-substituted	allyl	boron	reagent	calculated	with	ωB97XD/Def2SVP,	
calculations	were	carried	out	in	gas	phase.	
 PA(N) PA(N-1) Me (Z-1a) PA(N) PA(N-1) 
MEM (Z-
1b) 
C -0.24949 0.23611 -0.4856 -0.24598 0.23893 -0.50264 
C 0.09942 0.22627 -0.12685 0.09833 0.25715 -0.15882 














Identification code   C27 H29 F3 N O4 P	
Empirical formula   C27 H29 F3 N O4 P	
Formula weight    519.48	
Temperature    103(2) K	
Wavelength    0.71073 Å	
Crystal system    Monoclinic	
Space group    P21	
Unit cell dimensions  a = 12.3352(13) Å a= 90°.	
    b = 5.2931(6) Å  b= 97.645(4)°.	
    c = 19.893(2) Å  g= 90°.	
Volume    1287.3(2) Å3	
Z    2	
Density (calculated)  1.340 Mg/m3	
Absorption coefficient  0.162 mm-1	
F(000)    544	
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Crystal size   0.1 x 0.2 x 0.4 mm3	
Theta range for data collection 1.033 to 28.927°.	
Index ranges   -16<=h<=16, -7<=k<=7, -26<=l<=26	
Reflections collected  46965	
Independent reflections  6684 [R(int) = 0.0541]	
Completeness to theta = 25.242° 100.0 % 	
Refinement method  Full-matrix least-squares on F2	
Data / restraints / parameters 6684 / 4 / 358	
Goodness-of-fit on F2  1.064	
Final R indices [I>2sigma(I)] R1 = 0.0454, wR2 = 0.1197	
R indices (all data)  R1 = 0.0483, wR2 = 0.1225	
Absolute structure parameter -0.01(3)	
Extinction coefficient  n/a	





 x   y   z  U(eq)	
________________________________________________________________________________  	
F(1A) 8154(10) 3125(16)  9779(5)   58(2)	
F(2A) 7465(12) 6660(40)  9944(6)   91(4)	
F(3A) 9049(8)  6410(30)  9664(7)   78(4) 	
F(1B) 7357(12) 6000(60)  9963(9)   75(6)	
F(2B) 8860(30) 7020(70)  9711(12)  103(9)	
F(3B) 8420(30) 3190(40)  9713(12)  115(10)	
P(001) 4031(1)  7882(1)   6943(1)   15(1)	
O(2) 4434(2)  10503(3)  6861(1)   22(1)	
O(3) 7661(2)  5028(5)   6282(1)   30(1)	
O(4) 8785(2)  2048(5)   6902(1)   35(1)	
N(1) 4861(2)  5772(4)   6678(1)   17(1)	
O(5) 10602(2) 679(6)   7908(1)   54(1)	
C(1) 6603(2)  6013(5)   7470(1)   19(1)	
C(22) 6044(2)  6254(5)   6744(1)   18(1)	
C(17) 2720(2)  7236(5)   6457(1)   19(1)	
C(23) 6536(2)  4364(5)   6268(1)   24(1)	
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C(3) 7573(2)  5630(6)   8815(1)   26(1)	
C(10) 3864(2)  7252(5)   7819(1)   22(1)	
C(5) 7358(2)  7784(6)   7744(1)   26(1)	
C(00H) 6355(2)  4005(6)   7872(1)   27(1) 	
C(4) 7837(2)  7612(6)   8421(1)   31(1)	
C(2) 6830(3)  3799(6)   8545(1)   30(1)	
C(26) 8360(2)  2914(8)   6254(1)   36(1)	
C(16) 2596(2)  5543(7)   5921(2)   34(1)	
C(6) 8062(3)  5456(7)   9546(2)   37(1)	
C(21) 1583(3)  5286(8)   5519(2)   40(1)	
C(19) 808(3)  8308(8)   6192(2)   53(1)	
C(32) 5956(2)  4433(7)   5551(2)   35(1)	
C(20) 710(2)  6664(7)   5649(2)   39(1)	
C(11) 4362(4)  8753(9)   8328(2)   53(1)	
C(13) 3773(3)  6126(9)   9177(2)   49(1)	
C(15) 3330(4)  5105(8)   7994(2)   51(1)	
C(28) 9562(3)  3788(8)   7254(2)   42(1)	
C(18) 1816(3)  8591(6)   6602(2)   40(1)	
C(29) 9928(3)  2792(8)   7958(2)   40(1)	
C(24) 6411(3)  5006(8)   5012(2)   44(1)	
C(12) 4326(4)  8088(12)  9011(2)   62(1)	
C(31) 10973(4) -371(10)   8549(2)   56(1)	






F(1A)-C(6)    1.317(9)	
F(2A)-C(6)    1.317(10)	
F(3A)-C(6)    1.310(9)	
F(1B)-C(6)    1.312(16)	
F(2B)-C(6)    1.29(2)	
F(3B)-C(6)    1.31(2)	
P(001)-O(2)    1.4898(19)	
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P(001)-N(1)    1.648(2)	
P(001)-C(17)    1.804(2)	
P(001)-C(10)    1.813(2)	
O(3)-C(26)    1.418(4)	
O(3)-C(23)    1.428(3)	
O(4)-C(26)    1.404(4)	
O(4)-C(28)    1.442(4)	
N(1)-C(22)    1.471(3)	
N(1)-H(1)    0.86(4)	
O(5)-C(29)    1.405(5)	
O(5)-C(31)    1.410(5)	
C(1)-C(5)    1.381(4)	
C(1)-C(00H)    1.388(4)	
C(1)-C(22)    1.521(3)	
C(22)-C(23)    1.556(3)	
C(22)-H(22)    1.0000	
C(17)-C(16)    1.385(4)	
C(17)-C(18)    1.388(4)	
C(23)-C(32)    1.508(4)	
C(23)-H(23)    1.0000	
C(3)-C(4)    1.375(4)	
C(3)-C(2)    1.392(4)	
C(3)-C(6)    1.500(4)	
C(10)-C(11)    1.366(4)	
C(10)-C(15)    1.381(5)	
C(5)-C(4)    1.400(3)	
C(5)-H(5)    0.9500	
C(00H)-C(2)    1.393(4)	
C(00H)-H(00H)    0.9500	
C(4)-H(4)    0.9500	
C(2)-H(2)    0.9500	
C(26)-H(26A)    0.9900	
C(26)-H(26B)    0.9900	
C(16)-C(21)    1.397(4)	
C(16)-H(16)    0.9500	
C(21)-C(20)    1.355(5)	
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C(21)-H(21)    0.9500	
C(19)-C(20)    1.380(6)	
C(19)-C(18)    1.401(5)	
C(19)-H(19)    0.9500	
C(32)-C(24)    1.310(5)	
C(32)-H(32)    0.9500	
C(20)-H(20)    0.9500	
C(11)-C(12)    1.411(5)	
C(11)-H(11)    0.9500	
C(13)-C(12)    1.310(7)	
C(13)-C(14)    1.377(7)	
C(13)-H(13)    0.9500	
C(15)-C(14)    1.401(5)	
C(15)-H(15)    0.9500	
C(28)-C(29)    1.506(5)	
C(28)-H(28A)    0.9900	
C(28)-H(28B)    0.9900	
C(18)-H(18)    0.9500	
C(29)-H(29A)    0.9900	
C(29)-H(29B)    0.9900	
C(24)-H(24A)    0.9500	
C(24)-H(24B)    0.9500	
C(12)-H(12)    0.9500	
C(31)-H(31A)    0.9800	
C(31)-H(31B)    0.9800	
C(31)-H(31C)    0.9800	
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C(22)-N(1)-P(001)  120.35(16)	




C(5)-C(1)-C(22)   120.9(2)	
C(00H)-C(1)-C(22)  120.3(2)	















C(4)-C(3)-C(2)   120.3(2)	
C(4)-C(3)-C(6)   120.3(3)	




C(1)-C(5)-C(4)   120.7(3)	
C(1)-C(5)-H(5)   119.6	




C(3)-C(4)-C(5)   119.8(3)	
C(3)-C(4)-H(4)   120.1	
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C(5)-C(4)-H(4)   120.1	
C(3)-C(2)-C(00H)  119.2(3)	
C(3)-C(2)-H(2)   120.4	
C(00H)-C(2)-H(2)  120.4	















F(2B)-C(6)-C(3)   113.7(11)	
F(3B)-C(6)-C(3)   112.5(10)	
F(3A)-C(6)-C(3)   113.2(6)	
F(1B)-C(6)-C(3)   112.6(9)	
F(2A)-C(6)-C(3)   111.6(6)	






























































 U11  U22   U33  U23  U13  U12	
_____________________________________________________________________________________ 	
F(1A) 81(4)   54(4)  29(3)   15(3)  -24(2)   -10(4)	
F(2A) 124(9)   126(7)  21(3)   -24(4)  -1(4)   70(7)	
F(3A) 44(4)   147(11)  36(3)   17(5)  -24(2)   -40(4)	
F(1B) 44(6)   163(17)  18(5)   8(7)  3(3)   -1(9) 	
F(2B) 160(20)   95(12)  32(6)   17(6)  -43(10)   -84(13)	
F(3B) 166(19)   122(17)  41(7)   -27(8)  -48(9)   99(15)	
P(001) 18(1)   15(1)  13(1)   0(1)  -1(1)   1(1)	
O(2) 28(1)   16(1)  21(1)   -1(1)  -2(1)   0(1)	
O(3) 21(1)   45(1)  25(1)   4(1)  4(1)   0(1)	
O(4) 24(1)   47(1)  34(1)   2(1)  -2(1)   3(1) 	
N(1) 16(1)   15(1)  19(1)   -1(1)  1(1)   0(1)	
O(5) 49(1)   75(2)  34(1)   -9(1)  -9(1)   25(2)	
C(1) 19(1)   22(1)  16(1)   0(1)  1(1)   0(1)	
C(22) 17(1)   21(1)  16(1)   2(1)  1(1)   -1(1)	
C(17) 18(1)   22(1)  16(1)   4(1)  0(1)   -1(1)	
C(23) 21(1)   32(1)  19(1)   -1(1)  3(1)   3(1)	
C(3) 26(1)   34(1)  16(1)   -3(1)  -2(1)   2(1)	
C(10) 24(1)   28(1)  14(1)   2(1)  2(1)   6(1)	
C(5) 28(1)   28(1)  22(1)   4(1)  -1(1)   -8(1)	
C(00H) 32(1)   27(1)  20(1)   4(1)  -5(1)   -6(1)	
C(4) 30(1)   36(2)  24(1)   -4(1)  -4(1)   -8(1)	
C(2) 35(1)   35(1)  20(1)   7(1)  -3(1)   -6(1)	
C(26) 26(1)   56(2)  26(1)   -1(2)  7(1)   10(2)	
C(16) 20(1)   45(2)  35(1)   -14(1)  -2(1)   -2(1)	
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C(6) 41(2)   50(2)  19(1)   -2(1)  -4(1)   -1(2)	
C(21) 29(1)   55(2)  32(2)   -8(2)  -9(1)   -11(1)	
C(19) 25(1)   52(2)  78(3)   -8(2)  -11(2)   15(2)	
C(32) 25(1)   55(2)  24(1)   -12(1)  -3(1)   11(1)	
C(20) 24(1)   40(2)  47(2)   16(2)  -14(1)   -6(1)	
C(11) 63(2)   74(3)  21(1)   -8(2)  3(1)   -33(2)	
C(13) 46(2)   83(3)  18(1)   11(2)  6(1)   11(2)	
C(15) 79(3)   49(2)  26(2)   4(2)  14(2)   -15(2)	
C(28) 26(1)   53(2)  43(2)   4(2)  -5(1)   -3(1)	
C(18) 28(1)   37(2)  51(2)   -8(1)  -6(1)   8(1)	
C(29) 32(1)   49(2)  38(2)   -10(2)  -2(1)   2(2)	
C(24) 56(2)   52(2)  22(1)   -1(1)  -3(1)   17(2)	
C(12) 71(2)   96(3)  17(1)   -10(2)  2(1)   -28(3)	
C(31) 42(2)   71(3)  50(2)   8(2)  -13(2)   -2(2)	
C(14) 88(3)   70(3)  33(2)   20(2)  18(2)   -6(2)	
______________________________________________________________________________  
 
Table	 S8:	 Hydrogen	 coordinates	 (x104)	 and	 isotropic	 displacement	 parameters	 (Å2x	 103)	 for	
1.122.	
________________________________________________________________________________ 	
  x   y   z   U(eq)	
________________________________________________________________________________ 	
 	
H(22)  6161  8010  6582  22	
H(23)  6488  2615  6452  29	
H(5)  7555  9134  7469  32	
H(00H)  5852  2751  7685  32	
H(4)  8343  8862  8607  37	
H(2)  6649  2425  8817  36	
H(26A)  7947  1531  6002  43	
H(26B)  8972  3386  6003  43	
H(16)  3200  4554  5827  41	
H(21)  1507  4131  5150  48	
H(19)  191  9247  6289  64	
H(32)  5199  4029  5485  42	
H(20)  30  6500  5366  46	
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H(11)  4732  10244  8221  63	
H(13)  3702  5806  9640  59	
H(15)  2988  4017  7649  61	
H(28A)  9220  5469  7282  50	
H(28B)  10201  3970  7005  50	
H(18)  1881  9709  6978  48	
H(29A)  10337  4116  8237  48	
H(29B)  9284  2306  8177  48	
H(24A)  7167  5422  5056  53	
H(24B)  5986  5006  4577  53	
H(12)  4714  9090  9360  74	
H(31A)  11280  967  8858  84	
H(31B)  11538  -1638  8503  84	
H(31C)  10359  -1173  8733  84	
H(14)  2938  3033  8797  75	





O(2)-P(001)-N(1)-C(22)    32.3(2)	
C(17)-P(001)-N(1)-C(22)    155.92(17)	
C(10)-P(001)-N(1)-C(22)    -91.0(2)	
P(001)-N(1)-C(22)-C(1)    73.9(2)	
P(001)-N(1)-C(22)-C(23)    -163.36(17)	
C(5)-C(1)-C(22)-N(1)    -135.4(3)	
C(00H)-C(1)-C(22)-N(1)    44.2(3)	
C(5)-C(1)-C(22)-C(23)    104.0(3)	
C(00H)-C(1)-C(22)-C(23)    -76.4(3)	
O(2)-P(001)-C(17)-C(16)    113.3(2)	
N(1)-P(001)-C(17)-C(16)    -8.7(3)	
C(10)-P(001)-C(17)-C(16)   -124.5(2)	
O(2)-P(001)-C(17)-C(18)    -63.0(3)	
N(1)-P(001)-C(17)-C(18)    175.0(2)	
C(10)-P(001)-C(17)-C(18)   59.2(3)	
C(26)-O(3)-C(23)-C(32)    -93.8(3)	
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C(26)-O(3)-C(23)-C(22)    143.4(2)	
N(1)-C(22)-C(23)-O(3)    174.0(2)	
C(1)-C(22)-C(23)-O(3)    -62.1(3)	
N(1)-C(22)-C(23)-C(32)    52.6(3)	
C(1)-C(22)-C(23)-C(32)    176.5(2)	
O(2)-P(001)-C(10)-C(11)    -17.7(3)	
N(1)-P(001)-C(10)-C(11)    105.9(3)	
C(17)-P(001)-C(10)-C(11)   -141.9(3)	
O(2)-P(001)-C(10)-C(15)    169.1(3)	
N(1)-P(001)-C(10)-C(15)    -67.2(3)	
C(17)-P(001)-C(10)-C(15)   45.0(3)	
C(00H)-C(1)-C(5)-C(4)    -2.3(4)	
C(22)-C(1)-C(5)-C(4)    177.3(3)	
C(5)-C(1)-C(00H)-C(2)    1.8(4)	
C(22)-C(1)-C(00H)-C(2)    -177.8(3)	
C(2)-C(3)-C(4)-C(5)    -0.2(4)	
C(6)-C(3)-C(4)-C(5)    -178.7(3)	
C(1)-C(5)-C(4)-C(3)    1.5(5)	
C(4)-C(3)-C(2)-C(00H)    -0.3(5)	
C(6)-C(3)-C(2)-C(00H)    178.2(3)	
C(1)-C(00H)-C(2)-C(3)    -0.6(5)	
C(28)-O(4)-C(26)-O(3)    -69.6(3)	
C(23)-O(3)-C(26)-O(4)    -92.1(3)	
C(18)-C(17)-C(16)-C(21)    2.5(5)	
P(001)-C(17)-C(16)-C(21)   -173.8(3)	
C(4)-C(3)-C(6)-F(2B)    -12(2)	
C(2)-C(3)-C(6)-F(2B)    170(2)	
C(4)-C(3)-C(6)-F(3B)    -134(2)	
C(2)-C(3)-C(6)-F(3B)    48(2)	
C(4)-C(3)-C(6)-F(3A)    -31.7(10)	
C(2)-C(3)-C(6)-F(3A)    149.8(10)	
C(4)-C(3)-C(6)-F(1B)    106.5(15)	
C(2)-C(3)-C(6)-F(1B)    -72.0(15)	
C(4)-C(3)-C(6)-F(2A)    88.7(11)	
C(2)-C(3)-C(6)-F(2A)    -89.8(11)	
C(4)-C(3)-C(6)-F(1A)    -151.7(7)	
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C(2)-C(3)-C(6)-F(1A)    29.8(7)	
C(17)-C(16)-C(21)-C(20)    -0.6(6)	
O(3)-C(23)-C(32)-C(24)    0.3(5)	
C(22)-C(23)-C(32)-C(24)    119.5(4)	
C(16)-C(21)-C(20)-C(19)    -1.3(6)	
C(18)-C(19)-C(20)-C(21)    1.3(6)	
C(15)-C(10)-C(11)-C(12)    0.3(6)	
P(001)-C(10)-C(11)-C(12)   -173.1(4)	
C(11)-C(10)-C(15)-C(14)    1.0(6)	
P(001)-C(10)-C(15)-C(14)   174.2(4)	
C(26)-O(4)-C(28)-C(29)    176.8(3)	
C(16)-C(17)-C(18)-C(19)    -2.5(5)	
P(001)-C(17)-C(18)-C(19)   173.9(3)	
C(20)-C(19)-C(18)-C(17)    0.6(6)	
C(31)-O(5)-C(29)-C(28)    -179.6(3)	
O(4)-C(28)-C(29)-O(5)    71.4(3)	
C(14)-C(13)-C(12)-C(11)    6.1(8)	
C(10)-C(11)-C(12)-C(13)    -3.9(8)	
C(12)-C(13)-C(14)-C(15)    -4.7(7)	





Identification code  C25H29N2O4P 
Empirical formula  C25 H29 N2 O4 P 
Formula weight  452.47 
Temperature  100(2) K 
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Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 5.3430(2) Å a= 90°. 
 b = 12.1549(5) Å b= 90°. 
 c = 36.1182(13) Å g = 90°. 
Volume 2345.65(16) Å3 
Z 4 
Density (calculated) 1.281 Mg/m3 
Absorption coefficient 1.315 mm-1 
F(000) 960 
Crystal size 0.220 x 0.070 x 0.040 mm3 
Theta range for data collection 7.131 to 66.949°. 
Index ranges -6<=h<=6, -14<=k<=14, -43<=l<=42 
Reflections collected 23892 
Independent reflections 4159 [R(int) = 0.0808] 
Completeness to theta = 66.949° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.5931 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4159 / 1 / 293 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0410, wR2 = 0.0931 
R indices (all data) R1 = 0.0528, wR2 = 0.0996 
Absolute structure parameter 0.055(16) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.238 and -0.280 e. Å-3 
 
Table S11: Atomic coordinates (x104) and equivalent isotropic displacement parameters (Å2x103) 
for 1.126.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
P(1) 131(2) 8953(1) 3944(1) 23(1) 
O(1) 7394(6) 2531(2) 3375(1) 44(1) 
O(2) 5992(5) 4207(2) 3927(1) 39(1) 
O(3) 2919(5) 5103(2) 4274(1) 35(1) 
O(4) -2470(4) 8521(2) 3977(1) 27(1) 
N(1) 2197(5) 8050(2) 4096(1) 24(1) 
N(2) 364(6) 5529(3) 3117(1) 37(1) 
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C(1) 8835(9) 2418(4) 3051(1) 49(1) 
C(2) 5575(8) 3380(3) 3332(1) 42(1) 
C(3) 4350(8) 3580(4) 3696(1) 44(1) 
C(4) 5034(9) 4394(3) 4282(1) 42(1) 
C(5) 3544(7) 6237(3) 4301(1) 31(1) 
C(6) 1746(6) 6871(3) 4044(1) 25(1) 
C(7) 741(6) 10166(3) 4214(1) 26(1) 
C(8) -451(7) 11142(3) 4113(1) 42(1) 
C(9) -164(10) 12079(3) 4333(1) 53(1) 
C(10) 1318(9) 12033(4) 4648(1) 45(1) 
C(11) 2521(9) 11091(4) 4741(1) 46(1) 
C(12) 2227(8) 10151(3) 4526(1) 38(1) 
C(13) 3393(9) 6625(4) 4698(1) 42(1) 
C(14) 2759(9) 6013(4) 4979(1) 53(1) 
C(15) 2037(7) 6504(3) 3641(1) 26(1) 
C(16) 4097(7) 6822(3) 3435(1) 31(1) 
C(17) 4235(7) 6494(3) 3068(1) 33(1) 
C(18) 2341(7) 5869(3) 2924(1) 33(1) 
C(19) 261(7) 5858(3) 3474(1) 33(1) 
C(20) 858(6) 9316(3) 3471(1) 25(1) 
C(21) 3017(7) 9922(3) 3384(1) 34(1) 
C(22) 3655(8) 10113(4) 3019(1) 38(1) 
C(23) 2198(8) 9693(3) 2735(1) 38(1) 
C(24) 84(8) 9093(3) 2819(1) 36(1) 
C(25) -601(6) 8908(3) 3184(1) 31(1) 
________________________________________________________________________________  
 
Table S12: Bond lengths [Å] and angles [°] for 1.126. 
_____________________________________________________  
P(1)-O(4)  1.490(2) 
P(1)-N(1)  1.649(3) 
P(1)-C(7)  1.796(4) 
P(1)-C(20)  1.809(3) 
O(1)-C(1)  1.408(5) 
O(1)-C(2)  1.425(5) 
O(2)-C(4)  1.397(5) 
O(2)-C(3)  1.430(5) 
O(3)-C(5)  1.420(4) 
O(3)-C(4)  1.421(5) 
N(1)-C(6)  1.465(4) 
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N(1)-H(1N)  0.87(2) 
N(2)-C(18)  1.332(5) 
N(2)-C(19)  1.352(4) 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(2)-C(3)  1.490(6) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(13)  1.514(5) 
C(5)-C(6)  1.541(5) 
C(5)-H(5)  1.0000 
C(6)-C(15)  1.530(4) 
C(6)-H(6)  1.0000 
C(7)-C(12)  1.380(5) 
C(7)-C(8)  1.394(5) 
C(8)-C(9)  1.396(6) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.388(7) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.355(6) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.390(5) 
C(11)-H(11)  0.9500 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.303(6) 
C(13)-H(13)  0.9500 
C(14)-H(14A)  0.9500 
C(14)-H(14B)  0.9500 
C(15)-C(19)  1.372(5) 
C(15)-C(16)  1.384(5) 
C(16)-C(17)  1.386(5) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.369(5) 
C(17)-H(17)  0.9500 
C(18)-H(18)  0.9500 
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C(19)-H(19)  0.9500 
C(20)-C(25)  1.386(5) 
C(20)-C(21)  1.404(5) 
C(21)-C(22)  1.382(5) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.385(6) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.378(6) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.388(5) 
C(24)-H(24)  0.9500 
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Symmetry transformations used to generate equivalent atoms:  
  
Table S13: Anisotropic displacement parameters (Å2x 103) for 1.126. The anisotropic 
displacement factor exponent takes the form: –2p2[h2 a*2U11 + ...  + 2 h k a* b* U12]. 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
P(1) 18(1)  34(1) 16(1)  0(1) 0(1)  0(1) 
O(1) 48(2)  45(2) 39(2)  2(1) 6(2)  12(1) 
O(2) 39(1)  41(2) 36(1)  -5(1) 2(1)  3(1) 
O(3) 40(2)  35(1) 30(1)  3(1) 5(1)  1(1) 
O(4) 16(1)  42(1) 22(1)  -1(1) 0(1)  -1(1) 
N(1) 20(1)  33(2) 19(1)  0(1) -1(1)  -1(1) 
N(2) 35(2)  49(2) 25(2)  -4(1) -5(2)  -7(2) 
C(1) 49(3)  58(3) 39(2)  -5(2) 9(2)  4(2) 
C(2) 39(2)  43(2) 43(2)  -4(2) -7(2)  6(2) 
C(3) 39(2)  47(2) 47(2)  -9(2) 2(2)  1(2) 
C(4) 51(2)  43(2) 32(2)  4(2) -1(2)  12(2) 
C(5) 37(2)  31(2) 26(2)  1(2) -1(2)  0(2) 
C(6) 23(2)  34(2) 19(2)  -1(1) 0(1)  -3(2) 
C(7) 26(2)  32(2) 21(2)  2(1) 5(2)  0(2) 
C(8) 34(2)  47(2) 46(2)  -4(2) -3(2)  6(2) 
C(9) 42(2)  39(2) 76(3)  -10(2) 3(3)  7(2) 
C(10) 45(3)  41(2) 49(2)  -16(2) 16(2)  -10(2) 
C(11) 56(3)  47(2) 35(2)  -9(2) -3(2)  -11(2) 
C(12) 47(2)  37(2) 30(2)  -1(2) -10(2)  -3(2) 
C(13) 56(3)  44(2) 27(2)  -1(2) -6(2)  11(2) 
C(14) 59(3)  73(3) 27(2)  -1(2) 0(2)  22(3) 
C(15) 25(2)  30(2) 22(2)  1(1) 0(2)  2(2) 
C(16) 29(2)  40(2) 25(2)  -2(2) 0(2)  -3(2) 
C(17) 30(2)  45(2) 23(2)  -2(2) 3(2)  -1(2) 
C(18) 37(2)  41(2) 20(2)  -4(2) -1(2)  2(2) 
C(19) 31(2)  44(2) 23(2)  -3(1) 0(2)  -4(2) 
C(20) 24(2)  37(2) 16(2)  1(1) 3(1)  5(2) 
C(21) 28(2)  50(2) 22(2)  6(2) 0(2)  -2(2) 
C(22) 30(2)  54(3) 31(2)  10(2) 5(2)  0(2) 
C(23) 40(2)  54(2) 20(2)  7(2) 6(2)  13(2) 
C(24) 39(2)  53(2) 18(2)  0(2) -7(2)  8(2) 
C(25) 28(2)  43(2) 22(2)  1(2) -4(2)  -1(2) 
______________________________________________________________________________  
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Table S14: Hydrogen coordinates (x104) and isotropic displacement parameters (Å2x103) for 
1.126. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1N) 3740(50) 8240(30) 4061(10) 29 
H(1A) 7729 2265 2841 73 
H(1B) 10019 1809 3081 73 
H(1C) 9759 3101 3005 73 
H(2A) 4308 3155 3147 50 
H(2B) 6391 4062 3244 50 
H(3A) 2763 3985 3659 53 
H(3B) 3959 2869 3817 53 
H(4A) 6353 4726 4438 50 
H(4B) 4549 3683 4394 50 
H(5) 5295 6342 4210 37 
H(6) -7 6708 4124 30 
H(8) -1456 11170 3897 51 
H(9) -979 12745 4267 63 
H(10) 1491 12667 4800 54 
H(11) 3568 11073 4953 55 
H(12) 3059 9491 4595 46 
H(13) 3793 7373 4747 51 
H(14A) 2346 5261 4942 64 
H(14B) 2709 6319 5221 64 
H(16) 5386 7256 3543 37 
H(17) 5625 6699 2920 39 
H(18) 2444 5666 2670 39 
H(19) -1129 5626 3618 39 
H(21) 4043 10202 3577 40 
H(22) 5103 10535 2962 46 
H(23) 2652 9818 2485 46 
H(24) -914 8802 2624 44 
H(25) -2073 8500 3239 37 
________________________________________________________________________________  
 
Table S15: Torsion angles [°] for 1.126. 
________________________________________________________________  
 






























































Symmetry transformations used to generate equivalent atoms:  
  
Table S16: Hydrogen bonds for 1.126 [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(4)#1 0.87(2) 2.07(2) 2.938(4) 174(4) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z  
 
1.7.12 Coordinates for Calculated (DFT) Structures 
A_GS_M062x 
----------------------------------------- 




C    -4.358     0.655     0.143 
C    -4.461    -0.427    -0.730 
C    -3.158     1.358     0.302 
C    -3.353    -0.848    -1.463 
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C    -2.139    -0.178    -1.323 
C    -2.071     0.911    -0.450 
H    -3.428    -1.698    -2.144 
H    -5.232     0.976     0.714 
H    -5.413    -0.947    -0.840 
O    -0.878     1.613    -0.367 
C    -0.885    -0.562    -2.061 
N     0.291    -0.394    -1.144 
H    -0.917    -1.585    -2.448 
H    -0.700     0.111    -2.916 
B     0.281     1.117    -0.818 
C     0.301    -1.228     0.121 
C     1.614    -0.821     0.812 
O     2.621    -0.850     0.119 
N     1.607    -0.480     2.117 
C     0.461    -0.439     3.008 
C     2.880    -0.240     2.778 
H     0.505    -1.266     3.734 
H    -0.490    -0.494     2.472 
H     2.869     0.749     3.260 
H     3.048    -1.005     3.552 
H     1.188    -0.567    -1.635 
C     3.395     2.147     0.480 
C     2.208     2.562     0.041 
C     1.528     1.999    -1.188 
C     0.283    -2.776    -0.106 
H    -0.597    -0.949     0.681 
C     1.168    -3.188    -1.287 
H     1.177    -4.284    -1.365 
H     2.202    -2.844    -1.149 
H     0.796    -2.805    -2.250 
C    -1.151    -3.289    -0.301 
H    -1.812    -2.953     0.512 
H    -1.141    -4.389    -0.290 
H    -1.603    -2.986    -1.253 
C     0.823    -3.438     1.173 
H     0.720    -4.528     1.082 
H     0.254    -3.127     2.063 
H     1.888    -3.218     1.336 
H     0.477     0.506     3.570 
H     3.687    -0.282     2.041 
O     2.346     1.207    -2.014 
C     3.237     1.937    -2.830 
H     3.897     2.585    -2.233 
H     2.685     2.561    -3.555 
H     3.850     1.212    -3.378 
H     3.859     2.601     1.358 
H     3.929     1.344    -0.035 
H     1.662     3.359     0.557 
H     1.115     2.856    -1.763 
C    -3.018     2.531     1.237 
C    -2.196     2.204     2.485 
H    -1.164     1.933     2.217 
H    -2.644     1.370     3.045 
H    -2.149     3.073     3.155 
H    -4.023     2.867     1.529 
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H    -2.542     3.365     0.699 
                                                              
                                                                 
 Frequencies --     37.1143                48.8871                53.0716 
 Red. masses --      3.5819                 3.2934                 3.6074 
 Zero-point correction=                           0.537726 (Hartree/Particle) 
 Thermal correction to Energy=                    0.566179 
 Thermal correction to Enthalpy=                  0.567123 
 Thermal correction to Gibbs Free Energy=         0.481660 
 Sum of electronic and zero-point Energies=          -1178.707084 
 Sum of electronic and thermal Energies=             -1178.678631 
 Sum of electronic and thermal Enthalpies=           -1178.677687 
 Sum of electronic and thermal Free Energies=        -1178.763151 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 









C    -4.345    -0.587    -0.001 
C    -4.188    -0.685    -1.385 
C    -3.325    -0.100     0.816 
C    -2.986    -0.308    -1.972 
C    -1.939     0.183    -1.186 
C    -2.127     0.291     0.198 
H    -2.848    -0.398    -3.052 
H    -5.287    -0.891     0.462 
H    -5.003    -1.063    -2.003 
O    -1.128     0.793     0.994 
C    -0.627     0.578    -1.817 
N     0.504     0.489    -0.828 
H    -0.399    -0.048    -2.683 
H    -0.629     1.622    -2.161 
B    -0.049     1.395     0.341 
C     0.914    -0.895    -0.376 
C     2.284    -0.656     0.283 
O     3.085     0.018    -0.358 
N     2.554    -1.158     1.503 
C     1.681    -1.968     2.331 
C     3.894    -0.986     2.045 
H     2.080    -2.991     2.418 
H     0.664    -2.026     1.938 
H     3.834    -0.534     3.046 
H     4.390    -1.965     2.138 
H     1.333     0.931    -1.253 
C     1.558     1.910     1.526 
C     0.526     2.780     1.305 
C     0.040     2.979    -0.066 
C     1.067    -2.000    -1.478 
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H     0.142    -1.222     0.326 
C     1.883    -1.528    -2.687 
H     1.920    -2.339    -3.429 
H     2.912    -1.272    -2.404 
H     1.447    -0.652    -3.191 
C    -0.298    -2.559    -1.922 
H    -0.970    -2.722    -1.065 
H    -0.138    -3.532    -2.409 
H    -0.822    -1.932    -2.651 
C     1.820    -3.176    -0.826 
H     1.889    -3.997    -1.552 
H     1.287    -3.561     0.057 
H     2.847    -2.912    -0.535 
H     1.633    -1.535     3.342 
H     4.480    -0.345     1.382 
O     0.984     3.101    -1.074 
C     1.570     4.389    -1.167 
H     2.084     4.657    -0.229 
H     0.806     5.150    -1.391 
H     2.301     4.358    -1.983 
H     1.715     1.498     2.525 
H     2.341     1.768     0.779 
H    -0.201     2.957     2.103 
H    -0.863     3.593    -0.167 
C    -3.463    -0.016     2.315 
C    -2.692    -1.123     3.035 
H    -1.617    -1.055     2.813 
H    -3.045    -2.116     2.721 
H    -2.818    -1.046     4.124 
H    -4.529    -0.075     2.575 
H    -3.099     0.964     2.658 
 
                       
 Frequencies --   -151.0281                23.7125                34.8119 
 Red. masses --      4.8140                 4.0096                 3.5426 
 Zero-point correction=                           0.536547 (Hartree/Particle) 
 Thermal correction to Energy=                    0.564544 
 Thermal correction to Enthalpy=                  0.565488 
 Thermal correction to Gibbs Free Energy=         0.479940 
 Sum of electronic and zero-point Energies=          -1178.683194 
 Sum of electronic and thermal Energies=             -1178.655198 
 Sum of electronic and thermal Enthalpies=           -1178.654253 
 Sum of electronic and thermal Free Energies=        -1178.739802 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
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C    -4.347     0.657     0.110 
C    -4.444    -0.421    -0.768 
C    -3.149     1.360     0.283 
C    -3.330    -0.841    -1.491 
C    -2.118    -0.171    -1.339 
C    -2.057     0.917    -0.464 
H    -3.400    -1.689    -2.175 
H    -5.228     0.975     0.674 
H    -5.396    -0.941    -0.888 
O    -0.866     1.615    -0.376 
C    -0.855    -0.560    -2.059 
N     0.309    -0.399    -1.129 
H    -0.885    -1.581    -2.448 
H    -0.658     0.108    -2.916 
B     0.294     1.114    -0.814 
C     0.315    -1.245     0.128 
C     1.614    -0.836     0.841 
O     2.639    -0.873     0.174 
N     1.576    -0.470     2.141 
C     0.412    -0.436     3.004 
C     2.832    -0.200     2.819 
H     0.455    -1.246     3.749 
H    -0.527    -0.528     2.450 
H     2.797     0.793     3.291 
H     3.010    -0.955     3.601 
H     1.209    -0.563    -1.616 
C     3.386     2.223     0.490 
C     2.202     2.606     0.016 
C     1.534     2.001    -1.200 
C     0.291    -2.797    -0.101 
H    -0.588    -0.971     0.682 
C     1.183    -3.214    -1.276 
H     1.188    -4.310    -1.361 
H     2.219    -2.877    -1.134 
H     0.822    -2.827    -2.242 
C    -1.145    -3.304    -0.310 
H    -1.818    -2.959     0.489 
H    -1.146    -4.404    -0.292 
H    -1.583    -3.007    -1.270 
C     0.814    -3.463     1.186 
H     0.717    -4.554     1.090 
H     0.230    -3.162     2.069 
H     1.875    -3.245     1.372 
H     0.387     0.522     3.545 
H     3.651    -0.229     2.094 
O     2.355     1.199    -2.011 
C     3.236     1.903    -2.855 
H     3.909     2.565    -2.285 
H     2.682     2.511    -3.593 
H     3.843     1.160    -3.389 
H     3.826     2.711     1.362 
H     3.945     1.411     0.018 
H     1.640     3.413     0.500 
H     1.108     2.839    -1.793 
C    -3.025     2.527     1.229 
C    -2.234     2.198     2.495 
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H    -1.189     1.947     2.258 
H    -2.682     1.349     3.035 
H    -2.220     3.059     3.178 
H    -4.036     2.865     1.500 
H    -2.541     3.368     0.707 
 
                       
 Frequencies --     33.3194                47.1567                55.6993 
 Red. masses --      3.6642                 3.6215                 3.5967 
 Zero-point correction=                           0.539084 (Hartree/Particle) 
 Thermal correction to Energy=                    0.567362 
 Thermal correction to Enthalpy=                  0.568306 
 Thermal correction to Gibbs Free Energy=         0.483321 
 Sum of electronic and zero-point Energies=          -1178.910741 
 Sum of electronic and thermal Energies=             -1178.882463 
 Sum of electronic and thermal Enthalpies=           -1178.881518 
 Sum of electronic and thermal Free Energies=        -1178.966504 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 









C    -4.330    -0.638    -0.120 
C    -4.129    -0.730    -1.498 
C    -3.344    -0.136     0.730 
C    -2.917    -0.332    -2.047 
C    -1.905     0.176    -1.228 
C    -2.136     0.279     0.148 
H    -2.745    -0.418    -3.123 
H    -5.281    -0.961     0.311 
H    -4.919    -1.122    -2.142 
O    -1.168     0.784     0.969 
C    -0.582     0.597    -1.816 
N     0.526     0.502    -0.805 
H    -0.328    -0.012    -2.686 
H    -0.589     1.642    -2.152 
B    -0.055     1.386     0.371 
C     0.948    -0.891    -0.396 
C     2.241    -0.661     0.398 
O     3.087     0.058    -0.128 
N     2.402    -1.219     1.614 
C     1.455    -2.060     2.321 
C     3.670    -1.040     2.300 
H     1.893    -3.055     2.498 
H     0.520    -2.196     1.771 
H     3.504    -0.600     3.296 
H     4.169    -2.013     2.432 
H     1.357     0.971    -1.195 
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C     1.413     1.890     1.625 
C     0.431     2.805     1.337 
C     0.031     2.988    -0.055 
C     1.231    -1.925    -1.549 
H     0.130    -1.279     0.216 
C     2.043    -1.315    -2.701 
H     2.253    -2.095    -3.447 
H     3.002    -0.915    -2.347 
H     1.514    -0.508    -3.229 
C    -0.069    -2.564    -2.068 
H    -0.701    -2.923    -1.241 
H     0.181    -3.433    -2.694 
H    -0.681    -1.901    -2.690 
C     2.062    -3.075    -0.943 
H     2.209    -3.851    -1.707 
H     1.549    -3.551    -0.093 
H     3.061    -2.751    -0.617 
H     1.216    -1.613     3.299 
H     4.317    -0.382     1.713 
O     1.018     3.104    -1.019 
C     1.611     4.386    -1.108 
H     2.109     4.661    -0.162 
H     0.860     5.153    -1.359 
H     2.362     4.343    -1.907 
H     1.489     1.480     2.634 
H     2.261     1.743     0.951 
H    -0.342     3.003     2.087 
H    -0.874     3.588    -0.218 
C    -3.534    -0.064     2.224 
C    -2.793    -1.173     2.973 
H    -1.707    -1.104     2.807 
H    -3.127    -2.168     2.641 
H    -2.972    -1.102     4.057 
H    -4.609    -0.123     2.448 
H    -3.187     0.915     2.589 
 
                       
 Frequencies --   -183.3496                28.0787                39.1557 
 Red. masses --      5.4910                 4.2069                 3.3466 
 Zero-point correction=                           0.537998 (Hartree/Particle) 
 Thermal correction to Energy=                    0.565731 
 Thermal correction to Enthalpy=                  0.566675 
 Thermal correction to Gibbs Free Energy=         0.481985 
 Sum of electronic and zero-point Energies=          -1178.884161 
 Sum of electronic and thermal Energies=             -1178.856428 
 Sum of electronic and thermal Enthalpies=           -1178.855484 
 Sum of electronic and thermal Free Energies=        -1178.940174 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 




 Cartesian coordinates (Angstroms): 
 





C     2.245    -2.516    -1.498 
C     1.399    -3.405    -2.165 
C     1.815    -1.239    -1.107 
C     0.071    -3.060    -2.412 
C    -0.391    -1.799    -2.039 
C     0.501    -0.914    -1.440 
H    -0.611    -3.774    -2.880 
H     3.261    -2.836    -1.252 
H     1.765    -4.389    -2.457 
O     0.013     0.335    -1.110 
C    -1.820    -1.344    -2.152 
N    -2.187    -0.695    -0.836 
H    -1.973    -0.604    -2.951 
H    -2.468    -2.201    -2.331 
B    -1.247     0.527    -0.688 
C    -3.628    -0.445    -0.421 
C    -3.546    -0.757     1.099 
O    -2.721    -1.619     1.418 
N    -4.357    -0.172     1.984 
C    -5.188     0.996     1.755 
C    -4.317    -0.625     3.367 
H    -6.253     0.739     1.844 
H    -4.996     1.445     0.778 
H    -3.698     0.050     3.979 
H    -5.339    -0.626     3.770 
H    -1.913    -1.379    -0.071 
C    -3.330     2.920    -1.977 
C    -2.074     2.608    -1.655 
C    -1.661     2.007    -0.323 
H    -1.266     2.756    -2.379 
H    -4.147     2.802    -1.258 
C    -4.718    -1.319    -1.120 
H    -3.854     0.605    -0.620 
C    -4.539    -2.818    -0.843 
H    -5.257    -3.387    -1.452 
H    -4.737    -3.052     0.213 
H    -3.534    -3.204    -1.070 
C    -4.792    -1.009    -2.629 
H    -4.673     0.069    -2.822 
H    -5.785    -1.300    -3.001 
H    -4.066    -1.551    -3.244 
C    -6.086    -0.909    -0.548 
H    -6.864    -1.500    -1.052 
H    -6.303     0.153    -0.739 
H    -6.171    -1.109     0.527 
H    -4.950     1.744     2.526 
H    -3.902    -1.637     3.417 
Si     2.828    -0.099     0.033 
C     1.610     0.534     1.333 
C     1.663     1.859     1.787 
C     0.579    -0.290     1.820 
C     0.717     2.349     2.692 
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C    -0.373     0.195     2.716 
C    -0.305     1.521     3.152 
H    -1.047     1.906     3.854 
H     0.781     3.383     3.035 
H    -1.165    -0.468     3.068 
H     0.507    -1.332     1.486 
H     2.446     2.530     1.422 
C     3.593     1.337    -0.902 
C     3.049     1.844    -2.092 
C     3.619     2.948    -2.726 
C     4.745     3.564    -2.178 
C     5.301     3.073    -0.997 
C     4.730     1.968    -0.368 
H     2.171     1.367    -2.537 
H     5.194     4.425    -2.675 
H     3.190     3.327    -3.655 
H     5.182     1.586     0.552 
H     6.184     3.548    -0.567 
C     4.185    -1.130     0.822 
C     4.046    -1.657     2.115 
C     5.361    -1.419     0.107 
C     5.046    -2.453     2.675 
C     6.360    -2.216     0.663 
C     6.202    -2.734     1.949 
H     3.150    -1.437     2.702 
H     7.267    -2.430     0.095 
H     5.502    -1.008    -0.897 
H     6.985    -3.355     2.388 
H     4.924    -2.852     3.684 
O    -2.648     2.101     0.669 
C    -2.701     3.383     1.262 
H    -2.921     4.167     0.519 
H    -1.746     3.622     1.757 
H    -3.499     3.372     2.015 
H    -0.723     2.494     0.011 
H    -3.575     3.340    -2.955 
 
                       
 Frequencies --     21.1802                25.9989                34.8302 
 Red. masses --      4.3211                 4.7984                 3.7751 
 Zero-point correction=                           0.747759 (Hartree/Particle) 
 Thermal correction to Energy=                    0.789940 
 Thermal correction to Enthalpy=                  0.790884 
 Thermal correction to Gibbs Free Energy=         0.673522 
 Sum of electronic and zero-point Energies=          -2082.963307 
 Sum of electronic and thermal Energies=             -2082.921126 
 Sum of electronic and thermal Enthalpies=           -2082.920182 
 Sum of electronic and thermal Free Energies=        -2083.037544 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
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C    -2.069     2.931    -0.349 
C    -1.175     3.956    -0.671 
C    -1.717     1.583    -0.496 
C     0.110     3.649    -1.118 
C     0.487     2.316    -1.287 
C    -0.439     1.314    -0.995 
H     0.825     4.446    -1.332 
H    -3.056     3.186     0.044 
H    -1.470     4.998    -0.544 
O    -0.080     0.021    -1.181 
C     1.862     1.869    -1.698 
N     2.256     0.710    -0.799 
H     1.908     1.521    -2.739 
H     2.560     2.693    -1.574 
B     1.258    -0.442    -1.204 
C     3.706     0.422    -0.449 
C     3.603     0.205     1.092 
O     2.678     0.791     1.657 
N     4.512    -0.506     1.770 
C     5.433    -1.475     1.208 
C     4.400    -0.543     3.221 
H     6.476    -1.183     1.396 
H     5.282    -1.593     0.131 
H     3.763    -1.384     3.540 
H     5.402    -0.674     3.650 
H     1.926     0.997     0.164 
C     1.801    -1.304    -2.649 
C     1.103    -2.087    -1.704 
C     1.495    -2.050    -0.349 
H     0.031    -2.223    -1.874 
H     2.895    -1.269    -2.624 
C     4.745     1.544    -0.786 
H     4.010    -0.491    -0.967 
C     4.491     2.838     0.004 
H     5.150     3.632    -0.375 
H     4.732     2.689     1.067 
H     3.460     3.213    -0.029 
C     4.842     1.762    -2.310 
H     4.920     0.795    -2.832 
H     5.761     2.322    -2.530 
H     4.020     2.324    -2.762 
C     6.148     1.059    -0.373 
H     6.871     1.836    -0.658 
H     6.436     0.135    -0.895 
H     6.239     0.914     0.709 
H     5.256    -2.446     1.694 
H     3.965     0.392     3.587 
Si    -2.754     0.120     0.101 
C    -1.643    -0.874     1.273 
C    -1.861    -2.243     1.498 
C    -0.576    -0.259     1.949 
C    -1.052    -2.968     2.375 
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C     0.239    -0.979     2.825 
C    -0.001    -2.336     3.043 
H     0.627    -2.903     3.733 
H    -1.247    -4.030     2.541 
H     1.066    -0.471     3.323 
H    -0.364     0.804     1.792 
H    -2.673    -2.760     0.981 
C    -3.332    -0.945    -1.343 
C    -2.790    -0.808    -2.631 
C    -3.218    -1.617    -3.683 
C    -4.202    -2.582    -3.466 
C    -4.763    -2.726    -2.197 
C    -4.335    -1.911    -1.149 
H    -2.027    -0.049    -2.819 
H    -4.539    -3.215    -4.289 
H    -2.791    -1.489    -4.680 
H    -4.803    -2.023    -0.166 
H    -5.543    -3.470    -2.026 
C    -4.251     0.780     1.026 
C    -4.199     1.024     2.408 
C    -5.430     1.105     0.335 
C    -5.290     1.578     3.078 
C    -6.522     1.659     1.002 
C    -6.452     1.896     2.375 
H    -3.297     0.774     2.973 
H    -7.431     1.904     0.450 
H    -5.499     0.919    -0.740 
H    -7.307     2.328     2.899 
H    -5.235     1.759     4.153 
O     2.821    -2.234    -0.031 
C     3.112    -3.621     0.102 
H     2.821    -4.165    -0.811 
H     2.575    -4.049     0.964 
H     4.191    -3.730     0.253 
H     0.762    -2.342     0.414 
H     1.321    -1.117    -3.610 
 
                       
 Frequencies --   -317.0407                15.4358                24.7836 
 Red. masses --      7.4933                 4.7089                 4.2260 
 Zero-point correction=                           0.747594 (Hartree/Particle) 
 Thermal correction to Energy=                    0.788912 
 Thermal correction to Enthalpy=                  0.789857 
 Thermal correction to Gibbs Free Energy=         0.673701 
 Sum of electronic and zero-point Energies=          -2082.925059 
 Sum of electronic and thermal Energies=             -2082.883740 
 Sum of electronic and thermal Enthalpies=           -2082.882796 
 Sum of electronic and thermal Free Energies=        -2082.998952 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
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C     2.276    -2.530    -1.442 
C     1.434    -3.407    -2.130 
C     1.835    -1.267    -1.023 
C     0.108    -3.060    -2.385 
C    -0.363    -1.811    -1.985 
C     0.520    -0.945    -1.349 
H    -0.562    -3.763    -2.885 
H     3.297    -2.845    -1.211 
H     1.809    -4.382    -2.446 
O     0.033     0.293    -0.990 
C    -1.782    -1.339    -2.132 
N    -2.188    -0.693    -0.830 
H    -1.895    -0.595    -2.935 
H    -2.437    -2.184    -2.341 
B    -1.240     0.509    -0.637 
C    -3.637    -0.447    -0.447 
C    -3.588    -0.801     1.065 
O    -2.761    -1.666     1.378 
N    -4.415    -0.244     1.954 
C    -5.224     0.943     1.752 
C    -4.378    -0.730     3.325 
H    -6.295     0.708     1.839 
H    -5.030     1.408     0.783 
H    -3.725    -0.094     3.945 
H    -5.394    -0.702     3.743 
H    -1.950    -1.385    -0.056 
C    -3.292     2.994    -1.857 
C    -2.041     2.648    -1.548 
C    -1.626     1.991    -0.246 
H    -1.231     2.815    -2.268 
H    -4.114     2.861    -1.147 
C    -4.728    -1.276    -1.208 
H    -3.845     0.612    -0.615 
C    -4.590    -2.790    -0.983 
H    -5.312    -3.321    -1.621 
H    -4.810    -3.060     0.060 
H    -3.594    -3.196    -1.211 
C    -4.740    -0.913    -2.709 
H    -4.574     0.165    -2.865 
H    -5.726    -1.155    -3.131 
H    -4.010    -1.462    -3.313 
C    -6.107    -0.860    -0.664 
H    -6.883    -1.417    -1.209 
H    -6.305     0.211    -0.819 
H    -6.232    -1.098     0.400 
H    -4.970     1.676     2.531 
H    -4.002    -1.757     3.352 
Si     2.849    -0.092     0.074 
C     1.676     0.447     1.457 
C     1.687     1.756     1.957 
C     0.704    -0.439     1.954 
C     0.756     2.171     2.912 
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C    -0.239    -0.027     2.895 
C    -0.215     1.284     3.374 
H    -0.951     1.613     4.111 
H     0.788     3.195     3.291 
H    -0.996    -0.732     3.243 
H     0.661    -1.469     1.586 
H     2.422     2.478     1.589 
C     3.424     1.389    -0.931 
C     2.875     1.684    -2.189 
C     3.281     2.808    -2.907 
C     4.248     3.661    -2.377 
C     4.813     3.381    -1.133 
C     4.407     2.254    -0.420 
H     2.122     1.023    -2.625 
H     4.568     4.543    -2.938 
H     2.844     3.016    -3.886 
H     4.872     2.043     0.548 
H     5.578     4.042    -0.719 
C     4.319    -1.039     0.757 
C     4.257    -1.671     2.008 
C     5.494    -1.179    -0.002 
C     5.328    -2.427     2.484 
C     6.566    -1.935     0.471 
C     6.483    -2.560     1.715 
H     3.361    -1.571     2.628 
H     7.474    -2.031    -0.130 
H     5.578    -0.688    -0.976 
H     7.324    -3.150     2.088 
H     5.261    -2.911     3.461 
O    -2.590     2.062     0.769 
C    -2.606     3.301     1.440 
H    -2.844     4.136     0.759 
H    -1.633     3.503     1.919 
H    -3.377     3.251     2.220 
H    -0.675     2.451     0.088 
H    -3.529     3.458    -2.817 
 
                       
 Frequencies --     12.5265                27.0812                31.7303 
 Red. masses --      5.3221                 4.8735                 4.8615 
 Zero-point correction=                           0.750373 (Hartree/Particle) 
 Thermal correction to Energy=                    0.792166 
 Thermal correction to Enthalpy=                  0.793110 
 Thermal correction to Gibbs Free Energy=         0.675584 
 Sum of electronic and zero-point Energies=          -2083.230982 
 Sum of electronic and thermal Energies=             -2083.189190 
 Sum of electronic and thermal Enthalpies=           -2083.188245 
 Sum of electronic and thermal Free Energies=        -2083.305771 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
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C    -2.066     2.938    -0.249 
C    -1.159     3.972    -0.499 
C    -1.720     1.596    -0.452 
C     0.132     3.678    -0.934 
C     0.502     2.352    -1.162 
C    -0.433     1.345    -0.940 
H     0.858     4.480    -1.092 
H    -3.059     3.182     0.138 
H    -1.451     5.009    -0.326 
O    -0.072     0.066    -1.178 
C     1.877     1.917    -1.579 
N     2.269     0.715    -0.747 
H     1.931     1.633    -2.638 
H     2.580     2.728    -1.401 
B     1.261    -0.408    -1.200 
C     3.727     0.410    -0.443 
C     3.680     0.226     1.104 
O     2.782     0.837     1.689 
N     4.593    -0.492     1.772 
C     5.473    -1.503     1.219 
C     4.527    -0.479     3.226 
H     6.530    -1.238     1.374 
H     5.300    -1.656     0.151 
H     3.870    -1.284     3.596 
H     5.537    -0.632     3.630 
H     1.973     0.971     0.234 
C     1.805    -1.237    -2.660 
C     1.091    -2.052    -1.753 
C     1.448    -2.042    -0.384 
H     0.020    -2.178    -1.947 
H     2.900    -1.229    -2.633 
C     4.798     1.481    -0.869 
H     3.982    -0.528    -0.944 
C     4.695     2.790    -0.067 
H     5.412     3.521    -0.469 
H     4.954     2.625     0.990 
H     3.705     3.264    -0.074 
C     4.764     1.721    -2.395 
H     4.600     0.781    -2.945 
H     5.737     2.115    -2.720 
H     4.016     2.447    -2.729 
C     6.198     0.909    -0.579 
H     6.949     1.632    -0.930 
H     6.382    -0.037    -1.110 
H     6.376     0.763     0.492 
H     5.287    -2.455     1.738 
H     4.137     0.481     3.580 
Si    -2.776     0.125     0.088 
C    -1.694    -0.897     1.261 
C    -1.890    -2.276     1.432 
C    -0.656    -0.289     1.987 
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C    -1.085    -3.019     2.297 
C     0.158    -1.026     2.847 
C    -0.058    -2.395     3.006 
H     0.573    -2.976     3.683 
H    -1.262    -4.091     2.419 
H     0.966    -0.525     3.382 
H    -0.467     0.783     1.875 
H    -2.681    -2.790     0.880 
C    -3.336    -0.916    -1.380 
C    -2.780    -0.764    -2.660 
C    -3.191    -1.565    -3.726 
C    -4.171    -2.538    -3.530 
C    -4.746    -2.697    -2.270 
C    -4.336    -1.890    -1.209 
H    -2.017    -0.002    -2.834 
H    -4.495    -3.166    -4.364 
H    -2.750    -1.425    -4.715 
H    -4.815    -2.017    -0.234 
H    -5.525    -3.448    -2.115 
C    -4.284     0.775     1.005 
C    -4.268     0.958     2.397 
C    -5.439     1.153     0.299 
C    -5.366     1.504     3.062 
C    -6.538     1.698     0.960 
C    -6.502     1.875     2.343 
H    -3.386     0.669     2.976 
H    -7.429     1.983     0.395 
H    -5.485     1.014    -0.785 
H    -7.364     2.301     2.862 
H    -5.335     1.639     4.145 
O     2.748    -2.258    -0.007 
C     2.960    -3.624     0.314 
H     2.648    -4.276    -0.520 
H     2.398    -3.907     1.220 
H     4.031    -3.770     0.491 
H     0.683    -2.342     0.342 
H     1.342    -1.024    -3.625 
 
 
 Frequencies --   -348.2968                11.1715                27.1389 
 Red. masses --      7.5547                 4.8363                 4.2023 
 Zero-point correction=                           0.749806 (Hartree/Particle) 
 Thermal correction to Energy=                    0.791045 
 Thermal correction to Enthalpy=                  0.791989 
 Thermal correction to Gibbs Free Energy=         0.675374 
 Sum of electronic and zero-point Energies=          -2083.190657 
 Sum of electronic and thermal Energies=             -2083.149419 
 Sum of electronic and thermal Enthalpies=           -2083.148474 
 Sum of electronic and thermal Free Energies=        -2083.265090 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
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charge= 0    multiplicity= 1 
----------------------------------------- 




B     0.037     0.349     0.799 
C    -1.358     0.725     1.420 
C    -2.221     1.346     0.356 
H    -1.202     1.446     2.241 
H    -1.843    -0.170     1.835 
C    -3.199     0.710    -0.296 
H    -2.007     2.372     0.047 
O    -3.513    -0.585    -0.051 
H    -3.786     1.205    -1.081 
C    -4.750    -1.022    -0.542 
H    -4.832    -0.873    -1.635 
H    -5.593    -0.502    -0.053 
H    -4.827    -2.095    -0.330 
O     0.500    -0.928     0.645 
O     0.910     1.283     0.302 
C     1.851    -0.857     0.163 
C     1.904     0.586    -0.463 
C     2.769    -1.018     1.375 
H     2.523    -1.961     1.883 
H     2.626    -0.198     2.094 
H     3.828    -1.045     1.082 
C     2.086    -1.990    -0.825 
H     2.033    -2.955    -0.302 
H     3.082    -1.904    -1.286 
H     1.329    -1.995    -1.619 
C     1.445     0.620    -1.922 
H     2.183     0.156    -2.593 
H     1.309     1.668    -2.225 
H     0.481     0.106    -2.047 
C     3.240     1.297    -0.317 
H     4.039     0.730    -0.818 
H     3.512     1.433     0.738 
H     3.183     2.292    -0.781 
 
                       
 
 Frequencies --     10.2718                18.7164                47.3847 
 Red. masses --      3.5470                 3.7593                 2.5053 
 Zero-point correction=                           0.287374 (Hartree/Particle) 
 Thermal correction to Energy=                    0.303275 
 Thermal correction to Enthalpy=                  0.304219 
 Thermal correction to Gibbs Free Energy=         0.242094 
 Sum of electronic and zero-point Energies=           -642.171110 
 Sum of electronic and thermal Energies=              -642.155210 
 Sum of electronic and thermal Enthalpies=            -642.154265 
 Sum of electronic and thermal Free Energies=         -642.216390 
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         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
 
Summary of Natural Population Analysis:       
PA(N)                                                           
                                       Natural Population  
    Atom  No    Charge         Core      Valence    Rydberg      Total 
 ----------------------------------------------------------------------- 
      B    1    1.13132      1.99930     1.83695    0.03243     3.86868 
      C    2   -0.79430      1.99911     4.77708    0.01810     6.79430 
      C    3   -0.24949      1.99910     4.23035    0.02004     6.24949 
      H    4    0.23901      0.00000     0.75903    0.00196     0.76099 
      H    5    0.24696      0.00000     0.75081    0.00222     0.75304 
      C    6    0.09942      1.99881     3.88010    0.02167     5.90058 
      H    7    0.21363      0.00000     0.78480    0.00157     0.78637 
      O    8   -0.48625      1.99974     6.45574    0.03077     8.48625 
      H    9    0.16553      0.00000     0.83141    0.00306     0.83447 
      C   10   -0.24867      1.99934     4.23575    0.01358     6.24867 
      H   11    0.16359      0.00000     0.83387    0.00254     0.83641 
      H   12    0.16623      0.00000     0.83112    0.00265     0.83377 
      H   13    0.19285      0.00000     0.80544    0.00171     0.80715 
      O   14   -0.69710      1.99969     6.67331    0.02410     8.69710 
      O   15   -0.70547      1.99969     6.68200    0.02378     8.70547 
      C   16    0.23939      1.99923     3.74076    0.02061     5.76061 
      C   17    0.24013      1.99924     3.73994    0.02069     5.75987 
      C   18   -0.62799      1.99939     4.61527    0.01332     6.62799 
      H   19    0.22044      0.00000     0.77778    0.00179     0.77956 
      H   20    0.21313      0.00000     0.78532    0.00155     0.78687 
      H   21    0.21015      0.00000     0.78841    0.00144     0.78985 
      C   22   -0.62086      1.99939     4.60850    0.01297     6.62086 
      H   23    0.21846      0.00000     0.77978    0.00176     0.78154 
      H   24    0.20831      0.00000     0.79024    0.00144     0.79169 
      H   25    0.22004      0.00000     0.77844    0.00152     0.77996 
      C   26   -0.62966      1.99939     4.61684    0.01342     6.62966 
      H   27    0.20963      0.00000     0.78892    0.00144     0.79037 
      H   28    0.21965      0.00000     0.77855    0.00180     0.78035 
      H   29    0.21676      0.00000     0.78168    0.00156     0.78324 
      C   30   -0.62094      1.99939     4.60854    0.01301     6.62094 
      H   31    0.20901      0.00000     0.78955    0.00144     0.79099 
      H   32    0.21871      0.00000     0.77977    0.00152     0.78129 
      H   33    0.21836      0.00000     0.77986    0.00177     0.78164 
 =================================================================== 
 
Natural Population  
PA(N-1) 
    Atom  No    Charge         Core      Valence    Rydberg      Total 
 ----------------------------------------------------------------------- 
      B    1    1.13132      1.99930     1.83695    0.03243     3.86868 
      C    2   -0.79430      1.99911     4.77708    0.01810     6.79430 
      C    3   -0.24949      1.99910     4.23035    0.02004     6.24949 
      H    4    0.23901      0.00000     0.75903    0.00196     0.76099 
      H    5    0.24696      0.00000     0.75081    0.00222     0.75304 
      C    6    0.09942      1.99881     3.88010    0.02167     5.90058 
 
	 Page 104 
      H    7    0.21363      0.00000     0.78480    0.00157     0.78637 
      O    8   -0.48625      1.99974     6.45574    0.03077     8.48625 
      H    9    0.16553      0.00000     0.83141    0.00306     0.83447 
      C   10   -0.24867      1.99934     4.23575    0.01358     6.24867 
      H   11    0.16359      0.00000     0.83387    0.00254     0.83641 
      H   12    0.16623      0.00000     0.83112    0.00265     0.83377 
      H   13    0.19285      0.00000     0.80544    0.00171     0.80715 
      O   14   -0.69710      1.99969     6.67331    0.02410     8.69710 
      O   15   -0.70547      1.99969     6.68200    0.02378     8.70547 
      C   16    0.23939      1.99923     3.74076    0.02061     5.76061 
      C   17    0.24013      1.99924     3.73994    0.02069     5.75987 
      C   18   -0.62799      1.99939     4.61527    0.01332     6.62799 
      H   19    0.22044      0.00000     0.77778    0.00179     0.77956 
      H   20    0.21313      0.00000     0.78532    0.00155     0.78687 
      H   21    0.21015      0.00000     0.78841    0.00144     0.78985 
      C   22   -0.62086      1.99939     4.60850    0.01297     6.62086 
      H   23    0.21846      0.00000     0.77978    0.00176     0.78154 
      H   24    0.20831      0.00000     0.79024    0.00144     0.79169 
      H   25    0.22004      0.00000     0.77844    0.00152     0.77996 
      C   26   -0.62966      1.99939     4.61684    0.01342     6.62966 
      H   27    0.20963      0.00000     0.78892    0.00144     0.79037 
      H   28    0.21965      0.00000     0.77855    0.00180     0.78035 
      H   29    0.21676      0.00000     0.78168    0.00156     0.78324 
      C   30   -0.62094      1.99939     4.60854    0.01301     6.62094 
      H   31    0.20901      0.00000     0.78955    0.00144     0.79099 
      H   32    0.21871      0.00000     0.77977    0.00152     0.78129 





charge= 0    multiplicity= 1 
----------------------------------------- 




B    -2.259     1.113    -0.228 
C    -1.677     2.562    -0.434 
C    -0.426     2.863     0.343 
H    -2.472     3.273    -0.154 
H    -1.516     2.714    -1.516 
C     0.634     2.057     0.384 
H    -0.347     3.803     0.895 
O     0.649     0.880    -0.310 
H     1.552     2.295     0.929 
C     1.590    -0.046     0.093 
O     2.866     0.426    -0.203 
H     1.373    -0.978    -0.463 
H     1.505    -0.254     1.183 
C     3.900    -0.391     0.266 
C     5.221     0.264    -0.117 
H     3.828    -1.407    -0.174 
H     3.856    -0.510     1.367 
O     6.323    -0.470     0.331 
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H     5.269     1.258     0.353 
H     5.246     0.414    -1.213 
C     6.725    -1.510    -0.511 
H     6.995    -1.140    -1.519 
H     5.950    -2.291    -0.632 
H     7.612    -1.977    -0.063 
O    -2.918     0.426    -1.213 
O    -2.247     0.433     0.960 
C    -3.568    -0.701    -0.607 
C    -2.730    -0.894     0.711 
C    -5.017    -0.294    -0.337 
H    -5.476     0.031    -1.282 
H    -5.070     0.545     0.371 
H    -5.606    -1.130     0.066 
C    -3.527    -1.878    -1.570 
H    -4.141    -1.654    -2.454 
H    -3.931    -2.785    -1.093 
H    -2.506    -2.083    -1.913 
C    -3.530    -1.369     1.915 
H    -3.993    -2.347     1.714 
H    -4.318    -0.654     2.182 
H    -2.863    -1.476     2.782 
C    -1.506    -1.788     0.507 
H    -1.787    -2.844     0.386 
H    -0.854    -1.699     1.387 
H    -0.935    -1.470    -0.376 
 
                       
 Frequencies --      9.7138                23.3411                30.1984 
 Red. masses --      4.0269                 4.3979                 4.0213 
 Zero-point correction=                           0.383059 (Hartree/Particle) 
 Thermal correction to Energy=                    0.404917 
 Thermal correction to Enthalpy=                  0.405861 
 Thermal correction to Gibbs Free Energy=         0.328947 
 Sum of electronic and zero-point Energies=           -910.151847 
 Sum of electronic and thermal Energies=              -910.129990 
 Sum of electronic and thermal Enthalpies=            -910.129046 
 Sum of electronic and thermal Free Energies=         -910.205960 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
 
Summary of Natural Population Analysis:       
PA(N)                                                           
              
                                       Natural Population 
    Atom  No    Charge         Core      Valence    Rydberg      Total 
 ----------------------------------------------------------------------- 
      B    1    1.14250      1.99930     1.82124    0.03696     3.85750 
      C    2   -0.80252      1.99912     4.78706    0.01634     6.80252 
      C    3   -0.23697      1.99911     4.21829    0.01957     6.23697 
      H    4    0.24294      0.00000     0.75534    0.00172     0.75706 
      H    5    0.24715      0.00000     0.75087    0.00198     0.75285 
      C    6    0.09833      1.99879     3.87971    0.02318     5.90167 
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      H    7    0.21090      0.00000     0.78759    0.00150     0.78910 
      O    8   -0.49040      1.99972     6.46173    0.02895     8.49040 
      H    9    0.18472      0.00000     0.81307    0.00221     0.81528 
      C   10    0.23781      1.99937     3.74102    0.02180     5.76219 
      O   11   -0.51237      1.99973     6.48703    0.02561     8.51237 
      H   12    0.15053      0.00000     0.84620    0.00327     0.84947 
      H   13    0.12544      0.00000     0.86974    0.00481     0.87456 
      C   14   -0.09538      1.99930     4.07678    0.01930     6.09538 
      C   15   -0.07901      1.99929     4.05956    0.02016     6.07901 
      H   16    0.15448      0.00000     0.84266    0.00286     0.84552 
      H   17    0.16455      0.00000     0.83292    0.00254     0.83545 
      O   18   -0.49591      1.99977     6.47016    0.02597     8.49591 
      H   19    0.18832      0.00000     0.80961    0.00206     0.81168 
      H   20    0.16453      0.00000     0.83278    0.00269     0.83547 
      C   21   -0.25230      1.99935     4.23833    0.01462     6.25230 
      H   22    0.15940      0.00000     0.83759    0.00302     0.84060 
      H   23    0.15467      0.00000     0.84237    0.00297     0.84533 
      H   24    0.19134      0.00000     0.80688    0.00178     0.80866 
      O   25   -0.70422      1.99969     6.68125    0.02328     8.70422 
      O   26   -0.70557      1.99969     6.68251    0.02338     8.70557 
      C   27    0.23884      1.99923     3.74058    0.02135     5.76116 
      C   28    0.23966      1.99923     3.73910    0.02201     5.76034 
      C   29   -0.62818      1.99940     4.61581    0.01297     6.62818 
      H   30    0.22038      0.00000     0.77792    0.00169     0.77962 
      H   31    0.21340      0.00000     0.78512    0.00148     0.78660 
      H   32    0.21037      0.00000     0.78822    0.00141     0.78963 
      C   33   -0.62069      1.99939     4.60857    0.01273     6.62069 
      H   34    0.21891      0.00000     0.77941    0.00168     0.78109 
      H   35    0.20833      0.00000     0.79026    0.00141     0.79167 
      H   36    0.21909      0.00000     0.77940    0.00152     0.78091 
      C   37   -0.62065      1.99939     4.60854    0.01271     6.62065 
      H   38    0.20849      0.00000     0.79011    0.00140     0.79151 
      H   39    0.21925      0.00000     0.77924    0.00151     0.78075 
      H   40    0.21808      0.00000     0.78023    0.00169     0.78192 
      C   41   -0.63177      1.99940     4.61843    0.01395     6.63177 
      H   42    0.21062      0.00000     0.78794    0.00143     0.78938 
      H   43    0.21709      0.00000     0.78106    0.00184     0.78291 
      H   44    0.21581      0.00000     0.78214    0.00206     0.78419 
 ==================================================================== 
Natural Population  
PA(N-1) 
                                                           
                                       Natural Population  
    Atom  No    Charge         Core      Valence    Rydberg      Total 
 ----------------------------------------------------------------------- 
      B    1    0.57429      0.99955     0.90848    0.01768     1.92571 
      C    2   -0.40709      0.99954     2.39946    0.00809     3.40709 
      C    3    0.26567      0.99957     1.72629    0.00847     2.73433 
      H    4    0.14268      0.00000     0.35655    0.00077     0.35732 
      H    5    0.17931      0.00000     0.31991    0.00078     0.32069 
      C    6    0.25715      0.99943     1.73339    0.01004     2.74285 
      H    7    0.11679      0.00000     0.38262    0.00059     0.38321 
      O    8   -0.04807      0.99986     3.03575    0.01245     4.04807 
      H    9    0.11119      0.00000     0.38783    0.00098     0.38881 
      C   10    0.09810      0.99968     1.89173    0.01049     2.90190 
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      O   11   -0.24749      0.99986     3.23531    0.01232     4.24749 
      H   12    0.09405      0.00000     0.40445    0.00151     0.40595 
      H   13    0.08928      0.00000     0.40859    0.00213     0.41072 
      C   14   -0.05264      0.99965     2.04334    0.00966     3.05264 
      C   15   -0.03945      0.99964     2.02959    0.01022     3.03945 
      H   16    0.08606      0.00000     0.41266    0.00127     0.41394 
      H   17    0.08722      0.00000     0.41165    0.00112     0.41278 
      O   18   -0.24206      0.99989     3.22931    0.01286     4.24206 
      H   19    0.09462      0.00000     0.40437    0.00100     0.40538 
      H   20    0.08576      0.00000     0.41294    0.00130     0.41424 
      C   21   -0.12885      0.99968     2.12191    0.00727     3.12885 
      H   22    0.08344      0.00000     0.41520    0.00135     0.41656 
      H   23    0.07669      0.00000     0.42197    0.00134     0.42331 
      H   24    0.10262      0.00000     0.39655    0.00083     0.39738 
      O   25   -0.34356      0.99984     3.33191    0.01181     4.34356 
      O   26   -0.35390      0.99984     3.34245    0.01162     4.35390 
      C   27    0.12144      0.99961     1.86861    0.01034     2.87856 
      C   28    0.12174      0.99961     1.86795    0.01070     2.87826 
      C   29   -0.31586      0.99970     2.30961    0.00655     3.31586 
      H   30    0.11541      0.00000     0.38382    0.00078     0.38459 
      H   31    0.10542      0.00000     0.39387    0.00071     0.39458 
      H   32    0.11329      0.00000     0.38605    0.00066     0.38671 
      C   33   -0.31219      0.99969     2.30604    0.00646     3.31219 
      H   34    0.11592      0.00000     0.38330    0.00078     0.38408 
      H   35    0.11135      0.00000     0.38799    0.00066     0.38865 
      H   36    0.10860      0.00000     0.39067    0.00073     0.39140 
      C   37   -0.31281      0.99969     2.30664    0.00647     3.31281 
      H   38    0.11246      0.00000     0.38688    0.00065     0.38754 
      H   39    0.11350      0.00000     0.38579    0.00071     0.38650 
      H   40    0.11161      0.00000     0.38760    0.00079     0.38839 
      C   41   -0.31616      0.99970     2.30960    0.00686     3.31616 
      H   42    0.11748      0.00000     0.38185    0.00068     0.38252 
      H   43    0.10718      0.00000     0.39191    0.00092     0.39282 





charge= 0    multiplicity= 1 
----------------------------------------- 




B    -1.137    -0.968     0.715 
C    -0.033    -1.947     1.256 
C     0.803    -2.436     0.104 
H    -0.521    -2.802     1.754 
H     0.602    -1.435     1.993 
C     2.002    -1.942    -0.220 
H     0.400    -3.229    -0.531 
O     2.619    -0.974     0.499 
H     2.563    -2.332    -1.081 
Si     3.087     0.541    -0.087 
C     3.552     1.521     1.431 
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H     2.683     1.631     2.098 
H     3.906     2.527     1.159 
H     4.352     1.016     1.993 
C     1.629     1.292    -0.989 
H     0.745     1.270    -0.333 
H     1.395     0.719    -1.900 
H     1.827     2.335    -1.284 
O    -1.148     0.385     0.934 
O    -2.176    -1.371    -0.081 
C    -2.379     0.910     0.407 
C    -2.786    -0.195    -0.636 
C    -3.357     1.016     1.578 
H    -2.905     1.641     2.361 
H    -3.569     0.028     2.011 
H    -4.308     1.476     1.272 
C    -2.126     2.286    -0.189 
H    -1.834     2.986     0.607 
H    -3.039     2.673    -0.667 
H    -1.322     2.266    -0.934 
C    -2.155     0.026    -2.011 
H    -2.616     0.872    -2.540 
H    -2.296    -0.882    -2.615 
H    -1.074     0.211    -1.926 
C    -4.283    -0.424    -0.773 
H    -4.787     0.496    -1.105 
H    -4.730    -0.750     0.174 
H    -4.470    -1.207    -1.522 
C     4.552     0.325    -1.240 
H     5.395    -0.156    -0.720 
H     4.898     1.300    -1.621 
H     4.289    -0.297    -2.110 
 
                       
 Frequencies --     15.9598                29.0765                41.2154 
 Red. masses --      3.1973                 3.5680                 4.3082 
 Zero-point correction=                           0.360926 (Hartree/Particle) 
 Thermal correction to Energy=                    0.382666 
 Thermal correction to Enthalpy=                  0.383611 
 Thermal correction to Gibbs Free Energy=         0.310203 
 Sum of electronic and zero-point Energies=          -1011.343687 
 Sum of electronic and thermal Energies=             -1011.321946 
 Sum of electronic and thermal Enthalpies=           -1011.321002 
 Sum of electronic and thermal Free Energies=        -1011.394410 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
 
Summary of Natural Population Analysis:       
PA(N)                                                           
                                                           
    Atom  No    Charge         Core      Valence    Rydberg      Total 
 ----------------------------------------------------------------------- 
      B    1    1.13941      1.99929     1.82604    0.03526     3.86059 
      C    2   -0.80064      1.99912     4.78218    0.01935     6.80064 
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      C    3   -0.24450      1.99908     4.22509    0.02033     6.24450 
      H    4    0.24067      0.00000     0.75744    0.00189     0.75933 
      H    5    0.24586      0.00000     0.75150    0.00264     0.75414 
      C    6    0.11089      1.99884     3.86174    0.02853     5.88911 
      H    7    0.21144      0.00000     0.78699    0.00157     0.78856 
      O    8   -0.84299      1.99973     6.82424    0.01902     8.84299 
      H    9    0.16634      0.00000     0.83163    0.00203     0.83366 
     Si   10    1.91172      9.99795     2.05373    0.03659    12.08828 
      C   11   -1.13832      1.99944     5.11882    0.02006     7.13832 
      H   12    0.24388      0.00000     0.75458    0.00154     0.75612 
      H   13    0.23383      0.00000     0.76473    0.00144     0.76617 
      H   14    0.24126      0.00000     0.75719    0.00155     0.75874 
      C   15   -1.16481      1.99943     5.14289    0.02249     7.16481 
      H   16    0.25815      0.00000     0.74011    0.00174     0.74185 
      H   17    0.23593      0.00000     0.76220    0.00187     0.76407 
      H   18    0.23564      0.00000     0.76277    0.00159     0.76436 
      O   19   -0.71091      1.99969     6.68762    0.02360     8.71091 
      O   20   -0.70610      1.99969     6.68271    0.02370     8.70610 
      C   21    0.24137      1.99923     3.73755    0.02185     5.75863 
      C   22    0.23947      1.99923     3.74069    0.02061     5.76053 
      C   23   -0.62876      1.99940     4.61631    0.01305     6.62876 
      H   24    0.22045      0.00000     0.77783    0.00172     0.77955 
      H   25    0.21434      0.00000     0.78421    0.00146     0.78566 
      H   26    0.21117      0.00000     0.78741    0.00142     0.78883 
      C   27   -0.62588      1.99939     4.61355    0.01294     6.62588 
      H   28    0.21881      0.00000     0.77945    0.00173     0.78119 
      H   29    0.21123      0.00000     0.78735    0.00142     0.78877 
      H   30    0.22220      0.00000     0.77633    0.00148     0.77780 
      C   31   -0.63081      1.99939     4.61808    0.01334     6.63081 
      H   32    0.21033      0.00000     0.78824    0.00143     0.78967 
      H   33    0.22115      0.00000     0.77715    0.00170     0.77885 
      H   34    0.21766      0.00000     0.78083    0.00151     0.78234 
      C   35   -0.62073      1.99939     4.60854    0.01280     6.62073 
      H   36    0.20930      0.00000     0.78927    0.00143     0.79070 
      H   37    0.21914      0.00000     0.77934    0.00152     0.78086 
      H   38    0.21932      0.00000     0.77899    0.00169     0.78068 
      C   39   -1.14599      1.99945     5.12533    0.02120     7.14599 
      H   40    0.23895      0.00000     0.75954    0.00151     0.76105 
      H   41    0.23553      0.00000     0.76302    0.00145     0.76447 
      H   42    0.23502      0.00000     0.76338    0.00159     0.76498 
 ==================================================================== 
 
Natural Population  
PA(N-1) 
 
    Atom  No    Charge         Core      Valence    Rydberg      Total 
 ----------------------------------------------------------------------- 
      B    1    0.58121      0.99943     0.90076    0.01860     1.91879 
      C    2   -0.38084      0.99954     2.37143    0.00987     3.38084 
      C    3    0.23966      0.99956     1.75234    0.00844     2.76034 
      H    4    0.15980      0.00000     0.33934    0.00086     0.34020 
      H    5    0.14167      0.00000     0.35723    0.00110     0.35833 
      C    6    0.27925      0.99945     1.70880    0.01251     2.72075 
      H    7    0.11719      0.00000     0.38215    0.00065     0.38281 
      O    8   -0.23477      0.99986     3.22655    0.00836     4.23477 
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      H    9    0.10105      0.00000     0.39814    0.00081     0.39895 
     Si   10    0.92795      4.99885     1.05636    0.01684     6.07205 
      C   11   -0.57027      0.99971     2.56026    0.01030     3.57027 
      H   12    0.12546      0.00000     0.37379    0.00075     0.37454 
      H   13    0.13042      0.00000     0.36888    0.00070     0.36958 
      H   14    0.12718      0.00000     0.37209    0.00073     0.37282 
      C   15   -0.56478      0.99971     2.55405    0.01102     3.56478 
      H   16    0.13019      0.00000     0.36895    0.00086     0.36981 
      H   17    0.11854      0.00000     0.38058    0.00088     0.38146 
      H   18    0.13470      0.00000     0.36450    0.00080     0.36530 
      O   19   -0.34794      0.99984     3.33642    0.01168     4.34794 
      O   20   -0.34687      0.99984     3.33523    0.01181     4.34687 
      C   21    0.12352      0.99961     1.86626    0.01061     2.87648 
      C   22    0.12237      0.99961     1.86794    0.01008     2.87763 
      C   23   -0.31632      0.99970     2.31004    0.00659     3.31632 
      H   24    0.11420      0.00000     0.38501    0.00080     0.38580 
      H   25    0.10725      0.00000     0.39206    0.00069     0.39275 
      H   26    0.11407      0.00000     0.38527    0.00066     0.38593 
      C   27   -0.31441      0.99969     2.30818    0.00654     3.31441 
      H   28    0.11429      0.00000     0.38490    0.00082     0.38571 
      H   29    0.11444      0.00000     0.38490    0.00066     0.38556 
      H   30    0.10813      0.00000     0.39114    0.00073     0.39187 
      C   31   -0.31527      0.99970     2.30894    0.00663     3.31527 
      H   32    0.11525      0.00000     0.38408    0.00067     0.38475 
      H   33    0.11348      0.00000     0.38570    0.00081     0.38652 
      H   34    0.09960      0.00000     0.39965    0.00076     0.40040 
      C   35   -0.31299      0.99969     2.30678    0.00652     3.31299 
      H   36    0.11191      0.00000     0.38743    0.00066     0.38809 
      H   37    0.11325      0.00000     0.38602    0.00072     0.38675 
      H   38    0.11394      0.00000     0.38528    0.00078     0.38606 
      C   39   -0.57373      0.99972     2.56327    0.01074     3.57373 
      H   40    0.12668      0.00000     0.37259    0.00073     0.37332 
      H   41    0.13228      0.00000     0.36700    0.00072     0.36772 




1.7.13 NMR Spectra 
(appear on the following pages) 
	 	
 































































































































































1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
	
 






























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 




19F NMR (CDCl3, 376 MHz) 
	
 






























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 





























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 
































































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 






























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 125 MHz) 
	
 





























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 





























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 































































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 































































































































































1H NMR (CDCl3, 400 MHz) 
	
 




1H NMR (CDCl3, 400 MHz) 
	
 

























































































































































1H NMR (CDCl3, 600 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 








































































19F NMR (CDCl3, 564 MHz) 
	
 






























































































































































1H NMR (CDCl3, 600 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 































































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 































































































































































1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
	
 

































































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
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1.127 
1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 



























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 
































































































































































1H NMR (CDCl3, 500 MHz) 
	
 




1H NMR (CDCl3, 100 MHz) 
	
 



























































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 
































































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 
































































































































































1H NMR (CDCl3, 400 MHz) 
	
 




13C NMR (CDCl3, 100 MHz) 
	
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13 C NMR (CDCl3, 100 MHz) 
 
 




19F NMR (CDCl3, 376 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
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1H NMR (CDCl3, 400 MHz) 
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13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 150 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




1H NMR (CDCl3, 600 MHz) 
 
 




13C NMR (CDCl3, 150 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
 
 




1H NMR (CDCl3, 400 MHz) 
 
 




13C NMR (CDCl3, 100 MHz) 
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Chapter Two 
Regio- and Enantioselective Synthesis of Trifluoromethyl-Substituted 
𝛼-Tertiary NH2 Amines 
2.1 Introduction 
 The incorporation of one or more fluorine atoms as a strategy to modify chemical 
properties of a compound has emerged as a crucial approach for discovery of new classes of 
therapeutics,1 agrichemicals2 or materials.3 One important class of fluorine-containing compounds 
are those with a trifluoromethyl group adjacent to an amine, since this motif may modulate 
basicity, lipophilicity 4  or increase metabolic stability. 5  Despite considerable efforts directed 
towards the preparation of enantioenriched amines, 6  the efficiency with which an a-tertiary 
trifluoromethyl substituted amine bearing a Z alkene can be accessed remains lacking.  
																																																								
1) Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell, N. A. J. Med. Chem. 2015, 58, 8315–8359. 
2) Fugiwara, T.; O’Hagan, D. J. Fluorine Chem. 2014, 167, 16–29. 
3) Berger, R.; Resnati, G.; Metrangolo, P.; Weber, E.; Hullinger, J. Chem. Soc. Rev. 2011, 40, 3496–3508. 
4) Smart, B. E.; J. Fluorine Chem. 2001, 109, 3–11. 
5) Huchet, Q. A.; Kuhn, B.; Wagner, B.; Kratochwil, N. A.; Fischer, H.; Kansy, M.; Zimmerli, D.; Carreira, E. M.; 
Müller, K. J. Med. Chem. 2015, 58, 9041–9060. 
6) (a) Lauzon, C.; Charette, A. B. Org. Lett. 2006, 8, 2743–2745. (b) Fu, P.; Snapper, M. L.; Hoveyda, A. H. J. Am. 
Chem. Soc. 2008, 130, 5530–5541. (c) Enders, D.; Gottfried, K.; Raabe, G. Adv. Synth. Catal. 2010, 352, 3147–3152. 
(d) Huang, G.; Yang, J.; Zhang, X. Chem. Commun. 2011, 47, 5587–5589. (e) Husmann, R.; Sugiono, E.; Mersmann, 
S.; Raabe, G.; Rueping, M.; Bolm, C. Org. Lett. 2011, 13, 1044–1047. (f) Liu, Y.-L.; Shi, T. D.; Zhou, F.; Zhao, X.-
L.; Wang, X.; Zhou, J. Org. Lett. 2011, 13, 3826–3829.  (g) Xie, H.; Zhang, Y.; Zhang, S.; Chen, X.; Wang, W. 
Angew. Chem. Int. Ed. 2011, 50, 11773–11776. (g) Sun, L.-H.; Liang, Z.-Q.; Jia, W.-Q.; Ye, S. Angew. Chem. Int. Ed. 
2013, 52, 5803–5806. (h) Yuan, H.-N.; Li, S.; Nie, J.; Zheng, Y.; Ma, J.-A. Chem. Eur. J. 2013, 19, 15856–15860. (h) 
Grellepois, F. J. Org. Chem. 2013, 78, 1127–1137. (i) Wang, H.; Jiang, T.; Xu, M.-H. J. Am. Chem. Soc. 2013, 135, 
971–974. (j) Wang, L.; Chen, J.; Huang, Y. Angew. Chem. Int. Ed. 2015, 54, 15414–15418. (k) Zhang, S.; Li, L.; Hu, 
Y.; Li, Y.; Yang, Y.; Wang, Z. Org. Lett. 2015, 17, 5036–5039. (k) Trost, B. M.; Hung, C.-I.; Scharf, M. J. Angew. 
Chem. Int. Ed. 2018, 57, 11408–11412. 
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2.2 Background 
2.2.1 State-of-the-art for Diastereoselective Synthesis of Enantioenriched a-Tertiary 
Trifluoromethyl Amines 
Diastereoselective addition of allyl metal reagents to enantiomerically pure trifluoromethyl 
substituted imines (2.1, 2.6) is an effective strategy for synthesis of enantioenriched homoallylic 
amines. In an early report, Brigaud outlined diastereoselective addition to phenyl glycinol derived 
iminoester 2.1 affording a mixture of the desired homoallylic amine 2.3 and the closely related 
derivative 2.4 in 85:15 dr and 78% combined yield. However, to expose the free NH2 amine 2.5, 
a four-step procedure mandating cleavage of the ester, followed by treatment with lead acetate was 
required.7 In a related disclosure, Zhang detailed addition of allyl indium reagents to imino ester 
2.6 generating homoallylic amine 2.8 in 85% yield and 95:5 dr. The free amine 2.9 was unmasked 
through hydrogenolysis of the glycinol auxiliary with concomitant reduction of the terminal 
olefin.8 
Grellepois has reported on diastereoselective addition of Grignard reagents to N–sulfinyl 
hemiaminals 2.10, furnishing homoallylic amines 2.12 in 42–83% yield and 89:11 – 95:5 dr.9 In a 
follow-up study, the same authors showcased addition of allyl zinc and indium compounds to 
methyl or phenyl-substituted hemiacetals 2.10 in 26–77% yield and 79:21–99:1 dr.10 Deprotection 
of an aryl substituted a-tertiary trifluoromethyl amine was not reported, likely due to the sensitivity 




7) Chaume, G.; Van Severen, M.-C.; Marinkovic, S.; Brigaud, T. Org. Lett. 2006, 8, 6123–6126. 
8) Min, Q.-Q.; He, C.-Y.; Zhou, H.; Zhang, X. Chem. Commun. 2010, 46, 8029–8031.  
9) Grellepois, F.; Jamaa, A. B.; Gassama, A. Eur. J. Org. Chem. 2013, 29, 6694–6701. 
10) Grellepois, F.; Jamaa, A. B.; Rosa, N. S. Org. Biomol. Chem. 2017, 15, 9696–9709. For a related report, see: Guo, 
T.; Song, R.; Yuan, B.-H.; Chen, X.-Y.; Sun, X.-W.; Lin, G.-Q. Chem. Commun. 2013, 49, 5402–5404. 
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2.5 equiv Zn, dmf, –20 ºC, 15 h
2.13 2.0 equiv
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(Grellepois et al., Ref 9)
(Grellepois et al., Ref 10a)
R
2.10
G = CH3, 4-FC6H4, 3-MeOC6H4 or Ph
R2
2.10
G = CH3, or Ph
R1
(Zhang et al., Ref 8)
(Briguard et al., Ref 7)
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2.2.2 State-of-the-art for Catalytic Enantioselective Synthesis of Enantioenriched a Tertiary 
Trifluoromethyl Amines 
As originally shown by Deng, umpolung addition of trifluoromethyl containing aza-allyl 
anions 2.17 to enones 2.1811 is an attractive strategy for enantioselective synthesis of a-tertiary 
trifluoromethyl amines with vicinal stereocenters 2.19. 12  In these cases, enantiotopic 
discrimination is probably the result of transition state organization through interaction between 
the aza-allyl anion and the quaternary ammonium phase transfer catalyst 2.16. Accordingly, in the 
presence of cinchona alkaloid 2.16 (with loadings as low as 0.01 mol %), diastereo- and 
enantioselective addition of alkyl, alkenyl and aromatic aza-allyl anions 2.17 afforded homoallylic 
amine 2.19 in up to 90% yield, 95:5 dr and 97.5:2.5 er.   
 
Scheme 2.2. Enantio- and Diastereoselective Addition of Aza-allyl Anions to Enals 
 
Zhang has reported a highly enantioselective umpolung addition of aryl-, heteroaryl- and 
alkyl-substituted trifluoromethyl aza-allyl anions to Morita-Baylis-Hillman carbonates 2.20 
promoted by phosphine 2.21 in 73–91% yield and 96.5:3.5–99:1 er and subsequent elaboration of 
																																																								
11) (a) Wu, Y.; Hu, L.; Li, Z.; Deng, L. Nature, 2015, 523, 445–450. (b) Hu, L.; Wu, Y.; Li, Z.; Deng, L. J. Am. Chem. 
Soc. 2016, 138, 15817–15820. (c) Li, Z.; Hu, B.; Wu, Y.; Fei, C.; Deng, L. Proc. Natl. Acad. Sci. U. S. A. 2018, 115, 
1730−1735. (d) Hu, B.; Deng, L. J. Org. Chem. 2019, 84, 994–1005.  
12) For related studies, see (a) Wu, Y.; Deng, L. J. Am. Chem. Soc. 2012, 134, 14334–14337. (b) Hu, B.; Deng, L. 
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the products to a-methylene g-lactams.13 An ensuing disclosure detailed additions of aza-allyl 
anions promoted by the same catalyst to allenoate 2.23, affording b,g-unsaturated amino esters 
2.24.	The scope is	broad for alkyl substituted imines 2.15, affording 2.24 in 64–84% yield and 
90:10–97.5:2.5 er with complete E selectivity.14  
 
Scheme 2.3. Phosphine-Catalyzed Umpolung Addition of Aza-Allyl Anions 
 
Almost simultaneously, Niu15 and Wang16a introduced a strategy of umpolung addition of 
fluorenyl imine 2.28 to allyl carbonates 2.26 and 2.32 promoted by iridium-based phosphoramidite 
complex 2.27, followed by aza-Cope rearrangement of intermediate 2.29 furnishing a-tertiary 
																																																								
13) Chen, P.; Yue, Z.; Zhang, J.; Lv, Z.; Wang, L.; Zhang, J. Angew. Chem. Int. Ed. 2016, 55, 13316–13320. 
14) Chen, P.; Zhang. J. Org. Lett. 2017, 19, 6550–6553. 
15) Wang, Y.; Deng, L.-F.; Zhang, X.; Niu, D. Org. Lett. 2019, 21, 6951–6956. 
16) (a) Shen, C.; Wang, R.-Q.; Wei, L.; Wang, Z.-F.; Tao, H.-Y.; Wang, C.-J. Org. Lett. 2019, 21, 6940–6945. (b) 
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trifluoromethyl amines 2.31. Niu has outlined a method for addition to aromatic imines affording 
a-tertiary trifluoromethyl amines 2.31 in 67–87% yield and 96:4–99:1 er, and in a related study 
Wang shows that the same class of compounds may be accessed in 50–94% yield and up to 99:1 
er. A distinct advantage of Niu’s system is applicability to heteroaryl aza-allyl species. A separate, 
but closely related disclosure by the Wang group described a single example of synthesis of a-
tertiary imine 2.36 in 86% yield and 99:1 er; hydrolysis of analogous a-secondary imines were 
outlined, but unmasking of 2.36 was not included.16b  
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Kurti has recently disclosed enantioselective addition of allyl boronates to N-aryl 
iminoesters 2.37, 17  promoted by indium-based semicorrin complex 2.39. Addition proceeds 
readily to deliver an array of iminoesters exhibiting electronically diverse N-aryl substitution. 
However, the free amine 2.41 could only be accessed through oxidative cleavage (treatment with 
ceric ammonium nitrate) of the para-methoxyphenyl group 2.40 in 55% yield. 
 
Scheme 2.5. Allyl Addition to Iminoesters Promoted by Indium-Based Complexes 
	
	
2.2.3 N-H Ketimines as Electrophiles in Catalytic Transformations 
There are only a small number of examples detailing addition to unprotected ketimines,18 
and even fewer that do not require activated substrates such as those derived from 
trifluoropyruvate. Over a decade ago, Vovk first described proline-catalyzed Mannich-type 
reactions of aryl trifluoromethyl ketimines 2.42 affording 2.45 in 75–86% yield and 87:13–96:4 
er.19 In a related study (Scheme 2.6a), Nakamura described a class of heterosulfonyl prolinamide 
																																																								
17) Bhakta, U.; Kattamuri, P. V.; Siitonen, J. H.; Alemany, L. B.; Kürti, L. Org. Lett. 2019, 21, 9208–9211.  
18) (a) Dhudshia, B.; Tiburcio, J.; Thadani, A. N. Chem. Commun. 2005, 5551–5553. (b) Tran, D. C.; Cramer, N. 
Angew. Chem. Int. Ed. 2011, 50, 11098–11102. (c) Tran, D. C.; Cramer, N. Angew. Chem. Int. Ed. 2013, 52, 10630–
10634. 
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catalysts 2.44 for enantioselective addition with a larger scope of aromatic trifluoromethyl 
ketimines furnishing 2.45 in 61–95% yield and 88.5:11.5–96:4 er.20  
 
Scheme 2.6. Scheme 2.26 Mannich-Type Transformations Involving N-H Ketimines 
 
Oshima and Morimoto were able to accomplish enantioselective Mannich-type addition 
of 1,3-dicarbonyl compound 2.47, but the scope was limited to the activated iminoester 2.46 as 
the substrate. Products were isolated in 77–91% yield and 88.5:11.5–99:1 er, but required low 
temperatures and reaction times up to 48 hours.21 The same authors subsequently disclosed 
synthesis of propargylamines through addition of alkynyl-Zn reagents to aromatic and aliphatic 
trifluoromethyl substituted ketimines affording racemic a-tertiary trifluoromethyl amines in 82–
99% yield.22 Also attempted was the development of an enantioselective variant, where in the 
presence of a chiral phosphoric acid 2.51, addition proceeded efficiently (88% and 96% yield) 
																																																								
20) Hara, N.; Tamura, R.; Funahashi, Y.; Nakamura, S. Org. Lett. 2011, 13, 1662–1665. 
21) Sawa, M.; Morisaki, K.; Kondo, Y.; Morimoto, H.; Ohshima, T. Chem. Eur. J. 2017, 23, 17022–17028.  
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a. Representative prolinamide catalyzed Mannich addition involving trifluoromethyl ketimines
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but with only modest levels of enantioselectivity (80:20 er and 71:29 er for 2.52 and 2.53, 
respectively).  
 
Scheme 2.7. Catalytic Enantioselective Addition of Alkynyl and Aryl Metal Nucleophiles 
	
Most recently, Deng and Teng reported enantioselective addition of aryl boroximes 2.54 
to trifluoroketimine 2.42, promoted by a phosphine-Rh complex, generating enantioenriched 
diaryl amino methanes 2.55.23 Enantioselectivity was high (97.5:2.5–99:1 er), and a range of 
electronically diverse ketimines were suitable as substrates. Somewhat discouragingly, however, 
sterically encumbered ortho-substituted ketimines or boroximes were not tolerated, and substrates 
possessing sensitive functionality, such as acetal 2.56a and alkenyl 2.56b, were isolated in 
significantly lower yield (56 and 46% yield, respectively).  
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Scheme 2.8. Catalytic, Enantioselective Allyl Addition Promoted by NHC-Cu Complexes 
	
	 In 2017, our group reported a catalytic method for enantioselective synthesis of a-tertiary 
homoallylic amines 2.61 promoted by sulfonate-containing NHC-copper complex 2.60 in up to 
95% yield, 98:2 dr and 99:1 er.24 Nonetheless, the transformation did not tolerate trifluoromethyl 
ketimines as substrates (i.e., only alkyl substituted ketimines were compatible). Considering the 
inefficiencies surrounding the unmasking of phosphinoyl imines, as discussed in Chapter One, and 
the low-yielding transformation described in Scheme 2.5, we questioned whether N-H ketimines 
could be viable substrates for allyl addition promoted by aminophenol complexes. This would 
afford access to highly desirable NH2 amines without the need for treating the obtained products 
with acidic or oxidizing conditions typically needed for deprotection strategies.   
 
	
2.3 Additions to Halogen-Containing Substrates Promoted by Aminophenol 
Boron-Based Complexes  
 In 2016, our group detailed catalytic, enantioselective addition to trifluoromethyl ketones 
promoted by an aminophenol boron-based complex. Enantiofacial discrimination was influenced 
through an electrostatic attraction between the trifluoromethyl group of the ketone and the 
embedded ammonium group within the complex. Through the use of just 2.5 mol % of an 
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appropriate aminophenol and 10 mol % NaOt-Bu, homoallylic alcohols bearing a trifluoromethyl-
substituted stereogenic center were isolated in up to 98% yield and 99:1 er.25  
 




25) For a detailed account, see: Lee, K.; Silverio, D. L.; Torker, S.; Robbins, D. W.; Haeffner, F.; van der Mei, F. W.; 
Hoveyda, A. H. Nature Chem. 2016, 8, 768–777. For transformations of the same class, see: Fager, D. C.; Lee, K.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2019, 141, 16125–16138. For propargyl addition, see: Mszar, N. W.; Mikus, M. 
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 We expanded this to a selective addition of Z-substituted allyl boronate Z–2.64 in 2018, 
generating products in up to 98% yield, >98:2 Z:E and 99:1 er.26 We were somewhat surprised to 
find that contrary to additions to phosphinoyl imines (see Chapter One), direct addition of the 
initially generated allyl complex 2.65 was more competitive than 1,3-boyl shift. To develop a 
method for synthesis of a-tertiary trifluoromethyl amines, particularly those with defined olefin 
geometry, we initiated an investigation into N-H ketimines substituted with a trifluoromethyl 
group. It was not clear to us whether the smaller size difference between the two substituents would 
afford enantiotopic discrimination of if the product, a basic primary amine, could sequester the 
ammonium-based catalyst.  
 
2.4 Development of Catalytic, Enantioselective Synthesis Of a-Tertiary Trifluoromethyl 
Amines  
2.4.1 Methods for Synthesis of N-H Ketimines (Survey of the State-of-the-Art) 
 Our first objective was to identify a method to access the requisite ketimine 2.42. After a 
survey of the literature, we found three methods for synthesis of N-H trifluoromethyl ketimines: 
(1) Addition of Grignard reagent 2.73 to trifluoroacetonitrile 2.72,27 (2) Reaction of trifluoroketone 
2.62 with methylchloroaluminum amide 2.74,28 and (3) Aza-Wittig reaction of trifluoroketone 
2.62 with imino triphenylphosphorane 2.75.22 Each has its own drawback, including multiple step 
preparation requiring pyrophoric reagents for synthesis of aluminum complex 2.74, 
trifluoroacetonitrile 2.72 is a toxic gas, and the aza-Wittig reaction generates an equivalent of 
triphenylphosphine oxide 2.76 as a byproduct. 
 
																																																								
26) van der Mei, F. W.; Qin, C.; Morrison, R. J.; Hoveyda, A. H. J. Am. Chem. Soc. 2017, 139, 9053–9065. 
27) Koos, M.; Mosher, H. S. Tetrahedron 1993, 49, 1541–1546. 
28) Kende, A. S.; Liu, K. Tetrahedron Lett. 1995, 36, 4035–4038. 
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Scheme 2.10. Methods to Directly Access N-H Ketimines 
 
Recognizing that silyl-substituted aldimines are N-H surrogates29 and have been widely 
employed in enantioselective transformations involving alkyl nucleophiles, 30  allyl addition,31 
propargyl addition, 32  cycloaddition, 33  and Mannich-type reactions, 34  we reasoned that silyl 
ketimines may be well suited for our purpose.  
																																																								
29) Chen, G.-M.; Brown, H. C. J. Am. Chem. Soc. 2000, 122, 4217–4218. 
30) Itsuno, S.; Sasaki, M.; Kuroda, S.; Ito, K. Tetrahedron: Asymmetry 1995, 6, 1507–1510. 
31) (a) El-Shehawy, A. A.; Abdelaal, M. Y.; Watanabe, K.; Ito, K.; Isuno, S. Tetrahedron: Asymmetry 1997, 8, 1731–
1734. (b) Chen, G.-M.; Ramachandran, P. V.; Brown, H. C. Angew. Chem. Int. Ed. 1999, 38, 825–826. (c) 
Ramachandran, P. V.; Burghardt, T. E. Chem. Eur. J. 2005, 11, 4387–4395. (d) Canales, E.; Hernandez, E.; Soderquist, 
J. A. J. Am. Chem. Soc. 2006, 128, 8712–8713. (e) Sieber, J. D.; Morken, J. P. J. Am. Chem. Soc. 2006, 128, 74–75. 
(f) Román, J. G.; Soderquist, J. A. J. Org. Chem. 2007, 72, 9772–9775. (g) Chataigner, I.; Zammattio, F.; Lebreton, 
J.; Villiéras, J. Tetrahedron 2008, 64, 2441–2455. (h)  Kuznetsov, N. Y.; Maleev, V. I.; Khrustalev, V. N.; Mkrtchyan, 
A. F.; Godovikov, I. A.; Strelkova, T. V.; Bubnov, Y. N. Eur. J. Org. Chem. 2012, 334–344. (i) Chen, J. L.-Y.; 
Aggarwal, V. K. Angew. Chem. Int. Ed. 2014, 53, 10992–10996. 
32) (a) Chemla, F.; Ferreira, F.; Hebbe, V.; Stercklen, E. Eur. J. Org. Chem. 2002, 1385–1391. (b) Gonzalez, A. Z.; 
Soderquist, J. A. Org. Lett. 2007, 9, 1081–1084. 
33) (a) Barluenga, J.; Aznar, F.; Ribas, C.; Valdés, Fernández, M.; Cabal, M.-P.; Trujillo, J. Chem. Eur. J. 1996, 2, 
805–811. (b) Bongini, A.; Panunzio, M.; Bandini, E.; Campana, E.; Martelli, G.; Spunta, G. Tetrahedron: Asymmetry 
2001, 12, 439–454. (c) Fernández-Garcia, J. M.; Fernández-Rodriguez, M. A.; Aguilar, E. Org. Lett. 2011, 13, 5172–
5175. 
34) (a) Gennari, C.; Vulpetti, A.; Pain, G. Tetrahedron, 1997, 53, 5909–5924. (b) Fujieda, H.; Hata, S.; Yamada, K.-
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Scheme 2.11. Methods to Access Silyl-Substituted Imines 
 
 
Additionally, as a result of such widespread use, an array of methods have been developed 
to address synthesis of aryl–35 and alkyl–substituted imines,36 including compounds with an a-
stereogenic centers37 and other silyl protecting groups.38 We hoped these advances could extend 
to synthesis of ketimines and were pleased to find a report from Merck describing synthesis of N-
																																																								
35) Colvin, E. W.; McGarry, D.; Nugent, M. J. Tetrahedron, 1988, 44, 4157-4172. 
36) (a) Uyehara, T.; Suzuki, I.; Yamamoto, Y. Tetrahedron Lett., 1989, 30, 4275-7278. (b) Gyenes, F.; Bergmann, K. 
E.; Welch, J. T. J. Org. Chem. 1998, 63, 2824-2828. 
37) Cainelli, G.; Giacomini, D.; Galletti, P.; Quintavalla, A. Eur. J. Org. Chem. 2002, 3153-3161. 
38) (a) Colvin, E. W.; McGarry, D.; Nugent, M. J. Tetrahedron, 1988, 13, 4157-4172. (b) Guillemin, J.-C.; Ammi, 
L.; Denis, J. M. Tetrahedron Lett. 1988, 29, 1287-1288. (c) Cainelli, G.; Giacomini, D.; Galletti, P. Synthesis, 1997, 
886-890. (d) Richy, N.; Ghoraf, M.; Vidal, J. J. Org. Chem. 2012, 77, 10972−10977. 
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silyl trifluoromethylketimines, which we considered an excellent starting point to commence 
investigations.39 
 
Scheme 2.12. Synthesis of Silyl-Substituted Trifluoromethyl Ketimines 
 
2.4.2 Catalytic Enantioselective Addition to Ketimines 
We first synthesized silyl imine 2.88 as previously described39 and subjected it to 
conditions typically employed for aminophenol promoted allyl addition (5.0 mol % aminophenol, 
10 mol % Zn(OMe)2, 1.5 equiv iPrOH). 40 The transformation was inefficient, however (<2% 
conv). Recognizing that the silyl group was likely excised under the reaction conditions in the 
original report by Merck chemists, we synthesized N-H ketimine 2.42 to ascertain whether this 
species would be an appropriate electrophile, and thus we were able to isolate homoallylic amine 







39) Gosselin, F.; O’Shea, P. D.; Roy, S.; Reamer, R. A.; Chen, C.-y.; Volante, R. P. Org. Lett. 2005, 7, 355–358. In 
the course of preparing this manuscript, another report appeared detailing silyl imine synthesis: Sukach, V.; Melnykov, 
S.; Bertho, S.; Diachenko, I.; Retailleau, P.; Vovk. M.; Gillaizeau, I. Org. Lett. 2019, 21, 2340–2345. 
40) Typically, MeOH is employed as the proton source; however, under these conditions we observed ~20% 
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Scheme 2.13. Probing the Catalytic Reaction: The Need for N-H Ketiminesa 
	
aAll reactions were performed under N2 atm. Conv (±2%) determined by analysis of 19F NMR spectra of 
unpurified mixtures; Conv refers to disappearance of 2.88 and 2.42, respectively. Yield of isolated and 
purified product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for 
details.  
 
As a result of low yields for preparation of 2.42, we sought to find a method that could 
incorporate the easier-to-handle silyl derivative 2.88. We knew silyl removal could be effected by 
treatment with solvent quantities of methanol per the original disclosure, but then N-H ketimine 
2.42 could react further, furnishing stable hemiaminal 2.89, a species that was not suitable for allyl 
addition. To circumvent this, we opted to include an appropriate fluoride reagent and MeOH as 
the proton source. To our delight, soluble and non-hygroscopic tetrabutylammonium 
difluorotriphenylsilicate (tbat) yielded clean silyl removal in a matter of minutes without 
significant formation of 2.89.41  Despite considerable efforts towards optimization, the highest 
levels of enantioselectivity we could obtain for allyl addition were 91.5:8.5 er when promoted by 
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benzyl-threonine catalyst ap-3 (more on this later). What is more, screening of a subset of 
substrates revealed a broad distribution of yield and enantioselectivities.  
 
Scheme 2.14. Scope of Allyl Addition to Trifluoroketiminesa 
	
aAll reactions were performed under N2 atm. Conv (±2%) determined by analysis of 19F NMR spectra of 
unpurified mixtures; Conv refers to disappearance of the ketimine. Yield of isolated and purified product 
(±5%). Er values were determined by HPLC analysis (±1%). tbat: tetrabutylammonium 
difluorotriphenylsilicate. See Experimental Section for details.  
 
We could rationalize the lower selectivity obtained for addition to trifluoromethyl 
ketimines, as opposed to ketones,25 through analysis of transition state models. We reasoned that 
for ketones, enantiofacial discrimination is favored by an alleviation of electron-electron repulsion 
between the carbonyl oxygen and fluorine of the trifluoromethyl group (highlighted in Scheme 
2.15, 2.96) through coulombic attraction with the ammonium ion. For additions to ketimines 
(2.97), the benefit of a stabilizing interaction is no longer existent due to the N-H, and in these 
cases steric pressure between the catalyst’s tert-butyl group and the aryl fragment of the ketimine 
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Scheme 2.15. Stereochemical Models for Additions to Ketones and Ketimines 
 
To address poor regioselectivity, we considered addition of substituted allyl boronates 
because for additions to ketones, enantiomeric ratios were higher than the corresponding allyl 
additions. This is likely due to the influence of the additional allylic stereogenic center that is 
favorably oriented pseudo-axially (2.65, Scheme 2.9). Under these conditions, enantiotopic 
discrimination is favored by steric and electronic factors leading to larger energy differences 
between competitive transition states. Accordingly, we subjected trifluoroketimine 2.88 to Z–2.64 
promoted by 5.0 mol % ap-2, 10 mol % Zn(OMe)2 and 3.5 equiv MeOH affording Z–2.69 in 73% 
yield, 82:18 a:g ratio, 98:2 Z:E and 96:4 er. We were pleased to observe moderate levels of a 
selectivity, indicating that despite decreased electrophilicity, relative to ketones, a combination of 
the inductive and steric effects of the trifluoromethyl group were sufficient to favor direct addition 
versus 1,3-boryl shift. To circumvent pathways accounting for 18% of g-addition product 2.70, we 
turned to modifying the catalyst structure, which could be rapidly carried out due to modular 
synthesis of the scaffold.  
 We began by synthesizing ap-4, bearing an isoleucine residue, to probe whether increased 
steric bulk and the presence of an additional stereogenic center would affect the observed 
regioselectivity. However, these modifications proved ineffective. We thus incorporated the more 
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the zinc (II) co-catalyst or reversibly coordinate to the boron center preempting olefin association, 
nonetheless the impact was deleterious and favored the undesired g-product. In line with optimal 
results obtained for allyl addition to ketimines (Scheme 2.14), we found that reaction promoted by 
catalysts derived from O–methyl threonine proved more effective. Specifically, with ap-6 and ap-
7, regioselectivity improved to 91:9 and 97:3 a:g ratio, while retaining high Z selectivity, and in 
the case of ap-7, enantioselectivity was further improved to 97:3 er. 
 
Scheme 2.16. Identification and Evaluation of an Optimal Aminophenola 
 
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures; Conv refers to disappearance of 2.88. Yield of isolated and 
purified product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for 
details.  
Recognizing that improvement was not due to a steric effect (Scheme 2.16, c.f. ap-4 and 
ap-7), we reasoned that the benefit must be largely electronic. One possible explanation is that for 
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𝜎*C–O hyperconjugation. The reduced electron density on nitrogen increases the vacancy of the 
p-orbital on boron facilitating substrate coordination. Alternatively, in ap-6, in order for similar 
overlap to be feasible, a syn-pentane interaction develops between the methyl substituent and the 
catalyst backbone (Scheme 2.17, 2.106). The latter conformation is thereby higher in energy and 
affords greater chance for addition to occur through competitive modes, resulting in diminished 
a:g ratios and er.  
 
Scheme 2.17. Rationale for Selectivities Obtained with Diastereomeric Complexesa 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures; Conv refers to disappearance of 2.88. Yield of isolated and 
purified product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for 
details.  
 
For further optimization, we investigated additions to 2.88 in the presence of a variety of 
known promoters for Si–O bond cleavage to determine the effect. Under all conditions we 
observed complete consumption of 2.88, however the less soluble fluoride sources (CsF, 
(CH3)4NF; Table 1, entry 1 and 4) led to lower yields. The more basic and hygroscopic (n-Bu4)NF 
was less effective and afforded Z–2.69 with diminished Z selectivity (84:16–96:4 Z:E, Table 1, 
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Table 1. Examination of Different Fluoride Reagentsa 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures; Conv refers to disappearance of 2.88. Yield of isolated and 
purified product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for 
details.  
 
2.4.3 Scope  
With optimal conditions in hand, we explored the scope of the method. In most instances, 
the substitution on the aryl group had little effect on enantioselectivity, as electron-deficient para-
trifluoromethyl Z–2.105 and electron-rich para-methoxyphenyl Z–2.106 and were isolated in 61% 
and 78% yield, 98:2 and 94:6 a:g ratio, 96:4 and 92:2 Z:E and 97:3 and 98:2 er, respectively. Under 
the same conditions, for para-dimethylamino substituted Z–2.107 we observed <2% Si–O bond 
cleavage and recovery of starting material. Fortunately, subjecting the imine to silyl removal (tbat 
and 1.75 equivalents of MeOH) prior to the addition of an aminophenol and Zn(OMe)2 solution 
allowed us to isolate Z–2.107 in 50% yield, 87:13 a:g ratio, 98:2 Z:E and 98:2 er. The diminished 
regioselectivity is likely a consequence of the less electrophilic ketimine which affords greater 
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Scheme 2.18. Scope of Addition to Trifluoromethyl Ketiminesa 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures; Conv refers to disappearance of silyl ketimine. Yield of isolated 
and purified product (±5%). Er values were determined by HPLC analysis (±1%). bKetimine was fully 
desilylated in situ prior to addition of other reagents. c2.5 equiv MeOH were employed, and reaction was 
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Additions to alkenyl42 (Z–2.116) and alkynyl-substituted Z–2.117 proceeded with high 
efficiency, but a:g selectivity was notably lower for Z–2.117. Competitive addition of methanol 
to less hindered Z–2.117 resulted in significant (~20%) hemiaminal formation. The reversible 
formation of hemiaminal probably diminishes the effective concentration of ketimine present in 
solution, rendering boryl shift more competitive. Substitution of methanol for larger i-PrOH 
required elevated temperature and extended reaction time (60 °C, 14 h). While these conditions 
reduced hemiaminal formation, it was at the expense of enantioselectivity (86:14 vs 96.5:3.5 er). 
Heteroaryl-substituted ketimines may be used, as indicated by thienyl-Z–2.118 and benzofuranyl-
Z–2.119. Additions to the somewhat moisture-sensitive furyl substituted ketimines were less 
efficient (32% yield, 89:11 a:g ratio, 98:2 Z:E, 97:3 er). A noteworthy observation, however, is 
that, unlike additions to the corresponding ketones, additions to 2-substituted heterocycles did not 
afford products in lower er. Furthermore, the trend is reversed (i.e. thienyl-substituted Z–2.118 
was isolated with lower enantioselectivity than Z–2.120). The exact origin of this discrepancy 
remains to be investigated further, but demonstrates that the N-H may be involved. 
These data suggest that steric repulsion between an ortho substituent and the catalyst 
dramatically affects the efficiency. With larger substrates Z–2.108–2.112, repulsion between the 
ortho-substituent and the catalyst can disfavor addition and allow alternative pathways (either 
catalyzed or non-catalyzed) to become more competitive.  While steric factors could be playing a 
role, electronic factors might be operative as well, as underscored by the highly selective additions 
to o-OMe substituted Z–2.108 and o-F Z–2.109. In the proposed mode of addition (2.122) electron-
electron repulsion between the phenoxy oxygen of the catalyst and the lone pair of the ortho 
substituent cannot be relieved and the alternative ketimine conformer positioning the ortho-
substituent and the trifluoromethyl group in a proximal manner suffers from severe steric 
hindrance. Substrates possessing ortho-substitution with better orbital overlap with the arene, (i.e., 
o-F and o-OMe) underwent more efficient reactions, perhaps because of resonance structure 2.123 
																																																								
42) Synthesis of a disubstituted ketimines were not accomplished due to a facile [4+2] cycloaddition.  
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wherein repulsion can be reduced. Accordingly, we isolated  Z–2.109 in synthetically useful yield, 
which may be elaborated to a BACE-1 inhibitor, developed by Novartis.43  
 
Scheme 2.19. Resonance Structures Leading to Reduced Repulsion  
 
2.4.4 Derivatization of the Obtained Homoallylic Amines 
 The method is amenable to gram-scale synthesis allowing us to secure 1.86 g of 2.124, 
upon treating the unpurified amine with 1.5 equivalents of chloroacetyl chloride in refluxing 
toluene for four hours. The crystalline nature of the amide aided us in purifying the product, and 
allowed us to secure the X-ray structure for absolute and relative stereochemistry determination. 
Subsequent oxidative cleave of the olefin by treatment with ozone, followed by reductive work-
up (NaBH4) afforded an unpurified alcohol that was directly subjected to alkylation by treatment 
with KOt-Bu (thf/t-BuOH), affording 1.21 g of 2.125. The efficiency with which this core was 






43) Badiger, S.; Chebrolu, M.; Frederiksen, M.; Holzer, P.; Hurth, K.; Li, L.; Liu, H.; Lueoend, R. M.; Machauer, R.; 
Moebitz, H.; Meumann, U.; Ramos, R.; Rueeger, H.; Schaefer, M.; Tintelnot-Blomley, M.; Veenstra, S. J.; Voegtle, 







































	 Page 208 
Scheme 2.20. Gram-Scale Formal Synthesis of BACE-1 Inhibitora 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Er values were 
determined by HPLC analysis (±1%). See Experimental Section for details. 
 
The utility of the method extends beyond addition of methyl-substituted allyl boronate Z–
2.64. Additions of Z-Cl substituted allyl boronate furnished alkenyl chloride 2.129, albeit in lower 
er. We considered that perhaps selectivity could be improved with the sizable bromo-substituted 
reagent Z–2.128. To access the requisite reagent, we explored the possibility of stereoretentive 
cross-metathesis. A survey of molybdenum-based monoaryloxide pyrrolide complexes44 allowed 
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Scheme 2.21. Identification and Application of Mo-Based Complex for Cross-Metathesisa 
	
aAll reactions were performed under N2 atm. Conv and Z:E ratios (±2%) were determined by analysis of 1H NMR 
spectra of unpurified mixtures; Conv refers to disappearance of Z–2.64. Yield of isolated and purified product (±5%). 
pin: pinacolato. See Experimental Section for details.  
 
With phenyl-substituted ketimine 2.88, we found that although Si-O bond cleavage was 
readily accomplished, addition was sluggish, and afforded product in 35% yield and 89:11 er. We 
attributed the lower efficiency to the larger bromine substituent and longer C–Br bond (vs C–Cl) 
which could impede allyl transfer to the aminophenol boron-based complex. In such cases, 
competitive and non-selective processes, such as addition of methanol or hydrolysis of the 
ketimine, can become prevalent. This issue was addressed through the use of a ketimine possessing 
the strongly electron-withdrawing para-trifluoromethyl group, allowing us to secure Z–2.131 in 
76% yield, 93:7 a:g ratio, and 93:7 er, as a single olefin isomer. With para-chloro-substituted 
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to the less electrophilic halo-substituted substrate (vs trifluoromethyl) was not as competitive, 
likely as a result of the impetus to reduce steric pressure between the catalyst and bromo-
substituent through boryl shift. 
 
Scheme 2.22 Addition of g-Substituted Organoboron Reagentsa 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures; Conv refers to disappearance of silyl ketimine. Yield of isolated 
and purified product (±5%). Er values were determined by HPLC analysis (±1%). bKetimine was fully 
desilylated in situ prior to addition of other reagents. Experiments run at least in triplicate. See Experimental 
Section for details.  
 
Addition of n-heptyl-substituted allyl boronic ester, accessed through catalytic 1,4-boron 
hydride addition to a diene,45 proceeded with similar efficiency and enantioselectivity, furnishing 
Z–2.132 in 86% yield and 97:3 er. Equally notable, Z–2.133 bearing a trisubstituted olefin was 
isolated, albeit in 84:16 er, likely a consequence of increased steric pressure in the transition state 
caused by the C2 methyl on the corresponding allyl reagent. 
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  The utility of homoallylic amines bearing a Z-halo substituent was highlighted through a 
series of representative stereoretentive cross-coupling reactions. Such processes allow for the rapid 
synthesis of a diverse series of derivatives from a common intermediate.  
 
Scheme 2.23. Product Utility Highlighted Through Cross-Coupling Methodologiesa 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). dppf: 1,1’-
bis(diphenylphosphino)ferrocene; ruphos: 2-dicyclohexylphosphino-2,6’-diisopropoxybiphenyl. See 
Experimental Section for details.  
 
Chemoselective coupling of the more reactive aryl bromide within Z-2.134 was 
accomplished through Suzuki coupling of allyl boronic pinacol ester 2.38, promoted by a 
organophosphine-Pd complex under conditions reported by Aggarwal.46 Stereoretentive coupling 
of Z-alkenyl chloride Z-2.136 was accomplished through a phosphine-Pd-catalyzed reaction.47 
																																																								
46) Zhurakovsky, O.; Türkmen, Y. E.; Löffler, L. E.; Moorthie, V. A.; Chen, C. C.; Shaw, M. A.; Crimmin, M. R.; 
Ferrara, M.; Ahmad, M.; Ostovar, M.; Matlock, J. C.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2018, 57, 1346–1350. 
47) (a) Bruno, N. C.; Tudge, M. T.; Buchwald, S. L. Chem. Sci. 2013, 4, 916–920. (b) Bruno, N. C.; Niljiasnskul, N.; 
Buchwald, S. L. J. Org. Chem. 2014, 79, 4161–4166. 
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When shielded from light and kept at 55 °C, olefin isomerization was minimized and skipped diene 
Z-2.137 was isolated in 68% yield. Cross-coupling of alkenyl bromide Z-2.138 was accomplished 
in a similar manner (2.140 in 54% yield).  
 
Scheme 2.24. Diastereoselective Transformation Directed by Homoallylic Amine 
 
 To highlight the utility of alkyl-substituted Z olefins, we explored diastereoselective 
functionalization directed by the homoallylic amine, based on studies by Davies,48 who reported 
directed epoxidation of N-benzyl homoallylic amine 2.141. Subsequent ring opening through 
addition of an acetate anion, leading to the formation of differentially protected diol 2.144. 
followed by saponification with mild base furnished diol 2.145. As we considered applying this 
strategy to products obtained from our method, two important questions arose: (1) Would the 
reaction be efficient with an unprotected amine, particularly one that does not bear a donating 
benzyl substituent and possesses a withdrawing trifluoromethyl group? (2) Would an acyclic 
system afford similar regio- and stereoselectivity? Our hope was that the Z olefin would greatly 
																																																								
48) Bond, C. W.; Cresswell, A. J.; Davies, S. G.; Fletcher, A. M.; Kurosawa, W.; Lee, J. A.; Roberts, P. M.; Russell, 
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benefit us, as these transformations are typically more diastereoselective (vs E isomers) due to 
allylic strain in the transition state.49 
 
 
Scheme 2.25. Diastereoselective Epoxidation and Regioselective Ring Openinga 
 
	
aAll reactions were performed under N2 atm. Conv, and dr ratios (±2%) were determined by analysis of 19F 
NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Er values were determined 
by HPLC analysis (±1%). See Experimental Section for details.  
 
Treatment of Z–2.69 with four equivalents of trichloroacetic acid, followed by addition of 1.5 
equivalents of m-cpba afforded differentially protected diol 2.147. Subsequent saponification 
under conditions outlined by Davies furnished diol 2.148 in 57% yield and 93:7 dr. We were able 
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to confirm absolute and relative stereochemistry through treatment with trichloroacetic acid to 
mask the nucleophilic amine, and protect the diol as an acetal. Ensuing treatment with an acid 
chloride afforded amide 2.149 in 54% yield. The same procedure was applied to synthesis of 
trisubstituted 2.133, delivering 2.150 in 72% yield and 91:9 dr.  
 
2.5 Mechanism of Additions to Trifluoromethyl Ketimines 
2.5.1 Reactions with E- and Z-Crotyl Boronates 
 We have observed that for addition to phosphinoyl imines, regardless of the configuration 
of the allyl boronate (i.e. E- or Z-) anti-homoallylic amines are afforded exclusively.50 In contrast, 
for additions of E-substituted compounds to trifluoroketones possessing an ortho-substituent, the 
transformations remain highly Z selective, however the opposite enantiomer is obtained.51 To 
probe the effect of olefin configuration on additions to ketimines, we carried out reaction with E-
2.64 and Z-2.64. We found that addition of the former promoted by ap-7 was highly inefficient 
(<7% conv), which is unlike transformations involving ketones and highlights the benefit of 
utilizing the higher energy Z-2.64 for addition to less electrophilic ketimines. Moreover, we 
performed a parallel set of experiments promoted by diastereomeric ap-6. We found that, under 
these conditions, addition of E-2.64 is comparatively more efficient (38% conv).52 However, in 
accordance with our previous analysis, we found that additions promoted by ap-6 were less a-




50) van der Mei, F. W.; Miyamoto, H.; Silverio, D. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2016, 55, 4701–4706. 
51) For a detailed account of this phenomenon, see ref 23. 
52) The difference in efficiency likely arises from a more efficient allyl transfer due to a reduction in steric hindrance 
between the methyl substituent of the reagent and the backbone of the catalyst.  
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Table 2. Effect of Olefin Stereochemistry on Selectivity and Efficiencya 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures; Conv refers to disappearance of 2.88. Yield of isolated and 
purified product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for 
details.  
 
2.5.2 Computational Modeling of Transition States 
As introduced in section 2.3, high levels of enantioselectivity can result from electrostatic 
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studies for the C–C bond forming step, be it via a chair or boat transition state or either of the 
ketimine stereoisomers (i.e., H  syn to –CF3 or –Ph). 53 The lowest energy transition state was thus 
found to lead to R-2.69 as the major enantiomer and S-2.69 as the minor product (along with E–
2.70, Schemes 2.26 and 2.27).  
 
Scheme 2.26. Transition State Analysis to Account for Enantioselectivitya 
	
aCalculations performed at M06/DEF2TZVPP//M062X/DEF2SVPtoluene(SMD). See Experimental Section for 
details. 
We found that in the lowest energy transition state 2.152, which leads to the experimentally 
observed enantiomer, despite the imine reacting through its higher energy conformation (H syn to 
Ph, causing poor overlap between the non-bonding electron pair on nitrogen and s*C–CF3) the 
trifluoromethyl group is oriented towards the ammonium group. We believe that this is the result 
of a stabilizing coulombic interaction (ion-dipole). Addition to the opposite enantiotopic face lies 
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2.3 kcal/mol higher on the energy profile, in agreement with the experimentally observed 
enantiomeric ratio.  
Steric elements play a role in rendering the transformation enantioselective as well. There 
is probable repulsion between the pseudo-axially oriented methyl substituent and the catalyst’s t-
Bu unit (2.153) in the mode delivering minor enantiomer (S)–2.69. Interaction between the allylic 
substituent and the catalyst framework likely contribute to the high Z selectivity as well. The 
preference to orient the methyl substituent in a pseudo-axial position is probably owing to 
minimization of a costly syn-pentane interaction between the methyl group and the C–N bond of 
the catalyst framework (highlighted in red, Scheme 2.27). The computed energy difference (5.5 
kcal/mol) between 2.152, the lowest accessible state leading to an E-alkene, 2.154, agrees with the 
observed Z selectivity.  
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2.6 Conclusions 
 In summary, we have developed the first enantioselective method for additions of various 
Z-allyl boronates to trifluoromethyl ketimines, generating desirable a-tertiary trifluoromethyl-
substituted amines that contain a Z olefin. The requisite N-silyl ketimines are easily prepared and 
robust, and silyl deprotection and formation of the N-H ketimines takes place in situ through 
treatment with a combination of tbat and methanol. We have thus advanced the state-of-the-art by 
developing a catalytic method that can be used to prepare a-tertiary NH2 amines thereby obviating 
the need for inefficient deprotection sequences. Additionally, these investigations have offered 
further insight into factors that can lead to enhanced efficiency and enantioselectivity in reactions 
promoted by aminophenol boron-based catalysts. The utility of the approach was highlighted 
through a series of chemoselective and stereoretentive cross-coupling reactions, as well as a regio- 
and diastereoselective synthesis of differentially protected diols through a directed 
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2.7 Experimental Section 
2.7.1 General 
Infrared (IR) spectra were recorded on a Bruker alpha spectrophotometer, λmax in cm-1.  Bands are 
characterized as broad (br), strong (s), medium (m), and weak (w). 1H NMR spectra were recorded 
on a Varian Unity INOVA 400 (400 MHz) or a Varian Premium Shielded 600 (600 MHz) 
spectrometer. Chemical shifts are reported in ppm from tetramethylsilane with the solvent 
resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are reported as follows: chemical 
shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = 
multiplet), and coupling constants (Hz). 13C NMR spectra were recorded on a Varian Unity 
INOVA 400 (100 MHz) or a Varian Premium Shielded 600 (125 MHz) spectrometer with 
complete proton decoupling. 19F NMR spectra were recorded on a Varian Unity INOVA 400 (376 
MHz) or a Varian Premium Shielded 600 (564 MHz) spectrometer using trifluorotoluene as an 
external standard.  Chemical shifts are reported in ppm from tetramethylsilane with the solvent 
resonance as the internal standard (CDCl3: δ 77.16 ppm). Data are reported as follows: chemical 
shift, multiplicity (singlet unless otherwise noted), and coupling constant (Hz). High-resolution 
mass spectrometry was performed on a JEOL AccuTOF-DART (positive mode) at the Mass 
Spectrometry Facility, Boston College. Enantiomeric ratios (e.r.) were determined by HPLC 
analysis through the use of either a Shimadzu LC-2010AHT or SCL-10AVP chromatograph 
(Chiral Technologies Chiralcel OD-H (4.6 x 250 mm), Chiral Technologies Chiralcel OJ-H (4.6 x 
250 mm), Chiral Technologies Chiralpak AD-H (4.6 x 250 mm), Chiral Technologies Chiralpak 
AZ-H (4.6 x 250 mm), Chiral Technologies Chiralpak AS-H (4.6 x 250 mm) columns). Authentic 
racemic samples for HPLC analysis were obtained by performing the reaction with rac-ap-1a.  
Specific rotations were measured on a Rudolph Research Analytical Autopol IV Polarimeter. 
Melting points were determined by the use of a Thomas Hoover Uni-melt capillary melting point 
apparatus. Unless otherwise noted, reactions were carried out under an atmosphere of dry N2 in 
oven-dried (135 ºC) glassware.  Unless otherwise noted, solvents were purged with Argon and 
purified under a positive pressure of dry Argon by a modified Innovative Technologies purification 
system.  Toluene (Fisher, ACS Grade) was passed successively through activated copper and 
alumina columns.  Dichloromethane (Fisher, ACS Grade) and diethyl ether (Aldrich, 
Chromasolv®) were passed successively through two activated alumina columns. Tetrahydrofuran 
was purified by distillation from sodium benzophenone ketyl immediately prior to use. CDCl3 was 
purchased from Cambridge Isotope Laboratories and stored over activated 4Å molecular sieves 
prior to use. All work-up and purification procedures were carried out in air with reagent grade 
solvents (purchased from Fisher).   
2.7.2 Reagents 
1-(Benzofuran-2-yl)-2,2,2-trifluoroethan-1-one was synthesized according to a procedure in the 
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literature and the analytical data are consistent with those reported previously.1 
Bis(pinacolato)diboron was purchased from Frontier and recrystallized from pentane prior to use. 
Bis(trimethylsilyl)amine was purchased from Acros and used as received.   
Boc-D-Allo-Thr-OBn was purchased from Advanced ChemTech and used as received. 
Boc-Ile-OH was purchased from Advanced ChemTech and used as received. 
Boc-Thr-OH was purchased from ArkPharm and used as received. 
Boc-Thr(Bzl)-OH was purchased from ArkPharm and used as received. 
Boc-Thr(Me)-OH was purchased from Alfa Aesar and used as received. 
Boc-Val-OH was purchased from Advanced ChemTech and used as received.  
1-(2-Bromophenyl)-2,2,2-trifluoroethan-1-one was synthesized from the corresponding 
aldehyde (Aldrich, used as received).   
4’-Bromo-2,2,2-trifluoroacetophenone was purchased from Combi Blocks and used as received. 
1-Chloro-3-methyl-2-butene was purchased from Alfa Aesar and used as received.  
1-(2-Chlorophenyl)-2,2,2-trifluoroethan-1-one was synthesized from the corresponding 
aldehyde (Aldrich, used as received).   
1-(3-Chlorophenyl)-2,2,2-trifluoroethan-1-one was synthesized from the corresponding 
aldehyde (Aldrich, used as received).   
4’-Chloro-2,2,2-trifluoroacetophenone was purchased from Oakwood and used as received. 
Dess-Martin periodinane was purchased from Oakwood and used as received.   
1,2-Dibromoethylene was purchased from Aldrich and used as received.   
Dimethylamine (40 wt % in H2O) was purchased from Aldrich and used as received.  




(perfluorophenyl)molybdenumimine (Mo-1) was synthesized according to a procedure in the 
literature and the analytical data are consistent with those reported previously.2 
1-(2,5-Dimethyl-1H-pyrrol-1-yl)-1-(((1'r,3'r)-2,2'',4,4'',6,6''-hexamethyl-[1,1':3',1''-
terphenyl]-2'-yl)oxy)-1-(2-methyl-2-phenylpropylidene)-N-
(perfluorophenyl)molybdenumimine (Mo-2) was purchased from Strem and used as received. 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Hydrochloride (EDCHCl) was purchased 
from Advanced ChemTech and used as received.  
2’-Fluorobenzaldehyde was purchased from Aldrich and used as received.   
																																																								
1) Debien, L.; Trost, B. M.  J. Am. Chem. Soc. 2015, 137, 11606–11609. 
2) Zhang, H.; Yu, E.; Torker S.; Schrock, R. R.; Hoveyda, A. H.  J. Am. Chem. Soc. 2014, 136, 16493–16496. 
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Hydrochloric Acid (4.0 M in 1,4-dioxane) was purchased from Aldrich and used as received.  
1-Hydroxy-benzotriazole hydrate (HOBtH2O) was purchased from Advanced ChemTech and 
used as received.  
Lithium bis(trimethylsilyl)amide (1.0 M in thf) was purchased from Aldrich and used as 
received.   
Magnesium Sulfate was purchased from Fisher and flame-dried under vacuum prior to use.  
Methanol (99.8% anhydrous) was purchased from Alfa Aesar and used as received.  
2'-Methoxy-2,2,2-trifluoroacetophenone as purchased from Oakwood and used as received. 
4’-Methoxy-2,2,2-trifluoroacetophenone was purchased from Aldrich and used as received. 
n-Butyllithium (1.6 or 2.5 M in hexanes) was purchased from Aldrich and titrated with n-
benzylbenzamide prior to use. 
Palladium on carbon was purchased from Strem and used as received. 
2,2,3,3,3-Pentafluoro-1-(4-(trifluoromethyl)phenyl)propan-1-one was synthesized according 
to a procedure in the literature and the analytical data are consistent with those reported 
previously.3 
Pyrrolidine was purchased from Aldrich and used as received. 
Sodium Borohydride was purchased from Aldrich and used as received.  
3-tert-Butyl-2-hydroxybenzaldehyde was purchased from Aldrich and used as received.  
Tetrabutylammonium fluoride (1M in thf) was purchased from Oakwood and used as received. 
2,2,2,4’-Tetrafluoroacetophenone was purchased from Oakwood and used as received. 
Triethylamine was purchased from Aldrich and distilled from to use.  
2,2,2-Trifluoroacetophenone was purchased from Oakwood and used as received. 
4-(Trifluoroacetyl)toluene was purchased from Oakwood and used as received. 
2,2,2-Trifluoro-1-(2-fluorophenyl)ethan-1-one was synthesized from the corresponding 
aldehyde (Aldrich, used as received).   
2,2,2-Trifluoro-1-(furan-2-yl)ethan-1-one was purchased from Enamine and used as received. 
(E)-1,1,1-Trifluoro-3-methyl-4-phenylbut-3-en-2-one was synthesized according to a procedure 
in the literature and the analytical data are consistent with those reported previously.4 
1,1,1-Trifluoro-4-phenylbut-3-yn-2-one was synthesized according to a procedure in the 
literature and the analytical data are consistent with those reported previously.5 
																																																								
3).Antúnez, D-J. B.;  Greenhalgh, M. D.;  Brueckner, A. C.; Walden, D. M.; Elías-Rodríguez, P.; Roberts, P.; Young, 
B. G.; West, T. H.; Slawin, .A. M. Z.; Cheong, R. H-Y.; Smith, A. D. Chem. Sci. 2019, 10, 6162–6173. 
4) Buesking, A. W.; Ellman, J. A. Chem. Sci. 2014, 5, 1983–1987. 
5) Hung, C-I.; Scharf, M. J.; Trost, B. M. Angew. Chem., Int. Ed. 2018, 57, 11408–11412. 
	
 Page 222 
2,2,2-Trifluoro-1-(thiophen-2-yl)ethan-1-one was purchased from Oakwood and used as 
received. 
2,2,2-Trifluoro-1-(m-tolyl)ethan-1-one was purchased from Oakwood and used as received.   
2,2,2-Trifluoro-1-(o-tolyl)ethan-1-one was synthesized from the corresponding aldehyde (TCI 
America, used as received).   
2,2,2-Trifluoro-4′-(trifluoromethyl)acetophenone was purchased from Oakwood and used as 
received.   
2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)ethan-1-one was synthesized from the 
corresponding aldehyde (Aldrich, used as received).   
Trifluoromethyltrimethylsilane was purchased from Oakwood and used as received. 
Tris(dibenzylideneacetone)dipalladium(0) was purchased from Strem and used as received.   
Zinc (II) methoxide was purchased from Aldrich and used as received. 
 
2.7.3 Synthesis of N-Trimethylsilyl Ketimines 
Two different methods were used to synthesize N-trimethylsilyl (N-TMS) ketimines.  In general, 
ketones possessing electron-withdrawing substituents were synthesized by Method A, whereas 
condensation of electron-rich and/or hindered ketones were carried out under conditions outlined 
by Method B.  Note: In some cases, hexamethyldisilazide co-distills along with the ketimine 
product, but this does not affect the catalytic transformation.  Weight percent was determined and 
substrates were revised accordingly. 
Method A: Condensation was carried out according to a procedure described by Gosselin et. al.6  
To an oven-dried six-dram vial equipped with a magnetic stir-bar was added ketone (1.0 equiv.) 
and toluene (1.0 M).  The solution was cooled to 0 °C, then LiHMDS (1.0 M in thf, 1.1 equiv.) 
was added dropwise anner.  The solution was allowed to stir at 0 °C for one h, then the reaction 
was quenched by the addition of water (5 mL).  The organic layer was washed with water (2 x 10 
mL), dried over MgSO4, filtered, and concentrated under reduced pressure to afford the product as 
yellow oil, which was used without purification. 
 
Method B: Condensation was carried out according to a procedure described by Hart et. al.7  To 
an oven-dried six-dram vial equipped with a magnetic stir-bar was added HMDS (1.1 equiv.).  The 
vial was allowed to cool to 0 °C for 10 min, then n-BuLi (2.6 M in hexanes, 1.05 equiv.) was added 
in a dropwise manner.  The suspension was allowed to stir at 0 °C for five min and then allowed 
to warm to 22 °C for 10 min.  After re-cooling to 0 °C again, trifluoromethyl ketone (1.0 equiv.) 
																																																								
6) Gosselin, F.; O’Shea, P. D.; Roy, S.; Reamer, R. A.; Chen, C.; Volante, R. P. Org. Lett. 2005, 7, 355–358. 
7) Hart, D. J.;  Kanai, K.; Thomas, D. G.; Yang, T-K.  J. Org. Chem. 1983, 48, 289-294.  
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was added dropwise.  The yellow solution was allowed to stir at 0 °C for one h, then concentrated 
under reduced pressure (rotary evaporator) and the desired ketimine was distilled directly form the 
reaction flask under vacuum to afford the product as cololess or yellow oil.   
2,2,2-Trifluoro-1-phenyl-N-(trimethylsilyl)ethan-1-imine  was synthesized according to 
Method A and the analytical data are consistent with those reported previously.6  1H NMR (400 
MHz, CDCl3): δ 7.57–7.51 (m, 2H), 7.50–7.38 (m, 3H), 0.17 (s, 9H). 
2,2,2-Trifluoro-1-(2-fluorophenyl)-N-(trimethylsilyl)ethan-1-imine was synthesized according 
to Method B.  Yellow oil, 0.895 g, 65% yield, 3.39 mmol; IR (neat): 2962 (w), 1708 (m), 1489 
(m), 1452 (m), 1182 (s), 1133 (s), 822 (m), 758 (m), 744 (s), 612 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.43 (m, 1H), 7.25–7.15 (m, 2H), 7.11 (ddt, J = 9.4, 8.3, 1.0 Hz, 1H), 0.05 (s, 9H); 13C 
NMR (100 MHz, CDCl3): δ 159.0 (d, J = 248.4 Hz), 156.7 (q, J = 36.8 Hz), 131.7 (d, J = 8.0 Hz), 
129.0 (d, J = 3.2 Hz), 124.2 (d, J = 18.9 Hz), 124.1 (d, J = 3.6 Hz), 117.7 (q, J = 285.8 Hz), 115.9 
(d, J = 21.4 Hz), –0.6; 19F NMR (376 MHz, CDCl3): –74.0 (d, J = 5.1 Hz, 3F), –113.9 (dq, J = 
10.8, 5.5 Hz, 1F); HRMS (DART): Calcd for C11H14NF4Si [M+H]+: 264.0832; Found: 264.0842. 
1-(2-Chlorophenyl)-2,2,2-trifluoro-N-(trimethylsilyl)ethan-1-imine was synthesized according 
to Method B.  Yellow oil, 0.338 g, 50% yield, 1.21 mmol; IR (neat): 2962 (w), 1708 (m), 1186 
(s), 1126 (s), 1059 (m), 950 (s), 839 (s), 756 (s), 648 (m), 471 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.44–7.40 (m, 1H), 7.40–7.34 (m, 1H), 7.34–7.27 (m, 1H), 7.21–7.16 (m, 1H), 0.02 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ 159.1, 135.8, 131.8, 131.0, 129.9, 128.8, 126.8, 117.9 (q, J 
= 284.7 Hz), –0.6; 19F NMR (376 MHz, CDCl3): –73.5 (s, 3F); HRMS (DART): Calcd for 
C11H14NF3SiCl [M+H]+: 280.0531; Found: 280.0533. 
2,2,2-Trifluoro-1-(2-methoxyphenyl)-N-(trimethylsilyl)ethan-1-imine was synthesized 
according to Method B.  Yellow oil, 0.624 g, 97% yield, 2.26 mmol; IR (neat): 2958 (w), 1702 
(m), 1488 (m), 1247 (m), 1180 (s), 1125 (s), 944 (m), 802 (s), 751 (s), 657 (m), 575 (w) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.38 (ddd, J = 8.4, 7.5, 1.8 Hz, 1H), 7.09 (m, 1H), 6.96 (td, J = 7.5, 
0.9 Hz, 1H), 6.90 (dd, J = 8.4, 0.9 Hz, 1H), 3.81 (s, 3H), –0.01 (s, 9H); 13C NMR (100 MHz, 
CDCl3): δ 156.7, 132.7, 131.2, 130.8 (q, J = 288.0 Hz), 128.5, 120.8, 120.4, 111.9, 111.0, 55.9 (q, 
J = 27.3 Hz), 1.5, -0.4; 19F NMR (376 MHz, CDCl3): –73.9 (s, 3F); HRMS (DART): Calcd for 
C12H17NOF3Si [M+H]+: 276.1026; Found: 276.1022. 
(Z)-2,2,2-Trifluoro-1-(o-tolyl)-N-(trimethylsilyl)ethan-1-imine was synthesized according to 
Method B.  Yellow oil, 0.912 g, 89% yield, 3.52 mmol; IR (neat): 3051 (w), 1702 (w), 1420 (m), 
1304 (m), 1263 (m), 1184 (m), 930 (m), 859 (m), 730 (s), 702 (m), 513 (w) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.35–7.28 (m, 1H), 7.20 (m, 2H), 7.07 (d, J = 7.6 Hz, 1H), 2.25 (s, 3H), –0.02 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ 163.7 (q, J = 35.5 Hz), 136.7, 135.2, 130.4, 129.6, 127.3, 
125.7, 118.3 (q, J = 285 Hz), 19.7, –0.4; 19F NMR (376 MHz, CDCl3): –73.6 (s, 3F); HRMS 
(DART): Calcd for C12H17NF3Si [M+H]+: 260.1077; Found: 260.1072. 
1-(3-Chlorophenyl)-2,2,2-trifluoro-N-(trimethylsilyl)ethan-1-imine was synthesized according 
to Method A.  Yellow oil, 0.439 g, 66% yield, 1.57 mmol; IR (neat): 2957 (w), 1707 (m), 1568 
(w), 1251 (m), 1224 (s), 1178 (s), 840 (s), 674 (m), 622 (m), 540 (w) cm-1; 1H NMR (400 MHz, 
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CDCl3): δ 7.58 (m, 1H), 7.46 (m, 2H), 7.42–7.30 (m, 1H), 0.27–0.14 (m, 9H); 13C NMR (100 
MHz, CDCl3): δ 156.4 (q, J = 34.3 Hz), 137.2, 134.7, 131.0, 129.8, 128.1 (d, J = 1.8 Hz), 126.0 
(d, J = 1.9 Hz), 117.7 (d, J = 287.3 Hz), 0.5; 19F NMR (376 MHz, CDCl3): –68.9 (s, 3F); HRMS 
(DART): Calcd for C11H14NF3SiCl [M+H]+: 280.0531; Found: 280.0533. 
2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)-N-(trimethylsilyl)ethan-1-imine was 
synthesized according to Method A.  Yellow oil, 0.303 g, 55% yield, 0.968 mmol; IR (neat): 2959 
(w), 1960 (m), 1332 (m), 1165 (s), 1126 (s), 1099 (m), 863 (m), 842 (m), 648 (m) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.57 (m, 1H), 7.46 (m, 2H), 7.35 (m, 1H), 0.23–0.18 (s, 9H); 13C NMR 
(100 MHz, CDCl3): δ 156.4 (q, J = 34.3 Hz), 137.2, 134.7, 131.3 (q, J = 230.0 Hz), 131.1, 129.8, 
128.1 (d, J = 1.6 Hz), 126.0 (q, J = 1.8 Hz), 117.7 (q, J = 288.9 Hz), 0.5 (d, J = 1.4 Hz); 19F NMR 
(376 MHz, CDCl3): –68.9 (s, 3F), –62.9 (s, 3F); HRMS (DART): Calcd for C12H14NF6Si 
[M+H]+: 314.0794; Found: 314.0806. 
2,2,2-Trifluoro-1-(4-fluorophenyl)-N-(trimethylsilyl)ethan-1-imine was synthesized according 
Method A.  Yellow oil, 2.09 g, 80% yield, 7.92 mmol; IR (neat): 2961 (w), 1704 (m), 1602 (m), 
1509 (m), 1237 (m), 1160 (s), 1129 (s), 862 (s), 840 (s) 687 (m), 528 (w) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.64 (m, J = 7.1, 5.3, 0.9 Hz, 2H), 7.17–7.02 (m, 2H), 0.22 (s, 9H); 13C NMR 
(100 MHz, CDCl3): δ 165.7, 163.2, 130.3 (dq, J = 8.7, 1.8 Hz), 117.8 (d, J = 287.9 Hz), 115.7, 
115.5, 0.5; 19F NMR (376 MHz, CDCl3): –68.5 (s, 3F),  –108.9 (ddd, J = 8.2, 5.4, 3.1 Hz, 1F); 
HRMS (DART): Calcd for C11H14F4NSi [M+H]+: 264.0832; Found: 264.0826. 
(Z)-1-(4-Chlorophenyl)-2,2,2-trifluoro-N-(trimethylsilyl)ethan-1-imine was synthesized 
according to Method A.  Yellow oil, 0.573 g, 77% yield, 2.05 mmol; IR (neat): 2960 (w), 1702 
(m), 1609 (w), 1252 (m), 1174 (s), 1131 (s), 1023 (s), 952 (s), 726 (s), 528 (m) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.62–7.51 (m, 2H), 7.47–7.33 (m, 2H), 0.21 (s, 9H); 13C NMR (100 MHz, 
CDCl3): δ 156.5 (q, J = 33.8 Hz), 137.3, 133.9, 129.4 (q, J = 1.8 Hz), 128.8, 117.7 (q, J = 287.8 
Hz), 0.5; 19F NMR (376 MHz, CDCl3): –68.7 (d, J = 4.0 Hz, 3F); HRMS (DART): Calcd for 
C11H14NF3SiCl [M+H]+: 260.1077; Found: 260.1072. 
(Z)-1-(4-Bromophenyl)-2,2,2-trifluoro-N-(trimethylsilyl)ethan-1-imine was synthesized 
according to Method A and the analytical data are consistent with those reported previously.6   
2,2,2-Trifluoro-1-(4-(trifluoromethyl)phenyl)-N-(trimethylsilyl)ethan-1-imine was 
synthesized according to Method A. Yellow oil, 0.480 g, 87% yield, 1.53 mmol; IR (neat): 2254 
(w), 1712 (w), 1327 (m), 1188 (m), 1020 (m), 903 (s), 847 (s), 724 (s), 650 (m) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.75–7.62 (m, 4H), 0.20 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 156.5 (q, 
J = 34.4 Hz), 138.7, 132.5 (q, J = 32.6 Hz), 128.9, 122.3 (q, J = 272.5 Hz), 117.5 (q, J = 287.3 
Hz), 29.7, 0.2; 19F NMR (376 MHz, CDCl3): –63.0 (d, J = 6.1 Hz, 3F), –69.1 (d, J = 6.3 Hz, 3F); 
HRMS (DART): Calcd for C12H14NF6Si [M+H]+: 314.0800; Found: 314.0811. 
2,2,2-Trifluoro-1-(4-methoxyphenyl)-N-(trimethylsilyl)ethan-1-imine was synthesized 
according to Method B. Yellow oil, 0.371 g, 55% yield, 1.35 mmol; IR (neat): 2957 (w), 2834 
(w), 1697 (m), 1602 (m), 1577 (m), 1251 (s), 1164 (s), 1126 (s), 1032 (m), 862 (s), 837 (s), 761 
(m), 560 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.62 (m, J = 7.8, 1.2 Hz, 2H), 7.01–6.78 (m, 
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2H), 3.85 (d, J = 1.2 Hz, 3H), 0.22 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 161.7, 156.6 (q, J = 
33.1 Hz), 129.6 (q, J = 26.8 Hz), 128.0, 116.5 (q, J = 288.1 Hz), 113.5 (d, J = 13.2 Hz), 55.3 (q, J 
= 22.5 Hz), 0.5; 19F NMR (376 MHz, CDCl3): –68.0 (s, 3F); HRMS (DART): Calcd for 
C12H17NF3SiO [M+H]+: 276.1032; Found: 276.1044. 
N,N-Dimethyl-4-(2,2,2-trifluoro-1-((trimethylsilyl)imino)ethyl)aniline was synthesized 
according to Method B.  Yellow solid, 0.349 g, 52% yield, 1.21 mmol; M.p. = 56–58 °C; IR 
(neat): 2956 (w), 2899 (w), 1690 (m), 1602 (s), 1527 (w), 1369 (m), 1164 (s), 1129 (s), 864 (m), 
842 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.64 (d, J = 8.6 Hz, 2H), 6.65 (d, J = 8.9 Hz, 2H), 
3.03 (s, 6H), 0.23 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 152.1, 129.8 (q, J = 26.2 Hz), 122.8, 
118.0 (q, J = 289.0 Hz), 110.9, 110.8, 40.1, 40.0, 0.7; 19F NMR (376 MHz, CDCl3): –66.9 (s, 3F); 
HRMS (DART): Calcd for C13H20N2F3Si [M+H]+: 289.1342; Found: 289.1334. 
2,2,2-Trifluoro-1-(furan-2-yl)-N-(trimethylsilyl)ethan-1-imine was synthesized according to 
Method A and the analytical data are consistent with those reported previously.8  
1-(Benzofuran-2-yl)-2,2,2-trifluoro-N-(trimethylsilyl)ethan-1-imine was synthesized 
according to Method B.  Yellow solid, 0.649 g, 79% yield, 2.25 mmol; M.p. = 59–61°C; IR (neat): 
2958 (w), 1686 (s), 1407 (w), 1251 (s), 1200 (m), 1154 (s), 1129 (s), 982 (s), 905 (s), 843 (s), 743 
(s), 626 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.71 (dt, J = 7.9, 0.9 Hz, 1H), 7.54 (dd, J = 8.3, 
1.1 Hz, 1H), 7.44 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.36–7.28 (m, 2H), 0.38 (s, 9H); 13C NMR (100 
MHz, CDCl3): δ 155.1, 147.6, 127.5, 127.4, 124.0, 123.3, 117.1 (q, J = 285.4 Hz), 111.6, 111.5, 
111.5 (q, peaks overlapped), 0.7; 19F NMR (376 MHz, CDCl3): –70.1 (d, J = 1.8 Hz, 3F); HRMS 
(DART): Calcd for C13H15NOF3Si [M+H]+: 286.0870; Found: 286.0868. 
2,2,2-Trifluoro-1-(thiophen-2-yl)-N-(trimethylsilyl)ethan-1-imine was synthesized according 
to Method B.  Yellow oil, 0.289 g, 41% yield, 1.14 mmol; IR (neat): 2960 (w), 1682 (s), 1421 
(m), 1251 (m), 1184 (s), 1136 (s), 1061 (m), 841 (s), 712 (s), 567 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.56–7.45 (m, 2H), 7.09 (dt, J = 5.1, 2.3 Hz, 1H), 0.28 (s, 9H); 13C NMR (100 MHz, 
CDCl3): δ 142.9, 131.8, 130.01 (q, J = 3.2 Hz), 128.4, 117.1 (q, J = 289 Hz), 105.6, 0.7; 19F NMR 
(376 MHz, CDCl3): –67.6 (s, 3F); HRMS (DART): Calcd for C9H13NF3Si [M+H]+: 252.0485; 
Found: 252.0489. 
(E)-1,1,1-Trifluoro-3-methyl-4-phenyl-N-(trimethylsilyl)but-3-en-2-imine was synthesized 
according to Method B.  Yellow oil, 0.295 g, 52% yield, 1.04 mmol; IR (neat): 3298 (w), 2959 
(w), 1696 (m), 1608 (m), 1184 (s), 1129 (s), 953 (s), 839 (s), 696 (s), 626 (m), 506 (w) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.43–7.27 (m, 5H), 6.80 (s, 1H), 2.05 (dt, J = 1.6, 0.8 Hz, 3H), 0.27 
(s, 9H); 13C NMR (100 MHz, CDCl3): δ 161.7 (q, J = 32.6 Hz), 136.0, 134.7, 133.8 (q, J = 2.0 
Hz), 129.2, 128.4, 127.8, 117.9 (q, J = 287.9 Hz), 15.7 (q, J = 1.5 Hz), 0.5; 19F NMR (376 MHz, 
CDCl3): –68.4 (d, J = 5.8 Hz, 3F); HRMS (DART): Calcd for C14H19NF3Si [M+H]+: 286.1233; 
Found: 286.1231. 
1,1,1-Trifluoro-4-phenyl-N-(trimethylsilyl)but-3-yn-2-imine was synthesized according to 
																																																								
8)  Zhu,  J.; Huang, L.; Dong, W.; Li, N.; Yu, X.;. Deng T. W, Angew. Chem., Int. Ed. 2019, 58, 16119–16123. 
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Method B.  Yellow oil, 0.434 g, 64% yield, 1.61 mmol; IR (neat): 2959 (w), 2199 (m), 1654 (m), 
1319 (m), 1247 (s), 1196 (s), 1138 (s), 860 (s), 843 (s), 755 (s), 687 (m), 533 (m) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.57–7.51 (m, 2H), 7.49–7.43 (m, 1H), 7.43–7.36 (m, 2H), 0.37 (s, 9H); 13C 
NMR (100 MHz, CDCl3): δ 145.1 (q, J = 39.6 Hz), 132.4, 130.6, 128.7, 120.1, 117.1 (q, J = 
281.9), 94.3, 82.2, –0.7; 19F NMR (376 MHz, CDCl3): –74.5 (s, 3F); HRMS (DART): Calcd for 
C13H15NF3Si [M+H]+: 270.0920; Found: 270.0922. 
 
2.7.4 Boronic ester reagents  
2-Allyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from Frontier Scientific and 
distilled from calcium hydride prior to use. 
(Z)-2-(But-2-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was purchased from Aldrich or 
Santa Cruz and used as received.  
(Z)-1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)dec-2-en-5-one (S-1) was synthesized 
according to a procedure in the literature and the analytical data are consistent with those reported 
previously.9 
(Z)-2-(3-Chloroallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (S-2) was synthesized according 
to a procedure in the literature and the analytical data are consistent with those reported 
previously.10 
(Z)-2-(3-Bromoallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (Z-2.128):  
	
In a N2-filled glovebox, an oven-dried one-dram vial was charged with aryl-oxide (24.9 
mg, 0.05 mmol), bis-imidomolybdenum (33.7 mg, 0.055 mmol), and benzene (0.4 mL).  The vial 
was sealed with a Teflon cap and the solution was allowed to stir at 60 °C for one h. A separate 
oven-dried one-dram vial was charged with Z-2.64 (227.6 mg, 1.25 mmol), 1,2-dibromoethylene 
(mixture of cis- and trans-, 1.85 g, 10.0 mmol), HB(pin) (16.0 mg, 0.125 mmol) and benzene (0.1 
mL).  The solution was allowed to stir at 22 °C for 10 min.  The freshly prepared catalyst solution 
was allowed to cool to 22 °C before it was added in a dropwise manner (0.3 mL) to the vial 
containing the cross partners.  The solution was allowed to stir at 22 °C for two h, after which the 
																																																								
9)  Ely, R. J.;  Morken, J. P.  J. Am. Chem. Soc. 2010, 132, 2534–2535. 
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remaining catalyst stock solution (0.1 mL) was added. The solution was allowed to stir at 22 °C 
for an additional two 2, then reaction was quenched by the addition of CDCl3 and analyzed by 1H-
NMR spectroscopy affording the desired allyl boron in 95% conv, 97:3 Z:E. The volatiles were 
removed in vacuo prior and the remaining brown oil was purified by Kugelrohr distillation (90–
120 °C, 0.5 torr) to afford Z-2.128 (247.3 mg, 1.00 mmol, 80% yield) as light brown oil.  IR 
(neat): 2977 (m), 2930 (w), 1619 (w), 1468 (s), 1369 (s), 1302 (s), 1108 (s), 966 (m), 846 (m) 718 
(m), 675 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.23 (td, J = 7.6, 6.8 Hz, 1H), 6.15 (dt, J = 6.8, 
1.4 Hz, 1H), 1.86–1.83 (m, 2H), 1.26 (s, 12H); 13C NMR (100 MHz, CDCl3): δ 130.7, 108.0, 
83.7, 24.9, 24.7; HRMS (DART): Calcd for C9H17BO2Br [M+H]+: 247.0500; Found: 247.0497. 
(Z)-4,4,5,5-Tetramethyl-2-(2-methylhept-2-en-1-yl)-1,3,2-dioxaborolane (S-3) was 
synthesized according to a procedure in the literature.9  IR (neat): 2975 (m), 2924 (m), 1350 (s), 
1320 (s), 1141 (s), 967 (m), 847 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 5.11 (tq, J = 7.1, 1.3 
Hz, 1H), 1.94 (q, J = 6.6 Hz, 2H), 1.73 (q, J = 1.3 Hz, 3H), 1.65 (s, 2H), 1.30 (tt, J = 5.1, 2.4 Hz, 
4H), 1.23 (s, 12H), 0.93 – 0.78 (m, 3H); 13C NMR (150 MHz, CDCl3): δ 167.6, 131.8, 124.0 (d, 
J = 13.5 Hz) 97.6, 83.1, 32.0, 28.0, 25.7 (m), 24.7, 22.4, 14.1; HRMS (DART): Calcd for 
C14H28BO2 [M+H]+: 239.21769; Found: 239.21758. 
 
2.7.5  Aminophenol ligands 
(S)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-3-methyl-1-(pyrrolidin-1-yl)butan-1-one   
(ap-1) was synthesized in accordance to a procedure in the literature and the analytical data are 
consistent with those reported previously.11  
 (2S,3S)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-3-methyl-1-(pyrrolidin-1-yl)pentan-1-one (ap-4) was 
synthesized analogous to ap-1a except Boc-Ile-OH was used as the starting material. Colorless oil; IR (neat): 3279 
(w), 3042 (m, br), 1631 (s), 1433 (s), 1238 (m), 1023 (m), 840 (m), 748 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 10.95 
(s, 1H), 7.18 (dd, J = 7.7, 1.8 Hz, 1H), 6.76 (dd, J = 7.4, 1.7 Hz, 1H), 6.69 (t, J = 7.5 Hz, 1H), 4.11 (d, J = 13.7 Hz, 
3H), 3.68–3.56 (m, 1H), 3.49 (dd, J = 13.1, 8.9 Hz, 2H), 3.24 (ddd, J = 9.3, 7.0, 5.1 Hz, 1H), 3.19–3.10 (m, 2H), 1.96–
1.81 (m, 4H), 1.76–1.58 (m, 1H), 1.41 (s, 9H), 1.26–1.12 (m, 1H), 0.92–0.81 (m, 6H); 13C NMR (100 MHz, CDCl3): 
δ 171.2, 158.6, 138.3, 127.8, 126.2, 123.8, 118.4, 62.1, 51.3, 46.9, 45.1, 37.7, 34.2, 29.6, 26.2, 24.5, 23.5, 15.3, 11.1; 
HRMS (DART): Calcd for C21H35N2O2 [M+H]+: 347.2693; Found: 347.2684; Specific rotation: [α]24D –36.5 (c 2.24, 
CHCl3). 
(2S,3S)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-3-methoxy-1-(pyrrolidin-1-yl)butan-1-
one (ap-6) was synthesized analogous to ap-1a.  The requisite amino acid was obtained by 
alkylating Boc-allo-Thr-OBn with trimethyloxonium tetrafluoroborate (Meerwein’s Salt) 
																																																								
11) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.;  Haeffner, F.;  Hoveyda, A. H. Nature 
2013, 494, 216–221. 
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according to a reported procedure12 and subsequent hydrolysis of the benzyl ester according to a 
known protocol.13   Colorless oil; IR (neat): 3269 (w), 2948 (m, br), 1631 (s), 1434 (s), 1238 (m), 
1103 (m), 841 (m), 749 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 10.78 (s, 1H), 7.20 (dd, J = 7.8, 
1.7 Hz, 1H), 6.79 (dd, J = 7.4, 1.7 Hz, 1H), 6.71 (t, J = 7.5 Hz, 1H), 4.11 (d, J = 13.5 Hz, 1H), 3.65 
– 3.36 (m, 5H), 3.35 – 3.28 (m, 1H), 3.24 (s, 3H), 3.14 (dt, J = 8.9, 6.6 Hz, 1H), 1.88 (dq, J = 6.2, 
3.8, 2.2 Hz, 4H), 1.41 (s, 9H), 1.24 (d, J = 6.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 171.1, 
156.8, 137.0, 126.7, 126.1, 122.5, 118.4, 78.4, 62.2, 57.1, 50.8, 46.3, 45.9, 34.6, 29.4, 25.9, 24.3, 
16.6; HRMS (DART): Calcd for C20H33N2O3 [M+H]+: 349.2486; Found: 349.2475;  Specific 
rotation: [α]24D –35.7 (c 2.35, CHCl3). 
(2S,3R)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-3-methoxy-1-(pyrrolidin-1-yl)butan-1-
one (ap-7) was synthesized analogous to ap-1a in accordance to a reported procedure except Boc-
Thr(OMe)-OH was used as the starting material. Colorless oil; IR (neat): 3288 (w), 2949 (m, br), 
1631 (s), 1434 (s), 1238 (m), 1090 (s), 877 (s), 748 (m), 619 (s), 509 (w) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.20 (dd, J = 7.8, 1.7 Hz, 1H), 6.81 (dd, J = 7.4, 1.7 Hz, 1H), 6.70 (t, J = 7.6 Hz, 
1H), 4.11 (d, J = 13.5 Hz, 1H), 3.68 (d, J = 13.5 Hz, 1H), 3.64 – 3.39 (m, 5H), 3.31 (s, 3H), 3.24 
(dt, J = 10.5, 6.6 Hz, 1H), 1.89 (qt, J = 11.7, 5.1 Hz, 4H), 1.42 (s, 9H), 1.16 (d, J = 6.2 Hz, 3H); 
13C NMR (100 MHz, CDCl3): δ 169.7, 157.1, 137.0, 126.7, 126.1, 122.7, 118.3, 78.4, 61.5, 57.1, 
51.2, 46.5, 45.9, 34.7, 29.5, 26.1, 24.1, 15.5; HRMS (DART): Calcd for C20H33N2O3 [M+H]+: 
349.2486; Found: 349.2478; Specific rotation: [α]24D –21.6 (c 1.41, CHCl3). 
 
																																																								
12) Kiho, T.; Nakayama, M.; Yasuda, K.; Miyakoshi, S.; Inukai, M.;Kogen, H. Bioorg. Med. Chem. 2004, 12, 337–
361. 
13) Xiao, K.-J.; Chu, L.; Yu, J.-Q., Angew. Chem. Int. Ed. 2016, 55, 2856-2860. 
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2.7.6 In Situ Silyl Removal  
2.7.6.1 Screening of Fluoride Reagents 
	
2.7.6.2 Spectroscopic Analysis 
In a N2-filled glovebox, NTMS ketimine (0.1 mmol), tbat (5.0 mol %), and toluene (0.5 mL) were 
combined in a J-Young NMR tube. Immediately prior to placing the tube in the spectrometer, the 
solution was charged with iPrOH (2.5 equiv.) after which the tube was turned several times to 
ensure complete mixing.  Spectra (19F NMR) were collected every minute until complete 
disappearance of the N-TMS ketimine (~60 min).  The signals corresponding to E and Z isomers 
of the N-H ketimine can be observed increasing in intensity at the left and right of the N-TMS 





5.0 mol % Zn(OMe)2, 5.0 mol % tbat,





























































[a] All reactions were performed under N2 atm. [b] Conv., !:", and Z:E ratios were determined by analysis of 19F NMR spectra (±2%) 
of unpurified mixtures; Conv. refers to disappearance of 2.88.  [c] er values were determined by HPLC analysis (± 1%). See Supporting 
Information for details. tbat: tetrabutylammonium difluorotriphenylsilicate
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N-H ketimine generation and crotyl addition: In a N2-filled glovebox, ketimine (0.1 mmol), tbat 
(5.0 mol %), and toluene (0.25 mL) were combined in a J-Young NMR tube, after which the 
solution was charged with a solution of aminophenol (5.0 mol %) and Zn(OMe)2 (10.0 mol %) in 
tol. (0.25 mL).  Immediately prior to placement of the tube within the NMR instrument, MeOH 
(1.75 equiv.) was added and the tube was turned ~10 times to ensure complete mixing.  (Note: 
MeOH (1.75 equiv.) so that formation of N-H ketimine and homoallylamine formation could be 
monitored.)  Spectra (19F NMR) were collected until complete disappearance of N–TMS ketimine 























5.0 mol % Zn(OMe)2, 5.0 mol % tbat,
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2.7.7 Additions of Allyl–B(Pin) To Trifluoromethyl N-H Ketimines 
General procedure for addition of allyl–B(pin): In a N2-filled glovebox, an oven-dried two-dram 
vial equipped with a magnetic stir-bar was charged with ap-3 (3.3 mg, 0.01 mmol), Zn(OMe)2 (1.7 
mg, 0.01 mmol) and the solids were dissolved in toluene (0.20 mL). A second oven-dried two-
dram vial was charged with ketimine (0.1 mmol), tol. (0.10 mL), and tbat (2.7 mg, 0.005 mmol) 
to which was added the freshly prepared catalyst stock solution (0.1 mL) followed by allylboronic 
acid pinacol ester (25.3 mg, 0.15 mmol).  The vial was sealed (septum and electrical tape), and 
removed from the glovebox, and the solution was allowed to cool to 4 °C in a cold room.  To this 
solution was added iPrOH (19 µL, 0.25 mmol) and the mixture was allowed to stir for 3 h.  
Reaction progress (conv) was monitored by 19F NMR spectroscopy (aliquot removed).  Once 
transformation reached completion, the mixture was loaded onto a silica gel column and eluted 
with hexanes/Et2O to afford the α-tertiary amine as colorless oil.   
(R)-1,1,1-Trifluoro-2-phenylpent-4-en-2-amine (2.91):  The title compound was synthesized 
according to the general procedure and purified by silica gel chromatography to afford the product 
as colorless oil.  The analytical data are consistent with those reported previously.14  Colorless oil, 
																																																								










N–H N–H Product 
Hemiaminal 
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20.2 mg, 94% yield, 0.094 mmol; Specific Rotation: [α]24D +38.7 (c 2.57, CHCl3) for a 91:9 e.r. 
sample. The enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm) : tR: 17.980 min 
(major) and 20.475 min (minor). 
 
(R)-1,1,1-Trifluoro-2-(2-methoxyphenyl)pent-4-en-2-amine (2.92):  Colorless oil, 16.4 mg, 
67% yield, 0.067 mmol; IR (neat): 2254 (w), 2014 (w), 1495 (w), 1381 (w), 903 (s), 723 (s), 650 
(m), 543 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.46–7.40 (m, 1H), 7.32 (ddd, J = 8.2, 7.3, 1.7 
Hz, 1H), 7.01–6.92 (m, 2H), 5.73–5.61 (m, 1H), 5.24–5.07 (m, 2H), 3.86 (s, 3H), 3.30 (ddt, J = 
14.5, 6.3, 1.5 Hz, 1H), 2.61 (dd, J = 14.6, 7.9 Hz, 1H), 2.35 (br, 2H); 13C NMR (100 MHz, 
CDCl3): δ 159.1, 132.5, 130.2, 130.0, 127.2 (q, J = 286.7 Hz), 120.7, 119.7, 112.7, 62.0 (q, J = 
26.6 Hz), 55.8, 39.4; 19F NMR (376 MHz, CDCl3): –78.44 (s, 3F); HRMS (DART): Calcd for 
C12H15NOF3 [M+H]+: 246.1106; Found: 246.1118; Specific rotation: [α]24D = +18.8 (c 2.08, 
CHCl3) for a 91.5:8.5 e.r. sample. The enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 
220 nm): tR: 19.536 min (major) and 23.252 min (minor). 
 
(R)-1,1,1-Trifluoro-2-(2-fluorophenyl)pent-4-en-2-amine (2.93): Colorless oil, 15.9 mg, 68% 
yield, 0.068 mmol; IR (neat): 3444 (w), 3084 (w), 2933 (w), 1642 (m), 1489 (m), 1219 (m), 1149 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 16.985 51.194 1 17.980 91.006 
2 19.337 48.806 2 20.475 8.994 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 19.754 50.671 1 19.536 91.455 
2 23.470 49.329 2 23.252 8.545 
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(s), 818 (m), 757 (s), 573 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.58–7.51 (m, 1H), 7.36 (ddd, 
J = 14.0, 10.6, 4.5 Hz, 1H), 7.22–7.14 (m, 1H), 7.08 (ddd, J = 13.1, 8.3, 1.5 Hz, 1H), 5.76–5.52 
(m, 1H), 5.31–5.05 (m, 2H), 3.30 (dd, J = 14.5, 6.4 Hz, 1H), 2.61 (dd, J = 14.5, 7.8 Hz, 1H), 1.87 
(s, 2H); 13C NMR (100 MHz, CDCl3): δ 161.4 (d, J = 249.6 Hz), 135.1, 131.5, 130.6, 130.1, 129.3 
(q, J = 278.3 Hz), 124.3 (d, J = 3.5 Hz), 120.4, 117.0 (d, J = 25.4 Hz), 61.2 (q, J = 20.0 Hz), 39.1 
(d, J = 6.2 Hz); 19F NMR (376 MHz, CDCl3): δ –79.2 (d, J = 15.0 Hz, 3F), –108.5 (dt, J = 21.3, 
12.4 Hz, 1F); HRMS (DART): Calcd for C11H12F4N [M+H]+: 234.0906; Found: 234.0905; 
Specific rotation: [α]24D = +28.1 (c 1.42, CHCl3) for a 91:9 e.r. sample. The enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AD-
H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 17.544 min (minor) and 19.618 min (major). 
 
(R)-1,1,1-Trifluoro-2-(4-fluorophenyl)pent-4-en-2-amine (2.94): Colorless oil, 15.6 mg, 67% 
yield, 0.067 mmol; IR (neat): 2047 (w), 3083 (w), 2985 (w), 1642 (m), 1510 (m), 1147 (s), 830 
(s), 735 (m), 583 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.55 (dd, J = 8.4, 5.4 Hz, 2H), 7.06 
(dd, J = 9.0, 1.9 Hz, 2H), 5.50 (dq, J = 16.8, 7.9 Hz, 1H), 5.17–5.05 (m, 2H), 2.88 (dd, J = 14.4, 
6.6 Hz, 1H), 2.63 (dd, J = 14.4, 7.8 Hz, 1H), 1.73 (br, 2H); 13C NMR (100 MHz, CDCl3): δ 162.6 
(d, J = 247.6 Hz), 134.3 (d, J = 171.1 Hz), 131.0, 128.8 (d, J = 8.2 Hz), 126.9 (q, J = 285.2 Hz), 
120.5, 115.4 (d, J = 21.4 Hz), 60.9 (q, J = 26.0 Hz), 41.1; 19F NMR (376 MHz, CDCl3): –78.20 
(d, J = 13.8 Hz, 3F), –114.48 (s, 1F); HRMS (DART): Calcd for C11H12F4N [M+H]+: 234.0906; 
Found: 234.0911; Specific rotation: [α]24D = +34.8 (c 1.35, CHCl3) for a 86:14 e.r. sample. The 
enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AD-H, 99:1 hexanes:i-PrOH, 0.7 mL/min, 220 nm): tR: 9.508 min (major) and 
12.461 min (minor). 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 17.6 min 1824963 50.556 1 17.5 min 168514 8.805 
2 19.8 min 1784848 49.444 2 10.6 min 1745224 91.195 
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(R)-1,1,1-Trifluoro-2-(4-(trifluoromethyl)phenyl)pent-4-en-2-amine (2.95): Colorless oil, 9.06 
mg, 32% yield, 0.032 mmol; IR (neat): 2991 (w), 2942 (w), 2849 (w), 2053 (w), 1622 (m), 1325 
(s), 1117 (s), 1068 (s), 1019 (s), 839 (m), 579 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.74 (d, 
J = 8.3 Hz, 2H), 7.69–7.57 (m, 2H), 5.49 (ddd, J = 16.9, 9.5, 7.2 Hz, 1H), 5.24–5.05 (m, 2H), 2.91 
(dd, J = 14.4, 6.8 Hz, 1H), 2.69 (dd, J = 14.4, 7.6 Hz, 1H), 1.79 (s, 2H); 13C NMR (100 MHz, 
CDCl3): δ 141.8, 135.6, 130.7, 130.1 (q, J = 22.7 Hz), 127.6, 125.4 (d, J = 4.2 Hz), 124.6 (q, J = 
274.2 Hz), 120.9, 61.4 (q, J = 26.6 Hz), 41.1; 19F NMR (376 MHz, CDCl3): δ –62.79 (s, 3F), –
77.63 (s, 3F); HRMS (DART): Calcd for C12H12F6N [M+H]+: 284.0874; Found: 284.0882; 
Specific rotation: [α]24D = +26.6 (c 0.93, CHCl3) for a 89:11 e.r. sample. The enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AD-
H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 8.993 min (major) and 13.258 min (minor).   
 
 
2.7.8  Additions of Z-Substituted Allyl Boronates to Trifluoromethyl N-H Ketimines 
In a N2-filled glovebox, an oven-dried two-dram vial was charged with a stock solution of 
aminophenol ap-7 (3.5 mg, 0.01 mmol), Zn(OMe)2 (2.6 mg, 0.02 mmol), and tol. (0.5 mL).  A 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 9.404 49.387 1 9.508 85.977 
2 12.302 50.613 2 12.461 14.023 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 8.983 46.543 1 8.993 89.083 
2 13.239 53.457 2 13.258 10.917 
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separate oven-dried two-dram vial equipped with a magnetic stir-bar was charged with ketimine 
(0.1 mmol), tol. (0.25 mL), and tbat (2.7 mg, 0.005 mmol), followed by the freshly prepared stock 
solution of the catalyst (0.25 mL) and Z-2.64 (27 µL, 0.13 mmol) and MeOH (14 µL, 0.35 mmol).  
The mixture was allowed to stir for five min after which the vial was capped, removed from the 
glovebox, and the mixture was allowed to stir for 3 h at 22 °C.  Conversion and α:γ ratio were 
determined by spectroscopic analysis (19F NMR) of an aliquot sample.  The mixture was loaded 
onto silica gel and eluted with 100:0 → 3:1 hexanes:Et2O, resulting in the isolation of α-tertiary 
amine as colorless oil.  Note: In some cases, and as explicitly indicated in the body of the 
manuscript, yields of isolated products are reported as mixtures of a and g isomers.  The minor γ 
isomer accounts for the minor signals in the corresponding NMR spectra. 
(R,Z)-1,1,1-Trifluoro-2-phenylhex-4-en-2-amine (2.69): Colorless oil, 19.9 mg, 80% yield, 
0.080 mmol; IR (neat): 2254 (w), 1156 (w), 903 (s), 722 (s), 650 (s), 543 (m) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.61–7.53 (m, 2H), 7.52–7.31 (m, 3H), 5.60 (m, 1H), 5.25–5.03 (m, 1H), 2.88 
(dd, J = 14.9, 6.7 Hz, 1H), 2.82–2.63 (m, 1H), 1.77 (s, 2H), 1.62 (ddt, J = 6.9, 1.8, 0.9 Hz, 3H); 
13C NMR (100 MHz, CDCl3): δ 137.8, 128.7, 128.4, 128.2, 127.3 (q, J = 285.3 Hz), 126.1 (q, J 
= 1.6 Hz), 123.0, 61.6 (q, J = 25.8 Hz), 33.6, 13.3; 19F NMR (376 MHz, CDCl3): –77.9 (s, 3F); 
HRMS (DART): Calcd for C12H15NF3 [M+H]+: 230.1151; Found: 230.1156; Specific rotation: 
[α]24D = –6.1 (c 1.40, CHCl3) for a 97:3 e.r. sample; The enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (Chiralpak AD-H, 99:1 
hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 10.631 min (major) and 11.843 min (minor).  
 
(R,Z)-1,1,1-Trifluoro-2-(4-fluorophenyl)hex-4-en-2-amine (2.102): Colorless oil, 16.8 mg, 
68% yield, 0.068 mmol; IR (neat): 2924 (w), 1606 (m), 1511 (s), 1237 (m), 1145 (s), 831 (s), 737 
(m) cm-1; 1H NMR (400 MHz, CDCl3):  δ 7.62–7.45 (m, 2H), 7.17–6.98 (m, 2H), 5.72–5.54 (m, 
1H), 5.25–5.07 (m, 1H), 2.84 (dd, J = 15.0, 6.9 Hz, 1H), 2.70 (dd, J = 15.0, 7.6 Hz, 1H), 1.74 (s, 
2H), 1.61 (ddt, J = 6.8, 1.9, 0.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 162.6 (d, J = 247.5 Hz), 
133.6 (d, J = 3.2 Hz), 129.0, 128.9, 127.2 (q, J = 285.2 Hz), 122.7, 115.3 (d, J = 21.3 Hz), 61.4 (q, 
J = 25.9 Hz), 33.7, 13.2; 19F NMR (376 MHz, CDCl3): δ –78.2 (s, 3F), –114.6 (s, 1F); HRMS 
(DART): Calcd for C12H14NF4 [M+H]+: 248.1057; Found: 248.1064; Specific rotation: [α]25.1D 
+14.6 (c 0.77, CHCl3) for a 97:3 e.r. sample. Enantiomeric purity was determined by HPLC 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 8.402 51.910 1 10.631 97.547 
2 9.401 48.090 2 11.843 2.453 
	
 Page 236 
analysis in comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 
0.7 mL/min, 220 nm): tR: 12.251 min (major) and 15.020 min (minor).  
 
(R,Z)-2-(4-Chlorophenyl)-1,1,1-trifluorohex-4-en-2-amine (2.103): Colorless oil, 22.9 mg, 
87% yield, 0.087 mmol; IR (neat): 3397 (w), 3025 (w), 2925 (w), 1597 (m), 1493 (m), 1525 (m), 
1148 (s), 1096 (s), 820 (m), 692 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.4 Hz, 
2H), 7.35 (d, J = 8.7 Hz, 2H), 5.61 (m, 1H), 5.14 (m, 1H), 2.83 (dd, J = 15.0, 6.9 Hz, 1H), 2.70 
(dd, J = 14.9, 7.6 Hz, 1H), 1.72 (s, 2H), 1.61 (ddt, J = 6.9, 2.0, 1.0 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 136.4, 134.3, 129.0, 128.6, 128.6, 127.1 (q, J = 143.5 Hz), 122.5, 61.5 (q, J = 26.3Hz), 
33.7, 13.3; 19F NMR (376 MHz, CDCl3): δ –78.0 (s, 3F); HRMS (DART): Calcd for 
C12H14NF3Cl [M+H]+: 264.0761; Found: 264.0760; Specific rotation: [α]24.3D +18.9 (c 2.1, 
CHCl3) for a 96:4 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AS-H, 98:2 hexanes:iPrOH, 0.5 mL/min, 
220 nm): tR: 17.953 min (major) and 23.319 min (minor). 
 
(R,Z)-2-(4-Bromophenyl)-1,1,1-trifluorohex-4-en-2-amine (2.104): Colorless oil, 20.6 mg, 
67% yield, 0.067 mmol; IR (neat): 3026 (w), 1591 (m), 1490 (m), 1250 (m), 1137 (s), 1010 (m), 
818 (m), 751 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.54–7.48 (m, 2H), 7.48–7.43 (m, 2H), 
5.61 (m, 1H), 5.24–4.99 (m, 1H), 2.83 (dd, J = 15.0, 6.9 Hz, 1H), 2.79–2.61 (m, 1H), 1.73 (s, 2H), 
1.61 (ddt, J = 6.8, 1.8, 0.9 Hz, 3H).; 13C NMR (100 MHz, CDCl3): δ 137.0, 131.6, 129.1, 129.0 
(q, J = 1.5 Hz), 127.01 (q, J = 285.4 Hz), 122.6, 122.5, 61.6 (q, J = 26.0 Hz), 33.6, 13.3; 19F NMR 
(376 MHz, CDCl3): δ –78.0 (s, 3F); HRMS (DART): Calcd for C12H14NF3Br [M+H]+: 308.0256; 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 11.846 49.040 1 12.251 97.134 
2 14.521 50.960 2 15.020 2.866 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 18.093 45.821 1 17.953 95.991 
2 23.274 54.179 2 23.319 4.009 
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Found: 308.0252; Specific rotation: [α]25.2D +31.0 (c 1.3, CHCl3) for a 98:2 e.r. sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 13.500 min (major) and 
18.184 min (minor). 
 
 
(R,Z)-1,1,1-Trifluoro-2-(4-(trifluoromethyl)phenyl)hex-4-en-2-amine (2.105): Colorless oil, 
18.1 mg, 61% yield, 0.061 mmol; IR (neat): 2939 (w), 1622 (m), 1325 (s), 1152 (s), 1070 (s), 
1018 (m), 834 (m), 733 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.82–7.69 (m, 2H), 7.64 (d, J 
= 8.3 Hz, 2H), 5.62 (m, 1H), 5.22–5.07 (m, 1H), 2.87 (dd, J = 15.0, 7.0 Hz, 1H), 2.73 (dd, J = 15.1, 
7.5 Hz, 1H), 1.77 (s, 2H), 1.61 (ddt, J = 6.9, 1.9, 0.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 
142.0, 130.5 (q, J = 32.6 Hz), 129.3, 127.6 (q, J = 1.7 Hz), 127.0, 125.4 (q, J = 3.8 Hz), 124.1, 
122.3 (q, J = 274 Hz), 61.9 (q, J = 26.1 Hz), 33.8, 13.3; 19F NMR (376 MHz, CDCl3): δ –62.8 (s, 
3F), –77.7 (s, 3F); HRMS (DART): Calcd for C13H14NF6 [M+H]+: 298.1025; Found: 298.1035; 
Specific rotation: [α]26.0D +19.9 (c 1.5, CHCl3) for a 97.5:2.5 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AD-H, 
99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 11.572 min (major) and 14.955 min (minor).  
 
(R,Z)-1,1,1-Trifluoro-2-(4-methoxyphenyl)hex-4-en-2-amine (2.106): Colorless oil, 20.2 mg, 
78% yield, 0.078 mmol; IR (neat): 2937 (w), 2839 (w), 1612 (m), 1515 (s), 1254 (s), 1149 (s), 
1035 (m), 829 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.58–7.38 (m, 2H), 7.03–6.81 (m, 2H), 
5.74–5.49 (m, 1H), 5.27–5.07 (m, 1H), 3.81 (s, 3H), 2.85 (dd, J = 15.0, 6.7 Hz, 1H), 2.70 (dd, J = 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 13.809 48.771 1 13.500 98.021 
2 18.422 51.229 2 18.184 1.979 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 11.607 49.194 1 11.572 97.672 
2 15.053 50.806 2 14.995 2.328 
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14.9, 7.7 Hz, 1H), 1.72 (s, 2H), 1.63 (ddt, J = 6.9, 1.9, 0.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): 
δ 159.4, 129.7 (br), 128.6, 128.4 (q, J = 1.3 Hz), 127.3 (q, J = 285 Hz), 123.1, 113.7, 61.2 (q, J = 
26.0 Hz ), 53.4, 35.6, 13.3; 19F NMR (376 MHz, CDCl3): δ –78.4 (s, 3F); HRMS (DART): Calcd 
for C13H17NOF3 [M+H]+: 260.1257; Found: 260.1261; Specific rotation: [α]24.2D +23.6 (c 1.3, 
CHCl3) for a 98:2 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 
220 nm): tR: 16.220 min (major) and 19.445 min (minor). 
 
(R,Z)-4-(2-Amino-1,1,1-trifluorohex-4-en-2-yl)-N,N-dimethylaniline (2.107): Pale yellow oil, 
13.6 mg, 50% yield, 0.050 mmol; IR (neat): 2890 (w), 1614 (m), 1523 (m), 1355 (m), 1139 (s), 
947 (m), 909 (m), 813 (m), 734 (m)  cm-1; 1H NMR (400 MHz, CDCl3): δ 7.52–7.25 (m, 2H), 
6.71 (d, J = 9.0 Hz, 2H), 5.74–5.46 (m, 1H), 5.34–4.99 (m, 1H), 2.96 (s, 6H), 2.90–2.77 (m, 1H), 
2.70 (dddd, J = 14.9, 7.8, 1.6, 0.8 Hz, 1H), 1.71 (s, 2H), 1.64 (dt, J = 6.9, 1.0 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 150.0, 128.2, 127.7, 127.3 (q, J = 285 Hz), 124.7, 123.3, 111.8, 60.9 (q, J 
= 25.7 Hz), 40.3, 33.2, 13.2; 19F NMR (376 MHz, CDCl3): δ –78.6 (s, 3F); HRMS (DART): 
Calcd for C14H20N2F3 [M+H]+: 273.1573; Found: 273.1580; Specific rotation: [α]24.2D +23.6 (c 
1.3, CHCl3) for a 96.5:3.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 
220 nm): tR: 13.506 min (major) and 14.847 min (minor). 
 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 15.924 48.768 1 16.200 97.996 
2 19.043 48.655 2 19.445 2.004 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 13.682 50.335 1 13.506 96.559 
2 14.940 49.665 2 14.847 3.441 
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(R,Z)-1,1,1-Trifluoro-2-(2-methoxyphenyl)hex-4-en-2-amine (2.108): Colorless oil, 18.1 mg, 
70% yield, 0.070 mmol; IR (neat): 2941 (w, br), 1601 (w), 1492 (m), 1244 (m), 1218 (s), 1026 
(m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.51 (td, J = 8.1, 1.8 Hz, 1H), 7.34 (dddd, J = 8.1, 7.3, 
4.8, 1.7 Hz, 1H), 7.17 (td, J = 7.7, 1.3 Hz, 1H), 7.07 (m, 1H), 5.69–5.55 (m, 1H), 5.23 (m, 1H), 
3.86 (s, 3H), 3.29–3.12 (m, 1H), 2.78–2.57 (m, 1H), 2.00 (s, 2H), 1.76–1.58 (m, 3H); 13C NMR 
(100 MHz, CDCl3): δ 159.2, 130.3, 129.9, 127.4 (q, J = 286.8 Hz), 127.9, 124.7, 124.2, 120.7, 
112.7, 62.6 (q, J = 26.6 Hz), 55.8, 32.3, 13.4; 19F NMR (376 MHz, CDCl3): δ –78.5 (s, 3F); 
HRMS (DART): Calcd for C12H14NF4 [M+H]+: 248.1057; Found: 248.1068; Specific rotation: 
[α]24.8D –4.2 (c 1.6, CHCl3) for a 99:1 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 




(R,Z)-1,1,1-Trifluoro-2-(2-fluorophenyl)hex-4-en-2-amine (2.109): Colorless oil, 22.0 mg, 
89% yield, 0.089 mmol; IR (neat): 3030 (w), 2158 (w), 1614 (m), 1489 (m), 1445 (m), 1221 (s), 
1151 (s), 759 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.51 (td, J = 8.1, 1.8 Hz, 1H), 7.34 (dddd, 
J = 8.1, 7.3, 4.8, 1.7 Hz, 1H), 7.17 (td, J = 7.7, 1.3 Hz, 1H), 7.07 (ddd, J = 13.0, 8.2, 1.3 Hz, 1H), 
5.69–5.55 (m, 1H), 5.23 (m, 1H), 3.29–3.12 (m, 1H), 2.78–2.57 (m, 1H), 2.00 (s, 2H), 1.76–1.58 
(m, 3H); 13C NMR (100 MHz, CDCl3): δ 161.6 (d, J = 249.5 Hz), 138.0 (d, J = 74.0 Hz), 130.6 
(d, J = 9.3 Hz), 130.2 (d, J = 3.8 Hz), 128.8, 126.9 (q, J = 286.1 Hz), 124.2 (d, J = 3.4 Hz), 123.1, 
117.0 (d, J = 25.4 Hz), 61.6 (q, J = 26.7 Hz), 32.0 (d, J = 5.7 Hz), 13.3; 19F NMR (376 MHz, 
CDCl3): δ –79.2 (d, J = 15.0 Hz, 3F), –108.7 (ddt, J = 26.5, 18.5, 9.4 Hz, 1F); HRMS (DART): 
Calcd for C12H14NF4 [M+H]+: 248.1057; Found: 248.1068; Specific rotation: [α]24.0D +16.0 (c 
1.4, CHCl3) for a 98.5:1.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis of 
the derived chloroacetamide in comparison with authentic racemic material (Chiralpak AD-H, 
99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 13.658 min (minor) and 15.671 min (major).  
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 13.047 50.536 1 12.692 99.258 
2 14.536 49.464 2 14.106 0.742 
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(R,Z)-2-(2-Chlorophenyl)-1,1,1-trifluorohex-4-en-2-amine (2.110): Colorless oil, 20.8 mg, 
79% yield, 0.079 mmol; IR (neat): 2981 (w), 2160 (w), 1429 (m), 1245 (m), 1153 (s), 1042 (m), 
755 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.75–7.48 (m, 1H), 7.47–7.36 (m, 1H), 7.32–7.23 
(m, 2H), 5.62 (m, 1H), 5.39–5.15 (m, 1H), 3.39 (ddt, J = 15.6, 6.5, 1.5 Hz, 1H), 2.93–2.69 (m, 
1H), 2.24 (s, 2H), 1.69 (ddt, J = 6.8, 1.9, 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 137.6, 
134.2, 132.6, 131.1 (q, J = 1.5 Hz), 130.48 (q, J = 156.6 Hz), 129.5, 128.6, 126.7, 123.1, 63.3 (q, 
J = 26.6 Hz), 32.6, 13.2; 19F NMR (376 MHz, CDCl3): δ –76.8 (s, 3F); HRMS (DART): Calcd 
for C12H14NF3Cl [M+H]+: 264.0761; Found: 264.0770; Specific rotation: [α]24.9D +7.4 (c 1.2, 
CHCl3) for a 96.5:3.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralcel OJ-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 
220 nm): tR: 10.447 min (minor) and 10.963 min (major).  
 
 
(Z)-2-(2-Bromophenyl)-1,1,1-trifluorohex-4-en-2-amine (2.111): Clear oil; IR (neat): 2984 
(w,), 1621 (w), 1464 (m), 1424 (m), 1244 (m), 1155 (s), 1019 (m), 755 (m) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.78 (d, J = 8.0 Hz, 1H), 7.67  7.66f (m, 1H), 7.64 – 7.60 (m, 1H), 7.33 (dtd, J = 
8.6, 7.3, 1.4 Hz, 2H), 7.16 (m, 1H, peaks overlapped with g-addition product), 5.75 – 5.56 (m, 1H), 
5.34 – 5.17 (m, 1H, peaks overlapped with g-addition product),), 3.38 (dd, J = 15.7, 6.5 Hz, 1H), 
2.84 (dd, J = 15.7, 7.4 Hz, 1H), 2.29 (s, 2H), 1.69 (ddt, J = 6.9, 2.0, 1.0 Hz, 3H); 13C NMR (100 
MHz, CDCl3): δ 137.8, 136.7, 131.5 (q, J = 1.9 Hz), 129.8, 128.7, 127.1 (q, J = 285 Hz), 127.3, 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 13.581 50.822 1 13.658 1.347 
2 15.698 49.178 2 15.671 98.563 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 10.784 49.945 1 10.447 3.427 
2 11.404 50.055 2 10.963 96.573 
	
 Page 241 
123.3, 117.7, 63.8 (q, J = 26.3 Hz), 32.9 (q, J =1.3 Hz), 13.4; 19F NMR (376 MHz, CDCl3): –76.1 
(s, 3F), –106.2 (m, 2F); HRMS (DART): Calcd for C12H14NF3Br [M+H]+: 308.0256; Found: 
308.0248; Specific rotation: [α]24.6D +1.5 (c = 1.1, CHCl3) for a 97:3 e.r. sample. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material (Chiralcel 
OZ-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 6.278 min (major) and 6.584 min (minor). 
	
 
(R,Z)-1,1,1-Trifluoro-2-(o-tolyl)hex-4-en-2-amine (2.112): Colorless oil, 12.7 mg, 52% yield, 
0.052 mmol; IR (neat): 3315 (w, br), 2956 (w), 1762 (m), 1449 (m), 1239 (s), 1151 (s), 989 (m), 
676 (s), 623 (s), 573 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.50 (m, 1H), 7.24–7.13 (m, 3H), 
5.75–5.46 (m, 1H), 5.33–5.06 (m, 1H, overlapped with g-addn product), 3.16 (dd, J = 15.8, 6.4 Hz, 
1H), 2.70 (dd, J = 15.7, 7.5 Hz, 1H), 2.64 (s, 3H), 1.81 (s, 2H, overlapped with g-addition product), 
1.68 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 138.2, 135.1, 133.7, 129.5, 128.5, 128.3,  127.6 (q, 
J = 286.1 Hz), 125.9, 123.6, 63.6 (q, J = 25.8 Hz), 34.0, 23.7, 13.4; 19F NMR (376 MHz, CDCl3): 
δ –77.4 (s, 3F); HRMS (DART): Calcd for C13H17NF3 [M+H]+: 244.1308; Found: 244.1319; 
Specific rotation: [α]26.0D +29.5 (c 1.48, CHCl3) for a 95.5:4.5 e.r. sample. Enantiomeric purity 
was determined by HPLC analysis in comparison with authentic racemic material (Chiralcel OJ-
H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 11.463 min (major) and 12.557 min (minor).  
  
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 6.360 48.648 1 6.278 92.634 
2 6.687 51.352 2 6.584 7.366 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 11.275 49.404 1 11.463 95.445 
2 12.122 50.596 2 12.527 4.555 
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(R,Z)-2-(3-Chlorophenyl)-1,1,1-trifluorohex-4-en-2-amine (2.113): Colorless oil, 23.7 mg, 
90% yield, 0.090 mmol; IR (neat): 2232 (w), 2032 (w), 1573 (m), 1251 (m), 1141 (s), 780 (s), 
700 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.60 (m, 1H), 7.47 (m, 1H), 7.36–7.29 (m, 2H), 
5.78–5.41 (m, 1H), 5.22–4.94 (m, 1H), 2.83 (dd, J = 14.9, 7.0 Hz, 1H), 2.71 (dddd, J = 14.9, 7.7, 
1.7, 0.9 Hz, 1H), 1.74 (s, 2H), 1.67–1.49 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 139.9, 134.4, 
129.5, 129.0, 128.3, 127.4 (q, J = 1.4 Hz), 126.8 (q, J = 285.5 Hz), 125.1 (q, J = 1.8 Hz), 122.3, 
61.6 (q, J = 26.0 Hz), 33.5, 13.1; 19F NMR (376 MHz, CDCl3): δ –77.8 (s, 3F); HRMS (DART): 
Calcd for C12H14NF3Cl [M+H]+: 264.0761; Found: 264.0770; Specific rotation: [α]24.9D +25.6 (c 
1.2, CHCl3) for a 96.5:3.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralcel OZ-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 
220 nm): tR: 7.991 min (major) and 8.728 min (minor).  
 
(R,Z)-1,1,1-Trifluoro-2-(3-(trifluoromethyl)phenyl)hex-4-en-2-amine (2.114): Colorless oil, 
24.4 mg, 82% yield, 0.082 mmol; IR (neat): 2926 (w), 1617 (m), 1444 (m), 1329 (s), 1129 (s), 
1079 (m), 802 (m), 703 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.61 (m, 1H), 7.50–7.42 (m, 
1H), 7.38–7.27 (m, 2H), 5.74–5.51 (m, 1H), 5.27–4.97 (m, 1H), 2.83 (dd, J = 14.9, 7.0 Hz, 1H), 
2.71 (dddd, J = 14.9, 7.7, 1.7, 0.9 Hz, 1H), 1.74 (s, 2H), 1.69–1.45 (m, 3H); 13C NMR (100 MHz, 
CDCl3): δ 139.1, 130.9 (q, J = 32.1 Hz), 130.6 (m), 129.3, 128.9, 126.9 (q, J = 269.2 Hz), 125.2 
(q, J = 3.8 Hz), 124.2 (q, J = 272.3 Hz), 124.1 (m), 122.2, 61.8 (q, J = 26.0 Hz), 33.8 (q, J =1.4 
Hz), 13.2; 19F NMR (376 MHz, CDCl3): δ –62.6 (s, 3F), –77.8 (s, 3F); HRMS (DART): Calcd 
for C13H14NF6 [M+H]+: 298.1025; Found: 298.1038; Specific rotation: [α]24.3D +20.9 (c 1.4, 
CHCl3) for a 98:2 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak OZ-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 
220 nm): tR: 7.816 min (major) and 8.668 min (minor).  
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 8.374 49.046 1 7.991 96.491 
2 9.219 50.954 2 8.728 3.509 
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(R,Z)-1,1,1-Trifluoro-2-(m-tolyl)hex-4-en-2-amine (2.115): Clear oil; IR (neat): 3397 (w), 3027 
(w), 2923 (w), 1608 (w), 1446 (m), 1252 (m), 1142 (s), 839 (s), 785 (s), 717 (s), 532 (m) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.40 – 7.31 (m, 2H), 7.26 (t, J = 7.6 Hz, 1H), 7.14 (d, J = 7.4 Hz, 
1H), 5.59 (dddd, J = 11.6, 8.6, 5.9, 3.5 Hz, 1H), 5.15 (q, J = 8.1 Hz, 1H), 2.79 (ddd, J = 56.1, 14.9, 
7.2 Hz, 2H), 2.37 (s, 3H), 1.73 (s, 2H), 1.68 – 1.55 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 
138.00, 137.68, 128.94, 128.66, 128.27, 127.71, 127.1 (q, J = 219.1 Hz), 124.12, 123.06, 61.55 (q, 
J = 27.7, 27.0 Hz), 33.64, 21.79, 13.28; 19F NMR (376 MHz, CDCl3): –77.9 (s, 3F); HRMS 
(DART): Calcd for C13H17NF3 [M+H]+: 244.1308; Found: 244.1303; Specific rotation: [α]24.3D 
+18.4 (c = 1.3, CHCl3) for a 96:4 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralpak OJ-H, 97:3 hexanes:iPrOH, 0.5 
mL/min, 220 nm): tR: 12.058 min (major) and 10.325 min (minor). 
	
 
(R,1E,5Z)-2-Methyl-1-phenyl-3-(trifluoromethyl)hepta-1,5-dien-3-amine (2.116): Colorless 
oil, 17.2 g, 64% yield, 0.064 mmol; IR (neat): 3024 (w), 2935 (w), 1444 (m), 1250 (m), 1147 (m), 
1003 (m), 700 (m) cm-1; 1H NMR (600 MHz, CDCl3): δ 7.34 (m, 2H), 7.26–7.22 (m, 3H), 6.90 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 7.492 50.801 1 7.816 97.904 
2 8.307 49.199 2 8.668 2.096 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 10.279 47.612 1 10.325 3.736 
2 12.126 52.388 2 12.058 96.264 
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(s, 1H), 5.78–5.62 (m, 1H), 5.37 (m, 1H), 2.71 (dd, J = 15.1, 6.7 Hz, 1H), 2.51 (dd, J = 15.1, 7.5 
Hz, 1H), 1.90 (t, J = 1.3 Hz, 3H), 1.71 (dt, J = 6.8, 1.1 Hz, 3H), 1.57 (s, 2H); 13C NMR (100 MHz, 
CDCl3): δ 137.7, 134.3, 129.8, 129.1, 128.2, 128.1, 127.3 (q, J = 286.8 Hz), 126.7, 122.9, 62.9 (q, 
J = 25.0 Hz), 30.9, 15.0, 13.2; 19F NMR (376 MHz, CDCl3): δ –76.8 (s, 3F); HRMS (DART): 
Calcd for C15H19NF3 [M+H]+: 270.1464; Found: 270.1474; Specific rotation: [α]24.8D +4.4 (c 0.9, 
CHCl3) for a 98.5:1.5 e.r. sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 
220 nm): tR: 8.587 min (minor) and 9.560 min (major). 
 
(R,Z)-1-Phenyl-3-(trifluoromethyl)hept-5-en-1-yn-3-amine (2.117): Colorless oil, 20.5 mg, 
81% yield, 0.081 mmol; IR (neat): 3026 (w), 1617 (m), 1436 (m), 1143 (s), 1052 (m), 832 (m), 
701 (s) cm-1; 1H NMR (600 MHz, CDCl3): δ 7.52–7.37 (m, 2H), 7.36–7.27 (m, 3H), 5.84 (dqt, J 
= 12.3, 6.8, 1.5 Hz, 1H), 5.68 (td, J = 9.0, 6.8 Hz, 1H), 2.63 (d, J = 7.4 Hz, 2H), 1.83 (s, 2H), 1.72 
(dq, J = 6.7, 0.9 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 140.8 (q, J = 15.1 Hz), 134.5, 132.3, 
131.5, 128.9 (q, J = 190.1 Hz), 125.1, 124.5, 88.5, 87.8, 59.2 (q, J = 29.1 Hz), 35.5, 15.8; 19F 
NMR (376 MHz, CDCl3): δ –80.5 (s, 3F); HRMS (DART): Calcd for C14H15NF3 [M+H]+: 
254.1151; Found: 254.1153; Specific rotation: [α]26.0D +11.4 (c 1.85, CHCl3) for a 96.5:3.5 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 8.366 min 
(major) and 8.950 min (minor). 
 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 8.659 50.025 1 8.587 1.602 
2 9.577 49.975 2 9.560 98.398 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 8.059 50.368 1 8.366 3.724 
2 8.428 49.632 2 8.950 96.276 
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(R,Z)-1,1,1-Trifluoro-2-(thiophen-2-yl)hex-4-en-2-amine (2.118): Pale yellow oil, 19.8 mg, 
84% yield, 0.084 mmol; IR (neat): 3026 (w), 1617 (m), 1436 (m), 1143 (s), 1052 (m), 832 (m), 
701 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.35–7.25 (m, 1H), 7.11 (m, 1H), 7.02 (dd, J = 5.1, 
3.7 Hz, 1H), 5.67 (m, 1H), 5.43–5.14 (m, 1H), 2.76 (d, J = 7.4 Hz, 2H), 1.91 (s, 2H), 1.72–1.31 
(m, 3H); 13C NMR (100 MHz, CDCl3): δ 143.1, 129.2, 127.2, 126.4 (q, J = 285.2 Hz), 125.5 (q, 
J = 1.4 Hz), 125.4, 122.3, 61.0 (q, J = 27.1 Hz), 34.7, 13.1; 19F NMR (376 MHz, CDCl3): δ –79.2 
(s, 3F); HRMS (DART): Calcd for C10H13NF3S [M+H]+: 236.0715; Found: 236.0717; Specific 
rotation: [α]26.0D –20.0 (c 0.5, CHCl3) for a 93:7 e.r. sample. Enantiomeric purity was determined 
by HPLC analysis in comparison with authentic racemic material (Chiralcel OJ-H, 99:1 
hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 14.853 min (minor) and 15.650 min (major). 
 
 
(R,Z)-2-(Benzofuran-2-yl)-1,1,1-trifluorohex-4-en-2-amine (2.119): Pale yellow oil, 20.7 mg, 
77% yield, 0.077 mmol; IR (neat): 3400 (w), 3025 (w), 1705 (w), 1473 (m), 1138 (s), 1004 (m), 
739 (s), 629 (m), 429 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.57 (ddd, J = 7.6, 1.5, 0.8 Hz, 
1H), 7.49 (dq, J = 8.2, 0.9 Hz, 1H), 7.30 (ddd, J = 8.3, 7.2, 1.5 Hz, 1H), 7.23 (dd, J = 7.4, 1.1 Hz, 
1H), 6.80 (d, J = 0.9 Hz, 1H), 5.67 (m, 1H), 5.33–5.17 (m, 1H), 2.95 (dd, J = 14.6, 6.6 Hz, 1H), 
2.79 (dd, J = 14.6, 8.2 Hz, 1H), 1.95 (s, 2H), 1.66 (ddt, J = 6.9, 1.9, 0.9 Hz, 3H); 13C NMR (125 
MHz, CDCl3): δ 155.0, 154.3, 129.5, 127.8, 124.6, 124.4 (q, J = 204.4 Hz), 123.0, 122.0, 121.2, 
111.4, 105.7, 60.2 (q, J = 22.6 Hz), 31.3, 13.1; 19F NMR (376 MHz, CDCl3): δ –78.7 (s, 3F); 
HRMS (DART): Calcd for C14H15NOF3 [M+H]+: 270.1100; Found: 270.1098; Specific rotation: 
[α]26.0D +37.9 (c 10.7, CHCl3) for a 97:3 e.r. sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 
0.7 mL/min, 220 nm): tR: 11.248 min (major) and 12.690 min (minor). 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 15.032 49.672 1 14.853 7.153 
2 16.051 50.328 2 15.650 92.847 
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 (R,Z)-1,1,1-Trifluoro-2-(furan-2-yl)hex-4-en-2-amine (2.120): Pale yellow oil, 7.0 mg, 32% 
yield, 0.032 mmol; IR (neat): 3999 (w, br), 3025 (w), 1759 (w), 1616 (m), 1257 (m), 1144 (s), 
1016 (m), 738 (s), 556 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.42 (s, 1H), 6.55 – 6.01 (m, 
2H), 5.81 – 5.58 (m, 1H), 5.35 – 5.10 (m, 1H), 2.82 (dd, J = 14.6, 6.6 Hz, 1H), 2.70 (dd, J = 14.4, 
8.1 Hz, 1H), 1.81 (s, 2H), 1.64 (dt, J = 6.9, 0.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 151.6, 
142.9, 129.4, 126.1 (q, J = 285.4 Hz), 122.4, 110.6, 108.8, 59.8 (q, J = 27.3 Hz), 31.4, 13.2; 19F 
NMR (376 MHz, CDCl3): δ –79.3 (s, 3F); HRMS (DART): Calcd for C10H13NOF3 [M+H]+: 
220.0944; Found: 220.0940; Specific rotation: [α]26.0D +27.9 (c 1.72, CHCl3) for a 97:3 e.r. 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralcel OJ-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 10.198 min 
(minor) and 10.820 min (minor). 
 
 
(R,Z)-1,1,1,2,2-Pentafluoro-3-(4-(trifluoromethyl)phenyl)hept-5-en-3-amine (2.121): Pale 
yellow oil; IR (neat): 3027 (w), 2919 (w), 1620 (m), 1324 (s), 1209 (m), 1164 (s), 1121 (s), 1069 
(m), 751 (m), 599 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.72–7.58 (m, 4H), 5.61 (dtd, J = 
12.0, 8.4, 7.8, 6.3 Hz, 1H), 4.97 (q, J = 8.6 Hz, 1H), 3.02–2.79 (m, 2H), 1.78 (s, 2H), 1.63 (ddt, J 
= 6.8, 1.7, 0.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 141.66, 130.50 (dd, J = 65.6, 32.8 Hz), 
129.71, 127.86, 125.30, 124.11 (q, J = 272.0 Hz), 122.05, 121.03 (t, J = 37.1 Hz), 115.99 (tq, J = 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 11.409 51.383 1 11.248 97.487 
2 12.894 48.617 2 12.690 2.513 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 10.281 49.800 1 10.198 3.064 
2 10.957 50.200 2 10.820 96.936 
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37.2 Hz, J = 33.6 Hz, J = 33.6 Hz, J = 36.8, 34.9 Hz), 61.70 (t, J = 21.3 Hz), 33.61, 13.35; 19F 
NMR (376 MHz, CDCl3): –62.7 (s, 3F), –77.0 (s, 3F), –120.1 (dd, J = 73.8 Hz, J  = 124.1 Hz, 
2F); HRMS (DART): Calcd for C14H14NF8 [M+H]+: 348.0993; Found: 348.1002; Specific 
rotation: [α]26.0D +13.9 (c = 2.75, CHCl3) for a 97:3 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralcel AD-H, 
97:3 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 6.673 min (minor) and 8.264 min (minor). 
	
 
In a N2-filled glovebox, a stock solution of ap-7 (3.5 mg, 0.01 mmol), Zn(OMe)2 (2.6 mg, 0.02 
mmol), and tol. (0.5 mL) was prepared. A separate oven-dried two-dram vial equipped with a 
magnetic stir-bar was charged with NTMS-ketimine (0.1 mmol), tol. (0.25 mL), tbat (2.7 mg, 
0.005 mmol) and MeOH (7 µL, 0.175 mmol), and was subsequently charged with the freshly 
prepared catalyst stock solution (0.25 mL) followed by (Z)-2-(3-Chloroallyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (26.3 mg, 0.13 mmol), and MeOH (7 µL, 0.175 mmol).  The mixture was 
allowed to stir for five min prior and then the vessel was capped, removed from the glovebox, and 
the solution was allowed to stir for 14 h at 22 °C.  Conversion and α:γ ratio were determined by 
spectroscopic analysis (19F NMR) of an aliquot sample.  The mixture was directly loaded onto 
silica gel and eluted with 100:0 → 3:1 hexanes:Et2O to afford the desired α-tertiary amine as 
colorless oil.   
(R,Z)-5-Chloro-1,1,1-trifluoro-2-phenylpent-4-en-2-amine (2.129): Colorless oil, 22.7 mg, 
91% yield, 0.091 mmol; IR (neat): 2924 (m), 2853 (m), 1630 (m), 1449 (m), 1255 (m), 1152 (s), 
756 (m) cm-1; 1H NMR (600 MHz, CDCl3): δ 7.60–7.52 (m, 2H), 7.45–7.32 (m, 3H), 6.10 (dt, J 
= 7.2, 1.7 Hz, 1H), 5.54 (q, J = 7.0 Hz, 1H), 3.11 (ddd, J = 15.5, 6.6, 1.8 Hz, 1H), 2.89 (ddd, J = 
15.5, 7.2, 1.7 Hz, 1H), 1.81 (s, 2H); 13C NMR (100 MHz, CDCl3): δ 136.6, 128.4, 128.3, 126.9 
(q, J = 285.4 Hz), 126.8, 125.0, 121.7, 61.2 (q, J = 26.2 Hz), 33.8; 19F NMR (564 MHz, CDCl3): 
δ –78.7 (s, 3F); HRMS (DART): Calcd for C11H12NF3Cl [M+H]+: 250.0605; Found: 250.0616; 
Specific rotation: [α]24.5D +4.1 (c 1.3, CHCl3) for a 88.5:11.5 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralcel OJ-H, 
99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 16.891 min (minor) and 18.316 min (major). 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 6.727 51.574 1 6.673 97.314 
2 8.374 48.425 2 8.264 2.686 
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In a N2-filled glovebox, a stock solution of aminophenol ap-7 (3.5 mg, 0.01 mmol), Zn(OMe)2 
(2.6 mg, 0.02 mmol), and toluene (0.5 mL) was prepared.  A separate oven-dried two-dram vial 
equipped with a magnetic stir-bar was charged with NTMS-ketimine (0.1 mmol), toluene (0.25 
mL), TBAT (2.7 mg, 0.005 mmol) and MeOH (7 µL, 0.175 mmol).   The freshly prepared catalyst 
stock solution (0.25 mL) was then added followed by (Z)-2-(3-Bromoallyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (32.1 mg, 0.13 mmol), and MeOH (7 µL, 0.175 mmol).  The mixture was 
allowed to stir for five minutes prior to being sealed with a Teflon cap, removed from the glovebox, 
and allowed to stir at 22 °C for 14 h.  Conversion and α:γ ratio were determined by 19F NMR of 
an aliquot.  The mixture was loaded onto silica gel and eluted with 100:0 → 3:1 hexanes:Et2O to 
afford the α-tertiary amine as colorless oil.   
 
(R,Z)-5-Bromo-2-(4-chlorophenyl)-1,1,1-trifluoropent-4-en-2-amine (2.130): Yellow oil, 24.3 
mg, 74 % yield, 0.074 mmol; IR (neat): 3402 (w), 3334 (w), 2926 (w), 1624 (w), 1494 (m), 1151 
(s), 1075 (m), 824 (m), 699 (m), 581 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 8.3 
Hz, 2H), 7.39–7.33 (m, 2H), 6.26 (dt, J = 7.3, 1.7 Hz, 1H), 5.86 (q, J = 6.9 Hz, 1H), 3.05 (dd, J = 
15.5, 6.7 Hz, 1H), 2.82 (ddd, J = 15.4, 6.8, 1.7 Hz, 1H), 1.79 (s, 2H); 13C NMR (100 MHz, 
CDCl3): δ 135.4, 134.7, 129.9, 128.6, 128.0, 126.8 (q, J = 285.8 Hz), 112.1, 62.1 (q, J = 26.4 Hz), 
36.6; 19F NMR (564 MHz, CDCl3): δ –78.8 (s, 3F); HRMS (DART): Calcd for C11H11NF3ClBr 
[M+H]+: 327.9710; Found: 327.9718; Specific rotation: [α]24.5D –3.5 (c 0.85, CHCl3) for a 92:8 
e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 12.760 min 
(major) and 17.991 min (minor). 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 16.724 49.341 1 16.891 11.552 
2 18.690 50.659 2 18.316 88.448 
	




Colorless oil, 27.5 mg, 76% yield, 0.076 mmol; IR (neat): 3401 (w), 2993 (w), 2855 (w), 1623 
(w), 1324 (s), 1253 (m), 1158 (s), 1125 (s), 735 (m), 625 (m) cm-1; 1H NMR (400 MHz, CDCl3): 
δ 7.72 (d, J = 8.4 Hz, 2H), 7.66 (d, J = 8.4 Hz, 2H), 6.27 (dt, J = 7.3, 1.7 Hz, 1H), 5.85 (q, J = 6.9 
Hz, 1H), 3.10 (ddd, J = 15.5, 6.8, 1.6 Hz, 1H), 2.85 (ddd, J = 15.5, 6.7, 1.7 Hz, 1H), 1.80 (s, 2H); 
13C NMR (100 MHz, CDCl3): δ 161.6 (d, J = 249.5 Hz), 130.6, 130.4 (q, J = 35.8 Hz), 128.8, 
126.9 (q, J = 286.1 Hz), 124.2 (q, J = 3.4 Hz), 123.1, 117.0 (q, J = 25.4 Hz), 61.6 (q, J = 26.7 Hz), 
32.0; 19F NMR (564 MHz, CDCl3): δ –62.41 to –63.28 (m, 3F), –78.13 to –78.89 (m, 3F); HRMS 
(DART): Calcd for C12H11NF6Br [M+H]+: 361.9974; Found: 361.9980; Specific rotation: [α]24.5D 
–6.2 (c 7.8, CHCl3) for a 93:7 e.r. sample. Enantiomeric purity was determined by HPLC analysis 
in comparison with authentic racemic material (Chiralcel OJ-H, 98:2 hexanes:iPrOH, 0.5 mL/min, 
220 nm): tR: 15.988 min (major) and 21.552 min (minor). 
	
 
In a N2-filled glovebox, a stock solution of ap-7 (3.5 mg, 0.01 mmol), Zn(OMe)2 (2.6 mg, 0.02 
mmol), and tol. (0.5 mL) was prepared. A separate oven-dried two-dram vial equipped with a 
magnetic stir-bar was charged with NTMS-ketimine (0.1 mmol), toluene (0.25 mL), and tbat (2.7 
mg, 0.005 mmol).  The freshly prepared catalyst stock solution (0.25 mL) was then added followed 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 12.689 46.147 1 12.760 89.499 
2 17.648 53.853 2 17.991 10.501 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 15.995 49.717 1 15.988 7.159 
2 22.075 50.283 2 21.552 92.841 
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by (Z)-1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)dec-2-en-5-one (34.6 mg, 0.13 mmol), and 
MeOH (14 µL, 0.35 mmol).  The mixture was allowed to stir for five min before the vial was 
capped, removed from the glovebox, and the mixture was allowed to stir for 3 h at 22 °C.   
Conversion and α:γ ratio were determined by spectroscopic analysis (19F NMR) of an aliquot 
sample. The mixture was loaded onto silica gel and eluted with 100:0 → 3:1 hexanes:Et2O to 
afford the expected α-tertiary amine as colorless oil.   
(R,Z)-1,1,1-Trifluoro-2-phenyldodec-4-en-2-amine (2.132): Colorless oil, 27.0 mg, 86% yield, 
0.086 mmol; IR (neat): 2925 (m), 2855 (m), 1449 (m), 1252 (m), 1147 (s), 763 (m), 699 (s) cm-1; 
1H NMR (400 MHz, CDCl3): δ 7.63–7.52 (m, 2H), 7.45–7.31 (m, 3H), 5.58–5.41 (m, 1H), 5.20–
5.01 (m, 1H), 2.88 (dd, J = 15.1, 6.9 Hz, 1H), 2.79–2.64 (m, 1H), 2.13–1.95 (m, 2H), 1.74 (s, 2H), 
1.38–1.18 (m, 10H), 1.00–0.76 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 137.8, 134.9, 128.4, 
128.2, 127.3 (q, J = 285.4 Hz), 127.1 127.0, 121.7, 61.6 (q, J = 25.8 Hz), 32.0, 29.6, 29.4, 29.3, 
27.7, 22.8, 14.2; 19F NMR (376 MHz, CDCl3): δ –78.0 (s, 3F); HRMS (DART): Calcd for 
C18H27NF3 [M+H]+: 314.2090; Found: 314.2091; Specific rotation: [α]24.7D +16.4 (c 0.9, CHCl3) 
for a 97:3 e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralcel OD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 6.114 
min (minor) and 6.741 min (major). 
 
 
In a N2-filled glovebox, a stock solution of aminophenol ap-7 (3.5 mg, 0.01 mmol), Zn(OMe)2 
(2.6 mg, 0.02 mmol), and tol. (0.5 mL) was prepared.  A separate oven-dried two-dram vial 
equipped with a magnetic stir-bar was charged with NTMS-ketimine (0.1 mmol), tol. (0.25 mL), 
and TBAT (2.7 mg, 0.005 mmol), which was charged with the freshly prepared catalyst stock 
solution (0.25 mL) followed by (Z)-4,4,5,5-tetramethyl-2-(2-methylhept-2-en-1-yl)-1,3,2-
dioxaborolane (31.0 mg, 0.13 mmol), and MeOH (14 µL, 0.35 mmol). The mixture was allowed 
to stir for five min after which the vial was capped, removed from the glovebox, and the mixture 
was allowed to stir for 3 h at 22 °C.  Conversion and α:γ ratio were determined by 19F NMR of an 
aliquot The mixture was loaded onto silica gel and eluted with 100:0 → 3:1 hexanes:Et2O to afford 
the α-tertiary amine as colorless oil.    
 (R,Z)-1,1,1-Trifluoro-4-methyl-2-phenylnon-4-en-2-amine (2.133): Colorless oil, 25.1 mg, 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 6.139 49.817 1 6.114 3.003 
2 6.742 50.183 2 6.741 96.997 
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88% yield, 0.088 mmol; IR (neat): 2955 (m), 2855 (m), 1603 (w), 1143 (s), 760 (m), 700 (s), 509 
(m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.58 (d, J = 7.6 Hz, 2H), 7.43–7.28 (m, 3H), 5.56–5.44 
(m, 1H), 5.11 (q, J = 7.8 Hz, 1H), 2.88 (dd, J = 14.9, 6.6 Hz, 1H), 2.77–2.66 (m, 1H), 2.02 (m, 
2H), 1.75 (s, 1H), 1.28 (d, J = 8.3 Hz, 7H), 0.93–0.84 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 
137.8, 134.9, 128.4, 128.2, 127.3 (q, J = 285.4 Hz), 127.1 (q, J = 1.5 Hz), 121.7, 61.6 (q, J = 25.9 
Hz), 34.0 (d, J = 1.4 Hz), 32.0, 29.6, 29.4, 29.3, 27.7, 22.8; 19F NMR (564 MHz, CDCl3): δ –78.0 
(s, 3F); HRMS (DART): Calcd for C16H23NF3 [M+H]+: 286.1777; Found: 286.1778; Specific 
rotation: [α]24.5D +34.7 (c 1.77, CHCl3) for a 88.5:11.5 e.r. sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralcel OJ-H, 
99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 16.891 min (minor) and 18.316 min (major). 
 
  
2.7.9 Functionalization of Olefins 
In a N2-filled glovebox, a stock solution of ap-7 (3.5 mg, 0.01 mmol), Zn(OMe)2 (2.6 mg, 0.02 
mmol), and tol. (0.5 mL) was prepared. A separate oven-dried two-dram vial equipped with a 
magnetic stir-bar was charged with imine (0.1 mmol), toluene (0.25 mL), tbat (2.7 mg, 0.005 
mmol) and MeOH (7 µL, 0.175 mmol), and was subsequently charged with the freshly prepared 
catalyst stock solution (0.25 mL) followed by (Z)-2-(3-Chloroallyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (26.3 mg, 0.13 mmol), and MeOH (7 µL, 0.175 mmol).  The mixture was allowed 
to stir for five min prior and then the vessel was capped, removed from the glovebox, and the 
solution was allowed to stir for 14 h at 22 °C.  Conversion and α:γ ratio were determined by 
spectroscopic analysis (19F NMR) of an aliquot sample.  The mixture was directly loaded onto 
silica gel and eluted with 100:0 → 3:1 hexanes:Et2O to afford the α-tertiary amine as colorless oil.   
(R,Z)-2-(4-Bromophenyl)-5-chloro-1,1,1-trifluoropent-4-en-2-amine (2.134): Colorless oil, 
25.0 mg, 76% yield, 0.076 mmol; IR (neat): 3402 (w), 3337 (w), 2917 (w), 2848 (w), 1719 (w), 
1488 (m), 1151 (s), 1075 (m), 1009 (m), 821 (m), 541 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 16.724 49.341 1 16.891 11.552 
2 18.690 50.659 2 18.316 88.448 
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7.57–7.48 (m, 2H), 7.44 (d, J = 8.4 Hz, 2H), 6.14–6.07 (m, 1H), 5.52 (q, J = 7.0 Hz, 1H), 3.06 
(ddd, J = 15.4, 6.9, 1.6 Hz, 1H), 2.89–2.79 (m, 1H), 1.79 (s, 2H); 13C NMR (100 MHz, CDCl3): 
δ 135.9, 131.9, 131.7, 130.2, 128.9, 126.8 (q, J = 285.5 Hz), 124.6, 122.2, 61.3 (q, J = 26.3 Hz); 
19F NMR (564 MHz, CDCl3): δ –79.0 (s, 3F); HRMS (DART): Calcd for C11H11NF3ClBr 
[M+H]+: 327.9710; Found: 327.9709; Specific rotation: [α]24.5D –1.3 (c 2.1, CHCl3) for a 92.5:7.5 
e.r. sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralcel AD-H, 99:1 hexanes:iPrOH, 0.7 mL/min, 220 nm): tR: 13.474 min 
(major) and 18.794 min (minor). 
 
 
(R,Z)-2-(4-Allylphenyl)-5-chloro-1,1,1-trifluoropent-4-en-2-amine (2.135): In a N2-filled 
glovebox, an oven-dried two-dram vial equipped with a stir bar was charged with amine Z-2.134 
(20.8 mg, 0.063 mmol), Pd(dppf)Cl2•CH2Cl2 (1.3 mg, 0.00158 mmol) and thf (0.62 mL).  The 
solution was stirred for five minutes at 22 °C, then allyl–B(pin) (47.3 µL, 0.252 mmol) and CsF 
(28.7 mg, 0.186 mmol) were added.  The vial was sealed with a Teflon septa cap and removed 
from the glovebox.  Water (0.6 mL) was added to the vial and the solution was allowed stir at 60 
°C for 14 h.  The solution was then allowed to cool to 22 °C, filtered through a small (~5 cm) plug 
of silica gel eluting with Et2O after which the volatiles were removed in vacuo to afford brown 
residue, which was purified by silica gel chromatography (gradient: 100:00 → 2:1 hexanes/Et2O) 
to afford 17 as colorless oil (26.9 mg, 93% yield, 0.059 mmol).  IR (neat): 3078 (m), 2921 (m), 
2851 (m), 1637 (w), 1149 (s), 915 (m), 804 (m), 721 (m), 527 (w) cm-1; 1H NMR (600 MHz, 
CDCl3): δ 7.48 (d, J = 8.1 Hz, 2H), 7.22 (d, J = 8.0 Hz, 2H), 6.10 (d, J = 7.3 Hz, 1H), 5.97 (dq, J 
= 15.8, 7.2 Hz, 1H), 5.55 (q, J = 7.1 Hz, 1H), 5.14–5.04 (m, 2H), 3.40 (d, J = 6.7 Hz, 2H), 3.08 
(dd, J = 15.5, 6.6 Hz, 1H), 2.87 (dd, J = 15.5, 7.1 Hz, 1H), 1.79 (s, 2H); 13C NMR (100 MHz, 
CDCl3): δ 140.5, 137.1, 135.1, 130.3, 128.1, 126.7 (q, J = 287.9 Hz), 125.2, 121.8, 116.3, 61.2 (q, 
J = 26.7 Hz), 39.8, 33.9; 19F NMR (376 MHz, CDCl3): δ –78.8 (s, 3F); HRMS (DART): Calcd 
for C14H16NF3Cl [M+H]+: 290.0918; Found: 290.0914; Specific rotation: [α]25.0D +0.8 (c 1.1, 
CHCl3). 
 
(R,4Z,6E)-1,1,1-Trifluoro-2-(4-(trifluoromethyl)phenyl)trideca-4,6-dien-2-amine (2.140): In 
Peak # Ret. Time (min) Area % Peak # Ret. Time (min) Area % 
1 13.584 49.330 1 13.474 92.554 
2 19.043 50.670 2 18.794 7.446 
	
 Page 253 
a N2-filled glovebox, an oven-dried two-dram vial equipped with a stir bar was charged with Z-
2.138 (20.9 mg, 0.058 mmol), 2.139 (16.5 mg, 0.69 mmol), and thf (0.53 mL).  The mixture was 
allowed to stir for five min at 22 °C after which ruphos–Pd-G3 (4.85 mg, 0.0058 mmol), ruPhos 
(2.71 mg, 0.0058 mmol), and K3PO4 (12.3 mg, 0.17 mmol) were added.  The vial was capped and 
removed from the glovebox, after which water (53 µL) was added, and the vial was wrapped in 
aluminum foil. The solution was then allowed stir for 14 h at 60 °C, after which it was allowed to 
cool to room temperature, and % conv determined by analysis of 1H and 19F NMR spectra.  
Removal of the volatiles in vacuo and purification of the orange oil by silica gel chromatography 
(elution with hexanes/Et2O) to afford 2.140 as yellow oil (12.2 mg, 54% yield, 0.031 mmol).  IR 
(neat): 2955 (m), 1621 (w), 1412 (w), 1325 (s), 1156 (s), 1125 (s), 1070 (s), 834 (m), 725 (w) cm-
1; 1H NMR (600 MHz, CDCl3): δ 7.74 (d, J = 8.3 Hz, 2H), 7.64 (d, J = 8.4 Hz, 2H), 6.34–6.14 
(m, 1H), 6.07 (dd, J = 11.8, 10.1 Hz, 1H), 5.73 (dt, J = 14.5, 7.0 Hz, 1H), 4.97 (q, J = 8.1 Hz, 1H), 
2.99 (dd, J = 15.1, 7.1 Hz, 1H), 2.86 (dd, J = 15.1, 7.9 Hz, 1H), 2.10 (q, J = 7.2 Hz, 2H), 1.78 (s, 
2H), 1.49–1.17 (m, 8H), 0.96–0.79 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 141.8, 138.0, 133.7, 
130.6 (q, J = 32.7 Hz), 127.7, 125.4, 125.4 (q, J = 286.4 Hz), 124.73, 124.3 (q, J = 221.6 Hz), 
120.2, 61.9 (q, J = 26.0 Hz), 34.4, 33.1, 31.9, 29.4, 29.1, 22.8, 14.2; 19F NMR (376 MHz, CDCl3): 
δ –62.8 (s, 3F), –77.7 (s, 3F); HRMS (DART): Calcd for C20H26NF6 [M+H]+: 394.1964; Found: 
394.1961; Specific rotation: [α]25.0D +16.0 (c 1.3, CHCl3). 
 
2.7.10  Directed Epoxidation/Ring-Opening  
This sequence was carried out based on a procedure by Davies.15 To a cooled (0 °C) solution of 
amine Z-2.69 (126.0 mg, 0.55 mmol) in CH2Cl2 (2.0 mL) was added trichloroacetic acid (220 µL, 
2.20 mmol) and the solution was allowed to stir for 30 min. The mixture was charged with m-cpba 
(188.7 mg, 0.82 mmol; single portion), after which it was allowed to warm to 22 °C, and stir for 
18 h. The solution was diluted with CH2Cl2 (7.0 mL), and the reaction was quenched by the 
addition of a saturated aqueous solution of NaHCO3 and Na2S2O3. The pH was adjusted to 8 by 
the addition of a saturated solution of aqueous NaHCO3. The aqueous layer was washed with 
CH2Cl2 (2 x 5.0 mL) and the combined organics were dried over Na2SO4 and concentrated to afford 
yellow residue which was purified by silica gel chromatography to afford the desired product as 
white solid. 
(2R,3R,5R)-5-Amino-6,6,6-trifluoro-3-hydroxy-5-phenylhexan-2-yl-2,2,2-trichloroacetate 
(2.147): IR (neat): 3386 (w), 1760 (m), 1263 (m), 1155 (m), 1040 (w), 733 (s), 701 (s), 620 (m), 
502 (m) cm-1; 1H NMR (600 MHz, CDCl3): δ 7.49 (d, J = 7.3 Hz, 2H), 7.45–7.33 (m, 3H), 4.94–
																																																								
15)  Bond, C. W.; Cresswell, A. G.; Davies, S. G.; Fletcher, A. M.; Kurosawa, W.; Lee, J. A.;  Roberts, P. M.; Russell, 
A. J.; Smith, A. D.; Thomson, J. E.  J. Org. Chem. 2009, 74, 6735–6748.   
	
 Page 254 
4.84 (m, 1H), 3.46 (dd, J = 10.8, 3.6 Hz, 1H), 2.30 (d, J = 1.5 Hz, 1H), 2.26 (d, J = 1.5 Hz, 1H), 
2.05 (dd, J = 14.2, 10.6 Hz, 2H), 1.36–1.28 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 166.1, 131.6, 
129.8, 129.5, 127.3 (q, J = 157.3 Hz), 126.3, 94.5, 72.0, 70.8, 64.0 (q, J =27.3 Hz), 35.2, 19.4; 19F 
NMR (376 MHz, CDCl3): δ –79.5 (s, 3F); HRMS (DART): Calcd for C14H16NO2F3Cl3 [M+H]+: 
408.0142; Found: 408.0137; Specific rotation: [α]25.0D +9.4 (c 13.4, CHCl3). 
Trichloroacetate cleavage (2.148): To a solution of 2.147 in MeOH (8.0 mL) was added granular 
K2CO3 (304 mg, 5.5 mmol).  The mixture was allowed to stir for 4 h at 22 °C, after which the 
volatiles were removed to ~10% of the original volume.  The resulting yellow oil was passed 
through a (~5 cm) plug of silica gel eluting with Et2O and then thoroughly flushed with EtOAc.  
The filtrate was concentrated, diluted with EtOAc, and dried over MgSO4. The solids were filtered 
off and the filtrate was concentrated to afford yellow oil (82.5 mg, 57% yield, 0.314 mmol). 
(2R,3R,5R)-5-Amino-6,6,6-trifluoro-5-phenylhexane-2,3-diol (2.158): IR (neat): 3526 (br), 
2920 (m), 1799 (m), 1763 (m), 1249 (s), 1153 (s), 644 (m) cm-1; 1H NMR (600 MHz, CDCl3): δ 
7.55–7.32 (m, 5H), 5.12 (br, 1H), 3.52 (p, J = 6.1 Hz, 1H), 3.11 (ddd, J = 10.6, 5.0, 1.8 Hz, 1H), 
2.38 (s, 1H), 2.22 (dd, J = 14.4, 1.8 Hz, 1H), 2.18 (s, 2H), 2.02 (dd, J = 14.4, 10.6 Hz, 1H), 1.07 
(d, J = 6.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 135.2, 129.0, 128.8, 126.6 (q, J = 286.8 Hz), 
126.3 (q, J = 1.7 Hz), 72.2, 70.7, 62.3 (q, J = 26.4 Hz), 37.1, 19.2; 19F NMR (376 MHz, CDCl3): 
δ –80.9 (s, 3F); HRMS (DART): Calcd for C12H17NO2F3 [M+H]+: 264.1206; Found: 264.1208; 
Specific rotation: [α]25.0D +21.8 (c 2.3, CHCl3). 
Acetonide Formation (S-1): To a solution of diol 2.158 (82.2 mg, 0.30 mmol) in CH2Cl2 (0.6 mL) 
was added trichloroacetic acid (120 µL, 1.20 mmol) and the solution was allowed to stir for 30 
min.  Dimethoxypropane (183 µL, 1.50 mmol) was then added followed by conc. H2SO4 (25 µL).  
The solution was allowed to stir for 12 h, and then allowed to cool to 0 °C, after which the reaction 
was quenched by the addition of a saturated aqueous solution of NaHCO3.  At this point, NaOH 
(1M, 0.1 mL) was added until pH was ~9.  The aqueous layer was washed with CH2Cl2 (2 x 5.0 
mL) and the combined organic layerss were washed with brine (5.0 mL), dried over Na2SO4, 
filtered and concentrated to afford yellow oil, which was purified by silica gel chromatography 
(gradient: 100:0 → 3:1 hexanes:Et2O) to afford the desired product as colorless oil (72.8 mg, 80% 
yield, 0.24 mmol). 
(R)-1,1,1-Trifluoro-2-phenyl-3-((4R,5R)-2,2,5-trimethyl-1,3-dioxolan-4-yl)propan-2-amine 
(S-1): IR (neat): 3413 (w), 2983 (w), 1616 (w), 1311 (m), 1148 (s), 1094 (s), 763 (m), 701 (s), 
577 (w) cm-1; 1H NMR (600 MHz, CDCl3): δ 7.57 (d, J = 7.7 Hz, 2H), 7.40 (m, 3H), 3.77–3.66 
(m, 1H), 3.18 (m, 1H), 2.42 (m, 1H), 2.12 (m, 3H), 2.08 (m, 1H), 1.37 (s, 3H), 1.25 (s, 3H), 1.10–
1.02 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 137.6, 128.6, 128.4, 128.2 (q, J = 181.1 Hz), 127.2, 
108.8, 78.4, 77.0, 61.8 (q, J =214.1 Hz), 38.0, 27.4, 27.3, 16.6; 19F NMR (376 MHz, CDCl3): δ 
–79.2 (s, 3F): HRMS (DART): Calcd for C15H21NO2F3 [M+H]+: 304.1519; Found: 304.1523; 
Specific rotation: [α]25.0D +32.6 (c 5.7, CHCl3).  
Amide Formation (2.149): To a solution of S-1 (22.5 mg, 0.074 mmol) in tol. (0.5 mL) was added 
dropwise chloroacetyl chloride (12.5 mg, 0.11 mmol), and the resulting solution was allowed to 
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heat to 100 °C in a sealed vial for 4 h.  The mixture was then allowed to cool to 22 °C, the volatiles 
were removed in vacuo, and the resulting brown residue was purified by silica gel chromatography 
(hexanes → 2:1 hexanes:Et2O) to afford 2.149 (19.0 mg, 68% yield, 0.50 mmol) as white solid. 
2-Chloro-N-((R)-1,1,1-trifluoro-2-phenyl-3-((4R,5R)-2,2,5-trimethyl-1,3-dioxolan-4-
yl)propan-2-yl)acetamide (2.149): White solid, m.p. = 129–131°C; IR (neat): 3321 (br), 2982 
(w), 1704 (m), 11542 (m), 1233 (s), 1165 (s), 1025 (m), 700 (m), 628 (w) cm-1; 1H NMR (600 
MHz, CDCl3): δ 8.30 (s, 1H), 7.38 (m, 5H), 4.18–4.05 (m, 2H), 3.80–3.69 (m, 1H), 3.21 (t, J = 
9.2 Hz, 1H), 2.30 (dd, J = 14.6, 9.8 Hz, 1H), 2.20 (d, J = 14.4 Hz, 1H), 1.43 (s, 3H), 1.37 (s, 3H), 
1.03 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.3, 134.1, 128.9, 128.7, 126.0, 124.8 
(q, J = 122.1 Hz), 109.4, 77.7, 77.3, 62.4 (q, J = 44.1 Hz), 43.0, 39.1, 27.4, 27.2, 16.5; 19F NMR 
(376 MHz, CDCl3): δ –68.5 (s, 3F); HRMS (DART): Calcd for C17H22NO3F3Cl [M+H]+: 
380.1223; Found: 380.1229; Specific rotation: [α]25.0D +21.5 (c 1.9, CHCl3). 
 
(2R,4R,5R)-2-Amino-1,1,1-trifluoro-4-hydroxy-4-methyl-2-phenylnonan-5-yl-2,2,2-
trichloroacetate (2.150 ) was synthesized according to the above procedure to afford the product 
as yellow oil (66.9 mg, 72% yield, 0.144 mmol).  IR (neat): 3383 (w), 2955 (m), 1761 (m), 1233 
(s), 1155 (s), 990 (m), 825 (s), 737 (s), 704 (s), 676 (s), 576 (w) cm-1; 1H NMR (600 MHz, CDCl3 
& CD2Cl2): δ 7.56–7.50 (m, 2H), 7.44–7.38 (m, 3H), 4.83 (dd, J = 10.7, 2.1 Hz, 1H), 2.38 (d, J = 
14.7 Hz, 1H), 2.22 (d, J = 14.6 Hz, 1H), 1.42–1.28 (m, 6H), 1.27 (s, 2H), 0.93–0.90 (m, 3H), 0.63 
(s, 3H); 13C NMR (100 MHz, Acetone-d6): δ 162.4, 138.1, 135.8, 129.7 (q, J = 93.9 Hz), 129.2, 
128.2, 88.2, 74.4, 62.9 (q, J = 25.6 Hz), 55.1, 38.1, 29.2, 29.2, 24.6, 23.1, 14.3; 19F NMR (376 
MHz, acetone-d6): δ –79.5 (s, 3F); HRMS (DART): Calcd for C18H24NO3F3Cl3 [M+H]+: 
464.0768; Found: 464.0774; Specific rotation: [α]25.0D +27.6 (c 7.3, CHCl3). 
 
2.7.11  Gram-Scale Enantioselective Formal Synthesis of Bace-1 Inhibitor 
In a N2-filled glovebox, an oven-dried vial containing a stir bar was charged with ap-7 (0.146 g, 
0.42 mmol) and Zn(OMe)2 (0.107 g, 0.84 mmol).  The solids were dissolved in tol. (42.0 mL) and 
the mixture was allowed to stir for 10 min, after which it was sequentially charged with NTMS-
ketimine 2.88j (2.21 g, 8.38 mmol), tbat (0.227 g, 0.42 mmol), Z-crotyl boronic pinacol ester (1.83 
g, 10.1 mmol) and MeOH (0.940 g, 29.3 mmol).  The solution was allowed to stir for five min in 
open vial and then the vial was capped and removed from the glovebox, after which the mixture 
was allowed to stir for three h at 22 °C. Reaction progress was monitored spectroscopically (19F 
NMR) of aliquot samples until >98% conv was reached. The volatiles were removed in vacuo to 
~50 % of original volume (rotary evaporator), the solution was diluted with tol. (10 mL), and the 
volatiles were removed to ~50% volume; the azeotrope was carried out a total of three times. 
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Toluene (5 mL) was added such that total volume was 20 mL and the resulting solution was 
allowed to cool to 0 °C (ice-bath).  Chloroacetyl chloride (1.0 mL, 12.6 mmol) was added 
dropwise, the ice-bath was removed, and the mixture was allowed to heat for four h to 100 °C.  
The mixture was allowed to cool to 22 °C, the volatiles were removed in vacuo, and the resulting 
brown residue was purified by silica gel chromatography (hexanes → 2:1 hexanes:Et2O) to afford 
white solid (1.86 g, 69% yield, 5.75 mmol). 
(R,Z)-2-Chloro-N-(1,1,1-trifluoro-2-(2-fluorophenyl)hex-4-en-2-yl)acetamide (2.124): White 
solid, M.p. = 88–90 °C; IR (neat): 3298 (m), 3078 (m), 1682 (s), 1528 (s), 1490 (m), 1327 (m), 
1227 (s), 759 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.43 (ddt, J = 8.4, 6.9, 1.3 Hz, 1H), 7.36 
(dddd, J = 8.2, 7.4, 4.8, 1.7 Hz, 1H), 7.24–7.21 (m, 1H), 7.18 (ddd, J = 8.0, 7.4, 1.4 Hz, 1H), 7.08 
(ddd, J = 13.1, 8.2, 1.4 Hz, 1H), 5.88–5.65 (m, 1H), 5.50–5.20 (m, 1H), 4.04 (s, 2H), 3.32–3.05 
(m, 2H), 1.70 (ddt, J = 7.0, 1.9, 0.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.8, 160.6 (d, J 
= 249.8 Hz), 130.7 (d, J = 9.5 Hz), 130.1, 128.9 (q, J = 88.9 Hz), 125.5 (q, J = 287.2 Hz), 124.4 
(d, J = 3.4 Hz), 122.6 (d, J = 8.6 Hz), 122.2 (d, J = 1.6 Hz), 117.1 (d, J = 24.4 Hz), 63.7 (q, J = 
27.7 Hz), 42.7, 31.4 (d, J = 3.4 Hz), 13.0; 19F NMR (376 MHz, CDCl3): δ –72.9 (d, J = 8.6 Hz, 
3F), –110.4 (dq, J = 13.6, 7.4 Hz, 1F); HRMS (DART): Calcd for C14H15NF4Cl [M+H]+: 
324.0773; Found: 324.0780; Specific rotation: [α]24.5D +14.7 (c 1.3, CHCl3) for a 97:3 e.r. sample. 
The oxidation and cyclization steps were carried out according to a reported procedure.16  An oven-
dried flask equipped with a stir bar was charged with 2.124 (1.86 g, 5.75 mmol) and NaHCO3 
(0.745 g, 8.60 mmol).  The solids were dissolved in CH2Cl2:MeOH (50.0:12.5 mL) and the 
resulting mixture was allowed to cool to –78 °C.  Ozone was then introduced until blue color 
persisted (after ~ 45 min); the mixture was then purged with a stream of oxygen. At this time, 
NaBH4 (435.1 mg, 11.5 mmol) was added (2 portions) and the solution was allowed to stir for 10 
min, before allowing it to warm to 0 °C.  The mixture was poured into a cold (0 °C) aqueous 
solution of 1M HCl (30 mL) and washed with Et2O (3 x 25 mL). The combined organic layers 
were dried over Na2SO4, filtered, and concentrated in vacuo to afford colorless oil.  
An oven-dried flask was charged with KOt-Bu (1.30 g, 11.6 mmol, 2.0 equiv.), t-BuOH (44 mL), 
and the solution was allowed to reach reflux (85 °C).  A solution of the aforementioned alcohol, 
dissolved in thf (35 mL), was added slowly (over ~5 min), and the mixture was allowed to stir at 
reflux (85 °C) for 14 h before it allowed to cool to 0 °C. At this time, the reaction was quenched 
by addition of an aqueous solution of 1 M HCl (25 mL). The mixture was diluted with EtOAc (50 
mL) and the organic layerss were washed with brine (50 mL), dried over MgSO4, and concentrated 
in vacuo to afford brown solid, which was purified by silica gel chromatography (100:0 → 1:2 
hexanes:EtOAc) to afford 2.125 as white solid (1.21 g, 76% over 2 steps, 4.36 mmol).  
(R)-5-(2-Fluorophenyl)-5-(trifluoromethyl)-1,4-oxazepan-3-one (2.125): White solid, m.p. = 
																																																								
16) Badiger, S.; Chebrolu, M.; Frederiksen, M.; Holzer, P.; Hurth, K.; Li, L.; Liu, H.; Lueoend, R.M.; Machauer, R.; 
Moebitz, H.; Meumann, U.; Ramos, R.; Rueeger, H.; Schaefer, M; Tintelnot-Blomley, M.; Veenstra, S. J.; Voegtle, 
M.; Xiong, X. PCT. Int. Appl. 2012006953. 
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129–131°C; IR (neat): 2953 (w), 2918 (w), 1628 (m), 1489 (m), 1247 (m), 1159 (s), 1009 (m), 
819 (m), 784 (m), 643 (w) cm-1; 1H NMR (600 MHz, CDCl3): δ 7.55 (td, J = 8.0, 1.8 Hz, 1H), 
7.44 (dddd, J = 8.2, 7.5, 4.8, 1.7 Hz, 1H), 7.29–7.24 (m, 1H), 7.14 (ddd, J = 12.5, 8.2, 1.3 Hz, 1H), 
6.47 (s, 1H), 4.13 (q, J = 16.9 Hz, 2H), 3.91 (dd, J = 12.2, 6.1 Hz, 1H), 3.79–3.67 (m, 1H), 3.11 
(dddt, J = 15.3, 4.6, 3.1, 1.6 Hz, 1H), 2.71 (tdd, J = 15.0, 6.2, 2.0 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δ 174.6, 159.7 (d, J = 248.9 Hz), 130.1 (d, J = 3.4 Hz), 126.4, 125.0 (d, J = 3.4 Hz), 123.6, 
121.7 (d, J = 12.0 Hz), 117.0 (d, J = 25.0 Hz), 70.0, 65.9, 63.7 (q, J =  28.9 Hz), 32.3 (d, J = 7.5 
Hz); 19F NMR (376 MHz, CDCl3): δ –79.9 (d, J = 16.1 Hz, 3F), –109.9 to –110.3 (m, 1F); HRMS 
(DART): Calcd for C12H12NO2F4 [M+H]+: 278.0799; Found: 278.0805; Specific rotation: [α]25.0D 
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2.7.12 DFT Calculations 
DFT calculations were performed with the Gaussian 09 suite of programs[17] employing ωB97XD 
the functional. The DEF2SVP[18] basis set and SMD[19] solvation model (toluene) was used for 
geometry optimization and frequency calculation. The nature of all stationary points was checked 
through vibrational analysis. 20 Single point electronic energy (DEsp) calculations applying the 
ωB97XD functional and the DEF2TZVPP basis set in solution with the SMD solvation model 
were performed on the geometries obtained with the DEF2SVP basis set. The single point 
electronic energies (DEsp) at the DEF2TZVPP level were corrected by addition of thermal 
corrections to the Gibbs free energy (DGcorr) obtained at the corresponding DEF2SVP level.  
 
Structure E [Hartree] DE 
[kcal/mol] 






Z-1 -1957.394992 0.00 -1957.503140 0.00 0.00 -
330.2836 
Z-2 -1957.396999 -1.2  -1957.501356 1.1 2.4 -
267.5422 
Z-3 -1957.381746 8.3 -1957.488634 9.1 0.8 -
281.9097 
Z-4 -1957.373275 13.6 -1957.481719 13.4 -0.2 -
376.1261 
E-1 -1957.385416 6.0 -1957.493726 5.9 -0.1 -
407.0333 
E-2 -1957.385751 5.8 -1957.492660 6.5 0.8 -
311.3443 
																																																								
17) Frisch, M. J.; Trucks, G. W.;  Schlegel, H. B.; Scuseria, G.E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; 
Barone, V.; Mennucci, B.; Petersson, G. A. Nakatsuji, H.; Caricato,  M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; 
Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; 
Nakajima, T.; Honda, Y. Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, Jr. J.A.; Peralta, J. E.; Ogliaro, F.; Bearpark, 
M.;  Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayshi, R.; Normand, J.; Raghavachari, K.; Rendell, 
A.; Burant, J. C.; Iyenger, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; 
Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, 
C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.;  Dannenberg, J. J.; 
Dapprich, S.; Daniels, A. D.; Farkas, Ö; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, Revision 
D.01, Gaussian, Inc., Wallingford CT, 2009. 
18) Weigend, F.; Ahlrichs, R, Phys. Chem. Chem. Phys. 2005, 7, 3297–3305. 
19) Marenich, A. V.; Cramer, C. J.; Truhlar, D. G.; J. Phys. Chem. B 2009, 113, 6378–6396. 
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E-3 -1957.381513 8.4 -1957.489439 8.6 0.1 -
337.9035 




Structure Esp [Hartree] DEsp [kcal/mol] DGsp [kcal/mol] 
Z-1 -1959.605548 0.00 0.00 
Z-2 -1959.605717 -0.10 2.3 
Z-3 -1959.591430 7.0 9.6 
Z-4 -1959.586339 12.1 11.9 
E-1 -1959.597046 5.3 5.2 
E-2 -1959.597235 5.2 6.0 
E-3 -1959.591440 8.9 7.1 






#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -3.054     3.708     0.445 
C    -3.882     3.001     1.319 
C    -1.801     3.235     0.044 
C    -1.377     2.004     0.602 
C    -3.475     1.766     1.797 
C    -2.222     1.259     1.443 
H    -4.128     1.178     2.447 
H    -3.415     4.658     0.054 
H    -4.853     3.412     1.602 
C    -0.953     3.978    -1.004 
C     0.434     4.342    -0.444 
H     0.345     4.939     0.477 
H     0.988     4.946    -1.180 
H     1.029     3.450    -0.219 
C    -0.805     3.075    -2.245 
H    -0.155     3.560    -2.992 
H    -1.784     2.904    -2.719 
H    -0.379     2.095    -1.994 
C    -1.621     5.286    -1.451 
H    -0.992     5.771    -2.213 
H    -1.737     6.000    -0.620 
H    -2.608     5.119    -1.907 
O    -0.159     1.522     0.278 
C    -1.824    -0.116     1.916 
N    -0.786    -0.702     1.013 
H    -1.430    -0.119     2.939 
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H    -2.701    -0.777     1.927 
B     0.405     0.379     0.922 
C    -1.469    -1.116    -0.269 
C    -0.544    -1.548    -1.420 
C    -2.368    -2.288     0.147 
N    -3.640    -2.287    -0.269 
C    -4.347    -1.200    -0.960 
C    -4.510    -3.436    -0.002 
C    -5.738    -3.153    -0.862 
H    -4.757    -3.477     1.072 
H    -3.993    -4.372    -0.256 
C    -5.812    -1.626    -0.874 
H    -4.012    -1.123    -2.007 
H    -4.165    -0.232    -0.470 
H    -6.409    -1.222    -1.702 
H    -6.253    -1.260     0.067 
H    -6.644    -3.629    -0.465 
H    -5.579    -3.534    -1.883 
C     1.019     0.840     2.497 
C     1.962    -0.172     2.909 
C     1.568     2.262     2.370 
H     0.754     2.976     2.199 
H     2.273     2.370     1.534 
H     2.092     2.557     3.291 
H     0.154     0.841     3.171 
H    -0.475    -1.588     1.429 
O    -0.072    -0.366    -2.015 
H    -2.039    -0.250    -0.624 
C     1.011    -0.510    -2.892 
H     1.828    -1.106    -2.445 
H     1.389     0.498    -3.115 
H     0.725    -0.979    -3.849 
N     1.651    -0.014     0.145 
C     2.734    -0.737     0.441 
C     3.998    -0.378    -0.277 
C     2.519    -2.236     0.727 
C     4.260     0.983    -0.514 
C     4.919    -1.330    -0.735 
C     5.395     1.379    -1.209 
C     6.056    -0.927    -1.432 
C     6.298     0.422    -1.673 
H     5.582     2.441    -1.377 
H     7.193     0.730    -2.217 
H     3.584     1.750    -0.127 
H     6.759    -1.683    -1.789 
H     4.766    -2.396    -0.572 
F     1.403    -2.469     1.424 
F     3.521    -2.798     1.385 
F     2.388    -2.882    -0.436 
H     1.840     0.724    -0.531 
H     1.576    -1.053     3.433 
C     3.272    -0.182     2.498 
H     3.952    -0.970     2.826 
H     3.746     0.741     2.161 
O    -1.874    -3.174     0.837 
C    -1.256    -2.442    -2.433 
H    -0.566    -2.695    -3.250 
H    -2.129    -1.937    -2.871 
H    -1.571    -3.391    -1.980 
H     0.295    -2.128    -1.002 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -330.2836                19.3703                33.4019 
 Red. masses --      7.9061                 4.5199                 4.7113 
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 Zero-point correction=                           0.738890 (Hartree/Particle) 
 Thermal correction to Energy=                    0.778062 
 Thermal correction to Enthalpy=                  0.779006 
 Thermal correction to Gibbs Free Energy=         0.669913 
 Sum of electronic and zero-point Energies=          -1957.434164 
 Sum of electronic and thermal Energies=             -1957.394992 
 Sum of electronic and thermal Enthalpies=           -1957.394047 
 Sum of electronic and thermal Free Energies=        -1957.503140 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.17305312', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 420.37710663 kcal/mol 
H_corr: 488.83405506 kcal/mol 
S_corr: 68.4570289 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.4137685 kcal/mol 
S_rot: 11.2450254 kcal/mol 






#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -4.737    -0.309    -1.648 
C    -4.408     0.382    -2.814 
C    -3.779    -0.690    -0.704 
C    -2.435    -0.361    -1.002 
C    -3.092     0.741    -3.052 
C    -2.096     0.376    -2.146 
H    -2.827     1.320    -3.941 
H    -5.785    -0.548    -1.476 
H    -5.191     0.658    -3.523 
C    -4.181    -1.376     0.615 
C    -3.513    -2.754     0.766 
H    -3.762    -3.412    -0.080 
H    -3.875    -3.244     1.684 
H    -2.422    -2.673     0.835 
C    -3.770    -0.471     1.790 
H    -4.003    -0.960     2.750 
H    -4.321     0.481     1.756 
H    -2.696    -0.249     1.765 
C    -5.698    -1.592     0.704 
H    -5.942    -2.054     1.673 
H    -6.070    -2.266    -0.083 
H    -6.256    -0.646     0.644 
O    -1.443    -0.745    -0.152 
C    -0.683     0.840    -2.419 
N     0.262     0.572    -1.285 
H    -0.267     0.346    -3.308 
H    -0.694     1.918    -2.612 
B    -0.115    -0.843    -0.654 
C     0.393     1.694    -0.299 
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C     1.218     2.824    -0.939 
C    -0.935     2.287     0.194 
N    -1.201     2.182     1.508 
C    -0.446     1.440     2.521 
C    -2.323     2.926     2.084 
C    -2.047     2.876     3.584 
H    -3.274     2.438     1.820 
H    -2.351     3.943     1.669 
C    -1.329     1.539     3.766 
H     0.535     1.916     2.697 
H    -0.277     0.400     2.206 
H    -0.745     1.477     4.694 
H    -2.059     0.716     3.772 
H    -2.966     2.958     4.180 
H    -1.384     3.707     3.875 
C     0.048    -2.087    -1.853 
C     1.467    -2.280    -2.063 
C    -0.747    -3.316    -1.417 
H    -1.821    -3.096    -1.416 
H    -0.481    -3.667    -0.410 
H    -0.576    -4.152    -2.113 
H    -0.410    -1.652    -2.752 
H     1.209     0.556    -1.694 
C     1.684     3.825     0.107 
H     0.973     1.279     0.529 
N     0.779    -1.344     0.481 
C     2.069    -1.638     0.442 
C     2.514    -2.671     1.498 
C     3.109    -0.588     0.155 
F     2.655    -2.069     2.680 
F     3.666    -3.235     1.185 
C     4.018    -0.594    -0.905 
C     3.225     0.408     1.139 
O     2.270     2.174    -1.614 
H     0.580     3.352    -1.673 
H     1.977    -1.589    -2.745 
C     2.226    -3.134    -1.314 
H     3.296    -3.254    -1.491 
H     1.746    -3.938    -0.752 
O    -1.640     2.919    -0.578 
F     1.593    -3.626     1.650 
C     5.010     0.381    -0.988 
C     4.225     1.371     1.059 
C     5.120     1.363    -0.008 
H     3.979    -1.361    -1.674 
H     5.907     2.117    -0.071 
H     5.712     0.359    -1.824 
H     4.309     2.128     1.841 
H     2.542     0.412     1.991 
H     0.229    -1.986     1.056 
C     3.078     2.984    -2.430 
H     3.696     2.320    -3.049 
H     3.748     3.630    -1.838 
H     2.466     3.622    -3.094 
H     0.823     4.255     0.639 
H     2.217     4.662    -0.363 
H     2.354     3.349     0.836 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -267.5422                32.3312                42.7069 
 Red. masses --      6.6424                 5.0313                 5.3424 
 Zero-point correction=                           0.740397 (Hartree/Particle) 
 Thermal correction to Energy=                    0.778891 
 Thermal correction to Enthalpy=                  0.779835 
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 Thermal correction to Gibbs Free Energy=         0.674534 
 Sum of electronic and zero-point Energies=          -1957.435493 
 Sum of electronic and thermal Energies=             -1957.396999 
 Sum of electronic and thermal Enthalpies=           -1957.396055 
 Sum of electronic and thermal Free Energies=        -1957.501356 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.17589022', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 423.27683034 kcal/mol 
H_corr: 489.35426085 kcal/mol 
S_corr: 66.0777919 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.4137685 kcal/mol 
S_rot: 11.1728731 kcal/mol 







#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -4.860    -0.325    -1.115 
C    -4.675     0.359    -2.317 
C    -3.792    -0.758    -0.325 
C    -2.492    -0.481    -0.812 
C    -3.393     0.647    -2.752 
C    -2.292     0.229    -2.002 
H    -3.232     1.210    -3.675 
H    -5.881    -0.522    -0.792 
H    -5.541     0.679    -2.900 
C    -4.023    -1.487     1.012 
C    -3.394    -2.891     0.988 
H    -3.806    -3.496     0.165 
H    -3.613    -3.416     1.931 
H    -2.305    -2.846     0.871 
C    -3.407    -0.657     2.151 
H    -3.553    -1.164     3.119 
H    -3.888     0.331     2.215 
H    -2.330    -0.510     2.000 
C    -5.518    -1.659     1.316 
H    -5.635    -2.173     2.282 
H    -6.029    -2.269     0.556 
H    -6.042    -0.694     1.395 
O    -1.413    -0.907    -0.102 
C    -0.912     0.576    -2.501 
N     0.142     0.418    -1.449 
H    -0.629    -0.059    -3.352 
H    -0.902     1.616    -2.846 
B    -0.116    -0.957    -0.672 
C     0.345     1.636    -0.593 
C     1.253     2.614    -1.356 
C    -0.950     2.359    -0.189 
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N    -1.292     2.323     1.111 
C    -0.530     1.729     2.214 
C    -2.448     3.086     1.584 
C    -2.162     3.280     3.069 
H    -3.371     2.509     1.408 
H    -2.534     4.024     1.020 
C    -1.386     2.018     3.449 
H     0.455     2.218     2.302 
H    -0.369     0.652     2.055 
H    -0.774     2.139     4.353 
H    -2.082     1.186     3.628 
H    -3.079     3.416     3.658 
H    -1.535     4.174     3.216 
C     0.080    -2.281    -1.822 
C     1.341    -2.978    -1.651 
C    -1.129    -3.213    -1.849 
H    -2.066    -2.672    -2.027 
H    -1.234    -3.752    -0.897 
H    -1.026    -3.963    -2.647 
H     0.154    -1.717    -2.767 
H     1.050     0.362    -1.935 
C     1.737     3.734    -0.450 
H     0.896     1.288     0.283 
N     0.863    -1.306     0.464 
C     2.177    -1.516     0.418 
C     2.659    -2.699     1.282 
C     3.152    -0.375     0.420 
F     2.760    -2.312     2.552 
F     3.841    -3.149     0.893 
C     4.335    -0.311    -0.323 
C     2.924     0.586     1.416 
O     2.293     1.809    -1.868 
H     0.680     3.055    -2.194 
C     2.551    -2.351    -1.667 
H     1.309    -4.028    -1.334 
O    -1.578     2.986    -1.029 
F     1.786    -3.709     1.241 
C     5.242     0.722    -0.110 
C     3.843     1.607     1.640 
C     5.000     1.686     0.868 
H     4.569    -1.062    -1.073 
H     5.722     2.487     1.039 
H     6.156     0.765    -0.706 
H     3.656     2.340     2.428 
H     2.038     0.504     2.046 
H     0.372    -2.053     0.961 
C     3.220     2.446    -2.712 
H     3.828     1.662    -3.181 
H     3.891     3.118    -2.153 
H     2.714     3.025    -3.505 
H     0.884     4.274    -0.015 
H     2.328     4.467    -1.015 
H     2.363     3.332     0.359 
H     2.631    -1.348    -2.096 
H     3.476    -2.919    -1.559 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -281.9097                33.6336                41.3204 
 Red. masses --      7.2842                 4.3910                 5.1218 
 Zero-point correction=                           0.738687 (Hartree/Particle) 
 Thermal correction to Energy=                    0.777897 
 Thermal correction to Enthalpy=                  0.778841 
 Thermal correction to Gibbs Free Energy=         0.671010 
 Sum of electronic and zero-point Energies=          -1957.420956 
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 Sum of electronic and thermal Energies=             -1957.381746 
 Sum of electronic and thermal Enthalpies=           -1957.380802 
 Sum of electronic and thermal Free Energies=        -1957.488634 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.15964342', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 421.0654851 kcal/mol 
H_corr: 488.73051591 kcal/mol 
S_corr: 67.6651425 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.4137685 kcal/mol 
S_rot: 11.17496015 kcal/mol 






#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -2.502     3.953    -0.132 
C    -3.499     3.452     0.703 
C    -1.252     3.342    -0.279 
C    -1.029     2.162     0.473 
C    -3.263     2.292     1.423 
C    -2.031     1.649     1.315 
H    -4.033     1.874     2.077 
H    -2.716     4.863    -0.690 
H    -4.457     3.969     0.782 
C    -0.168     3.963    -1.177 
C    -0.684     5.193    -1.939 
H    -1.529     4.950    -2.601 
H     0.125     5.585    -2.574 
H    -0.991     6.007    -1.266 
C     0.991     4.431    -0.279 
H     1.809     4.844    -0.890 
H     1.394     3.610     0.320 
H     0.649     5.220     0.409 
C     0.316     2.950    -2.230 
O     0.153     1.501     0.364 
C    -1.782     0.377     2.071 
N    -0.893    -0.523     1.266 
H    -1.310     0.557     3.044 
H    -2.724    -0.149     2.274 
B     0.480     0.292     1.028 
C    -1.719    -1.022     0.111 
C    -0.970    -1.534    -1.155 
C    -2.587    -2.132     0.731 
C     1.200     0.610     2.678 
C     2.451    -0.088     2.737 
C     1.250     2.128     2.871 
H     0.255     2.580     2.766 
H     1.906     2.617     2.140 
H     1.621     2.367     3.879 
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H     0.503     0.144     3.387 
H    -0.750    -1.378     1.833 
H    -2.329    -0.175    -0.220 
N     1.495    -0.606     0.335 
C     2.830    -0.458     0.210 
C     3.286     0.754    -0.625 
C     3.623    -1.704    -0.089 
N    -3.794    -2.369     0.215 
C    -4.504    -1.591    -0.812 
C    -4.603    -3.484     0.720 
C    -5.784    -3.532    -0.246 
H    -4.921    -3.273     1.754 
H    -4.008    -4.408     0.741 
C    -5.946    -2.073    -0.673 
H    -6.685    -3.953     0.219 
H    -5.533    -4.156    -1.119 
O    -2.111    -2.773     1.668 
H    -4.086    -1.811    -1.804 
H    -4.399    -0.510    -0.634 
H    -6.464    -1.502     0.114 
H    -6.511    -1.950    -1.606 
H    -0.494     2.716    -2.939 
H     0.666     2.015    -1.781 
H     1.149     3.379    -2.809 
C     3.602     0.296     2.085 
C    -0.628    -3.012    -1.112 
O    -1.794    -1.323    -2.269 
C    -1.722    -0.031    -2.815 
H    -2.471     0.032    -3.615 
H    -0.725     0.165    -3.246 
H    -1.941     0.758    -2.071 
H    -0.097    -3.286    -0.189 
H    -0.013    -3.280    -1.982 
H    -1.547    -3.615    -1.155 
H    -0.050    -0.938    -1.269 
H     1.289    -1.576     0.573 
F     4.607     0.896    -0.614 
F     2.760     1.902    -0.223 
F     2.905     0.547    -1.886 
C     4.993    -1.825     0.186 
C     2.981    -2.765    -0.744 
C     5.679    -2.992    -0.133 
C     3.669    -3.934    -1.061 
C     5.019    -4.055    -0.748 
H     1.940    -2.673    -1.048 
H     6.743    -3.068     0.100 
H     5.543    -1.008     0.651 
H     5.562    -4.970    -0.993 
H     3.145    -4.745    -1.570 
H     4.505    -0.295     2.234 
H     3.754     1.345     1.823 
H     2.431    -1.115     3.123 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -376.1261                19.1149                28.8033 
 Red. masses --      8.6408                 4.3568                 5.2319 
 Zero-point correction=                           0.738813 (Hartree/Particle) 
 Thermal correction to Energy=                    0.778079 
 Thermal correction to Enthalpy=                  0.779023 
 Thermal correction to Gibbs Free Energy=         0.669634 
 Sum of electronic and zero-point Energies=          -1957.412540 
 Sum of electronic and thermal Energies=             -1957.373275 
 Sum of electronic and thermal Enthalpies=           -1957.372330 
 Sum of electronic and thermal Free Energies=        -1957.481719 
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         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.15135309', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 420.20203134 kcal/mol 
H_corr: 488.84472273 kcal/mol 
S_corr: 68.64218005 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.4137685 kcal/mol 
S_rot: 11.26679035 kcal/mol 






#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -2.811     3.850     0.063 
C    -3.794     3.182     0.793 
C    -1.522     3.337    -0.112 
C    -1.243     2.097     0.508 
C    -3.506     1.952     1.366 
C    -2.229     1.404     1.231 
H    -4.271     1.406     1.925 
H    -3.071     4.807    -0.388 
H    -4.786     3.624     0.902 
C    -0.456     4.073    -0.944 
C     0.755     4.427    -0.060 
H     0.450     5.060     0.788 
H     1.498     4.991    -0.646 
H     1.245     3.530     0.340 
C    -0.015     3.183    -2.122 
H     0.761     3.695    -2.713 
H    -0.863     2.969    -2.791 
H     0.382     2.221    -1.777 
C    -0.999     5.385    -1.527 
H    -0.210     5.873    -2.119 
H    -1.305     6.095    -0.744 
H    -1.855     5.218    -2.199 
O    -0.006     1.572     0.385 
C    -1.907     0.065     1.841 
N    -0.868    -0.629     1.017 
H    -1.528     0.147     2.868 
H    -2.806    -0.563     1.890 
B     0.415     0.342     0.961 
C    -1.538    -1.064    -0.266 
C    -2.457    -2.212     0.171 
C     1.013     0.633     2.631 
C     2.446     0.663     2.555 
C     0.442     1.932     3.211 
H    -0.652     1.951     3.251 
H     0.756     2.798     2.612 
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H     0.805     2.082     4.238 
H    -0.628    -1.516     1.482 
N     1.585    -0.178     0.145 
C     2.679    -0.888     0.479 
C     3.930    -0.571    -0.282 
C     2.405    -2.370     0.786 
C     4.226     0.781    -0.517 
C     4.801    -1.550    -0.777 
C     5.351     1.148    -1.244 
C     5.929    -1.178    -1.506 
C     6.207     0.166    -1.744 
H     5.565     2.204    -1.413 
H     7.095     0.450    -2.313 
H     3.579     1.561    -0.107 
H     6.596    -1.951    -1.891 
H     4.613    -2.611    -0.617 
F     1.321    -2.513     1.557 
F     3.412    -2.991     1.383 
F     2.165    -3.016    -0.359 
H     1.802     0.551    -0.532 
C     3.248    -0.452     2.487 
H     4.331    -0.338     2.408 
H     2.900    -1.366     2.970 
H     2.904     1.636     2.333 
H     0.680    -0.269     3.174 
C    -0.612    -1.518    -1.403 
O    -1.989    -3.079     0.902 
N    -3.721    -2.211    -0.269 
C    -4.406    -1.142    -1.008 
C    -4.608    -3.340     0.028 
C    -5.879    -1.537    -0.903 
H    -4.073    -1.119    -2.058 
H    -4.205    -0.157    -0.564 
C    -5.833    -3.063    -0.839 
H    -4.854    -3.350     1.103 
H    -4.106    -4.290    -0.202 
H    -6.747    -3.509    -0.424 
H    -5.685    -3.482    -1.847 
H    -6.471    -1.150    -1.742 
H    -6.309    -1.130     0.026 
H    -2.093    -0.202    -0.648 
O    -0.158    -0.337    -2.019 
C     0.899    -0.498    -2.925 
H     1.690    -1.157    -2.523 
H     1.329     0.496    -3.113 
H     0.566    -0.907    -3.895 
C    -1.307    -2.446    -2.395 
H    -2.182    -1.965    -2.856 
H    -1.617    -3.384    -1.915 
H    -0.607    -2.717    -3.197 
H     0.236    -2.069    -0.970 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -407.0333                24.4120                33.2003 
 Red. masses --      8.4451                 4.7693                 5.1749 
 Zero-point correction=                           0.738241 (Hartree/Particle) 
 Thermal correction to Energy=                    0.777637 
 Thermal correction to Enthalpy=                  0.778581 
 Thermal correction to Gibbs Free Energy=         0.669326 
 Sum of electronic and zero-point Energies=          -1957.424812 
 Sum of electronic and thermal Energies=             -1957.385416 
 Sum of electronic and thermal Enthalpies=           -1957.384471 
 Sum of electronic and thermal Free Energies=        -1957.493726 
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         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.16305252', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 420.00875826 kcal/mol 
H_corr: 488.56736331 kcal/mol 
S_corr: 68.5583999 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.4137685 kcal/mol 
S_rot: 11.24711245 kcal/mol 






#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -0.533     4.437     0.384 
C    -1.754     4.337     1.049 
C     0.273     3.329     0.105 
C    -0.199     2.066     0.540 
C    -2.197     3.094     1.470 
C    -1.422     1.957     1.230 
H    -3.145     2.994     2.004 
H    -0.202     5.428     0.073 
H    -2.347     5.233     1.240 
C     1.604     3.487    -0.650 
C     1.469     2.797    -2.017 
H     1.253     1.731    -1.895 
H     2.406     2.894    -2.588 
H     0.661     3.259    -2.607 
C     1.949     4.962    -0.901 
H     2.911     5.022    -1.431 
H     2.056     5.529     0.037 
H     1.202     5.469    -1.530 
C     2.772     2.873     0.146 
H     3.718     3.038    -0.391 
H     2.652     1.793     0.285 
H     2.866     3.351     1.135 
O     0.541     0.956     0.288 
C    -1.885     0.646     1.809 
N    -1.281    -0.500     1.077 
H    -1.614     0.547     2.867 
H    -2.981     0.566     1.763 
B     0.324    -0.239     1.022 
C    -2.100    -0.707    -0.173 
C    -1.467    -1.570    -1.291 
C    -2.506    -2.211    -2.211 
C    -3.374    -1.386     0.346 
C     0.984    -0.114     2.668 
C     2.382    -0.498     2.587 
C     0.886     1.276     3.324 
H    -0.139     1.610     3.512 
H     1.374     2.040     2.702 
H     1.397     1.265     4.298 
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H     0.416    -0.871     3.238 
H    -1.483    -1.352     1.625 
O    -0.493    -0.849    -1.998 
H    -2.303     0.289    -0.584 
C    -0.926     0.204    -2.819 
H    -1.676    -0.118    -3.560 
H    -0.046     0.563    -3.367 
H    -1.331     1.056    -2.244 
H    -0.921    -2.400    -0.826 
H    -3.225    -1.494    -2.631 
H    -3.068    -2.990    -1.678 
H    -1.976    -2.694    -3.044 
N     0.929    -1.531     0.501 
C     2.221    -1.818     0.395 
C     3.145    -0.936    -0.386 
C     2.684    -0.533    -1.645 
C     4.457    -0.636    -0.003 
C     5.287     0.079    -0.861 
C     3.529     0.163    -2.506 
C     4.828     0.476    -2.116 
H     5.485     1.030    -2.789 
H     3.161     0.470    -3.487 
H     6.305     0.319    -0.547 
H     4.844    -0.948     0.966 
H     1.661    -0.778    -1.937 
C     2.504    -3.321     0.189 
F     1.660    -4.075     0.905 
F     2.313    -3.623    -1.092 
F     3.741    -3.654     0.514 
C     2.843    -1.783     2.500 
H     2.194    -2.615     2.784 
H     3.913    -1.994     2.498 
H     3.107     0.315     2.456 
N    -4.560    -0.968    -0.108 
C    -4.834     0.225    -0.921 
C    -5.785    -1.691     0.249 
C    -6.827    -1.094    -0.690 
H    -6.030    -1.511     1.309 
H    -5.635    -2.772     0.125 
C    -6.357     0.352    -0.850 
H    -7.846    -1.178    -0.291 
H    -6.801    -1.613    -1.661 
O    -3.236    -2.304     1.151 
H    -4.493     0.079    -1.959 
H    -4.324     1.111    -0.516 
H    -6.642     0.943     0.035 
H    -6.770     0.853    -1.735 
H     0.380    -2.347     0.766 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -311.3443                19.3548                33.5629 
 Red. masses --      7.8037                 4.9433                 4.9624 
 Zero-point correction=                           0.739347 (Hartree/Particle) 
 Thermal correction to Energy=                    0.778225 
 Thermal correction to Enthalpy=                  0.779169 
 Thermal correction to Gibbs Free Energy=         0.671316 
 Sum of electronic and zero-point Energies=          -1957.424628 
 Sum of electronic and thermal Energies=             -1957.385751 
 Sum of electronic and thermal Enthalpies=           -1957.384807 
 Sum of electronic and thermal Free Energies=        -1957.492660 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
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SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.16397592', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 421.25750316 kcal/mol 
H_corr: 488.93633919 kcal/mol 
S_corr: 67.67915555 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.4137685 kcal/mol 
S_rot: 11.23220495 kcal/mol 






#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -2.913     3.724    -0.269 
C    -3.903     3.086     0.477 
C    -1.604     3.243    -0.363 
C    -1.305     2.055     0.350 
C    -3.596     1.917     1.155 
C    -2.300     1.400     1.099 
H    -4.360     1.392     1.735 
H    -3.183     4.637    -0.799 
H    -4.911     3.503     0.519 
C    -0.532     3.985    -1.179 
C     0.553     4.509    -0.220 
H     0.125     5.232     0.493 
H     1.346     5.024    -0.785 
H     1.019     3.698     0.349 
C     0.079     3.045    -2.236 
H     0.836     3.586    -2.825 
H    -0.697     2.688    -2.931 
H     0.554     2.172    -1.778 
C    -1.115     5.194    -1.924 
H    -0.314     5.683    -2.499 
H    -1.530     5.950    -1.240 
H    -1.900     4.903    -2.639 
O    -0.053     1.553     0.291 
C    -1.977     0.116     1.814 
N    -0.933    -0.621     1.044 
H    -1.604     0.267     2.833 
H    -2.874    -0.513     1.898 
B     0.367     0.370     0.945 
C    -1.632    -1.202    -0.166 
C    -2.374    -2.417     0.412 
C     0.935     0.750     2.587 
C     2.379     0.881     2.562 
C     0.301     2.037     3.140 
H    -0.790     2.002     3.222 
H     0.547     2.892     2.495 
H     0.690     2.251     4.147 
H    -0.676    -1.456     1.592 
N     1.476    -0.498     0.342 
C     2.802    -0.363     0.318 
C     3.343     0.959    -0.266 
C     3.649    -1.573     0.023 
	
 Page 272 
C     3.267    -0.151     2.408 
H     4.341     0.045     2.438 
H     2.962    -1.181     2.612 
H     2.781     1.900     2.521 
H     0.650    -0.146     3.167 
C    -0.757    -1.634    -1.349 
O    -1.733    -3.167     1.146 
N    -3.662    -2.603     0.111 
C    -4.551    -1.704    -0.639 
C    -4.367    -3.793     0.602 
C    -5.942    -2.219    -0.279 
H    -4.363    -1.792    -1.721 
H    -4.398    -0.654    -0.350 
C    -5.720    -3.721    -0.100 
H    -4.465    -3.737     1.699 
H    -3.792    -4.701     0.370 
H    -6.515    -4.213     0.476 
H    -5.663    -4.216    -1.083 
H    -6.685    -1.973    -1.050 
H    -6.277    -1.768     0.668 
H    -2.301    -0.425    -0.549 
O    -0.240    -0.459    -1.896 
C     0.811    -0.614    -2.812 
H     1.604    -1.275    -2.416 
H     1.241     0.380    -2.989 
H     0.469    -1.018    -3.780 
C    -1.551    -2.441    -2.373 
H    -2.385    -1.846    -2.774 
H    -1.943    -3.375    -1.948 
H    -0.899    -2.719    -3.212 
H     0.054    -2.291    -0.978 
F     2.497     1.960    -0.090 
F     3.525     0.799    -1.575 
F     4.507     1.335     0.263 
C     3.059    -2.806    -0.294 
C     5.052    -1.504     0.061 
C     3.837    -3.929    -0.558 
C     5.828    -2.627    -0.208 
C     5.226    -3.845    -0.515 
H     5.556    -0.573     0.307 
H     5.837    -4.726    -0.724 
H     6.915    -2.544    -0.172 
H     1.978    -2.927    -0.373 
H     3.348    -4.873    -0.805 
H     1.232    -1.480     0.418 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -337.9035                26.1277                26.8952 
 Red. masses --      8.7865                 5.4981                 4.8441 
 Zero-point correction=                           0.738915 (Hartree/Particle) 
 Thermal correction to Energy=                    0.778117 
 Thermal correction to Enthalpy=                  0.779061 
 Thermal correction to Gibbs Free Energy=         0.670191 
 Sum of electronic and zero-point Energies=          -1957.420715 
 Sum of electronic and thermal Energies=             -1957.381513 
 Sum of electronic and thermal Enthalpies=           -1957.380569 
 Sum of electronic and thermal Free Energies=        -1957.489439 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.15963005', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
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G_corr: 420.55155441 kcal/mol 
H_corr: 488.86856811 kcal/mol 
S_corr: 68.31719655 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.4137685 kcal/mol 
S_rot: 11.2623181 kcal/mol 





#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -3.803    -2.984    -0.171 
C    -4.442    -2.039    -0.977 
C    -2.430    -2.949     0.089 
C    -1.698    -1.909    -0.525 
C    -3.705    -1.010    -1.545 
C    -2.329    -0.944    -1.328 
H    -4.192    -0.250    -2.163 
H    -4.412    -3.771     0.271 
H    -5.517    -2.109    -1.148 
C    -1.744    -3.972     1.012 
C    -0.662    -4.749     0.237 
H    -1.098    -5.272    -0.629 
H    -0.206    -5.509     0.890 
H     0.137    -4.090    -0.126 
C    -1.115    -3.239     2.213 
H    -0.611    -3.961     2.875 
H    -1.886    -2.721     2.804 
H    -0.384    -2.486     1.893 
C    -2.745    -4.997     1.562 
H    -2.217    -5.704     2.219 
H    -3.219    -5.586     0.762 
H    -3.538    -4.524     2.161 
O    -0.366    -1.836    -0.319 
C    -1.510     0.168    -1.922 
N    -0.386     0.520    -0.995 
H    -1.074    -0.097    -2.893 
H    -2.127     1.059    -2.092 
B     0.487    -0.816    -0.808 
C    -0.984     1.200     0.211 
C    -1.471     2.550    -0.330 
C     1.153    -1.322    -2.437 
C     2.512    -1.745    -2.259 
C     0.272    -2.413    -3.054 
H    -0.785    -2.133    -3.135 
H     0.310    -3.332    -2.451 
H     0.619    -2.658    -4.068 
H     0.162     1.270    -1.443 
N     1.697    -0.735     0.095 
C     2.927    -0.246    -0.126 
C     4.008    -0.988     0.682 
C     3.097     1.244    -0.279 
C     3.594    -0.916    -2.068 
H     1.116    -0.370    -2.997 
C    -0.039     1.374     1.409 
O    -0.735     3.167    -1.095 
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N    -2.675     2.991     0.050 
C    -3.698     2.268     0.817 
C    -3.142     4.310    -0.391 
C    -4.968     3.069     0.535 
H    -3.454     2.273     1.892 
H    -3.779     1.221     0.490 
C    -4.451     4.498     0.371 
H    -3.296     4.302    -1.483 
H    -2.385     5.076    -0.173 
H    -5.151     5.155    -0.162 
H    -4.255     4.947     1.357 
H    -5.712     2.960     1.336 
H    -5.429     2.719    -0.402 
H    -1.808     0.570     0.562 
O    -0.117     0.158     2.108 
C     0.829    -0.012     3.128 
H     1.834     0.315     2.811 
H     0.868    -1.083     3.371 
H     0.556     0.535     4.048 
C    -0.391     2.571     2.286 
H    -1.398     2.476     2.717 
H    -0.318     3.511     1.723 
H     0.328     2.641     3.114 
H     0.985     1.532     1.029 
F     3.902    -2.307     0.499 
F     3.859    -0.777     1.996 
F     5.232    -0.614     0.348 
C     3.733     1.963     0.744 
C     2.520     1.962    -1.335 
C     3.772     3.356     0.711 
C     2.550     3.352    -1.360 
C     3.176     4.056    -0.333 
H     2.053     1.441    -2.171 
H     4.273     3.893     1.519 
H     4.191     1.454     1.590 
H     3.204     5.147    -0.353 
H     2.078     3.884    -2.186 
H     4.578    -1.365    -1.917 
H     2.659    -2.812    -2.043 
H     3.605     0.082    -2.505 
H     1.717    -1.644     0.563 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -414.9864                24.6148                29.8483 
 Red. masses --      8.7179                 4.6219                 4.9298 
 Zero-point correction=                           0.738225 (Hartree/Particle) 
 Thermal correction to Energy=                    0.777667 
 Thermal correction to Enthalpy=                  0.778611 
 Thermal correction to Gibbs Free Energy=         0.669468 
 Sum of electronic and zero-point Energies=          -1957.418896 
 Sum of electronic and thermal Energies=             -1957.379454 
 Sum of electronic and thermal Enthalpies=           -1957.378510 
 Sum of electronic and thermal Free Energies=        -1957.487654 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1958.15712157', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 420.09786468 kcal/mol 
H_corr: 488.58618861 kcal/mol 
S_corr: 68.4886328 kcal/mol 
S_elec: 0.0 kcal/mol 
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S_trans: 13.4137685 kcal/mol 
S_rot: 11.22027895 kcal/mol 
S_vib: 43.8542872 kcal/mol 
----------------------------------------- 
2.7.13  Crystallographic Data 
 
 
Table S2. Crystal data and structure refinement for C17H21ClF3NO3 
Identification code  C17H21ClF3NO3 
Empirical formula  C17 H21 Cl F3 N O3 
Formula weight  379.80 
Temperature  173(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Tetragonal 
Space group  P43212 
Unit cell dimensions a = 9.6003(2) ≈ a= 90∞. 
 b = 9.6003(2) ≈ b= 90∞. 
 c = 41.0420(14) ≈ c = 90∞. 
Volume 3782.7(2) ≈3 
Z 8 
Density (calculated) 1.334 Mg/m3 
Absorption coefficient 2.191 mm-1 
F(000) 1584 
Crystal size 0.460 x 0.370 x 0.220 mm3 
Theta range for data collection 4.730 to 66.407∞. 
Index ranges -11<=h<=11, -10<=k<=11, -48<=l<=48 
Reflections collected 40047 
Independent reflections 3300 [R(int) = 0.0240] 
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Completeness to theta = 66.407∞ 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.6464 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3300 / 1 / 230 
Goodness-of-fit on F2 1.072 
Final R indices [I>2sigma(I)] R1 = 0.0298, wR2 = 0.0800 
R indices (all data) R1 = 0.0304, wR2 = 0.0806 
Absolute structure parameter 0.03(2) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.224 and -0.342 e.≈-3 
 
Table S3. Atomic coordinates (x104) and equivalent isotropic displacement parameters (≈2x103) 
for C17H21ClF3NO3. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Cl(1) 8272(1) -232(1) 6572(1) 75(1) 
F(1) 7089(2) 4861(2) 5913(1) 53(1) 
F(2) 8189(2) 6719(2) 6042(1) 53(1) 
F(3) 9301(2) 4970(2) 5852(1) 60(1) 
N(1) 8919(2) 3293(2) 6364(1) 30(1) 
O(1) 6881(2) 2306(2) 6199(1) 41(1) 
O(2) 10243(2) 3902(2) 6978(1) 39(1) 
O(3) 11605(2) 5220(2) 7316(1) 47(1) 
C(1) 8879(2) 843(2) 6254(1) 41(1) 
C(2) 8117(2) 2222(2) 6267(1) 32(1) 
C(3) 8503(2) 4743(2) 6398(1) 29(1) 
C(4) 9769(2) 5538(2) 6542(1) 32(1) 
C(5) 9993(2) 5331(2) 6904(1) 32(1) 
C(6) 10973(3) 3876(3) 7282(1) 45(1) 
C(7) 11304(2) 6026(3) 7032(1) 38(1) 
C(8) 11144(3) 7537(3) 7121(1) 54(1) 
C(9) 7234(2) 4944(2) 6620(1) 27(1) 
C(10) 6834(2) 3907(2) 6835(1) 33(1) 
C(11) 5765(2) 4126(3) 7055(1) 41(1) 
	
 Page 277 
C(12) 5086(2) 5388(3) 7067(1) 42(1) 
C(13) 5489(2) 6434(3) 6862(1) 42(1) 
C(14) 6553(2) 6222(2) 6637(1) 35(1) 
C(15) 8253(2) 5321(3) 6051(1) 40(1) 
C(16) 12072(4) 2763(4) 7257(1) 69(1) 
C(17) 9963(3) 3676(4) 7561(1) 76(1) 
________________________________________________________________________________  
 
Table S4. Bond lengths [≈] and angles [∞] for C17H21ClF3NO3 
_____________________________________________________  
Cl(1)-C(1)  1.762(3) 
F(1)-C(15)  1.328(3) 
F(2)-C(15)  1.344(3) 
F(3)-C(15)  1.338(3) 
N(1)-C(2)  1.344(3) 
N(1)-C(3)  1.455(3) 
N(1)-H(1N)  0.847(19) 
O(1)-C(2)  1.222(3) 
O(2)-C(5)  1.426(3) 
O(2)-C(6)  1.433(3) 
O(3)-C(7)  1.428(3) 
O(3)-C(6)  1.433(3) 
C(1)-C(2)  1.513(3) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(3)-C(9)  1.534(3) 
C(3)-C(15)  1.549(3) 
C(3)-C(4)  1.551(3) 
C(4)-C(5)  1.515(3) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(7)  1.519(3) 
C(5)-H(5A)  1.0000 
C(6)-C(16)  1.505(4) 
C(6)-C(17)  1.511(4) 
C(7)-C(8)  1.503(4) 
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C(7)-H(7)  1.0000 
C(8)-H(8A)  0.9800 
C(8)-H(8B)  0.9800 
C(8)-H(8C)  0.9800 
C(9)-C(10)  1.384(3) 
C(9)-C(14)  1.392(3) 
C(10)-C(11)  1.384(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.376(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.369(4) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.390(3) 
C(13)-H(13)  0.9500 
C(14)-H(14)  0.9500 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
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_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table S5. Anisotropic displacement parameters (≈2x 103) for C17H21ClF3NO3. The anisotropic 
displacement factor exponent takes the form: –2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Cl(1) 65(1)  53(1) 108(1)  26(1) 25(1)  11(1) 
F(1) 48(1)  68(1) 43(1)  14(1) -18(1)  -14(1) 
F(2) 61(1)  50(1) 49(1)  20(1) -4(1)  -9(1) 
F(3) 55(1)  90(1) 36(1)  8(1) 12(1)  3(1) 
N(1) 15(1)  37(1) 37(1)  -5(1) 0(1)  1(1) 
O(1) 21(1)  47(1) 55(1)  -6(1) -6(1)  -2(1) 
O(2) 38(1)  41(1) 38(1)  3(1) -9(1)  -6(1) 
O(3) 40(1)  59(1) 42(1)  -1(1) -12(1)  -9(1) 
C(1) 30(1)  39(1) 54(1)  -12(1) 4(1)  -1(1) 
C(2) 22(1)  39(1) 34(1)  -6(1) 3(1)  -3(1) 
C(3) 21(1)  33(1) 32(1)  2(1) 0(1)  -2(1) 
C(4) 22(1)  36(1) 38(1)  1(1) 1(1)  -6(1) 
C(5) 24(1)  36(1) 36(1)  -3(1) 2(1)  -4(1) 
C(6) 41(1)  56(2) 39(1)  6(1) -8(1)  -9(1) 
C(7) 28(1)  52(1) 36(1)  -4(1) -1(1)  -10(1) 
C(8) 61(2)  52(2) 51(1)  -11(1) -2(1)  -18(1) 
C(9) 18(1)  32(1) 31(1)  0(1) -3(1)  -1(1) 
C(10) 29(1)  34(1) 36(1)  3(1) 1(1)  3(1) 
C(11) 36(1)  53(1) 36(1)  5(1) 6(1)  1(1) 
C(12) 27(1)  66(2) 34(1)  -8(1) 1(1)  9(1) 
C(13) 32(1)  45(1) 47(1)  -12(1) -9(1)  13(1) 
C(14) 29(1)  33(1) 44(1)  4(1) -6(1)  2(1) 
C(15) 34(1)  50(1) 36(1)  6(1) 0(1)  -5(1) 
C(16) 66(2)  66(2) 75(2)  14(2) -25(2)  4(2) 
C(17) 70(2)  115(3) 42(1)  11(2) 1(1)  -34(2) 
______________________________________________________________________________  
 
Table S6. Hydrogen coordinates (x104) and isotropic displacement parameters (≈2x103) 
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for C17H21ClF3NO3 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1N) 9780(20) 3130(30) 6393(6) 36 
H(1A) 9893 999 6278 49 
H(1B) 8712 387 6042 49 
H(4A) 10619 5235 6425 39 
H(4B) 9644 6545 6499 39 
H(5A) 9162 5671 7027 38 
H(7) 12075 5917 6870 46 
H(8A) 10939 8078 6924 82 
H(8B) 10379 7641 7277 82 
H(8C) 12010 7876 7219 82 
H(10) 7300 3034 6832 39 
H(11) 5497 3400 7199 50 
H(12) 4344 5530 7217 51 
H(13) 5038 7314 6872 50 
H(14) 6818 6955 6495 42 
H(16A) 12594 2716 7462 103 
H(16B) 11628 1862 7215 103 
H(16C) 12710 2987 7078 103 
H(17A) 10477 3660 7767 114 
H(17B) 9293 4445 7563 114 
H(17C) 9466 2792 7533 114 
________________________________________________________________________________  
 
























































Symmetry transformations used to generate equivalent atoms:  
  
Table S8. Hydrogen bonds for C17H21ClF3NO3 [≈ and ∞] 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(1)#1 0.847(19) 2.10(2) 2.913(2) 161(2) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  





Table S9. Crystal data and structure refinement for C14 H14 Cl F4 N O 
Identification code  C14 H14 Cl F4 N O 
Empirical formula  C14 H14 Cl F4 N O 
Formula weight  323.71 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Tetragonal 
Space group  P43 
Unit cell dimensions a = 9.6746(3) Å a= 90°. 
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 b = 9.6746(3) Å b= 90°. 
 c = 15.2638(5) Å c = 90°. 
Volume 1428.66(10) Å3 
Z 4 
Density (calculated) 1.505 Mg/m3 
Absorption coefficient 2.793 mm-1 
F(000) 664 
Crystal size 0.250 x 0.100 x 0.100 mm3 
Theta range for data collection 7.093 to 66.613°. 
Index ranges -11<=h<=11, -10<=k<=8, -17<=l<=15 
Reflections collected 6738 
Independent reflections 2293 [R(int) = 0.0268] 
Completeness to theta = 67.679° 97.5 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2293 / 1 / 191 
Goodness-of-fit on F2 1.658 
Final R indices [I>2sigma(I)] R1 = 0.0245, wR2 = 0.0605 
R indices (all data) R1 = 0.0246, wR2 = 0.0607 
Absolute structure parameter 0.086(7) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.195 and -0.255 e.Å-3 
 
Table S10. Atomic coordinates (x104) and equivalent isotropic displacement parameters (Å2x103) 
for C14 H14 Cl F4 N O.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Cl(01) 7488(1) 3176(1) 3774(1) 38(1) 
F(002) 5562(1) 10537(1) 4621(1) 26(1) 
F(003) 4660(1) 9303(1) 3600(1) 27(1) 
F(004) 6834(1) 9762(1) 3573(1) 28(1) 
F(005) 5428(1) 9492(1) 6307(1) 27(1) 
O(001) 6791(2) 5391(1) 4992(1) 21(1) 
N(001) 6275(2) 7035(2) 3994(1) 15(1) 
C(001) 6601(2) 5744(2) 4232(1) 17(1) 
C(002) 7403(2) 8363(2) 5206(1) 18(1) 
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C(003) 4788(2) 7847(2) 5218(1) 18(1) 
C(004) 5780(2) 9442(2) 4105(1) 20(1) 
C(005) 6075(2) 8134(2) 4644(1) 17(1) 
C(006) 3785(2) 6893(2) 4953(1) 21(1) 
C(014) 4541(2) 8508(2) 6008(1) 21(1) 
C(007) 3413(2) 8235(2) 6535(1) 26(1) 
C(008) 9753(2) 8990(2) 4605(1) 23(1) 
C(009) 6704(2) 4743(2) 3463(1) 23(1) 
C(010) 9730(2) 10515(2) 4771(2) 29(1) 
C(011) 8758(2) 8073(2) 4758(1) 21(1) 
C(012) 2453(2) 7264(2) 6264(2) 27(1) 
C(013) 2634(2) 6600(2) 5464(2) 26(1) 
________________________________________________________________________________  
 
Table S11. Bond lengths [Å] and angles [°] for C14 H14 Cl F4 N O 
_____________________________________________________  
Cl(01)-C(009)  1.760(2) 
F(002)-C(004)  1.338(2) 
F(003)-C(004)  1.337(2) 
F(004)-C(004)  1.340(3) 
F(005)-C(014)  1.361(2) 
O(001)-C(001)  1.224(3) 
N(001)-C(001)  1.339(3) 
N(001)-C(005)  1.467(2) 
N(001)-H(007)  0.8800 
C(001)-C(009)  1.525(3) 
C(002)-C(011)  1.505(3) 
C(002)-C(005)  1.561(3) 
C(002)-H(00A)  0.9900 
C(002)-H(00B)  0.9900 
C(003)-C(014)  1.385(3) 
C(003)-C(006)  1.400(3) 
C(003)-C(005)  1.548(3) 
C(004)-C(005)  1.536(3) 
C(006)-C(013)  1.389(3) 
C(006)-H(00D)  0.9500 
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C(014)-C(007)  1.382(3) 
C(007)-C(012)  1.384(3) 
C(007)-H(00F)  0.9500 
C(008)-C(011)  1.330(3) 
C(008)-C(010)  1.497(3) 
C(008)-H(00G)  0.9500 
C(009)-H(00C)  0.9900 
C(009)-H(00E)  0.9900 
C(010)-H(00H)  0.9800 
C(010)-H(00I)  0.9800 
C(010)-H(00J)  0.9800 
C(011)-H(00K)  0.9500 
C(012)-C(013)  1.391(4) 
C(012)-H(00L)  0.9500 



































































Symmetry transformations used to generate equivalent atoms:  
 
Table S12. Anisotropic displacement parameters (Å2x103) for C14 H14 Cl F4 N O.  The anisotropic 
displacement factor exponent takes the form: –2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Cl(01) 59(1)  18(1) 37(1)  -2(1) -8(1)  14(1) 
F(002) 36(1)  15(1) 29(1)  -4(1) -2(1)  4(1) 
F(003) 32(1)  21(1) 29(1)  2(1) -12(1)  5(1) 
F(004) 33(1)  24(1) 27(1)  8(1) 6(1)  2(1) 
F(005) 23(1)  32(1) 27(1)  -13(1) 2(1)  -7(1) 
O(001) 25(1)  19(1) 18(1)  3(1) -3(1)  -1(1) 
N(001) 20(1)  14(1) 13(1)  1(1) -1(1)  1(1) 
C(001) 14(1)  18(1) 19(1)  1(1) 0(1)  -2(1) 
C(002) 17(1)  20(1) 18(1)  1(1) -1(1)  -2(1) 
C(003) 17(1)  17(1) 20(1)  1(1) -2(1)  3(1) 
C(004) 21(1)  17(1) 22(1)  -1(1) 0(1)  1(1) 
C(005) 18(1)  15(1) 17(1)  -1(1) -1(1)  1(1) 
C(006) 20(1)  22(1) 22(1)  -3(1) -3(1)  1(1) 
C(014) 18(1)  22(1) 23(1)  -1(1) -3(1)  -1(1) 
C(007) 22(1)  31(1) 25(1)  -5(1) 3(1)  3(1) 
C(008) 18(1)  28(1) 22(1)  -4(1) 1(1)  -1(1) 
C(009) 28(1)  18(1) 22(1)  -1(1) 0(1)  2(1) 
C(010) 30(1)  27(1) 30(1)  -1(1) 4(1)  -9(1) 
C(011) 20(1)  20(1) 23(1)  -3(1) -1(1)  2(1) 
C(012) 18(1)  32(1) 32(1)  1(1) 7(1)  0(1) 
C(013) 19(1)  24(1) 34(1)  -3(1) -2(1)  -2(1) 
______________________________________________________________________________  
 
Table S13. Hydrogen coordinates (x104) and isotropic displacement parameters (Å2x103) 
	
 Page 290 
for C14 H14 Cl F4 N O 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(007) 6178 7230 3434 18 
H(00A) 7411 9335 5409 22 
H(00B) 7341 7769 5732 22 
H(00D) 3894 6432 4408 25 
H(00F) 3297 8707 7076 31 
H(00G) 10582 8633 4360 27 
H(00C) 7251 5175 2988 27 
H(00E) 5766 4554 3233 27 
H(00H) 8866 10764 5067 43 
H(00I) 9792 11009 4212 43 
H(00J) 10516 10769 5142 43 
H(00K) 8917 7151 4568 25 
H(00L) 1678 7052 6622 33 
H(00M) 1969 5947 5267 31 
________________________________________________________________________________  
 











































Symmetry transformations used to generate equivalent atoms:  
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Table S15. Crystal data and structure refinement for C14H15ClF3NO 
Identification code  C14H15ClF3NO 
Empirical formula  C14 H15 Cl F3 N O 
Formula weight  305.72 
Temperature  100(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 9.1349(4) ≈ a= 90∞. 
 b = 9.3369(4) ≈ b= 90∞. 
 c = 17.2799(7) ≈ g = 90∞. 
Volume 1473.83(11) ≈3 
Z 4 
Density (calculated) 1.378 Mg/m3 
Absorption coefficient 2.573 mm-1 
F(000) 632 
Crystal size 0.600 x 0.380 x 0.260 mm3 
Theta range for data collection 5.385 to 69.524∞. 
Index ranges -11<=h<=11, -11<=k<=11, -21<=l<=20 
Reflections collected 18445 
Independent reflections 2753 [R(int) = 0.0258] 
Completeness to theta = 67.679∞ 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7532 and 0.6007 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2753 / 1 / 186 
Goodness-of-fit on F2 1.088 
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Final R indices [I>2sigma(I)] R1 = 0.0238, wR2 = 0.0626 
R indices (all data) R1 = 0.0238, wR2 = 0.0626 
Absolute structure parameter 0.011(4) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.226 and -0.262 e.≈-3 
 
Table S16. Atomic coordinates (x104) and equivalent isotropic displacement parameters (≈2x103) 
for C14H15ClF3NO.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Cl(1) 2344(1) 5556(1) 7013(1) 30(1) 
F(1) 7180(1) 3967(1) 5982(1) 26(1) 
F(2) 8341(1) 3366(1) 7011(1) 24(1) 
F(3) 9340(1) 4806(1) 6199(1) 26(1) 
O(1) 5285(1) 7473(1) 7680(1) 19(1) 
N(1) 5922(2) 5311(2) 7188(1) 14(1) 
C(1) 7261(5) 7188(3) 9303(1) 60(1) 
C(2) 7551(3) 5679(2) 9063(1) 31(1) 
C(3) 8000(2) 5223(2) 8379(1) 21(1) 
C(4) 8336(2) 6141(2) 7684(1) 18(1) 
C(5) 7395(2) 5764(2) 6957(1) 14(1) 
C(6) 5015(2) 6204(2) 7559(1) 15(1) 
C(7) 3585(2) 5538(2) 7814(1) 19(1) 
C(8) 8066(2) 4474(2) 6537(1) 18(1) 
C(9) 7335(2) 6991(2) 6364(1) 16(1) 
C(10) 8519(2) 7922(2) 6283(1) 20(1) 
C(11) 8491(2) 8990(2) 5719(1) 24(1) 
C(12) 7297(3) 9138(2) 5242(1) 28(1) 
C(13) 6111(3) 8217(2) 5322(1) 30(1) 
C(14) 6131(2) 7142(2) 5879(1) 23(1) 
________________________________________________________________________________  
 
Table S17. Bond lengths [≈] and angles [∞] for C14H15ClF3NO 
_____________________________________________________  
Cl(1)-C(7)  1.789(2) 
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F(1)-C(8)  1.341(2) 
F(2)-C(8)  1.344(2) 
F(3)-C(8)  1.339(2) 
O(1)-C(6)  1.228(2) 
N(1)-C(6)  1.339(2) 
N(1)-C(5)  1.465(2) 
N(1)-H(1N)  0.864(19) 
C(1)-C(2)  1.492(3) 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(2)-C(3)  1.322(3) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.507(3) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.562(2) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(8)  1.534(2) 
C(5)-C(9)  1.538(2) 
C(6)-C(7)  1.513(3) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(9)-C(14)  1.390(3) 
C(9)-C(10)  1.395(3) 
C(10)-C(11)  1.394(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.375(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.390(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.391(3) 
C(13)-H(13)  0.9500 



































































Symmetry transformations used to generate equivalent atoms:  
  
 
Table S18. Anisotropic displacement parameters (≈2x103) for C14H15ClF3NO.  The anisotropic 
displacement factor exponent takes the form: –2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Cl(1) 18(1)  32(1) 41(1)  -14(1) -3(1)  0(1) 
F(1) 32(1)  23(1) 22(1)  -10(1) 2(1)  -1(1) 
F(2) 28(1)  13(1) 29(1)  2(1) 6(1)  5(1) 
F(3) 22(1)  21(1) 35(1)  -1(1) 15(1)  1(1) 
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O(1) 20(1)  11(1) 25(1)  -1(1) 5(1)  0(1) 
N(1) 14(1)  9(1) 17(1)  2(1) 2(1)  -2(1) 
C(1) 136(3)  26(1) 19(1)  2(1) 8(2)  11(2) 
C(2) 51(1)  21(1) 19(1)  5(1) -3(1)  1(1) 
C(3) 25(1)  18(1) 21(1)  2(1) -5(1)  4(1) 
C(4) 16(1)  19(1) 19(1)  -1(1) -2(1)  -1(1) 
C(5) 14(1)  14(1) 16(1)  -1(1) 2(1)  -1(1) 
C(6) 17(1)  12(1) 15(1)  2(1) 1(1)  2(1) 
C(7) 18(1)  13(1) 26(1)  0(1) 4(1)  0(1) 
C(8) 19(1)  16(1) 21(1)  -1(1) 5(1)  -1(1) 
C(9) 21(1)  13(1) 14(1)  -2(1) 4(1)  -1(1) 
C(10) 21(1)  17(1) 21(1)  -2(1) 6(1)  -1(1) 
C(11) 30(1)  18(1) 26(1)  1(1) 12(1)  -5(1) 
C(12) 50(1)  18(1) 17(1)  4(1) 3(1)  -4(1) 
C(13) 43(1)  25(1) 21(1)  4(1) -11(1)  -4(1) 
C(14) 28(1)  19(1) 20(1)  2(1) -4(1)  -6(1) 
______________________________________________________________________________  
 
Table S19. Hydrogen coordinates (x104) and isotropic displacement parameters (≈2x 103) 
for C14H15ClF3NO 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1N) 5700(30) 4410(20) 7198(13) 18(6) 
H(1A) 7336 7819 8852 90 
H(1B) 7982 7478 9693 90 
H(1C) 6274 7257 9523 90 
H(2) 7395 4964 9445 37 
H(3) 8124 4219 8319 26 
H(4A) 9384 6032 7551 21 
H(4B) 8167 7158 7821 21 
H(7A) 3167 6087 8251 23 
H(7B) 3752 4541 7988 23 
H(10) 9345 7828 6613 24 
H(11) 9303 9618 5665 29 
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H(12) 7282 9867 4859 34 
H(13) 5283 8323 4994 36 
H(14) 5320 6512 5929 27 
________________________________________________________________________________  
 












































Table S21.  Hydrogen bonds for C14H15ClF3NO [≈ and ∞]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(1)#1 0.864(19) 2.03(2) 2.879(2) 166(2) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  





2.7.14  NMR Spectra 
NMR spectra appear on the following pages: 
  
	



























































































































































































































13C NMR (CDCl3, 100 MHz)  
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1H NMR (CDCl3, 400 MHz)  
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Catalytic, Enantioselective Addition of Terminally Substituted Allyl 
Boronates to Aldehydes 
3.1  Introduction 
Homoallylic alcohols and their derivatives are ubiquitous motifs in polyketide scaffolds, 
many of which possess potent bioactivity. As a result, considerable effort has been directed 
towards enantioselective synthesis of these moieties.1 Of the strategies developed, those attributed 
to Brown, 2  Roush, 3  Leighton 4  and Krische 5  are employed due to high levels of selectivity, 
operational simplicity and/or predictable models for stereoselectivity. Despite these advances, the 
majority of these methods only address synthesis of products containing an internal allylic 
																																																								
1) For a recent review, see: Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774–7854. For 
representative examples, see: (a) Corey, E. J.; Mu, C.-M.; Kim, S. S. J. Am. Chem. Soc. 1989, 111, 5495–5496. (b) 
Burgos, C. H.; Canales, E.; Matos, K.; Soderquist, J. A. J. Am. Chem. Soc. 2005, 127, 8044–8049. (c) Jain, P.; Antilla, 
J. C. J. Am. Chem. Soc. 2010, 132, 11884–11886.  Xing, C.-H.; Liao, Y.-X.; Zhang, Y.; Sabarova, D.; Bassous, M.; 
Hu, Q.-S. Eur. J. Org. Chem. 2012, 6, 1115–1118. (d) Clot-Almenara, L.; Rodríguez-Escrich, C.; Osorio-Planes, L.; 
Pericàs, M. A. ACS Catalysis 2016, 6, 7647–7651. (e) Gao, S.; Chen, M. Org. Lett. 2018, 20, 6174–6177. 
2) Brown, H. C.; Jadhav, P. K. J. Am. Chem. Soc. 1983, 105, 2092–2093. 
3) Roush, W. R.; Walts, A. E.; Hoong, L. K. J. Am. Chem. Soc. 1985, 107, 8186–8190. 
4) Kubota, K.; Leighton, J. L. Angew. Chem. Int. Ed. 2003, 42, 946–948. 
5) (a) Kim, I. S.; Ngai, M.-Y.; Krische, M. J. J. Am. Chem. Soc. 2008, 130, 14891–14899. (b) Lu, Y.; Kim, I. S.; 
Hassan, A.; Del Valle, D. J.; Krische, M. J. Angew. Chem. Int. Ed. 2009, 48, 5018–5021. (c) Hassan, A.; Townsend, 
I. A.; Krische, M. J. Chem. Commun. 2011, 47, 10028–10030. (d) Zbeig, J. R.; Yamaguchi, E.; McInturff, E. L.; 
Krische, M. J. Science, 2012, 336, 324–327. (e) Feng, J.; Garza, V. J.; Krische, M. J. J. Am. Chem. Soc. 2014, 136, 
8911–8914. (f) Brito, G. A.; Della-Felice, F.; Luo, G.; Burns, A. S.; Pilli, R. A.; Rychnovsky, S. D.; Krische, M. J. 
Org. Lett. 2018, 20, 4144–4147. 
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substituent (commonly referred to as the branched product),6  and there are far fewer reports 
detailing synthesis of the regioisomeric linear products (more on this below).7  
 
Scheme 3.1. Representative Bioactive Compounds Possessing Z-Homoallylic Alcohol Motifs	
	
3.2 Background 
3.2.1 Z-Homoallylic Alcohols in Synthesis 
To access compounds such as those shown in Scheme 3.1, synthetic routes often require 
protection and deprotection sequences or extensive redox manipulations. A representative 
example, taken from Panek’s synthesis of epothilone A, is illustrated below (Scheme 3.2).8 A 
seven-step sequence involving resolution of allylic alcohol 3.2, followed by hydroboration of the 
alkene and subsequent oxidation to aldehyde 3.6 were all required before obtaining alkenyl iodide 
3.7. While this remains a reliable and stereoselective strategy for synthesis of homoallylic alcohols 
bearing a Z-alkenyl halide, in fact the lowest reported ratio for selectivity we could identify was 
94:6 Z:E,9 the sequence generates a large amount of waste and consumes valuable time to carry 
out. 
																																																								
6) (a) Denmark, S. E.; Wilson, T. W. Angew. Chem. Int. Ed. 2012, 51, 3236–3239. (b) Miura, T.; Nishida, Y.; 
Morimoto, M.; Murakami, M. J. Am. Chem. Soc. 2013, 135, 11497–11500. 
7) (a) Kobayashi, S.; Endo, T.; Schneider, U.; Ueno, M. Chem. Commun. 2010, 46, 1260–1262. (b) Kobayashi, S.; 
Endo, T.; Yoshino, T.; Schneider, U.; Ueno, M. Chem. Asian. J. 2013, 8, 2033–2045.  
8) Zhu, B.; Panek, J. S. Org. Lett. 2000, 2, 2575–2578. 
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Scheme 3.2. Synthesis of Z-Alkenyl Iodide En Route to Epothilone A 
	
With this insight, we reasoned that development of a method for direct enantioselective 
synthesis of Z–substituted homoallylic alcohols would be a compelling objective. There are several 
examples addressing synthesis of such motifs that possess an allylic substituent through addition 
of enantiomerically pure reagents;10 however, there are far fewer describing synthesis of those 
without an allylic substituent.11 Two representative examples are shown in Scheme 3.3.  
In the presence of a camphor-based auxiliary, Loh described stereoselective synthesis of 
homoallylic alcohols 3.10 through [3,3]-sigmatropic rearrangement of oxonium 3.12 formed upon 
reaction of diastereoenriched homoallylic alcohol 3.9 and an aldehyde (Scheme 3.3b).12 The scope 
is limited to aliphatic aldehydes, and those that are more sizable required extended reaction times 
(up to 240 h). In a different approach, Malkov reported synthesis of Z-homoallylic alcohols 
																																																								
10) (a) Yamamoto, Y.; Yatagai, H.; Maruyama, K. J. Am. Chem. Soc. 1981, 103, 3229–3231. (b) Pietruska, J.; Schöne, 
N. Angew. Chem. Int. Ed. 2003, 42, 5638–5641. (c) Beckmann, E.; Desai, V.; Hoppe, D. Synlett 2004, 2275–2280. 
(d) Beckmann, E.; Hoppe, D. Synthesis 2005, 217–222. (e) Fang, G. Y.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2007, 
46, 359–362. (f) Althaus, M.; Mahmood, A.; Suárez, J. R.; Thomas, S. P.; Aggarwal, V. K. J. Am. Chem. Soc. 2010, 
132, 4025–4028. (g) Binanzer, M.; Fang, G. Y.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2010, 49, 4264–4268. (h) 
Chen, J. L-Y.; Scott, H. K.; Hesse, M. J.; Willis, C. L.; Aggarwal, V. K. J. Am. Chem. Soc. 2013, 135, 5316–5319. 
11) Pietruszka, J.; Schöne, N.; Frey, W.; Grundl, L. Chem. Eur. J. 2008, 14, 5178–5197. 
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through resolution of secondary allyl boronate 3.14 promoted by phosphoric acid catalyst 3.15.13 
Z selectivity is likely the result of a preference to orient the methyl substituent in a pseudo-axial 
position (3.19) in order to alleviate steric hindrance between the alkyl substituent of the pinacolato 
ester and the methyl group. As indicated, alkyl, alkenyl, aryl, and heteroaryl-substituted aldehydes 
were all suitable affording products in 70–97% yield and 93.5:6.5–99:1 er.  
 
Scheme 3.3. State-of-the-Art for Synthesis of Z-Homoallylic Alcohols 
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b. Mechanism for oxonium [3,3]-sigmatropic rearrangement
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Morken has detailed a method for catalytic, enantioselective diboryl addition to allene 3.21 
(Scheme 3.4). The resulting enantioenriched allyl boronate reacts with aldehyde 3.24, furnishing 
homoallylic alcohol 3.25 bearing a trisubstituted olefin.14 The utility of the obtained products were 
highlighted through conversion to alkenyl iodide 3.26 in 48% yield and stereoretentive proto-
deboronation through treatment with refluxing acetic acid for synthesis of Z-homoallylic alcohol 
3.27 in 80% yield.  
 
Scheme 3.4. Catalytic Enantioselective Diboryl Addition to Allenes 
	
3.2.2 Synthesis of Z-Homoallylic Alcohols Without Alkyl Substitution   
These are key studies in light of recent advances in stereo-retentive cross-metathesis have 
benefited from higher efficiency when cross partners with stereodefined disubstituted olefins are 
employed. 15  However, we could only find limited examples for synthesis of Z-homoallylic 
alcohols that do not bear an alkyl substituent. One example is addition of a-silyl substituted allyl 
boronate 3.28 to 3.8a (Scheme 3.5),16 although Z selectivity is moderate and competitive addition 
of the allyl silane led to lower yields. In a different approach, Krische has reported stereoselective 
formation of Z-enol ether 3.34, wherein an iridium-based allyl species, generated through a 1,2-
																																																								
14) Woodward, A. R.; Burks, H. E.; Chan, L. M.; Morken, J. P. Org. Lett. 2005, 7, 5505–5507. 
15) Xu, C.; Shen, X.; Hoveyda, A. H. J. Am. Chem. Soc. 2017, 139, 10919–10928. 




































80% yield, 94.5:5.5 er
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hydride shift, as shown in Scheme 3.5, adds to an aldehyde.17 Selectivity is likely a result of 
reaction through the iridium-based haptomer shown due to the inductive effect of the oxygen atom 
in combination with a preference for formation of a less hindered C–C bond. Shibasaki has 
described synthesis of Z-alkenyl nitriles (3.37) through addition of allyl cyanide 3.35 to aldehydes 
promoted by a copper bis-phosphine complex. The method is not applicable to aliphatic aldehydes 
and substrates possessing alkenyl side chains were isolated with lower levels of g selectivity 
(71:29–77:23 g:a ratio). The obtained products were subsequently elaborated to lactone 3.38, a 
key intermediate in the synthesis of fostriecin.18 
 
Scheme 3.5. Additions of Allyl Reagents for Synthesis of Z-Homoallylic Alcohols 
	
																																																								
17) Liang, T.; Zhang, W.; Krische, M. J. J. Am. Chem. Soc. 2015, 137, 16024–16027. 
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3.2.3  State-of-the-Art for Addition of Halo-Substituted Allyl Nucleophiles  
Given the advances in modern cross-coupling methodologies and the prevalence of Z-halo 
homoallylic alcohols as synthetic intermediates, 19  we were somewhat surprised to find few 
examples detailing direct synthesis of these motifs, 20  and only one exhibiting appreciable 
enantioselectivity.20c Methods, however, for additions of halogen containing compounds affording 
the regioisomeric chlorohydrin product 3.41 are more prevalent, 21  and three representative 
examples are illustrated in Scheme 3.6. Kobayashi disclosed addition of  a-chloro allyl boronate 
3.39 to a variety of aliphatic and aromatic aldehydes promoted by readily accessible diol 3.40 
affording syn-chlorohydrin 3.41 in 73–99% yield, 87.5:12.5–98:2 dr and 92.5:7.5–99:1 er. 22 
Umani-Ronchi and co-workers accessed the same class of compounds through addition of 
dichloropropene 3.42 promoted by chromium-based salen 3.43 complexes, obtaining 
regioisomeric mixtures (i.e., a- and g-addition), which led to low yields upon separation.23 Finally, 
Leighton accomplished diastereodivergent synthesis of syn- and anti-3.47 through addition of allyl 
silanes 3.44 and 3.45, respectively. Despite the use of stoichiometric diamine, which can be 
recycled upon work-up, the reaction is efficient, as well as diastereo- and enantioselective.24 
																																																								
19) For recent examples, see: (a) Reddy, K. M.; Yamini, V.; Singarapu, K. K.; Ghosh, S. Org. Lett. 2014, 16, 2658–
2660. (b) Speed, A. W. H.; Mann, T. J.; O’Brien, R. V.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 
16136–16139. (c) Lei, H.; Yan. J.; Yu, J.; Liu, Y.; Wang, Z.; Xu, Z.; Ye, T. Angew. Chem. Int. Ed. 2014, 53, 6533–
6537. (d) Franke, J.; Bock, M.; Dehn, R.; Fohrer, J.; Mhaske, S. B.; Migliorini, A.l Kanakis, A. A.; Jansen, R.; 
Herrmann, J.; Müller, R.; Kirschning, A. Chem. Eur. J. 2015, 21, 4272–4284. (e) Yadav, J. S.; Dutta, P. J. Org. Chem. 
2016, 81, 1786–1797. (f) Nguyen, M. H.; Imanishi, M.; Kurogi, T.; Smith, A. N. J. Am. Chem. Soc. 2016, 138, 3675–
3678. (g)  Yoshikawa, Y.; Yamakawa, M.; Kobayashi, T.; Murai, K.; Arisawa, M.; Sumimoto, M.; Fujioka, H. Eur. 
J. Org. Chem. 2017, 2715–2718. 
20) (a) Hoffmann, R. W.; Landmann, B.; Tetrahedron Lett. 1983, 24, 3209–3212. (b) Hoffmann, R. W.; Dresely, S. 
Chem. Ber. 1989, 122, 903–909. (c) Sturmer, R.; Hoffmann, R. W. Synlett 1990, 759–760. (d) Mallaiah, K.; 
Satyamarayana, J.; Ila, H.; Junjappa, H. Tetrahedron Lett. 1993, 34, 3145–3148. 
21) (a) Jayaraman, S.; Hu, S.; Oehlschlager, A. C. Tetrahedron Lett. 1995, 36, 4765–4768. Hu, S.; Jayaraman, S.; 
Oehlschlager, A. C. J. Org. Chem. 1996, 61, 7513–7520. (b) Hertweck, C.; Boland, W. Eur. J. Org. Chem. 1998, 
2143–2148. Hu, S.; Jayaraman, S.; Oehlschlager, A. C. J. Org. Chem. 1998, 63, 8843–8849. 
22) Kobayashi, S.; Endo, T.; Ueno, M. Angew. Chem. Int. Ed. 2011, 50, 12262–12265. 
23) Bandini, M.; Cozzi, P. G.; Melchiorre, P.; Morganti, S.; Umani-Ronchi, A. Org. Lett. 2001, 3, 1153–1155. 
24) Tekle-Smith, M. A.; Williamson, K. S.; Hughes, I. F.; Leighton, J. L. Org. Lett. 2017, 19, 6024–6027. 
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Scheme 3.6. Enantioselective Addition of Chloro-Substituted Allyl Reagents 
	
	In 2005, Hall and co-workers outlined addition of allyl reagent 3.48 furnishing Z-bromo 
substituted alcohol 3.49.16 The high levels of Z selectivity are the result of minimization of dipole 
interaction between the polar halogen bond and the B–O bond of the boronate, as shown in 3.50.25 
Five years later, Roush and Chen26 reported synthesis and application of enantioenriched allyl 
																																																								
25) For other factors governing Z selectivity, see: (a) Hoffmann, R. W.; Landmann, B. Angew. Chem. Int. Ed. 1986, 
25, 189–190. (b) Hoffmann, R. W. Pure Appl. Chem. 1988, 60, 123–130. (c) Hoffmann, R. W.; Wolff, J. J. Chem. 
Ber. 1991, 124, 563–569. 
26) (a) Hoffmann, R. W.; Landmann, B. Angew. Chem. Int. Ed. 1984, 23, 437–438. (b) Chen, M.; Roush, W. R. Org. 
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boronate 3.52; although the transformation is Z-selective, enantiomeric ratios did not exceed 
65:35, probably owing to epimerization of the allylic position during reagent preparation.  
	
Scheme 3.7. State-of-the-Art for Synthesis of Z-Halo Substituted Alcohols 
	
3.3 Additions to Aldehydes Promoted by Aminophenol Complexes 
3.3.1  Challenges Surrounding Additions 
To address these shortcomings, we envisaged that a class of aminophenol boron-based 
catalysts, known to be a-selective,27 could be well suited to advance the state-of-the-art. Our group 
has previously utilized these for enantioselective addition of allyl boronates to phosphinoyl 
aldimines,27 ketones,28 and as discussed in Chapter Two, trifluoromethyl ketimines. Enantiotopic 
discrimination for additions to N-diphenylphosphinoyl aldimines was likely the result of an 
																																																								
27) (a) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. Nature 
2013, 494, 216–221. (b) van der Mei, F. W.; Qin, C.; Morrison, R. J.; Hoveyda, A. H. J. Am. Chem. Soc. 2017, 139, 
9053–9065. 
28) Robbins, D. W.; Lee, K.; Silverio, D. L.; Volkov, A.; Torker, S.; Hoveyda, A. H. H. Angew. Chem. Int. Ed. 2016, 
55, 9610–9614. Lee, K.; Silverio, D. L.; Torker, S.; Robbins, D. W.; Haeffner, F.; van der Mei, F. W.; Hoveyda, A. 







Me 1. n-BuLi, CH2Cl2,
–100 °C













92:8 Z:E, 65:35 er












0 °C, 25 h









 Page 465 
interaction between the phosphine oxide and ammonium ion within the catalyst, and selectivity for 
trifluoromethyl substituted ketones and ketimines was probably as a result of coulombic attraction 
with the ammonium. Aminophenol boron-based catalysts may also be employed for additions to 
methyl ketones 3.54, wherein selectivity is governed by steric factors (Scheme 3.8a). Based on 
this past experience, we reasoned that with an appropriate catalyst and reaction conditions, 
enantioselective additions to aldehydes could be achieved due the larger size difference between 
–H and –Ph (vs –CH3 and –Ph in the case of methyl ketone 3.54). 
 
Scheme 3.8. Past Investigations and Objective of Our Investigationsa 
	
aAll reactions were performed under N2 atm. Conv and a:g ratios (±2%) were determined by analysis of 1H 
NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). pin: pinacaloto See 
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a. Additions to ketones: enantiotopic discrimination based on steric control
b. Additions to aldehydes: efficient but non-selective
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However, under the best of circumstances, enantiomeric ratios did not exceed 62:38 er 
(Scheme 3.8b), which we attributed to competitive uncatalyzed addition to these more electrophilic 
substrates. To determine if this was the case, we prepared deuterated allyl boronate d2–3.55 with 
the rationale that, if a competitive non-selective process were to dominate, two deuterium atoms 
would be incorporated on the terminal carbon as shown in 3.59; however, we isolated 3.58 as the 
major product (95%). This indicated that additions promoted by an aminophenol boron-based 
complex were efficient, but non-selective.  
 Analysis of transition state models, based on those previously disclosed, led us to consider 
two possible modes of addition, 3.60 and 3.61. Unlike additions to ketone 3.54, the smaller 
hydrogen atom probably renders addition through 3.61 more competitive resulting in a smaller 
DDG‡. In previous investigations,27 we have observed that reaction of substituted allyl boronates 
and trifluoroketones and ketimines are typically more enantioselective due to an allylic substituent 
that generates a degree of steric pressure in modes leading to the minor enantiomer (see Chapter 
Two). If the same lessons could extend to addition to aldehydes, we sought to address two 
longstanding challenges: (1) Development of a robust, catalytic, and enantioselective method for 
additions to aldehydes promoted by aminophenol boron-based catalysts. (2) Directly synthesis of 
homoallylic alcohols that contain a Z-olefin.  
 
3.3.2  Initial Optimization and Method Development 
 We commenced our investigation with Z-3.62 to ascertain whether addition of substituted 
allyl boronates proceeded with the same levels of a selectivity as those for d2-3.55. Addition 
proved to be efficient and in moderate preference the desired isomer (81:19 a:g ratio); however, 
both diastereo- and Z selectivity were low (82:18 dr and 64:36 Z:E). We reasoned that may arise 
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Scheme 3.9. Initial Result for Addition of Crotyl Boronate to Aldehydesa 
	
aAll reactions were performed under N2 atm. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance of 3.8a. Yield of isolated and 
purified product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for 
details.  
 
Accordingly, we selected Z-3.66, accessible due to recent advances in Z-selective cross-
metathesis promoted by Mo-based complexes29 to address the need for enantioselective synthesis 
of Z-halo homoallylic alcohols. We are not the first to consider preparation of allyl reagents 
through catalytic cross-metathesis, but typically these transformations are promoted by Ru-based 
complexes and are highly E selective. 30 With the requisite reagent in hand, we considered the 











29) Koh, M. J.; Nguyen, T. T.; Zhang, H.; Schrock, R. R.; Hoveyda, A. H. Nature 2016, 531, 459–465. 









5.0 mol % Zn(OMe)2, 1.3 equiv MeOH
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Scheme 3.10. Possible Modes of Addition for Chloro-Substituted Aminophenol Complex 
	
 Stereospecific g-transfer of Z-3.66 to aminophenol boron-based complex 3.65 proceeds via 
3.67, affording complex 3.68 with a chloro-substituted stereogenic center. If, for a moment, we 
ignore the possibility of 1,3-boryl shift, allyl addition can proceed through two possible modes. In 
3.69, the chloro substituent is oriented pseudo-equatorially generating steric hindrance between 
the chloride and the amide, as well as a syn-pentane-like interaction with the catalyst backbone. 
Alternatively, addition through 3.71, wherein the chloride is pseudo-axial, these repulsive 
interactions are minimized. It was unclear, however, if such interactions could lead to a sufficient 
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Scheme 3.11. Initial Evaluation and Optimization of Aminophenol Catalysta 
	
aPerformed under an atmosphere of dry N2. Conv, a:g and Z:E ratios (±2%) were determined by analysis 
of 1H NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Er values were 
determined by HPLC analysis (±1%). See Experimental Section for details. 
 
We began optimization by using 1.5 equivalents of aldehyde 3.8a to ensure efficiency and 
maintain an excess of substrate to favor direct addition over competitive 1,3-boryl shift.31 Under 
these conditions, additions promoted by a triphenylsilyl-substituted aminophenol compound, the 
transformation was largely a- and Z–selective. In accordance with previous models, we found that 
enantioselectivity was correlated to the size of the amino acid residue (Scheme 3.11, c.f. ap-2 and 
ap-3), with hydroxyl-substituted adamantane ap-6 affording optimal results.  
	
																																																								
31) Excess aldehyde can be recovered in up to 97% yield. 
O
Ph 10 mol % Zn(OMe)2, 1.3 equiv MeOH
toluene, 22 °C, 14 h
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3.3.3  Scope of the Method   
 We explored the scope of the transformation. Substrates possessing an ortho-substituent, 
such as o-tolyl Z–3.73 and 2,6-difluorosubstituted Z–3.74 furnished products with exclusive a 
selectivity and in 95:5 and 94:6 er, respectively, indicating that association with complex 3.68 is 
favored over 1,3-shift even with more sizable substrates. Aryl halides such as Z–3.75 and Z–3.76 
were tolerated affording products in >98:2 a:g ratio and 96:4 and 93:7 er, respectively. 
Furthermore, the reaction proceeded with complete chemoselectivity as evidenced by Z–3.77. 
Electronic factors had little effect on the enantioselectivity of the reaction, although addition to 
para-methoxyphenyl substituted Z–3.78 resulted in diminished regioselectivity, likely due to a 
more competitive 1,3-boryl shift for this electron-rich case. This supports the idea that steric 
factors are underscored by electronics for kinetics of 1,3-boryl shift. Notably, aldehydes that 
contain para-substitution were isolated in lower er (88:12–90:10 er for Z–3.77–3.79, compared to 
94:6 er for Z-3.72) regardless of the electronics of the arene. To determine if this was the 
consequence of a competitive, non-catalyzed process, we carried out addition in the absence of 
aminophenol and found no indication of increased reactivity due to para-substitution. The 
implications of these findings, and how this pattern of substitution disfavors the major mode of 
addition still require investigation. The method is suitable for substrates that contain an acetal 
moiety Z–3.77, as well as those with a heterocyclic substituent. Both indole Z–3.81 and 3-pyridyl 
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Scheme 3.12. Scope of Aryl and Heteroaryl-Substituted Aldehydesa 
	
aPerformed under an atmosphere of dry N2. Conv, a:g  and Z:E ratios (±2%) were determined by analysis 
of 1H NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Experiments run at 
least in triplicate. Er values were determined by HPLC analysis (±1%). See Experimental Section for details. 
 
Enals, both di-(Z–3.83) and trisubstituted (Z–3.84–85), furnished product with efficiency, 
however, enantiomeric ratios for the former were lower probably owing to the small and linear 
nature of the alkyl group. This is indeed a consequence of reliance on steric factors for high levels 
of enantioselectivity. Nonetheless, replacement of an alkenyl hydrogen with a methyl or bromo 
substituent afforded access to Z–3.84 and Z–3.85 in 98:2 and 95:5 er, respectively. Additions to 
aliphatic aldehydes with an a-substituent were also efficient and enantioselective, although the 
O
G 10 mol % Zn(OMe)2, 1.3 equiv MeOH
toluene, 22 °C, 14 h
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decrease in regioselectivity may be the result of competitive 1,3-boryl shift for these less 
electrophilic and hindered substrates. 
	
Scheme 3.13. Scope of Alkenyl and Aliphatic Aldehydesa 
	
aPerformed under an atmosphere of dry N2. Conv, a:g  and Z:E ratios (±2%) were determined by analysis 
of 1H NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Experiments run at 
least in triplicate. Er values were determined by HPLC analysis (±1%). bConducted in the absence of 
methanol. See Experimental Section for details. 
The transformation is applicable to compounds that contain an a-stereogenic center (Z–
3.88-89). We found that by forgoing addition of methanol (trace amounts of moisture are sufficient 
to generate the ammonium ion), optimal a selectivity could be achieved. For example, when 
addition was carried out in the presence of 1.3 equivalents of MeOH, Z–3.88 and 3.89 were isolated 
in 53:47 and 62:38 a:g ratio, respectively. The precise origin of this phenomenon requires further 
investigation. However, it is reasonable to postulate that a less polar medium may affect the 
efficiency with which boryl shift proceeds or hamper the formation of extensive networks of 
hydrogen bonding that facilitate competitive and non-selective pathways. Addition proceeds under 
catalyst control, with the matched case (Felkin-Ahn model), generating product in 85% yield and 
97:3 dr. For the mismatched case, Z–3.88, diastereoselectivity remained high (97:3 dr), but 
increased steric pressure between the pseudo-axial chloride and the phenyl ring reduced the 
efficiency (3.92, Scheme 3.14). In accordance with results for additions to aldehydes possessing a 
Z–3.84
98:2 !:γ
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linear alkyl substituent, reaction with (+)-citronellal, although a-selective afforded Z–3.90 in 
83:17 dr. 
 
Scheme 3.14. Additions to Aldehydes Possessing a Stereogenic Centera 
	
aPerformed under an atmosphere of dry N2. Conv, a:g , dr and Z:E ratios (±2%) were determined by analysis 
of 1H NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Experiments run at 
least in triplicate. bConducted in the absence of methanol. See Experimental Section for details. 
	 	
Trisubstituted alkenyl chlorides were efficiently prepared. The requisite reagent, Z–3.97, 
which may be synthesized through cross-metathesis, promoted by Mo-based complex Mo-1, 32 of 
trisubstituted allyl boronate 3.9533 and dichloroethylene 3.96. Reaction with the more sizable 
reagent required higher catalyst loading (5.0 mol %) and an additional equivalent of methanol for 
efficiency. Under these conditions, additions to aryl, heteroaryl, and alkenyl-substituted aldehydes 
furnished products in 54–77% yield, 97:3–98:2 Z:E ratio and 86:14–95:5 er.  
	
																																																								
32) Nguyen, T. T.; Koh, M. J.; Mann, T. J.; Schrock, R. R.; Hoveyda, A. H. Nature 2017, 552, 347–354.  
33) Allyl boronate was synthesized through Ni-catalyzed 1,4-hydroboration, see: Ely, R. J.; Morken, J. P. J. Am. 




































49% conv, 97:3 !:γ 
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Scheme 3.15. Synthesis of Application of Trisubstituted Allyl Boronatesa 
	
aPerformed under an atmosphere of dry N2. Conv, a:g  and Z:E ratios (±2%) were determined by analysis 
of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance of Z–3.97 Yield of isolated and 
purified product (±5%). Experiments run at least in triplicate. Er values were determined by HPLC analysis 
(±1%). See Experimental Section for details. 
We reasoned that the diminished regioselectivity might be a consequence of increased 
steric pressure exerted on the complex by the C2 methyl substituent, impeding substrate 
coordination and allow a greater chance for boryl shift (Scheme 3.16). The diminution in 
enantioselectivity is likely affected by the same factors, as it is possible that the methyl substituent 
can cause distortion of the complex through interaction with the proximal amide, disrupting 
transition state organization. It is noteworthy, that addition remains Z-selective, indicating that 








1. 3.0 mol % Pd(PPh3)4, 2.4 equiv CsF
C6H6, 70 °C, 14 h
2. 5.0 mol % Ni(cod)2
5.0 mol % PCy3
1.1 equiv HB(pin)








10 mol % HB(pin)


















10 mol % Zn(OMe)2, 2.5 equiv MeOH
1.5 equiv GCHO,
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Scheme 3.16. Rationale for Diminished Selectivity 
	
	
3.3.4  g-Selective Additions to Aldehydes  
 Another notable observation was that the minor g-product was enantioenriched. We 
reasoned that with appropriate adjustments to the structure of the aminophenol and altered reaction 
conditions, we might be able to access both Z-alkenyl chlorides and chlorohydrins. For initial 
optimization, we carried out additions to aliphatic aldehyde 3.107, reasoning that hindrance 
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Scheme 3.17. Identification of an Effective Catalyst for g-Additiona 
	
aPerformed reagent under an atmosphere of dry N2. Conv, a:g  and dr ratios (±2%) were determined by 
analysis of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance of 3.107. Yield of isolated 
and purified product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section 
for details. 
 
	 As discussed in Section 3.3.3, to achieve a selectivity, the effective concentration of 
aldehyde must remain sufficiently high. We reasoned if the concentration of substrate could be 
decreased through a combination of diluting the reaction mixtures and forgoing excess aldehyde, 
boryl shift (which proceeds in an intramolecular fashion and is likely not dependent on aldehyde 
concentration) could be favored. Indeed, this was the case.  
 We probed a series of aminophenol compounds. Drawing upon insight from studies 
regarding g-addition to phosphinoyl imines (Chapter One), we hoped a combination of a small aryl 







5.0 mol % Zn(OMe)2, 1.3 equiv MeOH
toluene, 22 °C, 14 h
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Accordingly, we synthesized ap-7 and isolated 3.108 in 84:16 g:a ratio, 95:5 dr and 92:8 er. We 
found that similar selectivity, and improved enantioselectivity were obtained with catalysts bearing 
a t-Bu group on the arene, ap-10–11, and optimal results were obtained with ap-11. 
 
Table 1. Further Optimization Towards g-Selective Additiona 
	
aPerformed under an atmosphere of dry N2. Conv, a:g  and dr ratios (±2%) were determined by analysis of 
1H NMR spectra of unpurified mixtures; Conv refers to disappearance of 3.107. Yield of isolated and purified 
product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for details. 
Further dilution of the reaction mixture led to efficient addition; however, this was at the 
expensive of diastereoselectivity (Table 1, entry 1). Altering the loading or the identity of the 
zinc(II) salt, or increasing the polarity of the media (entries 2-3, 5) had little effect. Thus, with 5.0 
mol % ap-11, 5.0 mol % Zn(OMe)2 and 1.3 equivalents of methanol, we explored the scope of the 
method. In each case, the transformation was g-selective, although electron-rich para-
methoxyphenyl substituted 3.111 and hindered aliphatic aldehydes 3.112–113 were more suitable 










5.0 mol % Zn, 1.3–2.5 equiv MeOH
toluene, 22 °C, 14 h



















[c] = 0.08 M
2.5 mol % Zn(OMe)2
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Scheme 3.18. Representative g-Selective Additiona 
	
aPerformed under an atmosphere of dry N2. Conv, a:g  and dr ratios (±2%) were determined by analysis of 
1H NMR spectra of unpurified mixtures; Conv refers to disappearance of 3.8. Yield of isolated and purified 
product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for details. 
	 	
It is noteworthy that the transformation may be carried out with diethyl zinc in the absence 
of an alcohol. g Selectivity, as well as diastereoselectivity were improved compared to trials carried 
out with Zn(OMe)2, nonetheless, this was at the expense of enantioselectivity (91:9 vs 96:4 er). 
This corresponds to a significant energetic difference and indicates that in the presence of the more 
nucleophilic promoter, competitive non-catalyzed pathways might be responsible for such erosion.  
 
Scheme 3.19. Transformation Promoted by Dialkyl Zinca 
	
aPerformed reagent under an atmosphere of dry N2. Conv, a:g  and dr ratios (±2%) were determined by 
analysis of 1H NMR spectra of unpurified mixtures; Conv refers to disappearance of 3.8a. Yield of isolated 













5.0 mol % Zn(OMe)2, 1.3 equiv MeOH
toluene, 22 °C, 14 h


















88% yield, 93:7 dr
3.113
93:7 !:"











5.0 mol % ZnEt2
toluene, 22 °C, 14h
OH
Cl
>98% conv., 78:22 !:"
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3.3.5 Synthesis of Homoallylic Alcohols Bearing a Z–CF3 Motif 
The scope of the method is not limited to synthesis of Z-alkenyl halides; boronates 
possessing a withdrawing trifluoromethyl methyl group may be employed with efficiency and a 
selectivity.  
 
Scheme 3.20. Scope of Aryl and Heteroaryl-Substituted Homoallylic Alcoholsa 
	
aPerformed under an atmosphere of dry N2. Conv, a:g  and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Er values were 
determined by HPLC analysis (±1%). Experiments were conducted at least in triplicate. See Experimental 
Section for details. 
O
G 5 mol % Zn(OMe)2, 1.3 equiv MeOH
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Methods for synthesis of this class of compounds in a stereoselective manner are crucial to 
advancing recent developments for 1,2-functionalization of trifluoromethyl substituted alkenes.34 
Sterically hindered substrates, such as Z–3.117 and Z–3.118, were subjected to addition with 
efficiency and a selectivity (>98:2 and 93:7 a:g ratio, respectively). With electron-deficient para-
NO2-substituted Z–3.122, boryl shift may be preempted and the product was isolated as a single 
regioisomer. Heteroaryl cases are suitable as evidenced by Z–3.123-125, although Z selectivity 
was diminished for 2-substituted cases. This is likely owing to development of electron-electron 
repulsion between the oxygen of the heterocycle and the allylic trifluoromethyl group, allowing 
greater chance for competitive modes to become more predominant. It is evident that in these 
cases, steric factors play a role, as the larger benzofuranyl-substituted Z–3.118 underwent reaction 
with higher Z selectivity, as compared to the furanyl case. Electron-deficient and unhindered 
alkyne Z–3.126 was generated as a single regioisomer in 94:6 Z:E ratio and 97:3 er. Substrates 
bearing trisubstituted olefins Z-3.127 and Z-3.128 reacted smoothly, furnishing product in 98.5:1.5 
and 92:8 er, respectively. Furthermore, in accordance with results obtained for additions of chloro-
substituted boronates, aldehydes lacking an a-substituent were found to be less enantioselective 









34) (a) Corberan, R.; Mszar, N. W.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2011, 50, 7079–7082. (b) Liu, Y.; Zhou, 
Y.; Zhao, Y.; Qu, J. Org. Lett. 2017, 19, 946–949. (c)  Kojima, R.; Akiyama, S.; Ito, H. Angew. Chem. Int. Ed. 2018, 
57, 7196–7199. (d) Gao, P.; Yuan, C.; Zhao, Y.; Shi, Z. Chem 2018, 4, 2201–2211. (e) Zhao, X.; Li, C.; Wang, B.; 
Cao, S. Tetrahedron Lett. 2019, 60, 129–132. 
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aPerformed under an atmosphere of dry N2. Conv, a:g  and Z:E ratios (±2%) were determined by analysis 
of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Er values were 
determined by HPLC analysis (±1%). Experiments were conducted at least in triplicate. See Experimental 
Section for details. 
	
3.3.6 Application to Synthesis of Mycothiazole 
Next, we set out to demonstrate the utility of the method by a concise total synthesis of 
anti-tumor agent mycothiazole (Scheme 3.1).35  Isolated from Cacospongia mycofijiensis, the 
marine alkaloid exhibits nanomolar (0.36–13.8 nM) activity against small and non-small cell lung 
cancer lines. Degradation studies have elucidated that the thiazole component is essential for 
bioactivity, and the compound is cytostatic rather than cytotoxic, requiring a 12 hour incubation 
period before activation.36 We envisaged a method affording access to the heterocyclic core that 
is amenable to further functionalization and the development of new therapeutic candidates.  
 Synthesis of mycothiazole has been previously reported by Hale and co-workers in 2015,37 
commencing from enantioenriched epoxy alcohol 3.131. Similar to Panek’s work (see section 
																																																								
35) (a) Crews, P.; Kakou, Y.; Quiñoà, E. J. Am. Chem. Soc. 1998, 110, 4365–4368. (b) Sonnenschein, R. N.; Johnson, 
T. A.; Tenney, K.; Valeriote, F. A.; Crews, P. J. Nat. Prod. 2006, 69, 145–147. (c) Morgan, J. B.; Mahdi, F.; Liu, Y.; 
Coothankandaswamy, V.; Jekabsons, M. B.; Johnson, T. A.; Sashidhara, K. V.; Crews. P.; Nagle, D. G.; Zhou, Y.-D. 
Bioorg. Med. Chem. 2010, 18, 5988–5994. 
36) Meyer, K. J.; Singh, A. J.; Cameron, A.; Tan, A. S.; Leahy, D. C.; O’Sullivan, D.; Joshi, P.; La Flamme, A. C.; 
Northcote, P. T.; Berridge, M. V.; Miller, J. H. Mar. Drugs 2012, 10, 900–917. 
37 ) Wang, L.; Hale, K. J. Org. Lett. 2015, 17, 4200–4203. For other studies describing synthesis towards 
mycothiazole, see: (a) Sugiyama, H.; Yokokawa, F.; Shioiri, T. Org. Lett. 2000, 2, 2149–2152. (b) Sugiyama, H.; 
Yokokawa, F.; Shioiri, T. Tetrahedron 2003, 59, 6579–6593. (c) Le Flohic, A.; Meyer, C.; Cossy, J. Org. Lett. 2005, 
7, 339–342. (d) Le Flohic, A.; Meyer, C.; Cossy, J. Tetrahedron 2006, 62, 9017–9037. (e) Rega, M.; Candal, P.; 
Z–3.126
 >98:2 !:γ
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3.2.1), the Z-homoallylic alcohol was introduced through a series of oxidation state manipulations 
affording aldehyde 3.130, which may be then be converted to a Z-alkenyl iodide through Wittig 
olefination and then elaborated further by a cross-coupling reaction. Alternatively, the heterocyclic 
core Z–3.109 may be accessed through catalytic, enantioselective  a addition to the corresponding 
aldehyde. The Z-diene could then be appended through catalytic stereoretentive cross-coupling 
and the skipped diene could be introduced by cross-metathesis,38 followed by dehydration.  
	
Scheme 3.22. Strategies for Synthesis of Mycothiazole 
	
																																																								
Jiménez, C.; Rodríquez, J.; Eur. J. Org. Chem. 2007, 934–942. (f) Batt, F.; Fache, F. Eur. J. Org. Chem. 2011, 6039–
6055. 
38) (a) Khan, R. K. M.; Torker, S.; Hoveyda, A. H. J. Am. Chem. Soc. 2013, 135, 10258–10261. (b) Koh, M. J.; Khan, 
R. K. M.; Torker, S.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2014, 53, 1968–1972. (c) Koh, M. J.; Khan, R. K. M.; 

































previous synthesis: 20 LLS












b. A Multicatalytic Approach
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 We began by identifying an efficient catalyst for scalable preparation of Z–3.66. We found 
Mo-2 to be optimal, furnishing the desired allylic boronate in one hour, as a single stereoisomer.39 
Recent studies had informed us that if cross partners Z-3.62 and 3.134 were treated with 10 mol 
% of pinacolborane, prior to addition of a solution of Mo-based complex, trace amounts of 
moisture or residual pinacol that can sequester the catalyst may be consumed, thus enabling 
catalyst loadings to be lowered to 1.6 mol %.40 Furthermore, olefin metathesis was efficient when 
promoted by commercially available Mo-3. Following the same procedure for pretreatment with 
pinacolborane, just 3.0 mol % of the complex was required, generating Z–3.66 in 81% yield and 
98:2 Z:E ratio. An added benefit of employing a Mo-based complex is that purification may be 
carried out by distillation, allowing for efficient separation from residual metal salts.  
 
Scheme 3.23. Efficient, Scalable Access to Z-Alkenyl Halidesa 
	
aAll reactions were performed under N2 atm. Conv and Z:E ratios (±2%) were determined by analysis of 1H 
NMR spectra of unpurified mixtures; Conv refers to disappearance of Z–3.62. Yield of isolated and purified 
product (±5%). pin: pinacolato. See Experimental Section for details.  
																																																								
39) (a) Lam, J. K.; Zhu, C.; Bukhryakov, K. V.; Müller, P.; Hoveyda, A. H.; Schrock, R. R. J. Am. Chem. Soc. 2016, 
138, 15774–15783. (b) Koh, M. J.; Nguyen, T. T.; Lam, J. K.; Torker, S.; Hyvl, J.; Schrock, R. R.; Hoveyda, A. H. 
Nature, 2017, 542, 80–85. 




10 mol % HB(pin)
15 min, 22 °C;
1.6 mol % Mo-2
















10 mol % HB(pin)
15 min, 22 °C;
3.0 mol % Mo-3
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Addition of Z–3.66 to aldehyde 3.107, accessible in two steps according to a protocol 
reported by Cossy,37d proceeded under optimal conditions affording Z–3.109 in 86% yield, >98:2 
a:g ratio and 94:6 er. The excess aldehyde was recovered in 97% yield. Next, we carried out a 
chemoselective cross-coupling of the aryl bromide within the thiazole and allyl–B(pin), through a 
phosphine-Pd-catalyzed reaction under conditions outlined by Aggarwal.41   
 
Scheme 3.24. Preparation of Fragments for Cross-Couplinga 
	
aPerformed under an atmosphere of dry N2. Conv, a:g  and Z:E ratios (±2%) were determined by analysis 
of 1H NMR spectra of unpurified mixtures. Yield of isolated and purified product (±5%). Er values were 
determined by HPLC analysis (±1%). See Experimental Section for details. 
 
 To obtain the desired boronate to be employed for stereoretentive cross-coupling, we 
employed catalytic proto-boryl addition under modified conditions, previously developed in our 
laboratory. 42  Allene 3.137 was synthesized through Crabbé homologation 43  of propargyl 
carbamate 3.136. We found that in this case, sterically hindered imid-1 was essential for 
																																																								
41) Zhurakovsky, O.; Türkmen, Y. E.; Löffler, L. E.; Moorthie, V. A.; Chen, C. C.; Shaw, M. A.; Crimmin, M. R.; 
Ferrara, M.; Ahmad, M.; Ostovar, M.; Matlock, J. C.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2018, 57, 1346–1350. 
42) Meng, F.; Jung, B.; Haeffner, F.; Hoveyda, A. H. Org. Lett. 2013, 15, 1414–1417. 
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10 mol % Zn(OMe)2
1.3 equiv MeOH






1.5 equiv NHCy2, 3.0 equiv (CH2O)n







5.0 mol % CuCl
1.05 equiv B2(pin)2, 6.0 equiv i-PrOH














b. Proto-boryl addition to allenes: Access to alkenyl B(pin)
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regioselective copper-boryl additon since the sizable ortho substituents of the N-aryl rings favored 
positioning of the NHC-Cu complex in the least hindered terminal site. Selectivity could be further 
improved when isopropanol was employed as the proton source, allowing us to isolate 3.133 in 
76% yield. 
Scheme 3.25. Endgame of Synthesis of Mycothiazolea 
	
aPerformed under an atmosphere of dry N2. Conv, and Z:E ratios (±2%) were determined by analysis of 1H 
NMR spectra of unpurified mixtures; Yield of isolated and purified product (±5%). Reactions run at least in 
triplicate. dba: dibenzylidene acetone; dppf: 1,1’-bis(diphenylphosphino)ferrocene; ruphos: 2-
dicyclohexylphosphino-2,6’-diisopropoxybiphenyl; diox: 1.4-dioxane. See Experimental Section for details. 
 
 Out next objective was to join fragments 3.135 and 3.133 to forge the desired diene. After 
considerable optimization, we discovered that a class of Pd-based complexes developed by 
Buchwald44 were competent, although the reaction was not stereoretentive. Control experiments 
allowed us to identify that the diene was prone to isomerization in the presence of a Pd-based 
complex (at >65 °C); this was circumvented by carrying out the transformation at 55 °C in the 
																																																								
44) (a) Bruno, N. C.; Tudge, M. T.; Buchwald, S. L. Chem. Sci. 2013, 4, 916–920. (b) Bruno, N. C.; Niljiasnskul, N.; 
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8.0 mol % Ru-1
     100 torr (2 h), thf, 
760 torr (14 h), 22 °C
1.0 mol %
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absence of light. Upon filtration through silica gel to remove palladium salts, the desired 
compound 3.138 was isolated as a single stereoisomer.  
 To complete the synthesis, we carried out Z-selective cross-metathesis of 3.138 and 3.132 
in the presence of Ru-1. For maximum efficiency, we first treated 3.138 with an excess of Z-2-
butene and Ru-1 to convert the terminal olefin to the derived disubstituted olefin. This was 
necessary because previous studies had indicated that Ru-methylidene are more susceptible to 
decomposition.45  
 We were then able to complete the total synthesis of mycothiazole through a two-step 
sequence for preparation of the skipped diene. First, the primary alcohol was converted to an alkyl 
bromide according to a modified procedure disclosed by Shiori,46 in a dilute solution coupled with 
slow addition of triphenyl phosphine to prevent decomposition of reaction intermediates. The 
freshly prepared bromide was then subjected to elimination under conditions outlined by Fu, which 




 In summary, through mechanistic understanding we were able to determine that additions 
of Z-substituted allyl boronates to aldehydes may be carried out with exceptional enantio- and Z 
selectivity. We adopted a similar approach to identify an effective way to synthesize regioisomeric 
chlorohydrin products. The protecting group free total synthesis of mycothiazole highlights the 
considerable utility of the catalytic approach, and is expected to be applicable to preparation of a 
variety of other complex bioactive molecules.  
  
																																																								
45) Xu, C.; Shen, X.; Hoveyda, A. H. J. Am. Chem. Soc. 2017, 139, 10919–10928. 
46) Sugiyama, H.; Yokokawa, F.; Shiori, T. Org. Lett. 2000, 2, 2149–2152. 
47) Bissember, A. C.; Levina, A.; Fu, G. C. J. Am. Chem. Soc. 2012, 134, 14232–14337. 
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3.5 Experimental Section 
3.5.1 General 
Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) spectrophotometer, 
νmax in cm−1. Bands are characterized as broad (br), strong (s), medium (m), and weak (w). 1H 
NMR spectra were recorded on a Varian Unity INOVA 400 (400 MHz), 500 (500 MHz), or 600 
(600 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane with the 
solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, br s = broad 
singlet, m = multiplet, app = apparent), coupling constant (Hz) and integration. 13C NMR spectra 
were recorded on a Varian Unity INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 MHz) 
spectrometer with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16 ppm). 19F 
NMR spectra were recorded on a Varian Unity INOVA 400 (376 MHz) spectrometer. Chemical 
shifts are reported in ppm with C6H5CF3 as an external standard (C6H5CF3: –63.72 ppm). Data are 
reported as follows: chemical shift, multiplicity, coupling constants (Hz), and integration. Carbons 
with directly attached boron atoms were not observed in some compounds, most likely due to 
quadrupolar relaxation.1 High-resolution mass spectrometry was performed on a JEOL AccuTOF 
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Enantiomeric ratios 
were determined by high-performance liquid chromatography (HPLC) with a Shimadzu 
chromatograph (Chiral Technologies Chiralcel OD-H (4.6 x 250 mm), Chiralcel OJ-H (4.6 x 250 
mm), Chiralcel OZ-H (4.6 x 250 mm), Chiralpak AD-H (4.6 x 250 mm), Chiralpak AS-H (4.6 x 
250 mm)) in comparison with authentic racemic materials. Specific rotations were measured using 
either an Atago AP-300 Automated Polarimeter or a Rudolph Research Analytical Autopol IV 
Polarimeter. Unless otherwise noted, all reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with standard 
dry box or vacuum-line techniques. Solvents were purified under a positive pressure of dry argon 
by a modified Innovative Technologies purification system: toluene was purified through a copper 
oxide and alumina column. Dimethoxy ethane and tetrahydrofuran were freshly distilled from a 
sodium and benzophenone ketyl solution. CDCl3 was purchased from Cambridge Isotope 
Laboratories and store over activated 4Å molecular sieves prior to use. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from Fisher 
Scientific) in air. 
 
																																																								
1) Wrackmeyer, B. Prog. NMR Spectrosc. 1979, 12, 227–259. 
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3.5.2 Reagents 
Aldehydes were purchased from commercial sources. Liquid aldehydes were distilled over CaH2 
prior to use. Crystalline aldehydes were purified by silica gel chromatography. 
Allylboronic acid pinacol ester was purchased from Frontier and distilled over CaH2. 
Bis(1,5-cyclooctadiene)nickel(0) (Ni(cod)) was purchased from Strem and used as received.  
1,3-Bis(2,6-diisopropylphenyl)imidazolium chloride (imid-1) was purchased from Strem and 
used as received. 
[(S)-(-)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole][4-cyano-3-
nitrobenzenecarboxylato][1,2,3-η-2-propenyl]iridium(III) was synthesized according to a 
literature procedure.2 
[1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with 
dichloromethane was purchased from Sigma-Aldrich and used as received. 
Bis(pinacolato)diboron was purchased from Frontier Scientific and recrystallized from pentane. 
2-Bromopropene was purchased from Sigma-Aldrich and used as received.  
 (2S)-[(tert-Butoxycarbonyl)amino](3-hydroxytricyclo[3.3.1.13,7]decan-1-yl)ethanoic acid 
was purchased from ArkPharm and used as received. 
Z-2-Butene was purchased from Sigma-Aldrich and stored as a solution in tetrahydrofuran over 
4Å molecular sieves.  
Calcium Hydride was purchased from Strem and used as received. 
Carbon tetrabromide was purchased from Alfa Aesar and used as received.  
Cesium fluoride was purchased from Sigma-Aldrich and used as received. 
Chloro-3-methyl-2-butene was purchased from Alfa Aesar and used as received. 
Chlorotriethylsilane was purchased from Oakwood and used as received.  
Cis-1,1,1,4,4,4,-Hexafluoro-2-butene was purchased from CarboSynth.  
Z-Crotylboronic acid pinacol ester, 97% (Z-1a) was purchased from Sigma-Aldrich or Santa-
Cruz and distilled over CaH2 prior to use. 
Copper(I) chloride was purchased from Strem and used as received. 
Copper(I) iodide was purchased from Strem and used as received. 
d2-Allyl boronic pinacol ester was synthesized according to a literature procedure.3 
2,4-Dibromothiazole was purchased from Combi-Blocks and used as received. 
E-1,2-Dichloroethylene was purchased from TCI and used as received.  
Z-1,2-Dichloroethylene was purchased from TCI and distilled over CaH2 prior to use. 
Dicyclohexylamine was purchased from Sigma-Aldrich and used as received. 
2-Dicyclohexylphosphino-2′,6′-diisopropoxybiphenyl (ruphos) was purchased from Strem and 
used as received. 
																																																								
2) Gao, X.; Townsend, I. A.; Krische, M. J. J. Org. Chem. 2011, 76, 2350–2354.  
3) Sieber, J. D.; Morken, J. P.. J. Am. Chem. Soc. 2008, 130, 4978–4983. 
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(2-Dicyclohexylphosphino-2′,6′-diisopropoxy-1,1′-biphenyl)[2-(2′-amino-1,1′-
biphenyl)]palladium(II) methanesulfonate (ruPhos-Pd-G3) was purchased from Strem and 
used as received. 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC•HCl) was purchased 
from Advanced ChemTech and used as received. 
4-Dimethylaminopyridine was purchased from Oakwood and used as received. 
Di-tert-butylmethylphosphine was purchased from Strem and used as received.  
Z-4-Hexenol was purchased from Alfa Aesar and used as received. 
Hexylzinc bromide solution 0.5 M in THF was purchased from Alfa Aesar and used as received.  
Hydrochloric acid (4M in dioxane) was purchased from Acros and used as received. 
1-Hydroxybenzotriazole hydrate was purchased from Oakwood and used as received. 
Isoindoline hydrochloride was purchased from Combi-Blocks and used as received. 
Magnesium Sulfate was purchased from Oakwood and used as received. 
Magnesium turnings were purchased from Sigma-Aldrich and used as received. 
Methanol was purchased from Acros (99.8% anhydrous) and used as received. 
Methyl chloroformate was purchased Sigma-Aldrich and used as received. 
4-Nitrobenzoyl chloride was purchased from Sigma-Aldrich and used as received. 
N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester was purchased from Alfa Aesar 
and used as received. 
Osmium tetroxide (4 wt % in H2O) was purchased from Strem and used as received. 
Paraformaldehyde was purchased from Sigma-Aldrich and used as received. 
Pinacolborane was purchased from Oakwood and distilled over CaH2 prior to use. 
Potassium phosphate tribasic (K3PO4) was purchased from Fisher Scientific and dried under 
vacuum at 60 °C overnight prior to use. 
Potassium tert-butoxide was purchased from Strem and used as received.  
Propargyl amine was purchased from Combi-Blocks and used as received. 
Sodium borohydride was purchased from Sigma-Aldrich and used as received. 
Sodium periodate was purchased from Alfa Aesar and used as received. 
Sodium tert-Butoxide was purchased from Strem and used as received. 
Tetrakis(triphenylphosphine)palladium(0) was purchased from Strem and used as received.  
Trans-1-octen-1-ylboronic acid pinacol ester was purchased from Sigma-Aldrich and used as 
received.  
Tricyclohexylphosphine was purchased from Strem and used as received.  
Triethylamine was purchased from Sigma-Aldrich and used as received. 
Triphenylphosphine was purchased from Sigma-Aldrich and used as received.  
Tris(dibenzylideneacetone)dipalladium(0) was purchased from Oakwood and used as received.  
Zinc methoxide was purchased from Sigma-Aldrich and used as received. 
(Z)-4,4,5,5-Tetramethyl-2-(2-methylhept-2-en-1-yl)-1,3,2-dioxaborolane (3.95) was prepared 
as described in Scheme 7 of the manuscript. Cross-coupling was carried out under the conditions 
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reported previously,4 and described as follows. In an N2-filled glove box, an oven-dried flask 
equipped with a stir bar was charged with CsF (1.09 g, 7.3 mmol), 1-pentenylboronic acid (376.0 
mg, 3.3 mmol), Pd(PPh3)4 (104.0 mg, 0.09 mmol) and 2-bromopropene (0.27 mL, 3.0 mmol). The 
flask was then equipped with an oven-dried reflux condenser, sealed (septum and electrical tape) 
and removed from the glovebox. The mixture was diluted with benzene (15 mL) and allowed to 
stir for 16 h at 70 °Che mixture was then allowed to cool to 22 °C and pass through a short (~3 cm 
high x 5 cm wide; pentane). The filtrate was concentrated in an ice bath (4 °C) to ~4 mL of solution 
volume to obtain a 4.7 wt% solution of (E)-2-methylhepta-1,3-diene in benzene. Catalytic 1,4-
hydroboration was then performed as described formerly,5 and as follows. In an N2-filled glove 
box, an oven-dried flask equipped with a stir bar was charged with Ni(cod)2 (20.7 mg, 0.075 
mmol), PCy3 (21.0 mg, 0.075 mmol), pinacolborane (0.24 mL, 1.65 mmol) and (E)-2-methylhepta-
1,3-diene (3.47 g, 4.7 wt% in benzene). The flask was sealed (septum and electrical tape) and 
removed from the glovebox and the solution was allowed to stir for 3 h. The volatiles were 
removed to ~20% of the original volume and the resulting oil residue was purified by silica gel 
chromatography (silica gel dried at 130 °C for 12 h before use; 50:1 pentane:Et2O) to afford 3.95 
as colorless oil (266.8 mg, 34% overall yield). IR (neat): 2975 (m), 2924 (m), 1350 (s), 1320 (s), 
1141 (s), 967 (m), 847 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 5.11 (tq, J = 7.1, 1.3 Hz, 1H), 
1.94 (q, J = 6.6 Hz, 2H), 1.73 (q, J = 1.3 Hz, 3H), 1.65 (s, 2H), 1.30 (tt, J = 5.1, 2.4 Hz, 4H), 1.23 
(s, 12H), 0.93 – 0.78 (m, 3H); 13C NMR (150 MHz, CDCl3): δ 167.6, 131.8, 124.0 (d, J = 13.5 
Hz) 97.6, 83.1, 32.0, 28.0, 25.7 (m), 24.7, 22.4, 14.1; HRMS (DART): Calcd for C14H28BO2 
[M+H]+: 239.21769; Found: 239.21758.  
(Z)-2-(3-Chloro-2-methylallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (Z-3.97) was 
synthesized as described in Scheme 7 in the manuscript and described as follows. In a N2-filled 
glovebox, an oven-dried vial equipped with a stir bar was charged with 3.95 (238.0 mg, 1.0 mmol, 
dried azeotropically with anhydrous benzene), trans-1,2-dichloroethylene (484.8 mg, 5.0 mmol) 
and pinacolborane (12.8 mg, 0.1 mmol) and the mixture was allowed to stir for 10 min. A solution 
of Mo-1b (1.0 M in benzene, 300 µL, 0.03 mmol) was added dropwise. The vial was sealed and 
the solution was allowed to stir for 4 h, at which point an aliquot was removed and analyzed by 1H 
NMR spectroscopy, revealing ~98% consumption of 3.95. The vial was removed from the 
glovebox and concentrated to ~50% of the original solution volume and passed through a small (3 
cm high x 1 cm wide) plug of oven-dried silica (20:1 hexanes:Et2O). The volatiles were removed 
in vacuo to afford yellow oil, which was purified by distillation (70–100 °C, 0.5 torr), furnishing 
Z-3.97 as colorless oil. Analytical data is fully consistent with those reported previously.6 
																																																								
4) Burks, H. E.; Kilman, L. T. J. Am. Chem. Soc. 2009, 131, 9134–9135. 
5)  Ely, R. J.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 2534–2535.  
6) Nguyen, T. T.; Koh, M. J. Mann, T. J.; Schrock, R. R.; Hoveyda, A. H. Nature, 2017, 552, 347–354.  
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(Z)-4,4,5,5-tetramethyl-2-(4,4,4-trifluorobut-2-en-1-yl)-1,3,2-dioxaborolane (Z-3.114) was 
synthesized according to a previously reported procedure.7 
 
3.5.3 Olefin Metathesis Complexes 
 
Mo-1a-b,8 Mo-29 and Ru-110 was prepared according to a previously reported procedure, and Mo-




1-(pyrrolidin-1-yl)ethan-1-one (ap-5): White crystalline solid; synthesized according to a 
reported procedure.11 M.p. 155 – 158 °C, IR (neat): 3375 (br, m), 2915 (s), 2849 (m), 1623 (s), 
1427 (s), 1107 (s), 908 (m), 735 (m), 701 (s), 508 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 10.61 
(s, 1H), 7.66 – 7.57 (m, 6H), 7.45 – 7.30 (m, 9H), 7.12 (dd, J = 7.4, 1.7 Hz, 1H), 6.96 (dd, J = 7.4, 
1.7 Hz, 1H), 6.73 (t, J = 7.3 Hz, 1H), 4.23 (d, J = 14.1 Hz, 1H), 3.64 (dt, J = 11.2, 6.6 Hz, 1H), 
3.46 (d, J = 14.1 Hz, 2H), 3.21 (q, J = 8.4, 7.2 Hz, 1H), 3.05 – 2.81 (m, 2H), 2.56 (s, 1H), 2.09 (s, 
2H), 1.85 (td, J = 10.4, 9.1, 4.6 Hz, 4H), 1.60 – 1.37 (m, 10H), 1.27 – 0.96 (m, 4H); 13C NMR 
(150 MHz, CDCl3): δ 170.3, 163.2, 137.9, 136.4, 135.1, 131.1, 129.2, 127.6, 121.3, 120.8, 119.0, 
68.5, 64.7, 50.3, 47.0, 46.4, 45.5, 44.4, 39.7, 37.9, 37.0, 35.2, 30.3, 30.2, 26.2, 24.2; HRMS 
																																																								
7) Koh, M. J.; Nguyen, T. T.; Lam, J. K.; Torker, S. Hyvl, J.; Schrock, R. R.; Hoveyda, A. H. Nature, 2017, 542, 80–
85. 
8) Lam, J. K.; Zhu, C.; Bukhryakov, K. V.; Müller, P.; Hoveyda A.; Schrock, R. R. J. Am. Chem. Soc. 2016, 138, 
15774–15783. 
9) Nguyen, T. T.; Koh, M. J.; Shen, X.; Romiti, F.; Schrock, R. R.; Hoveyda, A. H. Science 2016, 352, 569–575.  
10) Koh, M. J.; Khan, R. K. M.; Torker, S.; Yu, M.; Mikus, M. S.; Hoveyda, A. H. Nature 2015, 517, 181–186. 
11) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H Nature 2013, 
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(DART): Calcd for C41H47N2O3Si [M+H]+: 643.33505; Found: 643.33497; Specific Rotation: 
[a]24.2 23.0° (c 1.0, CHCl3). 
(2S)-2-((2-Hydroxy-3-(triphenylsilyl)benzyl)amino)-2-((1s,3R)-3-hydroxyadamantan-1-yl)-
1-(isoindolin-2-yl)ethan-1-one (ap-6): White crystalline solid; M.p. 142 144 °C, IR (neat): 3303 
(br, m), 2908 (m), 2849 (m), 1632 (s), 1425 (s), 1133 (s), 942 (s), 730 (s), 700 (s), 507 (s) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 10.53 (s, 1H), 7.67 – 7.59 (m, 6H), 7.44 – 7.26 (m, 12H),7.22 – 7.00 
(m, 2H), 6.90 (d, J = 7.3 Hz, 1H), 6.64 (dd, J = 8.3, 6.6 Hz, 1H), 5.01 (d, J = 16.2 Hz, 1H), 4.79 
(d, J = 16.2 Hz, 1H), 4.65 (d, J = 13.6 Hz, 1H), 4.39 (d, J = 13.6 Hz, 1H), 4.25 (d, J = 14.1 Hz, 
1H), 3.48 (d, J = 14.0 Hz, 1H), 3.06 (s, 1H), 2.62 (s, 1H), 2.10 (s, 2H), 1.66 (m, 3H), 1.57 – 1.40 
(m, 7H), 1.36 – 1.11 (m, 5H); 13C NMR (100 MHz, CDCl3): δ 171.1, 163.2, 138.1, 136.4, 135.9, 
135.8, 135.1, 131.3, 129.2, 128.0, 127.7, 127.6, 123.1, 122.6, 121.2, 120.9, 119.2, 68.5, 64.7, 52.7, 
52.0, 50.5, 46.4, 44.5, 44.4, 39.9, 38.1, 37.1, 35.2, 30.3, 30.2; HRMS (DART): Calcd for 
C45H47N2O3Si [M+H]+:691.33505; Found: 691.33623; Specific Rotation: [a]25.2 20.2° (c 0.8, 
CHCl3). 
 
3.5.5 Preparation of Z-Cl-Substituted Allyl Boronate Z-3.66 
 
(Z)-2-(3-Chloroallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (Z-3.66). A previously reported 
procedure was used.12  In a N2-filled glovebox, Z-crotyl–B(pin) (3.62) (4.0 g, 21.9 mmol) and Z-
dichloroethylene (6.4 g, 66 mmol) were added to an oven-dried 40 mL vial equipped with a stir 
bar. Pinacolborane (320 µL, 2.2 mmol) was added (gentle release of gas). The mixture was sealed 
with a cap and allowed to stir for 10 min (22 °C). A solution of Mo-2 (333 mg, 0.35 mmol) in 
benzene (3.5 mL) was slowly added to the solution. The vial was capped and the mixture was 
allowed to stir for 1 h. The vial was removed from the glovebox and the volatiles were evaporated 
in vacuo. The resulting black oil residue was purified by (short path) distillation to afford the 
desired product as colorless oil (4.3 g, 96% yield, >98:2 Z:E). When performing the cross-
metathesis reaction with complex Mo-1c, the volatiles must first be removed from the unpurified 
mixture, the residue triturated with pentane and then passed through a small cotton plug prior to 
distillation to afford yellow oil.  
 
																																																								
12) (a) Nguyen, T. T.; Koh, M. J.; Mann, T. J.; Schrock, R. R.; Hoveyda, A. H. Nature 2017, 552, 347–354. (b) Mu, 





10 mol % HB(pin) (used as received),
15 min, 22 °C;
1.6 mol % Mo-2,
benzene, 1 h, 22 °C; distillation Z-3.66
>98% conv, 96% yield,
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3.5.6 Representative Procedure for Catalytic Enantioselective Additon 
In a N2-filled glovebox, a stock solution of ap-6 and zinc(II) methoxide was prepared. An oven-
dried vial (8 mL) equipped with a stir bar was charged with aminophenol (ap-6) (5.5 mg, 0.008 
mmol), zinc methoxide (5.1 mg, 0.04 mmol) and toluene (2.0 mL). The freshly prepared stock 
solution was allowed to stir for 15 min at 22 °C. In another vial (8 mL), aldehyde (0.15 mmol) was 
weighed out. The aminophenol/Zn(OMe)2 stock solution was then added by syringe (500 µL). Z-
Chloro-allyl–B(pin) (Z-3.66) (20.2 mg, 0.1 mmol), was added followed by MeOH (5 µL, 0.13 
mmol). The reaction vessel was equipped with a stir bar, sealed with a cap removed from the 
glovebox. The mixture was allowed to stir for 14 h at 22 °C, at which time the reaction was 
quenched by the addition of MeOH (1.5 mL). The mixture was then allowed to stir for 0.5 h at 22 
°C. The volatiles were removed in vacuo and the resulting opaque oil was purified by silica gel 
chromatography (10:1–4:1 hexanes:Et2O) to afford the desired homoallylic alcohol typically as 
colorless oil). 
 
3.5.7 Terminal Olefin Approach 
 
Enantiomerically enriched homoallylic alcohol S-1 was synthesized according to a previously 
reported procedure,2 and as follows. In a N2-filled glovebox, an oven-dried vial equipped with a 
magnetic stir bar was charged with aldehyde 3.107 (46.8 mg, 0.2 mmol), Ir-1 (10.3 mg, 0.01 
mmol), K3PO4 (21.5 mg, 0.1 mmol) and thf (1.0 mL). The vial was sealed (septum and electrical 
tape) before being removed from the glovebox. Isopropanol (31 µL, 0.4 mmol), H2O (18 µL, 1.0 
mmol) and allyl acetate (214 µL, 2.0 mmol) were added sequentially and the mixture was allowed 
to stir for 30 min before being placed in an oil bath at 60 °C and allowed to stir for 48 h. The 
mixture was then allowed to cool to 22 °C and the volatiles were removed in vacuo to afford yellow 
oil (1H NMR analysis revealed ~83% consumption of 3.107), which was purified by silica gel 
chromatography (gradient 100:0 → 3:1 hexanes:Et2O) to afford colorless oil (28.4 mg, 52% yield). 
Please note: this yield is unoptimized. An oven-dried vial was charged with a solution of the 
aforementioned homoallylic alcohol in CH2Cl2 (1.0 mL), imidazole (10.5 mg, 0.15 mmol) and 

































2.0 equiv i-PrOH, thf, 48 h, 60 °C
2. 1.0 equiv TESCl, 10 mol % dmap,












10 mol % HB(pin), 3.0 equiv Z-diCl-ethene,
benzene, 4 h, 22 °C
2. 1.5 equiv (n-Bu)4NF, thf, 3 h, 22 °C
1. 5.0 mol %
Mo-1a
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in vacuo to afford white oil, which was purified by silica gel chromatography (gradient 100:0 to 
10:1 hexanes:Et2O) to afford S-1 as colorless oil (39.1 mg, 82% yield).  
(R)-4-Bromo-2-(2-methyl-3-((triethylsilyl)oxy)hex-5-en-2-yl)thiazole (S-1): IR (neat): 2952 
(m), 2873 (m), 1463 (m), 1257 (s), 1097 (s), 1002 (s), 910 (m), 725 (s) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.09 (s, 1H), 5.85–5.52 (m, 1H), 5.10–4.74 (m, 2H), 4.01 (dd, J = 7.0, 4.0 Hz, 1H), 
2.52–2.17 (m, 1H), 2.10–1.89 (m, 1H), 1.43 (s, 3H), 1.36 (s, 3H), 0.93 (t, J = 7.9 Hz, 9H), 0.68–
0.22 (m, 6H); 13C NMR (100 MHz, CDCl3): δ 179.5, 135.9, 123.7, 116.5, 116.1, 79.2, 46.6, 38.3, 
25.6, 24.5, 7.0, 5.3; HRMS (DART): Calcd for C16H29OSiSBr [M+H]+: 390.09170; Found: 
390.09159; Specific Rotation: [a]23.8 2.0° (c 1.2, CHCl3) for a 99:1 er sample of the derived  
alcohol. Enantiomeric purity of the derived alcohol was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AZ-H, 99:1 hexanes:i-PrOH, 1.0 mL/min, 
220 nm): tR: 15.4 min (minor) and 16.6 min (major).  
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 15.993 min 5059768 49.914 1 15.347 min 37804 0.876 
2 17.531 min 5077111 50.086 2 16.649 min 4280228 99.124 
In a N2-filled glovebox, an oven-dried vial equipped with a stir bar was charged with S-1 (39.0 
mg, 0.1 mmol, azeotropically dried with anhydrous benzene), cis-1,2-dichloroethylene (29.1 mg, 
0.3 mmol), and pinacolborane (1.3 mg, 0.01 mmol) and the mixture was allowed to stir for 10 min. 
To the solution was added a solution of Mo-1a (1.0 M in benzene, 50 µL, 0.005 mmol) dropwise. 
The vial was sealed and the mixture was allowed to stir for 4 h, at which point an aliquot was 
removed and analyzed by 1H NMR spectroscopy, revealing ~48% consumption of S-1. The vial 
was removed from the glovebox and the volatiles were removed in vacuo to afford brown oil, 
which was diluted with thf (0.5 mL). Tetra(n-butyl)ammonium fluoride (0.15 mL, 1M in thf) was 
added and allowed to stir for 3 h. The mixture was concentrated to afford brown oil, which was 
purified by silica gel chromatography (100:0 → 3:1 hexanes:Et2O) to afford afford 3.109 as 
colorless oil (10.5 mg, 34% overall yield). (R,Z)-2-(4-Bromothiazol-2-yl)-6-chloro-2-
methylhex-5-en-3-ol (Z-3.109). IR (neat): 3421 (br, m), 2968 (m), 2931 (w), 1630 (w), 1465 (s), 
1387 (m), 1366 (m), 1257 (s), 1081 (s), 1050 (s), 885 (m), 838 (m), 748 (s) cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.14 (s, 1H), 6.09 (dt, J = 7.1, 1.5 Hz, 1H), 5.95 (q, J = 7.0 Hz, 1H), 3.82 (ddd, J 
= 10.2, 6.3, 2.7 Hz, 1H), 3.52 (dd, J = 6.3, 0.6 Hz, 1H), 2.56–2.47 (m, 1H), 2.15 (dddd, J = 14.8, 
10.2, 6.6, 1.5 Hz, 1H), 1.47 (s, 3H), 1.43 (s, 3H); 13C NMR (150 MHz, CDCl3): 179.9, 128.9, 
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124.3, 119.5, 116.0, 77.5, 45.3, 30.1, 26.7, 24.0; HRMS (DART): Calcd for C10H14BrClNOS 
[M+H]+: 309.9668; Found: 309.9673. 
 
3.5.8 Addition of d2-Allyl–B(pin)  
In a N2-filled glovebox, an oven-dried vial containing a magnetic stir bar was charged with ap-2 
(5.1 mg, 0.01 mmol), zinc(II) methoxide (2.6 mg, 0.02 mmol) and toluene (2.0 mL). The mixture 
was allowed to stir for 10 min at 22 °C. A separate oven dried vial was charged with benzaldehyde 
(20 µL, 0.2 mmol), and was then charged with the initial stock solution of ap-2/Zn(OMe)2 (1.0 
mL), which was added by syringe. d2-Allyl–B(pin) (41.0 mg, 0.24 mmol) was added followed by 
MeOH (11 µL), and the vial was sealed (septum and electrical tape) and removed from the 
glovebox, and the mixture was allowed to stir for 24 h at 22 °C. The reaction was quenched by the 
addition of MeOH (1.5 mL) and the mixture was allowed to stir for 30 min at 22 °C. The volatiles 
were removed in vacuo and the resulting opaque oil was purified by silica gel chromatography 
(gradient 10:1–4:1 hexanes:Et2O) to afford the desired homoallylic alcohol as colorless oil with 
spectral data in agreement with the previously reported values. 13  Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralcel OD-H, 
98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 25.3 min (minor) and 28.8 min (major). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 36.430 min 525281 50.260 1 35.939 min 5046888 36.738 
2 40.740 min 519838 49.740 2 40.260 min 8690486 63.262 
 
3.5.9 Analytical Data for Addition of Chloro–Substituted Allyl Boronates  
 (R,Z)-4-Chloro-1-phenylbut-3-en-1-ol (Z-3.72): Following the general procedure for addition, 
benzaldehyde (15.9 mg, 0.15 mmol) was transferred to an oven-dried vial to afford the title 
compound as colorless oil (17.4 mg, 0.095 mmol). IR (neat): 3366 (br, m), 1630 (w), 1453 (w), 
1335 (w), 1307 (w), 1053 (m), 743 (m), 699 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.41–7.34 
																																																								
13) Kobayashi, S.; Endo, T.; Yoshino, T.; Schneider, U.; Ueno, M. Chem. Asian J. 2013, 8, 2033-2045.  
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(m, 4H), 7.32–7.27 (m, 1H), 6.14 (dt, J = 7.1, 1.6 Hz, 1H), 5.84 (q, J = 7.1 Hz, 1H), 4.82 (ddd, J 
= 7.6, 5.6, 3.5 Hz, 1H), 2.86–2.60 (m, 2H), 1.90 (d, J = 3.5 Hz, 1H); 13C NMR (150 MHz, CDCl3): 
δ 143.8, 128.7, 128.0, 127.6, 125.9, 120.5, 73.4, 36.8; HRMS (DART): Calcd for C10H10Cl 
[M+H–H2O]+: 165.0471; Found: 165.0469; Specific Rotation: [a]24.6 +46.6° (c 1.0, CHCl3) for a 
95:5 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AZ-H, 99:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 25.3 
min (minor) and 28.8 min (major). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 22.454 min 5857752 48.093 1 25.280 min 462755 4.581 
2 25.616 min 6322284 51.907 2 28.823 min 9638657 95.419 
(R,Z)-4-Chloro-1-(o-tolyl)but-3-en-1-ol (Z-3.73): Following the general procedure for addition, 
2-methylbenzaldehyde (18.0 mg, 0.15 mmol) was transferred to an oven-dried vial  to afford the 
title compound as colorless oil (16.3 mg, 0.083 mmol). IR (neat): 3365 (br, m), 2924 (w), 1629 
(m), 1459 (m), 1331 (m), 1046 (s), 743 (s) cm-1; H NMR (400 MHz, CDCl3): δ 7.50 (dd, J = 7.6, 
1.5 Hz, 1H), 7.24–7.10 (m, 3H), 6.29–6.08 (m, 1H), 5.89 (q, J = 7.1 Hz, 1H), 5.04 (ddd, J = 8.0, 
4.9, 3.0 Hz, 1H), 3.01–2.46 (m, 2H), 2.36 (s, 3H), 1.82 (d, J = 3.3 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δ 141.7, 134.5, 130.5, 127.7, 127.5, 126.3, 125.1, 120.2, 69.7, 35.5, 19.0; HRMS 
(DART): Calcd for C11H12Cl [M+H–H2O]+: 179.06220; Found: 179.06140; Specific Rotation: 
[a]25.4 +47.3° (c 0.77, CHCl3) for a 95:5 er sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:i-PrOH, 
0.7 mL/min, 220 nm): tR: 27.7 min (major) and 32.5 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 28.050 min 1653422 51.909 1 27.733 min 22833378 94.605 
2 32.643 min 1531810 48.091 2 32.488 min 13202195 5.395 
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(R,Z)-4-(4-Chloro-1-hydroxybut-3-en-1-yl)-3,5-difluorobenzonitrile (Z-3.74): Following the 
general procedure, except the reaction was carried out at 40 °C,  3,5-Difluoro-4-formylbenzonitrile 
(25.0 mg, 0.15 mmol) was transferred to an oven-dried vial to afford the title compound as 
colorless oil (21.0 mg, 0.086 mmol). IR (neat): 3443 (br, m), 2237 (w), 1626 (m), 1573 (s), 1423 
(s), 1320 (s), 1203 (m), 1190 (m), 1048 (s), 1018 (s), 971 (m), 863 (s), 755 (m), 727 (m), 710 (m) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.25–7.18 (m, 2H), 6.17 (dt, J = 7.2, 1.5 Hz, 1H), 5.81 (q, 
J = 7.2 Hz, 1H), 5.18 (dt, J = 8.8, 7.1 Hz, 1H), 2.98–2.79 (m, 2H), 2.35 (dt, J = 8.8, 1.9 Hz, 1H); 
13C NMR (100 MHz, CDCl3): δ 160.8 (dd, J = 252.2, 9.2 Hz), 125.7, 124.8 (t, J = 16.4 Hz), 
121.9, 116.4 (t, J = 3.5 Hz), 116.1 (dd, J = 21, 9.0 Hz), 113.2 (t, J = 12.6 Hz), 65.3, 34.6; 19F 
NMR (376 MHz, CDCl3): δ –110.74 (d, J = 6.7 Hz). HRMS (DART): Calcd for C11H9NOF2Cl 
[M+H]+: 244.03352; Found: 244.03341; Specific Rotation: [a]20.0D +25.1° (c 1.25, CHCl3) for a 
94:6 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AD-H, 95:5 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 12.6 
min (minor) and 14.5 min (major). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 12.705 min 5263289 49.662 1 12.602 min 715068 5.788 
2 14.704 min 5334966 50.338 2 14.536 min 11639151 94.212 
(R,Z)-1-(6-Bromonaphthalen-2-yl)-4-chlorobut-3-en-1-ol (Z-3.75): Following the general 
procedure for addition, 6-Bromo-2-napthaldehyde (35.3 mg, 0.15 mmol) was transferred to an 
oven-dried vial to afford the title compound as colorless oil (29.6 mg, 0.095 mmol). IR (neat): 
3387 (br, m), 1630 (m), 1590 (m), 1497 (m), 1463 (w), 1337 (m), 1314 (m), 1161 (m), 1127 (m), 
1061 (s), 877 (s), 805 (s), 746 (s), 475 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.99 (d, J = 1.9 
Hz, 1H), 7.77 (d, J = 1.1 Hz, 1H), 7.74 (d, J = 8.6 Hz, 1H), 7.69 (d, J = 8.7 Hz, 1H), 7.55 (dd, J 
= 8.7, 2.0 Hz, 1H), 7.51 (dd, J = 8.5, 1.7 Hz, 1H), 6.15 (dt, J = 7.1, 1.5 Hz, 1H), 5.83 (q, J = 7.1 
Hz, 1H), 4.96 (td, J = 6.8, 2.9 Hz, 1H), 2.85 – 2.71 (m, 2H), 2.13 (d, J = 3.2 Hz, 1H); 13C NMR 
(150 MHz, CDCl3): 141.7, 134.2, 131.8, 129.9, 129.8, 129.7, 127.6, 127.3, 125.0, 124.6, 120.8, 
120.1, 73.3, 36.7; HRMS (DART): Calcd for C14H11BrCl [M+H–H2O]+: 292.9733; Found: 
292.9737; Specific Rotation: [a]24.6D +13.5° (c 1.97, CHCl3) for a 96:4 er sample. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material (Chiralcel 
OJ-H, 96:5 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 55.5 min (minor) and 74.7 min (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 56.560 min 37160771 48.726 1 55.570 min 4473795 3.615 
2 77.272 min 39103354 51.274 2 74.720 min 119267933 96.385 
(R,Z)-4-Chloro-1-(3-chlorophenyl)but-3-en-1-ol (Z-3.76): Following the general procedure for 
addition, 3-Chlorobenzaldehyde (21.1 mg, 0.15 mmol) was transferred to an oven-dried vial to 
afford the title compound as colorless oil (19.5 mg, 0.090 mmol). IR (neat): 3352 (br, m), 2912 
(w), 1630 (m), 1596 (m), 1573 (m), 1431 (s), 1199 (s), 1052 (s), 787 (s), 751 (s), 696 (s) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.38 (td, J = 1.7, 0.8 Hz, 1H), 7.34–7.19 (m, 3H), 6.16 (dt, J = 7.2, 
1.5 Hz, 1H), 5.81 (q, J = 7.2 Hz, 1H), 4.98–4.65 (m, 1H), 2.69 (dddq, J = 7.2, 5.7, 2.9, 1.5 Hz, 
2H), 1.98 (d, J = 3.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 145.6, 134.4, 129.8, 127.9, 126.9, 
126.0, 123.9, 120.9, 72.6, 36.6; HRMS (DART): Calcd for C10H9Cl2 [M+H–H2O]+: 199.00758; 
Found: 199.00699; Specific Rotation: [a]21.8D +22.2° (c 0.83, CHCl3) for a 93:7 er sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak OD-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 18.7 min (minor) and 
21.2 min (major). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 19.310 min 9399265 48.221 1 18.679 min 2978878 6.757 
2 22.644 min 10092938 51.779 2 21.191 min 44084786 93.243 
 (R,Z)-1-(4-(4-Chloro-1-hydroxybut-3-en-1-yl)phenyl)ethan-1-one (Z-3.77): Following the 
general procedure for addition, 4-Acetylbenzaldehyde (22.2 mg, 0.15 mmol) was transferred to an 
oven-dried vial to afford the title compound as colorless oil (20.7 mg, 0.092 mmol). IR (neat): 
3424 (br, m), 1671 (w), 1630 (w), 1607 (s), 1412 (m), 1359 (s), 1304 (m), 1268 (s), 1065 (m), 853 
(m), 752 (m), 722 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.95 (d, J = 8.3 Hz, 2H), 7.47 (d, J 
	
 Page 499 
= 8.3 Hz, 2H), 6.16 (dt, J = 7.1, 1.5 Hz, 1H), 5.82 (q, J = 7.1 Hz, 1H), 4.90 (td, J = 6.4, 3.2 Hz, 
1H), 2.74–2.69 (m, 2H), 2.60 (s, 3H), 2.10 (d, J = 3.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 
197.9, 149.0, 136.6, 128.7, 126.9, 126.0, 121.0, 72.7, 36.7, 26.7; HRMS (DART): Calcd for 
C12H14O2Cl [M+H]+: 225.06768; Found: 225.06659; Specific Rotation: [a]20.0D +21.4° (c 1.33, 
CHCl3) for a 88:12 er sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AD-H, 95:5 hexanes:i-PrOH, 1.0 mL/min, 
220 nm): tR: 22.0 min (major) and 23.8 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 21.877 min 6743165 50.457 1 22.005 min 10588026 88.248 
2 23.679 min 6621097 49.543 2 23.876 min 1410016 11.752 
(R,Z)-4-Chloro-1-(4-methoxyphenyl)but-3-en-1-ol (Z-3.78): Following the general procedure 
for addition, 4-Methoxybenzaldehyde (20.4 mg, 0.15 mmol) was transferred to an oven-dried vial 
to afford the title compound as colorless oil (19.6 mg, 0.092 mmol).  IR (neat): 3407 (br, m), 1611 
(m), 1512 (s), 1463 (w), 1441 (w), 1303 (m), 1246 (s), 1175 (m), 1034 (s), 832 (m), 746 (m) cm-
1; 1H NMR (600 MHz, CDCl3): δ 7.31 – 7.28 (m, 2H), 6.91 – 6.87 (m, 2H), 6.12 (dt, J = 7.1, 1.5 
Hz, 1H), 5.80 (q, J = 7.1 Hz, 1H), 4.75 (ddd, J = 7.8, 5.6, 2.3 Hz, 1H), 3.81 (s, 3H), 2.73 (dddd, J 
= 14.8, 7.6, 7.0, 1.5 Hz, 1H), 2.65 (dddd, J = 14.7, 7.1, 5.6, 1.6 Hz, 1H), 1.95 (d, J = 3.1 Hz, 1H); 
13C NMR (150 MHz, CDCl3): δ 159.3, 135.9, 127.7, 127.2, 120.3, 114.0, 72.9, 55.4, 36.7; HRMS 
(DART): Calcd for C11H12OCl [M+H–H2O]+: 195.05712; Found: 195.05662; Specific Rotation: 
[a]20.0D +28.1° (c 1.00, CHCl3) for a 89:11 er sample. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (Chiralcel OD-H, 98:2 hexanes:i-
PrOH, 1.0 mL/min, 220 nm): tR: 27.0 min (major) and 29.1 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 27.804 min 10380801 51.528 1 27.022 min 71138610 89.010 
2 29.898 min 9756582 48.429 2 29.151 min 8783690 10.990 
(R,Z)-4-Chloro-1-(4-(methylthio)phenyl)but-3-en-1-ol (Z-3.79): Following the general 
procedure for addition, 4-(Methylthio)benzaldehyde (22.8 mg, 0.15 mmol) was transferred to an 
oven-dried vial to afford the title compound as colorless oil (20.6 mg, 0.090 mmol).  IR (neat): 
3377 (br, m), 2920 (m), 1630 (m), 1599 (m), 1494 (s), 1435 (m), 1406 (m), 1300 (m), 1092 (s), 
1055 (s), 1014 (m), 968 (m), 821 (m), 749 (s), 729 (s), 712 (s) cm-1; 1H NMR (400 MHz, CDCl3): 
δ 7.38 – 7.10 (m, 4H), 6.14 (dt, J = 7.1, 1.6 Hz, 1H), 5.81 (q, J = 7.1 Hz, 1H), 4.78 (ddd, J = 7.4, 
5.5, 3.4 Hz, 1H), 2.85 – 2.59 (m, 2H), 2.49 (s, 3H), 1.91 (d, J = 2.1 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δ 140.6, 138.0, 127.4, 126.8, 126.4, 120.5, 72.9, 36.7, 16.0; HRMS (DART): Calcd for 
C11H12SCl [M+H–H2O]+: 211.03428; Found: 211.03309; Specific Rotation: [a]20.0D +16.0° (c 
1.35, CHCl3) for a 90:10 er sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AZ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 
220 nm): tR: 26.9 min (major) and 25.2 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 25.083 min 25284391 48.507 1 25.270 min 2994430 10.124 
2 26.848 min 26840597 51.493 2 26.952 min 26583250 89.876 
(R,Z)-1-(Benzo[d][1,3]dioxol-5-yl)-4-chlorobut-3-en-1-ol (Z-3.80): Following the general 
procedure for addition, Piperonal (22.5 mg, 0.15 mmol) was transferred to an oven-dried vial to 
afford the title compound as colorless oil (21.5 mg, 0.095 mmol).  IR (neat): 3384 (br, m), 2894 
(w), 1738 (m), 1503 (m), 1487 (s), 1442 (m), 1365 (w), 1321 (w), 1244 (s), 1095 (w), 1039 (s), 
933 (m), 747 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.89 (dd, J = 1.7, 0.5 Hz, 1H), 6.82 (ddd, 
J = 7.9, 1.7, 0.5 Hz, 1H), 6.78 (dd, J = 7.9, 0.5 Hz, 1H), 6.13 (dt, J = 7.2, 1.6 Hz, 1H), 5.96 (s, 
2H), 5.80 (q, J = 7.1 Hz, 1H), 4.73 (ddd, J = 7.7, 5.6, 3.3 Hz, 1H), 2.77 – 2.57 (m, 2H), 1.85 (d, J 
= 3.3 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 147.9, 147.2, 137.8, 127.5, 120.4, 119.3, 108.2, 
106.4, 101.1, 73.2, 36.8; HRMS (DART): Calcd for C11H10O2Cl [M+H–H2O]+: 209.03638; 
Found: 209.03521; Specific Rotation: [a]20.0D +16.9° (c 1.40, CHCl3) for a 95:5 er sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AZ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 37.9 min (major) and 
35.5 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 35.962 min 5711093 48.930 1 35.506 min 399379 5.163 
2 38.686 min 5960792 51.070 2 37.992 min 7336485 94.837 
tert-Butyl-(R,Z)-3-(4-Chloro-1-hydroxybut-3-en-1-yl)-1H-indole-1-carboxylate (Z-3.81): 
Following the general procedure for addition, tert-Butyl 3-formyl-1H-indole-1-carboxylate (36.8 
mg, 0.15 mmol) was transferred to an oven-dried vial to afford the title compound as colorless oil 
(30.9 mg, 0.096 mmol). IR (neat): 3421 (br, w), 2979 (w), 1732 (s), 1452 (s), 1370 (s), 1255 (m), 
1224 (m), 1156 (s), 1090 (m), 1056 (w), 1019 (w), 856 (w), 766 (m), 746 (s) cm-1; 1H NMR (500 
MHz, CDCl3): δ 8.15 (d, J = 5.9 Hz, 1H), 7.68 (d, J = 7.8 Hz, 1H), 7.58 (s, 1H), 7.33 (d, J = 8.1 
Hz, 1H), 7.25 (t, J = 7.5 Hz, 1H), 6.17 (dd, J = 7.2, 1.4 Hz, 1H), 5.97 – 5.87 (m, 1H), 5.08 (t, J = 
6.7 Hz, 1H), 3.03 – 2.77 (m, 2H), 2.08 (s, 1H), 1.67 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 
149.7, 135.9, 128.5, 127.7, 127.5, 124.9, 124.5, 123.2, 123.0, 122.8, 122.5, 122.4, 120.6, 120.4, 
119.9, 119.6, 115.5, 83.9, 67.2, 66.7, 35.1, 28.3, 28.2 (extra peaks were observed due to rotamers); 
HRMS (DART): Calcd for C17H19NO2Cl [M+H–H2O]+: 304.10988; Found: 304.10987; Specific 
Rotation: [a]20.0D +19.5° (c 1.35, CHCl3) for a 96:4 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralcel OD-H, 
98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 17.9 min (major) and 20.3 min (minor). 
  
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 17.803 min 25116671 51.727 1 17.987 min 42194991 96.228 
2 21.199 min 23439094 48.273 2 20.314 min 1653955 3.772 
(R,Z)-4-Chloro-1-(pyridin-3-yl)but-3-en-1-ol (Z-3.82):  Following the general procedure for 
addition, (16.1 mg, 0.15 mmol) was transferred to an oven-dried vial and purified by silica gel 
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chromatography (gradient eluting with 100:0 → 95:5 CH2Cl2:MeOH) to afford the title compound 
as colorless oil (16.7 mg, 0.091 mmol). IR (neat): 3184 (br, s), 2916 (br, m), 2854 (br, m), 1630 
(w), 1594 (w), 1580 (w), 1480 (w), 1427 (m), 1339 (w), 1314 (w), 1071 (m), 1028 (m), 748 (m), 
712 (s) cm-1; 1H NMR (400 MHz, CDCl3): 8.60 (d, J = 2.3 Hz, 1H), 8.54 (dd, J = 4.9, 1.7 Hz, 
1H), 7.74 (dddd, J = 7.9, 2.3, 1.7, 0.6 Hz, 1H), 7.35 – 7.27 (m, 1H), 6.18 (dt, J = 7.2, 1.5 Hz, 1H), 
5.83 (q, J = 7.2 Hz, 1H), 4.94 – 4.85 (m, 1H), 2.89 – 2.62 (m, 2H), 2.18 (s, 1H); 13C NMR (150 
MHz, CDCl3): δ  148.9, 147.6, 139.4, 133.8, 126.8, 123.6, 121.0, 70.8, 36.7; HRMS (DART): 
Calcd for C9H11ClNO [M+H]+: 184.0529; Found: 184.053; Specific Rotation: [a]20.0D +28.8° (c 
1.27, CHCl3) for a 94:6 er sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AZ-H, 97:3 hexanes:i-PrOH, 1.0 mL/min, 
254 nm): tR: 112.0 min (minor) and 146.1 min (major). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 104.526 min 3280059 48.927 1 112.020 min 258022 5.593 
2 139.047 min 3423948 51.073 2 146.122 min 4355131 94.407 
 
(S,Z)-6-Chloro-1-phenylhex-5-en-3-ol (Z-3.83): IR (neat): 3356 (br, m), 2924 (m), 1630 (m), 
1495 (w), 1453 (m), 1331 (w), 1081 (m), 1046  (m), 1030 (m), 931 (w), 861 (m), 744 (s), 696 (s) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.37 – 7.27 (m, 2H), 7.20 (ddt, J = 10.6, 6.4, 1.6 Hz, 3H), 
6.17 (dt, J = 7.1, 1.6 Hz, 1H), 5.87 (q, J = 7.2 Hz, 1H), 3.83 – 3.72 (m, 1H), 2.81 (ddd, J = 13.8, 
8.4, 6.6 Hz, 1H), 2.76 – 2.65 (m, 1H), 2.51 – 2.42 (m, 2H), 1.90 – 1.78 (m, 2H), 1.46 (d, J = 4.9 
Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 141.9, 128.5, 128.5, 127.7, 126.0, 120.4, 70.3, 38.7, 
35.2, 32.1; HRMS (DART): Calcd for C11H14BrF3NSO [M+H–H2O]+: 193.0784; Found: 
193.0783; Specific Rotation: [α]21.5D –27.4° (c 1.82, CHCl3) for a 79:21 er sample. Enantiomeric 
purity was determined by HPLC analysis in comparison with authentic racemic material (Chiralcel 
OD-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 29.1 min (major) and 46.9 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 29.727 min 1923131 50.679 1 29.179 min 3237834 79.212 
2 47.099 min 1871631 49.321 2 46.991 min 849731 20.788 
 
 (R,1E,5Z)-6-Chloro-2-methyl-1-(2-methylthiazol-4-yl)hexa-1,5-dien-3-ol (Z-3.84): Following 
the general procedure for addition, (E)-2-methyl-3-(2-methylthiazole-4-yl)acrylaldehyde (25.1 
mg, 0.15 mmol) was transferred to an oven-dried vial. The reaction was quenched by addition of 
a saturated aqueous solution of sodium periodate (1.0 mL), extracted with ethyl acetate, dried over  
MgSO4 and concentrated to afford an unpurified residue that was purified by silica gel 
chromatography to afford the title compound as colorless oil (20.9 mg, 0.086 mmol). IR (neat): 
3282 (br, s), 2921 (m), 1630 (w), 1507 (m), 1438 (m), 1306 (m), 1188 (s), 1046 (s), 879 (m), 746 
(s) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.94 (s, 1H), 6.56 (tt, J = 1.1, 0.6 Hz, 1H), 6.12 (ddd, J 
= 7.1, 1.8, 1.3 Hz, 1H), 5.85 (q, J = 7.0 Hz, 1H), 4.28 (t, J = 6.5 Hz, 1H), 2.70 (s, 2H), 2.67 – 2.51 
(m, 2H), 2.41 (s, 1H), 2.04 (d, J = 1.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.8, 152.6, 
141.4, 127.7, 120.1, 119.4, 115.8, 76.3, 33.1, 19.2, 14.3; HRMS (DART): Calcd for C11H14NOSCl 
[M+H]+: 243.04791; Found: 243.04791; Specific Rotation: [a]25.0D +13.9° (c 1.44, CHCl3) for a 
98:2 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AZ-H, 94:6 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 18.8 
min (major) and 15.9 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 15.708 min 23419221 48.167 1 15.959 min 462922 1.959 
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2 18.705 min 25201872 51.833 2 18.877 min 23169985 98.041 
(R,1Z,5Z)-2-Bromo-6-chloro-1-phenylhexa-1,5-dien-3-ol (Z-3.85): Following the general 
procedure for addition, 𝛼-Bromocinnamaldehyde (31.7 mg, 0.15 mmol) was transferred to an 
oven-dried vial to afford the title compound as colorless oil (27.1 mg, 0.095 mmol).  IR (neat): 
3381 (br, m), 1631 (w), 1491 (w), 1445 (w), 1338 (w), 1303 (w), 1275 (w), 1050 (m), 1030 (m), 
920 (w), 867 (w), 752 (s), 717 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.72 – 7.53 (m, 2H), 7.43 
– 7.29 (m, 3H), 7.09 (s, 1H), 6.20 (dt, J = 7.1, 1.5 Hz, 1H), 5.86 (q, J = 7.1 Hz, 1H), 4.40 (q, J = 
6.3 Hz, 1H), 2.76 (tt, J = 7.0, 1.6 Hz, 2H), 2.18 (d, J = 6.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): 
δ 134.9, 129.2, 128.9, 128.7, 128.4, 128.3, 126.5, 121.0, 76.4, 33.8; HRMS (DART): Calcd for 
C12H11BrCl [M+H–H2O]+: 268.9733; Found: 268.9736; Specific Rotation: [a]25.3D –31.4° (c 2.4, 
CHCl3) for a 95:5 er sample. Enantiomeric purity was determined by HPLC analysis in comparison 
with authentic racemic material (Chiralcel OZ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 
11.1 min (major) and 12.5 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 10.577 min 7137557 50.882 1 11.135 min 21193634 95.878 
2 11.865 min 6890042 49.118 2 12.547 min 911046 4.122 
(S,Z)-6-Chloro-1-phenylhex-5-en-3-ol (Z-3.86): Following the general procedure for addition, 
hydrocinnamaldehyde (20.1 mg, 0.15 mmol) was transferred to an oven-dried vial to afford the 
title compound as colorless oil (18.5 mg, 0.088 mmol).  IR (neat): 3356 (br, m), 2924 (m), 1630 
(m), 1495 (w), 1453 (m), 1331 (w), 1081 (m), 1046  (m), 1030 (m), 931 (w), 861 (m), 744 (s), 696 
(s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.37 – 7.27 (m, 2H), 7.20 (ddt, J = 10.6, 6.4, 1.6 Hz, 
3H), 6.17 (dt, J = 7.1, 1.6 Hz, 1H), 5.87 (q, J = 7.2 Hz, 1H), 3.83 – 3.72 (m, 1H), 2.81 (ddd, J = 
13.8, 8.4, 6.6 Hz, 1H), 2.76–2.65 (m, 1H), 2.51–2.42 (m, 2H), 1.90–1.78 (m, 2H), 1.46 (d, J = 4.9 
Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 141.9, 128.5, 128.5, 127.7, 126.0, 120.4, 70.3, 38.7, 
35.2, 32.1; HRMS (DART): Calcd for C12H13ClO [M+H–H2O]+: 193.0784; Found: 193.0783; 
Specific Rotation: [a]21.5D –27.4° (c 1.82, CHCl3) for a 79:21 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralcel OD-H, 
98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 29.1 min (major) and 46.9 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 29.727 min 1923131 50.679 1 29.179 min 3237834 79.212 
2 47.099 min 1871631 49.321 2 46.991 min 849731 20.788 
(R,Z)-4-Chloro-1-cyclohexylbut-3-en-1-ol (Z-3.87): Following the general procedure for 
addition, (16.8 mg, 0.15 mmol) was transferred to an oven-dried vial that was carefully 
concentrated under reduced pressure in an ice-bath to afford the title compound as volatile 
colorless oil (15.1 mg, 0.080 mmol).  IR (neat): 3361 (br, m), 2922 (s), 2851 (s), 1449 (m), 1334 
(w), 1102 (w), 1086 (w), 1059 (w), 1036 (m), 892 (w), 860 (w), 748 (m), 714 (m) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 6.14 (dt, J = 7.1, 1.6 Hz, 1H), 5.90 (q, J = 7.1 Hz, 1H), 3.53–3.42 (m, 1H), 
2.47 (dddd, J = 15.0, 6.9, 4.0, 1.7 Hz, 1H), 2.43–2.32 (m, 1H), 1.87 (dtt, J = 12.2, 3.3, 1.8 Hz, 
1H), 1.83–1.73 (m, 2H), 1.69 (dddd, J = 13.9, 8.0, 3.9, 2.3 Hz, 2H), 1.42 (d, J = 5.0 Hz, 1H), 1.40 
– 0.96 (m, 6H); 13C NMR (100 MHz, CDCl3): δ 128.6, 119.9, 75.3, 43.5, 32.2, 29.2, 28.0, 26.5, 
26.3, 26.2; HRMS (DART): Calcd for C10H16Cl [M+H–H2O]+: 171.09350; Found: 171.09304; 
Specific Rotation: [a]20.0D +8.1° (c 1.1, CHCl3) for a 94:6 er sample. Enantiomeric purity was 
determined by HPLC analysis of the p-nitrobenzoyl derived product in comparison with authentic 
racemic material (Chiralpak AS-H, 99:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 9.7 min 
(major) and 11.7 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 10.068 min 5771324 50.858 1 9.791 min 30377918 95.190 
2 11.824 min 5576522 49.142 2 11.782 min 1534882 4.810 
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3.5.10 Analytical Data for Diastereoselective Addition to Chiral Aldehydes 
(2R,3R,Z)-6-Chloro-2-phenylhex-5-en-3-ol (Z-3.88). Freshly prepared (R)-2-phenylpropanal 
(20.1 mg, 0.15 mmol) was transferred to an oven-dried vial and purified as described to afford the 
title compound as colorless oil (6.7 mg, 0.032 mmol). IR (neat): 3281 (br, m), 3024 (m), 2963 
(m), 1629 (m), 1492 (m), 1451 (m), 1008 (m), 699 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.31 
(dd, J = 8.5, 6.4 Hz, 2H), 7.24 – 7.18 (m, 3H), 6.11 (dt, J = 7.1, 1.6 Hz, 1H), 5.84 (q, J = 7.1 Hz, 
1H), 3.79 (ddt, J = 8.8, 6.2, 4.4 Hz, 1H), 2.81 (p, J = 6.9 Hz, 1H), 2.36 (dddd, J = 15.0, 7.1, 4.2, 
1.7 Hz, 1H), 2.30 – 2.21 (m, 1H), 1.50 (d, J = 5.0 Hz, 1H), 1.35 (d, J = 7.0 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 144.0, 128.6, 128.2, 127.7, 126.6, 120.0, 75.3, 45.6, 32.8, 15.8; HRMS 
(DART): Calcd for C11H14Cl [M+H–H2O]+: 193.07785; Found: 193.07763; Specific Rotation: 
[a]24.7D +45.6° (c 0.9, CHCl3). 
(2S,3R,Z)-6-Chloro-2-phenylhex-5-en-3-ol (Z-3.89). Freshly prepared (S)-2-phenylpropanal 
(20.1 mg, 0.15 mmol) was transferred to an oven-dried vial and purified as described to afford the 
title compound as colorless oil (17.9 mg, 0.085 mmol). IR (neat): IR (neat): 3438 (br, m), 3060 
(m), 2965 (m), 1629 (m), 1493 (s), 1442 (s), 1037 (m), 701 (s) cm-1; 1H NMR (400 MHz, CDCl3): 
δ 7.42 – 7.22 (m, 5H), 6.15 (dt, J = 7.1, 1.7 Hz, 1H), 5.96 (q, J = 7.0 Hz, 1H), 3.78 (d, J = 9.4 Hz, 
1H), 2.78 (p, J = 7.2 Hz, 1H), 2.56 (dddd, J = 15.1, 6.6, 3.7, 1.8 Hz, 1H), 2.42 – 2.25 (m, 1H), 1.41 
(s, 1H), 1.32 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 142.9, 128.7, 128.10, 128.08, 
126.9, 119.7, 75.1, 45.9, 32.2, 17.9; HRMS (DART): Calcd for C11H12Cl [M+H–H2O]+: 
193.07785; Found: 193.07751; Specific Rotation: [a]25.6D 9.6° (c 1.0, CHCl3).  
 
(4S,6S,Z)-1-Chloro-6,10-dimethylundeca-1,9-dien-4-ol (Z-3.90). Following the general 
procedure for addition, (23.1 mg, 0.15 mmol) was transferred to an oven-dried to afford the title 
compound as colorless oil (15.7 mg, 0.081 mmol). IR (neat): 3341 (br, m), 2959 (s), 2915 (s), 
2850 (m), 1630 (m), 1451 (m), 1376 (m), 1043 (s), 746 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 
6.17 (dq, J = 7.2, 1.4 Hz, 1H), 5.90 (qd, J = 6.6, 5.9, 0.9 Hz, 1H), 5.11 (ddq, J = 7.2, 4.2, 1.4 Hz, 
1H), 3.85 (td, J = 7.5, 3.7 Hz, 1H), 2.44 (tdd, J = 8.7, 7.6, 3.8 Hz, 1H), 2.41–2.29 (m, 1H), 2.10–
1.89 (m, 2H), 1.69 (s, 3H), 1.62 (s, 4H), 1.51–1.31 (m, 4H), 1.30–1.11 (m, 1H), 0.95 (dd, J = 6.7, 
0.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 131.4, 127.8, 124.6, 120.1, 69.0, 44.6, 36.7, 35.2, 
29.3, 25.7, 25.3, 20.2, 17.7; HRMS (DART): Calcd for C13H24OCl [M+H]+: 231.15102; Found: 
231.15018; Specific Rotation: [a]23.0D –1.8° (c 0.77, CHCl3). 
 
3.5.11 Analytical Data for Addition of Trisubstituted Allyl Boronates to Aldehydes 
(R,Z)-4-Chloro-3-methyl-1-phenylbut-3-en-1-ol (3.98): In a N2-filled glovebox, a stock solution 
of ap-6 and zinc(II) methoxide was prepared. An oven-dried vial (8 mL) equipped with a stir bar 
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was charged with aminophenol (ap-6) (13.8 mg, 0.02 mmol), zinc methoxide (5.1 mg, 0.04 mmol) 
and toluene (2.0 mL). The freshly prepared stock solution was allowed to stir for 15 min at 22 °C. 
In another vial (8 mL), benzaldehyde (15.9 mg, 0.15 mmol) was weighed out. The 
aminophenol/Zn(OMe)2 stock solution was then added by syringe (500 µL). Z-Chloro-allyl–B(pin) 
(Z-3.96) (32.5 mg, 0.1 mmol), was added followed by MeOH (10 µL, 0.25 mmol). The reaction 
vessel was equipped with a stir bar, sealed with a cap removed from the glovebox. The mixture 
was allowed to stir for 14 h at 22 °C, at which time the reaction was quenched by the addition of 
MeOH (1.5 mL). The mixture was then allowed to stir for 0.5 h at 22 °C. The volatiles were 
removed in vacuo and the resulting opaque oil was purified by silica gel chromatography (10:1–
4:1 hexanes:Et2O) to afford the title compound (12.0 mg, 0.061 mmol) as colorless oil. 
 IR (neat): 3392 (br, m), 2949 (m), 3062 (m), 3028 (m), 2914 (m), 1451 (s), 1048 (s), 1024 (s), 
752 (s), 699 (s) cm-1; 1H NMR (400 MHz, CDCl3): 7.49 – 7.32 (m, 4H), 7.32 – 7.26 (m, 1H), 5.92 
(d, J = 1.8 Hz, 1H), 4.92 (ddd, J = 8.7, 5.0, 3.4 Hz, 1H), 2.80 (dd, J = 13.5, 8.8 Hz, 1H), 2.51 (dd, 
J = 13.5, 5.1 Hz, 1H), 1.91 (d, J = 3.5 Hz, 1H), 1.74 (d, J = 1.5 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 144.0, 135.7, 128.5, 127.7, 125.8, 114.2, 72.5, 41.8, 21.8; HRMS (DART): Calcd for 
C11H12Cl [M+H–H2O]+: 179.06220; Found: 179.06137; Specific Rotation: [a]23.5D +14.8° (c 
0.54, CHCl3) for a 86:14 er sample. Enantiomeric purity was determined by HPLC in comparison 
with authentic racemic material (Chiralpak AD-H, 99:1 hexanes:i-PrOH, 0.7 mL/min, 220 nm): 
tR: 34.5 min (minor) and 36.1 min (major). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 35.267 min 8878193 48.730 1 34.541min 786809 13.279 
2 36.933 min 9340859 51.270 2 36.084 min 5138192 86.721 
tert-Bu-(R,Z)-5-(4-Chloro-1-hydroxy-3-methylbut-3-en-1-yl)-1H-indole-1-carboxylate 
(3.99): Following the general procedure for addition, (36.8 mg, 0.15 mmol) was transferred to an 
oven-dried vial that was carefully concentrated under reduced pressure in an ice-bath to afford the 
title compound as yellow oil (25.8 mg, 0.077 mmol).  IR (neat): 3430 (br, m), 2974 (m), 2915 
(m), 1730 (s), 1470 (m), 1369 (m), 1255 (m), 1159 (s), 1022 (s), 766 (m) cm-1; 1H NMR (400 
MHz, CDCl3): δ 8.10 (d, J = 8.5 Hz, 1H), 7.58 (m, 2H), 7.35 –7.33 (m, 1H), 6.55 (dd, J = 3.7, 0.8 
Hz, 1H), 5.90 (dt, J = 1.5, 0.7 Hz, 1H), 5.01 (ddd, J = 8.6, 5.3, 3.1 Hz, 1H), 3.01 – 2.74 (m, 1H), 
2.56 (dd, J = 13.5, 5.3 Hz, 1H), 1.94 (d, J = 3.3 Hz, 1H), 1.72 (d, J = 1.6 Hz, 3H), 1.66 (s, 9H); 
13C NMR (125 MHz, CDCl3): δ 149.7, 138.6, 135.9, 134.8, 130.6, 126.4, 122.2, 118.1, 115.1, 
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114.0, 107.3, 83.7, 72.7, 42.1, 28.2, 21.9. HRMS (DART): Calcd for C18H21NO2Cl [M+HH2O]+: 
318.12553; Found: 318.12483; Specific Rotation: [a]22.8D +5.8° (c 1.0, CHCl3) for a 89:11 er 
sample. Enantiomeric purity was determined by HPLC in comparison with authentic racemic 
material (Chiralpak OZ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR 11.1 min (minor) and 
12.6 min (major). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 11.170 min 9780776 50.690 1 11.139 min 3123440 11.159 
2 12.753 min 9514321 49.310 2 12.631 min 24866467 88.841 
(R,1E,5Z)-6-Chloro-5-methyl-1-(2-methylthiazol-4-yl)hexa-1,5-dien-3-ol (3.100): Following 
the general procedure for addition, (E)-2-methyl-3-(2-methylthiazole-4-yl)acrylaldehyde (25.1 
mg, 0.15 mmol) was transferred to an oven-dried vial. The reaction was quenched by addition of 
a saturated aqueous solution of sodium periodate (1.0 mL), extracted with ethyl acetate, dried over  
MgSO4 and concentrated to afford an unpurified residue that was purified by silica gel 
chromatography to afford the title compound as colorless oil (13.2 mg, 0.054 mmol). IR (neat): 
3314 (br, m), 2949 (m), 2918 (m), 1506 (m), 1440 (s), 1189 (s), 1047 (s), 1015 (m), 875 (m), 782 
(s) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.95 (s, 1H), 6.66 – 6.42 (m, 1H), 5.90 (dt, J = 1.6, 0.8 
Hz, 1H), 4.38 (dd, J = 8.4, 5.3 Hz, 1H), 2.69 (s, 3H), 2.60 – 2.42 (m, 2H), 2.08 (d, J = 1.3 Hz, 3H), 
1.95 – 1.87 (br s, 1H), 1.82 (d, J = 1.6 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.6, 152.6, 
141.5, 135.8, 119.1, 115.7, 113.9, 75.7, 38.1, 21.7, 14.2; HRMS (DART): Calcd for C11H17NOSCl 
[M+H]+: 258.07139; Found: 258.07166; Specific Rotation: [a]25.6D +5.7° (c 1.4, CHCl3) for a 
95:5 er sample. Enantiomeric purity was determined by HPLC in comparison with authentic 
racemic material (Chiralpak AD-H, 99:1 hexanes:i-PrOH, 0.7 mL/min, 220 nm): tR: 9.7 min 
(major) and 11.7 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 10.068 min 5771324 50.858 1 9.791 min 30377918 95.190 
2 11.824 min 5576522 49.142 2 11.782 min 1534882 4.810 
 
(3S,4R)-2-(4-Bromothiazol-2-yl)-4-chloro-2-methylhex-5-en-3-ol (3.108): 1H NMR (400 
MHz, CDCl3): δ 7.12 (s, 1H), 5.85 (dt, J = 17.1, 9.9 Hz, 1H), 5.11 – 4.94 (m, 2H), 4.56 (ddt, J = 
9.7, 2.4, 0.5 Hz, 1H), 4.11 (dd, J = 6.5, 2.4 Hz, 1H), 3.82 (d, J = 6.5 Hz, 1H), 1.51 (d, J = 4.0 Hz, 
6H.; 13C NMR (150 MHz, CDCl3): 178.5, 133.6, 124.1, 118.3, 116.3, 81.9, 64.6, 44.8, 27.4, 25.0; 
HRMS (DART): Calcd for C10H14BrClNOS [M+H]+: 309.96625; Found: 309.96681. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralcel OJ-H, 99:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 17.3 min (major) and 
21.6 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 18.997 min 1455687 50.690 1 17.247 min 5882453 97.266 
2 23.258 min 1416050 49.310 2 21.605 min 165321 2.734 
 
(1S,2R)-2-chloro-1-(4-Methoxyphenyl)but-3-en-1-ol (3.111): 1H NMR (400 MHz, CDCl3): δ 
7.33 – 7.27 (m, 2H), 6.92 – 6.85 (m, 2H), 5.93 (ddd, J = 17.0, 10.2, 8.6 Hz, 1H), 5.34 – 5.17 (m, 
2H), 4.88 (dd, J = 4.9, 2.8 Hz, 1H), 4.54 (ddt, J = 8.6, 4.9, 0.8 Hz, 1H), 3.81 (s, 3H), 2.45 (d, J = 
3.2 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 159.6, 133.8, 131.5, 128.1, 120.1, 113.8. 69.6, 67.6, 
55.4; HRMS (DART): Calcd for C11H12OCl [M+H–H2O]+: 195.05712; Found: 195.05650; 
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Specific Rotation: [α]22.7 +8.03° (c 0.56, CHCl3) for a 98:2 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AD-H, 
99:1 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 40.5 min (major) and 57.3 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 40.292 min 24840186 50.881 1 40.491 min 8010680 98.164 
2 54.569 min 23979813 49.119 2 57.258 min 149838 1.836 
  
(1S,2R)-2-Chloro-1-cyclohexylbut-3-en-1-ol (3.112): 1H NMR (400 MHz, CDCl3): δ 6.01 (ddd, 
J = 17.0, 10.1, 9.1 Hz, 1H), 5.47 – 5.15 (m, 2H), 4.54 (dd, J = 9.1, 4.1 Hz, 1H), 3.59 – 3.30 (m, 
1H), 2.12 (d, J = 3.4 Hz, 1H), 2.06 – 1.90 (m, 1H), 1.83 – 1.36 (m, 5H), 1.32 – 0.80 (m, 5H); 13C 
NMR (100 MHz, CDCl3): δ 134.0, 119.7, 78.5, 65.8, 40.0, 29.1, 28.6, 26.4, 26.1, 25.9; HRMS 
(DART): Calcd for C10H16Cl [M+H–H2O]+: 171.09350; Found: 171.09280; Specific Rotation: 
[α]22.4 +14.4° (c 1.39, CHCl3). 
 
(3S,4R)-4-Chloro-2,2-dimethylhex-5-en-3-ol (3.113): 1H NMR (400 MHz, CDCl3): δ 6.19 (dt, 
J = 17.2, 9.9 Hz, 1H), 5.51 – 5.03 (m, 2H), 4.74 (dd, J = 9.7, 2.1 Hz, 1H), 3.64 (dd, J = 3.7, 2.1 
Hz, 1H), 2.27 (dd, J = 3.6, 0.8 Hz, 1H), 0.97 (s, 9H); HRMS (DART): Calcd for C10H10Cl 
[M+H–H2O]+: 145.07785; Found: 145.07815; Specific Rotation: [α]22.4 +19.9° (c 0.71, CHCl3) 
for a 95:5 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AD-H, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 
63.1 min (minor) and 72.2 min (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 63.080 min 9978135 49.826 1 63.088 min 1593128 5.646 
2 72.397 min 10047633 50.174 2 72.157 min 26626055 94.354 
 
3.5.12 Representative Procedure for Catalytic Enantioselective Additions of Z–CF3 
Substituted Allyl Boronate 
In an N2-filled glovebox, an oven-dried vial equipped with a stir bar was charged with ap-3 (2.6 
mg, 0.005 mmol), zinc methoxide (3.2 mg, 0.025 mmol) and toluene (2.0 mL), and the resulting 
mixture was allowed to stir for 15 min at 22 °C. In another vial, an aldehyde was dissolved in 
toluene (1.0 mL). A third oven-dried vial was charged with the aforementioned aldehyde (stock) 
solution (100 µL, 0.1 mmol) and ap-3/Zn(OMe)2 (stock) solution (400 µL), followed by MeOH (5 
µL, 0.13 mmol). The vial was sealed (septum cap and electrical tape), brought out of the glovebox 
and allowed to cool to 4 °C. After 5 min, Z-3.114 (25 mg, 0.105 mmol) was added by syringe, and 
the mixture was allowed to stir for 2 h at 4 °C. The reaction was quenched by the addition of 
MeOH (1.5 mL) and the resulting solution was allowed to stir for 30 min at 22 °C. The volatiles 
were removed in vacuo and the resulting opaque oil was purified by silica gel column 
chromatography (gradient eluting with 10:1 ® 4:1 hexanes:Et2O).  
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3.5.13 Catalyst Screening for Additions of Z-CF3-Substituted Allyl Boronate 
 
 
3.5.14 Analytical Data for Addition of Z-CF3-Substituted Allyl Boronate 4d to Aldehydes  
(R,Z)-5,5,5-Trifluoro-1-phenylpent-3-en-1-ol (Z-3.116): Following the general procedure for 
addition, benzaldehyde (15.9 mg, 0.15 mmol) was transferred to an oven-dried vial to afford the 
title compound as colorless oil (19.0 mg, 0.088 mmol). IR (neat): 3375 (br, w), 2920 (w), 1671 
(w), 1454 (w), 1418 (w), 1274 (m), 1226 (m), 1195 (m), 1112 (s), 1051 (m), 698 (s) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.41 – 7.28 (m, 5H), 6.10 (dt, J = 11.7, 7.6 Hz, 1H), 5.70 (dqt, J = 11.9, 
8.5, 1.8 Hz, 1H), 4.80 (dd, J = 7.6, 5.5 Hz, 1H), 2.86 – 2.68 (m, 2H), 1.99 (s, 1H); 13C NMR (100 
MHz, CDCl3): δ 143.4, 138.6 (q, J = 5.4 Hz), 128.8, 128.2, 125.9, 123.3 (q, J = 271.8 Hz), 120.4 
(q, J = 33.4 Hz), 73.6, 37.7; 19F NMR (376 MHz, CDCl3): δ –57.97 (3F, dt, J = 8.5, 2.2 Hz); 
HRMS (DART): Calcd for C11H10F3 [M+H–H2O]+: 199.0735; Found: 199.0741; Specific 
Rotation: [α]20.0D +34.97° (c 0.74, CHCl3) for a 95:5 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AD-H, 
99.5:0.5 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 68.8 min (major) and 64.1 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 59.865 min 12218876 49.924 1 64.145 min 856550 4.501 
O
Ph 10 mol % Zn(OMe)2, 1.3 equiv. MeOH,
toluene, 22 °C, 14 h
5.0 mol % aminophenol
Z-3.114
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2 65.320 min 12256231 50.076 2 68.836 min 18174970 95.499 
(R,Z)-1-(2-Bromophenyl)-5,5,5-trifluoropent-3-en-1-ol (Z-3.117): Following the general 
procedure for addition, 2-Bromobenzaldehyde (27.8 mg, 0.15 mmol) was transferred to an oven-
dried vial to afford the title compound as colorless oil (26.9 mg, 0.095 mmol).  IR (neat): 3385 
(br, m), 1671 (w), 1468 (w), 1419 (m), 1275 (m), 1224 (m), 1196 (m), 1117 (s), 1062 (m), 1045 
(m), 1022 (m), 756 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.8, 1.8 Hz, 1H), 7.54 
(dd, J = 8.0, 1.2 Hz, 1H), 7.36 (tdd, J = 7.8, 1.2, 0.5 Hz, 1H), 7.16 (ddd, J = 7.9, 7.3, 1.7 Hz, 1H), 
6.18 (dt, J = 11.7, 7.5 Hz, 1H), 5.78 – 5.68 (dqt, J = 12.0, 8.4, 1.8 Hz, 1H), 5.21 (dt, J = 8.0, 4.0 
Hz, 1H), 2.89 – 2.79 (m, 1H), 2.79 – 2.67 (m, 1H), 2.02 (d, J = 3.7 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δ 142.2, 138.3 (q, J = 5.4 Hz), 132.9, 129.4, 128.0, 123.2 (q, J = 271.7 Hz), 121.9, 120.7 
(q, J = 33.5 Hz), 71.9, 36.0; 19F NMR (376 MHz, CDCl3): δ –58.22 (3F, dt, J = 8.5, 2.1 Hz); 
HRMS (DART): Calcd for C11H9BrF3 [M+H–H2O]+: 276.984; Found: 276.9834; Specific 
Rotation: [α]20.0D +59.6° (c 1.25, CHCl3) for a 98:2 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H, 
98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 8.7 min (major) and 10.2 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 8.904 min 9263210 50.372 1 8.752 min 13479253 97.904 
2 10.391 min 9126275 49.628 2 10.245 min 288610 2.096 
(R,Z)-5,5,5-Trifluoro-1-(o-tolyl)pent-3-en-1-ol (Z-3.118): Following the general procedure for 
addition, 2-Methylbenzaldehyde (18.0 mg, 0.15 mmol) was transferred to an oven-dried vial to 
afford the title compound as colorless oil (20.9 mg, 0.091 mmol). IR (neat): 3365 (br, m), 2930 
(w), 1670 (w), 1488 (w), 1461 (m), 1275 (m), 1228 (m), 1119 (s), 1049 (m), 758 (m), 729 (m) cm-
1; 1H NMR (400 MHz, CDCl3): δ 7.50 (dd, J = 7.6, 1.5 Hz, 1H), 7.29 – 7.12 (m, 3H), 6.19 (dtd, 
J = 11.7, 7.7, 0.7 Hz, 1H), 5.78 – 5.65 (m, 1H), 5.05 (ddd, J = 8.0, 5.1, 3.2 Hz, 1H), 2.77 – 2.66 
(m, 2H), 2.34 (s, 3H), 1.79 (d, J = 3.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ  141.6, 139.0 (q, 
J = 5.4 Hz), 134.5, 130.7, 127.8, 126.6, 125.2, 123.3 (q, J = 271.8 Hz), 120.3 (q, J = 33.4 Hz), 
69.9, 36.5, 19.0; 19F NMR (376 MHz, CDCl3): δ –59.09 (3F, dt, J = 8.4, 2.2 Hz); HRMS 
(DART): Calcd for C12H12F3 [M+H–H2O]+: 213.0891; Found: 213.0886; Specific Rotation: 
[α]20.0D +59.9° (c 0.95, CHCl3) for a 97:3 er sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralcel OD-H, 99:1 hexanes:i-PrOH, 
1.0 mL/min, 254 nm): tR: 31.3 min (major) and 22.7 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 22.418 min 327530 49.706 1 22.771 min 10671 2.543 
2 29.951 min 331402 50.294 2 31.320 min 408954 97.457 
(R,Z)-1-(6-Bromonaphthalen-2-yl)-5,5,5-trifluoropent-3-en-1-ol (Z-3.119): Following the 
general procedure for addition, 6-Bromo-2-napthaldehyde (35.3 mg, 0.15 mmol) was transferred 
to an oven-dried vial to afford the title compound as colorless oil (32.1 mg, 0.093 mmol). IR 
(neat): 3367 (br, m), 1671 (w), 1591 (w), 1418 (w), 1275 (m), 1228 (w), 1118 (s), 1062 (m), 877 
(m), 807 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.02 – 7.98 (m, 1H), 7.78 – 7.72 (m, 2H), 7.69 
(d, J = 8.7 Hz, 1H), 7.56 (dd, J = 8.7, 2.0 Hz, 1H), 7.49 (dd, J = 8.5, 1.8 Hz, 1H), 6.11 (dt, J = 
11.7, 7.6 Hz, 1H), 5.76 – 7.66 (m, 1H), 4.96 (dd, J = 7.3, 5.7 Hz, 1H), 2.91 – 2.78 (m, 2H), 2.11 
(s, 1H); 13C NMR (100 MHz, CDCl3): δ 141.2, 138.3 (q, J = 5.4 Hz), 134.3, 131.8, 129.92, 
129.89, 129.8, 127.8, 124.9, 124.6, 123.2 (q, J = 270 Hz), 120.7 (q, J = 33.3 Hz), 120.2, 73.5, 
37.5; 19F NMR (376 MHz, CDCl3): δ –59.13 (3F ,dt, J = 8.4, 2.2 Hz); HRMS (DART): Calcd 
for C15H11BrF3 [M+H–H2O]+: 326.9996; Found: 327.0002; Specific Rotation: [α]20.0D +21.9° (c 
1.50, CHCl3) for a 98:2 er sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralcel OD-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 
220 nm): tR: 57.9 min (major) and 29.2 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 27.539 min 191905224 47.936 1 29.220 min 766234 1.668 
2 53.838 min 2208427305 52.064 2 57.997 min 45176814 98.332 
(R,Z)-1-(3-Chlorophenyl)-5,5,5-trifluoropent-3-en-1-ol (Z-3.120): Following the general 
procedure for addition, 3-Chlorobenzaldehyde (21.1 mg, 0.15 mmol) was transferred to an oven-
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dried vial to afford the title compound as colorless oil (23.3 mg, 0.093 mmol).   IR (neat): 3354 
(br, m), 1671 (w), 1598 (w), 1576 (w), 1419 (m), 1276 (m), 1227 (m), 1197 (m), 1120 (s), 788 
(m), 698 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.40 – 7.34 (m, 1H), 7.35 – 7.19 (m, 3H), 6.09 
(dt, J = 11.7, 7.6 Hz, 1H), 5.77 – 5.67 (m, 1H), 4.87 – 4.74 (m, 1H), 2.77 – 2.72 (m, 2H), 1.93 (d, 
J = 3.6 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ 145.4, 138.0 (q, J = 5.3 Hz), 134.7, 130.1, 
128.3, 126.1, 124.0, 123.2 (q, J = 270.0 Hz) 120.9 (q, J = 33.5 Hz), 72.9, 37.7; 19F NMR (376 
MHz, CDCl3): δ –58.26 (3F, dt, J = 8.5, 2.1 Hz); HRMS (DART): Calcd for C11H9F3Cl [M+H–
H2O]+: 233.0345; Found: 233.0353; Specific Rotation: [α]20.0D +24.55° (c 1.00, CHCl3) for a 98:2 
er sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralcel OJ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 23.3 min 
(major) and 20.1 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 20.440 min 15920649 49.826 1 20.185 min 343979 2.010 
2 23.852 min 16032077 50.174 2 23.302 min 16769906 97.990 
(R,Z)-5,5,5-Trifluoro-1-(3-methoxyphenyl)pent-3-en-1-ol (Z-3.121): Following the general 
procedure for addition, 3-Methoxybenzaldehyde (20.4 mg, 0.15 mmol) was transferred to an oven-
dried vial to afford the title compound as colorless oil (21.2 mg, 0.086 mmol).  IR (neat): 3406 
(br, m), 1602 (w), 1587 (w), 1488 (w), 1419 (w), 1268 (m), 1118 (s), 1043 (m), 871 (w), 699 (w) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.33 – 7.26 (m, 1H), 6.99 – 6.90 (m, 2H), 6.89 – 6.80 (m, 
1H), 6.10 (dt, J = 11.7, 7.6 Hz, 1H), 5.77 – 5.63 (m, 1H), 4.81 – 4.77 (m, 1H), 3.82 (d, J = 0.9 Hz, 
3H), 2.83 – 2.72 (m, 2H), 1.89 (d, J = 3.5 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 160.0, 145.1, 
138.6 (q, J = 5.4 Hz), 129.9, 123.3 (q, J = 271.8 Hz), 120.4 (q, J = 33.4 Hz), 118.1, 113.5, 111.4, 
73.5, 55.4, 37.6; 19F NMR (376 MHz, CDCl3): δ –58.25 (3F, dt, J = 8.5, 2.2 Hz); HRMS 
(DART): Calcd for C12H12F3O [M+H–H2O]+: 229.084; Found: 229.085; Specific Rotation: 
[α]20.0D +15.2° (c 1.39, CHCl3) for a 97:3 er sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralcel OJ-H, 98:2 hexanes:i-PrOH, 1.0 
mL/min, 220 nm): tR: 30.9 min (major) and 32.6 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 30.486 min 22474231 49.830 1 30.975 min 490854 2.139 
2 32.657 min 22627254 50.170 2 32.658 min 22462335 97.861 
(R,Z)-5,5,5-Trifluoro-1-(4-nitrophenyl)pent-3-en-1-ol (Z-3.122): Following the general 
procedure for addition, 4-Nitrobenzaldehyde (22.7 mg, 0.15 mmol) was transferred to an oven-
dried vial to afford the title compound as colorless oil (25.5 mg, 0.098 mmol).  IR (neat): 3444 
(br, m), 1671 (w), 1605 (w), 1519 (s), 1418 (w), 1346 (s), 1276 (m), 1226 (m), 1198 (m), 1118 (s), 
1013 (m), 856 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ  8.33 – 8.11 (m, 2H), 7.61 – 7.43 (m, 
2H), 6.10 (dt, J = 11.7, 7.7 Hz, 1H), 5.79 – 5.69 (m, 1H), 4.97 (t, J = 6.3 Hz, 1H), 2.79 – 2.74 (m, 
2H), 2.24 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 150.5, 147.6, 137.3 (q, J = 5.4 Hz), 126.6, 
123.9, 123.0 (q, J = 271.9 Hz), 121.3 (q, J = 33.5 Hz), 72.5, 37.7; 19F NMR (376 MHz, CDCl3): 
δ –58.27 (3F, dt, J = 8.5, 2.1 Hz); HRMS (DART): Calcd for C11H11F3NO3 [M+H]+: 262.0691; 
Found: 262.0694; Specific Rotation: [α]20.0D +16.9° (c 1.21, CHCl3) for a 98:2 er sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AZ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 254 nm): tR: 23.6 min (major) and 
22.0 min (minor). 
  
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 24.576 min 23619537 50.258 1 23.496 min 389560 1.609 
2 26.788 min 23376975 49.742 2 25.335 min 23816871 98.391 
(R,Z)-5,5,5-Trifluoro-1-(furan-2-yl)pent-3-en-1-ol (Z-3.123): Following the general procedure 
for addition, furfural (14.4 mg, 0.15 mmol) was transferred to an oven-dried vial to afford the title 
compound as colorless oil (16.9 mg, 0.083 mmol).  IR (neat): 3373 (br, m), 1672 (w), 1420 (w), 
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1329 (m), 1278 (m), 1118 (s), 1011 (m), 740 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.39 (dd, 
J = 1.8, 0.8 Hz, 1H), 6.35 (dd, J = 3.2, 1.8 Hz, 1H), 6.27 (dt, J = 3.2, 0.7 Hz, 1H), 6.10 (dt, J = 
11.7, 7.4 Hz, 1H), 5.79 – 5.66 (m, 1H), 4.84 – 4.78 (m, 1H), 2.93 – 2.83 (m, 2H), 2.04 (d, J = 5.2 
Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 155.3, 142.5, 137.8 (q, J = 5.5 Hz), 123.2 (q, J = 270 
Hz),  120.6 (q, J = 33.5 Hz), 110.4, 106.6, 66.8, 37.6; 19F NMR (376 MHz, CDCl3): δ –58.43 
(3F, dt, J = 8.5, 2.3 Hz); HRMS (DART): Calcd for C9H8F3O [M+H–H2O]+: 189.0527.0891; 
Found: 189.0532; Specific Rotation: [α]20.0D +10.9° (c 0.74, CHCl3) for a 93:7 er sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralcel OJ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 20.3 min (major) and 
19.0 min (minor). 
  
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 19.475 min 11090925 49.991 1 19.005 min 453316 6.325 
2 20.734 min 11095040 50.009 2 20.309 min 6714278 93.675 
(R,Z)-1-(Benzofuran-2-yl)-5,5,5-trifluoropent-3-en-1-ol (Z-3.124): Following the general 
procedure for addition, 2-Benzofurancarboxaldehyde (21.9 mg, 0.15 mmol) was transferred to an 
oven-dried vial to afford the title compound as colorless oil (24.1 mg, 0.094 mmol).  IR (neat): 
3364 (br, m), 1672 (w), 1454 (m), 1420 (w), 1278 (m), 1253 (m), 1229 (m), 1120 (s), 1072 (m), 
880 (w), 810 (m), 750 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.56 (dd, J = 7.8, 1.1 Hz, 1H), 
7.47 (dd, J = 8.1, 0.9 Hz, 1H), 7.32 – 7.27 (m, 1H), 7.24 (td, J = 7.5, 1.2 Hz, 1H), 6.66 (s, 1H), 
6.15 (dt, J = 11.7, 7.4 Hz, 1H), 5.83 – 5.67 (m, 1H), 4.96 (dt, J = 7.1, 5.5 Hz, 1H), 3.05 – 2.92 (m, 
2H), 2.22 (d, J = 5.3 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 157.8, 154.9, 137.4 (q, J = 5.4 
Hz), 128.0, 124.6, 123.2 (q, J = 271.8 Hz), 123.1, 121.3, 120.9 (q, J = 33.5 Hz), 111.4, 103.3, 
67.3, 34.2; 19F NMR (376 MHz, CDCl3): δ –58.37 (3F, dt, J = 8.5, 2.2 Hz); HRMS (ESI+): 
Calcd for C13H10F3O [M+H–H2O]+: 239.068374; Found: 239.068298; Specific Rotation: [α]20.0D 
+11.3° (c 1.14, CHCl3) for a 95:5 er sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralcel OZ-H, 98:2 hexanes:i-PrOH, 
1.0 mL/min, 254 nm): tR: 14.7 min (major) and 11.7 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 11.178 min 23883206 49.505 1 11.261 min 1717733 6.844 
2 14.017 min 24360839 50.495 2 14.108 min 23379882 93.156 
(R,Z)-5,5,5-Trifluoro-1-(pyridin-3-yl)pent-3-en-1-ol (Z-3.125): Following the general 
procedure for addition, 3-Pyridinecarboxaldehyde (16.1 mg, 0.15 mmol) was transferred to an 
oven-dried vial to afford the title compound as colorless oil (19.3 mg, 0.089 mmol). IR (neat): 
3192 (br, m), 2917 (w), 1671 (w), 1422 (m), 1320 (m), 1277 (m), 1118 (s), 1070 (m), 1029 (w), 
714 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.56 – 8.31 (m, 2H), 7.72 (dt, J = 7.9, 2.1 Hz, 1H), 
7.28 (ddd, J = 7.9, 4.9, 0.9 Hz, 1H), 6.10 (dt, J = 11.7, 7.6 Hz, 1H), 5.76 – 5.65 (m, 1H), 4.84 (dd, 
J = 7.4, 5.6 Hz, 1H), 3.82 (s, 1H), 2.83 – 2.68 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 149.0, 
147.4, 139.3, 137.8 (q, J = 5.2 Hz), 133.9, 123.8, 123.1 (q, J = 271.8 Hz), 120.8 (q, J = 34.0 Hz), 
70.9, 37.6; 19F NMR (376 MHz, CDCl3): δ –58.31 (3F, dt, J = 8.4, 2.1 Hz); HRMS (DART): 
Calcd for C10H11F3NO [M+H]+: 218.0793; Found: 218.0793; Specific Rotation: [α]20.0D +46.1° 
(c 0.54, CHCl3) for a 93:7 er sample. Enantiomeric purity was determined by HPLC analysis in 
comparison with authentic racemic material (Chiralpak AZ-H, 95:5 hexanes:i-PrOH, 1.0 mL/min, 
254 nm): tR: 31.9 min (major) and 27.0 min (minor). 
  
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 26.447 min 1131463 50.678 1 27.012 min 351261 7.422 
2 31.864 min 1101207 49.322 2 31.993 min 4381557 92.578 
(R,Z)-7,7,7-Trifluoro-1-phenylhept-5-en-1-yn-3-ol (Z-3.126): Following the general procedure 
for addition, 3-Phenyl-2-propynal (19.5 mg, 0.15 mmol) was transferred to an oven-dried vial to 
afford the title compound as colorless oil (22.3 mg, 0.093 mmol). IR (neat): 3359 (br, m), 1672 
(w), 1492 (w), 1419 (w), 1277 (m), 1228 (m), 1120 (s), 1041 (m), 966 (m), 756 (m), 722 (m) cm-
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1; 1H NMR (400 MHz, CDCl3): δ 7.46 – 7.39 (m, 2H), 7.37 – 7.29 (m, 3H), 6.25 (dt, J = 11.8, 
7.5 Hz, 1H), 5.89 – 5.70 (m, 1H), 4.74 (app q, J = 5.9 Hz, 1H), 2.86 – 2.82 (m, 2H), 1.96 (d, J = 
5.3 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 172.1, 137.1 (q, J = 5.4 Hz), 131.8, 128.8, 128.4, 
123.2 (q, J = 271.9 Hz), 121.1 (q, J = 33.6 Hz), 88.4, 86.1, 61.7, 36.5; 19F NMR (376 MHz, 
CDCl3): δ –59.26 (3F, dt, J = 8.5, 2.1 Hz); HRMS (DART): Calcd for C13H10F3 [M+H–H2O]+: 
223.0735; Found: 223.0735; Specific Rotation: [α]20.0D –3.4° (c 1.1, CHCl3) for a 97:3 er sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AY-3, 99:1 hexanes:i-PrOH, 1.0 mL/min, 254 nm): tR: 16.7 min (major) and 
15.5 min (minor). 
  
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 15.413 min 15667125 49.536 1 15.511 min 312897 2.267 
2 16.880 min 15960613 50.464 2 16.789 min 13489402 97.733 
(R,1Z,5Z)-2-Bromo-7,7,7-trifluoro-1-phenylhepta-1,5-dien-3-ol (Z-3.127): Following the 
general procedure for addition, 𝛼-Bromocinnamaldehyde (31.7 mg, 0.15 mmol) was transferred to 
an oven-dried vial to afford the title compound as colorless oil (29.8 mg, 0.093 mmol). IR (neat): 
3386 (br, m), 1672 (w), 1429 (w), 1446 (w), 1418 (w), 1276 (m), 1228 (m), 1195 (m), 1119 (s), 
1074 (m), 1050 (m), 754 (m), 693 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.66 – 7.58 (m, 2H), 
7.43 – 7.32 (m, 3H), 7.12 (s, 1H), 6.12 (dt, J = 11.7, 7.6 Hz, 1H), 5.83 – 5.71 (m, 1H), 4.43 – 4.37 
(m, 1H), 2.89 – 2.76 (m, 2H), 2.22 (d, J = 5.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 137.3 (q, 
J = 5.4 Hz), 134.7, 129.2, 128.9, 128.5, 128.3, 128.3, 123.2 (q, J = 271.9 Hz), 120.9 (q, J = 33.6 
Hz), 76.5, 34.7; 19F NMR (376 MHz, CDCl3): δ –58.24 (3F, dt, J = 8.5, 2.1 Hz); HRMS (ESI+): 
Calcd for C13H11BrF3 [M+H–H2O]+: 302.9996; Found: 302.9992; Specific Rotation: [α]20.0D –
10.9° (c 1.37, CHCl3) for a 98.5:1.5 er sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralcel OJ-H, 98:2 hexanes:i-PrOH, 1.0 
mL/min, 254 nm): tR: 41.0 min (major) and 38.6 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 38.010 min 7419559 49.923 1 38.673 min 166532 1.456 
2 40.994 min 7442395 50.077 2 41.096 min 11270414 98.544 
(R,Z)-7,7,7-Trifluoro-1,1-diphenylhepta-1,5-dien-3-ol (Z-3.128):  Following the general 
procedure for addition, b-Phenylcinnamaldehyde (31.2 mg, 0.15 mmol) was transferred to an 
oven-dried vial to afford the title compound as colorless oil (24.8 mg, 0.078 mmol).  IR (neat): 
3343 (br, m), 3057 (w), 3024 (w), 1670 (w), 1493 (w), 1444 (w), 1275 (m), 1228 (m), 1197 (m), 
1119 (s), 1030 (m), 764 (m), 730 (w), 699 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.44 – 7.33 
(m, 3H), 7.33 – 7.16 (m, 7H), 6.16 – 6.01 (m, 2H), 5.75 – 5.65 (m, 1H), 4.41 – 4.22 (m, 1H), 2.67 
– 2.63 (m, 2H), 1.66 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 144.7, 141.4, 139.0, 138.3 (q, J = 
5.4 Hz), 129.6, 129.6, 128.5, 128.3, 128.0, 127.8, 127.6, 123.2 (q, J = 271.8 Hz), 120.3 (q, J = 
33.4 Hz), 68.6, 36.3; 19F NMR (376 MHz, CDCl3): δ –58.06 (3F, dt, J = 8.3, 2.0 Hz); HRMS 
(DART): Calcd for C19H16F3 [M+H–H2O]+: 301.1204; Found: 301.1199; Specific Rotation: 
[α]20.0D +22.7° (c 1.76, CHCl3) for a 92:8 er sample. Enantiomeric purity was determined by HPLC 
analysis in comparison with authentic racemic material (Chiralcel OD-H, 98:2 hexanes:i-PrOH, 
1.0 mL/min, 220 nm): tR: 35.7 min (major) and 27.4 min (minor). 
  
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 26.171 min 15640240 50.627 1 27.495 min 3931398 8.194 
2 34.219 min 15252636 49.373 2 35.715 min 44047550 91.806 
(S,Z)-7,7,7-Trifluoro-1-phenylhept-5-en-3-ol (Z-3.129): Following the general procedure for 
addition, hydrocinnamaldehyde (20.1 mg, 0.15 mmol) was transferred to an oven-dried vial to 
afford the title compound as colorless oil (15.9 mg, 0.088 mmol).  IR (neat): 3390 (br, m), 2921 
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(w), 1670 (w), 1496 (w), 1454 (w), 1418 (w), 1275 (m), 1227 (m), 1117 (s), 1083 (m), 1055 (m), 
747(w), 699 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ δ 7.33 – 7.27 (m, 2H), 7.22 – 7.19 (m, 3H), 
6.13 (dt, J = 11.7, 7.7 Hz, 1H), 5.72 (dqt, J = 12.0, 8.5, 1.8 Hz, 1H), 3.76 (tq, J = 7.3, 5.1 Hz, 1H), 
2.86 – 2.75 (m, 1H), 2.75 – 2.64 (m, 1H), 2.59 – 2.44 (m, 2H), 1.88 – 1.75 (m, 2H), 1.43 (d, J = 
5.2 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 141.6, 138.9 (q, J = 5.4 Hz), 128.6, 128.5, 126.1, 
123.3 (q, J = 271.7 Hz), 120.4 (q, J = 33.3 Hz), 70.3, 38.8, 36.2, 32.0; 19F NMR (376 MHz, 
CDCl3): δ –58.05 (3F, dt, J = 8.4, 2.2 Hz); HRMS (DART): Calcd for C13H14F3 [M+H–H2O]+: 
227.1048; Found: 227.1039; Specific Rotation: [α]20.0D –11.6° (c 0.25, CHCl3) for a 87:13 er 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralcel OD-H, 92:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 37.2 min 
(major) and 59.0 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 37.392 min 2007374 49.762 1 37.250 min 13997478 88.166 
2 58.173 min 2026611 50.238 2 59.030 min 1878879 11.834 
 
3.5.15 Determination of Absolute Stereochemistry for Additions with Z-CF3-Substituted Allyl 
Boronate Z-3.114 
(R)-1-Phenylpropane-1,3-diol: An 8-dram vial equipped with a stir bar was charged with S-2 
(0.07 mmol, 15.2 mg), NaHCO3 (47 mg, 0.56 mmol), MeOH (5 mL), and CH2Cl2 (10 mL). The 
solution was allowed to cool to –78 °C and a stream of ozone was introduced to the solution until 
it turned light blue. Oxygen was passed through the solution until it became colorless, after which 
it was charged with NaBH4 (80 mg, 2.1 mmol). The mixture was allowed to warm to 22 °C and 
stir for 12 h. The mixture was allowed to cool to 0 °C and then the reaction was quenched by the 
addition of water. The organic layer was removed and the aqueous layer was washed with EtOAc 
(3 x 10 mL). The combined organic layers were combined and dried over MgSO4 and filtered. 
The resulting oil was purified by silica gel chromatography (gradient 1:0 hexanes:EtOAc → 0:1 
hexanes:EtOAc) to afford the desired product as colorless oil (6.1 mg, 0.04 mmol, 57% yield). The 
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analytical data for this compound was fully consistent with those reported previously.14 Specific 
Rotation: [a]20.0D +36.8° (c 0.61, CHCl3) [literature: [a]24D +65.1° (c 1.05, CHCl3)].  
 
3.5.16 Procedures and Analytical Data for Total Synthesis of Mycothiazole 
2-(4-bromothiazol-2-yl)-2-methylpropanal (3.107). The procedures used were exactly the same 
as those reported by Cossy et al. The spectral data for the products were identical to those formerly 
disclosed.15  
Methyl buta-2,3-dien-1-ylcarbamate (3.137). Copper iodide (952 mg, 5.0 mmol) and 
paraformaldehyde (900 mg, 30 mmol) were added to a flame-dried round bottom flask equipped 
with stir bar and a reflux condenser. Dioxane (45 mL) was introduced after which a solution of 
propargyl amide16 (3.136, 1.0 g, 8.8 mmol) in dioxane (5 mL) and dicyclohexylamine (5.0 mL, 25 
mmol) were added. The mixture was heated to reflux and allowed to stir for 4 h under these 
conditions; it was then allowed to cool to 22 °C and diluted with water (50 mL) and Et2O (100 
mL). The aqueous layer was separated and washed with Et2O (3 x 10 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated to ~20% of the original volume, after 
which silica gel was added to generate a heterogenous mixture, and the volatiles were removed to 
dryness. The resulting brown powder was then purified by silica gel chromatography eluting with 
100:0 to 9:1 hexanes/EtOAc to afford allene 3.137 as pale yellow oil (880 mg, 79% yield). IR 
(neat): 3327 (br, m), 2936 (w), 1704 (s), 1530 (s), 1462 (w), 1467 (m), 1261 (s), 1193 (w), 850 
(w) cm-1; 1H NMR (400 MHz, CDCl3): δ 5.20 (p, J = 6.3 Hz, 1H), 4.90 – 4.73 (m, 3H), 3.78 (s, 
2H), 3.67 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 207.9, 156.9, 88.3, 77.7, 52.3, 39.2; HRMS 
(DART): Calcd for C6H10NO2 [M+H]+: 128.0712; Found: 128.0718. 
Methyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl)carbamate (3.133). In a 
N2-filled glovebox, an oven-dried 100 mL round bottom flask equipped with stir bar was charged 
with copper chloride (38 mg, 0.39 mmol), imid-1 (166 mg, 0.39 mmol) and NaOt-Bu (300 mg, 
3.13 mmol). Anhydrous tetrahydrofuran (39 mL) was added and the reaction vessel sealed with 
septum. The mixture was allowed to stir for 2 h at 22 °C, after which B2(pin)2 (2.01 g, 7.9 mmol) 
and allene 7 (1.0 g, 7.8 mmol) were added. The vial was re-sealed with septum, removed from the 
glovebox and solution was allowed to cool to 0 °C. At this point, i-PrOH (3.6 mL, 46.9 mmol) was 
added dropwise. The ice bath was then removed and the mixture allowed to warm to 22 °C and 
stir for 14 h, after which the mixture was diluted by the addition of Et2O (50 mL) and passed 
																																																								
14) Denmark, S. E.; Bui, T. J. Org. Chem. 2005, 70, 10190–10193. 
15)  Le Flohic, A.; Meyer, C.; Cossy, J. Tetrahedron, 2006, 62, 9017–9037.  
16) This compound has been previously synthesized in quantitative yield in a single step from commercially available 
starting materials; see: Teller, H.; Corbet, M.; Mantilli, L; Gopakumar, G.; Goddard, G.; Thiel, W.; Fürstner, A. J. 
Am. Chem. Soc. 2012, 134, 15331–15342. 
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through a plug (3 cm high x 6 cm wide) of silica gel topped with a layer of celite (~1 cm)  . The 
volatiles were removed to ~20% of the original volume, after which silica gel was added to 
generate a hetereogeneous mixture, which was concentrated to dryness. The resulting yellow 
powder was purified by silica gel chromatography (gradient elution, 10:1 → 2:1 hexanes/EtOAc) 
to afford alkenyl–B(pin) compound 3.133 as colorless oil (1.5 g, 76% yield).  IR (neat): 3350 (br, 
w), 2977 (m), 1703 (s), 1526 (m), 1439 (m), 1371 (s), 1309 (s), 1249 (s), 1215 (s), 1192 (m), 1167 
(m), 1139 (s), 854 (w), 832 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 5.88 (d, J = 3.3 Hz, 1H), 
5.68 (s, 1H), 4.93 (s, 1H), 3.64 (s, 3H), 3.28 (q, J = 6.3 Hz, 2H), 2.34 (t, J = 6.5 Hz, 2H), 1.27 (s, 
12H); 13C NMR (100 MHz, CDCl3): 157.1, 132.1, 83.8, 51.9, 40.9, 35.6, 24.8; HRMS (DART): 
Calcd for C12H23BNO4 [M+H]+: 256.172; Found: 256.1733. 
(R,Z)-2-(4-Bromothiazol-2-yl)-6-chloro-2-methylhex-5-en-3-ol (Z-3.109): In a N2-filled 
glovebox, an oven-dried round bottom flask (25 mL) containing a stir bar was charged with ap-5 
(69 mg, 0.1 mmol), Zn(OMe)2 (64 mg, 0.5 mmol) and toluene (25 mL). After the mixture was 
allowed to stir for 15 min at 22 °C, aldehyde 3.107 (1.76 g, 7.5 mmol), allyl boronate Z-3.66 (1.01 
g, 5.0 mmol), and MeOH (260 µL, 6.5 mmol) were added. The vessel was sealed with a septum, 
removed from the glovebox and the solution was allowed to stir at for 14 h 22 °C. The volatiles 
were removed and the resulting opaque oil was purified by silica gel chromatography (10:1 
hexanes:Et2O ® 4:1 hexanes:Et2O) to afford Z-3.109 as colorless oil (1.32 g, 4.3 mmol, 86% yield, 
>98:2 Z:E). The unreacted aldehyde (3.107) was collected and further purified by short path 
distillation to give pure 3.107 as colorless oil (570 mg, 2.4 mmol, 97% recovered). IR (neat): 3421 
(br, m), 2968 (m), 2931 (w), 1630 (w), 1465 (s), 1387 (m), 1366 (m), 1257 (s), 1081 (s), 1050 (s), 
885 (m), 838 (m), 748 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.14 (s, 1H), 6.09 (dt, J = 7.1, 1.5 
Hz, 1H), 5.95 (q, J = 7.0 Hz, 1H), 3.82 (ddd, J = 10.2, 6.3, 2.7 Hz, 1H), 3.52 (dd, J = 6.3, 0.6 Hz, 
1H), 2.56 – 2.47 (m, 1H), 2.15 (dddd, J = 14.8, 10.2, 6.6, 1.5 Hz, 1H), 1.47 (s, 3H), 1.43 (s, 3H); 
13C NMR (150 MHz, CDCl3): 179.9, 128.9, 124.3, 119.5, 116.0, 77.5, 45.3, 30.1, 26.7, 24.0; 
HRMS (DART): Calcd for C10H14BrClNOS [M+H]+: 309.9668; Found: 309.9673; Specific 
Rotation: [a]24.5 +13.3° (c 1.0, CHCl3) for a 94:6 er sample. Enantiomeric purity was determined 
by HPLC analysis in comparison with authentic racemic material (Chiralcel OD-H, 98:2 hexanes:i-
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 10.218 min 2183478 51.340 1 10.438 min 5064993 94.056 
2 11.334 min 2069486 48.660 2 11.629 min 320096 5.944 
(R,Z)-2-(4-Allylthiazol-2-yl)-6-chloro-2-methylhex-5-en-3-ol (3.135): The procedure used was 
based on that reported by Aggarwal et al.17 In a N2-filled glovebox, aryl bromide Z-3.109 (2.54 g, 
8.17 mmol) was added to an oven-dried round bottom flask that contained a stir bar. Complex 
Pd(dppf)Cl2•CH2Cl2 (166.8 mg, 0.2 mmol) was then added, followed by tetrahydrofuran (80 mL). 
The mixture was charged with allyl–B(pin) (5.49 g, 32.7 mmol) and then CsF (3.72 g, 24.5 mmol; 
added in portions (~0.5 g/addition). At this point, the vial was sealed with a septum and removed 
from the glovebox. The solution was charged with water (8 mL) and heated to 60 °C and allowed 
to stir for 14 h at this temperature. After the solution was allowed to cool to 22 °C, it was diluted 
with Et2O (100 mL) and passed through silica gel. The filtrate was concentrated to afford an orange 
residue, which was purified by silica gel chromatography (10:1 → 4:1 hexanes/Et2O) to afford 
3.135 as light-yellow oil (1.6 g, 72% yield). IR (neat): 3383 (br, m), 2963 (m), 2923 (s), 2854 
(m), 1638 (w), 1519 (m), 1466 (m), 1426 (s), 1327 (m), 1051 (s), 993 (m), 916 (s), 747 (s) cm-1; 
1H NMR (400 MHz, CDCl3): δ 6.79 (d, J = 1.0 Hz, 1H), 6.10 – 5.95 (m, 3H), 5.19 – 5.09 (m, 
2H), 4.90 (d, J = 6.3 Hz, 1H), 3.75 (ddd, J = 10.3, 6.3, 2.8 Hz, 1H), 3.51 (dq, J = 6.8, 1.3 Hz, 2H), 
2.59 – 2.46 (m, 1H), 2.13 (dddd, J = 14.8, 10.1, 6.3, 1.5 Hz, 1H), 1.47 (s, 3H), 1.43 (s, 3H); 13C 
NMR (100 MHz, CDCl3): 179.0, 154.8, 135.1, 129.4, 118.9, 117.0, 112.2, 77.8, 44.6, 35.9, 30.2, 
27.5, 24.2; HRMS (DART): Calcd for C13H19ClNOS [M+H]+: 272.0876; Found: 272.0881; 
Specific Rotation: [a]21.5D +10.3° (c 2.58, CHCl3) for a 94:6 er sample.  
Methyl-(R,Z)-(8-(4-Allylthiazol-2-yl)-7-hydroxy-8-methyl-3-methylenenon-4-en-1-
yl)carbamate (3.138): The procedure used was based on that reported by Buchwald and co-
workers.18 In a N2-filled glovebox, an oven-dried 40 mL vial equipped containing a stir bar was 
charged with 3.135 (500 mg, 1.84 mmol), alkenyl boronate 3.133 (492 mg, 1.93 mmol), ruphos-
Pd-G3 (150 mg, 0.18 mmol), ruphos (84 mg, 0.18 mmol) and K3PO4 (1.2 g, 5.52 mmol). 
Tetrahydrofuran (18 mL) was added and the vial was sealed with septum and removed from the 
glovebox. After addition of water (1.8 mL), the vial was then covered in aluminum foil, and the 
mixture was heated to 55 °C and allowed to stir for 14 h under such conditions. The solution was 
allowed to cool to 22 °C, diluted with Et2O (40 mL), and passed through silica gel. The filtrate 
was concentrated to give a yellow residue that was purified by medium pressure liquid 
chromatography (MPLC) with a Teledyne ISCO Combiflash RF instrument paired with a 24 g 
RediSep Rf Gold column (catalog number 69-2203-345) and a gradient elution method: 100% 
hexanes → 100% EtOAc) to furnish diene 3.138 as yellow oil (480 mg, 71% yield).  IR (neat): 
																																																								
17) Zhurakovskyi, O.; Türkmen, Y. E.; Löffler, L. E.; Moorthie, V. A.; Chen, C. C.; Shaw, M. A.; Crimmin, M. R.; 
Ferrara, M.; Ahmad, M.; Ostovar, M.; Matlock, J. V.; Aggarwal, V. K.. Angew. Chem., Int. Ed. 2018, 57, 1346–1350. 
18) (a) Bruno, N. C.; Niljiasnskul, N.; Buchwald, S. L. J. Org. Chem. 2014, 79, 4161–4166. (b) Bruno, N. C.; Tudge, 
M. T.; Buchwald, S. L. Chem. Sci. 2013, 4, 916–920. 
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3340 (br, m), 2965 (m), 1703 (s), 1521 (s), 1466 (m), 1447 (m), 1385 (w), 1364 (w), 1268 (s), 
1052 (m), 904 (m), 776 (w), 732 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.79 (s, 1H), 6.00 (ddt, 
J = 17.0, 10.2, 6.8 Hz, 1H), 5.87 (d, J = 11.6 Hz, 1H), 5.70 – 5.64 (m, 1H), 5.43 (s, 1H), 5.17 – 
5.08 (m, 2H), 5.00 (s, 1H), 4.89 (d, J = 3.6 Hz, 1H), 4.87 (s, 1H), 3.78 (d, J = 9.9 Hz, 1H), 3.62 
(s, 3H), 3.49 (d, J = 6.7 Hz, 2H), 3.37 – 3.10 (m, 2H), 2.45 – 2.19 (m, 4H), 1.43 (s, 3H), 1.38 (s, 
3H); 13C NMR (100 MHz, CDCl3): δ 179.5, 157.2, 154.7, 142.5, 135.0, 131.0, 130.7, 117.0, 
115.9, 112.3, 78.2, 51.9, 44.7, 39.5, 37.2, 35.9, 30.7, 26.8, 24.0; HRMS (DART): Calcd for 
C19H29N2O3S [M+H]+: 365.1899; Found: 365.1904; Specific Rotation: [a]23.9D –28.5° (c 2.45, 
CHCl3) for a 94:6 er sample. 
Methyl ((R,Z)-7-Hydroxy-8-(4-((Z)-6-hydroxyhex-2-en-1-yl)thiazol-2-yl)-8-methyl-3-
methylenenon-4-en-1-yl)carbamate (3.139): A previously reported procedure was used.19  In a 
N2-filled glovebox, an oven-dried 40 mL vial equipped containing a stir bar was charged with 
3.138 (410 mg, 1.12 mmol) and a thf solution of Z-2-butene (28 wt %, 2.08 g, 10.4 mmol). A 
solution of Ru-1 (10.7 mg, 0.014 mmol, 200 µL thf) was added, the vial was sealed with a cap, 
and mixture was allowed to stir for 1 h at 22 °C. Excess Z-2-butene was then removed in vacuo (5 
min, 100 torr). At this point, alcohol 3.132 (730 µL, 6.24 mmol) was added followed by a solution 
of Ru-1 (86 mg, 0.08 mmol, 2 mL thf), and the mixture was subjected to vacuum for 2 h (100 
torr). The vial was then capped and sealed with electrical tape, and the solution was allowed to stir 
for 12 h at 22 °C. The volatiles were removed, leaving behind a dark oil, which was purified by 
medium pressure liquid chromatography (MPLC) with a Teledyne ISCO Combiflash RF 
instrument paired with a 24 g RediSep Rf Gold column (catalog number 69-2203-345) and a 
gradient elution method: 100% CH2Cl2 → 9:1 CH2Cl2/MeOH to give primary alcohol 3.139 as 
dark oil (405 mg, 77% yield; along with ~5% of homocoupled thiazole impurity). IR (neat): 3322 
(br, m), 2934 (m), 1699 (s), 1520 (s), 1439 (m), 1385 (w), 1364 (w), 1271 (s), 1192 (m), 1144 (m), 
1051 (s), 1014 (s), 899 (m), 775 (m), 734 (m) cm-1; 1H NMR (400 MHz, CDCl3): 6.79 (s, 1H), 
5.87 (d, J = 11.5 Hz, 1H), 5.72 – 5.46 (m, 3H), 5.39 (s, 1H), 5.00 (s, 1H), 4.87 (s, 1H), 4.47 (d, J 
= 3.4 Hz, 1H), 3.81 (ddd, J = 10.3, 4.5, 2.5 Hz, 1H), 3.66 – 3.63 (m, 5H), 3.51 (d, J = 7.3 Hz, 2H), 
3.21 (ddq, J = 33.6, 13.6, 6.6 Hz, 2H), 2.48 (s, 1H), 2.45 – 2.13 (m, 6H), 1.72 – 1.62 (m, 2H), 1.43 
(s, 3H), 1.40 (s, 3H); 13C NMR (150 MHz, CDCl3): δ 179.6, 157.2, 155.2, 142.5, 131.1, 131.0, 
130.5, 126.8, 116.0, 112.1, 78.2, 61.3, 51.9, 44.8, 39.5, 37.2, 32.0, 30.8, 29.6, 26.1, 24.1, 23.4; 
HRMS (DART): Calcd for C22H35N2O4S [M+H]+: 423.23120; Found: 423.23033; Specific 
Rotation: [a]20.0D –6.7° (c 1.9, CHCl3) for a 94:6 er sample. 
Methyl ((R,Z)-8-(4-((Z)-6-bromohex-2-en-1-yl)thiazol-2-yl)-7-hydroxy-8-methyl-3-
methylenenon-4-en-1-yl)carbamate (S-3). In a N2-filled glovebox, an oven-dried 8 mL vial was 
charged with primary alcohol 3.139 (50.0 mg, 0.118 mmol) and CH2Cl2 (1.5 mL); the mixture was 
allowed to cool to 40 °C (freezer) and kept at this temperature for 1 h. In a separate oven-dried 8 
mLvial, a solution of CBr4 (47.1 mg, 0.142 mmol, 1.0 mL CH2Cl2) was allowed to cool to 40 °C 
																																																								
19) Xu, C.; Shen, X.; Hoveyda, A. H. J. Am. Chem. Soc. 2017, 139, 10919–10928. 
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(freezer). Triphenylphosphine (37.2 mg, 0.142 mmol) was added to the solution containing 3.139 
followed by addition of the solution of CBr4 in CH2Cl2 and the vessel was placed back in the –40 
°C freezer and allowed to remain there for 45 min. The vial was sealed with electrical tape, 
removed from the glovebox and wrapped in aluminum foil. The mixture was allowed to warm to 
+4 °C (cold room), and remain under these conditions for 45 min, after which the reaction was 
quenched by the addition of a saturated aqueous solution of NaHCO3 (2.0 mL). The aqueous layer 
was washed with CH2Cl2 (5 x 10 mL) and the combined organic layers were washed with brine, 
dried over MgSO4 and concentrated to ~10% of the original volume. The resulting light yellow oil 
was purified by silica gel chromatography (silica dried overnight at 120 °C; 100% hexanes–3:1 
hexanes:Et2O) to afford the desired primary bromide S-3 as colorless oil (38.9 mg, 68% yield). IR 
(neat): 3336 (br, m), 2962 (m), 2936 (m), 1703 (s), 1519 (s), 1440 (m), 1244 (s), 1052 (m), 900 
(m) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.77 (d, J = 1.0 Hz, 1H), 5.87 (d, J = 11.6 Hz, 1H), 5.78 
– 5.59 (m, 2H), 5.54 – 5.44 (m, 1H), 5.40 (s, 1H), 5.00 (d, J = 2.3 Hz, 1H), 4.86 (d, J = 5.2 Hz, 
2H), 3.77 (ddd, J = 9.9, 4.4, 2.7 Hz, 1H), 3.62 (s, 3H), 3.52 (d, J = 7.4 Hz, 2H), 3.41 (t, J = 6.6 Hz, 
2H), 3.31 – 3.09 (m, 2H), 2.53 – 2.09 (m, 4H), 1.94 (dq, J = 7.8, 6.6 Hz, 2H), 1.42 (s, 3H), 1.39 
(s, 3H); 13C NMR (100 MHz, CDCl3): δ 179.5, 157.1, 154.9, 142.5, 130.9, 130.6, 129.6, 127.4, 
115.8, 111.8, 78.1, 44.6, 39.4, 37.1, 33.3, 32.3, 30.6, 29.6, 26.6, 25.6, 23.8. HRMS (DART): 
Calcd for C22H34N2O3SBr [M+H]+: 485.14680; Found: 485.14443; Specific Rotation: [a]24.2D –
5.8° (c 0.43, CHCl3) for a 94:6 er sample. 
Mycothiazole [methyl ((R,Z)-8-(4-((Z)-Hexa-2,5-dien-1-yl)thiazol-2-yl)-7-hydroxy-8-methyl-
3-methylenenon-4-en-1-yl)carbamate]. The procedure used was based on that reported by Fu et 
al.20 In an N2-filled glovebox, an oven dried 4.0 mL vial equipped with a stir bar was charged with 
Pd2(dba)3 (19.1 mg, 0.021 mmol), P(t-Bu)2Me (13.3 mg, 0.083 mmol), KOt-Bu (2.4 mg, 0.021 
mmol) and dioxane (0.125 mL). To this was added Cy2NH (45.3 mg, 0.25 mmol) and the resulting 
mixture was allowed to stir for 2 h at 22 °C. A solution of the freshly prepared bromide S-3 was 
then added (101.3 mg, 0.21 mmol, 0.2 mL dioxane; to ensure complete transfer, the vial was 
carefully rinsed with additional dioxane (0.2 mL), which was then added to the mixture). The vial 
was capped and sealed with electrical tape and the mixture was allowed to stir for 8 h. The vial 
was removed from the glovebox and the volatiles were removed and the resulting yellow oil was 
loaded directly onto oven-dried silica gel for purification (100% hexanes–1:3 hexanes:Et2O) to 
afford mycothiazole as light yellow oil (68.8 mg, 82% yield). The analytical data was fully 
consistent with those found in the literature.21 IR (neat): 3334 (br, m), 2923 (s), 2851 (m), 1705 
(m), 1520 (s), 1465 (m), 1441 (m), 1269 (s), 1055 (m), 908 (m), 777 (w), 735 (w) cm-1; 1H NMR 
(400 MHz, CDCl3): δ 6.77 (s, 1H), 5.88 (d, J = 13.2 Hz, 1H), 5.88 – 5.76 (m, 1H), 5.76 – 5.64 
(m, 2H), 5.64 – 5.55 (m, 1H), 5.42 (s, 1H), 5.10 – 4.97 (m, 3H), 4.92 – 4.84 (m, 2H), 3.78 (d, J = 
10.0 Hz, 1H), 3.63 (s, 3H), 3.51 (d, J = 7.3 Hz, 2H), 3.37 – 3.11 (m, 2H), 2.88 (td, J = 6.8, 1.7 Hz, 
																																																								
20) Bissember, A. C.; Levina, A.; Fu, G. C. J. Am. Chem. Soc. 2012, 134, 14232–143237. 
21) Wang, L.; Hale, K. J. Org. Lett. 2015, 17, 4200–4203. 
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2H), 2.48 – 2.11 (m, 4H), 1.43 (s, 3H), 1.39 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 179.6, 157.2, 
155.1, 142.6, 136.5, 131.0, 130.7, 129.0, 126.8, 115.9, 115.1, 111.9, 78.2, 51.9, 44.7, 39.5, 37.3, 
31.6, 30.7, 29.5, 26.8, 23.9. HRMS (DART): Calcd for C22H33N2O3S [M+H]+: 405.22064; Found: 
405.22066; Specific Rotation: [a]20.0D –22.3° (c 0.2, CHCl3) for a 94:6 er sample. 
 
3.5.17 Representative Exampples of Cross-Coupling Involving a Z–Alkenyl Chloride  
 
 
(R,3Z,5E)-1-(4-(methylthio)phenyl)dodeca-3,5-dien-1-ol. In a N2-filled glovebox, an oven-
dried vial equipped with a stir bar was charged with ruphos-Pd-G3 (3.1 mg, 0.0037 mmol), ruphos 
(1.7 mg, 0.0037 mmol, K3PO4 (46.5 mg, 0.220 mmol) and trans-1-octen-ylboronic acid pinacol 
ester (19.0 mg, 0.080 mmol). Z-3.79 (16.6 mg, 0.073 mmol) was added as a solution in 
tetrahydrofuran (0.5 mL) and the vial was carefully rinsed with additional tetrahydrofuran (0.2 
mL). The vial was sealed with septum and removed from the glovebox. After addition of water 
(70 µL), the vial was then covered in aluminum foil, and the mixture was heated to 55 °C and 
allowed to stir for 14 h under such conditions. The solution was allowed to cool to 22 °C, diluted 
with Et2O (5 mL), and passed through silica gel to afford an unpurified brown residue that was 
purified by silica gel chromatography (gradient eluting with 100:0 ® 3:1 Hexanes:Et2O) to afford 
the title compound as colorless oil (15.5 mg, 0.051 mmol).  
IR (neat): 3391 (br, m), 2921 (m), 2852 (m), 1492 (m), 1435 (m), 1092 (m), 1047 (m), 1013 (m), 
818 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.33 – 7.28 (m, 2H), 7.26 – 7.21 (m, 2H), 6.28 
(ddq, J = 14.9, 10.9, 1.3 Hz, 1H), 6.12 (tt, J = 11.0, 1.6 Hz, 1H), 5.72 (dt, J = 14.6, 7.0 Hz, 1H), 
5.28 (dt, J = 10.6, 7.7 Hz, 1H), 4.70 (ddd, J = 8.0, 5.1, 2.9 Hz, 1H), 2.67 (dtd, J = 14.4, 8.0, 1.4 
Hz, 1H), 2.56 (dddd, J = 14.3, 7.0, 5.2, 1.5 Hz, 1H), 2.49 (s, 3H), 2.14 – 2.02 (m, 2H), 1.98 (d, J 
= 3.2 Hz, 1H), 1.53 – 1.08 (m, 8H), 0.93 – 0.85 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 140.3, 
138.1, 136.6, 132.6, 127.5, 126.4, 125.1, 124.0, 73.9, 40.0, 32.9, 31.7, 29.7, 28.9, 23.1, 17.5, 13.3; 
HRMS (DART): Calcd for C19H27S [M+H–H2O]+: 287.18280; Found: 287.18293; Specific 
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tert-butyl (R,Z)-4-(4-hydroxy-4-phenylbut-1-en-1-yl)-3,6-dihydropyridine-1(2H)-
carboxylate. In a N2-filled glovebox, an oven-dried vial equipped with a stir bar was charged with 
ruphos-Pd-G3 (6.5 mg, 0.0078 mmol), ruphos (3.6 mg, 0.0078 mmol, K3PO4 (48.8 mg, 0.230 
mmol) and N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester (19.0 mg, 0.080 mmol). 
Z-3.72 (14.2 mg, 0.078 mmol) was added as a solution in tetrahydrofuran (0.5 mL) and the vial 
was carefully rinsed with additional tetrahydrofuran (0.3 mL). The vial was sealed with septum 
and removed from the glovebox. After addition of water (80 µL), the vial was then covered in 
aluminum foil, and the mixture was heated to 55 °C and allowed to stir for 14 h under such 
conditions. The solution was allowed to cool to 22 °C, diluted with Et2O (5 mL), and passed 
through silica gel to afford an unpurified brown residue that was purified by silica gel 
chromatography (gradient eluting with 100:0 ® 1:1 Hexanes:Et2O) to afford the title compound 
as yellow oil (12.3 mg, 0.034 mmol). 
IR (neat): 3439 (br, m), 3001 (m), 2973 (m), 2928 (m), 1693 (s), 1420 (s), 1365 (m), 1240 (m), 
1168 (s), 1113 (m), 700 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.36 (d, J = 4.4 Hz, 4H), 7.31 
– 7.27 (m, 1H), 5.92 (d, J = 11.8 Hz, 1H), 5.55 (s, 1H), 5.42 (dt, J = 11.9, 7.5 Hz, 1H), 4.74 (ddd, 
J = 8.0, 5.2, 2.9 Hz, 1H), 3.97 – 3.92 (m, 2H), 3.57 – 3.43 (m, 2H), 2.84 – 2.71 (m, 2H), 2.71 – 
2.60 (m, 1H), 2.22 (s, 2H), 1.96 (d, J = 3.2 Hz, 1H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3): 
δ 154.8, 143.9, 132.8, 128.5, 127.7, 125.8, 125.8, 123.1 (broad signal), 79.6, 73.3, 43.2 (broad 
signal), 40.6 (broad signal), 39.7 (broad signal), 38.6, 28.5; HRMS (DART): Calcd for C20H26NO2 
[M+H–H2O]+: 312.19581; Found: 312.19617; Specific Rotation: [a]22.7D +26.4° (c 0.50, CHCl3). 
 
(R,3Z,5E)-3-methyl-1-phenyldodeca-3,5-dien-1-ol. In a N2-filled glovebox, an oven-dried vial 
equipped with a stir bar was charged with ruphos-Pd-G3 (2.4 mg, 0.0029 mmol), ruphos (1.3 mg, 
0.0029 mmol, K3PO4 (36.3 mg, 0.220 mmol) and trans-1-octen-ylboronic acid pinacol ester (14.9 
mg, 0.063 mmol). 3.98 (11.2 mg, 0.057 mmol) was added as a solution in tetrahydrofuran (0.4 
mL) and the vial was carefully rinsed with additional tetrahydrofuran (0.2 mL). The vial was sealed 
with septum and removed from the glovebox. After addition of water (60 µL), the vial was then 
covered in aluminum foil, and the mixture was heated to 55 °C and allowed to stir for 14 h under 
such conditions. The solution was allowed to cool to 22 °C, diluted with Et2O (5 mL), and passed 
through silica gel to afford an unpurified yellow residue that was purified by silica gel 
chromatography (gradient eluting with 100:0 ® 3:1 Hexanes:Et2O) to afford the title compound 
as colorless oil (11.0 mg, 0.040 mmol). 
IR (neat): 3414 (br, m), 2953 (m), 2922 (s), 2852 (m), 1451 (m), 1376 (m), 1325 (m), 1047 (m), 
961 (m), 753 (s), 699 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.47 – 7.32 (m, 4H), 7.32 – 7.20 
(m, 1H), 6.24 (ddt, J = 14.9, 10.9, 1.5 Hz, 1H), 6.01 (d, J = 10.9 Hz, 1H), 5.62 (dt, J = 14.6, 7.0 
Hz, 1H), 4.82 (ddd, J = 9.1, 4.5, 2.3 Hz, 1H), 2.78 (dd, J = 13.5, 9.1 Hz, 1H), 2.38 (dd, J = 13.5, 
4.5 Hz, 1H), 2.08 (q, J = 7.1 Hz, 2H), 2.00 (d, J = 2.5 Hz, 1H), 1.79 (s, 3H), 1.45 – 1.17 (m, 8H), 
0.93 – 0.84 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 144.2, 134.3, 131.8, 129.3, 128.9, 127.5, 
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125.8, 125.7, 72.1, 42.8, 32.5, 31.7, 29.4, 28.9, 24.0, 22.6, 14.1; HRMS (DART): Calcd for C19H27 
[M+H–H2O]+: 255.21073; Found: 255.21006; Specific Rotation: [a]23.7D +48.0° (c 0.82, CHCl3). 
 
(R,Z)-4-Chloro-1-(4-(trifluoromethyl)phenyl)but-3-en-1-ol (S-4): Following the general 
procedure for addition, 4-(Trifluoromethyl)benzaldehyde (26.1 mg, 0.15 mmol) was transferred to 
an oven-dried vial to afford the title compound as colorless oil (22.5 mg, 0.090 mmol). IR (neat): 
3359 (br, m), 1621 (w), 1418 (w), 1322 (s), 1162 (m), 1109 (s), 1065 (s), 1015 (m), 842 (m), 753 
(m), 737 (m), 710 (m), 607 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.67 – 7.56 (m, 2H), 7.55 – 
7.44 (m, 2H), 6.17 (dt, J = 7.1, 1.5 Hz, 1H), 5.82 (q, J = 7.2 Hz, 1H), 4.90 (td, J = 6.5, 3.6 Hz, 
1H), 2.83 – 2.60 (m, 2H), 2.01 (d, J = 3.6 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 147.6, 130.1(q, 
J = 32.4 Hz), 126.8, 126.2, 125.6 (q, J = 3.8 Hz), 124.2 (q, J = 271 Hz), 121.2, 72.7, 36.8; 19F 
NMR (376 MHz, CDCl3): δ –62.53 (s, 3F); HRMS (DART): Calcd for C11H9F3Cl [M+H–H2O]+: 
233.03394; Found: 233.03349; Specific Rotation: [α]20.0D +20.7° (c 1.48, CHCl3) for a 87:13 er 
sample. Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 14.1 min 
(major) and 14.9 min (minor). 
 
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 13.521 min 7375322 50.767 1 14.149 min 21314367 87.247 
2 14.225 min 7152534 49.233 2 14.910 min 3115505 12.753 
 
(R,Z)-1-(4-(trifluoromethyl)phenyl)dec-3-en-1-ol. The procedure used was based on that 
reported by Buchwald et al.22 In a N2-filled glovebox, an oven-dried vial equipped with a stir bar 
was charged with (R,Z)-4-chloro-1-(4-(trifluoromethyl)phenyl)but-3-en 1-ol  S-4 (16.9 mg, 0.067 
mmol) and diluted with tetrahydrofuran (0.3 mL). Pinacolborane (10.3 mg, 0.080 mmol) was 
added and allowed to stir at 22 °C for 10 minutes. The solution was then concentrated under 
vacuum to afford a yellow residue that was diluted with toluene (0.1 mL). In a separate oven-dried 
vial ruphos-Pd-G3 (1.8 mg, 0.0022 mmol) was weighed out, and the toluene solution was then 
added and the vial was carefully rinsed with additional toluene (0.1 mL). n-hexyl Zinc bromide 
																																																								
22) Buchwald, S. L.; Han, C. J. Am. Chem. Soc. 2009, 131, 7532–7533.  
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(0.5 M in thf, 0.17 mL) was then added in a dropwise manner. The vial was sealed with a cap and 
removed from the glovebox and allowed to stir at 22 °C for 14 h. The reaction was quenched by 
the addition of solid Na2SO4•10H2O (100 mg) and then diluted with Et2O (5 mL) and passed 
through a small plug of silica gel to afford an unpurified yellow residue that was purified by silica 
gel chromatography (gradient eluting with 100:0 ® 3:1 Hexanes:Et2O) to afford the title 
compound as colorless oil (11.5 mg, 0.038 mmol).  
IR (neat): 3355 (br, m), 2954 (m), 2925 (m), 2854 (m), 1324 (s), 1164 (m), 1126 (m), 1067 (m), 
841 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.2 Hz, 2H), 7.49 (d, J = 8.1 Hz, 2H), 
5.67 – 5.54 (m, 1H), 5.43 – 5.31 (m, 1H), 4.80 – 4.76 (m, 1H), 2.61 – 2.42 (m, 2H), 2.05 (d, J = 
3.2 Hz, 1H), 2.03 – 1.95 (m, 9H), 1.30 – 1.23 (m, 3H), 0.88 (t, J = 6.8 Hz, 1H); 13C NMR (100 
MHz, CDCl3): δ 134.7, 126.1, 125.3 (q, J = 3.8 Hz), 123.7, 73.2, 37.4, 31.7, 29.5, 28.9, 25.7, 22.1, 
13.1; 19F NMR (376 MHz): δ –62.5 (s, 3F); HRMS (DART): Calcd for C17H22F3 [M+H–H2O]+: 
283.16681; Found: 283.16733; Specific Rotation: [a]24.9D +24.9° (c 0.45, CHCl3). 
 
(S,Z)-1-phenyldodec-5-en-3-ol. The procedure used was based on that reported by Buchwald et 
al.23 In a N2-filled glovebox, an oven-dried vial equipped with a stir bar was charged with  Z-3.86 
(15.4 mg, 0.073 mmol) and diluted with tetrahydrofuran (0.3 mL). Pinacolborane (11.2 mg, 0.088 
mmol) was added and allowed to stir at 22 °C for 10 minutes. The solution was then concentrated 
under vacuum to afford a yellow residue that was diluted with toluene (0.15 mL). In a separate 
oven-dried vial ruphos-Pd-G3 (3.1 mg, 0.0036 mmol) was weighed out, and the toluene solution 
was then added and the vial was carefully rinsed with additional toluene (0.15 mL). n-hexyl Zinc 
bromide (0.5 M in thf, 0.30 mL) was then added in a dropwise manner. The vial was sealed with 
a cap and removed from the glovebox and allowed to stir at 22 °C for 14 h. The reaction was 
quenched by the addition of solid Na2SO4•10H2O (100 mg) and then diluted with Et2O (5 mL) and 
passed through a small plug of silica gel to afford an unpurified yellow residue that was purified 
by silica gel chromatography (gradient eluting with 100:0 ® 3:1 Hexanes:Et2O) to afford the title 
compound as colorless oil (15.2 mg, 0.058 mmol).  
IR (neat): 3415 (br, m), 2953 (m), 2921 (s), 2851 (s), 1451 (s), 1047 (m), 1026 (m), 971 (s), 753 
(s), 699 (s) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.32 – 7.26 (m, 2H), 7.23 – 7.16 (m, 3H), 5.64 
– 5.50 (m, 1H), 5.45 – 5.30 (m, 1H), 3.65 (ddd, J = 12.4, 7.1, 5.3 Hz, 1H), 2.82 (ddd, J = 13.7, 8.9, 
6.6 Hz, 1H), 2.69 (ddd, J = 13.8, 9.0, 7.2 Hz, 1H), 2.34 – 2.18 (m, 2H), 2.06 (qd, J = 7.3, 1.6 Hz, 
2H), 1.89 – 1.71 (m, 2H), 1.57 (s, 1H), 1.41 – 1.19 (m, 9H), 0.92 – 0.84 (m, 3H); 13C NMR (100 
MHz, CDCl3): δ 142.1, 133.9, 128.43, 128.37, 125.8, 124.8, 70.1, 39.5, 35.5, 33.0, 31.7, 29.6, 
28.3, 27.4, 21.6, 13.6; HRMS (DART): Calcd for C18H32NO [M+NH4]+: 278.24784; Found: 
278.24744; Specific Rotation: [a]23.2D –3.2° (c 0.94, CHCl3). 
																																																								
23) Bissember, A. C.; Levina, A.; Fu, G. C. J. Am. Chem. Soc. 2012, 134, 14232–143237. 
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3.5.17 Comparison of Natural and Synthetic Mycothiazole and Confirmation of Absolute 
Stereochemistry of the Addition Process 
Absolute configurations of all products were assigned as R, based on agreement between an optical 
rotation of –22.3° for synthetic material, and a reported21 value of –21.3° for (8R)-mycothiazole.  
 




(300/500 MHz, CDCl3) 
Synthetic 
Mycothiazole 
(400 MHz, CDCl3) 
Hale, K. J. 
et al. 21 
(400 MHz, CDCl3) 
6.73 (7, J = 2.0 Hz, 1H) 6.77 (s, 1H) 6.76 (s, 1H) 
5.83 (m, 1H) 5.88 (d, J = 13.2 Hz, 1H) 5.86 (d, J = 11.6 Hz, 1H) 
5.73 (m, 1H) 5.88 – 5.76 (m, 1H) 5.79 (m, 1H) 
5.68 (m, 1H), 5.65 (m, 1H) 5.76 – 5.64 (m, 2H) 5.68 (m, 2H) 
5.50 (m, 1H) 5.64 – 5.55 (m, 1H) 5.57 (m, 1H) 
NH not observed 5.42 (s, 1H) 5.40 (s, 1H) 
4.96 (m, 3H) 5.10 – 4.97 (m, 3H) 
5.04 (m, 1H), 
4.99 (m, 1H), 
4.96 (m, 1H) 
4.83 (m, 1H), 
OH not observed 
4.92 – 4.84 (m, 2H) 
4.83 (m, 1H), 
OH not observed 
3.74 (dd, J = 10.2, 3.0 Hz, 
1H) 3.78 (d, J = 10.0 Hz, 1H) 
3.78 (dd, J = 10.4, 2.4 Hz, 
1H) 
3.56 (s, 3H) 3.63 (s, 3H) 3.61 (s, 3H) 
3.46 (d, J = 7.2 Hz, 2H) 3.51 (d, J = 7.3 Hz, 2H) 3.51 (d, J = 7.2 Hz, 2H) 
																																																								
24) Crews, P.; Kakou, Y.; Quiñoà, E.. J. Am. Chem. Soc. 1998, 110, 4365–4368. (b) Sonnenschein, R. N.; Johnson, 
T. A.; Tenney, K.; Valeriote, F. A.; Crews, P. J. Nat. Prod. 2006, 69, 145–147. 
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3.23 (m, 1H), 3.14 (m, 1H) 3.37 – 3.11 (m, 2H) 3.27 (m, 1H), 3.16 (m, 1H) 
2.84 (dt, J = 6.3, 1.5 Hz, 
2H) 
2.88 (td, J = 6.4, 1.7 Hz, 
2H) 
2.86 (apparent t, J = 6.4, 1.5 
Hz, 2H) 
2.39 (m, 1H), 2.29 (m, 1H), 
2.24 (m, 1H), 2.18 (m, 1H) 
2.48 – 2.11 (m, 4H) 
2.36 (m, 2H), 2.31 (m, 1H), 
2.21 (m, 1H) 
1.39 (s, 3H) 1.42 (s, 3H) 1.42 (s, 3H) 








(75 MHz, CDCl3) 
Synthetic 
Mycothiazole 
(101 MHz, CDCl3) 
Hale, K. J. 
et al. 
(101 MHz, CDCl3) 
179.4 179.6 179.6 
157.1 157.2 157.1 
154.9 155.1 154.8 
142.4 142.6 142.5 
136.4 136.5 136.4 
130.8 131.0 131.0 
130.8 130.7 130.5 
128.8 129.0 129.0 
126.7 126.8 126.6 
115.8 115.9 115.8 
115.0 115.1 115.0 
111.8 111.9 111.9 
78.1 78.2 78.1 
51.8 51.9 51.8 
44.5 44.7 44.7 
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39.4 39.5 39.4 
37.1 37.3 37.2 
31.5 31.6 31.5 
30.6 30.7 30.6 
29.4 29.5 29.3 
26.6 26.8 26.6 
23.9 23.9 23.8 
 




13C NMR Signal  
(100 MHz) 
1H NMR Signal 
(400 MHz) 
1 115.1 5.10 – 4.97 (m, 2H) 
2 136.5 5.88 – 5.76 (m, 1H) 
3 31.6 2.88 (td, J = 6.4, 1.7 Hz, 2H) 
4 129.0 5.64 – 5.55 (m, 1H) 
5 126.8 5.76 – 5.64 (m, 1H) 
6 29.5 3.51 (d, J = 7.3 Hz, 2H) 
7 155.1  
8 111.9 6.77 (s, 1H) 
9 179.6  
10 44.7  
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12 23.9 1.39 (s, 3H) 
13 78.2 3.78 (d, J = 10.0 Hz, 1H) 
14 30.7 2.48 – 2.11 (m, 2H) 
15 130.7 5.76 – 5.64 (m, 1H) 
16 130.1 5.88 (d, J = 13.2 Hz, 1H) 
17 142.6  
18 115.9 5.10 – 4.97 (m, 1H), 4.92 – 4.84 (m, 1H) 
19 37.3 2.48 – 2.11 (m, 2H) 
20 39.5 3.37 – 3.11 (m, 2H) 
21 157.2  
22 51.9 3.63s, 3H) 
	
3.5.18 NMR spectra 
(Appear on the following pages) 
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Chapter Four 
Catalytic Enantioselective Addition of Fluorine-Containing 
Trisubstituted Allyl Boronates to Aldehydes 
4.1  Introduction 
As discussed in Chapter Two, the incorporation of stereogenic centers possessing 
fluorine into compounds may modulate biological activity, influence pharmokinetic 
properties,1 or improve catalytic activity through conformational bias.2 While methods for 
the introduction of such motifs through additions to pro-chiral substrates3 or synthesis of 
tertiary C–CF3 bonds4 are well established, much less developed are strategies to access 
molecules possessing trifluoromethyl-substituted all-carbon quaternary centers. The need 
for efficient methods to synthesize such compounds is evidenced by the effective 
agrichemicals and new therapeutics represented in Scheme 4.15  
																																																								
1)  Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Aceña, J. L.; Soloshonok, V. A.; Izawa, K.; Liu, H. Chem. 
Rev. 2016, 116, 422–518. 
2) Zimmer, L. E.; Sparr, C.; Gilmour, R. Angew. Chem. Int. Ed. 2011, 50, 11860–11871. (b) Cahard, D.; 
Bizet, V. Chem. Soc. Rev. 2014, 43, 135–147. 
3) Zheng, Y.;.Ma, J.-A. Adv. Synth. Catal. 2010, 352, 2745–2750. (b) Nie, J.; Guo, H.-C.; Cahard, D.; Ma, 
J.-A. Chem. Rev. 2011, 111, 455–529. (c) Dilman, A. D.; Levin, V. V. Eur. J. Org. Chem. 2011, 831–841. 
4) For recent examples, see: (a) Li, G.; Gagare, P. D.; Ramachandran, P. V. Tetrahedron Lett. 2014, 55, 
5736–5738. (b) Gao, X.; Zhang, Y. J.; Krische, M. J. Angew. Chem. Int. Ed. 2011, 50, 4173–4175. (c) Guo, 
R.; Yang, Q.; Tian, Q.; Zhang, G. Scientific Reports 2017, 7, 4873. (d) Tauber, J.; Schwartz, L. A.; Krische, 
M. J. Org. Process Res. Dev. 2019, 23, 730–736. 
5) For abscisic acid analogue, see: Todoroki, Y.; Hirai, N.; Koshimizu, K. Phytochemistry 1995, 38, 561–
568. (b) Kim, B. T.; Min, Y. K.; Asami, T.; Park, N. K.; Jeong, I. H.; Cho, K. Y.; Yoshida, S. Bioorg. Med. 
Chem. Lett. 1995, 5, 275–278. (c) Balko, T. W.; Fields, S. C.; Webster, J. D. Tetrahedron Lett. 1999, 40, 
6347–6351. For anti-viral pyrrolidine, see: Or, Y. S.; Ying, L.; Wang, C.; Long, J.; Qui, Y.-L. PCT. Int. Appl. 
2008, WO 2009003009. For fungicide, see: Jennings, L. D.; Rayner, D. R.; Jordan, D. B.; Okonya, J. F.; 
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Scheme 4.1. The Need for Efficient Methods for Synthesis of Trifluoromethyl 
Substituted Quaternary Centers 
 
	
4.2  Background 
4.2.1  Accessing Quaternary Carbon Centers Bearing Trifluoromethyl Substitution 
 Methods for synthesis of these compounds can be divided into two categories: (1) 
Trapping of an electrophilic source of a trifluoromethyl group such as those depicted in 
Scheme 4.2. (2) Manipulation of trifluoromethyl-containing building blocks. The former 
relies on hypervalent iodine, or thio-based reagents developed by Togni6 and Umemoto,7 
which in addition to poor atom-economy, have been shown to be shock sensitive.8  
 
Scheme 4.2. Common Sources of a Trifluoromethyl Group 
 
																																																								
Basarab, G. S.; Amorose, D. K.; Anaclerio, B. M.; Lee, J. K.; Schwartz, R. S.; Whitmore, K. A. Bioorg. Med. 
Chem. Lett. 2000, 8, 897–907. 
6) Charpentier, J.; Früh, N.; Togni, A. Chem. Rev. 2015, 115, 650–682. 
7) Barata-Vallejo, S.; Lantaño, B.; Postigo, A. Chem. Eur. J. 2014, 20, 16806–16829. 
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Despite these drawbacks, there are several reports detailing synthesis of quaternary 
stereogenic centers involving additions to enolates,9 in addition to an isolated example 
describing reaction of silyl ketene imines for synthesis of  a-trifluoromethyl substituted 
nitriles.10  One may consider that reaction with trifluoroiodomethane may be a viable 
strategy; however, in the presence of lithium-based ester enolates, the major product 
obtained is difluoromethyl-substituted 4.7 (C–F bond cleavage vs. C–I, Scheme 4.3a).11 
Radical-based strategies have been demonstrated to minimize fluoride elimination to some 
extent when involving titanium- or ammonium-based enolates, nonetheless these solutions 
are far from general.12  
 
Scheme 4.3. Challenges Surrounding Introduction of a Trifluoromethyl Group 
	
																																																								
9) (a) Umemoto, T.; Ishihara, S. J. Am. Chem. Soc. 1993, 115, 2156–2164. (b) Umemoto, T.; Adachi, K. J. 
Org. Chem. 1994, 59, 5692–5699. (c) Ma, J.-A.; Cahard, D. J. Org. Chem. 2003, 68, 8726–8729. (d) Sato, 
K.; Yuki, T.; Tarui, A.; Omote, M.; Kumadaki, I.; Ando, A. Tetrahedron Lett. 2008, 49, 3558–3561. (e) Li, 
L.; Chen, Q.-Y.; Guo, Y. J. Org. Chem. 2014, 79, 5145–5152.  
10) Früh, N.; Togni, A. Angew. Chem. Int. Ed. 2014, 53, 10813–10816. 
11) Mikami, K.; Tomita, Y.; Itoh, Y. Angew, Chem. Int. Ed. 2010, 49, 3819–3822. 
12) (a) Itoh, Y.; Mikami, K. Org. Lett. 2005, 7, 649–651. (b) Itoh, Y.; Mikami, K. Org. Lett. 2005, 7, 4883–
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or
	
 Page 673 
C–C bond forming reactions involving nucleophiles that possess an a-CF3 anion 
are underdeveloped, as these moieties are prone to elimination of fluoride and generation 
of 1,1-difluoro-olefins 4.11 (Scheme 4.3b).13 The rate of decomposition (4.9, 4.10) is 
dependent on the counter ion, and those that are more fluorophilic, accelerate elimination.14 
In a single report, Nakagawa identified that in the presence of base generated 
electrochemically from a-pyrrolidone in conjunction with a tetraethyl ammonium cation, 
trifluoromethyl-substituted malonates may react with alkyl, allyl and benzyl 
electrophiles.15  
 Fluorine-containing nucleophiles are more common in methods for allylic 
substitution, a strategy that has received considerable attention for synthesis of all-carbon 
quaternary centers, 16  nonetheless, these methods are not immune to facile fluoride 
elimination.17 In the state-of-the-art, illustrated in Scheme 4.4, a-trifluoromethyl β-keto 
carboxylates may be employed for Tsuji-Trost alkylation promoted by a phosphine-Pd 
complex. 18 However, despite enantioselective transformations of closely related, but non-
fluorine containing substrates,19 the method could not furnish trifluoromethyl substituted 
stereogenic centers under catalyst control or with non-racemic starting material.  
																																																								
13) Miura, T.; Ito, Y.; Murakami, M. Chem. Lett. 2008, 1006–1007. For a comprehensive review, see: 
Uneyama, K.; Katagiri, T.; Amii, H. Acc. Chem. Res. 2008, 41, 817–829.  
14) Yokozawa, T.; Nakai, T.; Ishikawa, N. Tetrahedron Lett. 1984, 26, 3987. 
15) Fuchigami, T.; Nakagawa, Y. J. Org. Chem. 1987, 52, 5276–5277. For a review, see: Ma, J.-A.; Cahard, 
D. J. Fluorine Chem. 2007, 128, 975–996. 
16) For recent reviews detailing methods to access quaternary centers, see: (a) Quasdorf, K. W.; Overman, 
L. E. Nature, 2014, 516, 181–191. (b) Feng, J.; Holmes, M.; Krische, M. J. Chem. Rev. 2017, 117, 12564–
12580. 
17) (a) Hiraoka, S.; Yamazaki, T.; Kitazume, T. Chem. Commun. 1997, 1497–1498. (b) Li, L.; Chen, Q.-Y.; 
Guo, Y. Chem. Commun. 2013, 49, 8764–8766. (c) Li, L.; Huang, D.; Chen, Q.-Y.; Guo, Y. Synlett, 2013, 
24, 611–614. (d) Trost, B. M.; Debien, L. J. Am. Chem. Soc. 2015, 137, 11606–11609. 
18) Shibata, N.; Suzuki, S.; Furukawa, T.; Kawai, H.; Tokunaga, E.; Yuan, Z.; Cahard, D. Adv. Synth. Catal. 
2011, 353, 2037–2041.  
19) (a) Mohr, J. T.; Stoltz, B. M. Chem. Asian. J. 2007, 2, 1476–1491. (b) Mukherjee, H.; McDougal, N. T.; 
Virgil, S. C.; Stoltz, B. M. Org. Lett. 2011, 13, 825–827. 
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Scheme 4.4. Erosion of Enantiomeric Purity Under Tsuji-Trost Conditions 
 
In a related disclosure, Ando has outlined a strategy for alkylation of a-
trifluoromethyl substituted ketones, yet attempts at extending the method for synthesis of 
stereogenic centers bearing a trifluoromethyl group were equally unsuccessful.20 Most 
recently, Guo and Chen have detailed a method for enantioselective addition of 
trifluoromethyl-substituted ketene aminoacetals to allylic carbonates in the presence of an 
unspecified palladium complex. However, the scope of products, furnished in 0–86% yield 
and 50:50–87:13 er, lack generality and further serve as a testament to what is lacking in 
the current state-of-the-art.21   
 
Scheme 4.5. Synthesis of Quaternary Stereogenic Centers through Addition of 
Tertiary Radical Species to Isonitriles 
 
 
 Wang and Chen have outlined an approach involving generation of trifluoromethyl-
containing radicals from bromine-containing ketene aminoacetals and subsequent addition 
																																																								
20) Sato, K.; Takiguchi, Y.; Yoshizawa, Y.; Iwase. K.; Shimizu, Y.; Tarui, A.; Omote, M.; Kumadaki, I.; 
Ando, A. Chem. Pharm. Bull. 2007, 55, 1593–1596. 













thf, 22 °C, 1 h
4.14
97% yield, 50:50 er
4.12
4.13
Cahard et  al. Ref 19
O N
MeO2C BrCF3
2.0 mol % Ir(ppy)3
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to electron deficient olefins22 and isonitriles (Scheme 4.5).23 The mild reaction conditions 
are tolerant of diverse functionality, but are neither diastereo- nor enantioselective. In a 
related disclosure, Murahashi outlined a catalytic strategy wherein phosphine-Ir complexes 
are proposed to insert into C–H bonds of trifluoromethyl containing alkanes and then react 
with acrylates and alkenyl nitriles.24 However, in a follow-up study, the authors discovered 
that the transformation can be carried out in the absence of a metal-based catalyst, and only 
requires a phosphine ligand (XPhos) for efficient carbon-carbon bond formation.24b Other 
notable strategies for synthesis of all-carbon trifluoromethyl substituted quaternary centers 
include cycloaddition,25 addition of trifluoromethyl substituted allyl zinc compounds to 
aldehydes,26 and Claisen rearrangement of g-substituted allylic alcohols.27 
 
4.2.2 Catalytic Enantioselective Formation of All-Carbon Quaternary Centers 
Bearing a Trifluoromethyl Group 
 There are even fewer methods for catalytic, enantioselective synthesis of quaternary 
trifluoromethyl substituted stereogenic centers. In one of the earliest reports, Davies and 
co-workers outlined diastereo- and enantioselective construction of trifluoromethyl-
																																																								
22) Huan, F.; Chen, Q.-Y.; Guo, Y. J. Org. Chem. 2016, 81, 7051–7063. 
23) Wang, W.; Guo, Y.; Sun, K.; Wang, S.; Zhang, S.; Liu, C.; Chen, Q.-Y. J. Org. Chem. 2018, 83, 14588–
14599. 
24) (a) Guo, Y.; Zhao, X.; Zhang, D.; Murahashi, S.-I. Angew. Chem. Int. Ed. 2009, 48, 2047–2049. (b) 
Wang, Q.; Huan, F.; Shen, H.; Xiao, J.-C.; Gao, M.; Yang, X.; Murahashi. S.-I.; Chen, Q.-Y.; Guo, Y. J. 
Org. Chem. 2013, 78, 12525–12531.  
25) (a) Hanzawa, Y.; Suzuki, M.; Kobayashi, Y. Tetrahedron Lett. 1989, 30, 571–574. (b) Hanzawa, Y.; 
Suzuki, M.; Kobayshi, Y.; Taguchi, T. J. Org. Chem. 1991, 56, 1718–1724. (c) Ogawa, S.; Nishimine, T.; 
Tokunaga, E.; Shibata, N. Synthesis, 2010, 19, 3274–3281. (d) Nikolaev, V. A.; Supurgibekov, M. B.; Davies, 
H. M. L.; Sieler, J.; Zakharova, V. M. J. Org. Chem. 2013, 78, 4239–4244. (e) Loska, R. Targets in 
Heterocyclic Systems–Chemistry and Properties, 2015, 19, 101–127. 
26) Gosmini, C.; Rollin, Y.; Perichon, J.; Wakselman, C.; Tordeux, M.; Marival, L. Tetrahedron, 1997, 53, 
6027–6034. 
27) Bouvet, D.; Sdassi, H.; Ourévitch, M.; Bonnet-Delpon, D. J. Org. Chem. 2000, 65, 2104–2107. 
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substituted cyclopropanes through addition of rhodium-based carbenoids to aryl olefins 
(Scheme 4.6), affording products as a single diastereomer in 61–80% yield and 94:6–99:1 
er. A notable feature of the method is that isolation of the volatile diazo compound 4.19 is 
obviated by in-situ preparation through mild oxidation of the corresponding hydrazone.28  
 
 





Enantioenriched quaternary stereogenic centers may be prepared through conjugate 
addition of various nucleophiles to b,b–disubstituted enones 4.25. In 2012, Shibata 
described the first example of cyanide conjugate addition to a number of enones including 
2-naphthyl, nitro, and various halo-substituted examples in high er. 29 However, in order to 
access 5-membered heterocycles such as 4.29, reduction of the nitrile required treatment 
with Raney-Ni, which furnished the desire amines in no more than 50% yield. 
 
																																																								
28) Denton, J. R.; Sukumaran, D.; Davies, H. M. L. Org. Lett. 2007, 9, 2625–2628. 












5.0 equiv aryl olefin
trifluorotoluene, 22 °C, 4 h
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To address these shortcomings, an ensuing disclosure by the same authors detailed 
enantioselective conjugate addition of nitromethane to a variety of structurally diverse 
enones (4.30–32), including one b-alkyl substrate (Scheme 4.7).30   Partially saturated 
pyrrolidines could then be accessed through reduction of the nitro group and subsequent 
condensation in up to 92% yield. In an almost identical, but less efficient process, 
Kwiatowski reported conjugate addition of nitromethane at high-pressure (10 kbar) for 
access to the same class of compounds in 56–99% yield and 72.5:27.5–97.5:2.5 er.31 
Another strategy entails addition to trifluoromethyl-substituted nitroalkenes.32 In 
2014, Wang detailed reaction of vinylogous enolates 4.33 with tri- and tetra-substituted 
alkenes 4.34 promoted by thiourea 4.35 in 60–92% yield and 99:1 er (Scheme 4.8a).33 
Shortly thereafter, Ma outlined a method for catalytic enantioselective addition of malonate 
derivatives 4.40 to indole-containing nitroalkenes 4.41. Considerable diversity was 
																																																								
30) Kawai, H.; Yuan, Z.; Kitayama, T.; Tokunaga, E.; Shibata, N. Angew. Chem. Int. Ed. 2013, 52, 5575–
5579. 
31) Kwiatkowski, P.; Cholewiak, A.; Kasztelan, A. Org. Lett. 2014, 16, 5930–5933. 
32) Du, D.; Jiang, Y.; Xu, Q.; Tang, X.-Y.; Shi, M. ChemCatChem, 2015, 7, 1366–1371. 



























































65 °C, 10 h 4.29
	
 Page 678 
tolerated among the alkene and malonate compounds, including different patterns of ester 
substitution, N-tosyl or N-Boc protecting groups, and substitution on the aryl ring. The 
derived products possessing quaternary stereogenic centers were obtained in 63–93% 
yield, however extended reaction times (24–96 h) were required for efficiency (Scheme 
4.8b).34  
In 2016, Shen described addition of cyclic 1,3-dicarbonyl compounds promoted by 
squaramide catalyst 4.48 to nitroalkenes affording hydroxyimino 
tetrahydrobenzofuranones in 65–81% yield and 78:22–94.5:5.5 er.35 In a follow-up study, 
the same authors carried out addition of pyrazolinones 4.47 to trifluoromethyl substituted 
nitroalkenes (Scheme 4.8c).36 Neither method is tolerant of ortho-substitution on the aryl 
ring or the nitroalkene (<2% conv) and require extended reaction times for efficient 
addition. Jiang has reported similar squaramide catalysts to be effective for promoting 
enantioselective addition of maleonitrile to trifluoromethyl-substituted acrylates. In these 
cases, quaternary stereogenic centers bearing a trifluoromethyl group were furnished in 
















34) Ma, C.-H.; Kang, T.-R.; He, L.; Liu, Q.-Z. Eur. J. Org. Chem. 2014, 3981–3985. 
35) Liu, W.; Lai, X.; Zha, G.; Xu, Y.; Sun, P.; Xia, T.; Shen, Y. Org. Biomol. Chem. 2016, 14, 3603–3607. 
36) Lai, A.; Zha, G.; Liu, W.; Xu, Y.; Sun, P.; Xia, T.; Shen, Y. Synlett, 2016, 27, 1983–1988. 
37) Lou, Q.; Ding, Y.; Xu, D.; Liu, G.; Zhao, J. Adv. Synth. Catal. 2017, 359, 2557–2563. 
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a. Wang et al. Ref 33
c. Shen et al. Ref 36
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Fu has outlined construction of all carbon quaternary centers through addition of 
nickel-based enolates to nitro alkenes.38 Thiazoyl, pyridyl and pyrazinyl ketones 4.53 
proved to be effective under the reaction conditions affording 4.55 in 71–97% yield and 
95.5:4.5–99:1 er (Scheme 4.9a). The reaction is promoted by a readily accessible bis-
oxazoline ligand under mild conditions, however, reaction times of up to 120 h were 
required for efficiency. Furthermore, more sizable ortho-substituted nitroalkenes were 
unreactive and attempts to extend the scope to other Michael acceptors such as acrylates or 
acrylonitrile were unsuccessful.   
Jia has developed a method for Friedel-Crafts alkylation of indole 4.59 and pyrrole 
with disubstituted nitro-olefins in the presence of a related nickel complex, generating 
products 4.61 in 51–97% yield and 66.5:33.5–98:2 er (Scheme 4.9b). 39 The utility was 
highlighted through conversion to valuable tryptamine derivatives possessing an 
enantioenriched benzylic stereogenic center. Analogous to Fu’s method, ortho-substituted 
nitroalkenes were unreactive, however the authors do include examples of alkyl (benzyl 
and n-octyl 4.63) substituted nitro alkenes. 
Suresh found that titanium-based salen complexes could effectively catalyze 
conjugate addition of cyanide 4.65 to aromatic nitroalkenes in 52–92% yield and 76:24–
95.5:4.5 er (Scheme 4.9c). 40  The obtained products may then be converted to 
trifluoromethyl-substituted β-amino acids. It is noteworthy that, contrary to the Ni-based 
protocols detailed above, this method can tolerate o-fluoro- and o-methoxy-substituted 
arenes furnishing products in 99:1 and 87.5:12.5 er, respectively. 
 
																																																								
38) Hou, X.; Ma, H.; Zhang, Z.; Xie, L.; Qin, A.; Fu, B. Chem. Commun. 2016, 52, 1470–1473. For a related 
report involving a Co-based complex, see: Hao, X.-Q.; Wang, C.; Liu, S.-L.; Wang, X.; Wang, L.; Gong, J.-
F.; Song, M.-P. Org. Chem. Front. 2017, 4, 308–312. 
39) Gao, J.-R.; Wu, H.; Xiang, B.; Yu, W.-B.; Han, L.; Jia, Y-X. J. Am. Chem. Soc. 2013, 135, 2983–2986. 
40) Jakhar, A.; Kumari, P.; Nazish, M.; Khan, N. H.; Kureshy, R. I.; Abdi, S, H. R.; Suresh, E. RSC Adv. 
2016, 6, 29977–29982. 
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Scheme 4.9. Catalytic Enantioselective Additions to Nitroalkenes Promoted by Ni 
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Zhang has disclosed diastereo- and enantioselective [3+2] cycloaddition of 
azomethine ylides 4.68 and trifluoromethyl substituted enones41 and esters42 for synthesis 
of pyrrolidines 4.71. The method exhibits a broad scope, affording products in 70–99% 
yield and 90:10–99:1 er and is promoted by a ligand well suited to rapid library generation 
due to its modular synthesis. In a related account, Zhou accomplished synthesis of the same 
class of pyrrolidines through dipolar cycloaddition of azomethine ylides and nitro alkenes 
furnishing nitro-substituted pyrrolidines in 71–86% yield and 95.5:4.5–99:1 er.43 
 
Scheme 4.10. Synthesis of Trifluoromethyl-Substituted Pyrrolidines through 








41) Zhang, Z.-M.; Xu, B.; Xu, S.; Wu, H.-H.; Zhang, J. Angew, Chem. Int. Ed. 2016, 55, 6324–6328. 
42) Xu, B.; Zhang, Z.-M.; Xu, S.; Liu, B.; Xiao, Y.; Zhang, J. ACS Catal. 2017, 7, 210–214. 
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4.2.3  Enantioselective Synthesis of Allylic or Propargylic Quaternary Stereogenic 
Centers Bearing a Trifluoromethyl Group 
There are few examples detailing synthesis of an allylic trifluoromethyl-substituted 
quaternary stereogenic center, despite the potential of these motifs as synthetic building 
blocks.  
 
Scheme 4.11. Methods for Synthesis of Allylic F3C-Subsituted Stereogenic Centers 
	
 
In 2004, Yamazaki reported SN2’ addition of alkyl Grignard reagents to 
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a. SN2’ substitution of allyl acetates with alkyl Grignard reagents
b. Catalytic enantioselective 1,4-addition of alkynyl metal nucleophiles
c. Formyl addition to trifluoromethyl substituted allyl iridium
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enone with stoichiometric (R)-BINAL-H. 44  In the presence of a suitable copper salt, 
namely CuCN, and chlorotrimethylsilane as an additive to promote rapid reductive 
elimination as a result of a favorable β-silicon effect,45 4.78 was isolated as a single olefin 
isomer with >98% enantiospecificity and in 92% yield (Scheme 4.11a).   
In a different approach, Pedro described the first example of addition of alkynyl-
Zn compounds to trifluoromethyl-substituted enones (Scheme 4.11b).46 The method is 
suitable for additions to compounds that are alkyl or aryl-substituted, albeit the former was 
obtained in 71.5:28.5 er for one containing a methyl substituent. The utility of the 
propargylic stereocenter in 4.82 was highlighted through stereoselective reduction to Z-
olefin 4.83, in addition to iodine-induced cyclization for synthesis of pyran derivatives.  
Krische has developed a method for synthesis of allylic quaternary stereogenic 
centers by reductive coupling of trifluoromethyl-substituted allenes and in-situ generated 
formaldehyde.47 The method has broad scope, affording 4.86 in 57–95% yield and 95:5–
97:3 er. Nonetheless, applicability is limited to aryl-substituted allenes. This is likely due 
to low yielding or inefficient preparations of trifluoromethyl-containing alkyl-substituted 
allenes,47b a fact that highlights current deficiencies in the state-of-the-art. 
	 Most recently, Aggarwal and co-workers described ring opening of 
trifluoromethyl-substituted epoxide 4.87, furnishing boronic ester 4.91. 48  Notably, the 
reaction affords a mixture of separable regioisomers resulting from [1,2]-shift of either the 
alkyl group or the oxygen substituent on boron. The fact that the latter is observed is likely 
																																																								
44) Kimura, M.; Yamazaki, T.; Kitazume, T.; Kubota, T. Org. Lett. 2004, 6, 4651–4654. 
45) Bertz, S. H.; Miao, G.; Rossiter, B. E.; Snyder, J. P. J. Am. Chem. Soc. 1995, 117, 11023–11024.  
46) Sanz-Marco, A.; Blay, G.; Vila, C.; Pedro, J. R. Org. Lett. 2016, 18, 3538–3541. 
47) Holmes, M.; Nguyen, K. D.; Schwartz, L. A.; Luong, T.; Krische, M. J. J. Am. Chem. Soc. 2017, 139, 
8114–8117. For examples of preparation of alkyl-substituted allenes, see: Miyake, Y.; Ota, S.-i.; Shibata, M.; 
Nakajima, K.; Nishibayashi, Y. Chem. Commu. 2013, 49, 7809–7811. 
48) Nandakumur, M.; Rubial, B.; Noble, A. Myers, E. L.; Aggarwal, V. K. Angew. Chem, Int. Ed. 2020, 59, 
1187–1191. 
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consequence of the trifluoromethyl group and emphasizes how incorporation of such 
motifs can alter the reactivity of organic compounds. Products bearing otherwise difficult-
to-access quaternary allylic and propargylic stereogenic centers were accessed through 
well-known methods for conversion of the obtained boronic esters.  
 
Scheme 4.12. Ring Opening of Trifluoromethyl-Substitued Epoxides through [1,2]-




In a different approach, Nishibayashi developed a method for substitution of 
racemic propargylic perfluorobenzoates 4.96 with indole.49 In the presence of a Cu-based 
pybox complex, 4.98 was obtained in 71–86% yield and 96.5:3.5–98.5:1.5 er, with similar 
results for reaction with other nitrogen-containing heterocyles such as pyrrole 4.101. The 
utility of the terminal alkyne was highlighted by conversion to various triazoles through 
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4.2.4  Catalytic Enantioselective Formation of All-Carbon Quaternary Centers 
Bearing a Trifluoromethyl Group (Cyclic Systems) 
  Access to compounds containing trifluoromethyl-substituted quaternary 
stereogenic centers in cyclic systems are lacking,50 and there are just five reports to date 
describing their synthesis. The earliest, disclosed by Gade in 2012, relates to 
enantioselective trapping of Cu-based enolates with Togni’s reagent 4.3 furnishing 
products (4.104) in 83–94% yield and 90:10–99:1 er (Scheme  4.14a).51 The method is 
suitable for reaction of 5- and 6-membered ketoesters, although enantioselectivities were 
diminished for the latter. Cahard has contributed to the field, developing a method for 
enantioselective synthesis of identical compounds promoted by chiral guanidine bases, 
however, selectivity did not exceed 85:15 er, even at –80°C. 52  Most recently, Togni 
																																																								
50) For an example of this motif in a bioactive molecule, see: Luzina, E. L.; Popov, A. V. J. Fluorine Chem. 
2014, 168, 121–127. 
51) Deng, Q.-H.; Wadepohl, H.; Gade, L. H. J. Am. Chem. Soc. 2012, 134, 10769–10772. 
52) Noritake, S.; Shibata, N.; Nomura, Y.; Huang, Y.; Matsnev, A.; Nakamura, S.; Toru, T.; Cahard, D. Org. 
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provided a single example of enantioselective synthesis of trifluoromethyl-substituted 
oxidole 4.107 in 68% yield and 94:6 er (Scheme 4.14b).53  
 




In 2015, Melchoirre developed a catalytic enantioselective method for introduction 
of perfluoro alkyl groups through reaction of ketoesters 4.102 and alkyl iodides. The 
authors found that the method could be extended to reaction with CF3I when promoted by 
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cinchona alkaloid phase transfer catalyst 4.109.54 Thus, under these reaction conditions, 
compounds containing quaternary stereogenic centers were isolated, however 
enantioselectivity fluctuated depending on the substitution pattern of the aromatic ring 
(e.g., R=H, 98:2 er; R=3-CH3, 89:11 er) and yields did not exceed 53% (Scheme 4.14c).  
 This year, Ge and Lu disclosed a method for synthesis of oxindoles 4.112 bearing 
a trifluoromethyl-substituted quaternary center through sequential Heck coupling of 
iodoacrylanilides 4.110 and a terminal alkyne 4.80.55 The method has considerable scope, 
tolerating a variety of nitrogen protecting groups including alkyl (–CH3, –Bn) and aryl 
(paramethoxybenzyl) substitution, in addition to alkyl, aryl and silyl substituents on the 
alkyne affording products 4.122 in 46–88% yield and 96:4–99:1 er.  
 
Scheme 4.15. Synthesis of Trifluoromethyl Substituted Oxindoles 
 
																																																								
54) Woźniak, L.; Murphy, J. J.; Melchiorre, P. J. Am. Chem. Soc. 2015, 137, 5678–5681. 
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4.2.5  Synthesis and Unique Reactivity of Allyl Fluorides 
 Due to the well-known benefits of incorporation of fluorine56 countless methods 
have been developed for synthesis of these motifs. 57  In fact, in 2018 alone, 17 new 
therapeutics approved by the FDA contained fluorine,58 however, the majority of these 
moieties are substituted on Csp2 atoms, as a result of advances enabled by metal-mediated 
reactions.59 Far less common are methods for synthesis Csp3 fluoro-substituted centers, 
despite emerging evidence of the benefits of such a motif, as indicated by the recently 









56) (a) Böhm, H.-J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Müller, K.; Obst-Sander, U.; Stahl, M. 
ChemBioChem 2004, 5, 637–643. (b) Müller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881–1886. (c) 
Purser, S.; Moore, P. R.; Swallow, S. Chem. Soc. Rev. 2008, 37, 320–330. (d) Hunter, L. Bielstein J. Org. 
Chem. 2010, 6, doi 10.3762/bjoc.6.38. (e) Wang, J.; Sánchez-Roselló, M.; Aceña, J. L.; del Pozo, C.; 
Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H. Chem. Rev. 2014, 114, 2432–2506. (f) Ilardi, E. 
A.; Vitaku, E.; Njardson, J. T. J. Med. Chem. 2014, 57, 2832–2842. (g) Huchet, Q. A.; Kuhn, B.; Wagner, 
B.; Kratochwil, N. A.; Fischer, H.; Kansy, M.; Zimmerli, D.; Carreira, E. M.; Müller, K. J. Med. Chem. 2015, 
58, 9041–9060. (h) Berger, A. A.; Völler, J.-S.; Budisa, N.; Koksch, N. Acc. Chem. Res. 2017, 50, 2093–
2103.  (i) Huhmann, S.; Koksch, B. Eur. J. Org. Chem. 2018, 3667–3679. Meanwell, N. A. J. Med. Chem. 
2018, 61, 5822–5880. 
57) (a) Bobbio, C.; Gouverneur, V. Org. Biomol. Chem. 2006, 4, 2065–2075. (b) Cahard, D,; Xu, X.; Couve-
Bonnaire, S.; Pannecoucke, X. Chem. Soc. Rev. 2010, 39, 558–568. (c) Lectard, S.; Hamashima, Y.; Sodeoka, 
M. Adv. Synth. Catal. 2010, 352, 2708–2732. (d) Yerien, D. E.; Bonesi, S.; Postigo, A. Org. Biomol. Chem. 
2016, 14, 8398–8427. 
58) Mei, H.; Han, J.; Fustero, S.; Medio-Simon, M.; Sedgwick, D. M.; Santi, C.; Ruzziconi, R.; Soloshonok, 
V. A. Chem. Eur. J. 2019, 25, 11797–11819. 
59) Furuya, T.; Kamlet, A. S.; Ritter, T. Nature 2011, 473, 470–477. 
60) For synthesis of odanacatib, see: O’Shea, P. D.; Chen, C.-y.; Gauvreau, D.; Gosselin, F.; Hughes, G.; 
Nadeau, C.; Volante, R. P. J. Org. Chem. 2009, 74, 1605–1610. For synthesis of tyrosine kinase inhibitor, 
see, Curtis, N. R.; Davies, S.; Gray, M.; Leach, S. G.; McKie, R. A.; Vernon, L. E.; Walkington, A. Org. 
Process Res. Dev. 2015, 19, 865–871. For synthesis of LY503430, see: Duthion, B.; Pardo, D. G.; Cossy, J. 
Org. Lett. 2010, 12, 4620–4623. 
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Scheme 4.16. Representative Bioactive Compounds with Quaternary Fluoro-
Substituted Stereogenic Centers 
 
 
A common method for introduction of fluorine at a Csp3 center is substitution of an 
alcohol with DAST (diethylaminosulfur trifluoride) or Deoxo-fluor (bis-2-
methoxyethylaminosulfur trifluoride). In addition to poor functional group tolerance, these 
reactions can lead to mixtures of regioisomeric products when allylic alcohols are the 
substrate. A representative example is shown in Scheme 4.17a, where Rapp attempted 
synthesis of allylic fluoride 4.114, obtaining the desired quaternary fluoro-substituted 
center in 26% yield.61 Further complicating the issue, the reaction proceeds with inversion 
of stereochemistry. In fact, the stereochemical outcomes for substitution are often 
unpredictable and substrate dependent. For instance, in a campaign to synthesize 
fluorinated prostaglandins, Kurozumi and co-workers found that no matter the epimer of 
allylic alcohol 4.116 they attempted to transform, only a single diastereomeric product 
4.117 was isolated (Scheme 4.17b).62  This is contrary to reports by Erasmuson, wherein 
stereochemistry was inverted for cases involving acyclic allylic alcohols,63 and those by 
Troupet where introduction of fluorine was stereoretentive in the presence of an iron 
																																																								
61) Rapp, M.; Bilska, M.; Koroniak, H. J. Fluorine Chem. 2011, 132, 1232–1240. For a detailed review 
regarding allylic and propargylic fluorides, see: Pacheco, M. C.; Purser, S.; Gouverneur, V. Chem. Rev. 2008, 
108, 1943–1981. 
62) (a) Bannai, K.; Toru, T.; Oba, T.; Tanaka, T.; Okamura, N.; Watanabe, K.; Hazato, A.; Kurozumi, S. 
Tetrahedron, 1983, 39, 3807–3819. (b) Sugiura, S.; Toru, T.; Tanaka, T.; Okamura, N.; Hazato, A.; Bannai, 
K.; Manabe, K.; Kurozumi, S. Chem. Pharm. Bull. 1984, 32, 1248–1251. 
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carbonyl co-catalyst. 64  Furthermore, the activated intermediate is susceptible to 
intramolecular displacement even in the presence of weakly nucleophilic groups. For 
instance, when transformation of Boc-protected amino alcohol 4.118 was attempted, the 
corresponding aziridine 4.119 was isolated in 65% yield (Scheme 4.17c).65  
 





64) Gree, D. M.; Kermarrec, C. J. M.; Martelli, J. T.; Gree, R. L.; Lellouche, J.-P.; Troupet, L. J. J. Org. 
Chem. 1996, 61, 1918–1919. 
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4.2.6  Catalytic Enantioselective Synthesis of Quaternary Carbons Containing 
Fluorine 
Strategies for synthesis of cyclic and acyclic carbonyl compounds possessing an a-
fluoro-substituted stereogenic center are well established.66 One representative example, 
as described by Paquin,67 furnishes these motifs through addition of silyl enol ether 4.120 
to allyl carbonate 4.121 (Scheme 4.18). Since the method does not require b-ketoesters as 
the substrate, as most others do, the need to extrude carbon dioxide in a subsequent 
synthetic manipulation is obviated.  
 
Scheme 4.18. Reaction of Silyl Enol Ethers with Allyl Carbonates 
 
A more recent example, involves conversion of racemic branched aldehydes to 
homobenzylic alcohols (4.128-129) with a fluoro-substituted stereogenic center (Scheme 
4.19).68 Upon reaction with primary amine catalyst 4.126, the likely in situ generated 
enamine may be quenched by reaction with NFSI. After reductive work-up, 
																																																								
66) For a comprehensive review, see: Zhu, Y.; Han, J.; Wang, J.; Shibata, N.; Sodeoka, M.; Soloshonok, V. 
A.; Coelho, J. A. S.; Toste, F. D. Chem. Rev. 2018, 118, 3887–3964. 
67) Bélanger, E.; Cantin, K.; Messe, O.; Trembaly, M.; Paquin, J. F. J. Am. Chem. Soc. 2007, 129, 1034–
1035. 
68) Shibatomi, K.; Kitahara, K.; Okimi, T.; Abe, Y.; Iwasa, S. Chem. Sci. 2016, 7, 1388–1392. For other 
examples of fluorination of aldehydes, see: (a) Brandes, S.; Niess, B.; Bella, M.; Prieto, A.; Overgaard, J.; 
Jfrgensen, K. A. Chem. Eur. J. 2006, 12, 6039–6052. (b) Shibatomu, K.; Yamamoto, H. Angew. Chem, Int. 
Ed. 2008, 47, 5796–5798. (c) Witten, M. R.; Jacobsen, E. N. Org. Lett. 2015, 17, 2772–2775. (d) Emma, M. 
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enantiomerically enriched alcohols were generated in 59–98% yield and 57:43–97.5:2.5 
er. Additions to aliphatic aldehydes 4.130, however, were less efficient (24% yield). 
 




Strategies for synthesis of quaternary fluoro-substituted stereogenic centers that are 
not adjacent to a carbonyl may be divided into two classes: (1) Reaction with a source of 
electrophilic fluorine (e.g., NFSI or Selectfluor)69 or addition of fluoride to an activated 
substrate. (2) Employing a building block that already contains fluorine. Representative 
examples for each of these cases are described below.  
In 2018, Jacobsen accomplished synthesis of β-fluoroaziridines through oxidative 
functionalization of homoallylic amines.70  In the presence of C2-symmetric iodoarene 
catalyst 4.133, the alkene may be sufficiently activated for addition of fluoride, thus 
forming an intermediary Csp3-IIII species, and ensuing substitution furnished aziridine 
4.134. However, only a single example of synthesis of a compound bearing a quaternary 
stereogenic center was addressed (4.134, 44% yield and 80.5:19.5 er; Scheme 4.20a).  
 
																																																								
69) For reviews, see: (a) Bobbio, C.; Gouverneur, V. Org. Biomol. Chem. 2006, 4, 2065–2075. (b) Brunet, 
V. A.; O’Hagan, D. Angew. Chem. Int. Ed. 2008, 47, 1179–1182. 
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This year, Marek detailed an approach for synthesis of quaternary fluoro-
substituted stereogenic centers through nucleophilic displacement of cyclic carbinols with 
tetrafluoroboric acid (Scheme 4.20b). Compounds 4.137, possessing valuable vicinal 
stereocenters, were obtained in 39–65% yield as a single diastereomer.71 Nonetheless, due 
to the requirement for an aqueous solution of HBF4, competitive formation of tertiary 
alcohols was observed leading to diminished yields.  
Among the approaches for synthesis of fluoro-substituted stereogenic centers,72 
methods for synthesis allylic moieties have received little attention. These compounds are 
known to induce conformational preferences for highly selective cycloadditions,73 or may 
be elaborated through ozonolysis 74  or dihydroxylation 75  to access to high-value 
																																																								
71) Lanke, V.; Marek, I. J. Am. Chem. Soc. 2020, 142, 5543–5548. 
72) (a) Ma, J.-A.; Cahard, D. Chem. Rev. 2008, 108, PR1–PR43. (b) Valero, F.; Companyó, X.; Rios, R. 
Chem. Eur. J. 2011, 17, 2018–2037. (c) Yang, A.; Wu, T.; Phipps, R. J.; Toste, F. D. Chem. Rev. 2015, 115, 
826–870.  
73) Grée, D.; Vallerie, L.; Grée, R.; Toupet, L.; Washington, I.; Pelicier, J.-P.; Villacampa, M.; Pérez, J. M.; 
Houk, K. N. J. Org. Chem. 2001, 66, 2374–2381. 
74) Hunter, L.; O’Hagan, D.; Slawin, A. M. Z. J. Am. Chem. Soc. 2006, 128, 16422–16423.  
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a. Jacobsen et al. Ref 70
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organofluorine compounds. One strategy for preparation involves reaction of an allyl silane 
with Selectfluor. 76  In 2003, Gouverneur reported an enantioselective variant wherein 
cinchona alkoid 4.140 and selectfluor react in situ to generate an enantiomerically enriched 
source of fluorine. (Scheme 4.21a).  
 
Scheme 4.21. Transformation Involving Allyl Silanes and Boronates   
	
Despite high efficiency, enantiomeric ratios were dependent on the identity of the 
 g-substituent, with a benzyl group being optimal.77 In the first example of enantioselective 
synthesis of acyclic allyl fluorides bearing a quaternary stereogenic center, Aggarwal 
																																																								
76) (a) Thibaudeau, S.; Gouverneur, V. Org. Lett. 2003, 5, 4891–4893.; (b) Tredwell, M.; Tenza, K.; Pacheco, 
M. C.; Gouverneur, V. Org. Lett. 2005, 7, 4495–4497. (c) Tredwell, M.; Gouverneur, V.; Org. Biomol. Chem. 
2006, 4, 26–32. (d) Purser, S.; Odell, B.; Claridge, T. D. W.; Moore, P. R.; Gouverneur, V. Chem. Eur. J. 
2006, 12, 9176–9185. (e) Purser, S.; Wilson, C.; Moore, P. R.; Gouverneur, V. Synlett, 2007, 1166–1168. (f) 
Lam, Y.-H.; Bobbio, C.; Cooper, I. R.; Gouverneur, V.; Angew. Chem. Int. Ed. 2007, 46, 5106–5110. (g) 
Lam, Y.-H.; Hopkinson, M. N.; Stanway, S. J.; Gouverneur, V. Synlett, 2007, 3022–3026. (h) Teare, H.; 
Robins, E. G.; Årstad, E.; Luthra, S. K.; Gouverneur, V. Chem. Commun. 2007, 23, 2330–2332. 
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documented stereoselective tapping of enantiomerically pure boron-ate complex 4.146 
with selectfluor furnishing allyl fluoride 4.147 in 76% yield and 95:5 dr. 78 
 
Scheme 4.22. Phosphoric Acid Promoted Synthesis of Exocyclic Allyl Fluorides 
 
In 2013, Toste detailed an approach for synthesis of five to seven membered cyclic 
allyl fluorides. 79  In the presence of an ion pair comprised of phosphate 4.149 and 
Selectfluor 4.139, obtained through exchange of one tetrafluoroborate anion, concerted 
deprotonation and incorporation of fluorine is proposed to generates β-fluoroamine 
derivatives 4.150 with an exocyclic olefin (Scheme 4.22).  
In an ensuing report, the same authors developed a strategy for synthesis of 
enantioenriched allyl fluorides through 1,4-addition across conjugated dienes 4.153, 
wherein 6-endo-trig cyclization furnished isoquinoline derivatives.80 Di-4.157–158 and tri-
substituted olefins 4.156 with various styrenyl substituents and aryl amides were suitable 
substrates, as illustrated in Scheme 4.23. Attempts to synthesize to the opposite 
																																																								
78) García-Ruiz, C.; Chen, J. L.-Y.; Sandford, C.; Feeney, K.; Lorenzo, P.; Berionni, G.; Mayr, H.; Aggarwal, 
V. K. J. Am. Chem. Soc. 2017, 139, 15324–15327. 
79) Wu, J.; Wang, Y.-M.; Drljevic, A.; Rauniyar, V.; Phipps, R. J.; Toste, F. D. Proc. Natl. Acad. Sci. U. S. 
A. 2013, 110, 13729–13733. 
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diastereomer, i.e., a Z-aryl olefin was utilized, were inefficient due to a buildup of allylic 
strain in the transition state.  
 
Scheme 4.23. Toste’s Method for Catalytic Enantioselective Addition to Dienes 
 
In 2018, Hartwig outlined the first catalytic enantioselective method for allylic 
substitution affording acyclic allylic fluorides 4.162,81 previously only accessible in a 
racemic manner.82 Additions of malonic acid derivatives 4.160 (including maleonitrile) to 
a variety of aryl and alkyl-substituted allyl carbonates furnished 4.162 in 56–98% yield 
and 74:26–99:1 er (Scheme 4.24a). In a subsequent disclosure,83 the authors described 
diastereodivergent synthesis of organofluorine compounds, wherein two catalysts, 
																																																								
81) Butcher, T. W.; Hartwig, J. F. Angew. Chem, Int. Ed. 2018, 57, 13125–13129. 
82) (a) Topczewski, J. J.; Tewson, T. J.; Nguyen, H. M. J. Am. Chem. Soc. 2011, 133, 19318–19321. (b) 
Katcher, M. H.; Sha, A.; Doyle, A. G. J. Am. Chem. Soc. 2011, 133, 15902–15905. (c) Konno, T.; Ikemoto, 
A.; Ishihara, T. Org. Biomol. Chem. 2012, 10, 8154–8163. 
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phosphine-Cu complex 4.165 and iridium complex 4.161, function cooperatively 84  to 
generate all four possible isomers in 99% yield and 99:1 er (Scheme 4.24b). 
 




More recently, You has developed an approach for diastereodivergent allylic 
substitution involving acyclic pyridyl-substituted ketones 4.167.85 In contrast to Hartwig’s 
method, only a single catalyst, 4.168, was required to access to all four possible 
stereoisomers. This was accomplished by selecting an appropriate sequence i.e., C–C bond 
																																																								
84) This is an example of cooperative catalysis, formally designated as Type I, see: Romiti, F.; del Pozo, J.; 
Paioti, P. H. S.; Gonsales, S. A.; Li, X.; Hartrampf, F. W. W.; Hoveyda, A. H. J. Am. Chem. Soc. 2019, 141, 
17952–17961.  
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b. Hartwig et al. Ref 83
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formation or introduction of fluorine as the first synthetic manipulation. Products 4.169, 
were thus generated in 56–97% yield, 82:18–98:2 dr and 96:4–99:1 er. 
 
 
Scheme 4.25. Sequence Specific Synthesis of Diastereomeric Quaternary F-
Substituted Stereogenic Centers 
 
 
 Resolution of fluorine containing diols represents another notable strategy. 86 
Narisano has shown that porcine pancreas (PPL) is an effective catalyst for enantioselective 
acylation of fluorine-containing diols 4.178-179. Under the same conditions, 
transformation of alkyl substituted cases were less efficient, however, synthesis of 4.176–
																																																								
86) (a) Guanti, G.; Marisans, E.; Riva, R. Tetrahedron: Asymmetry 1998, 9, 1859–1862. (b) Narisano, E.; 
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b. Access to all diastereomers through sequence specific fluorination
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177 were accomplished with Lipase PS in non-anhydrous media, generating the 
corresponding products in up to 97.5:2.5 er.  
 
Scheme 4.26. Enzymatic Resolution of Symmetrical Diols 
 
 
4.2.7  Enantioselective Synthesis of Fluorine-Containing Homoallylic Alcohols 
We are only aware of a few examples addressing synthesis of homoallylic 
alcohols87 or amines through addition of fluoro-substituted allylmetal compounds. In a 
disclosure by Huang, enantiomerically pure imines 4.180, generated in-situ, react with g,g-
difluoroallyl boronate 4.181, generating 4.182 in 80:20–99:1 dr and 80–94% yield (Scheme 
4.27a).88 However, the transformation requires 48 h at 60 °C for efficiency, and additions 
to aliphatic imines were not addressed. Furthermore, removal of the auxiliary required a 
three-step sequence involving reaction with Pb(OAc)4, followed by treatment with 
hydroxylamine. Homoallylic alcohols containing a fluoro-substituted allylic carbon may 
be accessed through addition of enantiomerically pure g,g-difluoroallyl boronate 4.186, 
however, an inherent limitation is that the C2 substituent is required for efficient 
																																																								
87) For a radical-based transformation, see: Lang, S. B.; Wiles, R. J.; Kelly, C. B.; Molander, G. A. Angew. 
Chem. Int. Ed. 2017, 56, 15073–15077. 
88) Yang, X.; Cao, Z.-H,; Zhou, Y.; Cheng, F.; Lin, Z.-W.; Ou, Z.; Yuan, Y.; Huang, Y. Y. Org. Lett. 2018, 
















64% yield, 98:2 er
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85% yield, 98:2 er
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91% yield, 97.5:2.5 er
4.177
67% yield, 95.5:4.5 er
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preparation of the boronate (Scheme 4.27b). 89  To access similar compounds without 
substitution (4.191), additions involving the more reactive alkyl borane 4.190 (prepared 
through treatment of fluorine-containing allene 4.189 with a pinene-derived borohydride) 
were required (Scheme 4.27c).90 
 






89) Ramachandran, P. V.; Tafelska-Kaczmarek, A.; Sakavuyi, K. Org. Lett. 2011, 13, 4044–4047. For 
examples of diastereoselective addition, see: (a) Ramanchandran, P. V.; Chatterjee, A. Org. Lett. 2008, 10, 
1195–1198. (b) Ramachandran, P. V.; Chatterjee, A. J. Fluorine Chem. 2009, 130, 144–150. (c) 
Ramachandran, P. V.; Tafelska-Kaczmarek, A.; Sakavuyi, K.; Chatterjee, A. Org. Lett. 2011, 13, 1302–1305. 
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(generated in situ)
a. Huang et al. Ref 88
b. Ramachandran et al. Ref 89
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 Recently, our group 91  and others 92  have developed catalytic methods for 
preparation of fluorine-containing allyl boronates through boryl allylic substitution of 
trifluoromethyl substituted alkenes. Subsequent addition of the obtained g,g-difluoroallyl 
boronates to imines and aldehydes furnished homoallylic amines and alcohols with gem 
difluoromethyl motifs.93 In 2019, in collaboration with Ito, we reported the first examples 
of regio- and stereoselective synthesis of trisubstituted fluorine-containing allyl 
boronates.94   Subsequent addition to aldehydes generated homoallylic alcohols 4.194, 
possessing a fluoro-substituted quaternary center in 33–60% yield. 
 
Scheme 4.28. Reaction of Enantiomerically Enriched Trisubstituted Allyl Boronates 
 
We reasoned that a more broadly applicable catalytic approach for additions would 
constitute a valuable addition to the state-of-the-art. Based on the benefits of incorporation 
of a fluoro- and trifluoromethyl motif, we reasoned a stereogenic center which incorporates 
each of these motifs could have a synergistic benefit.95 Furthermore, the current state of-
																																																								
91) Corberan, R.; Mszar, N. W.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2011, 50, 7079–7082.  
92) Liu, Y.; Zhou, Y.; Zhao, Y.; Qu, J. Org. Lett. 2017, 19, 946–949. Kojima, R.; Akiyama, S.; Ito, H. Angew. 
Chem. Int. Ed. 2018, 57, 7196–7199. Gao, P.; Yuan, C.; Zhao, Y.; Shi, Z. Chem 2018, 4, 2201–2211. Zhao, 
X.; Li, C.; Wang, B.; Cao, S. Tetrahedron Lett. 2019, 60, 129–132. For synthetic methods regarding synthesis 
of other fluorinated allyl compounds, see: Novikov, M. A.; Nefedov, O. M. Org. Biomol. Chem. 2018, 16, 
4963–4967. 
93) Liu, Y.-L.; Yu, J.-S.; Zhao, J. Asian J. Org. Chem. 2013, 2, 194–206. 
94) Akiyama, S.; Kubota, K.; Mikus, M. S.; Paioti, P. H. S.; Romiti, F.; Liu, Q.; Zhou, Y.; Hoveyda, A. H.; 
Ito, H. Angew. Chem. Int. Ed. 2019, 58, 11998–12003. 
95) For a recent example of a bioactive compound with a halogenated quaternary center, see: Cherney, R. J.; 
Cornelius, L. A. M.; Srivastava, A.; Weigelt, C. A.; Marcoux, D.; Duan, J. J.-W.; Shi, Q.; Batt, D. G.; Liu, 
Q.; Yip, S.; Wu, D.-R.; Ruzanov, M.; Sack, J.; Khan, J.; Wang, J.; Yarde, M.; Cvijic, M. E.; Mathur, A.; Li, 
Ph(pin)B
F
1.1 equiv n-BuLi 
1.2 equiv TFAA
thf, –78→22 ºC, 2 h
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the-art to access products of this sort was reported by Ishihara nearly three decades ago, 
and surrounds diastereoselective addition of boron-based enolates to aldehydes (Scheme 
4.29).96  
 
Scheme 4.29. Diastereoselective Addition of Boron-Based Enolates to Aldehydes 
 
4.3  Transformations Involving Fluorine-Containing Allyl Boronates 
4.3.1 Prior Work and Reaction Design 
As we considered which catalytic platform might be best suited to promote 
addition, we were attracted to aminophenol boron-based complexes, an emerging class of 
catalysts capable of promoting efficient and enantioselective addition to a variety of 
electrophiles, particularly those containing fluorine.97 For additions to trifluoromethyl-
substituted ketimines and ketones, enantiofacial discrimination is likely the result of 
coulombic attraction between the trifluoromethyl group and the embedded ammonium 
																																																								
S.; Shuster, D.; Khandelwal, P.; Borowski, V.; Xie, J.; Obermier, M.; Fura, A.; Stefanski, K.; Cornelius, G.; 
Tino, J. A.; Macor, J. E.; Salter-Cid, L.; Denton, R.; Zhao, Q.; Carter, P. H.; Dhar, T. G. M. ACS Med. Chem. 
Lett. 2020, doi: https://doi.org/10.1021/acsmedchemlett.0c00063 
96) (a) Kuroboshi, M.; Ishihara, T. Bull. Chem. Soc, Jpn. 1990, 63, 1191–1195. Ishihara, T.; Kuroboshi, M.; 
Yamaguchi, K. Chem. Lett. 1990, 211–214. (b) For non-selective addition of aluminum-based enolates to 
aldehydes, see: Ishihara, T.; Kuroboshi, M.; Yamaguchi, K.; Okada, Y. J. Org. Chem. 1990, 55, 3107–3114. 
(c) For diastereoselective reduction of related products, see: Ishihara, T.; Yamaguchi, K.; Kuroboshi, M.; 
Utimoro, K. Tetrahedron Lett. 1994, 35, 5263–5266. 
97) Lee, K.; Silverio, D. L.; Torker, S.; Robbins, D. W.; Haeffner, F.; van der Mei, F. W.; Hoveyda, A. H. 
Nature Chem. 2016, 8, 768–777. For transformations of the same class, see: Fager, D. C.; Lee, K.; Hoveyda, 
A. H. J. Am. Chem. Soc. 2019, 141, 16125–16138. For propargyl addition, see: Mszar, N. W.; Mikus, M. S.; 
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(Scheme 4.30, 4.198). As illustrated in 4.200, we questioned whether repulsion between 
fluorine on the catalyst’s allyl unit and the oxygen lone pair may be alleviated through 
attraction with the ammonium ion, a stabilizing interaction that is not present in 4.201. 
Whether these factors would be sufficient to render the transformation enantioselective 
remained to be determined. 
 
Scheme 4.30. Elements of Reaction Design for Enantiofacial Discrimination 
 
We then needed to address whether trisubstituted allyl boronates, particularly those 
possessing fluorine would efficiently react. As depicted in Scheme 4.31, p-donation from 
fluorine coupled with withdrawal of electron density through the s-framework polarizes 
the alkene, thereby decreasing nucleophilicity (4.203). Making the situation even more 
tenuous, we had devoted previous effort almost exclusively to additions of disubstituted 
allyl boronates for synthesis of Z alkenes or tertiary allylic stereogenic centers. In fact, 
since our first disclosure, we have only accessed quaternary centers on two occasions. The 
first involves addition of enantioenriched allyl boronates to phosphinoyl aldimines, 
wherein g-transfer of allyl boronate 4.209 furnishes a trisubstituted aminophenol allyl 
complex 4.211 that may subsequently react with a phosphinoyl imine. 98  The second 
																																																								
98) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. 
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involves a single example of addition of prenyl-substituted allyl boronate 4.205 to 
trifluoroketone 4.204,99 wherein a-product 4.206 was furnished in 89% yield and 89:11 er.  
 




To access quaternary stereogenic centers possessing fluoro- and trifluoromethyl 
substitution, we rationalized that 1,3-boryl shift must preempt direct addition (Scheme 
4.32c). It is plausible, that for additions to ketones, increased steric pressure, engendered 
by the two methyl substituents as a result of a change in hybridization at the boron center 
disfavors isomerization. While these factors may be implicated for an allyl boronate 
bearing two methyl groups, we postulated that one incorporating electron-withdrawing 
fluoro and trifluoromethyl moieties may enhance boron Lewis acidity. Thus, the strength 
of alkene coordination with the partially vacant p-orbital may be increased. We did have 
to contend with prior knowledge that addition of trifluoromethyl-substituted allyl boronate 
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Z-4.214 was predominately a-selective. Nonetheless, it is possible that the fully substituted 
allylic carbon (4.218 vs 4.215) could hinder initial substrate coordination. Compounds 
containing quaternary stereogenic centers may then be generated; however, if the products 
could be isolated with diastereo- or enantioselectivity remained to be determined.  
 
Scheme 4.32. Factors Influencing Additions of F-, F3C-Substituted Allyl Boronates 
 
4.3.2  Synthesis of Fluorine-Containing Allyl Boronates 
To begin, we required a method for regio- and stereoselective synthesis of fluorine 
containing allyl boronates. We surveyed a series of imidazolinium salts (imid 1-4) to 
promote synthesis of trisubstituted allyl boronate 4.202. Copper-boryl addition generates 
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weakened C-F bond as a result of overlap between sCu–C and s*C-F.100 Two practical 
considerations merit brief note before continued discussion: (1) The transformation must 
be carried out with excess B2(pin)2, otherwise the newly formed allyl boronate may react 
with the copper alkoxide species present in solution, generating allyl copper 4.224 that can 
eliminate fluoride. (2) Optimal efficiency and stereoselectivity required non-polar media. 
Under these conditions, in the absence of ligand, the transformation proceeds with to 78% 
conversion, furnishing the allyl boronate in 91:9 Z:E ratio (Scheme 4.33c). Previously, for 
additions of disubstituted allyl boronates to phosphinoyl imines, the stereochemistry of the 
compound did not affect selectivity;101 however, if the same would be true for additions of 
trisubstituted reagents was unclear. Improved stereoisomeric purity was obtained when the 
transformation was promoted by sulfonate containing imid-3 and phenyl glycinol based 
imid-4. could afford the allyl boronate with improved Z selectivity (Scheme 4.33c). We 
judged the cost and time required for preparation of imid-3 rendered it less attractive. 
 





100) For a detailed mechanistic analysis, see: Paioti, P. H. S.; del Pozo, J.; Mikus, M. S.; Lee, J.; Koh, M. J.; 
Romiti, F.; Torker, S.; Hoveyda, A. H. J. Am. Chem. Soc. 2019, 141, 19917–19934. 




























Facile elimination of allyl–Cu intermediate
(Z)
a. Mechanism of boryl allylic substitution
b. Possible mechanism for decomposition of allyl boronates
4.221 4.222 4.202
4.202 4.223 4.224 4.225
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aAll reactions were performed under an atmosphere of dry N2. Conv. and Z:E ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Experiments were conducted at 
least in triplicate. pin: pinacolato. See Experimental Section for details. 
 
Isolation of the moisture-sensitive boronate was not so straightforward, although 
this could be circumvented through purification with anhydrous solvent and oven-dried 
silica. In the event that LiOt-Bu was replaced with LiOTMS, the desired reagent 4.202 
could be isolated following filtration and distillation to remove residual salts, thereby 
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Scheme 4.34. Preparative Scale Synthesis of Fluorine-Containing Allyl Boronatesa 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. and Z:E ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified 
product (±5%). Experiments were conducted at least in triplicate. See Experimental Section for 
details. 
 
4.3.3  Initial Evaluation and Optimization 
 In line with previous investigations,98 the less acidic, and more soluble, Zn(Ot-Bu)2 
was optimal for efficiency. Furthermore, we found that there was no detectable conversion 
at 22 °C, likely a consequence of the steric pressure generated by the g-carbon and the 
reversed polarity of the reagent. To improve efficiency, the reaction was performed at 60 
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Scheme 4.35. Initial Evaluation and Identification of an Optimal Aminophenola 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). Experiments were 
conducted at least in triplicate. piv: pivaloyl. See Experimental Section for details. 
 
 Next, we sought to identity an effective catalyst to promote the transformation. We 
identified that regioselectivity was impacted by the size of the aryloxide substituent. In line 
with previous mechanistic models (see Chapter One), those possessing a smaller 
substituent, such as ap-3, exhibited increased g selectivity, however this was at the expense 
of diastero- and enatioselectivity. Reactions promoted by a catalyst with a more sizable 
tert-butyl group, afforded 4.220 in 88:12 dr and 92:8 er, and aminophenol compounds that 
were substituted with a sizable triphenylsilyl group were largely a-selective. We then 
probed a variety of compounds possessing different amino acid residues. Those containing 
a larger tert-leucine residue (ap-4) led to diminished regioselectivity, probably owing to 
O
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increased steric pressure in the transition state for 1,3-boryl shift. Threonine-based catalysts 
ap-5 and ap-6 offered little improvement. Thus, we selected ap-2 as optimal. 
 
4.3.4 Scope of the Catalytic Method 
 Additions to electron-rich aldehydes proceeded with efficiency, and para-
methoxyphenyl-substituted 4.228 and 4-methylthio-4.229 furnished products in 63 and 
67% yield and 96:4 and 96.5:4.5 er, respectively. The more electron-donating methyl ether 
(more efficient C–O overlap, as opposed to C–S) affords higher levels of g selectivity 
probably owing to decreased electrophilicity. Thus, allowing pathways for 1,3-boryl shift 
to be more viable. Heteroaryl-substituted aldehydes were equally effective, as evidenced 
by 3-thienyl 4.232 and 3-furyl 4.233, generated in 69 and 77% yield and 92:8 dr and 96:4 
er. Indole containing 4.234 was in 54% yield, 86:14 dr and 95:5 er, and the crystalline 
nature of the product allowed us to obtain an X-ray structure to determine relative and 
absolute stereochemistry. Contrary to additions of chloro-substituted allyl boronates (see 
Chapter Three), which rely on steric factors for enantiofacial discrimination, additions to 
more diminutive alkenyl and alkyl-substituted aldehydes furnished products 4.235-237 in 
89:11–92:8 dr and 91:9–94:6 er. Furthermore, the transformation is suitable with 
compounds possessing a stereogenic center, as the product derived from (+)-citronellal was 












 Page 712 




aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios  (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). Experiments were 
conducted at least in triplicate. Bn: benzyl. See Experimental Section for details. 
 
 Boronates possessing perfluoroalkyl substitution were prepared analogously 
through reaction with perfluoro hexane, affording 4.239. Under the same conditions for 
addition of trifluoromethyl-substituted boronates, 4.240 was obtained with exclusive g 
selectivity, 84:16 dr and 95:5 er. The higher proportion of g-isomer in the reaction mixture 
is likely consequence of the more sizable perfluoroalkyl substituent, which may hamper 
association of the aldehyde and/or exert greater pressure with the catalyst, favoring boryl 
O
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shift. We were able to secure an X-ray structure to confirm our previously assigned 
absolute and relative stereochemistry.   
 
Scheme 4.37 Additions of Perfluoroalkyl-Substituted Allyl Boronatesa 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). Experiments were 
conducted at least in triplicate. See Experimental Section for details. 
 
 Aldehydes possessing electron-withdrawing substituents exhibited diminished g 
selectivity. Under optimal conditions, m-Cl 4.241 and para-NO2 substituted 4.242 were 
isolated in 66:34 and 45:55 g:a ratio, respectively. Since the rate of addition is dependent 
on the concentration of aldehyde, whereas boryl shift likely does not exhibit the same 
concentration dependence, we rationalized that if the availability of these more 
electrophilic substrates was decreased, then g:a ratios may be improved. We went about 
this by modifying the reaction conditions, first reversing the stoichiometry of the reagents 
such that the allyl boronate was now in excess. Furthermore, we sought to take advantage 
of the reactivity of these more electrophilic aldehydes through reversible formation of their 
corresponding hemiacetals. Accordingly, when addition was carried out with 20 
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Scheme 4.38. Improved Conditions for Additions to Electron-Deficient Aldehydesa 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). Experiments were 
conducted at least in triplicate. See Experimental Section for details. 
 
4.3.5 Application to Synthesis of Sofosbuvir Analogue 
 One example of an organofluorine compound possessing a quaternary stereogenic 
center is HCV inhibitor Sofosbuvir,102 a recently developed treatment for Hepatitis C, a 
liver disease that effects millions annually. 103  We envisaged that a fluoro- and 
trifluoromethyl-substituted derivative of the furanose core may be efficiently synthesized 
through addition of fluorine-containing allyl boronates. Initial attempts for optimization 
(antipode of ap-2 employed for desired stereochemistry) revealed the benefit of an excess 
																																																								
102) (a) Liotta, D. C.; Painter, G. R.; Bluemling, G. R. PCT. Int. Appl. 2014124430 (b) Liotta, D. C.; Painter, 
G. R.; Blueming, G. R.; De La Rosa, A. PCT. Int. Appl. 2015038596. (c) Liotta, D. C.; Painter, G. R.; 
Blueming, G. R.; De La Rosa, A. PCT. Int. Appl. 2016145142. 
103) Sofia, M. J.; Bao, D.; Chang, W.; Du, J.; Nagarathnam, D.; Rachakonda, S.; Reddy, P. G.; Ross, B. S.; 
Wang, P.; Zhang, H.-R.; Bansal, S.; Espiritu, C.; Keilman, M.; Lam, A. M.; Micolochick Steuer, H. M.; Niu, 
C.; Otto, M. J.; Furman, P. A. J. Med. Chem. 2010, 53, 7202−7218. For bioactivity, see: (a) Lawitz, E.; 
Mangia, A.; Wyles, D.; Rodriguez-Torres, M.; Hassanein, T.; Gordon, S. C.; Schultz, M.; Davis, M. N.; 
Kayali, Z.; Reddy, K. R.; Jacobson, I. M.; Kowdley, K. V.;Nyberg, L.; Subramanian, G. M.; Hyland, R. H.; 
Arterburn, S.; Jiang, D.; McNally, J.; Brainard, D.; Symonds, W. T.; McHutchinson, J. G.; Sheikh, A. M.; 
Younossi, Z.; Gane, E. J. New England J. Medicine. 2013, 368, 1878–1887. (b) Fung, A.; Jin, Z.; Dyatkina, 
N.; Wang, G.; Beigelman, L.; Deval, J. Antivir. Chem. Chemother. 2014, 58, 3636–3645. (c) Kirby, B. J.; 
Symonds, W. T.; Kearney, B. P.; Mathias, A. A. Clin. Pharmokinet. 2015, 54, 677–670.  For recent studies 
regarding synthesis, see: Simmons, B.; Liu, Z.; Klapars, A.; Bellomo, A.; Silverman, S. M. J. Org. Chem. 
2017, 19, 2218–2221. (b) Cini, E.; Barreca, G.; Carcone, L.; Manetti, F.; Rasparini, M.; Taddei, M. Eur. J. 
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5.0 mol % ap-2
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68% yield (pure !)
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of allyl boronate 4.202 for additions to a-alkoxy aldehyde 4.249; however, g selectivity did 
not exceed 80:20 g:a ratio. To overcome this, we considered applying insight obtained for 
additions to other electrophilic aldehydes, wherein the concentration of the aldehyde may 
likely be reduced through reversible formation of the corresponding hemiacetal. 
Accordingly, in the presence of 20 equivalents of methanol, selectivity increased to 97:3 
g:a ratio, without any discernable impact on the diastereoselectivity of the transformation 
(Scheme 4.39c). To complete the formal synthesis, the secondary alcohol was converted to 
a benzyl ether by treatment with sodium hydride and benzyl bromide, and the diol was 
unmasked through treatment with camphor sulfonic acid in ethylene glycol to afford 4.252 
in 73% yield over two steps. With 4.252 in hand, we attempted the penultimate step; 
namely protection of the primary alcohol, however, to our surprise, the product obtained 
was the result of reaction with the secondary alcohol. Oxidative cleavage of the olefin 
through treatment with ozone and subsequent cyclization afforded puranose 4.254, the 
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Scheme 4.39. Sofosbuvir Analogue and Discovery of Unusual Reactivity Profilea 
 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). Experiments were 
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88% yield, 98:2 dr
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10 mol % Zn(Ot-Bu)2
20 equiv MeOH
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1. NaH, BnBr, thf
2. 6.0 equiv CSA

















a. Medicinal chemistry route towards furanose core of Sofosbuvir analogue
c. A catalytic approach towards furanose core: beneficial effect of more polar media
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To access the furanoside, an alternative route was developed. Oxidative cleavage 
through treatment with catalytic osmium and NMO, with citric acid to promote 
efficiency,104 furnished an unpurified aldehyde 4.255, which was immediately subjected to 
cyclization upon treatment with para-toluenesulfonic acid generating hemiacetal 4.256, 
instead of the expected methanol adduct. After filtration through NaHCO3 to neutralize 
excess acid, the water-soluble hemiacetal could then be protected and isolated as tris-
benzoate 4.257 in 73% yield over three-steps.  
 
Scheme 4.40. Synthesis of Furanoside Core of Sofosbuvir Analoguea 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). See Experimental Section for details. 
 
																																																								
104) (a) Dupau, P.; Epple, R.; Thomas, A. A.; Fokin, V. V.; Sharpless, K. B. Adv. Synth. Catal. 2002, 344, 
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5.0 mol % OsO4, 
4.0 equiv NMO
2.0 equiv citric acid
thf/H2O (2/1), 22 °C, 20 h;
then 5.0 equiv NaIO4, 22 °C, 4h





40 mol % dmap
CH2Cl2, 22 °C, 3h
4.250
97:3 !:"
88% yield (!), 98:2 dr
4.257
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4.4  Analysis of Mechanism 
4.4.1  Unique Selectivity for Benzyl Protection 
The origins of the unusual selectivity for benzyl ether formation intrigued us, 
especially considering precedent that in similar, but non-halogen containing compounds, 
the primary alcohol was selectively protected (Scheme 4.41). In one reported case, 
treatment with sodium hydride and benzyl bromide afforded benzyl ether 4.260 in 90% 
yield,105 and a second detailed isolation of the primary benzyl ether in 68% yield upon 
refluxing in acetone with K2CO3 as a mild buffer.106 Thus, we reasoned reaction at the 
secondary alcohol was likely a consequence of the incorporation fluorine, however, it had 
yet to be determined whether this was due to the allylic fluoride, trifluoromethyl group or 
a combination of the two. To probe these effects, we set out to prepare a series of 
derivatives. 
 
Scheme 4.41 Precedent for Selective Reaction at Primary Alcohola 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. and dr ratios (±2%) were 
determined by analysis of 1H NMR spectra of unpurified mixtures. Yield of isolated and purified 
product (±5%). See Experimental Section for details. 
																																																								
105) Li, M.; Xiong, J.; Huang, Y.; Wang, L.-J.; Tang, Y.; Yang, G-X.; Liu, Z.-H.; Wei, B.-G.; Fan, H.; Zhao, 
Y.; Zhai. W.-Z.; Hu. J.-F. Tetrahedron, 2015, 71, 5285–5295. 




thf (0.155 M), 0 °C, 3 h
1.5 equiv NaH
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OH 1.5 equiv BnBr
1.5 equiv NaH
10 mol % (n-Bu)4NI
thf, 0–22 °C, 5 h




a. Synthesis of non-fluorine containing diol
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We first synthesized allyl alcohol 4.259 under standard Barbier conditions as 
outlined by Fadnavis.107 Homoallylic alcohol 4.258 was isolated as a mixture of isomers, 
which upon conversion to the corresponding benzyl ethers were separable by 
chromatography. The diol could then be unmasked through treatment with trifluoroacetic 
acid.  
 
Scheme 4.42. Synthesis and Application of Fluoro-Substituted Allyl Boronatea 
	
aAll reactions were performed under an atmosphere of dry N2. Conv., Z:E and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). Bn: benzyl. See 
Experimental Section for details. 
 
A direct strategy for access to an analog possessing an allylic fluoride would 
involve allyl addition of a fluoro-substituted allyl boronate. Based on our own 
experience,108 we recognized the requisite reagent Z–4.263 could be synthesized through 
																																																								
107) Venkataiah, M.; Somaiah, P.; Reddipalli, G.; Fadnavis, N. W. Tetrahedron: Asymmetry 2009, 20, 2230–
2233. 

































1.1 equiv n-BuLi 
1.2 equiv tfaa










benzene, 22 °C, 4 h
4.264
95:5 dr
79% yield over two steps
then; 1.5 equiv BnBr
1.5 equiv NaH
10 mol % (n-Bu)4NI
thf, 0–22 °C, 5 h
50% aq. tfa
CH2Cl2






b. Diastereoselective allyl addition of fluoroallyl boronate
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cross-metathesis of prenyl–B(pin) 4.261 and bromo fluoro ethylene 4.262. 
Diastereoselective allyl addition, under conditions previously employed for fluorine-
containing allyl boronates, 109 then afforded a homoallylic alcohol which was protected as 
a benzyl ether prior to unmasking the diol (Scheme 4.42b).110 Unfortunately, attempts to 
access the alternative diastereomer through synthesis of an E–fluoro allyl boronate by 
cross-metathesis were unsuccessful.111  
 
Scheme 4.43. Establishment of Fluoro-Substituted Stereogenic Center Through 
Reaction with an Allyl Silanea 
 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios  (±2%) were 
determined by analysis of 1H or 19F NMR spectra of unpurified mixtures. Yield of isolated and 
purified product (±5%). See Experimental Section for details. 
 
Instead, we pursed a different strategy, wherein fluorine was introduced at a later 
stage in the synthesis. We commenced with non-selective addition of vinyl magnesium 
																																																								
109) Kojima, R.; Akiyama, S.; Ito, H. Angew. Chem. Int. Ed. 2018, 57, 7196–7199. 
110) Interestingly, when deprotection was attempted by treatment with CSA in ethylene glycol, fluorine was 
excised from the molecule.  
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bromide to aldehyde 4.266 affording a 1:1 mixture of diastereomers in 54% yield,112 and 
subsequent conversion to benzyl ether 4.268 allowed for separation of the diastereomeric 
products.113 At this stage, we carried out cross-metathesis of allylic benzyl ether 4.268 and 
allyl silane 4.269 promoted by Grubbs’ Second-Generation catalyst Ru-1 according to a 
procedure by Vankar.114 Finally, we secured allylic fluorides 4.271 and 4.272 by subjecting 
the obtained allyl silane to selectfluor and separating the diastereomeric products.76a To 
address the poor efficiency for synthesis of allyl silane 4.270, we considered reaction with 
phosphorane 4.275 and a-alkoxy aldehyde 4.274. Despite straightforward preparation of 
each of the components,115 reaction with branched aldehydes favors formation of 4.276 as 
the major product due to silyl migration over retro [2+2] collapse of oxaphosphatane 4.278 
(Scheme 4.44b).  
 




112) Bilska-Markowska, M.; Koroniak, H. J. Fluorine Chem. 2003, 203, 185–192. 
113) Allylic alcohol may be accessed in diastereomerically pure form in 3 steps from commercially available 
2,3:4,5-Di-o-isopropylidene-d-arabitol (CarboSynth, 500 mg, $70), see: Schneider, C.; Kazmaier, U. 
Synthesis 1998, 9, 1314–1320. 
114) Dubbu, S.; Bardhan, A.; Chennaiah, A.; Vankar, Y. D. Eur. J. Org. Chem. 2018, 6800–6808. 
115) For phosphorane prep, see: Fleming, I.; Paterson, I. Synthesis 1979, 446–448. For aldehyde prep, see: 



































b. Poor chemoselectivity for introduction of allyl silane
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Alternatively, allyl fluoride 4.272 may be accessed through treatment of aldehyde 
4.281 under conditions previously reported for a-fluorination (Scheme 4.45). When 
promoted with the matched antipode of pyrrolidine 4.283, diastereomeric ratios are 
reported to be excellent (>95:5),116 and unlike the branched examples discussed in Section 
4.2.5, linear aliphatic aldehydes afford the corresponding tertiary fluorides with efficiency 
and in high er.117 The somewhat sensitive aldehyde 4.284, may then be converted to an 
alkene as previously described by Guindon.118  
 




 For synthesis of 4.295, we considered recent advances in preparation of fluorine-
containing allyl boronates that are fluoro- and alkyl-substituted; however, Z selectivity is 
lower than the analogous aryl substituted examples (Scheme 4.46a).  Furthermore, the 
product of addition to an aldehyde would be a homoallylic alcohol containing a 
disubstituted olefin, requiring cleavage in a further synthetic manipulation. Furthermore, 
																																																								
116) Hu, X.-G.; Lawer, A.; Peterson, M. B.; Iranmanesh, H.; Ball, G. E.; Hunter, L. Org. Lett. 2016, 18, 662–
665. 
117) Beeson. T. D.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 8826–8828. (b) Marigo, M.; 
Fielenbach, D.; Braunton, A.; Kjoersgaard, A.; Jfrgensen, K. A. Angew. Chem. Int. Ed. 2005, 44, 3703–
3706. Steiner, D. D.; Mase, N.; Barbas, C. F. Angew. Chem. Int. Ed. 2005, 44, 3706–3710. 
118) Dostie, S.; Prévost, M.; Mochirian, P.; Tanveer, K.; Andrella, N.; Rostami, A.; Tambutet, G.; Guindon, 
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precedent informed us that  addition would likely afford the incorrect diastereomer (Felkin-
Ahn control). 
 
Scheme 4.46. Synthesis of Quaternary Fluoro-Substituted Stereogenic Centera 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified 
product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental Section for 
details. 
 
 Instead, we opted to commence with commercially available 4.290, obtained 
through dihydroxylation of the corresponding trisubstituted olefin,119 and obtained benzyl 
ether 4.291 in 59% yield. A three-step sequence, namely reduction of the ester, oxidation 
and Wittig olefination then furnished allylic alcohol 4.292 in 42% yield. Fluorine was 
introduced through treatment with DAST, generating regioisomeric allyl fluorides 4.293 
and 4.294, which were separable by silica gel chromatography. Cleavage of the acetal 
																																																								
119) Wang, P.; Chun, B.-K.; Rachakonda, S.; Du, J.; Khan, N.; Shi, J.; Stec, W.; Cleary, D.; Ross, B. S.; 
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a. State-of-the-art for synthesis of trisubstituted fluorine-containing allyl boron
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generated 4.294 as a single diastereomer with unknown stereochemistry (see discussion on 
ambiguity in Section 4.2.5). 
 
Scheme 4.47. Access to Diastereomeric Fluoro and Trifluoromethyl-Substituted 
Stereogenic Centera 
	
aAll reactions were performed under an atmosphere of dry N2. Conv and dr ratios (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified 
product (±5%). CSA: camphorsulfonic acid; tfaa: trifluoroacetic anhydride. See Experimental 
Section for details. 
  
To investigate the effect of relative stereochemistry on selectivity, we set out to 
synthesize 4.297. An analysis of models for addition revealed that if boronate 4.202 could 
be converted to a more reactive species, diastereoselective addition to a-alkoxy aldehyde 
4.249 would likely generate the Felkin-Ahn product (Scheme 4.47, 4.299). Accordingly, 
treatment with n-BuLi and trifluoroacetic anhydride, which probably converts the boronate 
to a more reactive borinate species (4.298), allowed us to isolate 4.296 in 26% yield. The 
diol was then obtained after alkylation of the secondary alcohol and hydrolysis of the acetal 
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OBn
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Scheme 4.48 Benzyl Protection for Fluorinated and Non-Fluorinated Analogsa 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. and product selectivity ratios 
(±2%) were determined by analysis of 1H or 19F NMR spectra of unpurified mixtures, Conv. refers 
to consumption of diol. Yield of isolated and purified products (±5%). Results are unoptimized and 
structural determinations tentative. See Experimental Section for details. 
 
  With a series of analogs in hand, we set out to examine their reactivity.  It is 
important to note the concentration dependence of the observed selectivity for reactions 
involving 4.252. The optimal conditions are reasonably dilute (0.016 M), a factor which 
we had rationalized should favor reaction with the more accessible primary alcohol. When 
the concentration was increased by a factor of ten, 4.301 was generated in 47% yield.120 
																																																								
120) Reaction in polar media, dmf (0.28 M), generated 4.301 as the major product in 42% yield, accompanied 
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a. Unusual selectivity for benzyl ether formation
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To ascertain the effect of incorporation of fluorine, we treated diol 4.259 with a 
combination of NaH and benzyl bromide, and found that the only product obtained was 
4.304 in 20% yield, wherein the primary and secondary alcohol had been converted to the 
corresponding benzyl ether. The remaining diol was recovered in 72% yield, a notable 
observation since in the case of 4.252, the starting material was completely consumed.  
 We then examined diastereomer 4.297, finding that reactivity was diminished 
relative to 4.252, and the product was afforded as a non-selective mixture of 1° and 2° 
benzyl ethers accompanied by 66% recovery of starting material. For allylic fluoride 4.303, 
where there is a syn relationship between the alcohol and fluoro substituent in the 
stereotriad, 57% of the diol was consumed and a mixture of products were furnished with 
a 2:1 preference for reaction at secondary alcohol. Transformation of 4.265 was similarly 
inefficient (33% conv), and the product mixture contained all three possible products, 
namely 1°, 2° and bis-benzyl ethers.  
 With this insight, we reasoned that the increased reactivity and selectivity could be 
the result of an interaction between the sodium alkoxide and the lone pair of one of the 
fluorine atoms incorporated within the molecule. This is expected to raise the HOMO of 
the alkoxide (Scheme 4.49) and increase the nucleophilicity of the secondary alcohol due 
its proximity. The above findings are mechanistically significant because it indicates the 
stereochemical identity of the quaternary stereogenic center is crucial. It could be that, 
interaction with an allylic fluorine versus one contained within a trifluoromethyl group, 
generates a more localized cloud of electron density that is responsible for increased 
nucleophilicity. Results obtained for diols possessing only an allylic fluoride (4.265 and 
4.30), reveal that reactivity is likely a consequence of the trifluoromethyl and fluoro 
substituents.121 Studies to gain further insight into such an interaction are underway. 
																																																								
121) Steric effects are likely underscored by electronics as reaction with fluoro, methyl analogue 4.295, 
afforded 13% conv. and a 1:1 mixture of 1° and 2° ethers. However, the ambiguity of the relative 
stereochemistry prevents further claims based on these findings. 
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We found further support for the key role a metal alkoxide may play by carrying 
out benzyl protection under set of conditions wherein an alkoxide is not likely formed (See 
Scheme 4.49). Although the reaction does not proceed with the same levels of efficiency, 
we found that for 4.252 and 4.297, the major product formed resulted from reaction with 
the less hindered 1° alcohol, although traces of the secondary product were detected as 
well.  
 
Scheme 4.49 Implication of an Alkoxide-Lone Pair Interactiona 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. and product selectivity ratios 
(±2%) were determined by analysis of 19F NMR spectra of unpurified mixtures, Conv. refers to 
consumption of diol. bSpectroscopic yield determined by 19F integration. See Experimental Section 
for details. 
 
The identity of the counterion effects selectivity and reactivity. When treated with 
potassium hydride, one product, namely 4.301 was generated in 61% yield, with 21% 



























































b. Conditions wherein an alkoxide is likely not formed
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treatment of the diol with butyl lithium, did not lead to formation of any benzyl ethers and 
instead, 4.252 was recovered along with an unknown decomposition product. 
 
Scheme 4.50 Effect of Different Bases on Regioselectivitya 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. and product selectivity ratios 
(±2%) were determined by analysis of 19F NMR spectra of unpurified mixtures, Conv. refers to 
consumption of diol. Yield of isolated and purified products (±5%). See Experimental Section for 
details. 
We were able to identify conditions for selective synthesis of the primary benzyl 
ether by treating 4.252 with one equivalent of dibutyl tin oxide and benzyl bromide in 
refluxing toluene.122 As shown in 4.311, tin alkoxide species are known to exist as dimeric 
structures in solution wherein the tin atoms are pentavalent. In these aggregates, one 
oxygen is situated in an apical position and is dicoordinated (labeled in red) and the other 
is oriented equatorially and tricoordinated (labeled in blue). Thus, those oxygens not 
involved in the Sn2O2 framework exhibit increased nucleophilic character and are more 
prone to rupture affording selective reaction at the primary alcohol.123  
 
																																																								
122) Kotkar, S. P.; Sudalai, A. Tetrahedron Lett. 2006, 47, 6813–6815. 
123) David, S.; Hanessian, S. Tetrahedron, 1985, 41, 643–663. For selective benzoylation, see: Iwasaki, F.; 
Maki, T.; Onomura, O.; Nakashima, W.; Matsumura, Y.; J. Org. Chem. 2000, 65, 996–1002.  
3.0 equiv KH
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Scheme 4.51 Conditions for Selective Reaction at the Primary Alcohola 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. and product selectivity ratios 
(±2%) were determined by analysis of 19F NMR spectra of unpurified mixtures, Conv. refers to 
consumption of diol. Yield of isolated and purified products (±5%). See Experimental Section for 
details. 
 
4.4.2  Mechanism of 1,3-Boryl Shift and Stereochemical Models  
 As introduced in Section 4.3.1, stereospecific transfer of fluoro-substituted 
boronates initially generates an aminophenol allyl complex with a stereogenic center at the 
allylic position. Analysis of molecular models indicated that the most favorable transition 
state for 1,3-boryl shift would be one wherein the trifluoromethyl group would be oriented 
away from the catalyst engendering a degree of kinetic selectivity. To gain further insight, 
we computed possible transition states for isomerization, which revealed that the lowest 
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Scheme 4.51 Computationally Modeled Transition States for 1,3–Boryl Shifta 
	
aCalculations performed at wB97XD/DEF2TZVPP//wB97XD/DEF2SVPtoluene(SMD) level of theory. 
See the Experimental Section for details.  
 
ΔG‡ = 3.6 kcal/mol
ΔG‡ = 4.7 kcal/mol
ΔG‡ = 10.8 kcal/mol























































































a. Olefin association from front
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 However, such a result does not align with the observed stereochemical outcome 
for the transformation. As shown in Scheme 4.52, two possible transition states for reaction 
of an aldehyde may be considered. Based on previous models, we would expect addition 
through 4.321 to be favored due to an alleviation of electron-electron repulsion through 
interaction with the ammonium. However, this would furnish the opposite enantiomer of 
the experimentally obtained product. Alternatively, reaction through 4.322, which predicts 
the correct enantiomer and diastereomer, suffers from electron-electron repulsion as 
indicated. 
 
Scheme 4.52. Stereochemical Models Incorrectly Predict Observed Stereoisomer 
 
One possible alternative is that hindered E-allyl complex 4.314 is unreactive, and 
instead there is substantial isomerization to Z-allyl complex 4.219 proceeding through a 
transition state resembling boryl shift (Scheme 4.53a). Preliminary calculations indicate 
that isomerization is favored to proceed through 4.325 by 1.0 kcal/mol affording Z-allyl 
complex 4.219. It is possible that at 22 °C none of these pathways are accessible, but at 60 
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 Further support was gleaned by carrying out the reaction with less 
stereoisomerically pure boronate 4.202. Addition with an 83:17 Z:E mixture124 (vs 95:5) 
afforded nearly the same diastereo- and enantioselectivity, but with increased yield. This 
is indicative of possible isomerization to a common intermediate prior to addition to the 
aldehyde, however, any attempt to detect isomerization of an aminophenol allyl complex 
were unsuccessful by spectroscopic analysis.  
 
Scheme 4.53. Invoking an Isomerization of the Aminophenol-Allyl Complexa 
 
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios  (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental 
Section for details. 
 
																																																								
124) Z:E selectivity may be reduced by performing boryl allylic substitution in more polar media, i.e. pure 
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a. Isomerization of aminophenol allyl complex
b. Reaction with less stereoisomerically pure boronate
4.314 4.325 4.219
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Scheme 4.53 Experimental Evidence for Proposed Stereochemical Modelsa 
	
aAll reactions were performed under an atmosphere of dry N2. Conv. a:g and dr ratios  (±2%) were 
determined by analysis of 19F NMR spectra of unpurified mixtures. Yield of isolated and purified g-
addition product (±5%). Er values were determined by HPLC analysis (±1%). See Experimental 
Section for details. 
 
Thus, to account for the observed major isomer, we propose that addition proceeds 
through 4.326, wherein the phenyl ring is oriented pseudo-axially. Upon analysis of the 
data, it is clear that aldehydes possessing five-membered rings (4.231–233) tend to be more 
diastereoselective than the larger six-membered arenes. Furthermore, results obtained from 
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b. Effect of ligand substitution on diastereoselectivity
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axial orientation. For additions promoted by the larger –SiPh3 substituted catalyst ap-1, 
observed diastereoselectivity is lower, likely due to increased steric pressure between the 
substrate and phenyl ring of the large substituent. 
 
4.5  Conclusions  
 In summary, we have developed a method for synthesis of homoallylic alcohols 
possessing quaternary centers substituted with a fluoro and trifluoromethyl group in 80:20–
98:2 dr and 91:9–96:4 er. Access to these otherwise difficult-to-access products were made 
possible by merging recent advances in boryl allylic substitution and addition of allyl 
boronates promoted by aminophenol boron-based catalysts. In doing so, we have 
demonstrated the first broadly applicable examples of addition of fluorine-containing 
trisubstituted allyl boronates as well as uncovered factors to favor 1,3-boryl shift. 
Furthermore, we showcased the synthetic utility of the products obtained through synthesis 
of the furanoside core of an analogue of Sofosbuvir analogue and discovered an unusual 
reactivity profile for compounds containing a fluoro- and trifluoromethyl substituted 
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4.6  Experimental Section 
4.6.1 General 
Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) spectrophotometer, 
νmax in cm−1. Bands are characterized as broad (br), strong (s), medium (m), and weak (w). 1H 
NMR spectra were recorded on a Varian Unity INOVA 400 (400 MHz), 500 (500 MHz), or 600 
(600 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane with the 
solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, br s = broad 
singlet, m = multiplet, app = apparent), coupling constant (Hz) and integration. 13C NMR spectra 
were recorded on a Varian Unity INOVA 400 (100 MHz), 500 (125 MHz), or 600 (150 MHz) 
spectrometer with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16 ppm). 19F 
NMR spectra were recorded on a Varian Unity INOVA 400 (376 MHz) spectrometer. Chemical 
shifts are reported in ppm with C6H5CF3 as an external standard (C6H5CF3: –63.72 ppm). Data are 
reported as follows: chemical shift, multiplicity, coupling constants (Hz), and integration. Carbons 
with directly attached boron atoms were not observed in some compounds, most likely due to 
quadrupolar relaxation.1 High-resolution mass spectrometry was performed on a JEOL AccuTOF 
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Enantiomeric ratios 
were determined by high-performance liquid chromatography (HPLC) with a Shimadzu 
chromatograph (Chiral Technologies Chiralcel OD-H (4.6 x 250 mm), Chiralcel OJ-H (4.6 x 250 
mm), Chiralcel OZ-H (4.6 x 250 mm), Chiralpak AD-H (4.6 x 250 mm), Chiralpak AS-H (4.6 x 
250 mm)) in comparison with authentic racemic materials. Specific rotations were measured using 
either an Atago AP-300 Automated Polarimeter or a Rudolph Research Analytical Autopol IV 
Polarimeter. Unless otherwise noted, all reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with standard 
dry box or vacuum-line techniques. Solvents were purified under a positive pressure of dry argon 
by a modified Innovative Technologies purification system: toluene was purified through a copper 
oxide and alumina column. Dimethoxy ethane and tetrahydrofuran were freshly distilled from a 
sodium and benzophenone ketyl solution. CDCl3 was purchased from Cambridge Isotope 
Laboratories and store over activated 4Å molecular sieves prior to use. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from Fisher 
Scientific) in air. 
 
																																																								
1) Wrackmeyer, B. Prog. NMR Spectrosc. 1979, 12, 227–259. 
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4.6.2 Reagents 
Acetonitrile (99.9% Extra Dry) was purchased from Acros and used as received. 
Aldehydes were purchased from commercial sources. Liquid aldehydes were distilled over CaH2  
prior to use. Crystalline aldehydes were purified by silica gel chromatography. 
Allyl bromide was purchased from Aldrich and distilled over CaH2. 
Allyltrimethylsilane was purchased from Aldrich and distilled over CaH2. 
Ammonium chloride was purchased from Acros and used as received. 
Benzyl Bromide was purchased from Oakwood and used as received. 
Bis(pinacolato)diboron was purchased form Frontier Scientific, Inc. and recrystallized from 
pentane. 
(R)-a,a-Bis[3,5-bis(trifluoromethyl)phenyl]-2-pyrrolidinemethanol trimethyl silyl ether was 
purchased from Aldrich and used as received.  
(Z)-1-Bromo-2-fluoroethylene was purchased from Synquest and used as received.  
N-Butyl Lithium (2.5 M in hexanes) was purchased from Aldrich and titrated with N-
Benzylbenzamide prior to each use. 
Calcium Hydride was purchased from Strem and used as received. 
Camphorsulfonic acid was purchased from Acros and used as received. 
Citric acid was purchased from Acros and used as received.  
Copper (I) chloride was purchased from Strem and used as received. 
Dichloro[1,3-bis(2,6-isopropylphenyl)-2 
imidazolidinylidene](benzylidene)(tricyclohexylphosphine)]ruthenium (II) was purchased 
from Aldrich and used as received.  
1,2:5,6-Di-O-cyclohexylidene-D-mannitol was purchased from Aldrich and used as received. 
1,2:5,6-Di-O-isopropylidene-D-mannitol was purchased from Aldrich and used as received.  
(Diethylamino)sulfur trifluoride was purchased from Oakwood and used as received.  
N,N-diisopropylethylamine was purchased from Oakwood and used as received. 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC•HCl) was purchased 
from Advanced ChemTech and used as received. 
4-Dimethylaminopyridine was purchased from Oakwood and used as received. 
Dimethyl sulfide was purchased from Aldrich and used as received. 
Ethylene glycol was purchased from Oakwood and used as received. 
N-Fluorobenzenesulfonimide was purchased from Oakwood and used as received. 
Hydrochloric Acid (4.0 M in 1,4-dioxane) was purchased from Aldrich and used as received. 
1-Hydroxybenzotriazole hydrate was purchased from Oakwood and used as received. 
Lithium Aluminum Hydride was purchased from Aldrich and used as received.  
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Lithium tert-butoxide was purchased from Strem and used as received. 
Lithium trimethyl silanolate was purchased from Aldrich and used as received.  
Magnesium Sulfate was purchased from Fisher and flame-dried under vacuum prior to use. 
Methanol  (99.7% Extra Dry) was purchased from Acros and used as received. 
3-Methylbut-2-enylboronic acid pinacol ester was prepared according to a literature procedure.2	  
2-C-Methyl-4,5-O-(1-methylethylidene)-D-arabinonic acid ethyl ester was purchased from 
AK Scientific and used as received.  
4-Methylmorpholine N-oxide was purchased from Aldrich and used as received.  
Methyl sulfoxide (99.7% Extra Dry) was purchased from Acros and used as received.  
Methyltriphenylphosphium bromide was purchased from Aldrich and azeotropically dried with 
benzene prior to use.  
4-Nitrobenzoyl chloride was purchased from Sigma-Aldrich and used as received. 
3,3,4,4,4-Pentafluorobutene was purchased from Synquest and used as received. 
Osmium tetroxide (4 wt % in H2O) was purchased from Strem and used as received. 
1H, 1H, 2H-Perfluorohexene was purchased from Synquest and used as received.  
Pinacolborane was purchased from Oakwood and distilled over CaH2 prior to use. 
Potassium Carbonate (granular) was purchased from Fisher and used as received.  
Potassium hydride (in paraffin) was purchased from Aldrich and used as received. 
Potassium tert-butoxide was purchased from Strem and used as received.  
Selectfluor was purchased from Oakwood and used as received.  
Sodium Hydride (90 wt%) was purchased from Aldrich and used as received. 
Sodium periodate was purchased from Alfa Aesar and used as received. 
Sulfur trioxide pyridine complex was purchased from Aldrich and used as received.  
Tetrabutylammonium iodide was purchased from Oakwood and used as received.  
Triethylamine was purchased from Aldrich and distilled from CaH2 prior to use. 
Trifluoroacetic acid was purchased from Oakwood and used as received. 
Trifluroacetic anhydride was purchased from Oakwood and distilled over CaH2 prior to use. 
L-Valine Ethyl Ester Hydrochloride was purchased from Aldrich and used as received. 
Vinylmagnesium bromide solution (1.0 M in thf) was purchased from Aldrich and used as 
received.  
Zinc dust was purchased from Strem and activated with 1 M HCl prior to use according to a 
previously established procedure.3 
																																																								
2) Ardolino, M. J.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 7092–7100. 
3) Lin, M.; Shen, A.; Sun, X.-W.; Xu, M.-H.; Lin, G-Q. Chem. Eur. J. 2010, 15, 10217–10224. 
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Zinc tert-Butoxide was prepared according to a previously reported procedure.4 
 
4.6.3 Ligands 
Imidazolinium salts (imid1-4) were synthesized in accordance to a procedure in the literature and the analytical data 
are fully consistent with those reported previously.5 
(R)-2-((3-(tert-Butyl)-2-hydroxybenzyl)amino)-N,N,3-trimethylbutanamide (ent-ap-2): The 
title compound was synthesized in accordance to a procedure in the literature and the analytical 
data are fully consistent with those reported previously.6 [α]20D –22.9 (c 0.94, CHCl3). 
 
4.6.4 Preparation of Fluorine-Containing Allyl Boron Reagents through Boryl Allylic 
Substitution 
(Z)-4,4,5,5-Tetramethyl-2-(3,4,4,4-tetrafluorobut-2-en-1-yl)-1,3,2-dioxaborolane (4.202): In 
an N2-filled glovebox, an oven-dried vial equipped with a magnetic stir bar was charged with imid- 
4 (60.1 mg, 0.132 mmol), CuCl (13.0 mg, 0.132 mmol) LiOt-Bu (212 mg, 1.32 mmol) and diluted 
with thf (1.0 mL). The mixture was allowed to stir at 22 °C for 1 h. Bis(pinacolato)diboron (1.22 
g, 4.8 mmol) was added to the mixture, and the solution was diluted with toluene (10 mL). The 
mixture was allowed to stir for 10 minutes at 22 °C and then placed in a –40°C freezer for 30 
minutes. A cooled (–40°C) solution of 3,3,4,4,4-pentafluoro-1-butene (1.03 g, 2.40 mmol, 34 wt% 
in THF) was then added and the vessel was quickly sealed, removed from the glovebox and 
allowed to stir at 22 °C for 8 hours. The unpurified mixture was concentrated to ~50% of its 
original volume and passed through a plug of oven dried silica gel (6.0 cm high x 1.0 cm wide) 
eluting with 50:1 hexanes:Et2O (solvent passed through columns of activated alumina prior to 
chromatography). The volatiles were removed and then the flask was fitted with a short path 
distillation head. The desired allyl boronate was distilled over as a solution in toluene, and the 
distillate was then concentrated to ~10-20% of its original volume. Dry hexanes (~0.5 mL) was 
added and the supernatant was divided, loaded onto three short plugs of oven-dried silica gel (5.0 
cm high x 1.0 cm wide) and quickly purified by silica gel column chromatography (eluting with 
hexanes/Et2O: 50/1) to afford product in 90-95% purity as colorless oil (286 mg, 1.1 mmol, 47%). 
																																																								
4) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. Nature 2013, 
494, 216–221. 
5) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 1490–1493. 
6) Silverio, D. L.; Torker, S.; Pilyugina, T.; Vieira, E. M.; Snapper, M. L.; Haeffner, F.; Hoveyda, A. H. Nature 2013, 
494, 216–221. 
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IR (neat): 2981 (w), 2932 (w), 1458 (w), 1381 (m), 1372 (m), 1139 (s), 843 (m) cm-1; 1H NMR 
(CDCl3, 400 MHz): δ 5.73 (1H, dt, J = 33.4, 8.2 Hz), 1.79 (2H, d, J = 8.1 Hz), 1.25 (12H, s); 13C 
NMR (CDCl3, 100 MHz): δ 145.5 (dq, JC-F  = 254.1, 38.5 Hz), 118.8 (apparent dd, JC-F  = 270.6, 
41.9 Hz), 109.7 (m), 84.1, 24.8; 19F NMR (376 MHz, CDCl3): δ –72.2 (3F, d, J = 12.0 Hz), –
138.3 (1F, m). 
Modification for Chromatography-Free Preparation of Allyl Boron 
The reaction was set up in an identical manner as described above, except LiOTMS (253.8 mg, 
1.32 mmol) was added as the nucleophilic promoter. After 8 hours of reaction, the volatiles were 
removed by rotary evaporation. The resulting toluene solution was passed through a plug of oven-
dried silica gel (8.0 cm high x 6.0 cm wide) eluting with 50:1 hexanes:Et2O. The volatiles were 
removed and then the flask was fitted with a short path distillation head. The desired allyl boronate 
was distilled over as a solution in toluene, the distillate was then concentrated and then passed 
through a cotton plug topped with 1.0 cm of oven dried silica to filter any remaining impurities. 
Note: If catalytic allyl addition reaction turns dark gray, repeat this filtration with any remaining 
reagent. 
Procedure for Ligand-Free Preparation of Allyl Boron 
In an N2-filled glovebox, an oven-dried vial equipped with a magnetic stir bar was charged with 
CuCl (13.0 mg, 0.132 mmol) LiOt-Bu (212 mg, 1.32 mmol) and Bis(pinacolato)diboron (1.22 g, 
4.8 mmol). The solids were then diluted with a pre-prepared mixture of 10 mL toluene and 1.0 mL 
thf. The mixture was allowed to stir at 22 °C for 10 min, then placed in a –40°C freezer for 30 
minutes. A cooled (–40°C) solution of 3,3,4,4,4-pentafluoro-1-butene (1.03 g, 2.40 mmol, 34 wt% 
in THF) was then added and the vessel was quickly sealed, removed from the glovebox and 
allowed to stir at 22 °C for 8 hours. The reaction was quenched and purified as described above. 
(Z)-4,4,5,5-Tetramethyl-2-(3,4,4,5,5,6,6,6-octafluorohex-2-en-1-yl)-1,3,2-dioxaborolane (S-
1): The title compound was synthesized analogous to 4.202 and purified by silica gel 
chromatography to afford S-1 (259 mg, 0.732 mmol, 61% yield) as colorless oil. 1H NMR (CDCl3, 
400 MHz): δ 5.72 (1H, dt, J = 33.6, 8.4 Hz), 1.82 (2H, d, J = 6.5 Hz), 1.25 (12H, s); 13C NMR 
(CDCl3, 150 MHz): δ 145.2 (dt, J =254.6, 28.8 Hz), 119.6–116.5 (m), 117.9 (tq, J =285.7, 33.6 
Hz), 116.1 (d, J=19.2 Hz), 114.4–114.2 (m), 113.2– 112.4 (m), 112.5–104.8 (m), 84.1, 24.8; 19F 
NMR (376 MHz, CDCl3): –80.9 (td, J = 9.0, 2.5 Hz, 3F), –117.4–119.6 (m, 2F), –127.6 (dd, J = 
9.1, 3.4 Hz, 2F), –134.0–134.56 (m, 1F). 
	
4.6.5 Represenative Procedure for Allyl Addition 
In a N2-filled glovebox, a stock solution of ap-2 and zinc(II) tert-butoxide was prepared. An oven-
dried vial (8 mL) equipped with a stir bar was charged with aminophenol (ap-2) (6.1 mg, 0.02 
mmol), zinc tert-butoxide (8.5 mg, 0.04 mmol) and toluene (2.0 mL). The freshly prepared stock 
solution was allowed to stir for 15 min at 22 °C. In another vial (8 mL), aldehyde (0.2 mmol) was 
	
 Page 740 
weighed out. The aminophenol/Zn(Ot-Bu)2 stock solution was then added by syringe (500 µL) 
followed by allyl boronate 4.202 (25.4 mg, 0.1 mmol), and the vial walls were rinsed with toluene 
(500 µL). MeOH (20 µL, 0.5 mmol) was then added and the reaction vessel was sealed with a cap 
removed from the glovebox. The mixture was placed into a preheated oil bath and allowed to stir 
for 6 h at 60 °C. Upon cooling to 22 °C the reaction was quenched by the addition of MeOH (1.5 
mL). The mixture was then allowed to stir for 0.5 h at 22 °C. The volatiles were removed in vacuo 
and the resulting opaque oil was purified by silica gel chromatography (100:0–5:1 hexanes:Et2O) 
to afford the desired homoallylic alcohol. 
 
4.6.6  Analytical Data for Addition of Fluoro–Substituted Allyl Boronates to Aldehydes  
(1S,2R)-2-fluoro-1-phenyl-2-(trifluoromethyl)but-3-en-1-ol (4.227). 1H NMR (400 MHz, 
CDCl3): δ 7.36 (m, 5H), 5.89 – 5.66 (m, 1H), 5.58 (dd, J = 17.3, 1.0 Hz, 1H), 5.50 (dd, J = 11.1, 
2.7 Hz, 1H), 5.11 (dd, J = 15.8, 4.5 Hz, 1H), 2.42 (ddd, J = 4.6, 1.8, 0.8 Hz, 1H); 13C NMR (100 
MHz, CDCl3): 136.2 (d, J = 4.4 Hz), 129.0, 128.3, 127.9, 126.5 (d, J = 19.0 Hz), 121.4 (d, J = 
11.9 Hz), 96.7 (qd, J = 28.9 Hz), 94.8 (q, J = 28.7 Hz), 74.2 (dd, J = 21.3, 5.0 Hz); HRMS 
(DART): Calcd for C11H9F4 [M+H–H2O]+: 217.0635; Found: 217.0631; Specific Rotation: for a 
94:6 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AZ-H, 98:2 hexanes:i-PrOH, 1.0 mL/min, 220 nm): tR: 16.5 
min (minor) and 21.5 min (major). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 17.292 min 2139959 49.206 1 16.506 min 526876 5.652 
2 22.591 min 2209063 50.794 2 21.461 min 8795516 94.348 
 
(1S,2R)-2-fluoro-1-(4-methoxyphenyl)-2-(trifluoromethyl)but-3-en-1-ol (4.228). Following 
the general procedure for addition, p-methoxy benzaldehyde (27.2 mg, 0.20 mmol) was transferred 
to an oven-dried vial to afford the title compound as colorless oil (16.6 mg, 0.063 mmol).  IR 
(neat): 3449 (br), 2918 (w), 2842 (w), 1613 (w), 1514 (m), 1250 (m), 1176 (s), 1029 (m), 980 (m) 
cm-1; 1H NMR (400 MHz, CDCl3): δ 7.31–7.23 (m, 2H), 6.92 – 6.82 (m, 2H), 5.74 (dddd, J = 
	
 Page 741 
21.4, 17.3, 11.2, 0.8 Hz, 1H), 5.57 (dd, J = 17.3, 1.0 Hz, 1H), 5.49 (dd, J = 11.1, 2.5 Hz, 1H), 5.05 
(dd, J = 15.7, 4.2 Hz, 1H), 3.80 (s, 2H), 2.39 (dd, J = 4.3, 1.7 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): 159.4, 129.2, 128.3 (d, J=4.3 Hz), 126.6 (d, J=18.9 Hz), 123.9 (d, J=29.1 Hz), 121.3 (d, 
J=11.7 Hz), 113.6, 95.8 (dq J=195.8, 28.9 Hz), 73.7 (d, J =21.4 Hz), 55.2; 19F NMR (376 MHz, 
CDCl3): δ –75.80 (d, J=6.7 Hz, 3F), –182.77 (m, 1F); HRMS (DART): Calcd for C12H11OF4 
[M+H−H2O]+: 247.0741, found: 247.0753; Specific Rotation: [α]20.0 +29.2 (c 1.50, CHCl3) for a 
95:5 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AZ-H column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): 
tR: 33.4 min (minor) and 36.4 min (major). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 32.538 min 8199345 51.462 1 33.398 min 797569 5.135 
2 35.510 min 7733464 48.538 2 36.445 min 14734774 94.865 
 
(1S,2R)-2-Fluoro-1-(4-(methylthio)phenyl)-2-(trifluoromethyl)but-3-en-1-ol (4.229): 
Following the general procedure for addition, 4-(methylthio)benzaldehyde (30.4 mg, 0.20 mmol) 
was transferred to an oven-dried vial to afford the title compound as a white solid (18.8 mg, 0.067 
mmol). M.p. 63–65 °C; IR (neat): 3414 (br), 2924 (w), 1601 (w), 1497 (w), 1414 (w), 1299 (m), 
1285 (m), 1189 (s), 1093 (m), 983 (m)   cm-1; 1H NMR (400 MHz, CDCl3): δ 7.29 – 7.16 (m, 
4H), 5.73 (ddd, J = 21.3, 17.2, 11.1 Hz, 1H), 5.62 – 5.53 (m, 1H), 5.50 (dd, J = 11.0, 2.5 Hz, 1H), 
5.05 (dd, J = 15.6, 4.4 Hz, 1H), 2.47 (s, 3H), 2.45 – 2.41 (m, 1H); 13C NMR (100 MHz, CDCl3): 
δ 139.7, 132.7 (d, J =4.2 Hz), 128.3, 126.4 (d, J =19.1 Hz), 125.9, 122.4 (dd, J =285.6, 29.1 Hz), 
121.5 (d, J=11.8 Hz), 95.7 (dq, J=194.7, 29.0 Hz), 73.8 (dd, J=21.5, 8.8 Hz), 15.4; 19F NMR (376 
MHz, CDCl3): δ –75.72 (3F, d, J=6.8 Hz), –182.75 (1F, m); HRMS (DART): Calcd for 
C12H13OF4S [M+H]+: 281.0618, found: 281.0620. Specific Rotation: [α]20.0 +29.9 (c 0.47, CHCl3) 
for 95.5:4.5 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralpak AZ-H column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): 
tR: 33.9 min (minor) and 35.4 min (major). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 34.012 min 1121208 51.382 1 33.855 min 530273 4.480 
2 35.715 min 1060888 48.618 2 35.365 min 11306680 95.520 
 
(1S,2R)-1-(6-Bromonaphthalen-2-yl)-2-fluoro-2-(trifluoromethyl)but-3-en-1-ol (4.230): 
Following the general procedure for addition, 6-Bromo-2-napthaldehyde (40.7 mg, 0.20 mmol) 
was transferred to an oven-dried vial to afford the title compound as pale yellow solid (18.2 mg, 
0.050 mmol). M.p. 72–74 °C; IR (neat): 3419 (br), 2922 (w), 2850 (w), 1591 (w), 1499 (w), 1338 
(m), 1297 (m), 1183 (s), 983 (m)  cm-1; 1H NMR (400 MHz, CDCl3): δ 8.00 (d, J = 1.9 Hz, 1H), 
7.79 (s, 1H), 7.72 (dd, J = 12.1, 8.7 Hz, 2H), 7.57 (dd, J = 8.7, 2.0 Hz, 1H), 7.53 – 7.47 (m, 1H), 
5.76 (ddd, J = 21.5, 17.2, 11.2 Hz, 1H), 5.58 (d, J = 17.2 Hz, 1H), 5.49 (dd, J = 11.3, 2.7 Hz, 1H), 
5.26 (dd, J = 15.7, 4.4 Hz, 1H), 2.54 (dd, J = 4.4, 1.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 
134.4, 134.1 (d, J=4.1 Hz), 131.4, 129.83, 129.79, 129.75, 127.7, 127.3, 126.6 (d,=19.1 Hz), 126.4, 
122.5 (dd, J =285.6, 29.0 Hz), 121.8 (d, JC-F  = 11.8 Hz), 120.9, 95.9 (dq, J=194.7, 29.0 Hz), 74.3 
(d, J=21.6 Hz); 19F NMR (376 MHz, CDCl3): δ –75.67 (3F, d, J=6.9 Hz), –182.86 (1F, qd, J=15.0, 
7.3 Hz); HRMS (DART): [M+H−H2O]+ Calcd for C15H10F4Br: 344.9897, found: 344.9904. 
Specific Rotation: [α]20.0 +28.0 (c 0.87, CHCl3) for a 94.5:5.5 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H 
column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 30.2 min (minor) and 32.3 min (major). 
 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 31.506 min 80223943 51.032 1 30.220 min 5698477 5.342 
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2 33.734 min 76979408 48.968 2 32.300 min 100972082 94.658 
 
(1S,2R)-2-Fluoro-1-ferrocenyl-2-(trifluoromethyl)but-3-en-1-ol (4.231): Following the general 
procedure for addition, ferrocenecarboxaldehyde (42.8 mg, 0.20 mmol) was transferred to an oven-
dried vial to afford the title compound as yellow oil (24.8 mg, 0.073 mmol). IR (neat): 3566 (br), 
3096 (w), 2923 (w), 1653 (w), 1296 (m), 1182 (s), 999 (m), 981 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 5.73 (ddd, J = 21.1, 17.2, 11.1 Hz, 1H), 5.54 (d, J = 17.2 Hz, 1H), 5.45 (dd, J = 11.1, 
2.6 Hz, 1H), 4.70 (dd, J = 15.6, 2.9 Hz, 1H), 4.31 – 4.24 (m, 2H), 4.23 (s, 4H), 4.21 (s, 2H), 2.41 
(d, J = 2.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 127.0 (dd, J =19.1, 0.8 Hz), 122.4 (dd, 
J=285.4, 29.1 Hz), 120.8 (d, J =11.9 Hz), 70.4 (d, J=22.0 Hz), 70.1 (d, J =1.3 Hz), 68.7, 68.0, 65.5 
(d, J = 1.9 Hz); 19F NMR (376 MHz, CDCl3): δ –75.89 (d, J =12.0 Hz, 3F), –182.19 (m, 1F); 
HRMS (DART): [M+H−H2O]+ Calcd for C15H13F4Fe: 325.0297, found: 325.0306. Specific 
Rotation: [α]20.0 −33.7 (c 0.51, CHCl3) for a 95:5 er sample. Enantiomeric purity was determined 
by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H column, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 14.4 min (major) and 30.5 min (minor). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 14.234 min 3482577 47.795 1 14.424 min 11720665 94.902 
2 29.060 min 3803840 52.205 2 30.458 min 629661 5.068 
(1S,2R)-2-Fluoro-1-(thiophen-3-yl)-2-(trifluoromethyl)but-3-en-1-ol (4.232): Following the 
general procedure for addition, 3-thiophenecarboxaldehyde (22.4 mg, 0.20 mmol) was transferred 
to an oven-dried vial to afford the title compound as colorless oil (16.6 mg, 0.069 mmol). IR (neat): 
3412 (br), 3110 (w), 2922 (w), 2851 (w), 1417 (w), 1296 (m), 1280 (m), 1181 (s), 1150 (s), 982 
(m), 946 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 7.34–7.27 (m, 2H), 7.12–7.06 (m, 1H), 5.77 
(ddd, J = 21.2, 17.2, 11.1 Hz, 1H), 5.60 (d, J = 17.2 Hz, 1H), 5.51 (dd, J = 11.2, 2.6 Hz, 1H), 5.21 
(dd, J = 16.4, 4.7 Hz, 1H), 2.40 (dt, J = 4.9, 1.6 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 137.2 
(d, J =4.6 Hz), 126.8 (d, J=18.2 Hz), 126.8 (d, J=1.4 Hz), 126.0, 124.5, 122.4 (dd, J =285.6, 29.2 
Hz), 121.4 (d, J=11.6 Hz), 95.6 (qd, J=194.5, 29.1 Hz), 70.5 (dd, J = 22.1, 6.3 Hz); 19F NMR (376 
MHz, CDCl3): δ –76.00 (d, J = 6.7 Hz, 3F), –183.13 (qd, J =15.5, 7.9 Hz, 1F); HRMS (DART): 
[M+H−H2O]+ Calcd for C9H7F4S: 223.0199, found: 223.0209. Specific Rotation: [α]20.0  +27.1 (c 
1.03, CHCl3) for a 96:4 er sample. Enantiomeric purity was determined by HPLC analysis in 
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comparison with authentic racemic material (Chiralpak AZ-H column, 98:2 hexanes:i-PrOH, 0.5 
mL/min, 220 nm): tR: 26.3 min (minor) and 35.8 min (major). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 27.056 min 32345462 50.413 1 26.307 min 1232734 4.130 
2 36.845 min 31815544 49.587 2 35.767 min 28613636 95.870 
 
(1S,2R)-2-Fluoro-1-(furan-3-yl)-2-(trifluoromethyl)but-3-en-1-ol (4.233): Following the 
general procedure for addition, 3-furancarboxaldehyde (19.2 mg, 0.20 mmol) was transferred to 
an oven-dried vial to afford the title compound as colorless oil (13.9 mg, 0.077 mmol). IR (neat): 
1H NMR (400 MHz, CDCl3): δ 7.47 (dt, J = 1.5, 0.7 Hz, 1H), 7.40 (t, J = 1.7 Hz, 1H), 6.43 (dt, J 
= 1.9, 1.0 Hz, 1H), 5.88–5.71 (m, 1H), 5.65 (dd, J = 17.2, 1.0 Hz, 1H), 5.59–5.51 (m, 1H), 5.09 
(dd, J = 16.7, 5.3 Hz, 1H), 2.25 (dd, J = 5.3, 1.6 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 146.1 
(d, J=4.2 Hz), 144.0 (d, J =3.9 Hz), 129.4 (d, J=19.3 Hz), 126.0 (d, J=29.3 Hz), 124.2 (d, J =11.5 
Hz), 124.0, 111.9 (d, J=4.7 Hz), 98.3 (apparent dd, J=193.7, 29.0 Hz), 70.1 (dd, J =22.7, 6.3 Hz); 
19F NMR (376 MHz, CDCl3): δ –75.99 (d, J = 6.6 Hz, 3F), –183.61 (qd, J = 22.6, 7.2 Hz, 1F); 
HRMS (DART): [M+H−H2O]+ Calcd for C9H7F4O: 207.0428, found: 204.0438. Specific 
Rotation: [α]20.0 +29.5 (c 0.86, CHCl3) for a 94.5:5.5 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H 
column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm). tR: 22.5 min (minor) and 26.0 min (major). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 22.756 min 3610206 50.922 1 22.521 min 303502 5.618 
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2 26.414 min 3479438 49.078 2 26.049 min 5098867 94.382 
 
tert-Butyl 5-((1S,2R)-2-fluoro-1-hydroxy-2-(trifluoromethyl)but-3-en-1-yl)-1H-indole-1-
carboxylate (4.234): Following the general procedure for addition, tert-butyl 5-formyl-1H-indole-
1-carboxylate (49.1 mg, 0.20 mmol) was transferred to an oven-dried vial to afford the title 
compound as white solid (20.1 mg, 0.054 mmol). M.p. 79–81 °C; IR (neat): 3503 (br), 2980 (w), 
2926 (w), 2855 (w), 1736 (m), 1507 (w), 1445 (w), 1352 (m), 1184 (s), 1131 (s), 1084 (m), 1023 
(m) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.10 (d, J = 8.6 Hz, 1H), 7.60 (d, J = 3.7 Hz, 1H), 7.56 
(d, J = 1.7 Hz, 1H), 7.29 (dd, J = 8.5, 1.8 Hz, 1H), 6.55 (dd, J = 3.7, 0.8 Hz, 1H), 5.78 (ddd, J = 
21.6, 17.2, 11.2 Hz, 1H), 5.57 (dd, J = 17.3, 0.9 Hz, 1H), 5.48 (dd, J = 11.3, 2.7 Hz, 1H), 5.19 (dd, 
J = 15.9, 4.3 Hz, 1H), 2.47 (dd, J = 4.4, 1.7 Hz, 1H), 1.66 (s, 9H); 13C NMR (150 MHz, CDCl3): 
δ 149.8, 135.5, 130.7, 130.6, 126.8 (d, J =18.8 Hz), 126.8, 124.2, 122.7 (dd, J=285.7, 29.2 Hz), 
121.4 (d, J=11.8 Hz), 120.7, 115.1, 107.4 (d, J=2.9 Hz), 96.1 (dq, J=194.6, 28.8 Hz), 84.1, 74.5 
(dd, J = 21.3, 6.3 Hz), 28.3; 19F NMR (376 MHz, CDCl3): δ –75.75 (d, J = 6.8 Hz, 3F), –182.74 
(m, 1F); HRMS (DART): [M+H]+ Calcd for C18H20F4NO3: 374.1374, found: 374.1381. Specific 
Rotation: [α]20.0 +23.0 (c 0.57, CHCl3) for a 96.5:3.5 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H 
column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 49.3 min (major) and 56.9 min (minor). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 48.346 min 76582799 48.432 1 49.250 min 32609887 96.423 
2 54.887 min 81542671 51.568 2 56.851 min 1209663 3.577 
 
(3S,4R,E)-4-Fluoro-1-phenyl-4-(trifluoromethyl)hexa-1,5-dien-3-ol (4.235): Following the 
general procedure for addition, cinnamaldehyde (26.4 mg, 0.20 mmol) was transferred to an oven-
dried vial to afford the title compound as white solid (13.8 mg, 0.053 mmol). IR (neat): 3399 (br), 
3027 (w), 2923 (w), 1297 (m), 1187 (s), 969 (m), 746 (m), 692 (m). 1H NMR (400 MHz, CDCl3): 
δ 7.42 – 7.27 (m, 5H), 6.78 (d, J = 15.9 Hz, 1H), 6.17 (ddt, J = 15.9, 6.7, 1.0 Hz, 1H), 5.89 (ddd, 
J = 21.0, 17.3, 11.0 Hz, 1H), 5.75 (d, J = 17.1 Hz, 1H), 5.67 – 5.59 (m, 1H), 4.73 (dt, J = 13.5, 6.1 
Hz, 1H), 2.15 (dd, J = 5.6, 1.6 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 135.8 134.7, 128.8, 128.4, 
126.7, 126.5, 123.2 (d, JC-F  = 6.1 Hz), 122.6 (app dd, JC-F  = 283.9, 28.7 Hz), 121.8 (d, J= 11.5 
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Hz), 95.4 (qd, J=192.4, 29.2 Hz), 72.8 (d, J =22.3 Hz); 19F NMR (376 MHz, CDCl3): δ –76.64 
(d, J = 7.5 Hz, 3F), –29.19 (ddq, J = 21.9, 14.8, 7.6 Hz, 1 F); HRMS (DART): [M+H−H2O]+ 
Calcd for C13H11F4: 243.0791, found: 243.0801. Specific Rotation: [α]20.0 +21.3 (c 0.56, CHCl3) 
for a 91:9 er sample. Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material (Chiralcel OZ-H column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): 
tR: 15.5 min (minor) and 17.5 min (major).  
 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 16.360 min 23994723 51.508 1 15.477 min 1528643 8.862 
2 18.547 min 22590014 48.492 2 17.488 min 15720715 91.138 
 
(3S,4R)-4-Fluoro-1-phenyl-4-(trifluoromethyl)hex-5-en-3-ol (4.236): Following the general 
procedure for addition, hydrocinnamaldehyde (26.8 mg, 0.20 mmol) was transferred to an oven-
dried vial to afford the title compound as white solid (17.1 mg, 0.065 mmol). IR (neat): 3421 (br), 
3063 (w), 3029 (w), 2930 (w), 2857 (w), 1472 (w), 1297 (m), 1174 (s), 987 (m), 946 (m) cm-1; 1H 
NMR (400 MHz, CDCl3): δ 7.33–7.27 (2H, m), 7.24–7.18 (3H, m), 5.80 (1H, ddd, J = 21.0, 17.5, 
10.9 Hz), 5.67 (1H, d, J = 17.1 Hz), 5.61–5.55 (1H, m), 4.05–3.91 (1H, m), 2.94 (ddd, J = 14.0, 
9.4, 4.8 Hz, 1H), 2.68 (ddd, J = 13.7, 9.1, 7.6 Hz, 1H), 2.02–1.91 (1H, m), 1.88 (1H, d, J = 6.7 Hz), 
1.83–1.69 (1H, m); 13C NMR (100 MHz, CDCl3): δ 140.9, 128.5 (d, J=5.9 Hz), 127.1(d, J=5.90 
Hz), 126.2, 122.8 (apparent dd, J=287.0, 29.4 Hz), 121.2 (d, J=12.0 Hz), 96.0 (dq, J=190.6, 29.4 
Hz), 71.1 (d, J=21.3 Hz), 21.2, 14.4; 19F NMR (376 MHz, CDCl3): δ –76.04 (d, J = 6.9 Hz, 3F), 
–184.55 (m, 1F); HRMS (DART): [M+H]+ Calcd for C13H15OF4: 263.1054, found: 263.1057. 
Specific Rotation: [α]20.0 +8.2 (c 0.38, CHCl3) for a 94:6 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H 
column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 13.1 min (major) and 14.9 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 12.591 min 2108752 49.312 1 13.095 min 1403858 93.874 
2 14.316 min 2168609 50.688 2 14.935 min 91605 6.126 
 
(3R,4S)-7-(Dibenzylamino)-3-fluoro-3-(trifluoromethyl)hept-1-en-4-ol (4.237) Following the 
general procedure for addition, 4-(dibenzylamino)butanol (53.5 mg, 0.20 mmol) was transferred 
to an oven-dried vial  and purified by preparative thin layer chromatography to afford the title 
compound as yellow oil (24.1 mg, 0.061 mmol).  IR (neat): 3399 (br), 3063 (w), 3029 (w), 2926 
(m), 2851 (w), 2801 (w), 1495 (w), 1453 (w), 1296 (m), 986 (m) cm-1; 1H NMR (400 MHz, 
CDCl3): δ 7.36−7.25 (10H, m), 5.83 (1H, ddd, J = 21.0, 17.3, 11.1 Hz), 5.66 (1H, d, J = 16.5 Hz), 
5.53 (1H, dd, J = 11.2, 1.8 Hz), 3.83 (1H, dd, J = 17.5, 10.8 Hz), 3.64 (2H, d, J = 13.4 Hz), 3.54 
(2H, d, J = 13.4 Hz), 2.50– 2.42 (2H, m), 1.82–1.66 (3H, m), 1.42–1.32 (1H, m); 13C NMR (100 
MHz, CDCl3): δ 138.0, 129.6, 128.6 (d, J =19.2 Hz), 128.5, 127.4, 123.0 (apparent dd, J =285.8, 
29.8 Hz), 120.3 (d, JC-F  = 11.9 Hz), 95.9 (apparent dd, JC-F  = 192.2, 29.1 Hz), 71.9 (d, JC-F  = 21.5 
Hz), 58.6, 53.3, 29.6, 23.6; 19F NMR (376 MHz, CDCl3): δ –75.57 (d, J = 6.7 Hz, 3F), –185.05 
(m, 1F); HRMS (DART): [M+H]+ Calcd for C22H26NOF4: 396.1945, found: 396.1933. Specific 
Rotation: [α]20.0  +1.6 (c 1.30, CHCl3) for 95:5 er sample. Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (Chiralpak AD-H column, 98:2 
hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 24.9 min (minor) and 27.3 min (major). 
 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
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1 24.630 min 7142206 51.393 1 24.963 min 848791 4.803 
2 27.564 min 6755136 48.607 2 27.307 min 16824201 95.197 
 
(3R,4S,6S)-3-Fluoro-6,10-dimethyl-3-(trifluoromethyl)undeca-1,9-dien-4-ol (4.238): 
Following the general procedure for addition, (+)-citronellal (30.8 mg, 0.20 mmol) was transferred 
to an oven-dried vial  and purified by preparative thin layer chromatography to afford the title 
compound as yellow oil (19.1 mg, 0.068 mmol). IR (neat): 3446 (br), 2961 (w), 2919 (w), 2856 
(w), 1457 (w), 1379 (w), 1295 (m), 1180 (s), 986 (m), 943 (m) cm-1; 1H NMR (400 MHz, CDCl3): 
δ 5.82 (1H, ddd, J = 21.0, 17.3, 11.0 Hz), 5.68 (1H, d, J = 17.1 Hz), 5.62–5.56 (1H, m), 5.13–5.06 
(1H, m), 4.14–4.03 (1H, m), 2.09–1.86 (2H, m), 1.82–1.72 (2H, m), 1.68 (3H, s), 1.60 (3H, s), 
1.57–1.40 (2H, m), 1.40–1.31 (1H, m), 1.15–1.04 (1H, m), 0.96 (3H, d, J = 6.8 Hz); 13C NMR 
(100 MHz, CDCl3): δ 131.7, 127.3 (dd, J =19.4, 0.8 Hz), 124.6, 122.8 (dq, J=285.5, 29.5 Hz), 
121.4 (d, J=11.8 Hz), 96.2 (qd, J=190.3, 29.2 Hz), 70.2 (d, J =21.3 Hz), 38.1 (dd, J=3.6, 1.5 Hz), 
35.4, 29.0, 25.9, 25.3, 20.7, 17.8; 19F NMR (376 MHz, CDCl3): δ –75.87 (d, J = 6.8 Hz, 3F), –
183.89 (m, 1F); HRMS (DART): [M+H]+ Calcd for C14H23OF4: 283.1680, found: 283.1695. 
Specific Rotation: [α]20.0 –7.7 (c 1.10, CHCl3).  
(1S,2R)-2,3,3,4,4,5,5,5-octafluoro-1-phenyl-2-vinylpentan-1-ol (4.240). Following the general 
procedure for addition, benzaldehyde (21.2 mg, 0.20 mmol) was transferred to an oven-dried vial 
to afford the title compound as white solid (18.0 mg, 0.054 mmol). M.p. 57–59 oC. IR (neat): 
3399 (br), 3036 (w), 2922 (w), 1342 (m), 1224 (s), 1192 (s), 1123 (s), 1001 (m), 816 (m), 730 (s), 
700 (s), 532 (m) cm-1; 1H NMR (600 MHz, CDCl3): δ 7.35 (5H, m), 5.83 – 5.68 (1H, m), 5.55 
(1H, d, J = 17.2 Hz), 5.50 (1H, d, J = 10.9 Hz), 5.23 (1H, dd, J = 14.5, 4.7 Hz), 2.49 (1H, dd, J = 
4.7, 2.1 Hz); 13C NMR (150 MHz, CDCl3): δ 136.5 (d, J = 3.3 Hz), 129.1, 128.4, 128.3, 126.6 (d, 
J=18.1 Hz), 120.8 (d, J = 12.0 Hz), 118.7 (qt, J = 290.0, 34.0 Hz), 114.4 (m), 109.7 (m), 96.8 (dt, 
J=196.5, 24.6 Hz), 74.2 (d, J = 21.5 Hz); 19F NMR (376 MHz, CDCl3): δ –81.72 (td, J = 10.8, 
4.0 Hz, 3F), –117.59 (dq, J = 292.8, 10.0 Hz, 1F), –120.49 (dq, J = 292.8, 11.8 Hz, 1F), –123.46 
(ddt, J = 288.9, 13.5, 7.0 Hz, 1F), –125.89 (ddd, J = 288.9, 27.0, 11.8 Hz, 1F), –183.91 (d, J = 27.0 
Hz, 1F); HRMS (DART): [M+NH4]+ Calcd for C13H14NOF8: 352.0948, found: 352.0923. 
Specific Rotation: [α]20.0D +41.2 (c 0.6 CHCl3) for a 95:5 er sample. Enantiomeric purity was 
determined by HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H, 
98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 21.4 min (major) and 22.6 min (minor). 
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Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 21.793 min 3267169 49.703 1 21.473 min 1032236 95.519 
2 22.979 min 3306225 50.297 2 22.622 min 48424 4.481 
 
(1S,2R)-1-(3-Chlorophenyl)-2-fluoro-2-(trifluoromethyl)but-3-en-1-ol (4.241): Following the 
general procedure for addition, 3-chlorobenzaldehyde (9.8 mg, 0.1 mmol), allylboronate (25.4 mg, 
0.20 mmol) and MeOH (56 µL, 1.4 mmol) were transferred to an oven-dried vial to afford the title 
compound as colorless oil (13.0 mg, 0.068 mmol). IR (neat): 1H NMR (400 MHz, CDCl3): δ 
7.40 – 7.21 (m, 5H), 5.82 – 5.65 (m, 1H), 5.59 (d, J = 17.0 Hz, 1H), 5.54 (dd, J = 11.3, 2.8 Hz, 
1H), 5.08 (dd, J = 15.6, 4.5 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 138.3 (d, J= 4.1 Hz), 134.4, 
129.6, 129.3, 128.3, 126.4, 126.3, 122.5 (dd, J  = 284.1, 28.9 Hz), 121.9 (d, J = 11.7 Hz), 95.7 (dq, 
J= 194.8, 29.1 Hz), 73.8 (d, J= 22.0 Hz);  19F NMR (376 MHz, CDCl3): δ –75.66 (dd, J = 6.8, 
2.3 Hz, 3F), –182.94–183.19 (m, 1F); HRMS (DART): [M+H−H2O]+ Calcd for C11H8F4Cl: 
251.0245, found: 251.0254. Specific Rotation: [α]20 Enantiomeric purity was determined by 
HPLC analysis in comparison with authentic racemic material (Chiralpak AZ-H column, 99:1 
hexanes:i-PrOH, 0.5 mL/min, 220 nm). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
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1 23.217 min 4027375 52.071 1 22.960 6428793 7.277 
2 29.452 min 3707025 47.929 2 28.373 81920250 92.723 
 
1S,2R)-2-fluoro-1-(4-nitrophenyl)-2-(trifluoromethyl)but-3-en-1-ol (4.242) Following the 
general procedure for addition, 4-nitrobenzaldehyde (7.5 mg, 0.1 mmol), allylboronate (25.4 mg, 
0.20 mmol) and MeOH (56 µL, 1.4 mmol) were transferred to an oven-dried vial to afford the title 
compound as white solid (13.0 mg, 0.068 mmol).  IR (neat): 3440 (br), 2916 (w), 2850 (w), 1604 
(m), 1517 (s), 1350 (s), 1184 (s), 1014 (m) 728 (m) cm-1; 1H NMR (400 MHz, CDCl3): δ 8.26 – 
8.17 (m, 2H), 7.59 – 7.50 (m, 2H), 5.71 (ddd, J = 20.8, 17.1, 10.9 Hz, 1H), 5.62 – 5.52 (m, 2H), 
5.31 – 5.17 (m, 1H), 2.64 (dd, J = 4.4, 1.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 148.2, 142.9 
(d, J = 3.9 Hz), 129.0, 125.8 (d, J = 18.9 Hz), 123.3, 122.3 (dd, J = 285.6, 28.8 Hz), 122.3 (d, J = 
11.8 Hz), 95.3 (dd, J=195.4, 29.5 Hz), 73.4 (d, J = 22.2 Hz); 19F NMR (376 MHz, CDCl3): δ –
75.48 (d, J = 6.9 Hz), –182.94 (ddd, J = 21.8, 14.7, 7.4 Hz); HRMS (DART): [M+H]+ Calcd for 
C11H10NO3F4: 280.0591, found: 280.0588. Specific Rotation: [α]25.0 +101 for 93:7 er sample. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic racemic 
material (Chiralpak AZ-H column, 98:2 hexanes:i-PrOH, 0.5 mL/min, 220 nm): tR: 48.4 min 
(minor) and 51.2 min (major). 
	
Peak # Ret. Time Area Area % Peak # Ret. Time Area Area % 
1 47.625 min 4907300 49.984 1 48.442 750840 6.609 
2 50.460 min 4910483 50.016 2 51.160 10610619 93.391 
 
4.6.7  Synthesis of Sofosbuvir Analogue 
In a N2-filled glovebox, a stock solution of aminophenol and zinc(II) tert-butoxide was prepared. 
An oven-dried round bottom flask (25 mL) equipped with a stir bar was charged with ent-ap-2 
(15.0 mg, 0.05 mmol), Zn(Ot-Bu)2 (21.0 mg mg, 0.02 mmol) and toluene (7.0 mL). The freshly 
prepared solution was allowed to stir at 22 °C for 15 min. Then freshly distilled (R)-1,4-
dioxaspiro[4.5]decane-2-carbaldehyde (4.249, 170 mg, 1.0 mmol) and allyl boronate 4.202 (508.1 
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mg, 2.0 mmol) were added followed by methanol (808 µL, 20 mmol). The vessel was sealed with 
a septa and electrical and removed from the glovebox. The reaction was then allowed to stir at 60 
ºC for 6 h. Upon cooling to 22 °C, the reaction was quenched by the addition of MeOH (10 mL) 
and allowed to stir for 0.5 h at 22 °C. The reaction mixture was then concentrated and the resulting 
opaque solid was purified by silica gel column chromatography (30:1 hexanes:Et2O ® 5:1 
hexanes:Et2O), to afford homoallylic alcohol as white solid (262.0 mg, 0.878 mmol, 88% yield). 
(1R,2S)-2-Fluoro-1-((R)-1,4-dioxaspiro[4.5]decan-2-yl)-2-(trifluoromethyl)but-3-en-1-ol 
(4.250): M.p.: 67–69 oC. IR (neat): 3451 (br), 2932 (s), 2855 (m), 1307 (m), 1172 (s), 1161 (s), 
1143 (s), 1107 (m), 799 (m), 737 (m) cm-1; 1H NMR (500 MHz, CDCl3): δ 5.83 (ddd, J = 21.1, 
17.3, 11.1 Hz, 1H), 5.67 (d, J = 17.3 Hz, 1H), 5.58  (dd, J = 11.1, 3.1 Hz, 1H), 4.30 (dt, J = 25.9, 
3.6 Hz, 1H), 4.22 (td, J = 6.8, 3.6 Hz, 1H), 4.03–4.00 (m, 1H), 3.96–3.92 (m, 1H), 2.47 (brs, 1H), 
1.67–1.52 (m, 8H), 1.40 (d, J = 3.2 Hz, 2H); 13C NMR (125 MHz, CDCl3): δ 127.9 (d, J = 19.4 
Hz), 122.3 (qd, J = 285.9, 30.4 Hz), 120.8 (d, J = 12.2 Hz), 109.5, 94.5 (dq, J = 195.9, 30.4 Hz), 
74.4, 70.7 (d, J = 19.2 Hz), 63.8 (d, J = 6.8 Hz), 36.1, 35.3, 25.2, 24.0, 23.9. 19F NMR (470 MHz, 
CDCl3): δ –77.30 (d, J = 6.0 Hz, 3F), –192.03 (brs, 1F); HRMS (DART): [M+H]+ Calcd for 
C13H19O3F4: 299.1270, found: 299.1262. Specific Rotation: [α]20.0 +12.6 (c 1.00, CHCl3). 
 
To a suspension of NaH (95%, 13 mg, 0.51 mmol) in freshly distilled thf (15 ml) was slowly added 
a solution of 4.250 (100 mg, 0.34 mmol) in thf (5.0 mL) at 0 oC, and the mixture was allowed to 
stir for 30 minutes. To the solution was then added benzyl bromide (86.6 mg, 0.51 mmol) followed 
by tetrabutylammonium iodide (TBAI, 12.5 mg, 0.034 mmol). The reaction mixture was gradually 
warmed to 22 oC and allowed to stir for 5 h, before it was quenched by addition of a saturated 
aqueous solution of ammonium chloride (10 mL) at 0 oC. The aqueous layer was washed with 
ethyl acetate (3 x 10 mL) and the combined organic layers were washed with a saturated aqueous 
solution of sodium chloride, dried over Na2SO4 and concentrated under reduced pressure to afford 
pale yellow oil. To the resulting residue was added ethylene glycol (5.0 ml) and camphorsulfonic 
acid (CSA, 470 mg, 2.02 mmol) and the solution was allowed to stir at 50 oC for 18h. Upon cooling 
to 0 oC, the reaction was quenched by addition of a saturated aqueous solution of NaHCO3. The 
aqueous layer was washed with ethyl acetate (3 x 10 mL) and the combined organics were washed 
with a saturated aqueous solution of sodium, dried over Na2SO4 and concentrated to afford opaque 
solid which was purified by silica gel column chromatography (20:1 hexanes: ethyl acetate ® 2:1 
hexanes: ethyl acetate), to afford 4.252 (81.0 mg, 0.26 mmol, 81% yield), as colorless oil. 
(2R,3R,4S)-3-(Benzyloxy)-4-fluoro-4-(trifluoromethyl)hex-5-ene-1,2-diol 4.252: IR (neat): 
3384 (br), 2939 (m), 2892 (m), 1307 (m), 1295 (m), 1169 (s), 1067 (s), 1028 (m), 947 (m), 736(s), 
697 (m) cm-1; 1H NMR (500 MHz, CDCl3): δ 7.36 (brs, 5H), 5.90 (td, J = 20.0, 17.2, 11.2 Hz, 
1H), 5.72 (d, J = 17.2 Hz, 1H), 5.59 (d, J = 11.2 Hz, 1H), 4.79 (m, 2H), 4.08 (d, J = 23.2 Hz, 1H), 
3.95 (1H, brs), 3.82 (1H, brs), 3.75 (1H, brs), 2.86 (1H, brs), 2.33 (1H, brs). 13C NMR (100 MHz, 
CDCl3): δ 137.2, 128.7, 128.5, 128.3, 127.9 (d, JC-F = 19.4 Hz), 122.7 (qd, J = 287.8, 30.3 Hz), 
120.8 (d, J = 12.1 Hz), 95.4 (dq, J = 195.6, 30.3 Hz), 81.37 (dd, J = 19.3, 3.1 Hz), 76.47 – 75.46 
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(m), 63.0 (d, J = 4.5 Hz). 19F NMR (376 MHz, CDCl3): δ –76.79 (d, J = 6.2 Hz, 3F), –186.43 
(brs, 1F); HRMS (DART): [M+H]+ Calcd for C14H17O3F4: 309.1114, found: 309.1102. Specific 
Rotation: [α]20.0 + 29.1 (c 1.00, CHCl3).  
4.6.8 Procedure for Selective Secondary Benzyl Ether Formation and Synthesis of Puranose 
In an N2-filled glovebox, an oven dried vial (8 mL) equipped with a magnetic stir bar was charged 
with 4.252 (25.0 mg, 0.081 mmol) and diluted with thf (5.0 mL). The solution was cooled to 0 oC 
and NaH (95%, 5.8 mg, 0.24 mmol) was then added to the solution at 0 oC and the mixture was 
allowed to stir at 22 oC for 1h. The solution was stored in a –40 oC freezer and then benzyl bromide 
(17 mg, 0.099 mmol) and tetrabutylammonium iodide (TBAI, 3.0 mg, 0.0081 mmol) were added. 
The mixture was allowed to stir at 22 °C for 5 h and then quenched at 0 oC by addition of a saturated 
solution of ammonium chloride (0.1 mL). The mixture was directly loaded onto a plug (4.0 cm 
high x 1.0 cm wide) of silica gel and eluted with ethyl acetate. The eluent was concentrated under 
reduced pressure to afford yellow oil that was purified by silica gel column chromatography (50:1 
hexanes:EtOAc ® 5:1 hexanes:EtOAc), to afford a 4.253 (20.0 mg, 0.050 mmol, 62% yield) as 
colorless oil. 
(2R,3R,4S)-2,3-bis(benzyloxy)-4-fluoro-4-(trifluoromethyl)hex-5-en-1-ol (4.253). IR (neat): 
3437 (br), 3063(w), 3030 (w), 2924 (m), 2878 (m), 1454 (m), 1295 (m), 1171 (s), 1072 (s), 995 
(m), 736(s), cm-1; 1H NMR (500 MHz, CDCl3): δ 7.40 – 7.29 (m, 10H), 5.83 (td, J = 20.3, 17.2, 
11.0 Hz, 1H), 5.69 (d, J = 17.2 Hz, 1H), 5.52 (d, J = 11.2 Hz, 1H), 4.78 (dd, J = 10.5 Hz, 2H), 4.54 
(brs, 2H), 4.10 (d, J = 23.3 Hz, 1H), 3.86 (brs, 1H), 3.77 (brs, 2H), 2.10 (brs). 13C NMR (150 
MHz, CDCl3): δ 137.6, 137.2, 128.7, 128.6, 128.4, 128.2 (d, J = 3.7 Hz), 128.0, 122.6 (qd, J = 
285.8, 30.3 Hz), 120.2 (d, J = 12.1 Hz), 95.4 (dq, J= 196.1, 30.3 Hz), 79.6 (d, J = 19.7 Hz), 79.5, 
79.0, 75.7, 71.9, 61.1 (d, J = 3.4 Hz). 19F NMR (470 MHz, CDCl3): δ –76.59 (d, J = 6.2 Hz, 3F), 
–187.53 (brs, 1F); HRMS (DART): [M+H]+ Calcd for C21H23O3F4: 399.1583 found: 398.1594. 
Specific Rotation: [α]20.0 + 16.6 (c 1.00, CHCl3).  
An oven-dried vial (8 mL) equipped with a stir bar was charged with 4.253 (40 mg, 0.100 mmol) 
and diluted with thf (1.0 mL) and MeOH (0.2 mL). The solution was allowed to cool to –78 °C 
and then O3 was bubbled through the solution (total exposure ~40 minutes) until a blue color 
persisted. The solution was then purged with a stream of N2 until it became clear. Dimethyl sulfide 
(25 mg, 0.40 mmol) was then added and the solution was allowed to warm to 22 °C and left with 
stirring for 2 hours. The reaction mixture was concentrated under reduced pressure to afford an 
opaque residue that was purified by silica gel column chromatography (30:1 hexanes:EtOAc ® 
1:1 hexanes:EtOAc), to afford 4.254 (27.0 mg, 0.067 mmol, 67% yield) as colorless oil. 
(2R,3R,4R,5R)-4,5-bis(benzyloxy)-3-fluoro-3-(trifluoromethyl)tetrahydro-2H-pyran-2-ol 
(4.254): IR (neat): 3401 (br), 3028(w), 2926 (w), 2876 (m), 1721 (w), 1453 (m), 1279 (m), 1191 
(s), 1103 (s), 1073(s), 1027 (s), 732 (m) cm-1; 1H NMR (500 MHz, CDCl3): δ 7.39 – 7.28 (m, 
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10H), 5.42 (d, J = 8.1 Hz, 1H), 4.71 (ABq, J = 12.0 Hz, 2H), 4.56 (ABq, J = 11.3 Hz, 2H), 4.03 
(dd, J = 28.7, 3.6 Hz, 1H), 3.94 (dd, J = 20.0, 15.0 Hz, 2H), 3.78 (brs, 1H), 2.82 (brs, 1H); 13C 
NMR (150 MHz, CDCl3): δ 137.9, 136.9, 128.6, 128.5, 128.3, 128.1, 122.5, 122.5 (qd, J= 286.1, 
29.3 Hz), 92.1 (d, J = 32.2 Hz), 91.1 (dq, J = 198.5, 29.3 Hz), 72.3, 72.0, 71.7 (d, J = 16.4 Hz), 
71.3, 60.7; 19F NMR (470 MHz, CDCl3): δ –73.83 (s, 2F), –185.41 (d, J = 28.8 Hz,1F); HRMS 
(DART): [M+NH4]+ Calcd for C20H24NO4F4: 418.1642 found: 418.1636. Specific Rotation: 
[α]20.0 –74.5 (c 0.6, CHCl3).  
4.6.9 Procedure for Selective Secondary Benzyl Ether Formation and Synthesis of Furanose 
Authentic primary benzyl ether 4.300 was prepared according to a procedure by Sudalai.7 An 
oven-dried vial (8 mL) equipped with a stir bar was charged with  (35.0 mg, 0.114 mmol), Bu2SnO 
(28 mg, 0.114 mmol) and toluene (4.0 mL). The suspension was heated to reflux (110 oC) with 
vigorous stirring for 12 h. After cooling to 22 oC, benzyl bromide (29 mg, 0.170 mmol) and 
tetrabutylammonium bromide (TBAB, 37.0 mg, 0.114 mmol) were added to the solution. The 
mixture was allowed to stir at 110 °C for 12 h. Upon cooling to 22 oC, the mixture was diluted 
with CH2Cl2 (5.0 mL) and washed with a saturated aqueous solution of NaHCO3 followed by a 
1.0 M aqueous solution of KF. The aqueous layers were back-extracted with CH2Cl2 and the 
combined organic layers were dried over Na2SO and concentrated to afford pale yellow oil, which 
was purified by silica gel column chromatography (30:1 hexanes: ethyl acetate ® 5:1 hexanes: 
ethyl acetate), to afford 4.300 (36.5 mg, 0.092 mmol, 81 % yield) as colorless oil. 
(2R,3R,4S)-1,3-Bis(benzyloxy)-4-fluoro-4-(trifluoromethyl)hex-5-en-2-ol (4.300). IR (neat): 
3448 (br), 3062(w), 3030 (w), 2920 (m), 2867 (m), 1496 (m), 1273 (m), 1171 (s), 1072 (s), 985 
(m), 736(s), 697 (s) cm-1; 1H NMR (500 MHz, CDCl3): δ 7.37–7.29 (m, 10H), 5.89 (ddd, J = 20.9, 
17.3, 11.2 Hz, 1H), 5.66 (d, J = 17.3 Hz, 1H), 5.55 (d, J = 11.2 Hz, 1H), 4.74 (m, 2H), 4.57 – 4.49 
(m, 2H), 4.14 – 4.07 (m, 1H), 4.06 (dd, J = 23.7, 4.0 Hz, 1H), 3.69 (d, J = 5.4 Hz, 2H), 2.59 (d, J 
= 3.9 Hz, 1H). 13C NMR (150 MHz, CDCl3): δ 137.8, 137.6, 128.8, 128.6, 128.5, 128.2, 128.1, 
128.0 122.6 (qd, J = 285.8, 30.6 Hz), 120.5 (d, J = 12.1 Hz), 95.6 (dq, J = 195.7, 30.3 Hz), 80.3 
(d, J = 19 Hz), 80.8, 73.6, 70.5, 70.3 (d, J = 3.8 Hz). 19F NMR (470 MHz, CDCl3): δ –75.73 (d, 
J = 6.6 Hz, 3F), –186.86 (brs, 1F); HRMS (DART): [M+H]+ Calcd for C21H23O3F4: 399.1583 
found: 398.1576. Specific Rotation: [α]20.0 14.0 (c 0.50, CHCl3).  
	
An oven dried vial (8 mL) equipped with a stir bar was charged with 4.300 (18 mg, 0.045 mmol) 
and diluted with CH2Cl2 (1.5 mL) and MeOH (0.3 mL). The solution was cooled to –78 °C and 
O3 was bubbled (total exposure ~20 minutes) into the reaction mixture until a blue color persisted. 
																																																								
7) Codée, J. D. C.; van den Bos, L. J.; de Jong, A-R.; Dinkelaar, J.; Lodder. G.; Overkleeft, H. S.; van der Marel, G. 
A. J. Org. Chem. 2009, 74. 38–47. 
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The mixture was then purged with a stream of N2 until it became clear. Dimethyl sulfide (11.2 mg, 
0.181 mmol) was then added and the mixture was allowed to gradually warm to 22 °C and left 
with stirring for 3 hours. The mixture was then concentrated to afford an opaque oily residue that 
was purified by preparative thin layer chromatography (30:1 CH2Cl2:EtOAc), to afford an 
anomeric mixture of S-2 (12.0 mg, 0.030 mmol, 66% yield) as colorless oil. 
(3S,4R,5R)-4-(Benzyloxy)-5-((benzyloxy)methyl)-3-fluoro-3-(trifluoromethyl) 
tetrahydrofuran-2-ol (S-2). IR (neat): 3371 (br), 3062(w), 2924 (w), 2867 (m), 1495 (m), 1361 
(m), 1191 (s), 1068 (s), 1026(s), 991 (s), 730 (s), 698 (s), 605 (w) cm-1; 1H NMR (500 MHz, 
CDCl3): δ7.41 – 7.27 (m, 9H), 7.25 – 7.19 (m, 1H), 5.54 (t, J = 5.9 Hz, 0.32H, minor anomer), 
5.28 (t, J = 8.5 Hz, 0.7H, major anomer), 4.78 (m, 1H), 4.61 (ddd, J = 21.0, 6.4, 1.3 Hz, 0.7H, 
major anomer), 4.54 (d, J = 12.0 Hz, 0.3H, minor anomer), 4.45 (m, 2H), 4.37 (t, J = 11.7 Hz, 1H), 
4.31 (dt, J = 7.3, 3.4 Hz, 0.3H, minor anomer), 4.27 (m, 0.7H, major anomer), 4.26 – 4.18 (m, 
0.3H, minor anomer), 4.08 (d, J = 9.1 Hz, 0.7H, major anomer), 3.65 (dt, J = 11.1, 2.0 Hz, 0.3H, 
minor anomer), 3.58 (dt, J = 10.5, 1.8 Hz, 0.7H, major anomer), 3.50 (ddd, J = 11.2, 4.1, 1.3 Hz, 
0.3H, minor anomer), 3.43 (m, 0.3H, minor anomer), 3.12 (dd, J = 10.5, 1.7 Hz, 0.7H, major 
anomer); 13C NMR (150 MHz, CDCl3): δ 137.8, 137.0, 136.8, 136.4, 128.9, 128.8, 128.7, 128.6, 
128.5, 128.49, 128.1, 128.0, 127.9, 122.2 (qd, J = 281.8, 29.5 Hz), 122.4 (qd, J = 281.8, 30.5 Hz), 
123.0 (qd, J = 281.8, 29.5 Hz), 99.1 (d, J = 30.9 Hz), 97.4 (dq, J = 200.4, 29.5 Hz), 94.0 (dq, J = 
208.8, 30.5 Hz), 82.0, 80.0, 75.3 (d, J = 15.8 Hz), 74.9 (d, J = 15.3 Hz), 73.9, 73.8, 73.7, 67.8, 
67.78. 19F NMR (470 MHz, CDCl3): δ –75.54 (d, J = 6.6 Hz, 1.0F), –79.67 (2.6F, d, J = 9.5 Hz, 
0.8F), –190.21 (dq, J = 21.2, 7.7, 7.2 Hz, 0.3F), –195.93 (ddt, J = 14.1, 9.2, 4.3 Hz, 0.2F); HRMS 
(DART): [M+NH4]+ Calcd for C20H24NO4F4: 418.1642 found: 418.1628. Specific Rotation: 
[α]20.0 60.5 (c 0.6, CHCl3).  
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To a solution of alkene 4.250 (100 mg, 0.34 mmol), NMO (157 mg, 1.34 mmol) and citric acid 
(129 mg, 0.67 mmol) in a 2:1 mixture of thf:H2O (3.3 mL total volume) at 22 °C, was added OsO4 
(4% wt in H2O, 107 µL, 17.0 µmol) and the resulting solution was allowed to stir at 22 °C for 20 
h. NaIO4 (359 mg, 1.68 mmol) was then added to the reaction and the resulting mixture was 
allowed to stir at 22 °C for 4 h. The reaction was quenched by addition of solid Na2SO3 (430 mg) 
and diluted with CH2Cl2 (4.0 mL) and H2O (4.0 mL). The resulting mixture was allowed to 
vigorously stir for 30 min, then the two phases were separated and the aqueous phase was back 
extracted with CH2Cl2 (4 × 3 mL). The combined organic extracts were dried over Na2SO4, filtered 
and concentrated under reduced pressure. The crude aldehyde 4.255 was directly subjected to 
cyclization without further purification. 
TsOH•H2O (13 mg, 67.0 µmol) was added to a solution of aldehyde 4.255 in MeOH (3.0 mL) and 
the resulting solution was allowed to stir at 22 °C for 5 h. The solution was neutralized (pH = 7) 
by addition of solid NaHCO3 and then the reaction was concentrated under reduced pressure. The 
resulting off-white residue was diluted with EtOAc (1 mL) and filtered through Celite® and 
thoroughly eluted with EtOAc. The filtrate was concentrated under reduced pressure to deliver 
deoxyribose 4.256, which was employed directly without further purification. 
To a solution of deoxyribose 4.256 in CH2Cl2 (3.0 mL) were sequentially added Et3N (234 µL, 
1.68 mmol), dmap (16.4 mg, 134 µmol) and benzoyl chloride (129 µL, 1.11 mmol). The resulting 
solution was allowed to stir at 22 °C for 3 h. The reaction was quenched by addition of 1.0 M 
aqueous solution of HCl (4.0 mL) and extracted with Et2O (3 × 4 mL). The combined organic 
layers were washed with a saturated aqueous solution of NaHCO3 (5.0 mL) and brine (5 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure to afford yellow residue that was 
purified by silica gel chromatography (hexanes:EtOAc = 20:1) afforded benzoylated deoxyribose 
4.257 (2:1 anomeric mixture, 130 mg, 0.244 mmol, 73% overall yield) as colorless solid. 
IR (neat): 2925 (w), 1739 (s), 1601 (w), 1452 (m), 1261 (s), 1209 (s), 1178 (m), 1106 (m), 1054 
(m), 1023 (s), 995 (m), 706 (s) cm−1; 1H NMR (CDCl3, 500 MHz): δ 8.15 (dd, J = 8.5, 1.4 Hz, 
1H), 8.10 (ddd, J = 8.5, 6.4, 1.3 Hz, 3H), 8.01 (ddd, J = 8.5, 5.9, 1.3 Hz, 3H), 7.87 (dd, J = 8.5, 
1.4 Hz, 2H), 7.63 (dddt, J = 13.9, 8.8, 7.4, 1.4 Hz, 3H), 7.58–7.51 (m, 0.5H), 7.54–7.44 (m, 4H), 
7.46–7.36 (m, 4H), 7.19–7.12 (m, 2H), 6.90 (d, J = 2.6 Hz, 0.5H minor anomer), 6.68 (d, J = 10.9 
Hz, 1H, major anomer), 6.40 (dd, J = 23.2, 8.0 Hz, 1H, major anomer), 5.92 (dd, J = 8.5, 7.0 Hz, 
0.5H, minor anomer), 4.89 (ddd, J = 7.1, 5.0, 3.8 Hz, 0.5H, minor anomer), 4.82–4.70 (m, 2.5H), 
4.60 (dd, J = 12.4, 5.0 Hz, 0.5H, minor anomer), 4.52 (dd, J = 12.4, 4.1 Hz, 1H, major anomer); 
13C NMR (CDCl3, 125 MHz): δ 166.0, 165.9, 164.7, 164.6, 164.1, 163.7, 130.2, 130.2, 130.1, 
130.1, 129.8, 129.6, 129.2, 129.2, 128.8, 128.7, 128.7, 128.7, 128.6, 128.5, 128.3, 128.2, 128.1, 
128.11, 128.0, 125.3, –121.9 (qd, J= 284.2, 30.1 Hz, minor anomer), 120.9 (qd, J = 282.5, 29.7 
Hz, major anomer), 97.0 (dq, J = 232.1, 33.5 Hz, major anomer), 95.8 (bd, J = 34.6 Hz, major 
anomer), 93.4 (dq, J = 219.5, 33.5 Hz, minor anomer), 93.3 (dq, J = 15.9, 1.7 Hz, minor anomer), 
80.2, 79.2, 68.9 (bd, J = 14.2 Hz, major anomer), 68.1 (bd, J = 14.2 Hz, minor anomer), 62.8, 62.3; 
19F NMR (CDCl3, 471 MHz): δ -74.68 (d, J = 5.8 Hz, major anomer), -79.21 (d, J = 10.4 Hz, 
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minor anomer), -189.01 (ddt, J = 23.1, 10.9, 6.4 Hz, major anomer), -189.15 (p, J = 9.6 Hz, minor 
anomer); HRMS (ESI+): Calcd for C27H21O7F4 [M+H]+: 533.1218, Found: 533.1212 
 
4.6.11  Preparation of Analogues For Benzyl Protection Studies 
(2R,3S)-3-(Benzyloxy)hex-5-ene-1,2-diol was synthesized according to a previously reported 
procedure.8 1H NMR (CDCl3, 500 MHz): δ 7.65 – 7.54 (m, 5H), 6.13 (ddt, J = 17.3, 10.3, 7.1 Hz, 
1H), 5.46 – 5.33 (m, 2H), 4.93 (d, J = 11.4 Hz, 1H), 4.77 (d, J = 11.3 Hz, 1H), 4.08 – 3.97 (m, 
2H), 3.89 (q, J = 5.6 Hz, 1H), 2.73 (dt, J = 13.7, 6.6 Hz, 1H), 2.68 – 2.58 (m, 1H), 2.42 (s, 1H), 





(Z)-2-(3-Fluoroallyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (4.263):  
In a N2-filled glovebox, prenyl–B(pin) (196 mg, 1.0 mmol) and (Z)-1-Bromo-2-fluoroethylene 
(250 mg, mmol) was added to an oven-dried 8 mL vial equipped with a stir bar. Pinacolborane 
(12.8 mg, 0.1 mmol) was added (gentle release of gas) and the mixture was sealed with a cap and 
allowed to stir for 10 min (22 °C). A solution of Mo-1 (16.7 mg, 0.02 mmol) in benzene (0.2 mL) 
was slowly added to the solution. The vial was capped and the mixture was allowed to stir for 2 h. 
The vial was removed from the glovebox and the volatiles were carefully evaporated in vacuo. 
The resulting black oil residue was purified by Kugelrohr distillation (22-35 °C) to afford 4.263 
as yellow oil (109.7 mg, 59% yield, 97:3 Z:E). IR (neat): 2977 (m), 1670 (m), 1322 (s), 1141 (s), 
970 (m), 846 (m), 753 (m), 689 (m), 539 (w) cm-1; 1H NMR (400 MHz, CDCl3): δ 6.47 (ddt, J = 
85.8, 4.6, 1.7 Hz, 1H), 4.84 (dtd, J = 43.0, 8.0, 4.6 Hz, 1H), 1.69 (d, J = 7.9 Hz, 2H), 1.25 (s, 12H); 
13C NMR (100 MHz, CDCl3): δ 149.03, 146.49, 106.27 (d, J = 6.1 Hz), 83.61, 24.90; 19F NMR 
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(376 MHz, CDCl3): –131.89 (dd, J = 86.4, 42.3 Hz); HRMS (DART): Calcd for C9H17BO2F 
[M+H]+: 187.1300; Found: 187.1293. 
 
To a cooled –78 °C solution of 4.263 in freshly distilled thf (4.0 mL) was added n-BuLi in hexanes 
(2.5 M, 0.18 mL) and the solution was allowed to stir for 15 minutes. Freshly distilled 
trifluoroacetic anhydride (76 µL, 0.54 mmol) was then added in a dropwise manner and the mixture 
was allowed to stir at –78 °C for an additional 30 minutes. Aldehyde 4.249 (116 mg, 0.675 mmol) 
was then added as a solution in thf (1.0 mL) and the mixture was allowed to stir at –78 °C for 2 h, 
then allowed to warm to 22 °C and stir for an additional 2 h. The reaction was quenched by the 
addition of a 0.5 M solution of NaOH and the layers were separated. The aqueous layer was back-
extracted with Et2O (3 x 5.0 mL). The combined organic layers were dried over Na2SO4, filtered 
and concentrated under reduced pressure to afford yellow residue which was purified by silica gel 
chromatography (hexanes:Et2O 100:0 → 3:1) to afford colorless oil. The obtained alcohol (100 
mg, 0.43 mmol) was then diluted in thf (3.0 mL) and benzyl bromide (111.4 mg, 0.65 mmol) and 
tetrabutylammonium iodide (TBAI, 13.9 mg, 0.043 mmol) were added. The mixture was placed 
in a –40 °C freezer for 10 minutes then NaH (90%, 15.6 mg, 0.65 mmol) was added in a single 
portion. The mixture was allowed to stir vigorously for 5 h at 22 °C. The reaction was quenched 
at 0 oC by addition of a saturated solution of ammonium chloride (0.1 mL). Then the mixture was 
directly loaded onto a plug (6.0 cm high x 5.0 cm wide) of silica gel to remove excess benzyl 
bromide to afford 4.264 (108.1 mg, 0.355 mmol, 79% yield) as colorless oil. 
To a cooled (0 °C) solution of benzyl ether 4.264 in CH2Cl2 (3.0 mL) was added a 50% aqueous 
solution of thf (3.0 mL). The mixture was then allowed to warm to 22 °C and left with stirring for 
14 h. The mixture was then diluted with CH2Cl2 (20 mL) and washed with a cold solution of 
saturated aqueous NaHCO3 (3 x 10 mL) followed by brine (1 x 10 mL). The combined organics 
were then dried over Na2SO4, filtered and concentrated under reduced pressure to afford yellow 
residue which was purified by silica gel chromatography (20:1 hexanes: ethyl acetate ® 2:1 
hexanes:EtOAc) to afford 4.265 (46.9 mg, 0.195 mmol) as colorless oil.  
(2R,3R,4R)-3-(Benzyloxy)-4-fluorohex-5-ene-1,2-diol (4.265). IR (neat): 3424 (br), 2923 (m), 
2822 (m), 1454 (m), 1088 (s), 1053 (s), 984 (s), 738 (m), 697 (m) −1; 1H NMR (CDCl3, 400 MHz): 
δ 7.41 – 7.31 (m, 5H), 6.02 (dddd, J = 17.2, 15.4, 10.7, 6.3 Hz, 1H), 5.49 (ddt, J = 17.3, 3.1, 1.4 
Hz, 1H), 5.37 (dt, J = 10.7, 1.3 Hz, 1H), 5.14 (dddt, J = 47.0, 5.9, 4.4, 1.4 Hz, 1H), 4.70 (dd, J = 
65.2, 11.2 Hz, 2H), 3.82 (m, 1H), 3.75 (m, 2H), 3.68 (ddd, J = 20.5, 6.3, 4.3 Hz, 1H), 2.43 (s, 1H), 
1.95 (s, 1H); 13C NMR (150 MHz, CDCl3): δ 140.0, 135.6 (d, J = 19.8 Hz), 131.6, 130.8, 121.8 
(d, J = 12.0 Hz), 96.1, 95.0, 83.9 (d, J = 19.6 Hz), 77.6, 73.1 (d, J = 4.5 Hz), 67.1; 19F NMR 
(CDCl3, 376 MHz): δ –190.37 (dd, J = 43.3, 22.2 Hz); HRMS (DART): Calcd for C13H18O3F 
[M+H]+: 241.12345, Found: 241.12271; Specific rotation: [a]27.3 +14.9 (c 0.72, CHCl3). 
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To a cooled (0 °C) solution of aldehyde 4.266 (502.4 mg, 3.86 mmol) in thf (4.0 mL) was added a 
solution of vinyl magnesium bromide (1.0 M in thf, 6.75 mL, 6.75 mmol) in a dropwise manner. 
The mixture was allowed to stir at 0 °C for 1 h and then it was quenched by addition of a saturated 
aqueous solution of ammonium chloride (5.0 mL). The aqueous layer was back-extracted with 
CH2Cl2 (3 x 10 mL) and the combined organic layers were dried over Na2SO4, filtered and 
concentrated under reduced pressure to afford 4.267 (332.5 mg, 2.08 mmol) as a mixture of 
diastereomers in 54% yield. The unpurified allylic alcohol was then diluted in thf (10 mL) and 
cooled to 0 °C. NaH (60% dispersion in oil, 126 mg, 3.15 mmol) was then added in a single portion 
and allowed to stir for 30 minutes. Benzyl bromide (540 mg, 3.15 mmol) and tetrabutylammonium 
iodide (15.5 mg, 0.042 mmol) were then added and the reaction was allowed to warm to 22 °C and 
stir for 3 h. The reaction was quenched at 0 °C by addition of a saturated solution of ammonium 
chloride (5.0 mL). The aqueous layer was back-extracted with CH2Cl2 (3 x 10 mL) and the 
combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure 
to afford yellow residue as a mixture of diastereomers which was purified by medium pressure 
liquid chromatography with a Teledyne ISCO Combiflash RF instrument paired with a 24 g 
RediSep Rf Gold column (catalog number 69-2203-346) and a gradient elution method: 100% 
hexanes → 30% EtOAc) to furnish 4.268 as colorless oil (215.4 mg, 0.87 mmol, 41% yield) with 
identical spectra to literature.9 
Cross-metathesis was performed according to a procedure by Vankar.10 To a oven-dried 10 mL 
round bottom flask equipped with a reflux condenser was added a solution of 4.268 (215.4 mg, 
0.87 mmol) in CH2Cl2 (5.0 mL) and allyl silane 4.269 (297.3 mg, 2.60 mmol) followed by a 
solution of Ru-1 (36.9 mg, 0.044 mmol) in CH2Cl2 (1.0 mL) under an atmosphere of N2. The 
mixture was heated to reflux (45 °C) for 15 h. Upon cooling to 22 °C, the mixture was concentrated 
																																																								
9) Kamal, A.; Reddy, P. V.; Prabhakar, S. Tetrahedron: Asymmetry 2009, 20, 1120–1124. 
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to afford dark brown residue which was purified by silica gel chromatography (20:1 hexanes: ethyl 
acetate ® 5:1 hexanes:EtOAc) to afford 4.270 (84.3 mg, 0.25 mmol) as colorless oil.  
Fluorination was carried out according to a procedure by Gouverneur et al.11 To a solution of allyl 
silane 4.270 (84.3 mg, 0.25 mmol) in acetonitrile (3.0 mL) was added selectfluor (88.6 mg, 0.25 
mmol) and the mixture was allowed to stir for 48 h at 22 °C. The mixture was then concentrated 
under reduced pressure to afford a white residue which was purified by medium pressure liquid 
chromatography with a Teledyne ISCO Combiflash RF instrument paired with a 12 g RediSep Rf 
Gold column (catalog number 69-2203-345) and a gradient elution method: 100% hexanes → 30% 
Et2O) afford 4.272 (27.1 mg, 0.097 mmol) as colorless oil. Unmasking of the diol was performed 
exactly as described above. 
(2R,3R,4S)-3-(Benzyloxy)-4-fluorohex-5-ene-1,2-diol (4.272). IR (neat); 1H NMR (CDCl3, 400 
MHz): δ 7.34 (m, 5H), 6.16 – 6.00 (m, 1H), 5.49 (ddt, J = 17.4, 3.8, 1.4 Hz, 1H), 5.41 (dt, J = 
10.7, 1.3 Hz, 1H), 5.31 – 5.09 (m, 1H), 4.81 (d, J = 11.3 Hz, 1H), 4.61 (d, J = 11.4 Hz, 1H), 3.83 
– 3.76 (m, 1H), 3.76 – 3.72 (m, 2H), 3.68 (dt, J = 8.1, 4.2 Hz, 1H), 2.52 (s, 1H), 1.94 (s, 1H); 13C 
NMR (150 MHz, CDCl3): δ 137.6, 132.3 (d, J = 19.5 Hz), 128.6, 128.2, 128.1, 119.8 (d, J = 12.2 
Hz), 94.2 (d, J = 170.2 Hz), 80.4 (d, J = 21.5 Hz), 74.1 (d, J = 2.2 Hz), 70.8 (d, J = 6.4 Hz), 63.4 
(d, J = 2.2 Hz); 19F NMR (CDCl3, 376 MHz): δ –184.64 (dtd, J = 46.6, 14.3, 3.8 Hz); HRMS 
(DART): Calcd for C13H21O3F [M+NH4]+: 258.15000, Found: 258.14953. 
 
Benzyl protection was carried out according to a procedure reported by Lee and Kang et al.12 To 
a cooled (0 °C) solution of diol 4.290 (2.31 g, 9.3 mmol) and benzyl bromide (1.66 mL, 14 mmol) 
in dmf (9.0 mL) was added NaH (580 mg, 14 mmol) in three equal portions. The mixture was 
allowed to stir and warmed to 22 °C over the course of 2 hours. The reaction was then cooled to 0 
°C and quenched by addition of a saturated aqueous solution of NH4Cl (10 mL). The mixture was 
diluted with ethyl acetate, the organic layer was removed and the aqueous was washed with ethyl 
acetate (20 mL x 3). The combined organics were washed with brine (50 mL), dried over MgSO4 
																																																								
11) Thibaudeau, S.; Gouverneur, V. Org. Lett. 2003, 5, 4891–4893. 
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and concentrated under reduced pressure to afford a brown oil which was purified by silica gel 
chromatography (gradient eluting with 100:0 ® 4:1 hexanes:EtOAc) to afford white solid (1.725 
g, 5.1 mmol, 55%). To a cooled (0 °C) solution of monobenzyl ether (1.725g, 5.1 mmol) in thf (25 
mL) was added LiAlH4 (386 mg, 10.2 mmol) in three equal portions. The mixture was allowed to 
stir and warmed to 22 °C over the course of 2 hours. The reaction was then cooled to 0 °C and 
quenched by addition of a saturated aqueous solution of potassium sodium tartrate (Rochelle’s salt, 
20 mL) and allowed to stir vigorously overnight. The organic layer was removed and the aqueous 
was washed with CH2Cl2 (20 mL x 3). The combined organics were dried over MgSO4 and 
concentrated to afford clear oil which was directly subjected to oxidation and subsequent 
olefination according to a procedure by Yorimitsu and Oshima et al.13. To a cooled (0 °C) solution 
of diol in CH2Cl2 (15 mL) was added N-Ethyldiisopropylamine (4.52 mL, 26 mmol) and methyl 
sulfoxide (3.7 mL, 52.5 mmol). Sulfur trioxide pyridine complex (2.47g, 15.5 mmol) was then 
added in a single portion and allowed to stir for 2 hours. The reaction was quenched by addition 
of a solution of 1 M HCl (15 mL), and the organic layer was removed. The aqueous layer was 
washed with CH2Cl2 (3 x 15 mL), and the combined organics were then washed with a saturated 
solution of NaHCO3 (30 mL), dried over Na2SO4 and concentrated under reduced pressure to 
afford the corresponding aldehyde as a solution in methyl sulfoxide which was used without 
further purification. To a solution of methyltriphenylphosphonium bromide (5.0 g, 14.0 mmol) in 
thf (10 mL) was added potassium tert-butoxide (1.51 g, 13.5 mmol) in a single portion, and the 
resulting yellow mixture was allowed to stir at 22 °C for 30 minutes. A solution of the unpurified 
aldehyde in thf (10 mL) was then added and the resulting mixture was heated to 50 °C for 2 hours. 
Upon cooling to 22 °C, the reaction was quenched by addition of a saturated aqueous solution of 
NaHCO3. The organic layer was collected, and the aqueous was washed with ethyl acetate (3 x 20 
mL). The combined organics were dried over Na2SO4 and concentrated under reduced pressure to 
afford a brown oil which was purified by silica gel chromatography (gradient eluting with 100:0 
® 3:1 hexanes:Et2O) to afford 4.292 as colorless oil (611.8 mg, 2.1 mmol, 42% yield over 3 steps).  
(1R,2R)-1-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-methylbut-3-en-2-ol 
(4.292): 1H NMR (CDCl3, 400 MHz): δ 7.40 – 7.25 (m, 5H), 6.06 (dd, J = 17.3, 10.8 Hz, 1H), 
5.36 (dd, J = 17.3, 1.5 Hz, 1H), 5.16 (dd, J = 10.8, 1.5 Hz, 1H), 4.93 – 4.54 (m, 2H), 4.29 – 4.20 
(m, 1H), 4.03 (dd, J = 8.4, 6.2 Hz, 1H), 3.89 (dd, J = 8.4, 6.9 Hz, 1H), 3.52 (d, J = 5.7 Hz, 1H), 
3.04 (s, 1H), 1.44 (s, 3H), 1.34 (s, 3H), 1.32 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 142.1, 
137.0, 128.4, 127.9, 127.2, 112.7, 108.1, 83.9, 76.4, 75.6, 75.3, 26.5, 25.3, 25.2; HRMS 
(DART): Calcd for C17H23O3 [M+H–H2O]+: 275.16417, Found: 275.16407; Specific rotation: 
[a]25.8 +5.9 (c 1.12, CHCl3). 
 
																																																								
13) Hayashi, S.; Yorimitsu, H.; Oshima, K. J. Am. Chem. Soc. 2009, 131, 2052–2053. 
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Fluorination was performed in analogy to a procedure by Rapp et al.14 To a cooled (–78 °C) 
solution of DAST (60 µL, 0.45 mmol) in CH2Cl2 (2.0 mL) was added a solution of tertiary 
alcohol 4.292 (100 mg, 0.34 mmol) in CH2Cl2 (2.0 mL) in a dropwise manner. The mixture was 
kept at –78 °C for 2 h and then allowed to warm to 22 °C and stir for an additional 1 h. The 
reaction was quenched by pouring the mixture into a saturated solution of NaHCO3 (5.0 mL) 
containing ice chips. The aqueous layer was back-extracted with CH2Cl2 (3 x 10 mL) and the 
combined organics were dried over Na2SO4, filtered and concentrated under reduced pressure to 
afford brown residue which was purified by silica gel chromatography (gradient eluting with 
100:0 ® 3:1 hexanes:Et2O) to afford 4.294 (33.0 mg, 0.112 mmol) as colorless oil.  
 
(2R,3R)-3-(Benzyloxy)-4-fluoro-4-methylhex-5-ene-1,2-diol (4.294): IR (neat): 3387 (br), 
2919 (m), 2870 (m), 1454 (m), 1384 (m), 1206 (m), 1098 (s), 1067(s), 977 (s), 737 (m), 699 (m) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.39 – 7.27 (m, 5H), 5.82 (dddt, J = 10.3, 6.7, 5.4, 1.2 Hz, 
1H), 5.14 – 5.02 (m, 1H), 5.02 – 4.89 (m, 1H), 4.42 (dd, J = 101.5, 11.6 Hz, 2H), 3.82 (m, 1H), 
3.79 – 3.68 (m, 3H), 2.21 (s, 1H), 2.07 (s, 1H), 1.76 (dd, J = 4.1, 1.3 Hz, 3H); 13C NMR (100 
MHz, CDCl3): δ 138.9 (d, J = 10.9 Hz), 137.1, 128.6, 128.0, 127.9, 125.1 (d, J = 18.6 Hz), 84.8, 
78.9 (d, J = 213 Hz), 71.0 (d, J = 2.4 Hz), 70.3, 61.6, 12.3; 19F NMR (564 MHz, CDCl3): δ -
212.18 (dd, J = 52.7, 41.6 Hz); HRMS (DART): Calcd for C13H18O3F [M+H–H2O]+: 237.12853, 




(2R,3R,4R)-3-(Benzyloxy)-4-fluoro-4 (trifluoromethyl)hex-5-ene-1,2-diol (4.297): 1H NMR 
(CDCl3, 400 MHz): δ 7.40 – 7.27 (m, 5H), 6.09 (ddd, J = 23.3, 17.5, 11.3 Hz, 1H), 5.73 (d, J = 
17.5 Hz, 1H), 5.60 (dd, J = 11.3, 3.2 Hz, 1H), 4.83 – 4.55 (m, 2H), 4.15 (t, J = 5.3 Hz, 1H), 3.91 
(q, J = 4.8 Hz, 1H), 3.85 – 3.72 (m, 2H), 2.49 (s, 1H), 2.03 (s, 1H); 13C NMR (100 MHz, 
CDCl3): δ 136.9, 128.6, 128.3, 128.1, 127.3 (d, J = 17.6 Hz), 122.7 (dd, J = 285.7, 28.7 Hz), 
120.9 (d, J = 12.7 Hz) 94.3 (qd, J = 192.6, 29.8 Hz), 79.0 (d, J = 23.2 Hz), 75.4, 71.1, 62.8 (d, J 
= 1.6 Hz); 19F NMR (564 MHz, CDCl3): δ –78.09 (d, J = 6.5 Hz), –180.58 (d, J = 23.9 Hz); 
HRMS (DART): Calcd for C14H17O3F4 [M+H]+: 309.11083, Found: 309.11239; Specific 
rotation: [a]D25.8 = +42.8 (c 0.71, CHCl3). 
 
																																																								







1.1 equiv n-BuLi 
1.2 equiv tfaa
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26% yield 4.29779% yield 
over 2 steps
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4.6.12  Crystal Structure Tables 
 
 Table 1.  Crystal data and structure refinement for 4.294. 
Identification code  C18H19F4NO3 
Empirical formula  C18 H19 F4 N O3 
Formula weight  373.34 
Temperature  100(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 6.2159(2) ≈ a= 90∞. 
 b = 16.8180(6) ≈ b= 90∞. 
 c = 16.9564(6) ≈ g = 90∞. 
Volume 1772.61(11) ≈3 
Z 4 
Density (calculated) 1.399 Mg/m3 
Absorption coefficient 1.062 mm-1 
F(000) 776 
Crystal size 0.540 x 0.120 x 0.100 mm3 
Theta range for data collection 3.702 to 66.556∞. 
Index ranges -7<=h<=7, -19<=k<=19, -20<=l<=17 
Reflections collected 12650 
Independent reflections 3122 [R(int) = 0.0377] 
Completeness to theta = 66.556∞ 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.5617 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3122 / 1 / 238 
Goodness-of-fit on F2 1.061 
Final R indices [I>2sigma(I)] R1 = 0.0306, wR2 = 0.0822 
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R indices (all data) R1 = 0.0320, wR2 = 0.0833 
Absolute structure parameter -0.02(5) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.214 and -0.206 e.≈-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 103) 
for 4.234.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
F(1) 3668(2) 4409(1) 4321(1) 30(1) 
F(2) -157(3) 4860(1) 4875(1) 37(1) 
F(3) -1406(2) 5074(1) 3713(1) 40(1) 
F(4) -441(3) 3892(1) 4061(1) 38(1) 
O(1) 1870(3) 6108(1) 3242(1) 25(1) 
O(2) 3433(3) 7905(1) 7903(1) 26(1) 
O(3) 642(3) 7930(1) 7038(1) 27(1) 
N(1) 3717(3) 7234(1) 6781(1) 20(1) 
C(1) 4211(5) 4054(2) 2774(2) 42(1) 
C(2) 2562(4) 4489(2) 2989(2) 28(1) 
C(3) 2335(4) 4820(1) 3806(1) 22(1) 
C(4) 3085(3) 5699(1) 3819(1) 20(1) 
C(5) 3080(4) 6100(1) 4618(1) 19(1) 
C(6) 4827(4) 5997(1) 5111(1) 22(1) 
C(7) 4880(4) 6396(1) 5834(1) 21(1) 
C(8) 6449(4) 6429(2) 6449(1) 25(1) 
C(9) 5730(4) 6929(1) 7007(1) 23(1) 
C(10) 3177(4) 6899(1) 6046(1) 19(1) 
C(11) 1395(4) 7014(1) 5559(1) 21(1) 
C(12) 1383(4) 6607(1) 4846(1) 21(1) 
C(13) 72(4) 4667(1) 4120(1) 26(1) 
C(14) 2425(4) 7724(1) 7240(1) 21(1) 
C(15) 2396(4) 8398(2) 8527(1) 28(1) 
C(16) 4171(5) 8455(2) 9138(2) 50(1) 
C(17) 1850(6) 9208(2) 8196(2) 41(1) 
C(18) 471(5) 7964(2) 8848(2) 40(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [≈] and angles [∞] for  4.294. 
_____________________________________________________  
F(1)-C(3)  1.388(3) 
F(2)-C(13)  1.329(3) 
F(3)-C(13)  1.338(3) 
F(4)-C(13)  1.345(3) 
O(1)-C(4)  1.414(3) 
O(1)-H(1O)  0.85(2) 
O(2)-C(14)  1.323(3) 
O(2)-C(15)  1.490(3) 
O(3)-C(14)  1.211(3) 
N(1)-C(14)  1.389(3) 
N(1)-C(9)  1.405(3) 
N(1)-C(10)  1.408(3) 
C(1)-C(2)  1.311(4) 
C(1)-H(1A)  0.9500 
C(1)-H(1B)  0.9500 
C(2)-C(3)  1.500(3) 
C(2)-H(2)  0.9500 
C(3)-C(13)  1.526(3) 
C(3)-C(4)  1.550(3) 
C(4)-C(5)  1.514(3) 
C(4)-H(4)  1.0000 
C(5)-C(6)  1.381(3) 
C(5)-C(12)  1.409(3) 
C(6)-C(7)  1.398(3) 
C(6)-H(6)  0.9500 
C(7)-C(10)  1.402(3) 
C(7)-C(8)  1.429(3) 
C(8)-C(9)  1.342(3) 
C(8)-H(8)  0.9500 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.395(3) 
C(11)-C(12)  1.389(3) 
C(11)-H(11)  0.9500 
C(12)-H(12)  0.9500 
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C(15)-C(18)  1.504(4) 
C(15)-C(17)  1.511(4) 
C(15)-C(16)  1.517(4) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 























































































Symmetry transformations used to generate equivalent atoms:  
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 Table 4.   Anisotropic displacement parameters  (≈2x 103) for 4.234.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
F(1) 33(1)  24(1) 34(1)  1(1) -7(1)  8(1) 
F(2) 45(1)  37(1) 29(1)  -5(1) 17(1)  -10(1) 
F(3) 19(1)  51(1) 51(1)  11(1) 2(1)  1(1) 
F(4) 41(1)  30(1) 42(1)  -5(1) 12(1)  -13(1) 
O(1) 27(1)  25(1) 22(1)  3(1) -3(1)  -1(1) 
O(2) 26(1)  31(1) 21(1)  -7(1) -2(1)  1(1) 
O(3) 25(1)  31(1) 24(1)  -5(1) -3(1)  7(1) 
N(1) 19(1)  21(1) 19(1)  0(1) 0(1)  -1(1) 
C(1) 35(1)  41(2) 50(2)  -23(1) 17(1)  -14(1) 
C(2) 29(1)  29(1) 26(1)  -6(1) 4(1)  -9(1) 
C(3) 22(1)  22(1) 22(1)  0(1) 0(1)  3(1) 
C(4) 17(1)  23(1) 21(1)  1(1) 1(1)  0(1) 
C(5) 19(1)  17(1) 21(1)  2(1) 3(1)  -2(1) 
C(6) 18(1)  21(1) 25(1)  -1(1) 4(1)  3(1) 
C(7) 19(1)  21(1) 23(1)  1(1) 2(1)  -1(1) 
C(8) 18(1)  29(1) 28(1)  -1(1) -2(1)  2(1) 
C(9) 20(1)  27(1) 23(1)  0(1) -5(1)  -3(1) 
C(10) 20(1)  18(1) 19(1)  2(1) 2(1)  -3(1) 
C(11) 21(1)  18(1) 23(1)  0(1) 1(1)  0(1) 
C(12) 19(1)  21(1) 22(1)  1(1) -2(1)  0(1) 
C(13) 29(1)  24(1) 26(1)  0(1) 5(1)  -3(1) 
C(14) 25(1)  20(1) 19(1)  0(1) 1(1)  -3(1) 
C(15) 32(1)  32(1) 18(1)  -7(1) -1(1)  4(1) 
C(16) 46(2)  69(2) 34(2)  -25(1) -12(1)  11(2) 
C(17) 66(2)  26(1) 32(1)  -7(1) 3(1)  3(1) 
C(18) 48(2)  42(2) 30(1)  -6(1) 12(1)  -4(1) 
______________________________________________________________________________ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for 4.234. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
H(1O) 2580(50) 6505(15) 3067(17) 29 
H(1A) 5320 3938 3142 50 
H(1B) 4297 3855 2250 50 
H(2) 1470 4600 2612 34 
H(4) 4611 5701 3631 24 
H(6) 5980 5659 4960 26 
H(8) 7772 6147 6461 30 
H(9) 6467 7057 7481 28 
H(11) 244 7354 5708 25 
H(12) 193 6672 4500 25 
H(16A) 3670 8772 9587 74 
H(16B) 4554 7920 9320 74 
H(16C) 5437 8709 8903 74 
H(17A) 1169 9531 8607 62 
H(17B) 3170 9470 8016 62 
H(17C) 858 9147 7751 62 
H(18A) -214 8287 9259 60 
H(18B) -560 7866 8422 60 
H(18C) 931 7455 9075 60 
________________________________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms:  
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 Table 7.  Hydrogen bonds for 4.234  [≈ and ∞]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(1)-H(1O)...O(3)#1 0.85(2) 2.13(3) 2.887(2) 147(3) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x+1/2,-y+3/2,-z+1      
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Table 1.  Crystal data and structure refinement for 4.250. 
Identification code  C13H18F4O3 
Empirical formula  C13 H18 F4 O3 
Formula weight  298.27 
Temperature  123(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 6.5631(4) ≈ a= 90∞. 
 b = 9.3970(5) ≈ b= 91.289(2)∞. 
 c = 11.1818(6) ≈ g = 90∞. 
Volume 689.45(7) ≈3 
Z 2 
Density (calculated) 1.437 Mg/m3 
Absorption coefficient 1.185 mm-1 
F(000) 312 
Crystal size 0.450 x 0.320 x 0.100 mm3 
Theta range for data collection 3.954 to 67.045∞. 
Index ranges -7<=h<=7, -11<=k<=11, -13<=l<=13 
Reflections collected 9575 
Independent reflections 2425 [R(int) = 0.0262] 
Completeness to theta = 67.045∞ 99.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7529 and 0.6036 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2425 / 2 / 184 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0229, wR2 = 0.0609 
R indices (all data) R1 = 0.0230, wR2 = 0.0610 
Absolute structure parameter 0.02(4) 
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Extinction coefficient n/a 
Largest diff. peak and hole 0.180 and -0.125 e.≈-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 103) 
for 4.250.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
F(1) 5314(2) 6521(1) 1505(1) 31(1) 
F(2) 5400(2) 4596(2) -387(1) 43(1) 
F(3) 3128(2) 4198(2) 894(1) 48(1) 
F(4) 5806(2) 2886(1) 882(1) 43(1) 
O(1) 4130(2) 4485(2) 3218(1) 28(1) 
O(2) 6120(2) 7125(1) 5381(1) 25(1) 
O(3) 7585(2) 5052(1) 4878(1) 21(1) 
C(1) 9258(3) 6487(3) 771(2) 40(1) 
C(2) 8460(3) 5335(2) 1229(2) 29(1) 
C(3) 6283(3) 5213(2) 1616(2) 23(1) 
C(4) 6170(3) 4702(2) 2918(2) 21(1) 
C(5) 7231(3) 5764(2) 3764(1) 21(1) 
C(6) 5951(3) 7057(2) 4101(2) 27(1) 
C(7) 7668(2) 6134(2) 5762(1) 20(1) 
C(8) 9735(3) 6874(2) 5818(2) 26(1) 
C(9) 11394(3) 5853(2) 6265(2) 29(1) 
C(10) 10863(3) 5229(2) 7478(2) 33(1) 
C(11) 8803(3) 4488(2) 7422(2) 29(1) 
C(12) 7130(3) 5492(2) 6960(2) 25(1) 
C(13) 5123(3) 4213(2) 749(2) 31(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [≈] and angles [∞] for 4.250. 
_____________________________________________________  
F(1)-C(3)  1.389(2) 
F(2)-C(13)  1.337(2) 
F(3)-C(13)  1.323(2) 
F(4)-C(13)  1.332(3) 
O(1)-C(4)  1.402(2) 
O(1)-H(1O)  0.85(2) 
O(2)-C(6)  1.435(2) 
O(2)-C(7)  1.436(2) 
O(3)-C(7)  1.4188(19) 
O(3)-C(5)  1.4290(19) 
C(1)-C(2)  1.312(3) 
C(1)-H(1A)  0.9500 
C(1)-H(1B)  0.9500 
C(2)-C(3)  1.506(2) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.537(2) 
C(3)-C(13)  1.540(2) 
C(4)-C(5)  1.532(2) 
C(4)-H(4)  1.0000 
C(5)-C(6)  1.529(3) 
C(5)-H(5)  1.0000 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(12)  1.518(2) 
C(7)-C(8)  1.524(2) 
C(8)-C(9)  1.526(3) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.526(3) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-C(11)  1.521(3) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
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C(11)-C(12)  1.529(2) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-H(12A)  0.9900 


















































































Symmetry transformations used to generate equivalent atoms:  
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 Table 4.   Anisotropic displacement parameters  (≈2x 103) for 4.250.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
F(1) 40(1)  27(1) 26(1)  7(1) 1(1)  11(1) 
F(2) 50(1)  59(1) 19(1)  0(1) -3(1)  -4(1) 
F(3) 28(1)  82(1) 34(1)  -12(1) -4(1)  -10(1) 
F(4) 60(1)  32(1) 37(1)  -10(1) -9(1)  -3(1) 
O(1) 26(1)  32(1) 26(1)  9(1) 0(1)  -6(1) 
O(2) 24(1)  24(1) 26(1)  -3(1) -1(1)  6(1) 
O(3) 25(1)  18(1) 19(1)  0(1) -1(1)  2(1) 
C(1) 40(1)  48(1) 32(1)  4(1) 6(1)  -8(1) 
C(2) 29(1)  35(1) 24(1)  -2(1) 4(1)  0(1) 
C(3) 26(1)  22(1) 21(1)  2(1) 0(1)  2(1) 
C(4) 23(1)  20(1) 21(1)  2(1) -1(1)  1(1) 
C(5) 24(1)  20(1) 20(1)  3(1) 0(1)  -1(1) 
C(6) 36(1)  21(1) 24(1)  3(1) -3(1)  4(1) 
C(7) 20(1)  18(1) 22(1)  -2(1) 0(1)  2(1) 
C(8) 22(1)  25(1) 31(1)  -2(1) 0(1)  -3(1) 
C(9) 19(1)  34(1) 35(1)  -3(1) -1(1)  0(1) 
C(10) 27(1)  42(1) 28(1)  -4(1) -6(1)  7(1) 
C(11) 30(1)  35(1) 21(1)  4(1) 2(1)  5(1) 
C(12) 22(1)  32(1) 22(1)  -3(1) 3(1)  1(1) 
C(13) 30(1)  39(1) 23(1)  -2(1) -1(1)  0(1) 
	
 Page 782 
 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for 4.250. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1O) 4140(40) 3830(30) 3740(20) 42 
H(1A) 8448 7318 665 47 
H(1B) 10644 6491 546 47 
H(2) 9312 4523 1323 35 
H(4) 6900 3770 2987 26 
H(5) 8553 6079 3423 25 
H(6A) 6490 7935 3734 33 
H(6B) 4513 6930 3836 33 
H(8A) 9671 7703 6361 31 
H(8B) 10076 7225 5012 31 
H(9A) 11552 5073 5679 35 
H(9B) 12708 6367 6335 35 
H(10A) 11928 4538 7731 39 
H(10B) 10834 6000 8081 39 
H(11A) 8459 4146 8230 35 
H(11B) 8879 3651 6887 35 
H(12A) 5832 4962 6874 30 
H(12B) 6933 6265 7548 30 
________________________________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms:  
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 Table 7.  Hydrogen bonds for 4.250  [≈ and ∞]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(1)-H(1O)...O(2)#1 0.85(2) 1.89(2) 2.7222(18) 167(3) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y-1/2,-z+1       
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Table 1.  Crystal data and structure refinement for 4.254. 
Identification code  C27H23F4NO7 
Empirical formula  C27 H23 F4 N O7 
Formula weight  549.46 
Temperature  173(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 5.6045(2) ≈ a= 90∞. 
 b = 14.0158(5) ≈ b= 90∞. 
 c = 31.3309(11) ≈ g = 90∞. 
Volume 2461.09(15) ≈3 
Z 4 
Density (calculated) 1.483 Mg/m3 
Absorption coefficient 1.095 mm-1 
F(000) 1136 
Crystal size 0.380 x 0.180 x 0.120 mm3 
Theta range for data collection 2.821 to 66.352∞. 
Index ranges -6<=h<=6, -16<=k<=15, -36<=l<=37 
Reflections collected 30730 
Independent reflections 4292 [R(int) = 0.0315] 
Completeness to theta = 66.352∞ 99.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.6578 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4292 / 0 / 352 
Goodness-of-fit on F2 1.034 
Final R indices [I>2sigma(I)] R1 = 0.0271, wR2 = 0.0697 
R indices (all data) R1 = 0.0287, wR2 = 0.0709 
Absolute structure parameter -0.02(3) 
Extinction coefficient n/a 
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Largest diff. peak and hole 0.145 and -0.241 e.≈-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 103) 
for 4.254.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
F(1) 13207(2) 5192(1) 4641(1) 36(1) 
F(2) 12126(3) 3467(1) 4459(1) 56(1) 
F(3) 12231(3) 3514(1) 5141(1) 63(1) 
F(4) 8862(3) 3454(1) 4818(1) 53(1) 
N(1) 1068(4) 3193(2) 6716(1) 58(1) 
O(1) 643(4) 3436(2) 7084(1) 86(1) 
O(2) -132(4) 2630(2) 6511(1) 69(1) 
O(3) 10417(3) 5425(1) 6073(1) 41(1) 
O(4) 8845(2) 4905(1) 5453(1) 28(1) 
O(5) 10549(2) 6340(1) 5229(1) 28(1) 
O(6) 10947(3) 6804(1) 4345(1) 34(1) 
O(7) 9397(2) 4924(1) 4084(1) 28(1) 
C(1) 3156(4) 3629(2) 6505(1) 44(1) 
C(2) 3760(4) 3317(2) 6104(1) 41(1) 
C(3) 5633(4) 3765(1) 5896(1) 35(1) 
C(4) 6857(4) 4503(1) 6094(1) 32(1) 
C(5) 6239(5) 4787(2) 6506(1) 44(1) 
C(6) 4356(5) 4353(2) 6714(1) 50(1) 
C(7) 8889(4) 4993(1) 5887(1) 30(1) 
C(8) 10810(3) 5359(1) 5240(1) 26(1) 
C(9) 8542(4) 6667(1) 4980(1) 30(1) 
C(10) 8854(3) 6385(1) 4515(1) 28(1) 
C(11) 9011(3) 5295(1) 4496(1) 24(1) 
C(12) 10968(3) 4924(1) 4788(1) 27(1) 
C(13) 10499(5) 7607(1) 4071(1) 46(1) 
C(14) 9783(4) 7306(1) 3630(1) 33(1) 
C(15) 7679(5) 7624(2) 3440(1) 46(1) 
C(16) 7067(4) 7321(2) 3030(1) 47(1) 
C(17) 8524(4) 6718(2) 2812(1) 40(1) 
C(18) 10613(4) 6409(2) 2994(1) 40(1) 
C(19) 11232(4) 6695(2) 3400(1) 36(1) 
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C(20) 7253(4) 4842(2) 3843(1) 37(1) 
C(21) 7771(3) 4442(1) 3410(1) 28(1) 
C(22) 6122(4) 4590(1) 3088(1) 34(1) 
C(23) 6510(4) 4237(2) 2680(1) 38(1) 
C(24) 8565(4) 3728(2) 2594(1) 39(1) 
C(25) 10213(4) 3565(2) 2914(1) 36(1) 
C(26) 9823(3) 3925(1) 3322(1) 31(1) 
C(27) 11039(4) 3827(1) 4799(1) 40(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [≈] and angles [∞] for  4.254. 
_____________________________________________________  
F(1)-C(12)  1.389(2) 
F(2)-C(27)  1.328(3) 
F(3)-C(27)  1.337(3) 
F(4)-C(27)  1.328(3) 
N(1)-O(2)  1.219(3) 
N(1)-O(1)  1.224(3) 
N(1)-C(1)  1.477(3) 
O(3)-C(7)  1.199(3) 
O(4)-C(7)  1.365(2) 
O(4)-C(8)  1.437(2) 
O(5)-C(8)  1.383(2) 
O(5)-C(9)  1.444(2) 
O(6)-C(10)  1.416(2) 
O(6)-C(13)  1.438(2) 
O(7)-C(11)  1.408(2) 
O(7)-C(20)  1.423(2) 
C(1)-C(2)  1.375(3) 
C(1)-C(6)  1.382(4) 
C(2)-C(3)  1.385(3) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.388(3) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.395(3) 
C(4)-C(7)  1.479(3) 
C(5)-C(6)  1.380(4) 
C(5)-H(5)  0.9500 
C(6)-H(6)  0.9500 
C(8)-C(12)  1.543(2) 
C(8)-H(8)  1.0000 
C(9)-C(10)  1.518(2) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-C(11)  1.531(2) 
C(10)-H(10)  1.0000 
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C(11)-C(12)  1.521(3) 
C(11)-H(11)  1.0000 
C(12)-C(27)  1.538(3) 
C(13)-C(14)  1.500(3) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-C(19)  1.384(3) 
C(14)-C(15)  1.394(3) 
C(15)-C(16)  1.397(4) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.359(3) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.373(3) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.377(3) 
C(18)-H(18)  0.9500 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.499(3) 
C(20)-H(20A)  0.9900 
C(20)-H(20B)  0.9900 
C(21)-C(22)  1.382(3) 
C(21)-C(26)  1.387(3) 
C(22)-C(23)  1.388(3) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.381(3) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.381(3) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.393(3) 
C(25)-H(25)  0.9500 
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_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table 4.   Anisotropic displacement parameters  (≈2x 103) for 4.254.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
F(1) 21(1)  50(1) 37(1)  -7(1) 3(1)  1(1) 
F(2) 74(1)  42(1) 52(1)  -17(1) -1(1)  23(1) 
F(3) 99(1)  37(1) 53(1)  -2(1) -28(1)  26(1) 
F(4) 74(1)  29(1) 55(1)  -1(1) -3(1)  -15(1) 
N(1) 41(1)  80(2) 54(1)  35(1) 16(1)  18(1) 
O(1) 64(1)  145(2) 51(1)  30(1) 29(1)  15(2) 
O(2) 46(1)  80(1) 83(1)  35(1) 14(1)  4(1) 
O(3) 50(1)  42(1) 30(1)  -5(1) -8(1)  -2(1) 
O(4) 35(1)  28(1) 22(1)  2(1) 0(1)  -5(1) 
O(5) 35(1)  24(1) 26(1)  -2(1) -2(1)  -4(1) 
O(6) 45(1)  34(1) 25(1)  3(1) 2(1)  -11(1) 
O(7) 23(1)  35(1) 25(1)  -8(1) 1(1)  -2(1) 
C(1) 41(1)  53(1) 38(1)  23(1) 10(1)  15(1) 
C(2) 42(1)  40(1) 40(1)  10(1) 6(1)  2(1) 
C(3) 43(1)  34(1) 27(1)  4(1) 5(1)  3(1) 
C(4) 42(1)  31(1) 24(1)  6(1) -1(1)  7(1) 
C(5) 56(1)  50(1) 25(1)  -1(1) 0(1)  8(1) 
C(6) 57(1)  66(2) 27(1)  9(1) 10(1)  20(1) 
C(7) 42(1)  25(1) 22(1)  0(1) -4(1)  6(1) 
C(8) 27(1)  24(1) 27(1)  0(1) -2(1)  -2(1) 
C(9) 36(1)  24(1) 29(1)  -1(1) 2(1)  4(1) 
C(10) 31(1)  29(1) 24(1)  1(1) 1(1)  0(1) 
C(11) 22(1)  27(1) 22(1)  -3(1) 2(1)  -2(1) 
C(12) 23(1)  28(1) 29(1)  -2(1) 2(1)  0(1) 
C(13) 81(2)  28(1) 28(1)  2(1) 6(1)  -9(1) 
C(14) 43(1)  26(1) 29(1)  6(1) 6(1)  -3(1) 
C(15) 47(1)  40(1) 51(1)  10(1) 17(1)  10(1) 
C(16) 36(1)  57(1) 48(1)  20(1) -6(1)  -2(1) 
C(17) 49(1)  40(1) 33(1)  7(1) -6(1)  -9(1) 
C(18) 53(1)  40(1) 28(1)  1(1) 0(1)  6(1) 
C(19) 37(1)  41(1) 30(1)  3(1) -2(1)  5(1) 
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C(20) 24(1)  55(1) 33(1)  -14(1) -4(1)  2(1) 
C(21) 27(1)  28(1) 29(1)  -4(1) 0(1)  -4(1) 
C(22) 30(1)  33(1) 37(1)  -5(1) -4(1)  4(1) 
C(23) 41(1)  43(1) 31(1)  -3(1) -12(1)  2(1) 
C(24) 45(1)  44(1) 28(1)  -9(1) -1(1)  1(1) 
C(25) 33(1)  42(1) 34(1)  -8(1) 1(1)  5(1) 
C(26) 28(1)  36(1) 29(1)  -4(1) -3(1)  1(1) 
C(27) 54(1)  29(1) 37(1)  -7(1) -7(1)  7(1) 
______________________________________________________________________________ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for 4.254. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
 H(2) 2915 2809 5972 49 
H(3) 6081 3566 5618 42 
H(5) 7113 5279 6644 52 
H(6) 3898 4547 6993 60 
H(8) 12312 5203 5397 31 
H(9A) 8408 7369 5002 36 
H(9B) 7053 6383 5093 36 
H(10) 7438 6604 4348 34 
H(11) 7459 5034 4602 29 
H(13A) 11957 8004 4054 55 
H(13B) 9214 8003 4196 55 
H(15) 6657 8049 3590 55 
H(16) 5627 7538 2902 56 
H(17) 8097 6511 2534 48 
H(18) 11639 5995 2840 48 
H(19) 12674 6469 3523 43 
H(20A) 6501 5478 3814 45 
H(20B) 6121 4419 3995 45 
H(22) 4706 4938 3147 40 
H(23) 5368 4344 2461 46 
H(24) 8845 3490 2315 47 
H(25) 11613 3206 2855 43 
H(26) 10964 3816 3541 37 
________________________________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms:  
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Table 1.  Crystal data and structure refinement for 4.240. 
Identification code  C13H10F8O 
Empirical formula  C13 H10 F8 O 
Formula weight  334.21 
Temperature  100(2) K 
Wavelength  1.54178 ≈ 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 12.2086(5) ≈ a= 90∞. 
 b = 5.3122(3) ≈ b= 95.195(3)∞. 
 c = 20.6191(10) ≈ g = 90∞. 
Volume 1331.75(11) ≈3 
Z 4 
Density (calculated) 1.667 Mg/m3 
Absorption coefficient 1.641 mm-1 
F(000) 672 
Crystal size 0.550 x 0.080 x 0.060 mm3 
Theta range for data collection 3.635 to 66.834∞. 
Index ranges -14<=h<=14, -6<=k<=6, -24<=l<=24 
Reflections collected 16578 
Independent reflections 4694 [R(int) = 0.0636] 
Completeness to theta = 66.834∞ 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.5346 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4694 / 1 / 399 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0458, wR2 = 0.1100 
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R indices (all data) R1 = 0.0553, wR2 = 0.1159 
Absolute structure parameter -0.05(14) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.263 and -0.222 e.≈-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 103) 
for 4.240.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
F(1) 4926(2) 2488(8) 5358(1) 57(1) 
F(2) 6167(2) 194(6) 5865(1) 47(1) 
F(3) 6355(2) 4239(7) 5860(1) 50(1) 
F(4) 4381(2) 502(6) 6512(1) 38(1) 
F(5) 4349(2) 4605(6) 6399(1) 42(1) 
F(6) 6632(2) 1424(5) 7093(1) 35(1) 
F(7) 6099(2) 5333(5) 7155(1) 37(1) 
F(8) 5036(2) -194(5) 7800(1) 29(1) 
O(1) 3382(2) 3120(6) 7477(1) 25(1) 
C(1) 5643(4) 2353(11) 5883(2) 39(1) 
C(2) 5004(3) 2583(10) 6497(2) 31(1) 
C(3) 5738(3) 2939(8) 7144(2) 27(1) 
C(4) 5288(3) 2359(8) 7811(2) 23(1) 
C(5) 4260(3) 3857(8) 7947(2) 22(1) 
C(6) 3941(3) 3438(8) 8637(2) 23(1) 
C(7) 3302(3) 1363(9) 8781(2) 26(1) 
C(8) 2993(3) 1031(9) 9408(2) 29(1) 
C(9) 3331(3) 2744(9) 9894(2) 30(1) 
C(10) 3971(3) 4794(9) 9756(2) 31(1) 
C(11) 4270(3) 5125(9) 9127(2) 27(1) 
C(12) 6219(3) 2872(9) 8326(2) 28(1) 
C(13) 6807(3) 1106(11) 8634(2) 37(1) 
F(9) -1167(2) 5467(7) 9305(1) 50(1) 
F(10) 313(3) 7690(7) 9376(1) 56(1) 
F(11) 383(2) 3728(7) 9172(1) 53(1) 
F(12) -1195(2) 8162(6) 8262(1) 39(1) 
F(13) -807(2) 4266(5) 8036(1) 37(1) 
F(14) 813(2) 9701(5) 8200(1) 34(1) 
F(15) 1454(2) 5848(6) 8236(1) 34(1) 
F(16) 590(2) 4788(5) 7070(1) 28(1) 
O(2) 2473(2) 8032(6) 7301(1) 25(1) 
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C(14) -192(4) 5798(11) 9061(2) 38(1) 
C(15) -409(3) 6380(9) 8329(2) 29(1) 
C(16) 612(3) 7325(9) 7995(2) 25(1) 
C(17) 510(3) 7318(8) 7239(2) 24(1) 
C(18) 1453(3) 8806(8) 6963(2) 24(1) 
C(19) 1464(3) 8430(8) 6232(2) 23(1) 
C(20) 976(3) 10186(8) 5796(2) 27(1) 
C(21) 1024(3) 9882(9) 5130(2) 30(1) 
C(22) 1563(3) 7816(9) 4903(2) 30(1) 
C(23) 2048(3) 6055(9) 5331(2) 27(1) 
C(24) 1993(3) 6355(9) 5993(2) 27(1) 
C(25) -587(3) 8371(9) 6967(2) 28(1) 
C(26) -1330(3) 7084(11) 6612(2) 38(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [≈] and angles [∞] for 4.240. 
_____________________________________________________  
F(1)-C(1)  1.331(5) 
F(2)-C(1)  1.316(6) 
F(3)-C(1)  1.330(6) 
F(4)-C(2)  1.343(6) 
F(5)-C(2)  1.343(5) 
F(6)-C(3)  1.368(5) 
F(7)-C(3)  1.346(5) 
F(8)-C(4)  1.390(5) 
O(1)-C(5)  1.433(5) 
O(1)-H(1O)  0.8400 
C(1)-C(2)  1.550(6) 
C(2)-C(3)  1.550(6) 
C(3)-C(4)  1.559(6) 
C(4)-C(12)  1.508(5) 
C(4)-C(5)  1.533(5) 
C(5)-C(6)  1.524(5) 
C(5)-H(5)  1.0000 
C(6)-C(11)  1.383(6) 
C(6)-C(7)  1.398(6) 
C(7)-C(8)  1.391(6) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.387(6) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.384(7) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.390(6) 
C(10)-H(10)  0.9500 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.310(7) 
C(12)-H(12)  0.9500 
C(13)-H(13A)  0.9500 
C(13)-H(13B)  0.9500 
F(9)-C(14)  1.346(5) 
F(10)-C(14)  1.319(6) 
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F(11)-C(14)  1.313(6) 
F(12)-C(15)  1.347(5) 
F(13)-C(15)  1.345(5) 
F(14)-C(16)  1.346(5) 
F(15)-C(16)  1.352(5) 
F(16)-C(17)  1.394(5) 
O(2)-C(18)  1.431(4) 
O(2)-H(2O)  0.8400 
C(14)-C(15)  1.539(7) 
C(15)-C(16)  1.561(6) 
C(16)-C(17)  1.552(6) 
C(17)-C(25)  1.511(5) 
C(17)-C(18)  1.548(6) 
C(18)-C(19)  1.521(6) 
C(18)-H(18)  1.0000 
C(19)-C(24)  1.390(6) 
C(19)-C(20)  1.391(6) 
C(20)-C(21)  1.390(6) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.383(7) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.383(6) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.382(6) 
C(23)-H(23)  0.9500 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.307(7) 
C(25)-H(25)  0.9500 
C(26)-H(26A)  0.9500 























































































































Symmetry transformations used to generate equivalent atoms:  
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 Table 4.   Anisotropic displacement parameters  (≈2x 103) for 4.240.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
F(1) 41(1)  99(3) 32(1)  3(2) 2(1)  10(2) 
F(2) 39(1)  63(2) 40(2)  -10(1) 9(1)  13(2) 
F(3) 34(1)  69(2) 50(2)  9(2) 18(1)  -2(2) 
F(4) 28(1)  47(2) 38(1)  -9(1) 6(1)  -7(1) 
F(5) 25(1)  53(2) 48(2)  13(1) 8(1)  14(1) 
F(6) 18(1)  48(2) 40(1)  -4(1) 5(1)  11(1) 
F(7) 34(1)  29(2) 49(2)  1(1) 12(1)  -6(1) 
F(8) 24(1)  20(1) 42(1)  -2(1) 6(1)  1(1) 
O(1) 16(1)  31(2) 28(1)  -2(1) -3(1)  3(1) 
C(1) 28(2)  57(3) 32(2)  -1(2) 6(2)  7(3) 
C(2) 19(2)  35(3) 38(2)  5(2) 6(2)  5(2) 
C(3) 16(2)  24(3) 40(2)  -1(2) 5(2)  4(2) 
C(4) 17(2)  19(2) 32(2)  0(2) 2(2)  0(2) 
C(5) 16(2)  23(2) 27(2)  -1(2) 1(1)  1(2) 
C(6) 15(2)  23(2) 29(2)  -1(2) 0(2)  3(2) 
C(7) 19(2)  27(2) 31(2)  -1(2) 1(2)  -1(2) 
C(8) 20(2)  30(2) 37(2)  2(2) 4(2)  -2(2) 
C(9) 25(2)  33(3) 32(2)  1(2) 4(2)  1(2) 
C(10) 29(2)  32(3) 32(2)  -7(2) 2(2)  1(2) 
C(11) 19(2)  26(2) 36(2)  -2(2) 3(2)  -1(2) 
C(12) 17(2)  34(3) 34(2)  -3(2) 1(2)  2(2) 
C(13) 24(2)  50(3) 37(2)  5(2) -2(2)  7(2) 
F(9) 37(1)  73(2) 44(2)  2(2) 21(1)  -1(2) 
F(10) 57(2)  75(3) 36(2)  -14(2) 9(1)  -14(2) 
F(11) 51(2)  68(2) 42(2)  17(2) 15(1)  18(2) 
F(12) 23(1)  48(2) 47(2)  -3(1) 10(1)  12(1) 
F(13) 32(1)  40(2) 40(1)  -5(1) 10(1)  -9(1) 
F(14) 31(1)  35(2) 36(1)  -11(1) 5(1)  -3(1) 
F(15) 21(1)  48(2) 34(1)  8(1) 4(1)  9(1) 
F(16) 25(1)  22(1) 37(1)  -4(1) 8(1)  2(1) 
O(2) 14(1)  29(2) 32(2)  -2(1) -3(1)  0(1) 
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C(14) 30(2)  47(3) 39(3)  -5(2) 14(2)  0(2) 
C(15) 21(2)  30(3) 38(2)  -4(2) 7(2)  4(2) 
C(16) 15(2)  26(2) 34(2)  -4(2) 1(2)  4(2) 
C(17) 16(2)  20(2) 34(2)  -3(2) 0(2)  1(2) 
C(18) 15(2)  24(2) 32(2)  -1(2) -3(2)  1(2) 
C(19) 14(2)  25(2) 29(2)  0(2) -1(2)  -2(2) 
C(20) 19(2)  26(2) 34(2)  0(2) 1(2)  0(2) 
C(21) 24(2)  31(2) 35(2)  8(2) 0(2)  -2(2) 
C(22) 22(2)  38(3) 30(2)  2(2) 4(2)  -4(2) 
C(23) 21(2)  28(2) 35(2)  0(2) 9(2)  1(2) 
C(24) 16(2)  30(3) 34(2)  3(2) 1(2)  4(2) 
C(25) 18(2)  30(2) 37(2)  1(2) 3(2)  6(2) 
C(26) 23(2)  52(3) 39(2)  -5(2) -4(2)  -1(2) 
______________________________________________________________________________ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for 4.240. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1O) 2964 4355 7390 38 
H(5) 4411 5689 7888 27 
H(7) 3079 177 8451 31 
H(8) 2550 -367 9505 35 
H(9) 3123 2510 10322 36 
H(10) 4204 5964 10088 37 
H(11) 4707 6535 9032 32 
H(12) 6390 4576 8433 34 
H(13A) 6656 -614 8538 45 
H(13B) 7385 1547 8954 45 
H(2O) 2909 9259 7335 38 
H(18) 1345 10638 7049 29 
H(20) 607 11602 5955 32 
H(21) 690 11083 4833 36 
H(22) 1599 7605 4448 36 
H(23) 2418 4644 5171 33 
H(24) 2319 5134 6287 32 
H(25) -746 10077 7060 34 
H(26A) -1197 5374 6510 46 
H(26B) -2004 7859 6456 46 
________________________________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms:  
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 Table 7.  Hydrogen bonds for 4.240  [≈ and ∞]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(1)-H(1O)...O(2) 0.84 2.05 2.846(4) 158.7 
 O(2)-H(2O)...O(1)#1 0.84 2.14 2.932(4) 156.1 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x,y+1,z       
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4.6.13  Coordinates for Calculated 1,3-Boryl Shift Transition States 
DFT calculations were performed with the Gaussian 09 suite of programs[15 ] employing the 
dispersion corrected ωB97XD[16] functional. The DEF2SVP[17] basis set and SMD[18] solvation 
model (toluene) was used for geometry optimization and frequency calculation. The nature of all 
stationary points was checked through vibrational analysis.  Single point electronic energy (DEsp) 
calculations applying the ωB97XD functional and the DEF2TZVPP basis set in solution with thew 
SMD solvation model were performed on the geometries obtained with the DEF2SVP basis set. 
The single point electronic energies (DEsp) at the DEF2TZVPP level were corrected by addition of 
thermal corrections to the Gibbs free energy (DGcorr) obtained at the corresponding DEF2SVP 
level.  
 
Structure E [Hartree] DE 
[kcal/mol] 





4.312 -1578.775582 0.00 -1578.867852 0.00 0.00 -360.4541 
4.314 -1578.76964 3.73 -1578.8604520 4.64 1.72 -232.4271 
4.316 -1578.772677 1.82 -1578.8622340 3.52 2.44 -337.1785 
4.317 -1578.850695 9.09 -1578.8506950 10.77 2.08 -323.1222 
	
Structure Esp [Hartree] DEsp [kcal/mol] DGsp [kcal/mol] 
4.312 -1581.1122897 0.00 0.00 
4.314 -1581.107638 2.92 4.64 
																																																								
15 M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, 
B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, 
J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. 
Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. 
N. Kudin, V. N. Staroverov, R. Kobayshi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyenger, J. 
Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. 
Gomperts. R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. 
Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas, J. 
B. Foresman, J. V. Ortiz, J. Cioslowski, D. J. Fox, Gaussian 09, Revision D.01, Gaussian, Inc., Wallingford CT, 2009. 
16 J.-D. Chai, M. Head-Gordon, Phys. Chem. Chem. Phys. 2008, 10, 6615. 
17 F. Weigend, R. Ahlrichs, Phys. Chem. Chem. Phys. 2005, 7, 3297–3305. 
18 A. V. Marenich, C. J. Cramer, D. G. Truhlar, J. Phys. Chem. B 2009, 113, 6378–6396. 
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4.316 -1581.110556 1.09 3.52 






#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -0.967    -1.926    -2.525 
C    -2.140    -2.656    -2.424 
C    -2.987    -2.459    -1.335 
C    -2.717    -1.528    -0.325 
C    -1.543    -0.763    -0.488 
C    -0.663    -0.972    -1.553 
H    -3.888    -3.067    -1.272 
H    -2.394    -3.398    -3.183 
H    -0.275    -2.090    -3.354 
O    -1.212     0.155     0.473 
C     0.596    -0.170    -1.699 
C     2.286    -0.341     0.348 
B    -0.050     0.920     0.438 
C    -0.388     2.620    -0.140 
F     0.291     3.074    -1.216 
C    -1.865     2.967    -0.249 
C     0.367     2.565     1.049 
C     3.564    -0.059    -0.468 
O     3.500    -0.136    -1.689 
N     4.719     0.241     0.166 
C     4.898     0.612     1.557 
H     5.477    -0.150     2.101 
H     3.945     0.752     2.075 
H     5.448     1.564     1.609 
C     5.922     0.323    -0.651 
H     6.791     0.067    -0.030 
H     6.062     1.336    -1.061 
H     5.856    -0.381    -1.488 
N     1.158     0.377    -0.400 
H     1.393    -0.726    -2.199 
H     0.400     0.726    -2.308 
H     1.638     1.214    -0.742 
C     2.116    -1.851     0.713 
C     3.305    -2.220     1.621 
H     3.183    -3.258     1.960 
H     3.349    -1.587     2.521 
H     4.269    -2.158     1.097 
C     0.832    -2.061     1.526 
H     0.837    -3.069     1.965 
H    -0.070    -1.993     0.909 
H     0.748    -1.342     2.356 
C     2.130    -2.791    -0.498 
H     2.316     0.192     1.305 
C    -3.632    -1.393     0.906 
C    -4.817    -2.367     0.838 
H    -5.467    -2.168    -0.028 
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H    -5.433    -2.246     1.742 
H    -4.496    -3.419     0.800 
C    -4.210     0.029     0.994 
H    -4.747     0.296     0.071 
H    -3.431     0.778     1.163 
H    -4.926     0.093     1.828 
C    -2.832    -1.720     2.182 
H    -1.999    -1.022     2.333 
H    -2.423    -2.742     2.141 
H    -3.489    -1.658     3.064 
C     0.099     1.625     2.056 
H     1.422     2.839     0.902 
H    -0.919     1.439     2.409 
H     0.901     1.418     2.765 
H     1.221    -2.707    -1.106 
H     2.173    -3.830    -0.140 
H     3.003    -2.623    -1.144 
F    -2.490     2.201    -1.132 
F    -1.987     4.228    -0.641 
F    -2.457     2.836     0.934 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -360.4541                31.6110                39.6940 
 Red. masses --      8.4704                 4.7868                 4.1167 
 Zero-point correction=                           0.558887 (Hartree/Particle) 
 Thermal correction to Energy=                    0.590899 
 Thermal correction to Enthalpy=                  0.591843 
 Thermal correction to Gibbs Free Energy=         0.498529 
 Sum of electronic and zero-point Energies=          -1578.807594 
 Sum of electronic and thermal Energies=             -1578.775582 
 Sum of electronic and thermal Enthalpies=           -1578.774638 
 Sum of electronic and thermal Free Energies=        -1578.867952 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1579.36648127', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 312.83193279 kcal/mol 
H_corr: 371.38740093 kcal/mol 
S_corr: 58.5554674 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.19283935 kcal/mol 
S_rot: 10.8103227 kcal/mol 





#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -0.743    -1.426    -2.665 
C    -1.884    -2.200    -2.804 
C    -2.813    -2.262    -1.765 
C    -2.655    -1.551    -0.571 
C    -1.501    -0.744    -0.478 
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C    -0.540    -0.694    -1.494 
H    -3.691    -2.891    -1.902 
H    -2.055    -2.769    -3.719 
H     0.003    -1.389    -3.463 
O    -1.300    -0.013     0.658 
C     0.701     0.151    -1.368 
C     2.209    -0.339     0.651 
B    -0.237     0.869     0.772 
C    -0.495     2.569     0.469 
F     0.691     3.173     0.194 
C    -1.587     3.129    -0.416 
C    -0.755     2.197     1.830 
C     3.460     0.316    -0.073 
O     3.284     1.523    -0.275 
N     4.661    -0.223    -0.343 
C     5.072    -1.606    -0.537 
H     4.285    -2.321    -0.320 
H     5.937    -1.832     0.105 
H     5.375    -1.742    -1.586 
C     5.684     0.729    -0.779 
H     5.567     0.970    -1.847 
H     6.670     0.276    -0.622 
H     5.613     1.660    -0.206 
N     1.084     0.488     0.048 
H     1.556    -0.344    -1.844 
H     0.564     1.114    -1.882 
H     1.655     1.370    -0.068 
C     2.008    -1.853     0.898 
C     3.139    -2.264     1.877 
H     3.265    -3.356     1.880 
H     2.868    -1.964     2.901 
H     4.117    -1.812     1.678 
C     0.708    -2.111     1.679 
H     0.728    -3.141     2.066 
H    -0.186    -2.023     1.058 
H     0.606    -1.440     2.546 
C     1.939    -2.703    -0.387 
H     2.329     0.086     1.660 
C    -3.685    -1.640     0.570 
C    -4.818    -2.616     0.226 
H    -5.381    -2.303    -0.666 
H    -5.531    -2.654     1.063 
H    -4.449    -3.640     0.062 
C    -4.318    -0.258     0.816 
H    -4.804     0.120    -0.096 
H    -3.576     0.483     1.135 
H    -5.086    -0.331     1.602 
C    -3.011    -2.152     1.858 
H    -2.245    -1.459     2.228 
H    -2.540    -3.134     1.696 
H    -3.766    -2.271     2.651 
H    -1.808     2.036     2.085 
C     0.209     1.481     2.514 
H     0.922    -2.698    -0.799 
H     2.189    -3.751    -0.167 
H     2.605    -2.361    -1.190 
F    -1.285     2.938    -1.698 
F    -1.744     4.435    -0.225 
F    -2.746     2.527    -0.162 
H    -0.083     0.920     3.404 
H     1.268     1.728     2.400 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -232.4271                26.7379                39.1465 
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 Red. masses --      7.5204                 3.4077                 5.1081 
 Zero-point correction=                           0.560184 (Hartree/Particle) 
 Thermal correction to Energy=                    0.591594 
 Thermal correction to Enthalpy=                  0.592539 
 Thermal correction to Gibbs Free Energy=         0.500783 
 Sum of electronic and zero-point Energies=          -1578.801050 
 Sum of electronic and thermal Energies=             -1578.769640 
 Sum of electronic and thermal Enthalpies=           -1578.768696 
 Sum of electronic and thermal Free Energies=        -1578.860452 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1579.36123465', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 314.24634033 kcal/mol 
H_corr: 371.82414789 kcal/mol 
S_corr: 57.5775354 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.19283935 kcal/mol 
S_rot: 10.8103227 kcal/mol 





#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C     2.466     3.204    -0.062 
C     3.789     3.095     0.336 
C     4.351     1.835     0.546 
C     3.633     0.649     0.366 
C     2.292     0.796    -0.046 
C     1.707     2.048    -0.259 
H     5.391     1.785     0.867 
H     4.389     3.992     0.497 
H     2.010     4.186    -0.214 
O     1.522    -0.320    -0.212 
C     0.265     2.180    -0.689 
H    -0.399     0.882     0.778 
B     0.289    -0.220    -0.849 
C    -0.133    -2.031    -1.027 
C    -0.387    -1.217    -2.145 
F     1.032    -2.666    -0.886 
C    -1.233    -2.826    -0.349 
N    -0.534     0.984    -0.264 
H    -0.152     3.072    -0.222 
H     0.173     2.292    -1.776 
C    -2.049     0.996    -0.278 
C     4.268    -0.735     0.588 
C     5.726    -0.614     1.053 
H     6.358    -0.100     0.314 
H     6.146    -1.621     1.197 
H     5.813    -0.084     2.014 
C     4.262    -1.519    -0.738 
H     4.816    -0.975    -1.519 
H     3.244    -1.711    -1.097 
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H     4.753    -2.496    -0.599 
C     3.494    -1.511     1.671 
H     2.456    -1.713     1.378 
H     3.484    -0.955     2.621 
H     3.985    -2.480     1.855 
F    -2.431    -2.428    -0.787 
F    -1.102    -4.114    -0.621 
F    -1.202    -2.674     0.970 
C     0.540    -0.281    -2.620 
H     0.162     0.482    -3.301 
H     1.604    -0.522    -2.693 
H    -1.449    -1.007    -2.306 
C    -2.750     2.408    -0.288 
C    -2.444     3.172    -1.594 
C    -2.416     3.241     0.962 
C    -4.277     2.207    -0.280 
H    -1.488     3.705    -1.598 
H    -3.219     3.937    -1.751 
H    -2.474     2.504    -2.469 
H    -1.344     3.383     1.153 
H    -2.841     2.786     1.868 
H    -2.862     4.241     0.855 
H    -4.631     1.660    -1.166 
H    -4.755     3.197    -0.300 
H    -4.633     1.702     0.626 
C    -2.358     0.224     1.043 
O    -1.505     0.335     1.927 
H    -2.393     0.451    -1.165 
N    -3.481    -0.487     1.215 
C    -4.480    -0.821     0.216 
C    -3.716    -1.102     2.515 
H    -3.036    -0.676     3.258 
H    -3.546    -2.188     2.456 
H    -4.758    -0.921     2.818 
H    -4.634    -1.908     0.216 
H    -4.176    -0.520    -0.789 
H    -5.440    -0.337     0.450 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -337.1785                27.7250                33.5212 
 Red. masses --      8.5050                 4.7437                 3.8180 
 Zero-point correction=                           0.561758 (Hartree/Particle) 
 Thermal correction to Energy=                    0.592620 
 Thermal correction to Enthalpy=                  0.593564 
 Thermal correction to Gibbs Free Energy=         0.503063 
 Sum of electronic and zero-point Energies=          -1578.803539 
 Sum of electronic and thermal Energies=             -1578.772677 
 Sum of electronic and thermal Enthalpies=           -1578.771733 
 Sum of electronic and thermal Free Energies=        -1578.862234 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000000     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1579.36529703', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 315.67706313 kcal/mol 
H_corr: 372.46734564 kcal/mol 
S_corr: 56.7904194 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.19283935 kcal/mol 
S_rot: 10.8061486 kcal/mol 
S_vib: 32.7911333 kcal/mol 
----------------------------------------- 
	




#P Geom=AllCheck Guess=TCheck SCRF=Check GenChk RwB97XD/def2SVP Freq   
  
charge= 1    multiplicity= 1 
----------------------------------------- 





C    -1.666    -2.982    -1.218 
C    -2.949    -3.293    -0.796 
C    -3.775    -2.293    -0.282 
C    -3.367    -0.959    -0.178 
C    -2.063    -0.675    -0.631 
C    -1.215    -1.665    -1.134 
H    -4.774    -2.573     0.049 
H    -3.315    -4.320    -0.857 
H    -1.002    -3.758    -1.605 
O    -1.599     0.604    -0.560 
C     0.164    -1.299    -1.605 
C     1.697    -0.490     0.277 
B    -0.312     0.987    -0.918 
C     0.205     2.647    -0.003 
C    -0.458     2.743    -1.227 
F    -0.482     3.010     1.084 
C     1.682     2.954     0.193 
C     2.964    -1.000    -0.527 
O     3.095    -0.410    -1.609 
N     3.931    -1.837    -0.121 
C     3.910    -2.903     0.868 
H     2.963    -2.974     1.394 
H     4.715    -2.756     1.604 
H     4.083    -3.862     0.355 
C     5.125    -1.861    -0.966 
H     4.951    -2.444    -1.884 
H     5.943    -2.321    -0.399 
H     5.409    -0.842    -1.253 
N     0.779    -0.127    -0.879 
H     0.848    -2.153    -1.514 
H     0.147    -1.015    -2.669 
H     1.563     0.148    -1.528 
C     1.119    -1.131     1.561 
C     2.201    -0.914     2.651 
H     1.975    -1.528     3.534 
H     2.196     0.138     2.971 
H     3.227    -1.137     2.339 
C    -0.092    -0.323     2.061 
H    -0.326    -0.639     3.088 
H    -0.991    -0.495     1.465 
H     0.113     0.756     2.093 
C     0.672    -2.602     1.405 
H     2.077     0.477     0.623 
C    -4.287     0.137     0.389 
C    -5.642    -0.437     0.824 
H    -6.190    -0.891    -0.015 
H    -6.269     0.375     1.223 
H    -5.539    -1.190     1.620 
C    -4.558     1.198    -0.695 
H    -5.032     0.743    -1.579 
H    -3.638     1.699    -1.022 
H    -5.243     1.968    -0.306 
C    -3.641     0.793     1.625 
	
 Page 825 
H    -2.701     1.305     1.386 
H    -3.436     0.044     2.406 
H    -4.329     1.538     2.052 
F     2.422     2.416    -0.777 
F     1.871     4.266     0.179 
F     2.122     2.496     1.363 
C    -0.099     1.934    -2.339 
H    -0.398    -2.662     1.170 
H     0.825    -3.156     2.343 
H     1.198    -3.144     0.606 
H     0.949     1.873    -2.650 
H    -0.836     1.883    -3.142 
H    -1.516     3.015    -1.125 
YYY 
                      1                      2                      3 
                      A                      A                      A 
 Frequencies --   -323.1222                27.3176                49.0144 
 Red. masses --      9.0379                 3.6607                 5.2402 
 Zero-point correction=                           0.560580 (Hartree/Particle) 
 Thermal correction to Energy=                    0.591715 
 Thermal correction to Enthalpy=                  0.592659 
 Thermal correction to Gibbs Free Energy=         0.502110 
 Sum of electronic and zero-point Energies=          -1578.792225 
 Sum of electronic and thermal Energies=             -1578.761090 
 Sum of electronic and thermal Enthalpies=           -1578.760146 
 Sum of electronic and thermal Free Energies=        -1578.850695 
 
         Item               Value     Threshold  Converged? 
 Maximum Force            0.000001     0.000015     YES 
 RMS     Force            0.000000     0.000010     YES 
SCF: ['SCF', 'Done:', 'E(RwB97XD)', '=', '-1579.35280468', 'A.U.', 'after', '1', 'cycles'] 
MP2: no data 
Temperature: 298.15 
G_corr: 315.0790461 kcal/mol 
H_corr: 371.89944909 kcal/mol 
S_corr: 56.82053255 kcal/mol 
S_elec: 0.0 kcal/mol 
S_trans: 13.19283935 kcal/mol 
S_rot: 10.79303 kcal/mol 
S_vib: 32.83436505 kcal/mol 
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4.6.14 NMR Spectra  
(Appear on the following pages) 
	 	
	





































































1H NMR (CDCl3, 400 MHz) 
 
	


































































19 FNMR (CDCl3, 376 MHz) 
 
	
































































19 FNMR (CDCl3, 376 MHz) 
 
	

























































































































13C NMR (CDCl3, 100 MHz) 
 
	





























































































19F NMR (CDCl3, 376 MHz) 
 
	














































































































1H NMR (CDCl3, 400 MHz) 
 
	






































































































































13C NMR (CDCl3, 100 MHz) 
 
	






































































19F NMR (CDCl3, 376 MHz) 
 
	




























































































1H NMR (CDCl3, 400 MHz) 
 
	




























































































































13C NMR (CDCl3, 100 MHz) 
 
	


































































19F NMR (CDCl3, 100 MHz) 
 
	











































































































1H NMR (CDCl3, 400 MHz) 
 
	





































































































































13C NMR (CDCl3, 100 MHz) 
 
	







































































19F NMR (CDCl3, 376 MHz) 
 
	











































































































1H NMR (CDCl3, 400 MHz) 
 
	


















































































































13C NMR (CDCl3, 100 MHz) 
 
	





































































19F NMR (CDCl3, 376 MHz) 
 
	





































































































1H NMR (CDCl3, 400 MHz) 
 
	














































































































































13C NMR (CDCl3, 100 MHz) 
 
	







































































1F NMR (CDCl3, 376 MHz) 
 
	




















































































1H NMR (CDCl3, 400 MHz) 
 
	



































































































1H NMR (CDCl3, 400 MHz) 
 
	









































































19F NMR (CDCl3, 376 MHz) 
 
	



































































































































1H NMR (CDCl3, 400 MHz) 
 
	















































































































13C NMR (CDCl3, 100 MHz) 
 
	






































































19F NMR (CDCl3, 376 MHz) 
 
	


































































































1H NMR (CDCl3, 400 MHz) 
 
	














































































13C NMR (CDCl3, 150 MHz) 
 
	































































19F NMR (CDCl3, 376 MHz) 
 
	














































































































































1H NMR (CDCl3, 400 MHz) 
 
	



















































































































13C NMR (CDCl3, 100 MHz) 
 
	


















































































1F NMR (CDCl3, 376 MHz) 
 
	





































































































































1H NMR (CDCl3, 400 MHz) 
 
	



























































































































13C NMR (CDCl3, 100 MHz) 
 
	



































































19F NMR (CDCl3, 376 MHz) 
 
	






























































































































1H NMR (CDCl3, 400 MHz) 
 
	























































































13C NMR (CDCl3, 100 MHz) 
 
	




















































































19F NMR (CDCl3, 376 MHz) 
 
	



























































































































































1H NMR (CDCl3, 400 MHz) 
 
	














































































































13C NMR (CDCl3, 400 MHz) 
 
	


































































19F NMR (CDCl3, 376 MHz) 
 
	





























































































1H NMR (CDCl3, 400 MHz) 
 
	



















































































































13C NMR (CDCl3, 150 MHz) 
 
	




























































19F NMR (CDCl3, 376 MHz) 
 
	


























































































1H NMR (CDCl3, 400 MHz) 
 
	



















































































































13C NMR (CDCl3, 400 MHz) 
 
	













































19F NMR (CDCl3, 400 MHz) 
 
	




















































1H NMR (CDCl3, 400 MHz) 
 
	






















































































































































13C NMR (CDCl3, 100 MHz) 
 
	

















































































































































13F NMR (CDCl3, 376 MHz) 
 
	























































































































1H NMR (CDCl3, 500 MHz) 
 
	




















































































































13C NMR (CDCl3, 125 MHz) 
 
	

































































19F NMR (CDCl3, 470 MHz) 
 
	

























































































1H NMR (CDCl3, 500 MHz) 
 
	











































































13C NMR (CDCl3, 100 MHz) 
 
	


































































19F NMR (CDCl3, 100 MHz) 
 
	





































































































1H NMR (CDCl3, 500 MHz) 
 
	













































































































































13C NMR (CDCl3, 150 MHz) 
 
	






























































19F NMR (CDCl3, 376 MHz) 
 
	






































1H COSY (CDCl3, 500 MHz) 
 
	
































































































1H NMR (CDCl3, 500 MHz) 
 
	




































































































13C NMR (CDCl3, 100 MHz) 
 
	




























































19F NMR (CDCl3, 376 MHz) 
 
	








































1H COSY (CDCl3, 500 MHz) 
 
	

























































































































































1H NMR (CDCl3, 500 MHz) 
 
	






























































































































































13C NMR (CDCl3, 100 MHz) 
 
	


















































































19F NMR (CDCl3, 376 MHz) 
 
	









































1H COSY (CDCl3, 400 MHz) 
 
	























































1H NMR (CDCl3, 500 MHz) 
 
	






























































































































13C NMR (CDCl33, 150 MHz) 
 
	


























































19F NMR (CDCl3, 376 MHz) 
 
	



































































































































































































1H NMR (CDCl3, 500 MHz) 
 
	
























































































































































































































































13C NMR (CDCl33, 150 MHz) 
 
	










































































































































19F NMR (CDCl3, 376 MHz) 
 
	
























































































































1H NMR (CDCl3, 400 MHz) 
 
	










































































































































1H NMR (CDCl3, 400 MHz) 
 
	















































































1H NMR (CDCl3, 400 MHz) 
 
	











































13C NMR (CDCl3, 400 MHz) 
 
	





















































































19F NMR (CDCl3, 400 MHz) 
 
	























































































































































1H NMR (CDCl3, 400 MHz) 
 
	





















































13C NMR (CDCl3, 150 MHz) 
 
	
































































19F NMR (CDCl3, 150 MHz) 
 
	












































































































































1H NMR (CDCl3, 400 MHz) 
 
	





















































13C NMR (CDCl3, 100 MHz) 
 
	



































































19F NMR (CDCl3, 376 MHz) 
 
	










































































































1H NMR (CDCl3, 400 MHz) 
 
	




















































13C NMR (CDCl3, 100 MHz) 
 
	








































































































































1H NMR (CDCl3, 400 MHz) 
 
	






















































13C NMR (CDCl3, 100 MHz) 
 
	





















































19F NMR (CDCl3, 376 MHz) 
 
	


































































































1H NMR (CDCl3, 400 MHz) 
 
	























































































































13C NMR (CDCl3, 100 MHz) 
 
	















































































19F NMR (CDCl3, 376 MHz) 
 
	
























































































































1H NMR (CDCl3, 400 MHz) 
 
	
























































1H NMR (CDCl3, 400 MHz) 
 
	

































































9F NMR (CDCl3, 376 MHz) 
 
	























































































































1H NMR (CDCl3, 400 MHz) 
 
	





























































19F NMR (CDCl3, 376 MHz) 
 
	



















































































































































1H NMR (CDCl3, 400 MHz) 
 
	


















































































9F NMR (CDCl3, 376 MHz) 
 
	



























































1H NMR (CDCl3, 400 MHz) 
 
	



























































19F NMR (CDCl3, 376 MHz) 
 
	





























































1H NMR (CDCl3, 400 MHz) 
 
	





























































19F NMR (CDCl3, 376 MHz) 
 
